Citrus Sinensis ID: 039002

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------22
Protein Sequence
MDSEVGLLSHLEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI
Secondary Structure (PSIPRED)
ccccccccccHHHHHHHHcccccccccccccEEHHHHHHHHHccccccccccccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHHHHcccccccccEEEEEEcccEEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEccccccccccccccccEEEEEcccccccccc
Secondary Structure Prediction (SSPRO)
cccHHcHEHHcccEEccccccccccccccccEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEHEHEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEcccHHHEEEccccccHHcHccHEEEccccccccEEEEEccccccccc
Coil and Loop (DISEMBL)
MDSEVGLLSHLEVLHIQLnrldgsippevgKILYDEIVKATndfdakycigngghasvyraelpsreVVAVKkfhsplpsdqtvdQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSylhhdcfppivhrdvssknllldlEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI
Flexible Loop (DISEMBL)
MDSEVGLLSHLEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHsplpsdqtvdqkEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI
Low Complexity Region (SEG)
MDSEVGLLSHLEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI
Disordered region (IsUnstruct)
*****GLLSHLEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFH***********KEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVAL**
Disordered Region (DISOPRED)
*************************PPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFH**************LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI
Disordered Region (DISEMBL)
MDSEVGLLSHLEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI
Disordered Region (DISPRO)
****VGLLSHLEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVAL**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDSEVGLLSHLEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	219	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.849	0.177	0.560	1e-59
Q9LP24	1120	Probable leucine-rich rep	no	no	0.849	0.166	0.544	2e-59
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.876	0.174	0.427	2e-39
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.826	0.164	0.423	6e-38
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.821	0.144	0.414	2e-37
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.831	0.145	0.417	3e-37
O49318	1124	Probable leucine-rich rep	no	no	0.863	0.168	0.383	2e-34
C0LGV1	1135	LRR receptor-like serine/	no	no	0.762	0.147	0.405	4e-34
C0LGW6	966	LRR receptor-like serine/	no	no	0.812	0.184	0.360	1e-33
Q9SSL9	1123	Leucine-rich repeat recep	no	no	0.821	0.160	0.377	2e-33

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  229 bits (584), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 106/189 (56%), Positives = 141/189 (74%), Gaps = 3/189 (1%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD--QTVDQK 87
           GK+ Y EI+KAT +FD KY IG GGH  VY+A+LP+  ++AVKK +    S       ++
Sbjct: 761 GKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPN-AIMAVKKLNETTDSSISNPSTKQ 819

Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           EFL E++ALTE RHRN+VK +GFCSH R++FL+ E++ERGSL  +L  D  A++L W +R
Sbjct: 820 EFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKR 879

Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE 207
           ++V+KGVA ALSY+HHD  P IVHRD+SS N+LL  +YEA ++DFG AK LK D+SNW+ 
Sbjct: 880 INVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSA 939

Query: 208 FAGTYGYVA 216
            AGTYGYVA
Sbjct: 940 VAGTYGYVA 948

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  228 bits (582), Expect = 2e-59,   Method: Composition-based stats.
 Identities = 103/189 (54%), Positives = 142/189 (75%), Gaps = 3/189 (1%)

Query: 30   GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD--QTVDQK 87
            GK  Y +I+++TN+FD  + IG GG++ VYRA L    ++AVK+ H  +  +  + V ++
Sbjct: 837  GKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQ 895

Query: 88   EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
            EFL EVKALTE RHRN+VK +GFCSH RH+FL+ E++E+GSL  +L  D  A+ L W++R
Sbjct: 896  EFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKR 955

Query: 148  MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE 207
            ++V+KGVA ALSY+HHD   PIVHRD+SS N+LLD +Y A ++DFG AK LK+D+SNW+ 
Sbjct: 956  INVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSA 1015

Query: 208  FAGTYGYVA 216
             AGTYGYVA
Sbjct: 1016 VAGTYGYVA 1024

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  162 bits (409), Expect = 2e-39,   Method: Composition-based stats.
 Identities = 85/199 (42%), Positives = 121/199 (60%), Gaps = 7/199 (3%)

Query: 21  LDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLP- 79
           LD   PP+ G   + ++V AT++FD  + +G G   +VY+A LP+   +AVKK  S    
Sbjct: 782 LDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEG 840

Query: 80  -SDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA 138
            ++  VD   F  E+  L   RHRNIVK +GFC+H   + LL E++ +GSL  IL+  + 
Sbjct: 841 GNNNNVDN-SFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC 899

Query: 139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
              L WS+R  +  G A  L+YLHHDC P I HRD+ S N+LLD ++EAHV DFG+AK +
Sbjct: 900 --NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 957

Query: 199 KSDAS-NWTEFAGTYGYVA 216
               S + +  AG+YGY+A
Sbjct: 958 DMPHSKSMSAIAGSYGYIA 976

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  157 bits (397), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 78/184 (42%), Positives = 107/184 (58%), Gaps = 3/184 (1%)

Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
           Y  +V AT +F     +G G   +VY+AE+   EV+AVKK +S    +       F  E+
Sbjct: 789 YQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--GEGASSDNSFRAEI 846

Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
             L + RHRNIVK YGFC H   + LL E++ +GSL   L        L W+ R  +  G
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALG 906

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK-SDASNWTEFAGTY 212
            A+ L YLHHDC P IVHRD+ S N+LLD  ++AHV DFG+AK +  S + + +  AG+Y
Sbjct: 907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSY 966

Query: 213 GYVA 216
           GY+A
Sbjct: 967 GYIA 970

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  155 bits (391), Expect = 2e-37,   Method: Composition-based stats.
 Identities = 82/198 (41%), Positives = 118/198 (59%), Gaps = 18/198 (9%)

Query: 32   ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
            I +++I++AT++   ++ IG+GG   VY+AEL + E VAVKK    L  D  +  K F  
Sbjct: 939  IRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI---LWKDDLMSNKSFSR 995

Query: 92   EVKALTETRHRNIVKFYGFCSHARH--SFLLCEFLERGSLAAILNTDAAAQE-----LGW 144
            EVK L   RHR++VK  G+CS      + L+ E+++ GS+   L+ D    E     L W
Sbjct: 996  EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055

Query: 145  SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL------ 198
              R+ +  G+A  + YLHHDC PPIVHRD+ S N+LLD   EAH+ DFG+AK L      
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115

Query: 199  KSDASNWTEFAGTYGYVA 216
             +D++ W  FA +YGY+A
Sbjct: 1116 NTDSNTW--FACSYGYIA 1131

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  155 bits (391), Expect = 3e-37,   Method: Composition-based stats.
 Identities = 81/194 (41%), Positives = 118/194 (60%), Gaps = 12/194 (6%)

Query: 32   ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
            I +D+I++AT+  + ++ IG+GG   VY+AEL + E +AVKK    L  D  +  K F  
Sbjct: 936  IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI---LWKDDLMSNKSFNR 992

Query: 92   EVKALTETRHRNIVKFYGFCSHARH--SFLLCEFLERGSLAAILNTDAAAQE---LGWSQ 146
            EVK L   RHR++VK  G+CS      + L+ E++  GS+   L+ +   ++   LGW  
Sbjct: 993  EVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWET 1052

Query: 147  RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
            R+ +  G+A  + YLH+DC PPIVHRD+ S N+LLD   EAH+ DFG+AK L  +    T
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNT 1112

Query: 207  E----FAGTYGYVA 216
            E    FAG+YGY+A
Sbjct: 1113 ESNTMFAGSYGYIA 1126

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  145 bits (366), Expect = 2e-34,   Method: Composition-based stats.
 Identities = 76/198 (38%), Positives = 114/198 (57%), Gaps = 9/198 (4%)

Query: 25  IPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV 84
           +P E  +    +I++AT  F   Y +G G   +VY+A +PS + +AVKK  S    +   
Sbjct: 802 VPKE--RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNN 859

Query: 85  DQKE---FLTEVKALTETRHRNIVKFYGFCSH--ARHSFLLCEFLERGSLAAILNTDAAA 139
                  F  E+  L + RHRNIV+ Y FC H  +  + LL E++ RGSL  +L+    +
Sbjct: 860 SNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLH-GGKS 918

Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
             + W  R ++  G A+ L+YLHHDC P I+HRD+ S N+L+D  +EAHV DFG+AK + 
Sbjct: 919 HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID 978

Query: 200 SDAS-NWTEFAGTYGYVA 216
              S + +  AG+YGY+A
Sbjct: 979 MPLSKSVSAVAGSYGYIA 996

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  144 bits (363), Expect = 4e-34,   Method: Composition-based stats.
 Identities = 71/175 (40%), Positives = 105/175 (60%), Gaps = 8/175 (4%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHS---PLPSDQTVD---QKEFLTEVKALTETRHRN 103
           IG G    VY+AE+P+REV+AVKK      P  +++T     +  F  EVK L   RH+N
Sbjct: 791 IGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKN 850

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           IV+F G C +     L+ +++  GSL ++L+  +    LGW  R  +I G A  L+YLHH
Sbjct: 851 IVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHH 910

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD--ASNWTEFAGTYGYVA 216
           DC PPIVHRD+ + N+L+  ++E ++ DFG+AK +     A +    AG+YGY+A
Sbjct: 911 DCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIA 965

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1

 Score =  143 bits (360), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 66/183 (36%), Positives = 111/183 (60%), Gaps = 5/183 (2%)

Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
           +D+I++ T + + K+ IG G  ++VY+  L S   +A+K+ ++  P +     +EF TE+
Sbjct: 638 FDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNL----REFETEL 693

Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
           + +   RHRNIV  +G+      + L  +++E GSL  +L+      +L W  R+ +  G
Sbjct: 694 ETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVG 753

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA-GTY 212
            A  L+YLHHDC P I+HRD+ S N+LLD  +EAH++DFGIAK + +  ++ + +  GT 
Sbjct: 754 AAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTI 813

Query: 213 GYV 215
           GY+
Sbjct: 814 GYI 816

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1

 Score =  142 bits (357), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 113/188 (60%), Gaps = 8/188 (4%)

Query: 32  ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKK--FHSPLPSDQTVDQKEF 89
           +L ++++ AT++ + KY IG G H  VYRA L S +V AVK+  F S + ++Q++     
Sbjct: 815 LLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASHIRANQSM----- 869

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-LGWSQRM 148
           + E+  + + RHRN++K  GF        +L  ++ +GSL  +L+  +  +  L WS R 
Sbjct: 870 MREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARY 929

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
           +V  GVA  L+YLH+DC PPIVHRD+  +N+L+D + E H+ DFG+A+ L     +    
Sbjct: 930 NVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVSTATV 989

Query: 209 AGTYGYVA 216
            GT GY+A
Sbjct: 990 TGTTGYIA 997

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	219
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.844	0.179	0.636	7e-69
359491509	1032	PREDICTED: probable LRR receptor-like se	0.844	0.179	0.631	2e-68
359484860	972	PREDICTED: probable LRR receptor-like se	0.849	0.191	0.609	6e-67
225456159	1038	PREDICTED: probable LRR receptor-like se	0.835	0.176	0.632	7e-67
147772402	996	hypothetical protein VITISV_022117 [Viti	0.835	0.183	0.627	8e-67
359484862	991	PREDICTED: probable LRR receptor-like se	0.849	0.187	0.604	1e-66
297743682	466	unnamed protein product [Vitis vinifera]	0.849	0.399	0.604	6e-66
359484864	1091	PREDICTED: probable LRR receptor-like se	0.849	0.170	0.595	7e-65
356574018	961	PREDICTED: probable LRR receptor-like se	0.849	0.193	0.598	7e-65
225456161	1037	PREDICTED: probable LRR receptor-like se	0.835	0.176	0.617	8e-65

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  265 bits (678), Expect = 7e-69,   Method: Composition-based stats.
 Identities = 119/187 (63%), Positives = 146/187 (78%), Gaps = 2/187 (1%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           G+  Y+ I++AT DFD  YCIG GGH SVY+AELPS  +VAVKK H          QK+F
Sbjct: 748 GRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRF--DIDMAHQKDF 805

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           + E++ALTE +HRNIVK  GFCSH+RHSFL+ E+LERGSL  IL+ +  A+E+GW  R++
Sbjct: 806 MNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVN 865

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           +IKGVA ALSYLHHDC PPIVHRD+SS N+LLD +YEAHV+DFG AKFLK D+SNW+  A
Sbjct: 866 IIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLA 925

Query: 210 GTYGYVA 216
           GTYGYVA
Sbjct: 926 GTYGYVA 932

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  264 bits (674), Expect = 2e-68,   Method: Composition-based stats.
 Identities = 118/187 (63%), Positives = 146/187 (78%), Gaps = 2/187 (1%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           G+  Y+ I++AT DFD  YCIG GGH SVY+AELPS  +VAVKK H          QK+F
Sbjct: 748 GRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRF--DIDMAHQKDF 805

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           + E++ALTE +HRNIVK  GFCSH+RHSFL+ E+LERGSL  IL+ +  A+E+GW  R++
Sbjct: 806 VNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVN 865

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           +IKGV+ ALSYLHHDC PPIVHRD+SS N+LLD +YEAHV+DFG AKFLK D+SNW+  A
Sbjct: 866 IIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLA 925

Query: 210 GTYGYVA 216
           GTYGYVA
Sbjct: 926 GTYGYVA 932

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484860|ref|XP_002274434.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  259 bits (661), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 114/187 (60%), Positives = 147/187 (78%), Gaps = 1/187 (0%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           G++LY++I+K T +F++KYCIG GG+ +VY+AELP+  VVAVKK H P       D K F
Sbjct: 647 GEMLYEDIIKVTKEFNSKYCIGGGGYGTVYKAELPTGRVVAVKKLH-PQQDGGMADLKAF 705

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
             E++ALTE RHRNIVK YGFCSHA H+FL+ EF+E+GSL  IL+ +  A EL WS R++
Sbjct: 706 TAEIRALTEMRHRNIVKLYGFCSHAEHTFLIYEFMEKGSLRHILSNEEEALELDWSMRLN 765

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           ++KGVA+ALSY+HHDC PPI+HRD+SS N+LLD EYE HV+DFG A+ LK D+SNWT FA
Sbjct: 766 IVKGVAEALSYMHHDCSPPIIHRDISSSNVLLDSEYEGHVSDFGTARLLKPDSSNWTSFA 825

Query: 210 GTYGYVA 216
           GT+GY A
Sbjct: 826 GTFGYTA 832

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  259 bits (661), Expect = 7e-67,   Method: Compositional matrix adjust.
 Identities = 119/188 (63%), Positives = 151/188 (80%), Gaps = 5/188 (2%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD-QTVDQKE 88
           G+ +Y+EI+KAT DFD  YCIG GGH SVY+AELPS  +VAVKK H   PSD +  +QK+
Sbjct: 755 GRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH---PSDTEMANQKD 811

Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           FL E++ALTE +HRNIVK  GFCSH RH FL+ E+LERGSLA IL+ + A ++LGW+ R+
Sbjct: 812 FLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEA-KKLGWATRV 870

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
           ++IKGVA AL+Y+HHDC PPIVHRDVSS N+LLD +YEAH++DFG AK LK D+SN +  
Sbjct: 871 NIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSIL 930

Query: 209 AGTYGYVA 216
           AGT+GY+A
Sbjct: 931 AGTFGYLA 938

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  258 bits (660), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 118/188 (62%), Positives = 151/188 (80%), Gaps = 5/188 (2%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD-QTVDQKE 88
           G+ +Y+EI+KAT DFD  YCIG GGH SVY+AELPS  +VAVKK H   PSD +  +QK+
Sbjct: 713 GRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH---PSDTEMANQKD 769

Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           FL E++ALTE +HRNIVK  GFCSH RH FL+ E+LERGSLA IL+ + A ++LGW+ R+
Sbjct: 770 FLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEA-KKLGWATRV 828

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
           ++IKGVA AL+Y+HHDC PPIVHRD+SS N+LLD +YEAH++DFG AK LK D+SN +  
Sbjct: 829 NIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSIL 888

Query: 209 AGTYGYVA 216
           AGT+GY+A
Sbjct: 889 AGTFGYLA 896

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484862|ref|XP_002274094.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  258 bits (659), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 113/187 (60%), Positives = 147/187 (78%), Gaps = 1/187 (0%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           G++LY++I+K T +F++KYCIG GG+ +VY+AELP+  VVAVKK H P       D K F
Sbjct: 665 GEMLYEDIIKVTEEFNSKYCIGGGGYGTVYKAELPTGRVVAVKKLH-PQQDGGMADLKAF 723

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
             E++ALTE RHRNIVK YGFCSHA H+FL+ EF+E+GSL  +L+ +  A EL WS R++
Sbjct: 724 TAEIRALTEMRHRNIVKLYGFCSHAEHTFLIYEFMEKGSLRHVLSNEEEALELDWSMRLN 783

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           ++KGVA+ALSY+HHDC PPI+HRD+SS N+LLD EYE HV+DFG A+ LK D+SNWT FA
Sbjct: 784 IVKGVAEALSYMHHDCSPPIIHRDISSSNVLLDSEYEGHVSDFGTARLLKPDSSNWTSFA 843

Query: 210 GTYGYVA 216
           GT+GY A
Sbjct: 844 GTFGYTA 850

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297743682|emb|CBI36565.3| unnamed protein product [Vitis vinifera]

 Score =  256 bits (653), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 113/187 (60%), Positives = 147/187 (78%), Gaps = 1/187 (0%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           G++LY++I+K T +F++KYCIG GG+ +VY+AELP+  VVAVKK H P       D K F
Sbjct: 115 GEMLYEDIIKVTEEFNSKYCIGGGGYGTVYKAELPTGRVVAVKKLH-PQQDGGMADLKAF 173

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
             E++ALTE RHRNIVK YGFCSHA H+FL+ EF+E+GSL  +L+ +  A EL WS R++
Sbjct: 174 TAEIRALTEMRHRNIVKLYGFCSHAEHTFLIYEFMEKGSLRHVLSNEEEALELDWSMRLN 233

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           ++KGVA+ALSY+HHDC PPI+HRD+SS N+LLD EYE HV+DFG A+ LK D+SNWT FA
Sbjct: 234 IVKGVAEALSYMHHDCSPPIIHRDISSSNVLLDSEYEGHVSDFGTARLLKPDSSNWTSFA 293

Query: 210 GTYGYVA 216
           GT+GY A
Sbjct: 294 GTFGYTA 300

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484864|ref|XP_002273966.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  252 bits (644), Expect = 7e-65,   Method: Composition-based stats.
 Identities = 112/188 (59%), Positives = 148/188 (78%), Gaps = 2/188 (1%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           G ILY +I++ T +F++KYCIG+GG  +VY+AELP+  VVAVKK H P   + +   K F
Sbjct: 780 GGILYQDIIEVTEEFNSKYCIGSGGQGTVYKAELPTGRVVAVKKLHPPQDGEMS-SLKAF 838

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
            +E++ALTE RHRNIVKFYG+CSHARHSFL+ + +E+GSL  IL+ +  A  L W +R++
Sbjct: 839 TSEIRALTEIRHRNIVKFYGYCSHARHSFLVYKLMEKGSLRNILSNEEEAIGLDWIRRLN 898

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD-ASNWTEF 208
           ++KGVA+ALSY+HHDC PPI+HRD+SS N+LLD EYEAHV+DFG A+ LK D +SNWT F
Sbjct: 899 IVKGVAEALSYMHHDCSPPIIHRDISSNNVLLDSEYEAHVSDFGTARLLKPDSSSNWTSF 958

Query: 209 AGTYGYVA 216
           AGT+GY A
Sbjct: 959 AGTFGYSA 966

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574018|ref|XP_003555150.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  252 bits (644), Expect = 7e-65,   Method: Composition-based stats.
 Identities = 112/187 (59%), Positives = 146/187 (78%), Gaps = 1/187 (0%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           GK++++ I++AT  FD KY IG GG   VY+A LP+ EVVAVKK HS +P+ + ++QK F
Sbjct: 654 GKMMFENIIEATEYFDDKYLIGVGGQGRVYKAMLPTGEVVAVKKLHS-IPNGEMLNQKAF 712

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
            +E++ALTE RHRNIVK +GFCSH+++SFL+CEFLE G +  IL  D  A    W++R+ 
Sbjct: 713 TSEIQALTEIRHRNIVKLHGFCSHSQYSFLVCEFLEMGDVKKILKDDEQAIAFDWNKRVD 772

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           V+KGVA+AL Y+HHDC PPIVHRD+SSKN+LLD +Y AHV+DFG AKFL  D+SNWT FA
Sbjct: 773 VVKGVANALCYMHHDCSPPIVHRDISSKNVLLDSDYVAHVSDFGTAKFLNPDSSNWTSFA 832

Query: 210 GTYGYVA 216
           GT+GY A
Sbjct: 833 GTFGYAA 839

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  252 bits (643), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 116/188 (61%), Positives = 150/188 (79%), Gaps = 5/188 (2%)

Query: 30  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV-DQKE 88
           G+ +Y+EI+KAT DFD  YCIG GGH SVY+AELPS  +VAVKK H   PSD  + +QK+
Sbjct: 755 GRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLH---PSDMDMANQKD 811

Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           FL +V+A+TE +HRNIV+  GFCS+ RHSFL+ E+LERGSLA IL+ + A ++LGW+ R+
Sbjct: 812 FLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSREEA-KKLGWATRV 870

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
            +IKGVA ALSY+HHDC PPIVHRD+SS N+LLD +YEAH+++ G AK LK D+SN ++ 
Sbjct: 871 KIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKL 930

Query: 209 AGTYGYVA 216
           AGT GYVA
Sbjct: 931 AGTVGYVA 938

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	219
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.849	0.177	0.560	1.2e-60
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.849	0.166	0.544	1.4e-57
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.876	0.174	0.427	5.8e-42
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.881	0.175	0.411	1e-39
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.831	0.145	0.427	1.8e-38
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.863	0.168	0.383	7.2e-38
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.821	0.144	0.414	1e-37
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.812	0.184	0.360	1.3e-36
TAIR|locus:2032697	1123	PEPR1 "PEP1 receptor 1" [Arabi	0.821	0.160	0.377	7.8e-36
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.831	0.140	0.385	1.2e-35

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 571 (206.1 bits), Expect = 1.2e-60, Sum P(2) = 1.2e-60
 Identities = 106/189 (56%), Positives = 141/189 (74%)

Query:    30 GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD--QTVDQK 87
             GK+ Y EI+KAT +FD KY IG GGH  VY+A+LP+  ++AVKK +    S       ++
Sbjct:   761 GKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQ 819

Query:    88 EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
             EFL E++ALTE RHRN+VK +GFCSH R++FL+ E++ERGSL  +L  D  A++L W +R
Sbjct:   820 EFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKR 879

Query:   148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE 207
             ++V+KGVA ALSY+HHD  P IVHRD+SS N+LL  +YEA ++DFG AK LK D+SNW+ 
Sbjct:   880 INVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSA 939

Query:   208 FAGTYGYVA 216
              AGTYGYVA
Sbjct:   940 VAGTYGYVA 948

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 563 (203.2 bits), Expect = 1.4e-57, Sum P(2) = 1.4e-57
 Identities = 103/189 (54%), Positives = 142/189 (75%)

Query:    30 GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD--QTVDQK 87
             GK  Y +I+++TN+FD  + IG GG++ VYRA L    ++AVK+ H  +  +  + V ++
Sbjct:   837 GKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDT-IIAVKRLHDTIDEEISKPVVKQ 895

Query:    88 EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
             EFL EVKALTE RHRN+VK +GFCSH RH+FL+ E++E+GSL  +L  D  A+ L W++R
Sbjct:   896 EFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKR 955

Query:   148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE 207
             ++V+KGVA ALSY+HHD   PIVHRD+SS N+LLD +Y A ++DFG AK LK+D+SNW+ 
Sbjct:   956 INVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSA 1015

Query:   208 FAGTYGYVA 216
              AGTYGYVA
Sbjct:  1016 VAGTYGYVA 1024

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 407 (148.3 bits), Expect = 5.8e-42, Sum P(2) = 5.8e-42
 Identities = 85/199 (42%), Positives = 121/199 (60%)

Query:    21 LDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLP- 79
             LD   PP+ G   + ++V AT++FD  + +G G   +VY+A LP+   +AVKK  S    
Sbjct:   782 LDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEG 840

Query:    80 -SDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA 138
              ++  VD   F  E+  L   RHRNIVK +GFC+H   + LL E++ +GSL  IL+  + 
Sbjct:   841 GNNNNVDNS-FRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC 899

Query:   139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
                L WS+R  +  G A  L+YLHHDC P I HRD+ S N+LLD ++EAHV DFG+AK +
Sbjct:   900 --NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 957

Query:   199 KSDAS-NWTEFAGTYGYVA 216
                 S + +  AG+YGY+A
Sbjct:   958 DMPHSKSMSAIAGSYGYIA 976

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 393 (143.4 bits), Expect = 1.0e-39, Sum P(2) = 1.0e-39
 Identities = 81/197 (41%), Positives = 112/197 (56%)

Query:    21 LDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPS 80
             +D    P+ G   Y  +V AT +F     +G G   +VY+AE+   EV+AVKK +S    
Sbjct:   777 MDSYYFPKKG-FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--G 833

Query:    81 DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ 140
             +       F  E+  L + RHRNIVK YGFC H   + LL E++ +GSL   L       
Sbjct:   834 EGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNC 893

Query:   141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK- 199
              L W+ R  +  G A+ L YLHHDC P IVHRD+ S N+LLD  ++AHV DFG+AK +  
Sbjct:   894 LLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDL 953

Query:   200 SDASNWTEFAGTYGYVA 216
             S + + +  AG+YGY+A
Sbjct:   954 SYSKSMSAVAGSYGYIA 970

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 385 (140.6 bits), Expect = 1.8e-38, Sum P(2) = 1.8e-38
 Identities = 83/194 (42%), Positives = 118/194 (60%)

Query:    32 ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
             I +D+I++AT+  + ++ IG+GG   VY+AEL + E +AVKK    L  D  +  K F  
Sbjct:   936 IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI---LWKDDLMSNKSFNR 992

Query:    92 EVKALTETRHRNIVKFYGFCSHARH--SFLLCEFLERGSLAAIL--NTDAAAQE-LGWSQ 146
             EVK L   RHR++VK  G+CS      + L+ E++  GS+   L  N +   +E LGW  
Sbjct:   993 EVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWET 1052

Query:   147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
             R+ +  G+A  + YLH+DC PPIVHRD+ S N+LLD   EAH+ DFG+AK L  +    T
Sbjct:  1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNT 1112

Query:   207 E----FAGTYGYVA 216
             E    FAG+YGY+A
Sbjct:  1113 ESNTMFAGSYGYIA 1126

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 374 (136.7 bits), Expect = 7.2e-38, Sum P(2) = 7.2e-38
 Identities = 76/198 (38%), Positives = 114/198 (57%)

Query:    25 IPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV 84
             +P E  +    +I++AT  F   Y +G G   +VY+A +PS + +AVKK  S    +   
Sbjct:   802 VPKE--RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNN 859

Query:    85 DQK---EFLTEVKALTETRHRNIVKFYGFCSH--ARHSFLLCEFLERGSLAAILNTDAAA 139
                    F  E+  L + RHRNIV+ Y FC H  +  + LL E++ RGSL  +L+    +
Sbjct:   860 SNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLH-GGKS 918

Query:   140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
               + W  R ++  G A+ L+YLHHDC P I+HRD+ S N+L+D  +EAHV DFG+AK + 
Sbjct:   919 HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID 978

Query:   200 SDAS-NWTEFAGTYGYVA 216
                S + +  AG+YGY+A
Sbjct:   979 MPLSKSVSAVAGSYGYIA 996

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 380 (138.8 bits), Expect = 1.0e-37, Sum P(2) = 1.0e-37
 Identities = 82/198 (41%), Positives = 118/198 (59%)

Query:    32 ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
             I +++I++AT++   ++ IG+GG   VY+AEL + E VAVKK    L  D  +  K F  
Sbjct:   939 IRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI---LWKDDLMSNKSFSR 995

Query:    92 EVKALTETRHRNIVKFYGFCSHARH--SFLLCEFLERGSLAAILNTDAAAQE-----LGW 144
             EVK L   RHR++VK  G+CS      + L+ E+++ GS+   L+ D    E     L W
Sbjct:   996 EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055

Query:   145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL------ 198
               R+ +  G+A  + YLHHDC PPIVHRD+ S N+LLD   EAH+ DFG+AK L      
Sbjct:  1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115

Query:   199 KSDASNWTEFAGTYGYVA 216
              +D++ W  FA +YGY+A
Sbjct:  1116 NTDSNTW--FACSYGYIA 1131

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 355 (130.0 bits), Expect = 1.3e-36, Sum P(2) = 1.3e-36
 Identities = 66/183 (36%), Positives = 111/183 (60%)

Query:    34 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
             +D+I++ T + + K+ IG G  ++VY+  L S   +A+K+ ++  P +     +EF TE+
Sbjct:   638 FDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNL----REFETEL 693

Query:    94 KALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
             + +   RHRNIV  +G+      + L  +++E GSL  +L+      +L W  R+ +  G
Sbjct:   694 ETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVG 753

Query:   154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA-GTY 212
              A  L+YLHHDC P I+HRD+ S N+LLD  +EAH++DFGIAK + +  ++ + +  GT 
Sbjct:   754 AAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTI 813

Query:   213 GYV 215
             GY+
Sbjct:   814 GYI 816

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 351 (128.6 bits), Expect = 7.8e-36, Sum P(2) = 7.8e-36
 Identities = 71/188 (37%), Positives = 113/188 (60%)

Query:    32 ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKK--FHSPLPSDQTVDQKEF 89
             +L ++++ AT++ + KY IG G H  VYRA L S +V AVK+  F S + ++Q++     
Sbjct:   815 LLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASHIRANQSM----- 869

Query:    90 LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-LGWSQRM 148
             + E+  + + RHRN++K  GF        +L  ++ +GSL  +L+  +  +  L WS R 
Sbjct:   870 MREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARY 929

Query:   149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
             +V  GVA  L+YLH+DC PPIVHRD+  +N+L+D + E H+ DFG+A+ L     +    
Sbjct:   930 NVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVSTATV 989

Query:   209 AGTYGYVA 216
              GT GY+A
Sbjct:   990 TGTTGYIA 997

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045087 "innate immune response" evidence=TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006955 "immune response" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 360 (131.8 bits), Expect = 1.2e-35, Sum P(2) = 1.2e-35
 Identities = 72/187 (38%), Positives = 112/187 (59%)

Query:    31 KILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFL 90
             ++  D+I+KAT +F   + IG+GG  +VY+A LP    VA+K+ H      Q    +EFL
Sbjct:   989 RVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHG---GHQFQGDREFL 1045

Query:    91 TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-LGWSQRMS 149
              E++ + + +H N+V   G+C      FL+ E++E GSL   L   A A E LGW  R+ 
Sbjct:  1046 AEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLK 1105

Query:   150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW-TEF 208
             +  G A  L++LHH   P I+HRD+ S N+LLD  +E  V+DFG+A+ + +  ++  T+ 
Sbjct:  1106 ICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDI 1165

Query:   209 AGTYGYV 215
             AGT+GY+
Sbjct:  1166 AGTFGYI 1172

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00017829001 SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (399 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	219
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-28
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-23
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-20
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-12
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-12
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-09
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-05
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-05
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-05
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-05
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-04
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	0.001
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	0.001
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.001
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	0.001
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	0.001
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	0.002
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.002
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.002
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.002
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	0.002
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.002
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.003
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.003
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.003
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.003
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	0.004
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.004
pfam13526	181	pfam13526, DUF4125, Protein of unknown function (D	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  120 bits (304), Expect = 5e-34
 Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 10/169 (5%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G GG  +VY A    + + VA+K        D +   +E L E++ L +  H NIVK Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIK---KEDSSSLLEELLREIEILKKLNHPNIVKLY 57

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G      H +L+ E+ E GSL  +L  +    +L   + + ++  + + L YLH +    
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---G 112

Query: 169 IVHRDVSSKNLLLD-LEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           I+HRD+  +N+LLD    +  +ADFG++K L SD S      GT  Y+A
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMA 161

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  116 bits (294), Expect = 4e-32
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 9/169 (5%)

Query: 49  CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
            +G+G   +VY+A    + ++VAVK       S+++   +    E++ L    H NIV+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKIL--KKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
                   H +L+ E+ E G L   L+       L   +   +   +   L YLH +   
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            I+HRD+  +N+LLD      +ADFG+AK L   +S+ T F GT  Y+A
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  106 bits (267), Expect = 3e-28
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 12/157 (7%)

Query: 50  IGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G    VY+  L          VAVK         Q    +EFL E + + +  H NI
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ---IEEFLREARIMRKLDHPNI 63

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G C+      ++ E++  G L   L      +EL  S  +S    +A  + YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                +HRD++++N L+       ++DFG+++ L  D
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  106 bits (266), Expect = 5e-28
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 11/168 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G    VY A +  + ++VA+K            D++  L E+K L + +H NIV+ Y
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIK---KKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +L+ E+ E G L  +L       E    +    ++ +  AL YLH      
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG--- 117

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           IVHRD+  +N+LLD +    +ADFG+A+ L       T F GT  Y+A
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMA 164

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  103 bits (260), Expect = 3e-27
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G    VY+ +L       +  VAVK         Q    +EFL E + + +  H N+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ---IEEFLREARIMRKLDHPNV 63

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G C+     +++ E++E G L + L       +L  S  +S    +A  + YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                +HRD++++N L+       ++DFG+++ L  D
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  103 bits (259), Expect = 4e-27
 Identities = 55/177 (31%), Positives = 86/177 (48%), Gaps = 15/177 (8%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            F+    IG GG   VY+A    + + VA+K     L S +   +++ + E++ L + +H
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKE--KKEKIINEIQILKKCKH 56

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NIVK+YG        +++ EF   GSL  +L   +  Q L  SQ   V K +   L YL
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYL 114

Query: 162 H--HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H        I+HRD+ + N+LL  + E  + DFG++  L SD        GT  ++A
Sbjct: 115 HSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMA 165

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 99.1 bits (248), Expect = 3e-25
 Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 15/158 (9%)

Query: 50  IGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G    VY+  L      +   VAVK            +++EFL E   + +  H NI
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-H 163
           V+  G C+     +++ E++  G L   L      ++L     + +   +A  + YL   
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +     VHRD++++N L+       ++DFG+++ +  D
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYED 155

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 94.9 bits (237), Expect = 1e-23
 Identities = 38/162 (23%), Positives = 72/162 (44%), Gaps = 16/162 (9%)

Query: 50  IGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G    VY+ +L         VAVK   +        ++K+FL E + + +  H N+V
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 106 KFYGFCSHARHSFLLCEFLERGSL------AAILNTDAAAQELGWSQRMSVIKGVADALS 159
           +  G C+     +L+ E++E G L      +  +        L     +S    +A  + 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           YL        VHRD++++N L+  +    ++DFG+++ +  D
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 93.8 bits (234), Expect = 3e-23
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 23/173 (13%)

Query: 49  CIGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
            +G G   SVY A      E++AVK     L  D   + +    E++ L+  +H NIV++
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 108 YGFCSHARHSFL--LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA----DALSYL 161
           YG       + L    E++  GSL+++L       E        VI+       + L+YL
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYL 117

Query: 162 H-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE--FAGT 211
           H +     IVHRD+   N+L+D +    +ADFG AK L    +        GT
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 93.4 bits (233), Expect = 4e-23
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 15/177 (8%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +D +    +G G    VY+    P+ ++ A+KK H          +K+ L E+K L    
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD---GDEEFRKQLLRELKTLRSCE 57

Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGVADA 157
              +VK YG F      S +L E+++ GSLA     D   +     + +   + + +   
Sbjct: 58  SPYVVKCYGAFYKEGEISIVL-EYMDGGSLA-----DLLKKVGKIPEPVLAYIARQILKG 111

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
           L YLH      I+HRD+   NLL++ + E  +ADFGI+K L++       F GT  Y
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY 166

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 89.8 bits (223), Expect = 8e-22
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 8/152 (5%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    V+     +R  VA+K     L SD  + Q++F  EV+AL   RH++++  + 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKI----LKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            CS     +++ E +E+GSL A L      Q L  +  + +   VA+ ++YL        
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N+L+  +    VADFG+A+ +K D
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKED 157

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.3 bits (217), Expect = 2e-20
 Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 14/175 (8%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKFY 108
           +G G    VY A    R++VA+K     L S    + + FL E++ L    H  NIVK Y
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSK-EVERFLREIQILASLNHPPNIVKLY 64

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
            F       +L+ E+++ GSL  +L        L  S+ + ++  +  AL YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 169 IVHRDVSSKNLLLDLEY-EAHVADFGIAKFLKSDASN------WTEFAGTYGYVA 216
           I+HRD+  +N+LLD +     + DFG+AK L    S        +   GT GY+A
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 2e-20
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 9/164 (5%)

Query: 49  CIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
            IG G    VY+   L + + VA+K+    L   +    K  + E+  L   +H NIVK+
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
            G    +   +++ E+ E GSL  I+       E   S     +  V   L+YLH     
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SLVAVYVYQVLQGLAYLHEQ--- 118

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
            ++HRD+ + N+L   +    +ADFG+A  L   + +     GT
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 4e-19
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 14/166 (8%)

Query: 50  IGNGGHASVYRA--ELPSREV--VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    V R   +LP ++   VA+K   +     Q +D   FLTE   + +  H NI+
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPNII 68

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           +  G  + +R   ++ E++E GSL   L   D    +    Q + +++G+A  + YL   
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
            +   VHRD++++N+L++      V+DFG+++ L+   + +T   G
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG 168

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 5e-18
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 11/169 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  VY+A +  + E+VA+KK    L  +     K  L E+K L E  H NI+K  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFP 167
               H    +L+ EF++   L  ++      + L  S   S +  +   L++ H H    
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL- 120

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              HRD+  +NLL++ E    +ADFG+A+   S    +T +  T  Y A
Sbjct: 121 ---HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 1e-17
 Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 10/155 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            +      IG G    V   +   ++V AVK     L  D T  Q  FL E   +T  RH
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYRGQKV-AVKC----LKDDSTAAQA-FLAEASVMTTLRH 59

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            N+V+  G        +++ E++ +GSL   L +   A  +  +Q++     V + + YL
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYL 118

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               F   VHRD++++N+L+  +  A V+DFG+AK
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 77.6 bits (191), Expect = 3e-17
 Identities = 51/161 (31%), Positives = 88/161 (54%), Gaps = 12/161 (7%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT-----EVKALTETRHRN 103
           IG+G   SVY      S E++AVK+   P  S  + D+K  +      E+  L E +H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           IV++ G    A H  +  E++  GS+AA+LN   A +E   +   + ++ +   L+YLH+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
                I+HRD+   N+L+D +    ++DFGI+K L++++ +
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 78.0 bits (193), Expect = 3e-17
 Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)

Query: 31  KILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           + LY  + K          IG G    VY+A +  + + VA+KK    L       ++  
Sbjct: 18  RELYKNLEK----------IGEGASGEVYKATDRATGKEVAIKKMR--LRKQN---KELI 62

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRM 148
           + E+  + + +H NIV +Y         +++ E+++ GSL  I+        E    Q  
Sbjct: 63  INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE---PQIA 119

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
            V + V   L YLH      ++HRD+ S N+LL  +    +ADFG A  L  + S     
Sbjct: 120 YVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176

Query: 209 AGT 211
            GT
Sbjct: 177 VGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 8e-17
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 14/166 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVD-QKE--FLTEVKALTETRHRNIV 105
           IG G + +VYR   +P+  VVA+K  +   P D   D Q+E   L++++   +++  NI 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR---QSQPPNIT 65

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           K+YG        +++ E+ E GS+  ++     A  +       +I+ V  AL Y+H   
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKV- 120

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
              ++HRD+ + N+L+       + DFG+A  L  ++S  + F GT
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 75.8 bits (187), Expect = 1e-16
 Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 10/168 (5%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G    V +    P+ +++AVK     L  ++ + QK+ L E+  L +     IV FY
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAI-QKQILRELDILHKCNSPYIVGFY 65

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G   +     +  E+++ GSL  IL        +       +   V   L+YLH      
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           I+HRDV   N+L++   +  + DFG++  L +  +    F GT  Y+A
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMA 167

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 76.3 bits (188), Expect = 1e-16
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G    V+  E         +E+VAVK       +D    +K+F  E + LT  +H N
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFEREAELLTNFQHEN 69

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAIL-----------NTDAAAQELGWSQRMSVIK 152
           IVKFYG C+      ++ E++E G L   L           + D+   EL  SQ + +  
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +A  + YL    F   VHRD++++N L+  +    + DFG+++
Sbjct: 130 QIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 75.9 bits (187), Expect = 1e-16
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 11/172 (6%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G  A VY A  LP+ E VA+K+    L   QT    E   EV+A+++  H N+VK+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRID--LEKCQT-SVDELRKEVQAMSQCNHPNVVKYY 65

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +L+  +L  GSL  I+ +      L  +   +V+K V   L YLH +    
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---G 122

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW----TEFAGTYGYVA 216
            +HRD+ + N+LL  +    +ADFG++  L             F GT  ++A
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 2e-16
 Identities = 47/162 (29%), Positives = 85/162 (52%), Gaps = 12/162 (7%)

Query: 50  IGNGGHASVYRAELP---SREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    V R  L     RE+ VA+K   S     Q   +++FL+E   + +  H NI+
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNII 68

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
              G  + +R   ++ EF+E G+L + L  +    +    Q + +++G+A  + YL    
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE 207
           +   VHRD++++N+L++      V+DFG+++FL+ D S+ T 
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 4e-16
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 8/147 (5%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G    VY+  L     VAVK   S LP D    +++FL E + L +  H NIVK  G
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C   +  +++ E +  GSL   L        +    +MS+    A  + YL        
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESKN---C 114

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +HRD++++N L+       ++DFG+++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 74.2 bits (183), Expect = 4e-16
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 12/155 (7%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
             FD    +G G + SVY+A    + +VVA+K     +P ++  D +E + E+  L +  
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV----VPVEE--DLQEIIKEISILKQCD 56

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
              IVK+YG        +++ E+   GS++ I+      + L   +  +++      L Y
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEY 114

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           LH       +HRD+ + N+LL+ E +A +ADFG++
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 4e-16
 Identities = 41/162 (25%), Positives = 80/162 (49%), Gaps = 13/162 (8%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    V+  +   +  VA+K        +  + + +F+ E K + +  H N+V+ YG
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L          W   + +   V +A+ YL  + F   
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGF--- 121

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD---ASNWTEF 208
           +HRD++++N L+  +    V+DFG+A+++  D   +S  T+F
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.0 bits (177), Expect = 4e-15
 Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 12/170 (7%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G +  V +     + E+VA+KKF      D+ V +K  L EVK L + RH NIV   
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDV-KKTALREVKVLRQLRHENIVNLK 66

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFP 167
                    +L+ E++ER  L  +   +A+   L      S I  +  A++Y H H+   
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSHN--- 120

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK-SDASNWTEFAGTYGYVA 216
            I+HRD+  +N+L+       + DFG A+ L+   AS  T++  T  Y A
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.5 bits (175), Expect = 4e-15
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)

Query: 50  IGNGGHASVYRA--ELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    V+R   ++P R+   VA+K         Q  D   FL+E   + +  H NI+
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMGQFSHHNII 69

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G  +  + + ++ E++E G+L   L       E    Q + +++G+A  + YL    
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +   VHRD++++N+L++   E  V+DFG+++ L+ D
Sbjct: 128 Y---VHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 6e-15
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 8/162 (4%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+     + A  K       ++  D   F+ E+  L+E +H NIV  Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
              +    ++L EF + G+L +I+      + L   Q   V + + +AL++LH      +
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           +HRD+ + N+LL L+ +  +ADFG++   KS       F GT
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGT 166

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 71.0 bits (174), Expect = 8e-15
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 12/169 (7%)

Query: 43  DFDAKYCIGNGGHASVYRAELPSRE-VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           D   K+ +G G +  VY          VAVK        + T++ +EFL E   + E +H
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 61

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ YL
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
               F   +HRD++++N L+   +   VADFG+++ +  D   +T  AG
Sbjct: 121 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAG 164

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 55/180 (30%), Positives = 79/180 (43%), Gaps = 29/180 (16%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVK--KFHSPLPS--DQTVDQKEFLTEVKALTETRHRNI 104
           IG G    VY A  L + E++AVK  +     P    +  D      E+K L   +H N+
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD------EMKVLELLKHPNL 61

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA----DALSY 160
           VK+YG   H    ++  E+   G+L  +L       E G      VI+       + L+Y
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAY 114

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE----FAGTYGYVA 216
           LH      IVHRD+   N+ LD      + DFG A  LK++ +   E     AGT  Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.9 bits (171), Expect = 2e-14
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 10/165 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVK--KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G G  +S Y+A ++ +  ++AVK   +     S+Q    +    E++ +    H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
             G      H  L  E++  GS++ +L+   A +E   +  ++  + +   LSYLH +  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122

Query: 167 PPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASNWTEFAG 210
             I+HRDV   NLL+D       +ADFG A  L +  +   EF G
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.0 bits (169), Expect = 5e-14
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 13/156 (8%)

Query: 51  GNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           G+ G   + R +     + E VAVK   S   S +   + +F  E++ L    H NIVK+
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVK---SLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 108 YGFC--SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            G C     R   L+ E+L  GSL   L        L   + +     +   + YL    
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQ- 128

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
               +HRD++++N+L++ E    ++DFG+AK L  D
Sbjct: 129 --RYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 8e-14
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 16/173 (9%)

Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           D++    IG+G +  VY+A ++ + E+VA+K     +  +   D +    E+  L E RH
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKV----IKLEPGDDFEIIQQEISMLKECRH 59

Query: 102 RNIVKFYGFCSHARHSFL-LC-EFLERGSLAAILN-TDAAAQELGWSQRMSVIKGVADAL 158
            NIV ++G  S+ R   L +  E+   GSL  I   T     EL   Q   V +     L
Sbjct: 60  PNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---QIAYVCRETLKGL 114

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           +YLH       +HRD+   N+LL  + +  +ADFG++  L +  +    F GT
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGT 164

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 67.2 bits (164), Expect = 2e-13
 Identities = 36/152 (23%), Positives = 78/152 (51%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    V+  +  ++  VA+K  +     +  + +++F+ E K + +  H  +V+ YG
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-----EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  +  +++ EF+E G L   L       +L     +S+ + V + + YL  + F   
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF--- 121

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L+       V+DFG+ +++  D
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 24/164 (14%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQ--KEFLTEVKALTETRHRNIVK 106
           +G+G   SVY    L   +  AVK+  S     QT  +  K+   E+  L++ +H NIV+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI----KGVADALSYLH 162
           + G      + ++  E +  GSLA +L      ++ G S    VI    + +   L YLH
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLL------KKYG-SFPEPVIRLYTRQILLGLEYLH 119

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK------FLKS 200
                  VHRD+   N+L+D      +ADFG+AK      F KS
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.3 bits (164), Expect = 2e-13
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 26/173 (15%)

Query: 43  DFDAKYCIGNGGHASVYRAEL----PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           D   K  +G G    V+ AE     P+++  +VAVK    P  + +    K+F  E + L
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR----KDFQREAELL 61

Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT---DA----------AAQELG 143
           T  +H +IVKFYG C       ++ E+++ G L   L     DA          A  ELG
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            SQ + +   +A  + YL    F   VHRD++++N L+       + DFG+++
Sbjct: 122 LSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.4 bits (162), Expect = 3e-13
 Identities = 32/119 (26%), Positives = 65/119 (54%), Gaps = 5/119 (4%)

Query: 83  TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL 142
           ++ + EF+ E K + +  H  +V+ YG C+  R  +++ E++  G L   L      +  
Sbjct: 40  SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE--HGKRF 97

Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             SQ + + K V + ++YL    F   +HRD++++N L+D +    V+DFG+++++  D
Sbjct: 98  QPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.8 bits (160), Expect = 6e-13
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 25/172 (14%)

Query: 43  DFDAKYCIGNGGHASVYRAE----LPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           D   K+ +G G    V+ AE    LP ++  +VAVK       S +    ++F  E + L
Sbjct: 6   DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELL 61

Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT------------DAAAQELGW 144
           T  +H++IV+FYG C+  R   ++ E++  G L   L +            D A  +L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            Q +++   +A  + YL    F   VHRD++++N L+       + DFG+++
Sbjct: 122 GQMLAIASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 65.3 bits (159), Expect = 7e-13
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVKALTETRHRNIVK 106
           +G G + +VY       +++AVK+      S+    +KE+     EV  L   +H NIV+
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELD-TSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
           + G C       +  EF+  GS+++ILN      E  + +     K + D ++YLH++C 
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
             +VHRD+   N++L       + DFG A+ L
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.9 bits (161), Expect = 8e-13
 Identities = 51/157 (32%), Positives = 73/157 (46%), Gaps = 25/157 (15%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHS-------PLPSDQTVDQKEFLTEVKALTETRH 101
           IG G +  VYRA +  S E+VA+KK          P+ S         L E+  L   RH
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---------LREITLLLNLRH 65

Query: 102 RNIVKFYGFC--SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
            NIV+        H    FL+ E+ E+  LA++L  D        SQ   ++  +   L 
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL--DNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           YLH +    I+HRD+   NLLL  +    +ADFG+A+
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 65.2 bits (160), Expect = 9e-13
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 17/154 (11%)

Query: 49  CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVD--QKEFLTEVKALTETRHRNIV 105
            +G G +  VY+A +  + E+VA+KK       D   +      L E+  L E +H NIV
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRL----DNEEEGIPSTALREISLLKELKHPNIV 61

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS--VIKGVADALSYLHH 163
           K        R  +L+ E+ +   L   L+           + +   +++G+A    Y H 
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCHS 116

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
                I+HRD+  +N+L++ +    +ADFG+A+ 
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 65.3 bits (159), Expect = 9e-13
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 17/152 (11%)

Query: 51  GNGGHASVYRAELPSR----EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           G+ G  S+Y  + P+     E+VAVK          T   K+   E+  L    H NIVK
Sbjct: 15  GHFGKVSLYCYD-PANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHENIVK 70

Query: 107 FYGFCSHA--RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           + G CS    +   L+ E++  GSL   L       +L  +Q +   + + + ++YLH  
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +   +HRD++++N+LLD +    + DFG+AK
Sbjct: 127 HY---IHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.4 bits (159), Expect = 1e-12
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 23/172 (13%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           ND   +  IG G    V +A +     R   A+K+       D   D ++F  E++ L +
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 63

Query: 99  T-RHRNIVKFYGFCSHARHSFLLCEFLERGSL------AAILNTDAA-------AQELGW 144
              H NI+   G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            Q +     VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 64.4 bits (158), Expect = 1e-12
 Identities = 45/179 (25%), Positives = 74/179 (41%), Gaps = 13/179 (7%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEF-LTEVKALTETR 100
            ++    IG G    VY        ++  +K+    L S+ +  ++E  L EVK L +  
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKE--IDL-SNMSEKEREDALNEVKILKKLN 57

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLA-AILNTDAAAQELGWSQRMSVIKGVADALS 159
           H NI+K+Y          ++ E+ + G L+  I       +     Q +     +  AL 
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 160 YLH--HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           YLH        I+HRD+  +N+ L       + DFGI+K L S         GT  Y++
Sbjct: 118 YLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 9/152 (5%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+     +   VAVK          T+D K+FL E + + + RH  +++ Y 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKP-----GTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+     +++ E ++ GSL   L   A    L   Q + +   VA  ++YL    +   
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNY--- 124

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N+L+       VADFG+A+ +K D
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKED 156

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 14/170 (8%)

Query: 51  GNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG- 109
           G GG  SV +  L +  ++   K  +  P+     QK+ L E++     +   IVK+YG 
Sbjct: 12  GAGG--SVTKCRLKNTGMIFALKTITTDPNPDL--QKQILRELEINKSCKSPYIVKYYGA 67

Query: 110 FCSHARHSFLLC-EFLERGSLAAIL-NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           F   +  S  +  E+ E GSL +I          +G      + + V   LSYLH     
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR--- 124

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIA-KFLKSDASNWTEFAGTYGYVA 216
            I+HRD+   N+LL  + +  + DFG++ + + S A     F GT  Y+A
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT---FTGTSFYMA 171

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 15/159 (9%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE------FLTEVKALTETRHR 102
           IG G +  VY A  + + E++AVK+   P       D ++        +E++ L +  H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           NIV++ GF +   +  +  E++  GS+ + L T    +E          + V + L+YLH
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE---QLVRFFTEQVLEGLAYLH 125

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                 I+HRD+ + NLL+D +    ++DFGI+K  KSD
Sbjct: 126 SK---GILHRDLKADNLLVDADGICKISDFGISK--KSD 159

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 64.1 bits (157), Expect = 2e-12
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 21/163 (12%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALTETRHRN 103
           IG G +  VY+A    + E+VA+KK        +  ++KE      + E+K L + RH N
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI-------RMENEKEGFPITAIREIKLLQKLRHPN 59

Query: 104 IVKFYGFC-SHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
           IV+      S  + S +++ E+++   L  +L  D+   +   SQ    +K + + L YL
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
           H +    I+HRD+   N+L++ +    +ADFG+A+      S 
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 53/176 (30%), Positives = 74/176 (42%), Gaps = 25/176 (14%)

Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVD---QKEFLTEVKALTETRHRNIV 105
           +G GG   V   ++       A+K           V+   Q+   +E + L E  H  IV
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV----KKRHIVETGQQEHIFSEKEILEECNHPFIV 56

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILN-----TDAAAQELGWSQRMSVIKGVADALSY 160
           K Y      ++ ++L E+   G L  IL       +  A+          I  V  A  Y
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY--------IACVVLAFEY 108

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           LH+     I++RD+  +NLLLD      + DFG AK LKS    WT F GT  YVA
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVA 160

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 3e-12
 Identities = 29/100 (29%), Positives = 56/100 (56%), Gaps = 6/100 (6%)

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
            +E+  + + +H NIVK  G C   + ++L+ E++E  +L+ +L        L W +R  
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRK 784

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV 189
           +  G+A AL +LH  C P +V  ++S + +++D + E H+
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 63.1 bits (153), Expect = 4e-12
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 10/148 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V++  L  +  VAVK     LP +  +   +FL+E + L +  H NIVK  G
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI---KFLSEARILKQYDHPNIVKLIG 59

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFPP 168
            C+  +  +++ E +  G   + L       EL   Q +      A  ++YL   +C   
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKNC--- 114

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +HRD++++N L+       ++DFG+++
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 4e-12
 Identities = 44/156 (28%), Positives = 82/156 (52%), Gaps = 12/156 (7%)

Query: 50  IGNG--GHASVYRAELPS-REV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G  G     R +LP  RE+ VA+K   +     Q   +++FL+E   + +  H NI+
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ---RRDFLSEASIMGQFDHPNII 68

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
              G  + ++   ++ E++E GSL A L       +    Q + +++G+A  + YL    
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 63.0 bits (153), Expect = 5e-12
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 16/164 (9%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+      +  VA+K       S++     +F+ E + + +  H  +V+ YG
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-----DFIEEAQVMMKLSHPKLVQLYG 66

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR--MSVIKGVADALSYLHHDCFP 167
            C+      L+ EF+E G L+  L      Q   +SQ   + +   V + ++YL      
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSNV- 121

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             +HRD++++N L+       V+DFG+ +F+  D   +T   GT
Sbjct: 122 --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGT 161

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.7 bits (152), Expect = 6e-12
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 9/148 (6%)

Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V+   L +    VAVK     LP D    + +FL E + L +  H NIV+  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 59

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G C+  +  +++ E ++ G     L T+     L   + + +++  A  + YL       
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH--- 114

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +HRD++++N L+  +    ++DFG+++
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 62.7 bits (153), Expect = 8e-12
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 11/156 (7%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G H  V++A +  + E VA+KK              + L E+KAL   +H  +VK  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALREIKALQACQHPYVVKLL 65

Query: 109 GFCSHARHSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
               H     L+ E++    L+ +L + +    E   +Q  S ++ +   ++Y+H +   
Sbjct: 66  DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPE---AQVKSYMRMLLKGVAYMHAN--- 118

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
            I+HRD+   NLL+  +    +ADFG+A+    +  
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 62.2 bits (152), Expect = 1e-11
 Identities = 42/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)

Query: 90  LTEVKALTETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE   L+   H  IVK  Y F +     +L+ E+   G L + L+     +E  +S+  
Sbjct: 41  LTERNILSRINHPFIVKLHYAFQTE-EKLYLVLEYAPGGELFSHLS-----KEGRFSEER 94

Query: 149 SVIKG--VADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           +      +  AL YLH       I++RD+  +N+LLD +    + DFG+AK L S+ S  
Sbjct: 95  ARFYAAEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT 150

Query: 206 TEFAGTYGYVA 216
             F GT  Y+A
Sbjct: 151 NTFCGTPEYLA 161

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 22/182 (12%)

Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE---FLTEVKALTE 98
           D++    IG G   +V +       +++  K+          + +KE    ++EV  L E
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY-----GNMTEKEKQQLVSEVNILRE 55

Query: 99  TRHRNIVKFYG-FCSHARHS-FLLCEFLERGSLAAIL-----NTDAAAQELGWSQRMSVI 151
            +H NIV++Y      +  + +++ E+ E G LA ++           +E  W     ++
Sbjct: 56  LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RIL 111

Query: 152 KGVADALSYLHH--DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
             +  AL   H+  D    ++HRD+   N+ LD      + DFG+AK L  D+S    + 
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171

Query: 210 GT 211
           GT
Sbjct: 172 GT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.0 bits (150), Expect = 1e-11
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+     V+A  K       ++  D   ++ E+  L    H NIVK   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED---YMVEIDILASCDHPNIVKLLD 69

Query: 110 FCSHARHSFLLCEFLERGSL-AAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
              +  + ++L EF   G++ A +L  +    E    Q   V K   +AL+YLH +    
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLELERPLTE---PQIRVVCKQTLEALNYLHEN---K 123

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIA 195
           I+HRD+ + N+L  L+ +  +ADFG++
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 61.4 bits (149), Expect = 2e-11
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 17/173 (9%)

Query: 43  DFDAKYCIGNGGHASVYRAELPS-REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           DF+    IG G    V++    + + V A+K+    L      +++E + E + L +   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDS 58

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA---AQELGWSQRMSVIKGVADAL 158
             I+++Y          ++ E+ E G L  +L         ++  W   + ++ G    L
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           ++LH      I+HRD+ S NL LD      + D G+AK L SD +N   FA T
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTN---FANT 160

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 48/142 (33%), Positives = 69/142 (48%), Gaps = 21/142 (14%)

Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SHARHSF-LLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C S  R +  L+ E+L
Sbjct: 34  EVVAVKK----LQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89

Query: 125 ERGSLAAILNT-----DAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNL 179
             GSL   L       D     L  SQ   + KG    + YL    +   VHRD++++N+
Sbjct: 90  PYGSLRDYLQKHRERLDHRKLLLYASQ---ICKG----MEYLGSKRY---VHRDLATRNI 139

Query: 180 LLDLEYEAHVADFGIAKFLKSD 201
           L++ E    + DFG+ K L  D
Sbjct: 140 LVESENRVKIGDFGLTKVLPQD 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.8 bits (151), Expect = 2e-11
 Identities = 54/189 (28%), Positives = 77/189 (40%), Gaps = 37/189 (19%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE---FLTEVKALT 97
           +DF+    +G G    V       S +  A+K     L   + V  K+    L E + L 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI----LSKAKIVKLKQVEHVLNEKRILQ 56

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-------NTDA---AAQELGWSQR 147
             RH  +V  YG      + +L+ E++  G L + L          A   AAQ       
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ------- 109

Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE 207
                 V  AL YLH      IV+RD+  +NLLLD +    + DFG AK +K     +T 
Sbjct: 110 ------VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT- 157

Query: 208 FAGTYGYVA 216
             GT  Y+A
Sbjct: 158 LCGTPEYLA 166

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 23/163 (14%)

Query: 50  IGNGGHASVYRAEL----PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G    V+ AE     P ++  +VAVK       SD    +K+F  E + LT  +H +
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNA--RKDFHREAELLTNLQHEH 68

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSL----------AAILNTDAAAQELGWSQRMSVIKG 153
           IVKFYG C       ++ E+++ G L          A ++       EL  SQ + + + 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +A  + YL    F   VHRD++++N L+       + DFG+++
Sbjct: 129 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 27/172 (15%)

Query: 49  CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVK 106
           CIG G    VY+A +  + +VVA+K     +  ++  D+ E +  E++ L++ R   I K
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKV----IDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63

Query: 107 FYGFCSHARHSFL-------LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
           +YG       SFL       + E+   GS   +L       +L  +    +++ V   L 
Sbjct: 64  YYG-------SFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLE 112

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           YLH +     +HRD+ + N+LL  E +  +ADFG++  L S  S    F GT
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT 161

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 60.7 bits (147), Expect = 4e-11
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 10/142 (7%)

Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHSFLLCEFL 124
           E VAVK        +   D K+   E++ L    H NIVK+ G C+        L+ EFL
Sbjct: 34  EQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L  +     L    + +V   +   + YL    +   VHRD++++N+L++ E
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLGSRQY---VHRDLAARNVLVESE 145

Query: 185 YEAHVADFGIAKFLKSDASNWT 206
           ++  + DFG+ K +++D   +T
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYT 167

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 5e-11
 Identities = 35/133 (26%), Positives = 70/133 (52%), Gaps = 9/133 (6%)

Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS 128
           VAVK          T+  + FL E + + + RH  +V+ Y  CS     +++ E++ +GS
Sbjct: 33  VAVKTLKP-----GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87

Query: 129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH 188
           L   L +    ++L   Q + +   +A+ ++YL    +   +HRD++++N+L+       
Sbjct: 88  LLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNY---IHRDLAARNILVGENLVCK 143

Query: 189 VADFGIAKFLKSD 201
           +ADFG+A+ ++ D
Sbjct: 144 IADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 60.0 bits (145), Expect = 7e-11
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 11/153 (7%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+      +A  K       ++  D   ++ E++ L    H  IVK  G
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YMVEIEILATCNHPYIVKLLG 76

Query: 110 FCSHARHSFLLCEFLERGSLAAI-LNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                   +++ EF   G++ AI L  D    E    Q   + + + +AL YLH      
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---K 130

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGI-AKFLKS 200
           I+HRD+ + N+LL L+ +  +ADFG+ AK +K+
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 7e-11
 Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 18/122 (14%)

Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL--NTDA--AAQE 141
            KE L E   +    H ++V+  G C  ++   L+ + +  G L   +  + D   +   
Sbjct: 53  NKEILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYL 111

Query: 142 LGWSQRMSVIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           L W  +      +A  +SYL         +VHRD++++N+L+       + DFG+AK L 
Sbjct: 112 LNWCVQ------IAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160

Query: 200 SD 201
            D
Sbjct: 161 VD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 59.5 bits (144), Expect = 9e-11
 Identities = 55/169 (32%), Positives = 88/169 (52%), Gaps = 22/169 (13%)

Query: 51  GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVD-QKEFLTEVKALTETRHRNIVKFY 108
           GNGG  +VY+A  L +R ++AVK     +P D TV+ QK+ ++E++ L +     I+ FY
Sbjct: 12  GNGG--TVYKAYHLLTRRILAVKV----IPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 109 G-FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           G F    R S +  EF++ GSL   +        LG   R++V   V   L+YL      
Sbjct: 66  GAFFVENRIS-ICTEFMDGGSLD--VYRKIPEHVLG---RIAV--AVVKGLTYLWS---L 114

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            I+HRDV   N+L++   +  + DFG++  L +  +    + GT  Y+A
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMA 161

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 27/186 (14%)

Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
            T  F+    IG G +  VY+A    + ++VA+K        +     +E   E   L +
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-----EEIKEEYNILRK 58

Query: 99  -TRHRNIVKFYGFCSHARHS------FLLCEFLERGSLAAILNTDAAAQELGWSQRMS-- 149
            + H NI  FYG              +L+ E    GS+     TD         +R+   
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKGKRLKEE 113

Query: 150 ----VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
               +++     L+YLH +    ++HRD+  +N+LL    E  + DFG++  L S     
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Query: 206 TEFAGT 211
             F GT
Sbjct: 171 NTFIGT 176

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 18/180 (10%)

Query: 43  DFDAKYC----IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL-TEVKAL 96
           D   KY     IG G   +VY A ++ + + VA+K+ +      Q   +KE +  E+  +
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL---QQQP--KKELIINEILVM 70

Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            E +H NIV +          +++ E+L  GSL  ++ T+    E    Q  +V +    
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQ 126

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL +LH +    ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 127 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.9 bits (143), Expect = 1e-10
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 24/160 (15%)

Query: 50  IGNGGHASVYRAEL--PSREV--VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G+G    V R E      +V  VAVK   S   SD      +FL E   +    H N++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI---MDDFLKEAAIMHSLDHENLI 59

Query: 106 KFYGFCSHARHSFLLC-EFLERGSLAAILNTDAAAQEL-----GWSQRMSVIKGVADALS 159
           + YG      H  ++  E    GSL   L  DA    L      ++ +      +A+ + 
Sbjct: 60  RLYGVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMR 111

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           YL    F   +HRD++++N+LL  + +  + DFG+ + L 
Sbjct: 112 YLESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALP 148

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 14/134 (10%)

Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS 128
           VAVK      P      +++FL EVK L+     NI +  G C+      ++ E++E G 
Sbjct: 49  VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 129 LAAIL-------NTDAAAQE-LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLL 180
           L   L       +  A   + L +S  + +   +A  + YL    F   VHRD++++N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCL 162

Query: 181 LDLEYEAHVADFGI 194
           +   Y   +ADFG+
Sbjct: 163 VGKNYTIKIADFGM 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 11/170 (6%)

Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G +  VY A   S +V +A+K+    +P   +   +    E+   +  +HRNIV++ 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKE----IPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G  S      +  E +  GSL+A+L +     +      +   K + + L YLH +    
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128

Query: 169 IVHRDVSSKNLLLDLEYEA--HVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           IVHRD+   N+L++  Y     ++DFG +K L         F GT  Y+A
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 58.4 bits (141), Expect = 2e-10
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 12/147 (8%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G   +V + E   ++V AVK           V  + FL E   +T+  H+N+V+  G
Sbjct: 14  IGEGEFGAVLQGEYTGQKV-AVKNIKC------DVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
              H    +++ E + +G+L   L T   A  +   Q +     VA+ + YL       +
Sbjct: 67  VILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAK 196
           VHRD++++N+L+  +  A V+DFG+A+
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 16/165 (9%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQ-KEFLTEVKALTETRHRNIVKF 107
           IG+G   +VY A ++ + EVVA+KK        Q+ ++ ++ + EV+ L + RH N +++
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 108 YGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            G C    H+ +L+ E+   GS + IL  +   + L   +  ++  G    L+YLH    
Sbjct: 81  KG-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE- 135

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
              +HRD+ + N+LL       +ADFG A  L S A++   F GT
Sbjct: 136 --RIHRDIKAGNILLTEPGTVKLADFGSAS-LVSPANS---FVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 15/171 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPS-DQTVDQKEFLTEVKALTETRHRNIVKF 107
           IG G +  V++     + ++VA+KKF   + S D  V +K  L E++ L + +H N+V  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF---VESEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNT-DAAAQELGWSQRMSVIKGVADALSYLH-HDC 165
                  R   L+ E+ +      +LN  +   + +       +I     A+++ H H+C
Sbjct: 66  IEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
               +HRDV  +N+L+  + +  + DFG A+ L     ++T++  T  Y A
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.1 bits (141), Expect = 2e-10
 Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 12/155 (7%)

Query: 51  GNGG--HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           GN G     VY  +      VAVK             +KEFL E   + +  H  IV+  
Sbjct: 6   GNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G C       L+ E    G L   L            +       VA  ++YL    F  
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLESKHF-- 116

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
            VHRD++++N+LL   ++A ++DFG+++ L + + 
Sbjct: 117 -VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 58.3 bits (142), Expect = 3e-10
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 10/154 (6%)

Query: 49  CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNIVK 106
            +G+G   SVY A    + E+VA+KK      S +       L EVK+L +   H NIVK
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEHPNIVK 62

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
                      + + E++E G+L  ++  D   +    S   S+I  +   L+++H   F
Sbjct: 63  LKEVFRENDELYFVFEYME-GNLYQLM-KDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
               HRD+  +NLL+       +ADFG+A+ ++S
Sbjct: 121 ---FHRDLKPENLLVSGPEVVKIADFGLAREIRS 151

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 57.3 bits (138), Expect = 5e-10
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +GNG    V+         VAVK          T+  + FL E + + + RH  +V+ Y 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKP-----GTMSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  D   + L     + +   VA  ++Y+    +   
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 123

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ S N+L+       +ADFG+A+ ++ +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 16/192 (8%)

Query: 27  PEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVD 85
           PE+  + Y +       F   + IG+G   +VY A    + EVVAVKK        QT +
Sbjct: 8   PEIADLFYKD--DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM--SYSGKQTNE 63

Query: 86  Q-KEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGW 144
           + ++ + EVK L + +H N +++ G C    H+  L      GS + +L  +   + L  
Sbjct: 64  KWQDIIKEVKFLQQLKHPNTIEYKG-CYLKEHTAWLVMEYCLGSASDLL--EVHKKPLQE 120

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
            +  ++  G    L+YLH      ++HRD+ + N+LL    +  +ADFG A    S +S 
Sbjct: 121 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA----SKSSP 173

Query: 205 WTEFAGTYGYVA 216
              F GT  ++A
Sbjct: 174 ANSFVGTPYWMA 185

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.3 bits (138), Expect = 6e-10
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 13/177 (7%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +D++    +G+G +  VY+A  L + E+ AVK        D ++ Q+E       + E +
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM----VKECK 64

Query: 101 HRNIVKFYGFCSHARHSFLLC-EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
           H NIV ++G    +R    +C E+   GSL  I +      EL   Q   V +     L+
Sbjct: 65  HCNIVAYFG-SYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLA 120

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           YLH       +HRD+   N+LL    +  +ADFG+A  + +  +    F GT  ++A
Sbjct: 121 YLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.3 bits (138), Expect = 6e-10
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 8/132 (6%)

Query: 86  QKEFL-TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGW 144
           ++E L  EV  + + +H+N+V+ Y         ++L EFL+ G+L  I++     +E   
Sbjct: 61  RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE--- 117

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
            Q  +V + V  AL YLH      ++HRD+ S ++LL L+    ++DFG    +  D   
Sbjct: 118 -QIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173

Query: 205 WTEFAGTYGYVA 216
                GT  ++A
Sbjct: 174 RKSLVGTPYWMA 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 57.1 bits (138), Expect = 8e-10
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 14/168 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G   +VY+    P+  + A+K  +     + TV +++   E++ L +  H N+VK +
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTV-RRQICREIEILRDVNHPNVVKCH 138

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
               H     +L EF++ GSL         A E        V + +   ++YLH      
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEG----THIADEQ---FLADVARQILSGIAYLHRR---H 188

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           IVHRD+   NLL++      +ADFG+++ L           GT  Y++
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMS 236

Length = 353

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 56.9 bits (137), Expect = 8e-10
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 5/109 (4%)

Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           FL E   +T+ RH N+V+  G     +   +++ E++ +GSL   L +   +  LG    
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCL 104

Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +     V +A+ YL  + F   VHRD++++N+L+  +  A V+DFG+ K
Sbjct: 105 LKFSLDVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.7 bits (137), Expect = 8e-10
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 23/172 (13%)

Query: 51  GNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           GNGG  SV + + +P+  V+A K  H  + +  +V +K+ L E++ + E R   IV FYG
Sbjct: 16  GNGG--SVSKVKHIPTGTVMAKKVVH--IGAKSSV-RKQILRELQIMHECRSPYIVSFYG 70

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADALSYL---HHD 164
              +  +  +  EF++ GSL  I           LG      +   V + L+YL   H  
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVHR- 124

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
               I+HRD+   N+L++   +  + DFG++  L +  ++   F GT  Y++
Sbjct: 125 ----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMS 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.0 bits (137), Expect = 9e-10
 Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 12/168 (7%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G   +VY A ++ + + VA+++ +      Q   ++  + E+  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +++ E+L  GSL  ++ T+    E    Q  +V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---Q 136

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 56.7 bits (136), Expect = 1e-09
 Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 14/169 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G   +V+ A ++ + + VA+K+ +      Q   +KE +  E+  + E ++ NIV F
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQPKKELIINEILVMKELKNPNIVNF 81

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
                     F++ E+L  GSL  ++ T+    E   +Q  +V +    AL +LH +   
Sbjct: 82  LDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDE---AQIAAVCRECLQALEFLHAN--- 134

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 19/160 (11%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY               VAVK       S+Q  D+ +FL E   +++  H+N
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-SCSEQ--DESDFLMEALIMSKFNHQN 70

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS----VIKGVADALS 159
           IV+  G        F+L E +  G L + L  +    E   S  M       + VA    
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAK 196
           YL  + F   +HRD++++N LL  +     A +ADFG+A+
Sbjct: 131 YLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.1 bits (135), Expect = 1e-09
 Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 15/142 (10%)

Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERG 127
           +VAVK   + +       + +FL E+K ++  ++ NI++  G C       ++ E++E G
Sbjct: 46  LVAVKMLRADVTKTA---RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102

Query: 128 SLAAILNTDAAAQELGWSQRMSVIK---------GVADALSYLHHDCFPPIVHRDVSSKN 178
            L   L+          +  +  +           +A  + YL    F   VHRD++++N
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRN 159

Query: 179 LLLDLEYEAHVADFGIAKFLKS 200
            L+   Y   +ADFG+++ L S
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYS 181

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 31/172 (18%)

Query: 50  IGNGGHASVYRAE----LPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           IG G    V++A     LP     +VAVK       S     Q +F  E   + E  H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADM--QADFQREAALMAEFDHPN 69

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAIL------NTDAAAQ-------------ELGW 144
           IVK  G C+  +   LL E++  G L   L         + +               L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           ++++ + K VA  ++YL    F   VHRD++++N L+       +ADFG+++
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.9 bits (134), Expect = 2e-09
 Identities = 42/168 (25%), Positives = 81/168 (48%), Gaps = 12/168 (7%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G   +VY A ++ + + VA+K+ +      Q   ++  + E+  + E ++ NIV + 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 82

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +++ E+L  GSL  ++ T+    E    Q  +V +    AL +LH +    
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALDFLHSN---Q 135

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 55.3 bits (134), Expect = 3e-09
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 26/181 (14%)

Query: 50  IGNGGHASVYRAELPS-REVVAVKKFHSPLPSDQTVD---QKEFLTEVKALTETRHRNIV 105
           I  G +  V+ A+  S  ++ A+K     +     +      + LTE   L++ +   +V
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKV----IKKADMIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV--IKGVADALSYLHH 163
           K Y      ++ +L+ E+L  G LA++L    +  E      ++   I  +  AL YLH 
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-----DVARIYIAEIVLALEYLHS 111

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF-LKSDASNW-------TEFAGTYGYV 215
           +    I+HRD+   N+L+D      + DFG++K  L     N            GT  Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 216 A 216
           A
Sbjct: 169 A 169

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 4/63 (6%)

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +  AL YLH      I+HRD+   N+LLD +   H+ DF IA  +  D +  T  +GT G
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPG 164

Query: 214 YVA 216
           Y+A
Sbjct: 165 YMA 167

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.1 bits (132), Expect = 4e-09
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 20/194 (10%)

Query: 27  PEVGKILY-DEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTV 84
           P+V ++ + D+  K  +D      IG+G   +VY A ++ + EVVA+KK        Q+ 
Sbjct: 2   PDVAELFFKDDPEKLFSDLRE---IGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSN 56

Query: 85  DQ-KEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELG 143
           ++ ++ + EV+ L + RH N +++ G C    H+  L      GS + +L  +   + L 
Sbjct: 57  EKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCLGSASDLL--EVHKKPLQ 113

Query: 144 WSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
             +  +V  G    L+YLH H+    ++HRDV + N+LL       + DFG A  +    
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169

Query: 203 SNWTEFAGTYGYVA 216
                F GT  ++A
Sbjct: 170 X----FVGTPYWMA 179

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 55.1 bits (133), Expect = 4e-09
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 18/148 (12%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A +  +   VAVKK    L   Q   ++E L  EV  + + +H NIV+ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHPNIVEM 81

Query: 108 YGFCSH--ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           Y   S+      +++ EFLE G+L  I+      +E    Q  +V   V  ALS+LH   
Sbjct: 82  YS--SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKALSFLHAQ- 134

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFG 193
              ++HRD+ S ++LL  +    ++DFG
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 4e-09
 Identities = 34/160 (21%), Positives = 68/160 (42%), Gaps = 19/160 (11%)

Query: 50  IGNGGHASVYR---AELPSREV---VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G    VY      +   E    VA+K  +    +    ++ EFL E   + E    +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAIL------NTDAAAQELGWSQRMSVIKG-VAD 156
           +V+  G  S  + + ++ E + +G L + L        +         Q+   +   +AD
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            ++YL    F   VHRD++++N ++  +    + DFG+ +
Sbjct: 131 GMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 54.7 bits (131), Expect = 4e-09
 Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VA+K          T+  + FL E + + + RH  +V+ Y 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  +     L   Q + +   +A  ++Y+    +   
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNY--- 123

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 54.7 bits (131), Expect = 5e-09
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 11/175 (6%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           DF+    IG+G +  VY+A  + + E+ A+K        D  V Q+E +     + + +H
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM----MKDCKH 65

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NIV ++G        ++  EF   GSL  I +      E   SQ   V +     L YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE---SQIAYVSRETLQGLYYL 122

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H       +HRD+   N+LL       +ADFG++  + +  +    F GT  ++A
Sbjct: 123 HSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 54.3 bits (130), Expect = 6e-09
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    VY+  +  ++EVVA+K        D+  D ++   E+  L++     I ++Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L      +    +   ++++ +   L YLH +    
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSE---R 121

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL  + +  +ADFG+A  L         F GT  ++A
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 54.3 bits (131), Expect = 6e-09
 Identities = 40/169 (23%), Positives = 78/169 (46%), Gaps = 11/169 (6%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPS-DQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G +  V + +   + ++VA+KKF   L S D  + +K  + E++ L + RH N+V  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
                  +  +L+ EF++   L  +   +     L  S+    +  +   + + H     
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            I+HRD+  +N+L+       + DFG A+ L +    +T++  T  Y A
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 54.2 bits (131), Expect = 7e-09
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 29/159 (18%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVK--KFHS-----PLPSDQTVDQKEFLTEVKALTETRH 101
           I  G +  VYRA +  + E+VA+K  K        P+ S         L E+  L + +H
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS---------LREINILLKLQH 63

Query: 102 RNIVKF----YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
            NIV       G  S+    +++ E++E   L +++ T    Q    S+   ++  +   
Sbjct: 64  PNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSG 118

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +++LH +    I+HRD+ + NLLL+      + DFG+A+
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 54.1 bits (131), Expect = 8e-09
 Identities = 46/186 (24%), Positives = 68/186 (36%), Gaps = 51/186 (27%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK----AL 96
           +DF     IG G  ++V  A E  + +  A+K           +  K  L + K      
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIK-----------ILDKRQLIKEKKVKYVK 49

Query: 97  TE-------TRHRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDA----------A 138
            E         H  I+K Y  F       F+L E+   G L   +              A
Sbjct: 50  IEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL-EYAPNGELLQYIRKYGSLDEKCTRFYA 108

Query: 139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
           A+             +  AL YLH      I+HRD+  +N+LLD +    + DFG AK L
Sbjct: 109 AE-------------ILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152

Query: 199 KSDASN 204
             ++S 
Sbjct: 153 DPNSSP 158

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.3 bits (130), Expect = 8e-09
 Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 16/192 (8%)

Query: 27  PEVGKILY-DEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTV 84
           PE+ ++ + ++  K   D      IG+G   +VY A ++ + EVVA+KK  S        
Sbjct: 12  PEIAELFFKEDPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNE 67

Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGW 144
             ++ + EVK L   +H N +++ G       ++L+ E+   GS + +L  +   + L  
Sbjct: 68  KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQE 124

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
            +  ++  G    L+YLH      ++HRD+ + N+LL    +  +ADFG A    S AS 
Sbjct: 125 VEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA----SIASP 177

Query: 205 WTEFAGTYGYVA 216
              F GT  ++A
Sbjct: 178 ANSFVGTPYWMA 189

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 29/116 (25%), Positives = 57/116 (49%), Gaps = 10/116 (8%)

Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E    Q 
Sbjct: 55  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 148 MSVIKG-------VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              +K        +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.4 bits (128), Expect = 1e-08
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 15/153 (9%)

Query: 50  IGNGGHASVYRAELPS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           IGNG    V   E+ S      V VK+      S    +Q +FL E +     +H N+++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRV---SASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ----ELGWSQRMSVIKGVADALSYLH 162
             G C+      L+ EF   G L   L +   A+    +    QRM+    +A  L +LH
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH 117

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
            + F   +H D++ +N LL  +    + D+G++
Sbjct: 118 KNNF---IHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.2 bits (127), Expect = 1e-08
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++  +  +++VVA+K        D+  D ++   E+  L++     + K+Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L        L  +Q  ++++ +   L YLH +    
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 121

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL    E  +ADFG+A  L         F GT  ++A
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.2 bits (128), Expect = 1e-08
 Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 18/159 (11%)

Query: 50  IGNGGHASVYRAELPSRE------VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G    V+ A+    E      +V VK       +     Q EF  E+    +  H+N
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRRELDMFRKLSHKN 69

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------LGWSQRMSVIKGVADA 157
           +V+  G C  A   +++ E+ + G L   L    +  E      L   Q++++   +A  
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           + +L +  F   VHRD++++N L+  + E  V+   ++K
Sbjct: 130 MDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 12/166 (7%)

Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   D K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 2   EIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKP-----GTMMPEAFLQEAQI 54

Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V  Y   S     +++ EF+ +GSL   L  +   + L   Q + +   +A
Sbjct: 55  MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIA 112

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           D ++Y+    +   +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 113 DGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 35/171 (20%)

Query: 50  IGNGGHASVYRAEL--PSRE-------VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +G G    VY+ EL  P+         +  +K+   P        Q+EF  E + +++ +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP------KVQQEFRQEAELMSDLQ 66

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-----NTDAAAQE--------LGWSQR 147
           H NIV   G C+  + + +L E+L  G L   L     ++D  A+         L  S  
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 148 MSVIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           + +   +A  + YL  HH      VHRD++++N L+       ++DFG+++
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 12/176 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEF-LTEVKALTET 99
           N F+    +G G +  V +     ++E+VA+KKF     S++  + KE  L E+K L   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD---SEENEEVKETTLRELKMLRTL 57

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
           +  NIV+           +L+ E++E+  L  +             +  S I  +  A+ 
Sbjct: 58  KQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIH 114

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL-KSDASNWTEFAGTYGY 214
           + H +    IVHRD+  +NLL+       + DFG A+ L +   +N+TE+  T  Y
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 41/173 (23%), Positives = 74/173 (42%), Gaps = 11/173 (6%)

Query: 49  CIGNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            +G G    VY   ++ +   +AVK+    P   +   +      E++ L   +H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
           +YG         +  E++  GS+   L    A  E   +      + + + + YLH +  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE---TVTRKYTRQILEGVEYLHSN-- 123

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT---EFAGTYGYVA 216
             IVHRD+   N+L D      + DFG +K L++  S+ T      GT  +++
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++  +  +++VVA+K        D+  D ++   E+  L++     + K+Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L     A      Q  +++K +   L YLH +    
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---K 121

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL  + +  +ADFG+A  L         F GT  ++A
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 52.6 bits (127), Expect = 2e-08
 Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 38/174 (21%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPS------DQTVDQKEFLTEVKALTETRHR 102
           +G G +A VY+A    +  +VA+KK             + T      L E+K L E +H 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA-----LREIKLLQELKHP 62

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD------ 156
           NI+       H  +  L+ EF+E   L  ++               S++   AD      
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFME-TDLEKVIK------------DKSIVLTPADIKSYML 109

Query: 157 ----ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
                L YLH   +  I+HRD+   NLL+  +    +ADFG+A+   S     T
Sbjct: 110 MTLRGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 34/152 (22%), Positives = 71/152 (46%), Gaps = 9/152 (5%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+     +   VAVK      P   +V  + FL E   +   +H  +V+ Y 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSV--QAFLEEANLMKTLQHDKLVRLYA 68

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++ +GSL   L +D   + L   + +     +A+ ++Y+    +   
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 124

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDN 156

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.4 bits (125), Expect = 2e-08
 Identities = 47/183 (25%), Positives = 83/183 (45%), Gaps = 21/183 (11%)

Query: 44  FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTE-TR 100
           F+    +GNG +  VY+   + + ++ A+K        D T D++E +  E+  L + + 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTGDEEEEIKQEINMLKKYSH 61

Query: 101 HRNIVKFYGFCSHAR------HSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMSVIKG 153
           HRNI  +YG              +L+ EF   GS+  ++ NT     +  W     + + 
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICRE 119

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +   LS+LH      ++HRD+  +N+LL    E  + DFG++  L         F GT  
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176

Query: 214 YVA 216
           ++A
Sbjct: 177 WMA 179

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 12/155 (7%)

Query: 50  IGNGGHASVYRA---ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G   +V +       S + VAVK   +   ++    + E L E   + +  +  IV+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYIVR 60

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
             G C  A    L+ E  E G L   L  +    E   ++   ++  V+  + YL    F
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF 116

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              VHRD++++N+LL  ++ A ++DFG++K L +D
Sbjct: 117 ---VHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 4e-08
 Identities = 31/152 (20%), Positives = 71/152 (46%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VA+K          ++  + FL E   + + +H  +V+ Y 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T    + L  ++ + +   +A+ ++++    +   
Sbjct: 69  VVTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY--- 123

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 10/149 (6%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H NIVK  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFP 167
                    +L+ EFL +  L   ++  +    +      S +  +   L++ H H    
Sbjct: 66  DVIHTENKLYLVFEFLHQ-DLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSHR--- 120

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 121 -VLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 25/185 (13%)

Query: 44  FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTE-TR 100
           F+    +GNG +  VY+   + + ++ A+K        D T D++E +  E+  L + + 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTEDEEEEIKLEINMLKKYSH 71

Query: 101 HRNIVKFYGF------CSHARHSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMS--VI 151
           HRNI  +YG         H    +L+ EF   GS+  ++ NT   A +  W   +   ++
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           +G+A    + H      ++HRD+  +N+LL    E  + DFG++  L         F GT
Sbjct: 132 RGLAHL--HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184

Query: 212 YGYVA 216
             ++A
Sbjct: 185 PYWMA 189

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.0 bits (124), Expect = 5e-08
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 15/168 (8%)

Query: 51  GNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG- 109
           GNGG  +  + + PS  ++A K  H  +   +   + + + E++ L E     IV FYG 
Sbjct: 16  GNGGVVTKVQHK-PSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 110 FCSHARHSFLLCEFLERGSLAAILN-TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           F S    S  + E ++ GSL  +L       +E+     ++V++G    L+YL       
Sbjct: 72  FYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG----LAYLREK--HQ 124

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 170

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 13/160 (8%)

Query: 47  KYCIGNGG----HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR 102
             CIG G     +  VY +    +  VAVK   +   +  +V +K FL E   + +  H 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREK-FLQEAYIMRQFDHP 67

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           +IVK  G  +     +++ E    G L + L  +     L  +  +     ++ AL+YL 
Sbjct: 68  HIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE 124

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
              F   VHRD++++N+L+       + DFG++++L+ ++
Sbjct: 125 SKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 42/175 (24%), Positives = 78/175 (44%), Gaps = 29/175 (16%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           DF     +G G + SVY+ + L   +  A+K+      S +  ++++ + E++ L    H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--EREDAVNEIRILASVNH 58

Query: 102 RNIVKFYGFCSHARHSFL----LC---EFLERGSLAAILNTDAAA-----QELGWSQRMS 149
            NI+ +       + +FL    LC   E+   G L+  ++          ++  W   + 
Sbjct: 59  PNIISY-------KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
           +++G    L  LH      I+HRD+ S N+LL       + D GI+K LK + + 
Sbjct: 112 LLRG----LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)

Query: 50  IGNGGHASVY--RAELPSREVVAVKK--FHSP------LPSDQTVDQKEFLTEVKALTET 99
           +G+G    VY  R +   + ++A+K+   H+P         D+++   + ++EV  + E 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG--DIVSEVTIIKEQ 65

Query: 100 -RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM-SVIKGVADA 157
            RH NIV++Y         +++ + +E   L    N+    ++    +R+ ++   +  A
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
           L YLH +    IVHRD++  N++L  + +  + DFG+AK  K   S  T   GT  Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILY 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 51.2 bits (122), Expect = 7e-08
 Identities = 38/160 (23%), Positives = 79/160 (49%), Gaps = 15/160 (9%)

Query: 50  IGNGGHASVYRAELPS--REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVK 106
           IG G    V RA +     ++ A  K      S+   D ++F  E++ L +   H NI+ 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHHPNIIN 67

Query: 107 FYGFCSHARHSFLLCEFLERGSL------AAILNTDAA-AQELGWSQRMS---VIKGVAD 156
             G C +  + ++  E+   G+L      + +L TD A A+E G +  ++   +++  +D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             + + +      +HRD++++N+L+     + +ADFG+++
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.2 bits (122), Expect = 9e-08
 Identities = 42/130 (32%), Positives = 65/130 (50%), Gaps = 12/130 (9%)

Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  TRH  +    Y F +  R  F++ E++  G L   L     ++E  +S+  
Sbjct: 43  LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM-EYVNGGELFFHL-----SRERVFSEDR 96

Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH      IV+RD+  +NL+LD +    + DFG+ K   +DA+   
Sbjct: 97  TRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153

Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 154 TFCGTPEYLA 163

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 17/179 (9%)

Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  ++A K  H  +   +   + + + E++ L E  
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61

Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 62  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 115

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 116 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 170

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 20/158 (12%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKF 107
           IG G   +V +    PS  ++AVK+  S    D+  +QK  L ++  +  +     IVKF
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEK-EQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 108 YGFCSHARHSFLLCEFLERGSLA-------AILNTDAAAQELGWSQRMSVIKGVADALSY 160
           YG        ++  E ++  SL         +L +    + LG      +      AL+Y
Sbjct: 69  YGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNY 122

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
           L  +    I+HRDV   N+LLD      + DFGI+  L
Sbjct: 123 LKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 29/176 (16%)

Query: 44  FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALT 97
           FD    IG G +  VY+A +  + E+VA+KK        +  ++KE      + E+K L 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKV-------RLDNEKEGFPITAIREIKILR 61

Query: 98  ETRHRNIVKFY----------GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           +  HRNIV              F       +L+ E+++   L  +L  ++          
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHI 118

Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
            S +K + + L+Y H   F   +HRD+   N+LL+ + +  +ADFG+A+   S+ S
Sbjct: 119 KSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 6/178 (3%)

Query: 41  TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
             +F  +  IG G  + VY+A  L    VVA+KK       D    Q   L E+  L + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEIDLLKQL 59

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLA-AILNTDAAAQELGWSQRMSVIKGVADAL 158
            H N++K+           ++ E  + G L+  I +     + +           +  AL
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++H      I+HRD+   N+ +       + D G+ +F  S  +      GT  Y++
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 50.3 bits (121), Expect = 1e-07
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 16/156 (10%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV---KALTETRHRNIV 105
           IG G + +VY+A +L +   VA+KK   PL S++ +     L E+   K L    H NIV
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLST-LREIALLKQLESFEHPNIV 64

Query: 106 KFYGFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           +    C            L+ E +++  LA  L+       L       +++ +   + +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-KCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           LH      IVHRD+  +N+L+  + +  +ADFG+A+
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 14/169 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A E  + + VAVKK    L   Q   ++E L  EV  + +  H N+V  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQ---RRELLFNEVVIMRDYHHENVVDM 84

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALSYLH+    
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ--- 137

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 13/152 (8%)

Query: 50  IGNGGHASVYRAE---LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           IGNG    V   E     S+  V VK+  +   S    +Q  FL EV+   E  H N+++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRA---SATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK---GVADALSYLHH 163
             G C  +    L+ EF   G L   L ++        +Q+  + +    VA  L +LH 
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             F   +H D++ +N  L  +    + D+G+A
Sbjct: 119 ADF---IHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.5 bits (120), Expect = 1e-07
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 15/160 (9%)

Query: 50  IGNGGHASVYRAELPSR--EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVK 106
           IG G    V +A +      + A  K      S    D ++F  E++ L +   H NI+ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIIN 60

Query: 107 FYGFCSHARHSFLLCEFLERGSL------AAILNTDAA-AQELGWSQRMS---VIKGVAD 156
             G C H  + +L  E+   G+L      + +L TD A A     +  +S   ++   AD
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               + +      +HRD++++N+L+   Y A +ADFG+++
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 14/169 (8%)

Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A + S  ++VAVKK    L   Q   ++E L  EV  + + +H N+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQ---RRELLFNEVVIMRDYQHENVVEM 82

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALS LH     
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQ--- 135

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 25/182 (13%)

Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSP----LPSDQTV-DQKEFLTEVKAL 96
           D +    +G G    V+   +  S    A+K    P    L  +Q V ++K  L EV   
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV--- 58

Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
               H  I++ +      R  ++L E++  G L + L          +S    +     +
Sbjct: 59  ---SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEI 110

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      IV+RD+  +N+LLD E    + DFG AK L+     WT   GT  Y
Sbjct: 111 VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWT-LCGTPEY 164

Query: 215 VA 216
           +A
Sbjct: 165 LA 166

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 12/161 (7%)

Query: 50  IGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G   SV  A+L     S + VAVK   + + S  + D +EFL E   + E  H N++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVI 64

Query: 106 KFYGFCSHARHS------FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
           K  G    +R         ++  F++ G L   L      +E       ++++ + D  S
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
            + +      +HRD++++N +L+      VADFG++K + S
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 16/142 (11%)

Query: 68  VVAVKKFHSPLPSDQTVDQK-EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLER 126
           +VAVK     L  D   + + +FL E+K ++  +  NI++    C  +    ++ E++E 
Sbjct: 48  LVAVKM----LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103

Query: 127 GSLAAILN--------TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN 178
           G L   L+          A    + +S  + +   +A  + YL    F   VHRD++++N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRN 160

Query: 179 LLLDLEYEAHVADFGIAKFLKS 200
            L+   Y   +ADFG+++ L S
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYS 182

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 37/166 (22%), Positives = 76/166 (45%), Gaps = 12/166 (7%)

Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+ A       VAVK      P   +V+   FL E   
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANV 54

Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           +   +H  +VK +   +     +++ EF+ +GSL   L +D    +    + +     +A
Sbjct: 55  MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIA 112

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           + ++++    +   +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 113 EGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDN 155

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.9 bits (119), Expect = 2e-07
 Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 29/172 (16%)

Query: 50  IGNGGHASVYRAEL---------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +G+G    VY             P R  VAVK       +DQ  ++KEFL E   ++   
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIR--VAVKTLRKG-ATDQ--EKKEFLKEAHLMSNFN 57

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-----LGWSQRMSVIKGVA 155
           H NIVK  G C      +++ E +E G L + L  DA  +      L   + + +   VA
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLR-DARVERFGPPLLTLKELLDICLDVA 116

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLL-----DLEYEAHVADFGIAKFL-KSD 201
               YL    F   +HRD++++N L+     D +    + DFG+A+ + KSD
Sbjct: 117 KGCVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 18/161 (11%)

Query: 42  NDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQ----KEFLTEVKAL 96
            DF     +G GG+  V+ A+   + E+VA+K+          + +    +  LTE   L
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRM-----KKSLLFKLNEVRHVLTERDIL 55

Query: 97  TETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           T T+   +VK  Y F     + +L  E++  G    +LN      E     R  + +   
Sbjct: 56  TTTKSEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFE 112

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            A+  LH       +HRD+  +N L+D      + DFG++K
Sbjct: 113 -AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 49.7 bits (118), Expect = 3e-07
 Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 4/135 (2%)

Query: 66  REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE 125
           RE+ A +    P   + + +      E++ L   +H  IV++YG C   R    L  F+E
Sbjct: 28  RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFME 86

Query: 126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY 185
                ++ +   A   L  S      + + + +SYLH +    IVHRD+   N+L D   
Sbjct: 87  YMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAG 143

Query: 186 EAHVADFGIAKFLKS 200
              + DFG +K L++
Sbjct: 144 NVKLGDFGASKRLQT 158

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 39/183 (21%)

Query: 28  EVGKILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQ 86
           EV K  Y+++ K          IG G    V++A    ++++VA+KK           ++
Sbjct: 10  EVSK--YEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKV-------LMENE 50

Query: 87  KE-F----LTEVKALTETRHRNIVKFYGFC-------SHARHSF-LLCEFLERGSLAAIL 133
           KE F    L E+K L   +H N+V     C       +  + SF L+ EF E   LA +L
Sbjct: 51  KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL 109

Query: 134 NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
           +       L   +++  +K + + L Y+H      I+HRD+ + N+L+  +    +ADFG
Sbjct: 110 SNKNVKFTLSEIKKV--MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG 164

Query: 194 IAK 196
           +A+
Sbjct: 165 LAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 42/130 (32%), Positives = 64/130 (49%), Gaps = 12/130 (9%)

Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  TRH  +    Y F +H R  F++ E+   G L   L     ++E  +S+  
Sbjct: 43  LTESRVLQNTRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-----SRERVFSEDR 96

Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +   
Sbjct: 97  ARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153

Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 154 TFCGTPEYLA 163

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 12/150 (8%)

Query: 50  IGNGGHASVYRAELPSR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G G +A+VY+    +R   E+VA+K+ H  L +++       + E+  + E +H NIV+
Sbjct: 8   LGEGTYATVYKGR--NRTTGEIVALKEIH--LDAEEGTPSTA-IREISLMKELKHENIVR 62

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +          L+ E+++   L   ++T      L  +   S    +   +++ H +  
Sbjct: 63  LHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-- 119

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             ++HRD+  +NLL++   E  +ADFG+A+
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  VY+A +  + E +A+KK       D+ V     + E+  L E +H NIV+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLE-QEDEGVPSTA-IREISLLKEMQHGNIVRLQ 67

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM------SVIKGVADALSYLH 162
                 +  +L+ E+L+   L    + D++  +   + R+       +++G+A    Y H
Sbjct: 68  DVVHSEKRLYLVFEYLD---LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIA----YCH 119

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAK 196
                 ++HRD+  +NLL+D    A  +ADFG+A+
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 31/161 (19%)

Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERG 127
           +VAVK      P      + +FL EVK L+  +  NI++  G C       ++ E++E G
Sbjct: 48  LVAVKILR---PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENG 104

Query: 128 SLAAILNT----------------DAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVH 171
            L   L++                      + +S  + V   +A  + YL    F   VH
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VH 161

Query: 172 RDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTY 212
           RD++++N L+       +ADFG+++ L         +AG Y
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNL---------YAGDY 193

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 48.7 bits (116), Expect = 5e-07
 Identities = 38/160 (23%), Positives = 73/160 (45%), Gaps = 18/160 (11%)

Query: 50  IGNGGHASVYRAELPSREV----VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G   SV   +L   +     VAVK     + +   ++  EFL+E   + +  H N++
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE--EFLSEAACMKDFDHPNVM 64

Query: 106 KFYGFC--SHARHSF----LLCEFLERGSLAAIL---NTDAAAQELGWSQRMSVIKGVAD 156
           K  G C  + +        ++  F++ G L + L         ++L     +  +  +A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            + YL +  F   +HRD++++N +L  +    VADFG++K
Sbjct: 125 GMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 12/130 (9%)

Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           +TE + L  TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  
Sbjct: 43  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEER 96

Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +   
Sbjct: 97  ARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153

Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 154 TFCGTPEYLA 163

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.9 bits (116), Expect = 6e-07
 Identities = 39/130 (30%), Positives = 63/130 (48%), Gaps = 11/130 (8%)

Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  +RH  +    Y F +H R  F++ E+   G L   L+ +       +S+  
Sbjct: 43  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERV-----FSEDR 96

Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +   
Sbjct: 97  ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154

Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 155 TFCGTPEYLA 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.4 bits (115), Expect = 6e-07
 Identities = 39/160 (24%), Positives = 79/160 (49%), Gaps = 12/160 (7%)

Query: 50  IGNGGHASVYRA--ELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V +   ++  +++ VA+K   +    ++   + E + E + + +  +  IV+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
             G C  A    L+ E    G L   L+      E+  S  + ++  V+  + YL    F
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
              VHRD++++N+LL  ++ A ++DFG++K L +D S + 
Sbjct: 117 ---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.3 bits (115), Expect = 8e-07
 Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 9/138 (6%)

Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLERG 127
           VAVK       S +    +  ++E+K ++    H NIV   G C+      ++ E+   G
Sbjct: 68  VAVKMLKPTAHSSER---EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124

Query: 128 SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA 187
            L   L     +  L     +S    VA  +++L        +HRD++++N+LL      
Sbjct: 125 DLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIV 180

Query: 188 HVADFGIAKFLKSDASNW 205
            + DFG+A+ + +D SN+
Sbjct: 181 KICDFGLARDIMND-SNY 197

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 48.2 bits (115), Expect = 8e-07
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 7/148 (4%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  VY+     + ++VA+KK    L S++       + E+  L E +H NIV   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIR--LESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +L+ EFL    L   L++    Q +      S +  +   + + H      
Sbjct: 66  DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           ++HRD+  +NLL+D +    +ADFG+A+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 9e-07
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)

Query: 44  FDAKYCIGNGGHASVYRA---ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           ++ + CIG G +  VY+A        +  A+KKF         + Q     E+  L E +
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRELK 60

Query: 101 HRNIVKFYG-FCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGVAD 156
           H N+V     F  HA  S +LL ++ E   L  I+     A+ +     M  S++  + +
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH----VADFGIAKF 197
            + YLH +    ++HRD+   N+L+  E        + D G+A+ 
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.0 bits (114), Expect = 9e-07
 Identities = 39/169 (23%), Positives = 75/169 (44%), Gaps = 28/169 (16%)

Query: 50  IGNGGHASVYRAEL-------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RH 101
           +G G    V RAE        P + V    K      +D+  D  + ++E++ +    +H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK--DLADLISEMELMKLIGKH 77

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQRM 148
           +NI+   G C+     +++ E+  +G+L   L              T    ++L +   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 149 SVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 14/167 (8%)

Query: 41  TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-T 99
           T+ ++    IG G +  VY+        +A  K   P+ SD  VD+ E   E   L    
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SD--VDE-EIEAEYNILQSLP 76

Query: 100 RHRNIVKFYGFCSHARHS-----FLLCEFLERGSLAAILN-TDAAAQELGWSQRMSVIKG 153
            H N+VKFYG    A        +L+ E    GS+  ++       Q L  +    ++ G
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
               L +LH++    I+HRDV   N+LL  E    + DFG++  L S
Sbjct: 137 ALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 25/173 (14%)

Query: 51  GNGG--HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           GNGG     ++R   PS  ++A K  H  L     + + + + E+K L E     IV FY
Sbjct: 12  GNGGVVTKVLHR---PSGLIMARKLIH--LEIKPAI-RNQIIRELKVLHECNSPYIVGFY 65

Query: 109 G-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADALSYLH--H 163
           G F S    S  + E ++ GSL  +L       E  LG      +   V   L+YL   H
Sbjct: 66  GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKH 119

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 120 K----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 166

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 17/183 (9%)

Query: 27  PEVGK-ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVD 85
           P  GK I++D     ++ ++    IG G +  V++         A  K   P+       
Sbjct: 2   PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61

Query: 86  QKEFLTEVKALTETRHRNIVKFYGF-----CSHARHSFLLCEFLERGSLAAILNTDAAAQ 140
           + E+   +KAL++  H N+VKFYG        +    +L+ E    GS+     TD    
Sbjct: 62  EAEY-NILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKG 113

Query: 141 ELGWSQRMS---VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
            L   +RM    +   + +AL  L H      +HRDV   N+LL  E    + DFG++  
Sbjct: 114 FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173

Query: 198 LKS 200
           L S
Sbjct: 174 LTS 176

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 10/149 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  VY+A +  + E+VA+KK    L ++        + E+  L E  H NIV+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFP 167
                    +L+ EFL+   L   +++ +    L      S +  +   ++Y H H    
Sbjct: 65  DVVHSENKLYLVFEFLDL-DLKKYMDS-SPLTGLDPPLIKSYLYQLLQGIAYCHSHR--- 119

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            ++HRD+  +NLL+D E    +ADFG+A+
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 28/168 (16%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQT-VDQKEFLTEVKAL-TETRH 101
           +G G    V +AE            VAVK     L  D T  D  + ++E++ +    +H
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKM----LKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAIL------NTDAA-------AQELGWSQRM 148
           +NI+   G C+     +++ E+   G+L   L         A+        + L     +
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           S    VA  + +L        +HRD++++N+L+  ++   +ADFG+A+
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.8 bits (111), Expect = 2e-06
 Identities = 36/157 (22%), Positives = 71/157 (45%), Gaps = 12/157 (7%)

Query: 50  IGNGGHASVYRA--ELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G    + R   +LPS+    VA+    +     Q   ++ FL E   L +  H NIV
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ---RRGFLAEALTLGQFDHSNIV 69

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G  +      ++ E++  G+L + L       +L   Q M ++ G+A  + YL    
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           +   VH+ +++  +L++ +    ++ F   +  KS+A
Sbjct: 128 Y---VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 26/177 (14%)

Query: 44  FDAKYCIGNGGHASVYRAELPSREVVAVKK---FHSPLPSDQTVDQKEFLTEVKALTETR 100
           ++    IG G    +Y A+  S     V K          ++   +KE    V  L + +
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKE----VILLAKMK 57

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA-----QELGWSQRMSVIKGVA 155
           H NIV F+         F++ E+ + G L   +N          Q L W  ++S+     
Sbjct: 58  HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----- 112

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASNWTEFAGT 211
             L ++H      I+HRD+ S+N+ L      A + DFGIA+ L    ++  E A T
Sbjct: 113 -GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYT 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 15/160 (9%)

Query: 50  IGNGGHASVYRAELP--SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           IG GG   VY A  P  SR V A+KK    L S+  + +K FL E K   +  H  IV  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRV-ALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNT----DAAAQELGWSQR----MSVIKGVADALS 159
           Y  CS     +    ++E  +L ++L +    ++ ++EL         +S+   +   + 
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           Y+H      ++HRD+   N+LL L  E  + D+G A F K
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164

Length = 932

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 20/168 (11%)

Query: 43  DFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
           D  ++Y     IG+G +  V  A +  S + VA+KK   P   D     K  L E+K L 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILR 59

Query: 98  ETRHRNIVK----FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM-SVIK 152
             +H NI+          +  +  +++ + +E   L  I+++D    E      +  +++
Sbjct: 60  HFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
           G    L Y+H      ++HRD+   NLL++ + E  + DFG+A+ L S
Sbjct: 119 G----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 83  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 138

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 46.5 bits (110), Expect = 3e-06
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 18/157 (11%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSD----QTVDQKEFLTEVKALTETRHRNI 104
           IG G + +VY+A +  S   VA+K        D     TV +   L   K L    H NI
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALL---KRLEAFDHPNI 64

Query: 105 VKFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
           V+    C+ +R        L+ E +++  L   L+       L       +++     L 
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLD 122

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +LH +C   IVHRD+  +N+L+    +  +ADFG+A+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 46.0 bits (109), Expect = 3e-06
 Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 14/121 (11%)

Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA----- 139
           +++E   EV  L+  +H NIV++        + +++ ++ E G L   +N          
Sbjct: 42  EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED 101

Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           Q L W  ++ +      AL ++H      I+HRD+ S+N+ L  +    + DFGIA+ L 
Sbjct: 102 QILDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152

Query: 200 S 200
           S
Sbjct: 153 S 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 21/165 (12%)

Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTE 92
           Y+++ K          IG G + +V++A    + E+VA+K+    L  D        L E
Sbjct: 2   YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALRE 49

Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           +  L E +H+NIV+ Y      +   L+ E+ ++  L      D+   ++      S + 
Sbjct: 50  ICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF--DSCNGDIDPEIVKSFMF 106

Query: 153 GVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +   L++ H H+    ++HRD+  +NLL++   E  +ADFG+A+
Sbjct: 107 QLLKGLAFCHSHN----VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.2 bits (109), Expect = 4e-06
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 7/149 (4%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +   R+ VAVKK   P  S   +  +    E++ L   +H N++   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLL 80

Query: 109 GFCSHARHSFLLCE-FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
              + A       E +L    + A LN     Q+L       +I  +   L Y+H     
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---A 137

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            I+HRD+   N+ ++ + E  + DFG+A+
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.9 bits (109), Expect = 4e-06
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 15/171 (8%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKF--HSPLPSDQTVDQKEFLTEVKALTE 98
            DF+    I NG + +VY      +R+  A+KK    + +  +Q + Q     E   LT 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-IQQ--VFVERDILTF 57

Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMSVIKGVADA 157
             +  +V  +      RH  ++ E++E G  A +L N  A   ++    RM   + V  A
Sbjct: 58  AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMYFAETVL-A 113

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF-LKSDASNWTE 207
           L YLH+     IVHRD+   NLL+       + DFG++K  L S  +N  E
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.8 bits (108), Expect = 5e-06
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 17/159 (10%)

Query: 50  IGNGGHASVYRAELPSREV---VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G G   SV   +L   +    VAVK     + +    + ++FL+E   + E  H N+++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNVMR 64

Query: 107 FYGFC--SHARHSF----LLCEFLERGSLAA-ILNTDAAAQELGWSQRMSV--IKGVADA 157
             G C  +     +    ++  F++ G L + +L +           +M V  +  +A  
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           + YL    F   +HRD++++N +L+      VADFG++K
Sbjct: 125 MEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 45.7 bits (108), Expect = 5e-06
 Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 33/158 (20%)

Query: 63  LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE 122
                 VAVK       +  + + ++ L+E   L +  H +++K YG CS      L+ E
Sbjct: 27  RAGYTTVAVKMLKE---NASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83

Query: 123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI------------- 169
           + + GSL + L     ++++G S    +        SYL +     +             
Sbjct: 84  YAKYGSLRSFLRE---SRKVGPS---YLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS 137

Query: 170 -----------VHRDVSSKNLLLDLEYEAHVADFGIAK 196
                      VHRD++++N+L+    +  ++DFG+++
Sbjct: 138 RGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.7 bits (108), Expect = 5e-06
 Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 14/105 (13%)

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL--NTDAAAQE--LGWSQRMSVIKGVAD 156
           H  IV+  G C  A    L+ +    GSL   +  + D+   +  L W  +      +A 
Sbjct: 68  HAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAK 120

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL       +VHR+++++N+LL  +    +ADFG+A  L  D
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.4 bits (107), Expect = 6e-06
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 10/155 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           +G G    VY   +  +   +AVK+      S +T  +   L  E++ L    H  IV++
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 108 YGFCSHARHSFL--LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           YG         L    E +  GS+   L +  A  E   +++ +  + + + +SYLH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLHSNM 126

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
              IVHRD+   N+L D      + DFG +K L++
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 6e-06
 Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 17/150 (11%)

Query: 41  TNDFDAKYCIGNGGHASVYRAELPS---------REVVAVKKFHSPLPSDQTVDQKEFLT 91
           TN +D +  +  GG       E            RE+  V K   P   D  +    F  
Sbjct: 9   TNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIAL---AFFE 65

Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
               +++  H ++   +G C     + ++ EF+E G L   L  +     + W  +++V 
Sbjct: 66  TASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVA 123

Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLL 181
           + +A ALSYL       +VH +V +KN+LL
Sbjct: 124 QQLASALSYLEDK---NLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (107), Expect = 7e-06
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 16/158 (10%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE---FLTEVKALTETRHRNIV 105
           +G G    VY   +  +   +AVK+   P   D     KE      E++ L   RH  IV
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQV--PFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 106 KFYGFC---SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           ++YG C      +   +  E++  GS+   L    A  E   ++R +  + +   +SYLH
Sbjct: 68  QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGVSYLH 123

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
            +    IVHRD+   N+L D      + DFG +K +++
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 37/161 (22%), Positives = 74/161 (45%), Gaps = 24/161 (14%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFH-SPLPSDQTVDQKEF---------LTEVKALTE 98
           +G G +  V +A    + ++VA+KK     + +D T D++           L E+K + E
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 99  TRHRNIVKFYG-FCSHARHSF--LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            +H NI+     +       F  L+ + +    L  +++      E   SQ   ++  + 
Sbjct: 77  IKHENIMGLVDVYVEG---DFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQIL 129

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           + L+ LH   +   +HRD+S  N+ ++ +    +ADFG+A+
Sbjct: 130 NGLNVLH-KWY--FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 33/141 (23%), Positives = 62/141 (43%), Gaps = 13/141 (9%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE------FLTEVKALTETRHRN 103
           +G G    +++     REV    + H      + +D+        F      +++  H++
Sbjct: 3   LGQGTFTKIFKGI--RREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           +V  YG C     S ++ E+++ GSL   L  +     + W  ++ V K +A AL +L  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED 118

Query: 164 DCFPPIVHRDVSSKNLLLDLE 184
                + H +V +KN+LL  E
Sbjct: 119 K---GLTHGNVCAKNVLLIRE 136

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 44.4 bits (105), Expect = 1e-05
 Identities = 32/127 (25%), Positives = 55/127 (43%), Gaps = 4/127 (3%)

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           L E+  L+  +H NI+ +Y          +  E+   G+L   +      Q       + 
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV-RQKGQLFEEEMVLW 105

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
            +  +  A+SY+H      I+HRD+ + N+ L       + DFGI+K L S+ S      
Sbjct: 106 YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162

Query: 210 GTYGYVA 216
           GT  Y++
Sbjct: 163 GTPYYMS 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 1e-05
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 5/96 (5%)

Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           F      + +  H++IV  YG C     + ++ EF+E G L   ++  +      W  + 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
            V K +A ALSYL       +VH +V +KN+LL  E
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 32/171 (18%)

Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 81

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L              T    ++L +  
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 142 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 16/153 (10%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  + E VA+KK   P  S+  +  K    E+  L   +H N++   
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLL 80

Query: 109 G-FCS----HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
             F S         F L     +  L  I+    +  ++ +     ++  +   L Y+H 
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS 135

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
                I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 136 ---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 19/182 (10%)

Query: 45  DAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           D KY     IG G +  V  A    + E VA+KK  +    D  +D K  L E+K L   
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHL 61

Query: 100 RHRNIVKFYGFCS-HARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
            H N++          R +F    ++ E ++   L  I+ +   +Q L        +  +
Sbjct: 62  DHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRS---SQTLSDDHCQYFLYQL 117

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
              L Y+H      ++HRD+   NLLL+   +  + DFG+A+         TE+  T  Y
Sbjct: 118 LRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174

Query: 215 VA 216
            A
Sbjct: 175 RA 176

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 43.7 bits (103), Expect = 3e-05
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 20/154 (12%)

Query: 50  IGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           IGNG    V  +E+        V VK+  +   +  + +Q EFL +       +H NI++
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNT------DAAAQELGWSQRMSVIKGVADALSY 160
             G C  A    L+ E+ E G L + L+       ++    L   QRM+    +A  +++
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMAC--EIAAGVTH 114

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI 194
           +H   F   +H D++ +N  L  +    V D+GI
Sbjct: 115 MHKHNF---LHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 17/155 (10%)

Query: 50  IGNGGHA---SVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIV 105
           +G G +    S   AE    E VA+KK  +     + +  K  L E+K L   R H+NI 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNIT 65

Query: 106 KFYG----FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
             Y     F  +    +L  E +E   L  I+ +    Q L  +   S I  +   L Y+
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYI 121

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           H      ++HRD+   NLL++ + E  + DFG+A+
Sbjct: 122 HS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 43.1 bits (101), Expect = 3e-05
 Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 4/175 (2%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F  +  IG G  + VYRA  L  R+ VA+KK       D    Q + + E+  L +  H
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-DCVKEIDLLKQLNH 61

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            N++K+           ++ E  + G L+ ++      + L      +V K      S +
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFVQLCSAV 119

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            H     ++HRD+   N+ +       + D G+ +F  S  +      GT  Y++
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.0 bits (101), Expect = 4e-05
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 22/174 (12%)

Query: 51  GNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGF 110
           G+ G  S+ R     ++ V +KK +  L +    ++K    E + L++ +H NIV +   
Sbjct: 11  GSYGEVSLVRHRTDGKQYV-IKKLN--LRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64

Query: 111 CSHARHS--------FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
               R S        +++  F E G L   L  +   + L  +Q +     +A AL YLH
Sbjct: 65  ----RESWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                 I+HRD+ ++N+ L       V D GIA+ L++     +   GT  Y++
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 27/159 (16%)

Query: 50  IGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L      +   AVK   + +   + V+Q  FL E   + +  H N++
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQ--FLKEGIIMKDFSHPNVL 59

Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG-------VADA 157
              G C  +  S  ++  +++ G L   + ++              +K        VA  
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKG 110

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           + YL    F   VHRD++++N +LD  +   VADFG+A+
Sbjct: 111 MEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 42.7 bits (100), Expect = 5e-05
 Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 21/171 (12%)

Query: 54  GHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           G  S  RA L     S +  A+K+   P  S    D ++   E   L + +H NIV F  
Sbjct: 9   GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFKE 65

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAA-----QELGWSQRMSVIKGVADALSYLHHD 164
                 H +++ E+ + G L   +             L W  +M +       + ++H  
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
               ++HRD+ SKN+ L    +  + DFG A+ L S  +    + GT  YV
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV 167

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 42.5 bits (100), Expect = 5e-05
 Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 13/171 (7%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEF--LTEVKALTETRHRNIVK 106
           +G G    V+       +++V +K+    +P +Q    +      E + L    H NI++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
           +Y      +   ++ E+   G+LA  +     +         +++      L  LHH   
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQILLALHHVHT 119

Query: 167 PPIVHRDVSSKNLLLDLEYE-AHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             I+HRD+ ++N+LLD       + DFGI+K L S +  +T   GT  Y++
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYIS 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 11/129 (8%)

Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG-FCSHARHSFLLCEFLERG 127
           VA+KK   P  +   V  K    E+K L   RH NI+     F S     + + E L   
Sbjct: 38  VAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT- 94

Query: 128 SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA 187
            L  +L +    ++        +++G    L Y+H      +VHRD+   N+L++   + 
Sbjct: 95  DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---AGVVHRDLKPSNILINENCDL 147

Query: 188 HVADFGIAK 196
            + DFG+A+
Sbjct: 148 KICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 42.4 bits (99), Expect = 7e-05
 Identities = 37/166 (22%), Positives = 71/166 (42%), Gaps = 14/166 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVV----AVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G+G   +VY+   +P  E V    A+K  +        V   EF+ E   +    H ++
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV---EFMDEALIMASMDHPHL 71

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           V+  G C       L+ + +  G L   ++       +G    ++    +A  + YL   
Sbjct: 72  VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
               +VHRD++++N+L+       + DFG+A+ L+ D   +    G
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 42.5 bits (100), Expect = 7e-05
 Identities = 49/184 (26%), Positives = 74/184 (40%), Gaps = 34/184 (18%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A +  + E VA+KK +     +   D    L E+K L   RH +IV+  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEI- 64

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF-- 166
                 +H  L     E   +  +        EL  S    VIK   D L+  HH  F  
Sbjct: 65  ------KHIMLPPSRREFKDIYVVF-------ELMESDLHQVIKA-NDDLTPEHHQFFLY 110

Query: 167 -----------PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTY 212
                        + HRD+  KN+L + + +  + DFG+A+   +D      WT++  T 
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 213 GYVA 216
            Y A
Sbjct: 171 WYRA 174

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.3 bits (99), Expect = 7e-05
 Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 27/164 (16%)

Query: 50  IGNGGHASVY--------RAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +G G    VY        + E  +R  VAVK  +    S    ++ EFL E   +     
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTC 68

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAIL---------NTDAAAQELGWSQRMSVIK 152
            ++V+  G  S  + + ++ E +  G L + L         N       L    +M+   
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA-- 126

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +AD ++YL+   F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 127 EIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 8e-05
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 22/177 (12%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A   P+   VA+KK  SP    QT  Q+  L E+K L   +H NI+   
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKI-SPF-EHQTFCQRT-LREIKILRRFKHENIIGIL 69

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS------VIKGVADALSYLH 162
                         F +   +  ++ TD    +L  +Q +S       +  +   L Y+H
Sbjct: 70  DI-IRPPS---FESFNDVYIVQELMETD--LYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVA 216
                 ++HRD+   NLLL+   +  + DFG+A+    +  +    TE+  T  Y A
Sbjct: 124 S---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 42.1 bits (100), Expect = 8e-05
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 34/181 (18%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G +  V  A    +   VA+KK       D  +D K  L E+K L   RH NI+   
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 109 G-FCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMS-----VIKGVADAL 158
                 +   F    ++ E +E   L  ++ +    Q L     +      +++G    L
Sbjct: 66  DILRPPSPEDFNDVYIVTELME-TDLHKVIKSP---QPLT-DDHIQYFLYQILRG----L 116

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD---ASNWTEFAGTYGYV 215
            YLH      ++HRD+   N+L++   +  + DFG+A+ +  D       TE      YV
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE------YV 167

Query: 216 A 216
            
Sbjct: 168 V 168

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 42.3 bits (100), Expect = 9e-05
 Identities = 33/152 (21%), Positives = 62/152 (40%), Gaps = 23/152 (15%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           C  +     + + + P+  +VAVKK +  L S    D K    E+    + +H NI+ + 
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKIN--LDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTD--------AAAQELGWSQRMSVIKGVADALSY 160
                    +++   +  GS   +L T         A A          ++K V +AL Y
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---------ILKDVLNALDY 116

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF 192
           +H   F   +HR V + ++LL  + +  ++  
Sbjct: 117 IHSKGF---IHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 41.9 bits (98), Expect = 9e-05
 Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 4/175 (2%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F  +  IG G  + VYRA  L     VA+KK       D      + + E+  L +  H
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLNH 61

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            N++K+Y          ++ E  + G L+ ++      + L      +V K      S L
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPEKTVWKYFVQLCSAL 119

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            H     ++HRD+   N+ +       + D G+ +F  S  +      GT  Y++
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 25/111 (22%), Positives = 51/111 (45%), Gaps = 18/111 (16%)

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 139 LVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 28/111 (25%), Positives = 53/111 (47%), Gaps = 18/111 (16%)

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT----------DAAA---QELGWSQ 146
           +H+NI+   G C+     ++L E+  +G+L   L            D      ++L +  
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 136 LVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 23/174 (13%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA-----LTETRHRNI 104
           I  G   SVY A    ++      F   +     +  K  +T VKA     + +     +
Sbjct: 4   ISKGAFGSVYLA----KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
            K Y       + +L+ E+L  G  A+++ T     E  W+++   I  V   +  LH  
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWAKQY--IAEVVLGVEDLHQR 116

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK--FLKSDASNWTEFAGTYGYVA 216
               I+HRD+  +NLL+D      + DFG+++             F GT  Y+A
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLA 161

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 37/182 (20%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKK----FHSPLPSDQTVDQKEFLTEVKALTETR-HRN 103
           +G G +  V++A +  ++EVVA+KK    F      + T  Q+ F  E+  L E   H N
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAF-----RNATDAQRTF-REIMFLQELGDHPN 68

Query: 104 IVKFYGF--CSHARHSFLLCEFLERGSLAAILNTDAAA-------QELGWSQRMSVIKGV 154
           IVK        + +  +L+ E++E         TD  A       +++    +  ++  +
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYME---------TDLHAVIRANILEDV---HKRYIMYQL 116

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL Y+H      ++HRD+   N+LL+ +    +ADFG+A+ L     N      T  Y
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-Y 172

Query: 215 VA 216
           VA
Sbjct: 173 VA 174

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 9/134 (6%)

Query: 85  DQKEFLTEVKALTET-RHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL 142
           +QK  + E   L +  +H  +V   Y F +  +  F+L +F+  G L   L  + +  E 
Sbjct: 38  EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL-DFVNGGELFFHLQRERSFPE- 95

Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
              +       +A AL YLH      IV+RD+  +N+LLD +    + DFG+ K   + +
Sbjct: 96  --PRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150

Query: 203 SNWTEFAGTYGYVA 216
              T F GT  Y+A
Sbjct: 151 DTTTTFCGTPEYLA 164

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 30/158 (18%)

Query: 50  IGNGGHASVY--RAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G +A+V+  R++L +  +VA+K+    L  ++       + EV  L   +H NIV  
Sbjct: 13  LGEGTYATVFKGRSKL-TENLVALKEIR--LEHEEGAPCTA-IREVSLLKNLKHANIVTL 68

Query: 108 YGFCSHARHSFLLCEFLER---------GSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
           +      R   L+ E+L+          G+L ++ N      +L        ++G    L
Sbjct: 69  HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL--------LRG----L 116

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           SY H      I+HRD+  +NLL++ + E  +ADFG+A+
Sbjct: 117 SYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 12/109 (11%)

Query: 91  TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV 150
            E  AL  ++   IV  Y     A + +L+ E+L  G + ++L+      E      M+V
Sbjct: 53  AERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAV 107

Query: 151 --IKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             I  VA AL YLH H     I+HRD+   N+L+  E    + DFG++K
Sbjct: 108 KYISEVALALDYLHRHG----IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 41.1 bits (97), Expect = 2e-04
 Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 31/173 (17%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKF--HSPLPSDQTVDQKE-F----LTEVKALTETRH 101
           +G G    VY+A ++ +  VVA+KK   H+         +K+ F    L E+K L + +H
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHN---------EKDGFPITALREIKILKKLKH 66

Query: 102 RNIVK----FY---GFCSHARHSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMSVIKG 153
            N+V                R S  +        L+ +L N      E   SQ    +  
Sbjct: 67  PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE---SQIKCYMLQ 123

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           + + ++YLH +    I+HRD+ + N+L+D +    +ADFG+A+       N  
Sbjct: 124 LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 16/129 (12%)

Query: 86  QKEFLTEVKA----LTETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAIL-NTDAAA 139
           +KE +  ++A    L E     +VK FY F    R+ +L+ EFL  G +  +L   D  +
Sbjct: 41  EKEQVAHIRAERDILVEADGAWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99

Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           +E         I     A+  +H   F   +HRD+   NLLLD +    ++DFG+   LK
Sbjct: 100 EE----ATQFYIAETVLAIDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152

Query: 200 SDASNWTEF 208
              ++ TEF
Sbjct: 153 K--AHRTEF 159

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 35/147 (23%), Positives = 66/147 (44%), Gaps = 6/147 (4%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G + SVY+    P+   +A+K+    L  +   +Q   + E+  L +     IV FY
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQ--IIMELDILHKAVSPYIVDFY 65

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        ++  E+++ GSL  +     A + +       +   V   L +L  +    
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIA 195
           I+HRDV   N+L++   +  + DFG++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 31/127 (24%), Positives = 58/127 (45%), Gaps = 17/127 (13%)

Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQ- 146
           EF  E   + E  H NIV   G  +  +   +L E+L +G L   L   +   ++G S  
Sbjct: 53  EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112

Query: 147 -----RMSVIKG--------VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
                + S+  G        +A  + YL    F   VH+D++++N+L+  +    ++D G
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLG 169

Query: 194 IAKFLKS 200
           +++ + S
Sbjct: 170 LSREIYS 176

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 3e-04
 Identities = 20/66 (30%), Positives = 34/66 (51%), Gaps = 4/66 (6%)

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           Q + + K + + L YLH      I+HRDV ++N+ ++   +  + D G A+F    A  +
Sbjct: 158 QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAF 213

Query: 206 TEFAGT 211
              AGT
Sbjct: 214 LGLAGT 219

Length = 357

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 41.0 bits (96), Expect = 3e-04
 Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 24/162 (14%)

Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY--GFCSHARHSFLLCEFLER 126
           VA+K   +  P ++   +  F  E        H NIV     G        F + E++  
Sbjct: 6   VAIKLLRTDAPEEEH-QRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPG 63

Query: 127 GSLAAILNTDAA--AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL--- 181
            +L  +L  D A  A E G      ++  V DAL+  H+     IVHRD+  +N+++   
Sbjct: 64  RTLREVLAADGALPAGETG-----RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115

Query: 182 DLEYEAHVADFGIAKFL-------KSDASNWTEFAGTYGYVA 216
            +   A V DFGI   L        +  +  TE  GT  Y A
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCA 157

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 42/181 (23%), Positives = 75/181 (41%), Gaps = 32/181 (17%)

Query: 43  DFDAKYC----IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
           D  ++Y     +G G +  V+ A +    + VAVKK    +        K  L E+K + 
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK----IVLTDPQSVKHALREIKIIR 57

Query: 98  ETRHRNIVKFY--------------GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELG 143
              H NIVK Y              G  +     +++ E++E   LA +L     ++E  
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHA 116

Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDA 202
                 +++G    L Y+H      ++HRD+   N+ ++ E     + DFG+A+ +    
Sbjct: 117 RLFMYQLLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 203 S 203
           S
Sbjct: 170 S 170

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.8 bits (93), Expect = 5e-04
 Identities = 24/64 (37%), Positives = 34/64 (53%), Gaps = 5/64 (7%)

Query: 154 VADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTY 212
           V  AL +LH H     +++RD+   N+LLD E    +ADFG+ K    +    T F GT 
Sbjct: 105 VTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160

Query: 213 GYVA 216
            Y+A
Sbjct: 161 DYIA 164

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 20/180 (11%)

Query: 43  DFDAKYCIGNGGHASVYRAELPSREV--VAVKKFH-SPLPSDQTVDQKEFLTEVKALTET 99
           DF+    +G G    V  A   + +   VA+K+F  S +   + VD     +E K L   
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH--VFSERKILNYI 88

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA-AQELG--WSQRMSVIKGVAD 156
            H   V  YG      + +L+ EF+  G     L  +     ++G  ++ ++ +I     
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +L+         IV+RD+  +NLLLD +    + DFG AK +  D   +T   GT  Y+A
Sbjct: 149 SLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIA 196

Length = 340

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 39.4 bits (92), Expect = 7e-04
 Identities = 25/70 (35%), Positives = 38/70 (54%), Gaps = 7/70 (10%)

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           Q +++ + + +AL+YLH      I+HRDV ++N+ LD    A + DFG A   K DA   
Sbjct: 186 QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPD 240

Query: 206 TEFAGTYGYV 215
           T     YG+ 
Sbjct: 241 T--PQCYGWS 248

Length = 392

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 39.6 bits (92), Expect = 7e-04
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 18/127 (14%)

Query: 91  TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTD-----AAAQELGWS 145
           TE   L    H +I++  G  ++ +     C  L R        TD     AA + +   
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNK---FTCLILPR------YKTDLYCYLAAKRNIAIC 182

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF-LKSDASN 204
             +++ + V  A+ YLH +    I+HRD+ ++N+ ++   +  + DFG A F +  +A+ 
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239

Query: 205 WTEFAGT 211
           +  +AGT
Sbjct: 240 YYGWAGT 246

Length = 391

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 39.4 bits (92), Expect = 7e-04
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 8/126 (6%)

Query: 92  EVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV 150
           E   L E  H  IVK  Y F +  +  +L+ +FL  G L   L+ +    E         
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFY 103

Query: 151 IKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
           +  +A AL +LH      I++RD+  +N+LLD E    + DFG++K           F G
Sbjct: 104 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160

Query: 211 TYGYVA 216
           T  Y+A
Sbjct: 161 TVEYMA 166

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 39.3 bits (92), Expect = 8e-04
 Identities = 25/70 (35%), Positives = 35/70 (50%), Gaps = 11/70 (15%)

Query: 149 SVIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +++K    AL YL   H     ++HRDV   N+LLD      + DFGI+  L  D+   T
Sbjct: 122 AIVK----ALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRL-VDSKAKT 172

Query: 207 EFAGTYGYVA 216
             AG   Y+A
Sbjct: 173 RSAGCAAYMA 182

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 39.2 bits (91), Expect = 8e-04
 Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 16/168 (9%)

Query: 34  YDEIVK-------ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQ 86
           Y++IV+          D+D    IG G    V      S + V   K  S     +  D 
Sbjct: 28  YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 87  KEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-NTDAAAQELGWS 145
             F  E   +       +V+ +      ++ +++ E++  G L  ++ N D   +   W+
Sbjct: 88  AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WA 144

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
           +  +    V  AL  +H      ++HRDV   N+LLD      +ADFG
Sbjct: 145 KFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 38.9 bits (91), Expect = 0.001
 Identities = 21/64 (32%), Positives = 31/64 (48%), Gaps = 5/64 (7%)

Query: 154 VADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTY 212
           +   L +LH       I++RD+   N+LLD E    +ADFG+ K         + F GT 
Sbjct: 105 IVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160

Query: 213 GYVA 216
            Y+A
Sbjct: 161 DYIA 164

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 38.9 bits (91), Expect = 0.001
 Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 44/187 (23%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKF 107
           +G G +  V +   +P+  ++AVK+  + +    + +QK  L ++     +      V F
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSVDCPYTVTF 65

Query: 108 YG---------FCSHA---------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           YG          C            +  +     +    L  I               +S
Sbjct: 66  YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKI--------------AVS 111

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           ++K    AL YLH      ++HRDV   N+L++   +  + DFGI+ +L    +  T  A
Sbjct: 112 IVK----ALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-TIDA 164

Query: 210 GTYGYVA 216
           G   Y+A
Sbjct: 165 GCKPYMA 171

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 35/157 (22%), Positives = 69/157 (43%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASV-YRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + +V    +  +   VA+KK + P  S+  +  K    E++ L   +H N++   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMKHENVI--- 77

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAA----QELGWSQRMSVIKGVADALSYLHHD 164
           G          L  F +   +   + TD       ++L   +   ++  +   L Y+H  
Sbjct: 78  GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA- 136

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
               I+HRD+   NL ++ + E  + DFG+A+   S+
Sbjct: 137 --AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 38.7 bits (90), Expect = 0.001
 Identities = 21/59 (35%), Positives = 34/59 (57%), Gaps = 3/59 (5%)

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L +LH      I++RD+  +N+LLD +    ++D G+A  LK   S    +AGT G++A
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 48/162 (29%), Positives = 60/162 (37%), Gaps = 22/162 (13%)

Query: 43  DFDAKYCIGNGGHASVYRAELPSR-EVVAVK--KFHSPLPSDQTVDQKEFLTEVKALTET 99
           DF+    +G G    V  A+     E  A+K  K    L   Q    +    E   L E 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---VQHVAQEKSILMEL 75

Query: 100 RHRNIVKFY-GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK----GV 154
            H  IV     F    R  FLL EF+  G L   L                V K     +
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPN-------DVAKFYHAEL 127

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             A  YLH      I++RD+  +NLLLD +    V DFG AK
Sbjct: 128 VLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 5/61 (8%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           AL +LH +D    IV+RD+  +N+LLD      + DFG++K   +D      F GT  Y+
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163

Query: 216 A 216
           A
Sbjct: 164 A 164

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 20/153 (13%)

Query: 50  IGNGGHASVY--RAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G +A+VY  R++L +  +VA+K+    L  ++       + EV  L + +H NIV  
Sbjct: 14  LGEGTYATVYKGRSKL-TDNLVALKEIR--LEHEEGAPCTA-IREVSLLKDLKHANIVTL 69

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK----GVADALSYLHH 163
           +      +   L+ E+L++  L   L+      + G S  M  +K     +   L+Y H 
Sbjct: 70  HDIIHTEKSLTLVFEYLDK-DLKQYLD------DCGNSINMHNVKLFLFQLLRGLNYCHR 122

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
                ++HRD+  +NLL++   E  +ADFG+A+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 38.0 bits (88), Expect = 0.002
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK-FLKSDASNWTEFAGTYGYV 215
           AL +LH      IV+RD+  +N+LLD E    + DFG++K FL  +      F GT  Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 216 A 216
           A
Sbjct: 174 A 174

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 38.0 bits (88), Expect = 0.002
 Identities = 22/63 (34%), Positives = 33/63 (52%), Gaps = 3/63 (4%)

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +  AL +LH      I++RD+   N+LLD E    +ADFG+ K    +    + F GT  
Sbjct: 105 ITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161

Query: 214 YVA 216
           Y+A
Sbjct: 162 YIA 164

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 15/170 (8%)

Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+             KE L 
Sbjct: 3   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA---NKEILD 58

Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 115

Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L +D
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 38.0 bits (88), Expect = 0.002
 Identities = 38/158 (24%), Positives = 77/158 (48%), Gaps = 30/158 (18%)

Query: 50  IGNGGHASVY--RAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G +A+V+  R++L +  +VA+K+    L  ++       + EV  L + +H NIV  
Sbjct: 14  LGEGTYATVFKGRSKL-TENLVALKEIR--LEHEEGAPCTA-IREVSLLKDLKHANIVTL 69

Query: 108 YGFCSHARHSFLLCEFLER---------GSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
           +      +   L+ E+L++         G++ ++ N      +        +++G    L
Sbjct: 70  HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQ--------ILRG----L 117

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +Y H      ++HRD+  +NLL++   E  +ADFG+A+
Sbjct: 118 AYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 38.0 bits (88), Expect = 0.002
 Identities = 22/63 (34%), Positives = 33/63 (52%), Gaps = 3/63 (4%)

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           VA A+ YLH      I++RD+  +N+LLD +    + DFG+ K         + F GT  
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE 161

Query: 214 YVA 216
           Y+A
Sbjct: 162 YLA 164

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 37.8 bits (88), Expect = 0.002
 Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 3/63 (4%)

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +A AL YLH      I++RD+  +N+LLD +    + DFG+ K     +   + F GT  
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161

Query: 214 YVA 216
           Y+A
Sbjct: 162 YLA 164

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 37.7 bits (88), Expect = 0.003
 Identities = 19/40 (47%), Positives = 24/40 (60%), Gaps = 3/40 (7%)

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            L YLH +    IV+RD+   NLLLD E    +ADFG+ K
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 3/63 (4%)

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +A AL YLH      IV+RD+  +N+LLD +    + DFG+ K         + F GT  
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161

Query: 214 YVA 216
           Y+A
Sbjct: 162 YLA 164

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 37.6 bits (87), Expect = 0.003
 Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 7/62 (11%)

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA--DFGIAKFLKSDASNWTEFAGTYGY 214
           AL  LH      +++RD+  +N+LLD  Y+ H+A  DFG+ K    D      F GT  Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 215 VA 216
           +A
Sbjct: 160 LA 161

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 37.3 bits (86), Expect = 0.003
 Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 3/66 (4%)

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +A  L +LH      I++RD+   N++LD E    +ADFG+ K    D      F GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 214 YVALGI 219
           Y+A  I
Sbjct: 167 YIAPEI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 37.3 bits (87), Expect = 0.004
 Identities = 42/199 (21%), Positives = 74/199 (37%), Gaps = 44/199 (22%)

Query: 36  EIVKATNDFDAKY----CIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFL 90
           E+ K   +   +Y     +G+G +  V  A    +   VA+KK   P  S   +  K   
Sbjct: 5   ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTY 62

Query: 91  TEVKALTETRHRNIV-------------KFYGFCSHARHSFLLCEFLERGSLAAILNTDA 137
            E++ L    H N++              F          +L+   +      A LN   
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDV-------YLVTHLM-----GADLNNIV 110

Query: 138 AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
             Q+L       ++  +   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+ 
Sbjct: 111 KCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167

Query: 198 LKSDASNWTEFAGTYGYVA 216
              + +         GYVA
Sbjct: 168 TDDEMT---------GYVA 177

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 37.2 bits (86), Expect = 0.004
 Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 1/48 (2%)

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           IV+RD+  +N+LLD +    ++D G+A  LK D    T+ AGT GY+A
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRAGTNGYMA 162

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|222198 pfam13526, DUF4125, Protein of unknown function (DUF4125)

 Score = 36.5 bits (85), Expect = 0.004
 Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 34/114 (29%)

Query: 20  RLDGSIPPEVGKILYDEIVKA----TNDFDAKY---------CIGNGGHASV---YRAEL 63
           R+    PPE  K L   IV+       +F  KY                 S     R EL
Sbjct: 75  RMMKLTPPENIKPLIPRIVEIQLAWQKEFRKKYPKLGQAGRLLTSEDDGTSFETYLRGEL 134

Query: 64  PSREVVAVKKFHSPLPSDQTVDQ-KEFLTEVKA----LTETRHRNIVKFYGFCS 112
            +              S++T+D   E++  ++     L E  + N+V+ YG+ S
Sbjct: 135 ETY-------------SEKTLDLYLEYVERLQEKGRNLAEETYENLVRMYGYDS 175

Length = 181

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	219
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.98
KOG0198	313	consensus MEKK and related serine/threonine protei	99.98
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.96
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.96
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
KOG0610	459	consensus Putative serine/threonine protein kinase	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
KOG0584	632	consensus Serine/threonine protein kinase [General	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
PTZ00283	496	serine/threonine protein kinase; Provisional	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.95
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.94
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.94
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.94
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.94
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
PTZ00284	467	protein kinase; Provisional	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.94
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.94
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.94
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.93
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.93
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.93
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.93
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.93
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.93
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.93
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.93
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.92
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.92
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.92
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.92
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.92
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.92
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.92
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.92
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.92
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.91
PHA02882	294	putative serine/threonine kinase; Provisional	99.91
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.9
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.88
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.87
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.86
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
smart00090	237	RIO RIO-like kinase.	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.76
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.66
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
PLN00181	793	protein SPA1-RELATED; Provisional	99.62
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.33
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.32
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.32
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.31
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.28
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.21
KOG1243	690	consensus Protein kinase [General function predict	99.19
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.19
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.17
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.97
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.9
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
PRK09902	216	hypothetical protein; Provisional	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.53
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.49
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.44
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.35
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.33
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
PF01636	239	APH: Phosphotransferase enzyme family This family	98.12
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.11
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.1
PLN02876	822	acyl-CoA dehydrogenase	98.03
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.76
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.63
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.62
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.53
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.49
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.33
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.26
KOG2270	520	consensus Serine/threonine protein kinase involved	97.13
PRK05231	319	homoserine kinase; Provisional	97.11
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.05
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.04
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.03
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.92
COG4248	637	Uncharacterized protein with protein kinase and he	96.83
PLN02756	418	S-methyl-5-thioribose kinase	96.55
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.48
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.4
PLN02236	344	choline kinase	96.37
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.09
KOG2137	700	consensus Protein kinase [Signal transduction mech	96.01
PRK10593	297	hypothetical protein; Provisional	95.89
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.3
PRK12396	409	5-methylribose kinase; Reviewed	95.09
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.55
PRK06148	1013	hypothetical protein; Provisional	94.3
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.22
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.03
PTZ00384	383	choline kinase; Provisional	93.15
PRK10271	188	thiK thiamine kinase; Provisional	92.96
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.88
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.57
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.24
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	90.95
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	90.9
COG2334	331	Putative homoserine kinase type II (protein kinase	90.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.44
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	90.25

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=260.88  Aligned_cols=172  Identities=28%  Similarity=0.445  Sum_probs=149.4

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...++|.+...||.|+|+.||+|+ ..++..||||.+.....  .....+.+..|+.+|+.++|||||.+++++.+++.+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            346889999999999999999994 55788999999865322  233456678899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC------CcEEEee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE------YEAHVAD  191 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~------~~~kl~d  191 (219)
                      |+|||||.+|+|.+++...+   .+++.++..++.|++.|+.+||++   +|+||||||+|||++..      -.+||+|
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            99999999999999998764   388999999999999999999999   99999999999999864      4589999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||+|+.+.. ..-..+.+|++.|||||+
T Consensus       159 FGfAR~L~~-~~~a~tlcGSplYMAPEV  185 (429)
T KOG0595|consen  159 FGFARFLQP-GSMAETLCGSPLYMAPEV  185 (429)
T ss_pred             cchhhhCCc-hhHHHHhhCCccccCHHH
Confidence            999998763 333466899999999996

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=251.15  Aligned_cols=173  Identities=24%  Similarity=0.369  Sum_probs=155.0

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++++.||+|+||+|+++ +..+++.+|+|.+++...... ........|..+|..++||+|+.+...|++.+.+|
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            3578999999999999999999 566888999999876443332 34566788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +|+||+.||.|...+..++.   +++.++..++.+|+.||.|||..   +|+||||||+|||++.+|.++|+|||+|+..
T Consensus       102 lVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999999987654   78899999999999999999999   9999999999999999999999999999977


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+++||+.||||||
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEi  196 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEI  196 (357)
T ss_pred             ccCCCccccccCCccccChHH
Confidence            666666778999999999996

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-37  Score=246.05  Aligned_cols=173  Identities=25%  Similarity=0.384  Sum_probs=147.4

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc---hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ---TVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ..+.|.+.+.||+|+||.|.+| +..+|+.||||++........   ........+|+.+|++++||||++++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4467888999999999999999 788999999999876433321   112334579999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC---CcEEEeec
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE---YEAHVADF  192 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~---~~~kl~df  192 (219)
                      ..|+||||+.||+|.+++-.++.   +.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   -.+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999976543   55666678899999999999999   99999999999999866   46899999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |+|+... ..+-..++||||.|.|||+
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEV  349 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEV  349 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhh
Confidence            9999775 3344577899999999996

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=247.90  Aligned_cols=187  Identities=39%  Similarity=0.715  Sum_probs=160.8

Q ss_pred             ccccccHHHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCcccee
Q 039002           28 EVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF  107 (219)
Q Consensus        28 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~  107 (219)
                      ....++++++..++++|.....||+|+||.||+|...++..+|||++......   . ...|.+|+.++.+++|||++++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~L  136 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKL  136 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccE
Confidence            45668899999999999999999999999999999988899999987643211   0 3459999999999999999999


Q ss_pred             EeEEEeCC-cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          108 YGFCSHAR-HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       108 ~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                      +|+|.+.+ +.+||+||+++|+|.+.+...... .++|.++.+|+.+++.||.|||..+.++|+|||||++|||+|.+.+
T Consensus       137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            99999988 599999999999999999765432 5899999999999999999999987778999999999999999999


Q ss_pred             EEEeeccceeeecCCCCccccc-ccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDASNWTEF-AGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~~~~~~-~gt~~y~aPE~  219 (219)
                      +||+|||+|+............ .||.+|+||||
T Consensus       216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy  249 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEY  249 (361)
T ss_pred             EEccCccCcccCCccccceeeecCCCCccCChhh
Confidence            9999999997654311111222 79999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-39  Score=243.42  Aligned_cols=179  Identities=22%  Similarity=0.333  Sum_probs=153.4

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEe-EEEeCC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG-FCSHAR  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~-~~~~~~  115 (219)
                      ..++.+|++.++||.|.||.||++ ...+|..+|.|.+.  ....+......+..|+.+|+.++||||+++++ .|..++
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~--f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ--FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc--hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            344678999999999999999999 77899999999986  33445556677889999999999999999998 444444


Q ss_pred             c-ceEEEEecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeCCCCcEEEee
Q 039002          116 H-SFLLCEFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       116 ~-~~lv~e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~~~~~~kl~d  191 (219)
                      + ++|+||+|..|+|...++.... ...+++..+++++.|++.|+..+|.... +  ++||||||.||+++..|.+|++|
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeecc
Confidence            4 8999999999999999975322 2447999999999999999999999322 4  99999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||+++++....+-..+++|||+||+||.
T Consensus       172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~  199 (375)
T KOG0591|consen  172 FGLGRFLSSKTTFAHSLVGTPYYMSPER  199 (375)
T ss_pred             chhHhHhcchhHHHHhhcCCCcccCHHH
Confidence            9999999877766678899999999994

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=237.60  Aligned_cols=169  Identities=27%  Similarity=0.442  Sum_probs=149.4

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc-c
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH-S  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~  117 (219)
                      ..++.+.++.||+|..|.|+++ ..++++.+|+|.+..   ..+....+.+.+|+++++..+||+|+.+|++|.+++. .
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~---~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL---NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc---cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            3456777899999999999999 566888999999854   3345677889999999999999999999999999994 9


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      .|+||||++|+|.++.+..+   .+++.....++.+|+.||.|||+..  +|+||||||+|+|+..+|++||+|||.+..
T Consensus       154 sI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            99999999999999997653   3788999999999999999999731  999999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccCC
Q 039002          198 LKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      +.++.  .++++||..|||||
T Consensus       229 lvnS~--a~tfvGT~~YMsPE  247 (364)
T KOG0581|consen  229 LVNSI--ANTFVGTSAYMSPE  247 (364)
T ss_pred             hhhhh--cccccccccccChh
Confidence            87663  35789999999999

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-37  Score=235.54  Aligned_cols=170  Identities=22%  Similarity=0.392  Sum_probs=149.7

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +.|+.+.++|+|+||.|+++ ...+|+.||||++...  .++....+.+++|+.+|+.++|+|++.+.++|.....++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            46888999999999999999 5668999999998653  34455667789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|||+. ++.+-+....  ..++...+..++.|++.|+.|+|.+   +++||||||+|||++.+|.+|+||||+|+.+..
T Consensus        80 FE~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             eeecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            999976 5555554432  3478888999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      +....+..+.|.+|+|||.
T Consensus       154 pgd~YTDYVATRWYRaPEL  172 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPEL  172 (396)
T ss_pred             CcchhhhhhhhhhccChhh
Confidence            8777788899999999993

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-36  Score=246.55  Aligned_cols=171  Identities=30%  Similarity=0.515  Sum_probs=153.4

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ..|...+.||+|+|..||.++ ..+|+.||+|.+...... .......+.+|+++.+.++||||++++++|++.+++|++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            569999999999999999994 589999999998653322 233456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|+|+.++|..+.+...   .+++..+..++.||+.|+.|||+.   +|+|||||..|++++++..+||+|||+|..+..
T Consensus        97 LELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EEecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999998433   388999999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.....+.||||-|+|||+
T Consensus       171 ~~Erk~TlCGTPNYIAPEV  189 (592)
T KOG0575|consen  171 DGERKKTLCGTPNYIAPEV  189 (592)
T ss_pred             cccccceecCCCcccChhH
Confidence            7666678899999999996

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-36  Score=242.02  Aligned_cols=171  Identities=26%  Similarity=0.423  Sum_probs=149.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Ccc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  117 (219)
                      .+.|+-+++||+|+||.||+| +..+|+.||+|++.-..  .+......+.+||.+|++++||||+++.+...+.  ..+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~--~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN--EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc--CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            455888999999999999999 67899999999987543  2345667788999999999999999999998776  689


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+|+||+++ +|..++...+  ..+++.++..++.|++.||+|||++   +++|||||.+|||++.+|.+||+|||+|++
T Consensus       194 YlVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence            999999976 8888886543  3488999999999999999999999   999999999999999999999999999998


Q ss_pred             ecCCCCc-ccccccccccccCCC
Q 039002          198 LKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      ++..... .+..+-|.+|+|||.
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPEL  290 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPEL  290 (560)
T ss_pred             ccCCCCcccccceEEeeccChHH
Confidence            8765533 566788999999994

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=238.08  Aligned_cols=176  Identities=31%  Similarity=0.562  Sum_probs=148.4

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC-c
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR-H  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~  116 (219)
                      .....+..+...+|+|+||.||+|.+.....||+|++.........  ...+.+|+.++.+++||||++++|++.... .
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3334555666779999999999998876656999998765433332  678999999999999999999999998887 7


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC-eEecCCCCCCEEeCCCC-cEEEeeccc
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP-IVHRDVSSKNLLLDLEY-EAHVADFGI  194 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H~dlkp~nili~~~~-~~kl~dfg~  194 (219)
                      ..|||||+++|+|..++... ....+++..++.++.+|+.||.|||++   + |+||||||+|+|++.++ .+||+|||+
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            99999999999999999763 224588999999999999999999999   8 99999999999999997 999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.............||+.|||||+
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv  215 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEV  215 (362)
T ss_pred             ceeeccccccccCCCCCccccChhh
Confidence            9877654222344699999999995

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=224.29  Aligned_cols=171  Identities=25%  Similarity=0.329  Sum_probs=149.0

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ..+++|+.++.||.|+||+|.+++ ..+|..+|+|.+.....-+. ...++..+|..+|+.+.||+++++++.+.+.+++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVkl-KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKL-KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHH-HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            346789999999999999999994 55778899999865332221 2235668899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+||||.+||.+..++...+   ++++..+..++.||+.|++|||++   +|++|||||+|||+|++|-+||+|||+|+.
T Consensus       120 ymvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             EEEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            99999999999999997644   488899999999999999999999   999999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....   ..+.||||.|+|||+
T Consensus       194 v~~r---T~TlCGTPeYLAPEi  212 (355)
T KOG0616|consen  194 VSGR---TWTLCGTPEYLAPEI  212 (355)
T ss_pred             ecCc---EEEecCCccccChHH
Confidence            7544   356799999999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.5e-34  Score=216.27  Aligned_cols=170  Identities=27%  Similarity=0.372  Sum_probs=149.7

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .+|.-.+.+|+|+||.||+| ...+|+.||||+++.....+  .....+.+|+..|+.++|+||+.+.++|-+.+.+-||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            46777899999999999999 67899999999998764333  3456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||++ .+|...++....  -+...++..++.+++.|+.|||.+   .|+|||+||.|+|++.+|.+|++|||+|+.+.+
T Consensus        80 fEfm~-tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             EEecc-ccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            99995 599999976543  367788999999999999999999   899999999999999999999999999999987


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.......+-|.+|+|||.
T Consensus       154 p~~~~~~~V~TRWYRAPEL  172 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPEL  172 (318)
T ss_pred             CCcccccceeeeeccChHH
Confidence            7665555588999999993

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=231.71  Aligned_cols=175  Identities=22%  Similarity=0.352  Sum_probs=149.2

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCch-hhHHHHHHHHHHHhcCC-CCccceeEeEEEeCC
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTETR-HRNIVKFYGFCSHAR  115 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~  115 (219)
                      ...+.|.+.+.||+|+||+|+.| ...++..||+|.+......... .....+.+|+.+++.++ ||||+++++++.+..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44689999999999999999999 5668899999976543222111 23445668999999999 999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEeeccc
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGI  194 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~dfg~  194 (219)
                      ..++||||+.+|+|.+++...+   .+.+..+..++.|++.|+.|||++   +|+||||||+|++++.+ +.+||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999998743   377888999999999999999999   99999999999999988 9999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +............++||+.|+|||+
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEv  192 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEV  192 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHH
Confidence            9877423334467899999999995

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=235.05  Aligned_cols=171  Identities=23%  Similarity=0.434  Sum_probs=154.1

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ..+...|....+||+|+.|.||.| ...+++.||+|++....    ....+-+++|+.+|+..+|+||+.+++.|..++.
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de  344 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE  344 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc----CCchhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence            456677999999999999999999 56788899999986532    2344567899999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +|+||||+++|+|.+.+...    .+.+.++..++.+++.||.|||.+   +|+|||||.+||+++.+|.+||+|||+|.
T Consensus       345 LWVVMEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             eEEEEeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence            99999999999999999753    278899999999999999999999   99999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+.....+..+.+|||+|||||+
T Consensus       418 qi~~~~~KR~TmVGTPYWMAPEV  440 (550)
T KOG0578|consen  418 QISEEQSKRSTMVGTPYWMAPEV  440 (550)
T ss_pred             ccccccCccccccCCCCccchhh
Confidence            99888777788899999999995

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-34  Score=229.88  Aligned_cols=171  Identities=22%  Similarity=0.385  Sum_probs=154.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..+|++.+.||+|+||+|-+| +...|+.||||.+++....+ .++.-++.+|+++|+.++||||+.+|.+|++.+...|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            456899999999999999999 67889999999998766554 4567788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||..+|.|+++++..+   .++++....++.||+.|+.|||.+   +++|||||.+|||+|.++.+||.|||++-.+.
T Consensus       131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999998754   388999999999999999999999   99999999999999999999999999986553


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      + .+-.++|||+|.|.+|||
T Consensus       205 ~-~kfLqTFCGSPLYASPEI  223 (668)
T KOG0611|consen  205 D-KKFLQTFCGSPLYASPEI  223 (668)
T ss_pred             c-ccHHHHhcCCcccCCccc
Confidence            3 344588999999999997

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.6e-34  Score=221.62  Aligned_cols=173  Identities=26%  Similarity=0.364  Sum_probs=151.1

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CC
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--AR  115 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~  115 (219)
                      ...++|+.++.|++|+||.||+| +..+++.||+|+++...  ......-..++|+.+|.+.+||||+.+..+...  -+
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            34567889999999999999999 67789999999997654  334566677899999999999999999998854  36


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .+|+|||||.. +|..++..-  ++.+....+..++.|++.|+.|||+.   -|+||||||+|+|+...|.+||+|||+|
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA  224 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA  224 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence            79999999965 888888642  24577888999999999999999999   8999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.+.++.+..+..+-|.+|+|||.
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPEL  248 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPEL  248 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHH
Confidence            999998888888899999999994

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-33  Score=229.64  Aligned_cols=154  Identities=23%  Similarity=0.303  Sum_probs=136.6

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ....++|++++.||+|+||.||+| +..+|..+|+|++++..... ......+..|-.+|...++++||++|..|++.+.
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            346789999999999999999999 66789999999987643222 2234667889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +||||||.+||++..++...+.   +++..+..++.+.+.|+..+|..   |++||||||+|+|+|..|.+||+|||++.
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999987654   88888999999999999999999   99999999999999999999999999986


Q ss_pred             ee
Q 039002          197 FL  198 (219)
Q Consensus       197 ~~  198 (219)
                      .+
T Consensus       290 gl  291 (550)
T KOG0605|consen  290 GL  291 (550)
T ss_pred             hh
Confidence            43

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=236.21  Aligned_cols=174  Identities=24%  Similarity=0.356  Sum_probs=151.6

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHAR  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  115 (219)
                      ...+++|.++++||+|.||+|+++. ..+++.+|||.+++.....+. ..+....|..++... +||+++.++..|++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d-~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD-EVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc-cHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            4457899999999999999999994 567889999999876544432 445677788877777 5999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ++|.||||+.||++..++..    ..+++.++..|+..|+.||.|||++   +||+||||.+|||+|.+|.+||+|||+|
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             eEEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence            99999999999996555543    2488899999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +..........++||||.|||||+
T Consensus       516 Ke~m~~g~~TsTfCGTpey~aPEi  539 (694)
T KOG0694|consen  516 KEGMGQGDRTSTFCGTPEFLAPEV  539 (694)
T ss_pred             cccCCCCCccccccCChhhcChhh
Confidence            988766667788999999999996

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.4e-34  Score=233.17  Aligned_cols=169  Identities=28%  Similarity=0.422  Sum_probs=149.9

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|-+.+.||+|.||.||+| +..+.+.||+|.+.+..  +.....+.+.+|+++++.++||||+.++++|++..++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            57888899999999999999 55678889999886543  2334556789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+.+ +|..++...+.   +++..+..++.+++.|+.|||+.   +|+|||+||+||+++..|.+|++|||+|+....
T Consensus        80 te~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             ehhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            999976 99999976543   89999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...-.+...|||.|||||.
T Consensus       153 ~t~vltsikGtPlYmAPEl  171 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPEL  171 (808)
T ss_pred             CceeeeeccCcccccCHHH
Confidence            6555677899999999993

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=232.24  Aligned_cols=171  Identities=25%  Similarity=0.385  Sum_probs=148.9

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCC-
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHAR-  115 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~-  115 (219)
                      ...++|.+.++||.|+||.||+| ...+++.||||+++.....-   ....-+||+.-|++++ ||||+++.+++.+.+ 
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            34578999999999999999999 67789999999998754431   1223478999999998 999999999998887 


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .+|+|||++. .+|+++++...  ..+++..+..|+.||++||.|+|.+   |+.|||+||+|||+.....+||+|||+|
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence            9999999994 59999998653  4589999999999999999999999   9999999999999998889999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.+.+... .+..+.|.+|+|||+
T Consensus       158 Rev~SkpP-YTeYVSTRWYRAPEv  180 (538)
T KOG0661|consen  158 REVRSKPP-YTEYVSTRWYRAPEV  180 (538)
T ss_pred             cccccCCC-cchhhhcccccchHH
Confidence            99876654 466799999999995

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-33  Score=222.67  Aligned_cols=176  Identities=24%  Similarity=0.327  Sum_probs=142.6

Q ss_pred             HHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc-----hhh-----HHHHHHHHHHHhcCCCCccc
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ-----TVD-----QKEFLTEVKALTETRHRNIV  105 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~-----~~~-----~~~~~~e~~~l~~l~h~ni~  105 (219)
                      -...+++|++.+.||+|.||+|.+| ...+++.||||.+.+......     ...     .+...+|+.++++++|+||+
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3456788999999999999999999 566889999999854221111     001     24678999999999999999


Q ss_pred             eeEeEEEeC--CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          106 KFYGFCSHA--RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       106 ~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      +++.+..+.  +.+|+|+|||..|.+...-. .  +..+.+.++.+++..++.||+|||.+   +|+||||||+|+|++.
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d--~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-D--KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCC-C--cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            999998764  67999999999888753221 1  12278899999999999999999999   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCC-----CCcccccccccccccCC
Q 039002          184 EYEAHVADFGIAKFLKSD-----ASNWTEFAGTYGYVALG  218 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE  218 (219)
                      +|++||+|||.+..+...     .......+|||.|+|||
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE  285 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPE  285 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchH
Confidence            999999999999877322     22334569999999999

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-33  Score=215.97  Aligned_cols=173  Identities=25%  Similarity=0.351  Sum_probs=147.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc-cceeEeEEEeCC---
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN-IVKFYGFCSHAR---  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~---  115 (219)
                      ...|+.+++||+|+||.||+| ...+|+.||+|++.....  ++.......+|+.+++.++|+| |+.+++++.+.+   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~--~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE--EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc--ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            456777889999999999999 567889999999976432  2335567789999999999999 999999998877   


Q ss_pred             ---cceEEEEecCCCCHHHHhcccchh-hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          116 ---HSFLLCEFLERGSLAAILNTDAAA-QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       116 ---~~~lv~e~~~~~~l~~~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                         .+++++|+.. -+|..++...... ..++...+..++.|++.|+.|||++   +|+||||||+|++++.+|.+||+|
T Consensus        88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence               7889999995 5899988764421 2366678899999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||+|+.+..+..+.+..++|.+|+|||+
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEv  191 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEV  191 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHH
Confidence            9999977766666677799999999995

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-32  Score=218.62  Aligned_cols=177  Identities=29%  Similarity=0.436  Sum_probs=155.4

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      ++....++|++...||.|.-+.||+| ..+.++.||||++..+....   ....+.+|++.++.++||||++++..|..+
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            44556789999999999999999999 67888999999997654433   356789999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ..+|+||.++.+|++.++++..-. ..+.+..+..+..+++.||.|||.+   |-+|||+|+.|||++.+|.++|+|||.
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence            999999999999999999986433 3388899999999999999999999   999999999999999999999999998


Q ss_pred             eeeecCCCCcc----cccccccccccCCC
Q 039002          195 AKFLKSDASNW----TEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~----~~~~gt~~y~aPE~  219 (219)
                      ...+.++....    +.++||+.|||||+
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEv  201 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEV  201 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHH
Confidence            88776554321    56799999999995

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8e-33  Score=225.56  Aligned_cols=175  Identities=28%  Similarity=0.406  Sum_probs=148.5

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHAR  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  115 (219)
                      .....||.+.+.||.|+|++|++| +..+++.+|||.+.+.....+ ...+-+.+|-..|..| .||.|+++|..|++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike-~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE-KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh-cccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            334578999999999999999999 677899999998754322222 1223356677888888 8999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .+|.|+||+++|+|.+++...+.   +.+.....++.+|+.|++|+|++   |||||||||+|||++.+|.++|+|||.|
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999999987654   78888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCc-------------ccccccccccccCCC
Q 039002          196 KFLKSDASN-------------WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~-------------~~~~~gt~~y~aPE~  219 (219)
                      +.+......             ..+|+||..|++||.
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPEl  258 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPEL  258 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHH
Confidence            987643221             156999999999993

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=9.4e-33  Score=225.03  Aligned_cols=177  Identities=23%  Similarity=0.433  Sum_probs=147.0

Q ss_pred             HHHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           34 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        34 ~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      .+.|......++..+.||+|.||.||.|.+.....||+|.++..     ......+.+|+++|++++|+||+++++++..
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            45566666677788999999999999999988889999998753     2344568899999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      ++.++|||||++.|+|.+++.... ...+...+.+.++.||++||+||+++   ++|||||..+|||++.+..+||+|||
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccc
Confidence            889999999999999999998622 23477888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcc-cccccccccccCCC
Q 039002          194 IAKFLKSDASNW-TEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~-~~~~gt~~y~aPE~  219 (219)
                      +|+...+..-.. ..---...|.|||.
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa  375 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEA  375 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHH
Confidence            999544332111 11122355899983

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-31  Score=212.31  Aligned_cols=170  Identities=29%  Similarity=0.456  Sum_probs=143.2

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC--cc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR--HS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~  117 (219)
                      ..++...+.||+|+||.||++ ..++|...|+|.+...   +.. ....+.+|+.+|+.++||||++++|......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            456778899999999999999 4556889999987543   111 1456789999999999999999999855544  58


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEeecccee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVADFGIAK  196 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~  196 (219)
                      ++.|||+++|+|.+++...+.  .+++..+..+..|+++|+.|||++   +++|+||||+|||++. ++.+||+|||+++
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence            899999999999999987654  489999999999999999999999   9999999999999999 6999999999998


Q ss_pred             eecCCCC---cccccccccccccCCC
Q 039002          197 FLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      .......   ....+.||+.|||||+
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEv  192 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEV  192 (313)
T ss_pred             ccccccccccccccccCCccccCchh
Confidence            7663111   1235789999999995

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.2e-32  Score=221.87  Aligned_cols=173  Identities=21%  Similarity=0.368  Sum_probs=152.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc-ce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH-SF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~  118 (219)
                      .++|..++++|+|+||.++.++ ..++..+++|++........  .++.+.+|+.++++++||||+.+.+.|..++. ++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~--~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP--ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch--hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            5789999999999999999994 45777899999876544433  33477899999999999999999999999888 99


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      |+|+||.||++.+.++... ...+++.++..++.|++.|+.|||..   +|+|||||+.|||+.+++.++|+|||+|+.+
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence            9999999999999998765 34588999999999999999999988   9999999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..+.+-..+.+||+.||+||+
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEi  177 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEI  177 (426)
T ss_pred             CCchhhhheecCCCcccCHHH
Confidence            776545566899999999995

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=2.4e-31  Score=218.44  Aligned_cols=150  Identities=24%  Similarity=0.320  Sum_probs=129.9

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.++..++|+||+++++.+.+.+.++++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence            47899999999999999999 5567889999998532111 112334567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      |||+++|+|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++.+
T Consensus        80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          80 MEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            99999999999986543   378888999999999999999998   9999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=5.1e-31  Score=213.31  Aligned_cols=165  Identities=24%  Similarity=0.295  Sum_probs=138.7

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLER  126 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  126 (219)
                      +.||+|+||.||+| ...+++.+|+|.++...... ......+.+|+.+++.++||||+++++++...+..+++|||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999 45688899999886422111 12334567899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccc
Q 039002          127 GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT  206 (219)
Q Consensus       127 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  206 (219)
                      ++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          80 GELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            99998886543   367888889999999999999999   999999999999999999999999999876544433445


Q ss_pred             ccccccccccCCC
Q 039002          207 EFAGTYGYVALGI  219 (219)
Q Consensus       207 ~~~gt~~y~aPE~  219 (219)
                      ..+||+.|+|||+
T Consensus       154 ~~~gt~~y~aPE~  166 (323)
T cd05571         154 TFCGTPEYLAPEV  166 (323)
T ss_pred             ceecCccccChhh
Confidence            5689999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.4e-32  Score=202.84  Aligned_cols=171  Identities=28%  Similarity=0.451  Sum_probs=148.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++.+.||+|-||.||+| ..+++-.||+|.+.+... ........+.+|+.+-+.++||||.++|++|.+....||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-HHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            588999999999999999999 566788899998755331 223345667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||.+.|.+...+..... ..+.+.....++.|++.|+.|+|..   +++|||+||+|+|++..|.+|++|||-+..-.
T Consensus       100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999998875444 3478888899999999999999999   99999999999999999999999999886543


Q ss_pred             CCCCcccccccccccccCC
Q 039002          200 SDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE  218 (219)
                        .....+.|||.-|++||
T Consensus       176 --~~kR~tlcgt~dyl~pE  192 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPE  192 (281)
T ss_pred             --CCCceeeecccccCCHh
Confidence              34457789999999999

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=218.10  Aligned_cols=170  Identities=25%  Similarity=0.435  Sum_probs=150.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ...|+....||+|.||.||+| ...+++.||+|.+..+...+   .-..+++|+.++..++++||.++|+.+..+..+|+
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d---eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED---EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcch---hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            345777899999999999999 77889999999987654333   23567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||||.+|++.+.++....   +.+..+..++.+++.|+.|+|..   +.+|||||+.||++..+|.+|++|||++.++.
T Consensus        89 iMey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence            9999999999999986543   36667777889999999999999   99999999999999999999999999999998


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ........++|||.|||||+
T Consensus       163 ~~~~rr~tfvGTPfwMAPEV  182 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEV  182 (467)
T ss_pred             chhhccccccccccccchhh
Confidence            87777788999999999996

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.8e-31  Score=217.23  Aligned_cols=151  Identities=24%  Similarity=0.337  Sum_probs=130.8

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|.+...... .......+.+|+.+++.++|+||+++++++.+++..+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            47999999999999999999 4567889999998642111 112334567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      |||+.+++|.+++....   .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++..+.
T Consensus        80 ~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          80 MEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             ECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999986543   378888999999999999999999   99999999999999999999999999987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.1e-31  Score=221.63  Aligned_cols=171  Identities=23%  Similarity=0.368  Sum_probs=150.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+-|++.+.||.|+.|.|-+| ...+|+.+|||.+....... ......+-+|+.+|+.++|||++++|++|+++.++|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccc-cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            466889999999999999999 56799999999986543222 2234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +.||+++|.|.+++-..+.   +++.....++.||+.|+.|||..   +|+|||+||+|++++.++.+||+|||.|.. .
T Consensus        90 vlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsL-e  162 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASL-E  162 (786)
T ss_pred             EEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeec-c
Confidence            9999999999999977654   88899999999999999999998   999999999999999999999999999974 4


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      -+.+...+.||+|.|.||||
T Consensus       163 ~~gklLeTSCGSPHYA~PEI  182 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEI  182 (786)
T ss_pred             cCCccccccCCCcccCCchh
Confidence            45566677899999999997

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1.2e-30  Score=207.81  Aligned_cols=170  Identities=23%  Similarity=0.320  Sum_probs=142.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...++..||+|.++....   ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            478999999999999999999 456788999998864321   1223456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+ ++.+++...+  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            9999974 8888875433  2367788889999999999999998   99999999999999999999999999998655


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~  174 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDV  174 (288)
T ss_pred             CCCccccCceecccccChHH
Confidence            44333344578999999994

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=6.6e-31  Score=216.79  Aligned_cols=149  Identities=18%  Similarity=0.257  Sum_probs=128.4

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.+|+|.+....... ......+.+|+.+++.++|+||+++++.+..++.++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM-RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            47999999999999999999 55678899999875321111 12235577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |||+++++|.+++...+   .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||+|..
T Consensus        80 ~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          80 MDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            99999999999986543   267788888899999999999998   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=5.1e-31  Score=216.95  Aligned_cols=174  Identities=21%  Similarity=0.283  Sum_probs=144.7

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ....++|++.+.||+|+||.||+|. ..+++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+++.
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445789999999999999999994 557888999987532111 11223456789999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence            99999999999999988643    367788888999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCC-cccccccccccccCCC
Q 039002          197 FLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ....... .....+||+.|+|||+
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~  214 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEV  214 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHH
Confidence            7653322 2235679999999994

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.8e-31  Score=213.03  Aligned_cols=168  Identities=25%  Similarity=0.370  Sum_probs=143.0

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.++..++|+||+++++++...+..+++
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            479999999999999999995 557889999998642211 112335677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+++++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          80 MEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999986543   367888889999999999999999   999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                         .....+||+.|+|||+
T Consensus       154 ---~~~~~~gt~~y~aPE~  169 (333)
T cd05600         154 ---YANSVVGSPDYMAPEV  169 (333)
T ss_pred             ---ccCCcccCccccChhH
Confidence               2234689999999995

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=8e-31  Score=216.67  Aligned_cols=150  Identities=19%  Similarity=0.276  Sum_probs=129.3

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +.|++++.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            36889999999999999999 5678889999998542211 122345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      |||+++|+|.+++....   .+++..+..++.|++.|+.|||..   +|+||||||+||+++.++.++|+|||++..+
T Consensus        80 ~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          80 MDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999999986543   367788888899999999999998   9999999999999999999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=1.3e-30  Score=210.97  Aligned_cols=165  Identities=24%  Similarity=0.295  Sum_probs=138.0

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLER  126 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  126 (219)
                      +.||+|+||.||++ ...++..||+|.+....... ......+.+|+.+++.++||||+++++++...+..+++|||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46899999999999 45678899999986432111 12334567899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccc
Q 039002          127 GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT  206 (219)
Q Consensus       127 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  206 (219)
                      ++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++...........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          80 GELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            99988886543   377888999999999999999998   999999999999999999999999999876443333334


Q ss_pred             ccccccccccCCC
Q 039002          207 EFAGTYGYVALGI  219 (219)
Q Consensus       207 ~~~gt~~y~aPE~  219 (219)
                      ...||+.|+|||+
T Consensus       154 ~~~gt~~y~aPE~  166 (323)
T cd05595         154 TFCGTPEYLAPEV  166 (323)
T ss_pred             cccCCcCcCCccc
Confidence            5689999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=7.1e-31  Score=213.00  Aligned_cols=169  Identities=25%  Similarity=0.309  Sum_probs=143.4

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+...... .......+.+|+.+++.++||||+++++.+...+..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            4789999999999999999994 557889999987542111 11233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        96 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999999886543   367788888999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...   ....||+.|+|||+
T Consensus       170 ~~~---~~~~gt~~y~aPE~  186 (329)
T PTZ00263        170 DRT---FTLCGTPEYLAPEV  186 (329)
T ss_pred             CCc---ceecCChhhcCHHH
Confidence            332   34579999999994

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=1.9e-30  Score=210.43  Aligned_cols=165  Identities=25%  Similarity=0.317  Sum_probs=138.8

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLER  126 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  126 (219)
                      +.||+|+||.||++ ...+++.+|+|.+....... ......+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999 45678899999986432221 22345677899999999999999999999999999999999999


Q ss_pred             CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccc
Q 039002          127 GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT  206 (219)
Q Consensus       127 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  206 (219)
                      ++|...+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++...........
T Consensus        80 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          80 GELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            99998886543   377888899999999999999998   999999999999999999999999999876543333334


Q ss_pred             ccccccccccCCC
Q 039002          207 EFAGTYGYVALGI  219 (219)
Q Consensus       207 ~~~gt~~y~aPE~  219 (219)
                      ..+||+.|+|||+
T Consensus       154 ~~~gt~~y~aPE~  166 (328)
T cd05593         154 TFCGTPEYLAPEV  166 (328)
T ss_pred             cccCCcCccChhh
Confidence            5689999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.6e-31  Score=210.61  Aligned_cols=168  Identities=26%  Similarity=0.373  Sum_probs=142.3

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            47899999999999999999 4557889999987542111 112335577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+++++|.+++...+   .+++.....++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          80 MEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999986543   367788888999999999999999   999999999999999999999999999886643


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .   .....|++.|+|||+
T Consensus       154 ~---~~~~~gt~~y~aPE~  169 (291)
T cd05612         154 R---TWTLCGTPEYLAPEV  169 (291)
T ss_pred             C---cccccCChhhcCHHH
Confidence            2   234579999999994

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=211.98  Aligned_cols=173  Identities=27%  Similarity=0.398  Sum_probs=149.9

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHAR  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~  115 (219)
                      ......|++.+.||+|.||.||++ ...+|+.+|+|.+.+...... .....+.+|+.+|+.+. ||||+.++++|++.+
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            334567999999999999999999 556799999999876543322 23456789999999998 999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC----CcEEEee
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE----YEAHVAD  191 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~----~~~kl~d  191 (219)
                      .+++|||++.||.|.+.+...    .+++..+..++.|++.++.|+|..   +++|||+||+|+|+...    +.++++|
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence            999999999999999998754    278899999999999999999998   99999999999999743    4799999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++..... .......+||+.|+|||+
T Consensus       183 FGla~~~~~-~~~~~~~~Gtp~y~APEv  209 (382)
T KOG0032|consen  183 FGLAKFIKP-GERLHTIVGTPEYVAPEV  209 (382)
T ss_pred             CCCceEccC-CceEeeecCCccccCchh
Confidence            999998876 555677899999999995

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.8e-31  Score=215.86  Aligned_cols=149  Identities=21%  Similarity=0.288  Sum_probs=128.7

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..|++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            47899999999999999999 5668889999987532111 122335677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          80 MEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            99999999999886543   367788888999999999999999   999999999999999999999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.8e-30  Score=210.13  Aligned_cols=167  Identities=23%  Similarity=0.327  Sum_probs=137.5

Q ss_pred             cceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           47 KYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      ++.||+|+||.||+++.    .+++.+|+|.+..............+.+|+.+++.++||||+++++++..++..+++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36799999999999953    35778999987542211122233456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+.+++|.+++...+   .+.+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999886543   256777888899999999999998   99999999999999999999999999987654443


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......||+.|+|||+
T Consensus       155 ~~~~~~~gt~~y~aPE~  171 (323)
T cd05584         155 TVTHTFCGTIEYMAPEI  171 (323)
T ss_pred             CcccccCCCccccChhh
Confidence            33345689999999995

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.4e-30  Score=215.20  Aligned_cols=149  Identities=17%  Similarity=0.260  Sum_probs=128.1

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +.|+.++.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.+++.++|+||+++++.+.+++..+++
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            35889999999999999999 5567889999987532111 122345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |||+++|+|.+++...+   .+++..+..++.|++.|+.|+|..   +|+||||||+||+++.+|.++|+|||++..
T Consensus        80 ~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          80 MDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999999886543   267788888999999999999999   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=1.3e-30  Score=212.30  Aligned_cols=170  Identities=25%  Similarity=0.325  Sum_probs=142.5

Q ss_pred             HhCCCCCcceeccccceeEEEEEc-CC-CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAEL-PS-REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~-~~-~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ..++|++.+.||+|+||.||+|.. .+ +..+|+|.+....... ......+.+|+.+++.++||||+++++++...+..
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            356899999999999999999953 33 3579999875322111 12335577899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999987543   377888889999999999999999   999999999999999999999999999986


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....   .....||+.|+|||+
T Consensus       181 ~~~~---~~~~~gt~~y~aPE~  199 (340)
T PTZ00426        181 VDTR---TYTLCGTPEYIAPEI  199 (340)
T ss_pred             cCCC---cceecCChhhcCHHH
Confidence            6432   234689999999994

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=4e-30  Score=208.23  Aligned_cols=165  Identities=23%  Similarity=0.294  Sum_probs=137.5

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLER  126 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  126 (219)
                      +.||+|+||.||++ ...+++.+|+|.+....... ......+.+|+.+++.++|+||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999 45688899999986432111 12234567889999999999999999999999999999999999


Q ss_pred             CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          127 GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       127 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      ++|..++....   .+++..+..++.|++.|+.|||+ .   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          80 GELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            99998886543   37788899999999999999997 6   99999999999999999999999999987654433333


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (325)
T cd05594         154 KTFCGTPEYLAPEV  167 (325)
T ss_pred             ccccCCcccCCHHH
Confidence            45679999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=4.4e-30  Score=205.96  Aligned_cols=170  Identities=22%  Similarity=0.302  Sum_probs=140.8

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+.....   ......+.+|+.+++.++|+||+++++++.+....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            4789999999999999999995 45788999999864321   1223456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+. +++.+++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++....
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            999995 57777765432  2367788889999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~  174 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDV  174 (303)
T ss_pred             CCCccCCCCcccCCCCChHH
Confidence            43333344578999999994

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-30  Score=208.38  Aligned_cols=163  Identities=23%  Similarity=0.322  Sum_probs=136.7

Q ss_pred             eccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.+++.++||||+++++++...+..+++|||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            699999999999 4557889999987532111 12233566789999999999999999999999999999999999999


Q ss_pred             HHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccccc
Q 039002          129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF  208 (219)
Q Consensus       129 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  208 (219)
                      |.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++............
T Consensus        80 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          80 LFHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            999886543   377888889999999999999998   99999999999999999999999999987654333333456


Q ss_pred             ccccccccCCC
Q 039002          209 AGTYGYVALGI  219 (219)
Q Consensus       209 ~gt~~y~aPE~  219 (219)
                      +||+.|+|||+
T Consensus       154 ~gt~~y~aPE~  164 (312)
T cd05585         154 CGTPEYLAPEL  164 (312)
T ss_pred             cCCcccCCHHH
Confidence            89999999994

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=2.1e-30  Score=212.61  Aligned_cols=150  Identities=24%  Similarity=0.341  Sum_probs=129.5

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.++..++|++++++++.+.+.+..+++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            47899999999999999999 4567889999988532111 122335677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      |||+++++|.+++....   .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.+|.++|+|||++..+
T Consensus        80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          80 MEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            99999999999986543   377888889999999999999998   9999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=4.1e-30  Score=208.10  Aligned_cols=170  Identities=22%  Similarity=0.300  Sum_probs=140.2

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC-ccceeEeEEEeCCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR-NIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~lv  120 (219)
                      +|++.+.||+|+||.||+| ...+++.||+|.+....... ......+..|..++..++|+ +++.+++++...+..|++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            5889999999999999999 45677899999986432211 12334567788899988764 688899999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+.+++|..++....   .+++..+..++.|++.|+.|||..   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          80 MEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999998886543   367888889999999999999998   999999999999999999999999999875433


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+||+.|+|||+
T Consensus       154 ~~~~~~~~~gt~~y~aPE~  172 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEI  172 (324)
T ss_pred             CCCceeeecCCccccChhh
Confidence            3333445689999999994

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=2.2e-30  Score=213.22  Aligned_cols=172  Identities=22%  Similarity=0.296  Sum_probs=143.0

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            4578999999999999999999 4567889999987532111 1122344678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++|||+++|+|.+++...    .+++.....++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999988642    267777888899999999999998   9999999999999999999999999999876


Q ss_pred             cCCCC-cccccccccccccCCC
Q 039002          199 KSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ..... .....+||+.|+|||+
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~  214 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEV  214 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHH
Confidence            43321 2234579999999994

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=3.6e-30  Score=208.32  Aligned_cols=165  Identities=24%  Similarity=0.327  Sum_probs=133.9

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHH-HHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK-ALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+| ...+++.+|+|.+........ .....+.+|.. +++.++||||+++++.+...+..+++|||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            46899999999999 456788999999854221111 12233444444 5678999999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            999998886543   367788888999999999999999   99999999999999999999999999987654433334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (323)
T cd05575         154 STFCGTPEYLAPEV  167 (323)
T ss_pred             ccccCChhhcChhh
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=2.8e-30  Score=212.65  Aligned_cols=175  Identities=21%  Similarity=0.288  Sum_probs=144.8

Q ss_pred             HHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      +....++|++.+.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+.+++.++||||+++++.+..++
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3444589999999999999999999 4557889999987531111 1122345678999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++|||+++++|.+++...    .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999988643    267777888999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC-cccccccccccccCCC
Q 039002          196 KFLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ........ .....+||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~  214 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEV  214 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHH
Confidence            87654322 2234679999999994

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=208.66  Aligned_cols=172  Identities=23%  Similarity=0.264  Sum_probs=142.7

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||++. ..+++.+|+|.+..... ........+.+|+.+++.++|+||+.+++++.+.+..+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            479999999999999999995 56788999998753111 1112334567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+.+++|.+++....  ..+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||++..+..
T Consensus        80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             EecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999986432  2377888889999999999999999   999999999999999999999999999977654


Q ss_pred             CCCc-ccccccccccccCCC
Q 039002          201 DASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~-~~~~~gt~~y~aPE~  219 (219)
                      .... .....||+.|+|||+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~  174 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEI  174 (331)
T ss_pred             CCCccccceeccccccCHHH
Confidence            3322 223479999999984

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=3.1e-30  Score=209.36  Aligned_cols=171  Identities=22%  Similarity=0.268  Sum_probs=141.0

Q ss_pred             CCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcc
Q 039002           43 DFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  117 (219)
                      +|++.+.||+|+||.||+++.    .+++.+|+|.+..............+.+|+.+++.+ +|++|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588999999999999999843    367889999875422222222345567899999999 589999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999886532   377888889999999999999998   999999999999999999999999999876


Q ss_pred             ecCCC-CcccccccccccccCCC
Q 039002          198 LKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      +.... ......+||+.|+|||+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~  177 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEI  177 (332)
T ss_pred             ccccCCCccccccCCccccCHHH
Confidence            54332 22234689999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=4.5e-30  Score=210.15  Aligned_cols=166  Identities=25%  Similarity=0.423  Sum_probs=139.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|+..+.||+|+||.||+|. ..+++.||+|.+...   ........+.+|+.+++.++|+||+++++++...+..++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC---CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            4667888999999999999994 567889999998542   122344668899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||+.+++|....       ...+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..+.
T Consensus       150 v~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        150 LLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            99999999886432       134566778999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........||..|+|||+
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~  239 (353)
T PLN00034        220 QTMDPCNSSVGTIAYMSPER  239 (353)
T ss_pred             cccccccccccCccccCccc
Confidence            44333345689999999994

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-31  Score=189.02  Aligned_cols=170  Identities=24%  Similarity=0.361  Sum_probs=149.3

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .+|.-.++||+|+||+||+| .+.+++.||+|.++..  .++.....+..+|+.+++.++|+||+++++...++..+.+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrld--dddegvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEecc--CCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            34666789999999999999 6778999999998764  34456778899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|+|. .+|..++.+..  ..+.......++.|++.|+.++|+.   ++.|||+||+|.++..+|++|+.|||+++-+..
T Consensus        80 fe~cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   80 FEFCD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             HHHhh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            99994 58888886543  2367777888999999999999999   999999999999999999999999999999988


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      +..|.+..+-|.+|++|.+
T Consensus       154 pvrcysaevvtlwyrppdv  172 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDV  172 (292)
T ss_pred             ceEeeeceeeeeeccCcce
Confidence            8877777788999999964

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=206.06  Aligned_cols=173  Identities=24%  Similarity=0.310  Sum_probs=152.9

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|..++.||+|+||+|-++ +..+++.+|+|++++...-... ...+-..|-.+|...+||++..+-..|++.++++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-EVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-EVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-HhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            4678999999999999999999 6778999999999876654432 3345678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      .||||..||.|.-.+++..   .+++.+...+-..|+.||.|||++   +|+.||+|.+|.+++.+|.+||+|||+|+.-
T Consensus       245 FVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999988776643   377888888899999999999998   9999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+||||.|+|||+
T Consensus       319 I~~g~t~kTFCGTPEYLAPEV  339 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEV  339 (516)
T ss_pred             ccccceeccccCChhhcCchh
Confidence            777777788999999999995

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=5.3e-30  Score=206.81  Aligned_cols=165  Identities=24%  Similarity=0.354  Sum_probs=134.1

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhc-CCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.||+|.++....... ........|..++.. .+||||+++++++..++..+++|||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            369999999999994 56788999998864322111 122334455565554 489999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          80 GGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            999999886543   377888889999999999999998   99999999999999999999999999998654443444


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (316)
T cd05592         154 STFCGTPDYIAPEI  167 (316)
T ss_pred             ccccCCccccCHHH
Confidence            55689999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=4.7e-30  Score=207.72  Aligned_cols=168  Identities=25%  Similarity=0.335  Sum_probs=138.0

Q ss_pred             CCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHH---hcCCCCccceeEeEEEeCCcceE
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL---TETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      |++.+.||+|+||.||+| ...+++.||+|.++...... ......+.+|+.++   +.++||||+++++++...+..++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            678899999999999999 45678899999986422111 11234455565544   56789999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|...+...    .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++....
T Consensus        80 v~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          80 VMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999998887542    378888999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+|++.|+|||+
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~  172 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEV  172 (324)
T ss_pred             CCCCcccccccCccccCHhH
Confidence            44344455789999999994

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=5.5e-30  Score=207.44  Aligned_cols=165  Identities=25%  Similarity=0.343  Sum_probs=134.1

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHH-HHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK-ALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+| ...+++.+|+|.+........ .....+..|.. +++.++||||+++++++...+..+++|||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            46899999999999 456788999998854221111 12234444544 5778999999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|...+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            999988876533   377888899999999999999998   99999999999999999999999999987644333334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (325)
T cd05604         154 TTFCGTPEYLAPEV  167 (325)
T ss_pred             ccccCChhhCCHHH
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=1.1e-29  Score=201.92  Aligned_cols=171  Identities=20%  Similarity=0.248  Sum_probs=141.0

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .|+..+.||+|+||.||+| ...+++.+|+|.+....... ......+.+|+.+++.++|++++++++.+...+..++++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            3778899999999999999 45688899999875432111 122345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+.+++|...+..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          80 TIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999999887753221 2367888899999999999999999   9999999999999999999999999999875432


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      . ......||+.|+|||+
T Consensus       156 ~-~~~~~~g~~~y~aPE~  172 (285)
T cd05631         156 E-TVRGRVGTVGYMAPEV  172 (285)
T ss_pred             C-eecCCCCCCCccCHhh
Confidence            2 2234579999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-30  Score=211.26  Aligned_cols=171  Identities=23%  Similarity=0.331  Sum_probs=144.2

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+|. ..+++.+|+|.+....... ......+.+|+.++..++|+||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            479999999999999999994 5578899999986422111 12335677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+.+++|.+++....   .+++..+..++.|++.|+.|||..   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          80 MEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999999987542   377888899999999999999998   999999999999999999999999999986654


Q ss_pred             CC-----------------------------CcccccccccccccCCC
Q 039002          201 DA-----------------------------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~-----------------------------~~~~~~~gt~~y~aPE~  219 (219)
                      ..                             .......||+.|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  201 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV  201 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence            33                             12234579999999994

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=5.2e-30  Score=207.19  Aligned_cols=165  Identities=24%  Similarity=0.298  Sum_probs=132.9

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHH-HHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEV-KALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.+........ .....+..|. .+++.++|+||+++++++.+.+..+++|||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            369999999999994 56788999998754221111 1223344454 46788999999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|...+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          80 GGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            999988876432   367778888999999999999998   99999999999999999999999999987643333333


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (321)
T cd05603         154 STFCGTPEYLAPEV  167 (321)
T ss_pred             ccccCCcccCCHHH
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=5.5e-30  Score=207.42  Aligned_cols=165  Identities=24%  Similarity=0.311  Sum_probs=132.5

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHH-HHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEV-KALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.+........ .....+.+|. .+++.++|+||+++++++...+..+++|||+.
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            369999999999994 55778899998754211111 1222334443 45688899999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+.+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          80 GGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            999999886543   266777888899999999999998   99999999999999999999999999987654433334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (325)
T cd05602         154 STFCGTPEYLAPEV  167 (325)
T ss_pred             ccccCCccccCHHH
Confidence            55689999999994

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=7.5e-30  Score=207.16  Aligned_cols=172  Identities=22%  Similarity=0.267  Sum_probs=142.4

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||++. ..+++.+|+|.+...... .......+.+|..++..++|++|+.+++++...+..|++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            579999999999999999995 557788999987531111 112334567889999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+.+|+|..++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999996532  2367788888999999999999998   999999999999999999999999999987654


Q ss_pred             CCCc-ccccccccccccCCC
Q 039002          201 DASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~-~~~~~gt~~y~aPE~  219 (219)
                      .... .....||+.|+|||+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~  174 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEI  174 (331)
T ss_pred             CCceeeccccCCcccCCHHH
Confidence            3322 233579999999994

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=8.6e-30  Score=206.65  Aligned_cols=165  Identities=25%  Similarity=0.322  Sum_probs=137.5

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+| ...+++.||+|.++...... ......+.+|..++..+ +||||+++++++...+..+++|||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            36899999999999 45678899999986432221 22334567888988888 79999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||+++.........
T Consensus        80 ~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            999998886442   378889999999999999999999   99999999999999999999999999987543333333


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (329)
T cd05588         154 STFCGTPNYIAPEI  167 (329)
T ss_pred             ccccCCccccCHHH
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=1e-29  Score=205.62  Aligned_cols=170  Identities=22%  Similarity=0.313  Sum_probs=139.8

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +|++.+.||+|+||.||+| ...+++.+|+|.+....... .........|..++..+ +|++++.+++++...+..+++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            5889999999999999999 45577899999886532211 12233456677777776 578999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+++++|...+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          80 MEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             EcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999998886543   377888899999999999999998   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........||+.|+|||+
T Consensus       154 ~~~~~~~~~gt~~y~aPE~  172 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEI  172 (323)
T ss_pred             CCCccccCCCChhhcCHHH
Confidence            3333445689999999994

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=1.7e-29  Score=202.53  Aligned_cols=173  Identities=24%  Similarity=0.381  Sum_probs=139.2

Q ss_pred             hCCCCCcceeccccceeEEEEEcC-----------------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP-----------------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN  103 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~-----------------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n  103 (219)
                      .++|++.+.||+|+||.||+|...                 ++..+|+|.+....   .......+.+|+.++++++|+|
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence            468999999999999999999532                 23469999886432   2233456889999999999999


Q ss_pred             cceeEeEEEeCCcceEEEEecCCCCHHHHhcccc----------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCC
Q 039002          104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDA----------------AAQELGWSQRMSVIKGVADALSYLHHDCFP  167 (219)
Q Consensus       104 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~  167 (219)
                      |+++++++...+..+++|||+.+++|.+++....                ....+++.....++.|++.|+.|||+.   
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  157 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---  157 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence            9999999999999999999999999999885421                112356677889999999999999998   


Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +++|+||||+||+++.++.++|+|||++........  ......++..|+|||+
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC  211 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHH
Confidence            999999999999999999999999999976533221  1122345788999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=1.2e-29  Score=205.78  Aligned_cols=165  Identities=25%  Similarity=0.323  Sum_probs=137.0

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.+....... ......+.+|+.++..+ +||||+++++++...+..+++|||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            369999999999994 5678899999986532222 22334567788877766 79999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            999988876543   378888899999999999999999   99999999999999999999999999987644333334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (329)
T cd05618         154 STFCGTPNYIAPEI  167 (329)
T ss_pred             ccccCCccccCHHH
Confidence            55689999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=7e-30  Score=211.08  Aligned_cols=172  Identities=24%  Similarity=0.382  Sum_probs=151.0

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...+.|.+.+.||+|.|+.|.+| ...++..||+|.+.+.....  ....++.+|+++++.++||||++++.+..+...+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~--~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP--SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh--HHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            34578999999999999999999 55688999999987654332  2345588999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+||||+.+|.+.+++...+.   ..+..+..++.|++.|++|||++   .|+|||||++|++++.+..+||+|||++.+
T Consensus       131 ylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence            999999999999999987654   44567778889999999999999   999999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +. ...-.++++|++.|.|||.
T Consensus       205 ~~-~~~~lqt~cgsppyAaPEl  225 (596)
T KOG0586|consen  205 FD-YGLMLQTFCGSPPYAAPEL  225 (596)
T ss_pred             ec-ccccccccCCCCCccChHh
Confidence            87 4455688899999999994

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=8.2e-30  Score=207.34  Aligned_cols=175  Identities=22%  Similarity=0.355  Sum_probs=137.7

Q ss_pred             HHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEE
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFC  111 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~  111 (219)
                      .+.++|++.+.||+|+||.||+|..      .++..||+|.+....   .......+.+|+.+++.+ +||||+++++++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            4567899999999999999999942      234579999886421   122345678899999999 899999999988


Q ss_pred             EeC-CcceEEEEecCCCCHHHHhcccch----------------------------------------------------
Q 039002          112 SHA-RHSFLLCEFLERGSLAAILNTDAA----------------------------------------------------  138 (219)
Q Consensus       112 ~~~-~~~~lv~e~~~~~~l~~~~~~~~~----------------------------------------------------  138 (219)
                      ... +.++++|||+++|+|.+++.....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            754 458899999999999998864211                                                    


Q ss_pred             -------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc--ccccc
Q 039002          139 -------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFA  209 (219)
Q Consensus       139 -------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~  209 (219)
                             ...+.+.....++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++........  .....
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                   01255677788999999999999998   9999999999999999999999999999865432211  12234


Q ss_pred             cccccccCCC
Q 039002          210 GTYGYVALGI  219 (219)
Q Consensus       210 gt~~y~aPE~  219 (219)
                      +++.|+|||+
T Consensus       238 ~~~~y~aPE~  247 (338)
T cd05102         238 LPLKWMAPES  247 (338)
T ss_pred             CCccccCcHH
Confidence            5678999994

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=215.16  Aligned_cols=175  Identities=26%  Similarity=0.439  Sum_probs=148.4

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      ++|.++-++..+...||+|.||+||+|.|..  .||||.+.-....+  +..+.|.+|+.++++-+|.||+-+.|++-..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            5677778888899999999999999997653  69999987654443  3667899999999999999999999999887


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +. .||+.+|.|.+|+.++....  .++.+.+...|+.|+++|+.|||++   +|+|+|||..||++.++++|||+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence            76 99999999999999997654  3477888899999999999999999   999999999999999999999999999


Q ss_pred             eeeecC--CCCcccccccccccccCCC
Q 039002          195 AKFLKS--DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~--~~~~~~~~~gt~~y~aPE~  219 (219)
                      +..-.-  .........|...|||||+
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEv  561 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEV  561 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHH
Confidence            864321  1122244578899999995

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=3.3e-29  Score=203.36  Aligned_cols=169  Identities=26%  Similarity=0.384  Sum_probs=144.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||++ ...++..+|+|.+....   .......+.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            478999999999999999999 55678889999876421   22344568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+++++|.+++....   .+++..+..++.|++.|+.|+|+..  +++|+||||+||+++.++.++|+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            999999999999986543   3678888899999999999999852  59999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .....|++.|+|||+
T Consensus       156 ~~~--~~~~~g~~~y~aPE~  173 (331)
T cd06649         156 DSM--ANSFVGTRSYMSPER  173 (331)
T ss_pred             ccc--cccCCCCcCcCCHhH
Confidence            332  244679999999995

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=1.1e-29  Score=205.92  Aligned_cols=172  Identities=23%  Similarity=0.275  Sum_probs=143.9

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.+|+|.++...... ......+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            47899999999999999999 45678899999986432111 12334567889999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+++++|.+++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++..+..
T Consensus        80 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             ECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999986542  2377888888999999999999999   999999999999999999999999999987654


Q ss_pred             CCCc-ccccccccccccCCC
Q 039002          201 DASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~-~~~~~gt~~y~aPE~  219 (219)
                      .... .....||+.|+|||+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~  174 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEV  174 (330)
T ss_pred             CCceeeecccCCccccCHHH
Confidence            3322 233578999999994

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=2.3e-30  Score=202.60  Aligned_cols=163  Identities=28%  Similarity=0.366  Sum_probs=131.3

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC---c--
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR---H--  116 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~--  116 (219)
                      .|+..+.+|.|+||.||+|. ..+++.+|||+...+..        --.+|+++|+.++||||+++.-+|.+..   .  
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            36778999999999999994 55678999999754221        1246999999999999999988775432   2  


Q ss_pred             ceEEEEecCCCCHHHHhccc-chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEeeccc
Q 039002          117 SFLLCEFLERGSLAAILNTD-AAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGI  194 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~dfg~  194 (219)
                      ..+||||++ .+|...++.. .....++...+..+..|+..|+.|||..   +|+||||||+|+|+|.+ |.+||||||.
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            348999996 4888888631 1123467777888999999999999998   99999999999999966 9999999999


Q ss_pred             eeeecCCCCcccccccccccccCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      |+.+.....+ .+..+|..|+|||
T Consensus       173 AK~L~~~epn-iSYicSRyYRaPE  195 (364)
T KOG0658|consen  173 AKVLVKGEPN-ISYICSRYYRAPE  195 (364)
T ss_pred             ceeeccCCCc-eeEEEeccccCHH
Confidence            9988765444 5567899999999

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-30  Score=201.18  Aligned_cols=172  Identities=27%  Similarity=0.436  Sum_probs=145.6

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe----
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH----  113 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----  113 (219)
                      .....|...+.||+|+||.|+.+ ...+|+.||+|++..+.  +.....++..+|+..++.++|+||+.+.+++..    
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            33456777899999999999999 67789999999987543  334456778999999999999999999999865    


Q ss_pred             -CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          114 -ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       114 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                       .+.+|+|+|++ ..+|...++.+..   ++......++.|++.|+.|+|+.   +++||||||.|++++.+..+||+||
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence             35689999999 5699999976532   77788889999999999999999   9999999999999999999999999


Q ss_pred             cceeeecCC--CCcccccccccccccCCC
Q 039002          193 GIAKFLKSD--ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~--~~~~~~~~gt~~y~aPE~  219 (219)
                      |+|+.....  ....+..+.|.+|+|||+
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPEl  198 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPEL  198 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHH
Confidence            999987542  222366789999999995

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.4e-30  Score=197.33  Aligned_cols=172  Identities=24%  Similarity=0.402  Sum_probs=145.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCch----hhHHHHHHHHHHHhcC-CCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQT----VDQKEFLTEVKALTET-RHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  114 (219)
                      -++|.-.+.||.|..+.|-++ ..+++..+|+|++.........    .-.+...+|+.+|+++ .||+|+++.++++++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356788899999999988888 6678888999987442222111    1123446799999998 599999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ..+|+|+|.++.|.|.+++.+.-   .+++.....++.|+.+|++|+|.+   +|+||||||+|||++.+.+++|+|||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999997542   378888899999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.+. +..+....||||+|+|||+
T Consensus       170 a~~l~-~GekLrelCGTPgYLAPEt  193 (411)
T KOG0599|consen  170 ACQLE-PGEKLRELCGTPGYLAPET  193 (411)
T ss_pred             eeccC-CchhHHHhcCCCcccChhh
Confidence            99875 4456678899999999995

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=1.7e-29  Score=200.83  Aligned_cols=170  Identities=26%  Similarity=0.412  Sum_probs=140.6

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+|. ..+++.+|+|.+......  ......+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            479999999999999999995 457888999998653222  22345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+.++.+..+....   ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          79 FEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9999887666554322   2377888899999999999999998   999999999999999999999999999987643


Q ss_pred             CCC-cccccccccccccCCC
Q 039002          201 DAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ... ......|++.|+|||+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~  172 (287)
T cd07848         153 GSNANYTEYVATRWYRSPEL  172 (287)
T ss_pred             cccccccccccccccCCcHH
Confidence            321 2234578999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.7e-29  Score=209.24  Aligned_cols=163  Identities=20%  Similarity=0.322  Sum_probs=137.7

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|...          ...+.+|+.+++.++||||+++++++..+...+
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            3467999999999999999999 56788899999642          123578999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++|++. +++..++....   .+++..+..++.|++.||.|+|+.   +|+||||||+||+++.++.++|+|||++...
T Consensus       160 lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             EEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            9999985 68887775432   377888999999999999999998   9999999999999999999999999998754


Q ss_pred             cCCC-CcccccccccccccCCC
Q 039002          199 KSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      .... ......+||+.|+|||+
T Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~  254 (391)
T PHA03212        233 VDINANKYYGWAGTIATNAPEL  254 (391)
T ss_pred             ccccccccccccCccCCCChhh
Confidence            3221 22234589999999995

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.96  E-value=1.5e-29  Score=204.52  Aligned_cols=165  Identities=25%  Similarity=0.327  Sum_probs=135.6

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.+....... ......+..|..++..+ +||||+++++++.+.+..++||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            368999999999994 5578899999986432111 12234456788888765 79999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|...+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          80 GGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            999998886543   367788889999999999999999   99999999999999999999999999988654444334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (321)
T cd05591         154 TTFCGTPDYIAPEI  167 (321)
T ss_pred             cccccCccccCHHH
Confidence            45679999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-31  Score=199.96  Aligned_cols=170  Identities=26%  Similarity=0.426  Sum_probs=143.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+|+.|+++ ..++|+.+|+|.+.......  ...+.+-+|+.+.+.++||||+++.+.+.+.+..|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            478999999999999999999 77889999999875543332  245678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC---CcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE---YEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~  196 (219)
                      |+|++.|++|..-+-..   ...++..+--++.|+++++.|+|.+   +|+|||+||+|+++..+   .-+|++|||+|.
T Consensus        88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999887654221   1245666778899999999999999   99999999999999643   468999999999


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+. ...-+..++|||.|||||+
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEv  183 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEV  183 (355)
T ss_pred             EeC-CccccccccCCCcccCHHH
Confidence            987 5566778999999999995

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=1.4e-29  Score=204.37  Aligned_cols=164  Identities=25%  Similarity=0.310  Sum_probs=137.5

Q ss_pred             ceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEe
Q 039002           48 YCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      +.||+|+||.||+++.    .+++.+|+|.+......  ......+.+|+.+++.++|+||+++++++..++..|++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999843    46788999988642211  12234567799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS  203 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  203 (219)
                      +.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          80 LRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            99999999886432   378888999999999999999999   999999999999999999999999999886654433


Q ss_pred             cccccccccccccCCC
Q 039002          204 NWTEFAGTYGYVALGI  219 (219)
Q Consensus       204 ~~~~~~gt~~y~aPE~  219 (219)
                      ......|++.|+|||+
T Consensus       154 ~~~~~~g~~~y~aPE~  169 (318)
T cd05582         154 KAYSFCGTVEYMAPEV  169 (318)
T ss_pred             ceecccCChhhcCHHH
Confidence            3445689999999994

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.96  E-value=1.4e-29  Score=204.60  Aligned_cols=165  Identities=25%  Similarity=0.349  Sum_probs=135.5

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.||+|.+........ .....+..|..++..+ +|+||+++++++...+..+++|||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc-cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            368999999999994 55788999998864221111 2234456777777766 69999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          80 GGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             CchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            999998886543   377888899999999999999998   99999999999999999999999999987654333334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (320)
T cd05590         154 STFCGTPDYIAPEI  167 (320)
T ss_pred             cccccCccccCHHH
Confidence            55689999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=215.59  Aligned_cols=169  Identities=28%  Similarity=0.430  Sum_probs=143.1

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      +..-|+.+..||-|+||.||-| +..+.+.||||++.-.. .........+.+|+..|++++|||++.|-++|.-....|
T Consensus        24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            3455778899999999999999 56788899999985322 122334466889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      |||||| -|+..+++.....  .+.+..+..|..+.+.||.|||+.   +.||||||.-|||++..|.||++|||.|...
T Consensus       103 LVMEYC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  103 LVMEYC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence            999999 5688888865543  266788889999999999999998   9999999999999999999999999999754


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .    .-++|+|||+|||||+
T Consensus       177 ~----PAnsFvGTPywMAPEV  193 (948)
T KOG0577|consen  177 A----PANSFVGTPYWMAPEV  193 (948)
T ss_pred             C----chhcccCCccccchhH
Confidence            2    2367999999999995

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=2.2e-29  Score=203.15  Aligned_cols=165  Identities=24%  Similarity=0.323  Sum_probs=133.9

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhc-CCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.++....... ........|..++.. .+|+||+++++++...+..+++|||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            469999999999994 55788999999864321111 122345567777765 489999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          80 GGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            999998886542   367888889999999999999999   99999999999999999999999999987543333333


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (316)
T cd05620         154 STFCGTPDYIAPEI  167 (316)
T ss_pred             eccCCCcCccCHHH
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=2.9e-29  Score=202.53  Aligned_cols=165  Identities=24%  Similarity=0.339  Sum_probs=134.1

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhc-CCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.++....... ........|..++.. ++||||+++++++.+.+..+++|||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            469999999999995 55788999998864321111 122345567777765 589999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++.....++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          80 GGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            999999886532   367788889999999999999999   99999999999999999999999999987644333333


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (316)
T cd05619         154 CTFCGTPDYIAPEI  167 (316)
T ss_pred             eeecCCccccCHHH
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=5.2e-29  Score=211.35  Aligned_cols=171  Identities=20%  Similarity=0.226  Sum_probs=140.4

Q ss_pred             CCCCCcceeccccceeEEEEE-cCC-CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPS-REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~-~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..|.+.+.||+|++|.||+|. ..+ +..+++|.+..    ........+.+|+.+++.++||||+++++++...+..|+
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            348999999999999999994 444 56788887643    122333456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +|||+++++|.+.+.... ....+++..+..++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++..+
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            999999999998775321 112367778888999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCC--cccccccccccccCCC
Q 039002          199 KSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      .....  .....+||+.|+|||+
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~  242 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPEL  242 (478)
T ss_pred             CCccccccccccCCCccccCHhH
Confidence            54322  2344679999999994

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=6.3e-29  Score=201.90  Aligned_cols=169  Identities=26%  Similarity=0.402  Sum_probs=142.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||++ ...++..+|+|.+....   .......+.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            478999999999999999999 45578889999876431   22234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++....   .+++.....++.+++.|+.|+|+..  +++|+||||+||+++.++.++|+|||++..+.
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            999999999999986543   2677888899999999999999742  69999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .....|+..|+|||.
T Consensus       156 ~~~--~~~~~~~~~y~aPE~  173 (333)
T cd06650         156 DSM--ANSFVGTRSYMSPER  173 (333)
T ss_pred             hhc--cccCCCCccccCHHH
Confidence            322  234578999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=2.8e-29  Score=203.88  Aligned_cols=172  Identities=22%  Similarity=0.278  Sum_probs=141.0

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||++. ..+++.+|+|.+...... .......+.+|+.++..++|++|+++++.+.+.+..+++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            478999999999999999995 456778999987431111 111223467788999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+.+|+|.+++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++..+..
T Consensus        80 ~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999996532  2367788888999999999999998   999999999999999999999999999876543


Q ss_pred             CCC-cccccccccccccCCC
Q 039002          201 DAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ... ......||+.|+|||+
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~  174 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEI  174 (332)
T ss_pred             CCcceecccccCccccCHHH
Confidence            322 2233579999999994

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=3e-29  Score=203.35  Aligned_cols=165  Identities=24%  Similarity=0.312  Sum_probs=137.2

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.+....... ......+.+|+.++..+ +|+||+.+++++...+..+++|||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            369999999999994 5677889999986532221 12334567888888888 69999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|...+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          80 GGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            999998876433   378889999999999999999998   99999999999999999999999999987644333334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (327)
T cd05617         154 STFCGTPNYIAPEI  167 (327)
T ss_pred             ecccCCcccCCHHH
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-30  Score=214.24  Aligned_cols=168  Identities=27%  Similarity=0.438  Sum_probs=143.6

Q ss_pred             CCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC------c
Q 039002           44 FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR------H  116 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~  116 (219)
                      +.-.+.||+|+||.||+|+ ..+|+.+|||.++....   ....+...+|++++++++|+|||+++++-.+..      .
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~---~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS---LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcc---cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            3445789999999999995 77999999999876442   234456789999999999999999999876544      4


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC--CCCc--EEEeec
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD--LEYE--AHVADF  192 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~--~~~~--~kl~df  192 (219)
                      ..++||||.+|+|...+....+...+++..++.++..+..|+.|||.+   +|+||||||.||++.  .+|+  .||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            679999999999999998766666799999999999999999999998   999999999999885  4454  699999


Q ss_pred             cceeeecCCCCcccccccccccccCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      |.|+.+.+.. ..++++||..|++||
T Consensus       169 G~Arel~d~s-~~~S~vGT~~YLhPe  193 (732)
T KOG4250|consen  169 GAARELDDNS-LFTSLVGTEEYLHPE  193 (732)
T ss_pred             cccccCCCCC-eeeeecCchhhcChH
Confidence            9999887654 568899999999998

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-31  Score=219.29  Aligned_cols=171  Identities=28%  Similarity=0.416  Sum_probs=145.8

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      +.+-+.++..||.|+||+||+|. ..++-..|.|.+..    ........++-|+.+|...+||+|+++++.|...+.+|
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            34556778899999999999994 44444455666542    22345577888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +..|+|+||.+...+-..+.  .+.+.++..++.|++.||.|||++   +|+|||||.-|||+..+|.+++.|||.+...
T Consensus       106 iliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             EEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence            99999999999998876543  388999999999999999999999   9999999999999999999999999998766


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+|.|||+|||||+
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEV  201 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEV  201 (1187)
T ss_pred             hhHHhhhccccCCcccccchh
Confidence            655566688999999999995

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=209.30  Aligned_cols=182  Identities=23%  Similarity=0.328  Sum_probs=147.5

Q ss_pred             ccHHHHHHHhCCCCCcceeccccceeEEEEEcC--CC---cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccce
Q 039002           32 ILYDEIVKATNDFDAKYCIGNGGHASVYRAELP--SR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK  106 (219)
Q Consensus        32 ~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~--~~---~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~  106 (219)
                      +....|....++-.+.++||+|+||.||+|...  .+   ..||+|..+.... ........+++|+++++.++||||++
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            344567777888888899999999999999543  22   2389998774221 22345577899999999999999999


Q ss_pred             eEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       107 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                      +||+......++|+||+|.+|+|.+++.....  .++..+...++.+.+.||.|||.+   +++||||-.+|+|++.++.
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCe
Confidence            99999999999999999999999999987543  488899999999999999999999   9999999999999999999


Q ss_pred             EEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +||+|||+++.-.........---...|+|||.
T Consensus       301 vKISDFGLs~~~~~~~~~~~~~klPirWLAPEt  333 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPET  333 (474)
T ss_pred             EEeCccccccCCcceeeccccccCcceecChhh
Confidence            999999998754311111111124577999994

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=5.1e-29  Score=197.74  Aligned_cols=166  Identities=22%  Similarity=0.287  Sum_probs=136.7

Q ss_pred             eccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||+|+||.||++ ...+++.+|+|.+...... .......+..|+.+++.++|+|++++.+++..++..+++|||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            689999999999 4567889999987542211 11122456789999999999999999999999999999999999999


Q ss_pred             HHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcccc
Q 039002          129 LAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE  207 (219)
Q Consensus       129 l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  207 (219)
                      |...+.... ....+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++..+.........
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            988774321 123478888999999999999999999   9999999999999999999999999999876554444445


Q ss_pred             cccccccccCCC
Q 039002          208 FAGTYGYVALGI  219 (219)
Q Consensus       208 ~~gt~~y~aPE~  219 (219)
                      ..||+.|+|||+
T Consensus       157 ~~g~~~y~aPE~  168 (280)
T cd05608         157 YAGTPGFMAPEL  168 (280)
T ss_pred             cCCCcCccCHHH
Confidence            689999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.96  E-value=3.2e-29  Score=202.83  Aligned_cols=170  Identities=22%  Similarity=0.315  Sum_probs=139.3

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +|+..+.||+|+||.||+| ...+++.||+|.+....... ......+..|..++..+. |++++++++++...+..+++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            4778899999999999999 45678899999886422111 122345667888888875 57788899999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+++++|..++....   .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          80 MEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999999886543   378888999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........||+.|+|||+
T Consensus       154 ~~~~~~~~~gt~~y~aPE~  172 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEI  172 (323)
T ss_pred             CCccccCccCCccccCHHH
Confidence            3333345679999999994

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=4.5e-29  Score=202.76  Aligned_cols=168  Identities=26%  Similarity=0.452  Sum_probs=137.2

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----Cc
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----RH  116 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~  116 (219)
                      +|++.+.||+|+||.||+| ...++..||+|++......  ......+.+|+.+++.++||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH--VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc--chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            5889999999999999999 4668889999988643211  12334678899999999999999999988543     24


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+. ++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          79 IYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            799999995 68888886543   378888899999999999999999   99999999999999999999999999997


Q ss_pred             eecCCCC---cccccccccccccCCC
Q 039002          197 FLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      .......   ......||+.|+|||+
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~  177 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPEL  177 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHH
Confidence            6533221   1234579999999994

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=2e-29  Score=199.99  Aligned_cols=151  Identities=23%  Similarity=0.257  Sum_probs=131.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+.|++++.||+|.-|.||+++ ..++..+|+|.+.+..... .....+++.|-++|+.++||+++++|..|++....++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            3458889999999999999995 4567899999986543222 2344667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +||||+||+|..+.+.+.. ..+++..+..++.+++.||+|||-.   ||++|||||+|||+.++|.+-|+||.++.
T Consensus       155 ~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            9999999999999987654 4588999999999999999999999   99999999999999999999999998743

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=8.9e-29  Score=198.92  Aligned_cols=170  Identities=21%  Similarity=0.327  Sum_probs=140.5

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+......   .....+.+|+.+++.++|+|++++++++..++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            3679999999999999999994 557788999998643221   223456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+ ++..++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++....
T Consensus        82 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            9999965 7877775432  2367788888999999999999998   99999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~  175 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDV  175 (309)
T ss_pred             CCccccccccccccccCCHH
Confidence            44333344578999999994

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=1.6e-28  Score=193.18  Aligned_cols=170  Identities=27%  Similarity=0.398  Sum_probs=143.9

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.+++|.+....    ......+.+|+.+++.++|+|++++++.+...+..+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            34689999999999999999995 5678889999885421    112345678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++||+++++|.+++....   .+++..+..++.|++.|+.|+|+.   +++|+|++|+||+++.++.++++|||++...
T Consensus        83 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceee
Confidence            9999999999999886432   367788889999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........+++.|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~y~~PE~  177 (267)
T cd06646         157 TATIAKRKSFIGTPYWMAPEV  177 (267)
T ss_pred             cccccccCccccCccccCHhH
Confidence            544333344578899999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=1.4e-28  Score=217.16  Aligned_cols=174  Identities=28%  Similarity=0.433  Sum_probs=142.5

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|++..... .......++.+|+.+++.++|||++++++++..++..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            68999999999999999999 456788999999865332 2233456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccch--------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          121 CEFLERGSLAAILNTDAA--------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                      |||+++++|.+++.....        ....++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence            999999999998853211        11234566788899999999999999   9999999999999999999999999


Q ss_pred             cceeeecCCC------------------CcccccccccccccCCC
Q 039002          193 GIAKFLKSDA------------------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~------------------~~~~~~~gt~~y~aPE~  219 (219)
                      |++.......                  ......+||+.|+|||+
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~  202 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER  202 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHH
Confidence            9998762111                  01123579999999994

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=4.2e-30  Score=212.83  Aligned_cols=173  Identities=22%  Similarity=0.371  Sum_probs=144.5

Q ss_pred             HhCCC-CCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc-
Q 039002           40 ATNDF-DAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH-  116 (219)
Q Consensus        40 ~~~~y-~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-  116 (219)
                      +.++| +....||+|+|-+||+| +-.+|..||.-.++............++..|+.+|+.|+|+||+++|+.|.+..+ 
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence            34555 55678999999999999 6667777776554443334445556788999999999999999999999987665 


Q ss_pred             -ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-CCCcEEEeeccc
Q 039002          117 -SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LEYEAHVADFGI  194 (219)
Q Consensus       117 -~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-~~~~~kl~dfg~  194 (219)
                       .-+|+|.+..|+|..+.+..+.   +..+.+..++.||+.||.|||++.. +|+|||||.+||||. ..|.|||+|+|+
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhH
Confidence             6689999999999999987653   7778889999999999999999865 899999999999998 569999999999


Q ss_pred             eeeecCCCCcccccccccccccCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      |.....+...  ...|||.|||||
T Consensus       193 Atl~r~s~ak--svIGTPEFMAPE  214 (632)
T KOG0584|consen  193 ATLLRKSHAK--SVIGTPEFMAPE  214 (632)
T ss_pred             HHHhhccccc--eeccCccccChH
Confidence            9987665433  469999999999

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-31  Score=203.17  Aligned_cols=167  Identities=27%  Similarity=0.433  Sum_probs=149.3

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .-|.++.+||+|+||.||+| ...+|..+|+|++.-      ..+...+.+|+.++...+.+.++++||.+.....+|||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            34667889999999999999 677899999998742      23556788999999999999999999999888899999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||||..|++.+.+....  ..+.+..+..++...+.||.|||..   .-+|||||.-|||+..+|..|+.|||.|-.+++
T Consensus       107 MEYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             hhhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            99999999999986533  3478888999999999999999998   889999999999999999999999999999988


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...+.++..|||.|||||+
T Consensus       182 TMAKRNTVIGTPFWMAPEV  200 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEV  200 (502)
T ss_pred             hHHhhCccccCcccccHHH
Confidence            8888888999999999984

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=8.1e-29  Score=194.90  Aligned_cols=169  Identities=27%  Similarity=0.408  Sum_probs=144.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+++|.++...    ......+.+|+.+++.++|+|++++++.+...+..++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            357888999999999999999 45678899999876431    1223456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||+++++|.+++...+   .+++.++..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            999999999999886543   378889999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........|++.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~  177 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEV  177 (267)
T ss_pred             CcccccccccCcccccChhh
Confidence            54444455689999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.2e-28  Score=196.12  Aligned_cols=171  Identities=20%  Similarity=0.258  Sum_probs=140.9

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .|++.+.||+|+||.||++. ..+++.+|+|.+....... ......+.+|+.+++.++|+||+++++.+..++..+++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            47889999999999999994 5678899999885422111 112344678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+.+++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             eccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999988754321 2378888999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      . ......|++.|+|||+
T Consensus       156 ~-~~~~~~~~~~y~aPE~  172 (285)
T cd05605         156 E-TIRGRVGTVGYMAPEV  172 (285)
T ss_pred             C-ccccccCCCCccCcHH
Confidence            2 2234578999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-29  Score=211.20  Aligned_cols=181  Identities=24%  Similarity=0.410  Sum_probs=156.4

Q ss_pred             ccccHHHHHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCcccee
Q 039002           30 GKILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKF  107 (219)
Q Consensus        30 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  107 (219)
                      ..+.++.+..+.+-|++...||+|.+|.||++ ..++++..|+|+.......+     ..+-.|..+++.. .|||++.+
T Consensus         7 ~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-----eEiE~eynil~~~~~hpnv~~f   81 (953)
T KOG0587|consen    7 MDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-----EEIELEYNMLKKYSHHPNVATF   81 (953)
T ss_pred             cccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-----HHHHHHHHHHHhccCCCCcceE
Confidence            34556667778899999999999999999999 56788889999876543222     3455688888887 58999999


Q ss_pred             EeEEE-----eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          108 YGFCS-----HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       108 ~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      |++|.     .++++|||||+|.+|++.++++... ...+.|..+.+|+..++.|+.+||..   .++|||+|-.|||+.
T Consensus        82 yg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT  157 (953)
T KOG0587|consen   82 YGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLT  157 (953)
T ss_pred             EEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEe
Confidence            99984     4578999999999999999998654 45688999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          183 LEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+|.+|++|||++..++......++++|||.|||||+
T Consensus       158 ~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEV  194 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEV  194 (953)
T ss_pred             ccCcEEEeeeeeeeeeecccccccCcCCCccccccee
Confidence            9999999999999999888777788999999999995

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=211.32  Aligned_cols=166  Identities=26%  Similarity=0.413  Sum_probs=144.2

Q ss_pred             cceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           47 KYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .-.||+|+||+||-|+ ..+....|||.+.    ..+......+++|+.+.+.++|+||++++|.+..++..-|.||-.+
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIp----ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIP----EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecc----cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            3469999999999995 4556678999874    3334455678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-CCCcEEEeeccceeeecCCCCc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LEYEAHVADFGIAKFLKSDASN  204 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~  204 (219)
                      ||+|.+++.+...+.+=.+.++..+..||++|+.|||+.   .|+|||||-+|+++. -.|.+||+|||.++.+-.-+.+
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            999999998755443336788899999999999999999   999999999999998 5799999999999887766677


Q ss_pred             ccccccccccccCCC
Q 039002          205 WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 ~~~~~gt~~y~aPE~  219 (219)
                      ..++.||..|||||+
T Consensus       733 TETFTGTLQYMAPEv  747 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEV  747 (1226)
T ss_pred             ccccccchhhhChHh
Confidence            788999999999996

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.4e-29  Score=201.19  Aligned_cols=163  Identities=25%  Similarity=0.320  Sum_probs=131.0

Q ss_pred             eccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC---CCCccceeEeEEEeCCcceEEEEecC
Q 039002           50 IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET---RHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        50 lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      ||+|+||.||+| ...+++.+|+|.+........ ........|..++...   +||||+.+++.+...+..+++|||+.
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh-hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            699999999999 456788999998753211111 1122334555555544   69999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          80 GGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             CChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            999998886543   378888999999999999999999   99999999999999999999999999987544333334


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+||+.|+|||+
T Consensus       154 ~~~~gt~~y~aPE~  167 (330)
T cd05586         154 NTFCGTTEYLAPEV  167 (330)
T ss_pred             cCccCCccccCHHH
Confidence            45689999999994

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=1.3e-28  Score=203.11  Aligned_cols=178  Identities=22%  Similarity=0.340  Sum_probs=141.9

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeE
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFY  108 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  108 (219)
                      .+..+.++|++.+.||+|+||.||+|.+      .++..+|+|.++...   .......+.+|+.+++.+ +||||++++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence            3455567899999999999999999942      245579999986432   122345678899999999 899999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccch--------------------------------------------------
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAA--------------------------------------------------  138 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------------------------------------------------  138 (219)
                      +++...+..+++|||+++|+|.+++.....                                                  
T Consensus       106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            999999999999999999999998853210                                                  


Q ss_pred             ----------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          139 ----------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       139 ----------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                                            ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~  262 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR  262 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccce
Confidence                                  01256777888999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCCC
Q 039002          197 FLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      ........  .....++..|+|||.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~y~aPE~  287 (375)
T cd05104         263 DIRNDSNYVVKGNARLPVKWMAPES  287 (375)
T ss_pred             eccCcccccccCCCCCCcceeChhH
Confidence            76543221  112344567999994

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=1e-28  Score=203.59  Aligned_cols=179  Identities=23%  Similarity=0.368  Sum_probs=141.8

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEc-C-----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCcccee
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAEL-P-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKF  107 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~-~-----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  107 (219)
                      +.|..+.++|++.+.||+|+||.||+|.. .     ++..||+|.+....   .......+.+|+.+++.+ +|+||+++
T Consensus        31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeE
Confidence            34556677899999999999999999842 2     33579999986432   122345678899999999 89999999


Q ss_pred             EeEEEeCCcceEEEEecCCCCHHHHhcccch-------------------------------------------------
Q 039002          108 YGFCSHARHSFLLCEFLERGSLAAILNTDAA-------------------------------------------------  138 (219)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------------------------------------------  138 (219)
                      ++++...+..+++|||+.+|+|.+++.....                                                 
T Consensus       108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            9999999999999999999999998753210                                                 


Q ss_pred             ------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          139 ------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       139 ------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                                        ...+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||++.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                              01256677889999999999999998   999999999999999999999999999986643


Q ss_pred             CCCc--ccccccccccccCCC
Q 039002          201 DASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~--~~~~~gt~~y~aPE~  219 (219)
                      ....  .....++..|+|||+
T Consensus       265 ~~~~~~~~~~~~~~~y~aPE~  285 (374)
T cd05106         265 DSNYVVKGNARLPVKWMAPES  285 (374)
T ss_pred             CcceeeccCCCCccceeCHHH
Confidence            3211  112234567999994

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=2.9e-28  Score=191.65  Aligned_cols=175  Identities=20%  Similarity=0.322  Sum_probs=144.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+..... .+......+.+|+.+++.++|||++++++.+...+..++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            3689999999999999999994 55788999998754221 122334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++|++++++|.+++..... ...++......++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..+
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            9999999999988853211 12367788889999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........+++.|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~  177 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             cchhHHHhcCCCCccccChhh
Confidence            554433344578899999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=1e-28  Score=199.43  Aligned_cols=165  Identities=24%  Similarity=0.324  Sum_probs=135.5

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+||.||+|. ..+++.+|+|.++...... ......+.+|..++..+ +|+||+++++++...+..+++|||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            369999999999994 5578899999886422111 12234456788888777 69999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|...+....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          80 GGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            999998886543   378888999999999999999998   99999999999999999999999999987643333333


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ...+|++.|+|||+
T Consensus       154 ~~~~g~~~y~aPE~  167 (318)
T cd05570         154 STFCGTPDYIAPEI  167 (318)
T ss_pred             cceecCccccCHHH
Confidence            45679999999994

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=4.3e-28  Score=192.44  Aligned_cols=171  Identities=25%  Similarity=0.326  Sum_probs=141.4

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||+|. ..++..+++|.+.....  .......+.+|+.+++.++|+|++++++++..++..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            58889999999999999995 45788999999864321  1223356778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+. +++.+++........+++..+..++.|++.||.|+|+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            9996 68888876533223478888999999999999999998   9999999999999999999999999998766443


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~y~aPE~  172 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEV  172 (285)
T ss_pred             cccccCCcccccccChHH
Confidence            333333467899999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=1e-28  Score=205.74  Aligned_cols=164  Identities=23%  Similarity=0.335  Sum_probs=141.3

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-C-----CccceeEeEEEeCC
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-H-----RNIVKFYGFCSHAR  115 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~ni~~~~~~~~~~~  115 (219)
                      +|.+.+.||+|+||.|.+| +.++++.||||++++.     .........|+.+|..++ |     -|+++++++|...+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            6889999999999999999 7788999999999763     345566678999999996 3     39999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC--CcEEEeecc
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE--YEAHVADFG  193 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~--~~~kl~dfg  193 (219)
                      +.|||+|.+ .-+|.++++.... ..++...+..++.||+.||.+||..   +|||+||||+|||+..-  ..+||+|||
T Consensus       262 HlciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            999999998 5699999987554 3478899999999999999999998   99999999999999743  579999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+++.....   -..+.+..|+|||+
T Consensus       337 SSc~~~q~v---ytYiQSRfYRAPEV  359 (586)
T KOG0667|consen  337 SSCFESQRV---YTYIQSRFYRAPEV  359 (586)
T ss_pred             cccccCCcc---eeeeeccccccchh
Confidence            998754332   35688999999996

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=5.8e-28  Score=192.60  Aligned_cols=173  Identities=24%  Similarity=0.396  Sum_probs=144.9

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ..+-+.|++++.||+|+||.||+|. ..++..+++|.+...    .......+.+|+.+++.++|+|++++++.+..++.
T Consensus         8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (292)
T cd06644           8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK   83 (292)
T ss_pred             cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence            3445789999999999999999994 456888999987532    22345667889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||++++++..++....  ..+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence            999999999999988775322  2367888999999999999999998   99999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............+++.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~  181 (292)
T cd06644         159 KNVKTLQRRDSFIGTPYWMAPEV  181 (292)
T ss_pred             eccccccccceecCCccccCcee
Confidence            65443333345678899999994

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1e-29  Score=195.61  Aligned_cols=176  Identities=25%  Similarity=0.357  Sum_probs=146.0

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCC----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS  112 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  112 (219)
                      .+.+..|+++..||+|+||.||+| ...+    .+.+|+|+++...  +......++.+|+.+++.++|+|++.+..+|.
T Consensus        20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k--d~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl   97 (438)
T KOG0666|consen   20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK--DGTGISMSACREIALLRELKHPNVISLVKVFL   97 (438)
T ss_pred             HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC--CCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence            456788999999999999999999 3332    2369999997643  23345567899999999999999999999997


Q ss_pred             e-CCcceEEEEecCCCCHHHHhcccch--hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC----C
Q 039002          113 H-ARHSFLLCEFLERGSLAAILNTDAA--AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE----Y  185 (219)
Q Consensus       113 ~-~~~~~lv~e~~~~~~l~~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~----~  185 (219)
                      + +..+|+++||.+. +|+..++..+.  ...++...+..++.|++.|+.|||++   =++||||||.||++--+    |
T Consensus        98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen   98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence            7 7789999999965 89998865332  23467778889999999999999998   68999999999999755    8


Q ss_pred             cEEEeeccceeeecCCCCcc---cccccccccccCCC
Q 039002          186 EAHVADFGIAKFLKSDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       186 ~~kl~dfg~~~~~~~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      ++||+|||+++.+.++....   ...+-|.+|+|||.
T Consensus       174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPEL  210 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPEL  210 (438)
T ss_pred             eeEeecccHHHHhhccccccccCCceEEEEEecChHH
Confidence            99999999999998776543   44688999999993

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=203.16  Aligned_cols=174  Identities=21%  Similarity=0.247  Sum_probs=149.1

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..+.|+.-..||+|+||.|+-+ ...+|+.+|.|++.+..... .......+.|-+++.+++.++||.+-.+|++.+.++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            3456888999999999999999 56789999999875432221 123344678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +|+..+.||+|.-.+...++ ..+++.++..++.+|+.||++||..   +|++||+||+|||+|..|.++|+|+|+|..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999998887665 3488999999999999999999999   9999999999999999999999999999988


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... ....+||.+|||||+
T Consensus       338 ~~g~~-~~~rvGT~GYMAPEv  357 (591)
T KOG0986|consen  338 PEGKP-IRGRVGTVGYMAPEV  357 (591)
T ss_pred             CCCCc-cccccCcccccCHHH
Confidence            65433 244599999999995

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-28  Score=200.53  Aligned_cols=165  Identities=25%  Similarity=0.347  Sum_probs=139.5

Q ss_pred             cceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           47 KYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .+.||.|.||.||-| ..++|+.||||.+.+.....+  ....+..|+.+|..++||.|+.+..-|++.+.+|+|||.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k--qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK--QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc--hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            378999999999999 567899999999876554443  33667889999999999999999999999999999999997


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEeeccceeeecCCC
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~dfg~~~~~~~~~  202 (219)
                      |.-|...++...  .+++++.-..++.||+.||.|||.+   +|+|.||||+|+|+..   ..++||||||+|+++....
T Consensus       647 GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  647 GDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             chHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            665666555432  3488888889999999999999999   9999999999999963   3689999999999886543


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                       -..+.+|||.|+|||+
T Consensus       722 -FRrsVVGTPAYLaPEV  737 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEV  737 (888)
T ss_pred             -hhhhhcCCccccCHHH
Confidence             2356799999999994

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=5.6e-28  Score=190.32  Aligned_cols=171  Identities=20%  Similarity=0.317  Sum_probs=138.9

Q ss_pred             hCCCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ..+|++.+.||+|+||.||+|..    ..+..+|+|.++...   .......+.+|+..++.++|||++++++++..++.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            35788999999999999999953    245679999986532   12234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+++++|.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            999999999999999986532  2378888999999999999999998   99999999999999999999999999876


Q ss_pred             eecCCCCc-ccccccccccccCCC
Q 039002          197 FLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      ........ .....++..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~  179 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEA  179 (266)
T ss_pred             cccccchhcccCCCCceeecCHHH
Confidence            53222111 112245678999994

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.96  E-value=8.8e-28  Score=191.26  Aligned_cols=170  Identities=22%  Similarity=0.353  Sum_probs=133.7

Q ss_pred             CCCCCcceeccccceeEEEEEc-C-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC---CCCccceeEeEEE----
Q 039002           42 NDFDAKYCIGNGGHASVYRAEL-P-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET---RHRNIVKFYGFCS----  112 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~-~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~----  112 (219)
                      ++|++.+.||+|+||.||+|.. . ++..+|+|.+.......  .....+.+|+..++.+   +||||+++++++.    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            4799999999999999999953 3 46789999876433222  1223445677666655   6999999999885    


Q ss_pred             -eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          113 -HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       113 -~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                       .....++++|++. +++.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence             2456889999996 588888864322 2367888999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++...... .......||+.|+|||.
T Consensus       154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~  180 (290)
T cd07862         154 FGLARIYSFQ-MALTSVVVTLWYRAPEV  180 (290)
T ss_pred             ccceEeccCC-cccccccccccccChHH
Confidence            9999876543 22344578999999993

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=8.2e-28  Score=190.53  Aligned_cols=164  Identities=25%  Similarity=0.305  Sum_probs=134.1

Q ss_pred             eccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||+|+||.||++. ..+++.+|+|.+....... ......+..|+.+++.++||||+++++++.++...+++|||+.+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            6999999999994 5678899999885422111 1122345669999999999999999999999999999999999999


Q ss_pred             HHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccccc
Q 039002          129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF  208 (219)
Q Consensus       129 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  208 (219)
                      |.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....... .....
T Consensus        80 L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~  154 (277)
T cd05607          80 LKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQR  154 (277)
T ss_pred             HHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeecc
Confidence            9888754322 2367788888999999999999998   99999999999999999999999999998765432 22345


Q ss_pred             ccccccccCCC
Q 039002          209 AGTYGYVALGI  219 (219)
Q Consensus       209 ~gt~~y~aPE~  219 (219)
                      .|++.|+|||+
T Consensus       155 ~~~~~y~aPE~  165 (277)
T cd05607         155 AGTNGYMAPEI  165 (277)
T ss_pred             CCCCCccCHHH
Confidence            78999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=7.1e-28  Score=188.15  Aligned_cols=171  Identities=24%  Similarity=0.376  Sum_probs=145.2

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||+|. ..+++.+++|.+......  ......+.+|+.+++.++|+|++++++.+...+..++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            57888999999999999994 557889999987543222  234566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+++++|.+++.... ...+++..+..++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..+...
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          79 EYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999986532 23477888899999999999999998   9999999999999999999999999999877655


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........|++.|+|||+
T Consensus       155 ~~~~~~~~~~~~y~aPE~  172 (256)
T cd08529         155 TNFANTIVGTPYYLSPEL  172 (256)
T ss_pred             cchhhccccCccccCHHH
Confidence            444455678999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=6.9e-28  Score=193.02  Aligned_cols=170  Identities=22%  Similarity=0.323  Sum_probs=141.3

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+......   .....+.+|+..++.++|+||+++++++...+..++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            4689999999999999999994 557889999988643211   223456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||+. +++..++....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        82 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            999996 58888775432  2367788889999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~  175 (301)
T cd07873         156 IPTKTYSNEVVTLWYRPPDI  175 (301)
T ss_pred             CCCCcccccceeecccCcHH
Confidence            44333344577899999984

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=7.1e-28  Score=197.58  Aligned_cols=169  Identities=22%  Similarity=0.349  Sum_probs=137.1

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC--
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR--  115 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  115 (219)
                      ...++|++.+.||+|+||.||+| ...++..+|+|.+.....  .......+.+|+.+++.++|+||+++++++...+  
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            45689999999999999999999 456788999999865322  2233456778999999999999999999986443  


Q ss_pred             ----cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          116 ----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       116 ----~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                          ..+++|||+.+ ++...+..     .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence                47999999965 56555532     266777888999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++....... ......||+.|+|||.
T Consensus       167 fg~a~~~~~~~-~~~~~~~t~~y~aPE~  193 (359)
T cd07876         167 FGLARTACTNF-MMTPYVVTRYYRAPEV  193 (359)
T ss_pred             CCCccccccCc-cCCCCcccCCCCCchh
Confidence            99997543322 2234578999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=6.7e-28  Score=198.64  Aligned_cols=168  Identities=25%  Similarity=0.367  Sum_probs=138.1

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC-----c
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR-----H  116 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~  116 (219)
                      +|++.+.||+|+||.||+|. ..+++.||+|++....  ........+.+|+.+++.++|+||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            57889999999999999994 5688899999875422  12223456789999999999999999999998776     7


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++||+. +++...+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence            899999996 57777775432   377888999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCC-cccccccccccccCCC
Q 039002          197 FLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ....... ......+++.|+|||+
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~  175 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEI  175 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHH
Confidence            6543322 1233467899999984

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=1.7e-27  Score=186.20  Aligned_cols=170  Identities=21%  Similarity=0.343  Sum_probs=142.8

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|+||.||++ ...++..+++|.+....   .......+.+|+.+++.++|+|++++++.+.+++.+++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            5888999999999999999 45578889999885432   1223456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||++++++.+++..... ..+++.....++.|++.|+.++|+.   +++|+||||+||+++.++.++++|||.+......
T Consensus        78 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          78 EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eeCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            99999999998864321 2367788889999999999999998   9999999999999999999999999999877554


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........|++.|+|||.
T Consensus       154 ~~~~~~~~~~~~~~aPE~  171 (255)
T cd08219         154 GAYACTYVGTPYYVPPEI  171 (255)
T ss_pred             ccccccccCCccccCHHH
Confidence            433345678999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.96  E-value=1.3e-27  Score=192.07  Aligned_cols=168  Identities=26%  Similarity=0.388  Sum_probs=141.8

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||++ ...++..+++|.+....   .......+.+|+.+++.++|+||+++++.+..++.++++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            47899999999999999999 45578889999876421   223345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+++++|.+++....   .+++.....++.|++.|+.|+|+..  +++|+||+|+||+++.++.++++|||++.....
T Consensus        78 ~ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          78 MEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             eeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            99999999999986542   3678888899999999999999732  899999999999999999999999999876543


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..  .....+++.|+|||.
T Consensus       153 ~~--~~~~~~~~~~~aPE~  169 (308)
T cd06615         153 SM--ANSFVGTRSYMSPER  169 (308)
T ss_pred             cc--cccCCCCcCccChhH
Confidence            32  234578999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=1.9e-27  Score=188.50  Aligned_cols=163  Identities=26%  Similarity=0.408  Sum_probs=138.4

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...++..+|+|.+....   .......+.+|+.+++.++|||++++++.+...+..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            36888999999999999999 55678899999875421   222345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||++++++..+.       .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          78 TEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            9999999886542       256677888999999999999998   999999999999999999999999999986644


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..  .....++..|+|||+
T Consensus       148 ~~--~~~~~~~~~y~aPE~  164 (279)
T cd06619         148 SI--AKTYVGTNAYMAPER  164 (279)
T ss_pred             cc--ccCCCCChhhcCcee
Confidence            32  234589999999994

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=7.4e-28  Score=199.83  Aligned_cols=178  Identities=21%  Similarity=0.318  Sum_probs=142.6

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEc-C-----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeE
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAEL-P-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFY  108 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~-~-----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~  108 (219)
                      ++..+.++|++.+.||+|+||.||+|.. .     ....||+|.+....   .......+.+|+.+++.+. ||||++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~  107 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLL  107 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            5666788999999999999999999953 2     23469999986432   1223456889999999996 99999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccch--------------------------------------------------
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAA--------------------------------------------------  138 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------------------------------------------------  138 (219)
                      +++...+..+++|||+++|+|.+++.....                                                  
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            999999999999999999999988753210                                                  


Q ss_pred             -------------------------------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          139 -------------------------------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       139 -------------------------------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                                                                 ...+++..+..++.|++.|+.|||+.   +++|+|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dik  264 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLA  264 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCC
Confidence                                                       01256667788999999999999998   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++.++++|||++.........  .....+++.|+|||.
T Consensus       265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  310 (400)
T cd05105         265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES  310 (400)
T ss_pred             hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhh
Confidence            99999999999999999999876433221  123456788999994

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-28  Score=200.83  Aligned_cols=171  Identities=24%  Similarity=0.340  Sum_probs=149.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+=|.+.+.||+|-|..|.+| ..-+|+.||||.+.+...  +.....++++|+..|+.++||||+++|.+..+...+||
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            366888999999999999999 456999999999876432  33456788999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-CCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~  198 (219)
                      |+|.-.+|+|.+++..+..  .+.+....+++.||+.|+.|||..   .++||||||+|+++- .-|-+|++|||++-.+
T Consensus        95 iLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999999976443  277888899999999999999998   999999999999886 4599999999998665


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                       .+.+..++.||+..|-||||
T Consensus       170 -~PG~kL~TsCGSLAYSAPEI  189 (864)
T KOG4717|consen  170 -QPGKKLTTSCGSLAYSAPEI  189 (864)
T ss_pred             -CCcchhhcccchhhccCchh
Confidence             34566788899999999997

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=3.6e-28  Score=190.12  Aligned_cols=168  Identities=30%  Similarity=0.483  Sum_probs=140.7

Q ss_pred             CCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |++.+.||+|+||.||++ ...+++.+|+|.+....  ..........+|+..++.++|+||+++++++......+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--ccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            678899999999999999 45567789999986532  111222233569999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      ++.+++|.+++...   ..+++..+..++.|++.|+.+||+.   +++|+||||+||+++.++.++|+|||.+.......
T Consensus        79 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   79 YCPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             EETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999998732   2378889999999999999999999   99999999999999999999999999998653334


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......+++.|+|||+
T Consensus       153 ~~~~~~~~~~~y~aPE~  169 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEV  169 (260)
T ss_dssp             SEBSSSSSSGGGSCHHH
T ss_pred             ccccccccccccccccc
Confidence            44455688999999984

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.4e-28  Score=192.05  Aligned_cols=171  Identities=27%  Similarity=0.429  Sum_probs=145.1

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      +.++|++.+.||+|++|.||+|. ..++..+++|.+...    .......+.+|+.+++.++|+|++++++.+..++..+
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            45679999999999999999995 457888999987532    2234456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++|||+.+++|..++....  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          79 ILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             EEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            9999999999999886532  2378888999999999999999999   9999999999999999999999999988765


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........+++.|+|||.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~  174 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEV  174 (280)
T ss_pred             cccccccceeecchhhcCHHH
Confidence            444333345678999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=1.5e-27  Score=187.37  Aligned_cols=175  Identities=22%  Similarity=0.334  Sum_probs=145.8

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++.+.||+|++|.||+|. ..+++.+++|.++.....+ ......+.+|+.+++.++|+|++++++.+...+..++
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3689999999999999999994 4588899999876422222 2234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++||+++++|..++.... ....+++.++..++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..+
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            999999999999885421 123367888999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........+++.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~  177 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             cCCCcccceecCCccccCHHH
Confidence            554433344578999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=6.5e-28  Score=191.58  Aligned_cols=180  Identities=23%  Similarity=0.348  Sum_probs=145.9

Q ss_pred             ccHHHHHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           32 ILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        32 ~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      +..+.+....++|++.+.||+|+||.||+| ...+++.+++|.+...     ......+.+|+.+++.+ +|+|++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            445667778899999999999999999999 4567788999986531     11224567789999998 6999999999


Q ss_pred             EEE-----eCCcceEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          110 FCS-----HARHSFLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       110 ~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      ++.     .++..+++|||+++++|.+++.... ....+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence            873     3456899999999999998875321 112367788889999999999999998   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++++|||++..............|++.|+|||+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  195 (286)
T ss_pred             CCCEEEccCCceeecccCCCccccccCCCcccChhh
Confidence            999999999999876544333344578999999994

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=1.6e-27  Score=189.16  Aligned_cols=167  Identities=26%  Similarity=0.417  Sum_probs=140.3

Q ss_pred             CCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |++.+.||+|+||.||+|. ..++..+++|.+...    .......+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            6788899999999999994 556778899987532    22334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+.++++..++....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999988775422  2377888999999999999999998   99999999999999999999999999987654433


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......+++.|+|||+
T Consensus       158 ~~~~~~~~~~~y~aPE~  174 (282)
T cd06643         158 QRRDSFIGTPYWMAPEV  174 (282)
T ss_pred             cccccccccccccCHhh
Confidence            33445678999999994

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=1.7e-27  Score=186.18  Aligned_cols=171  Identities=22%  Similarity=0.313  Sum_probs=145.4

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|+||.|+.+ ...++..+++|.+......  ......+.+|+.+++.++|+|++++++++.+.+..++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS--EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc--hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            5889999999999999999 4567888999987543222  233456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+++++|.+++.... ...+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999987542 13467888899999999999999998   9999999999999999999999999999877655


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~y~ape~  172 (256)
T cd08221         155 YSMAETVVGTPYYMSPEL  172 (256)
T ss_pred             cccccccCCCccccCHhh
Confidence            434455678999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=6.1e-28  Score=189.33  Aligned_cols=172  Identities=19%  Similarity=0.379  Sum_probs=142.9

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ...++|++.++||+|++|.||+|...++..+++|.+...     ......+.+|+.+++.++|+|++++++.+...+..+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            346789999999999999999997777778999987532     123456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++|++++++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++...
T Consensus        78 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence            99999999999999865321 2367788888999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCC-cccccccccccccCCC
Q 039002          199 KSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ..... ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~  175 (261)
T cd05072         154 EDNEYTAREGAKFPIKWTAPEA  175 (261)
T ss_pred             CCCceeccCCCccceecCCHHH
Confidence            54321 1122345678999984

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=5e-28  Score=205.85  Aligned_cols=178  Identities=23%  Similarity=0.254  Sum_probs=143.8

Q ss_pred             HHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .....++|++.+.||+|+||.||+| ...+++.||+|.+.....  .......+.+|+..+..++|+|+++++..+...+
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            3445689999999999999999999 566889999999865322  2233456778999999999999999988775432


Q ss_pred             --------cceEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          116 --------HSFLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       116 --------~~~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                              .++++|||+.+|+|.+++.... ....+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence                    3679999999999999886422 123467888899999999999999999   9999999999999999999


Q ss_pred             EEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ++|+|||+++.+.....  .....+||+.|+|||+
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~  216 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI  216 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHH
Confidence            99999999987653321  2234689999999994

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.6e-27  Score=186.84  Aligned_cols=170  Identities=28%  Similarity=0.436  Sum_probs=145.3

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|++|.||+|. ..+++.+++|.+....    ......+.+|+.+++.++|+|++++++.+...+.+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            4789999999999999999994 4567789999886432    1234667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.++++..++....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        78 ~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence            999999999999886532  2377888999999999999999998   99999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........++..|+|||.
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~  172 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEV  172 (262)
T ss_pred             hhhhccccccCCccccCchh
Confidence            44433445678999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-29  Score=204.36  Aligned_cols=164  Identities=30%  Similarity=0.490  Sum_probs=139.2

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      |.++-+...-++.||.|+.|.||+|+... +.||||+++..           --.+|.-|++|+|+||+++.|+|.....
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~n-etVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtqsPc  186 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLHN-ETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQSPC  186 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeeccC-ceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence            33333333447899999999999997654 57999987521           1237888999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      ++||||||+.|.|...++....   +.....+.+..+|+.|+.|||..   .|||||||.-||||+.+..+||+|||.++
T Consensus       187 yCIiMEfCa~GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  187 YCIIMEFCAQGQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             eEEeeeccccccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence            9999999999999999986533   66777888999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+.+. +..-.|+||..|||||+
T Consensus       261 e~~~~-STkMSFaGTVaWMAPEv  282 (904)
T KOG4721|consen  261 ELSDK-STKMSFAGTVAWMAPEV  282 (904)
T ss_pred             hhhhh-hhhhhhhhhHhhhCHHH
Confidence            87665 44466999999999995

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=1e-27  Score=191.05  Aligned_cols=168  Identities=28%  Similarity=0.357  Sum_probs=142.7

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|++|.||++. ..+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++..++..+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            478999999999999999994 557889999987542211 112345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||++++++|.+++....   .++...+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          80 MEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999986543   377888889999999999999998   999999999999999999999999999887644


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .   .....+++.|+|||.
T Consensus       154 ~---~~~~~~~~~y~aPE~  169 (290)
T cd05580         154 R---TYTLCGTPEYLAPEI  169 (290)
T ss_pred             C---CCCCCCCccccChhh
Confidence            3   234578999999994

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.95  E-value=1.2e-27  Score=187.24  Aligned_cols=168  Identities=21%  Similarity=0.430  Sum_probs=139.5

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+....     .....+.+|+.+++.++|||++++++++...+..+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            5688899999999999999987777789999875321     12356788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+++++|.+++....  ..+++.....++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            9999999999886432  2367888899999999999999998   9999999999999999999999999998765332


Q ss_pred             CC-cccccccccccccCCC
Q 039002          202 AS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~-~~~~~~gt~~y~aPE~  219 (219)
                      .. ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~  172 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEV  172 (256)
T ss_pred             ceeccCCCCCchhhCChhh
Confidence            21 1122345668999994

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=1.4e-27  Score=190.98  Aligned_cols=171  Identities=23%  Similarity=0.414  Sum_probs=144.9

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .....+|++.+.||+|++|.||+|. ..++..+|+|.+....    ......+.+|+.+++.++|+|++++++.+..++.
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            3445789999999999999999994 5688899999886422    1233557789999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++||++++++.+++...    .+++..+..++.|++.++.|+|+.   +++|+||||+||+++.++.++++|||++.
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence            99999999999999988542    267788889999999999999998   99999999999999999999999999988


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............+++.|+|||.
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~  186 (297)
T cd06656         164 QITPEQSKRSTMVGTPYWMAPEV  186 (297)
T ss_pred             EccCCccCcCcccCCccccCHHH
Confidence            76544333344578899999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=1.7e-27  Score=188.94  Aligned_cols=170  Identities=23%  Similarity=0.393  Sum_probs=142.3

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|++|.||+|. ..+++.+|+|.+.....  .......+.+|+.+++.++|+|++++++++...+..+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            478999999999999999995 45788999998754321  112334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||++++.+..+.....   .+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          79 FEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EeccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            99999888887765432   378888999999999999999998   999999999999999999999999999987755


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~aPE~  171 (286)
T cd07847         153 PGDDYTDYVATRWYRAPEL  171 (286)
T ss_pred             CcccccCcccccccCCHHH
Confidence            4433344568889999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=1.7e-27  Score=189.47  Aligned_cols=171  Identities=20%  Similarity=0.266  Sum_probs=140.4

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .|+..+.||+|+||.||++ ...+++.+|+|.+...... .......+.+|+.+++.++|++++.+++.+.+.+..+++|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            3677889999999999999 5668889999987643221 1122345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+.+++|.+++..... ..+++..+..++.|++.|+.|+|..   +++|+||||+||+++.++.++++|||++......
T Consensus        80 e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          80 TLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999988854322 2377888899999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      . ......|+..|+|||+
T Consensus       156 ~-~~~~~~g~~~y~aPE~  172 (285)
T cd05630         156 Q-TIKGRVGTVGYMAPEV  172 (285)
T ss_pred             c-cccCCCCCccccChHH
Confidence            2 2233478999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-29  Score=220.06  Aligned_cols=175  Identities=22%  Similarity=0.250  Sum_probs=149.0

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      -...++|.+++.||+|+||.|..++ ..+++.||+|++.+-.-. .......|..|-.+|..-+.+.|+.++.+|+++++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3445789999999999999999994 567889999998641111 12233557788899988899999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +|+||||++||+|..+++...   .+++.-+.+|+..++.|+..+|..   |.||||+||+|||+|..|.+|++|||.|.
T Consensus       150 LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence            999999999999999998765   388888999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc-ccccccccccccCCC
Q 039002          197 FLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      .+...+.- ...-+|||-|++||+
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEv  247 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEV  247 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHH
Confidence            77755432 244599999999995

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=1.5e-27  Score=209.30  Aligned_cols=171  Identities=24%  Similarity=0.296  Sum_probs=145.6

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.++..... .......+.+|+..++.++|+||+++++.+...+..|+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            5789999999999999999994 557889999998643222 22234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||+.+++|.+++....   .+++..+..++.|++.||.|||..   +|+||||||+|||++.++.++|+|||+++...
T Consensus        82 VmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            999999999999986533   367788899999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCC
Q 039002          200 SDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE  218 (219)
                      ..........+|+.|++||
T Consensus       156 ~~~~~~~~~~~t~~~~~pe  174 (669)
T cd05610         156 NRELNMMDILTTPSMAKPK  174 (669)
T ss_pred             CCcccccccccCccccCcc
Confidence            5444445568899999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.95  E-value=1.8e-27  Score=189.27  Aligned_cols=170  Identities=19%  Similarity=0.237  Sum_probs=140.3

Q ss_pred             CCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |+..+.||+|+||.||+| ...+++.+|+|.+....... ......+.+|+.+++.++|+|++.+.+.+..++..++++|
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            677889999999999999 55678899999885432111 1223446789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+.+++|..++..... ..+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999988754322 2378889999999999999999998   99999999999999999999999999987653322


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                       ......|+..|+|||+
T Consensus       157 -~~~~~~g~~~~~aPE~  172 (285)
T cd05632         157 -SIRGRVGTVGYMAPEV  172 (285)
T ss_pred             -cccCCCCCcCccChHH
Confidence             2234578999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=1.6e-27  Score=189.27  Aligned_cols=173  Identities=19%  Similarity=0.339  Sum_probs=139.8

Q ss_pred             hCCCCCcceeccccceeEEEEEc-----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|..     .++..+++|.+...   ........+.+|+.+++.++|+|++++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            46789999999999999999952     34568999988642   12233456788999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccch--------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe
Q 039002          116 HSFLLCEFLERGSLAAILNTDAA--------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL  181 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili  181 (219)
                      ..+++|||+.+++|.+++.....              ...+++.....++.|++.|+.|+|++   +++|+||||+||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili  157 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILI  157 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEE
Confidence            99999999999999998843210              12367788889999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeccceeeecCCC--CcccccccccccccCCC
Q 039002          182 DLEYEAHVADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       182 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      +.++.++++|||++.......  .......++..|+|||+
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA  197 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCCCccceecChHH
Confidence            999999999999997653322  11223455678999994

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=7.7e-28  Score=197.08  Aligned_cols=170  Identities=21%  Similarity=0.349  Sum_probs=138.2

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--  114 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  114 (219)
                      ....++|++.+.||+|+||.||+| ....++.+|+|.+.....  .......+.+|+.+++.++|+||+++++++...  
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            456789999999999999999999 455788899999865322  222345677899999999999999999988643  


Q ss_pred             ----CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          115 ----RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       115 ----~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                          ...+++||++.+ ++...+..     .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+
T Consensus        91 ~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          91 LEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ccccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence                347899999965 66665542     267778888999999999999998   99999999999999999999999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||+++...... ......||+.|+|||+
T Consensus       162 Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~  189 (355)
T cd07874         162 DFGLARTAGTSF-MMTPYVVTRYYRAPEV  189 (355)
T ss_pred             eCcccccCCCcc-ccCCccccCCccCHHH
Confidence            999998654332 2234578999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.2e-27  Score=185.28  Aligned_cols=172  Identities=23%  Similarity=0.373  Sum_probs=142.1

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc-hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ-TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ++|++.+.||+|++|.||.| ...++..+++|.+........ ......+.+|+.++++++|+||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999 456788999998764322211 1123467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++|++++++|.+++....   .+++.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999886543   267778888999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcc---cccccccccccCCC
Q 039002          200 SDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      ......   ....++..|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~  178 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEV  178 (263)
T ss_pred             ccccccccccCCCcCccccCcce
Confidence            322111   34568889999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=9.2e-28  Score=195.73  Aligned_cols=167  Identities=24%  Similarity=0.417  Sum_probs=137.9

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC----
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA----  114 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  114 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|++.....  .......+.+|+.+++.++|+||+++++++...    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            3578999999999999999999 566788999999864321  112334567899999999999999999887533    


Q ss_pred             --CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          115 --RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       115 --~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                        ...+++++++ ++++..++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence              3468999988 77898887532    378888999999999999999999   9999999999999999999999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |++......   .....||+.|+|||+
T Consensus       163 g~~~~~~~~---~~~~~~t~~y~aPE~  186 (343)
T cd07878         163 GLARQADDE---MTGYVATRWYRAPEI  186 (343)
T ss_pred             ccceecCCC---cCCccccccccCchH
Confidence            999865433   234578999999994

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=6.6e-28  Score=202.58  Aligned_cols=167  Identities=23%  Similarity=0.296  Sum_probs=131.7

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC----
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA----  114 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  114 (219)
                      ...+|++.+.||+|+||.||+| ...+++.||+|++...    .    ....+|+.+++.++|+||+++++++...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----P----QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----c----chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            4467999999999999999999 4567889999987431    1    1234699999999999999998877432    


Q ss_pred             ----CcceEEEEecCCCCHHHHhccc-chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEE
Q 039002          115 ----RHSFLLCEFLERGSLAAILNTD-AAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAH  188 (219)
Q Consensus       115 ----~~~~lv~e~~~~~~l~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~k  188 (219)
                          ..++++|||+++ ++.+++... .....+++..+..++.|++.||.|||+.   +|+||||||+||+++.+ +.+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence                236689999964 676666431 1123477888899999999999999999   99999999999999966 4799


Q ss_pred             EeeccceeeecCCCCcccccccccccccCCC
Q 039002          189 VADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |+|||+++.+..... .....||+.|+|||+
T Consensus       212 L~DFGla~~~~~~~~-~~~~~~t~~y~aPE~  241 (440)
T PTZ00036        212 LCDFGSAKNLLAGQR-SVSYICSRFYRAPEL  241 (440)
T ss_pred             eeccccchhccCCCC-cccCCCCcCccCHHH
Confidence            999999986643322 234578999999994

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=9.7e-28  Score=188.68  Aligned_cols=174  Identities=21%  Similarity=0.330  Sum_probs=145.0

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|++|.||+|. ..++..+++|.+...... .......+.+|+.+++.++|+|++++++++..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            678999999999999999995 568889999987542211 223345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|++.+++|.+++.... ....+++.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999999886321 123467888899999999999999998   99999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........++..|+|||.
T Consensus       158 ~~~~~~~~~~~~~~~~ape~  177 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             cCCcccccccCCcCccCHHH
Confidence            44433344578999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.5e-27  Score=185.89  Aligned_cols=171  Identities=25%  Similarity=0.429  Sum_probs=141.5

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++.+.||+|++|.||+|...+++.+|+|.++...     .....+.+|+.+++.++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            356799999999999999999976667789999876421     123557889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++|++.+++|.+++.... ...+++..+..++.|++.|+.++|+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            999999999999986533 23477888999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCc-ccccccccccccCCC
Q 039002          200 SDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      ..... ......+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~  175 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEA  175 (261)
T ss_pred             CCcccccCCCcCceeccCccc
Confidence            33211 111223457999995

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=1.6e-27  Score=189.42  Aligned_cols=171  Identities=22%  Similarity=0.371  Sum_probs=141.9

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++++.||+|+||.||+|. ..++..+|+|.+....   .......+.+|+.+++.++|+|++++++.+...+..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            468899999999999999995 4578899999875421   222345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||++++++..++........+++..+..++.+++.|+.|||+..  +++|+||+|+||+++.++.++++|||++..+..
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            999999999988865322224788889999999999999999632  899999999999999999999999999876643


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  ....+++.|+|||.
T Consensus       156 ~~~--~~~~~~~~y~aPE~  172 (286)
T cd06622         156 SLA--KTNIGCQSYMAPER  172 (286)
T ss_pred             Ccc--ccCCCccCccCcch
Confidence            322  23468889999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=2.4e-27  Score=188.93  Aligned_cols=170  Identities=21%  Similarity=0.265  Sum_probs=138.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++.+.||+|+||.||+| ...++..+++|.+.....   ......+.+|+.+++.++|+||+++++++..++..++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            578999999999999999999 456788999999864321   1122345789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++|++. +++..++....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            999995 67766664322  2256677888999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||.
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~  174 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDV  174 (291)
T ss_pred             CCCCCCCCccccccccCCce
Confidence            43333344567899999994

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=3.4e-27  Score=184.48  Aligned_cols=171  Identities=24%  Similarity=0.318  Sum_probs=141.9

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe-CCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH-ARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv  120 (219)
                      +|++.+.||+|++|.||++ ...+++.+++|++......  ......+.+|+.+++.++|+|++++++.+.. .+.++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS--RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            5889999999999999999 4556788999998542211  2234557789999999999999999988764 4468899


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|+++++++.+++..... ..+++.++..++.+++.++.++|+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ecccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            999999999998865321 2378889999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~  173 (257)
T cd08223         155 QCDMASTLIGTPYYMSPEL  173 (257)
T ss_pred             cCCccccccCCcCccChhH
Confidence            4444455678999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=2e-27  Score=190.10  Aligned_cols=171  Identities=22%  Similarity=0.412  Sum_probs=143.6

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .....+|++.+.||+|++|.||+|. ..++..+++|.+....    ......+.+|+.+++.++|+|++++++.+..++.
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            3445789999999999999999994 5678899999876422    1223567789999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++||+++++|.+++...    .+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             EEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            99999999999999988542    267788889999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............+++.|+|||+
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~  187 (296)
T cd06654         165 QITPEQSKRSTMVGTPYWMAPEV  187 (296)
T ss_pred             hccccccccCcccCCccccCHHH
Confidence            65433322334578999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=2.3e-27  Score=191.28  Aligned_cols=170  Identities=22%  Similarity=0.442  Sum_probs=136.8

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCc----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ..+|++.+.||+|+||.||+|.+ .+++    .+|+|.+...   ........+.+|+.+++.++|+||+++++++... 
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            36799999999999999999953 3443    3899987532   1223446678899999999999999999998764 


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++.+|++.+++....  ..+++.....++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence            5789999999999999987532  2367788889999999999999998   9999999999999999999999999999


Q ss_pred             eeecCCCCcc--cccccccccccCCC
Q 039002          196 KFLKSDASNW--TEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~--~~~~gt~~y~aPE~  219 (219)
                      +.+.......  ....++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~  182 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALES  182 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHH
Confidence            8765433221  11234567999984

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=1.6e-27  Score=187.95  Aligned_cols=172  Identities=24%  Similarity=0.426  Sum_probs=142.4

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeC--
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHA--  114 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--  114 (219)
                      .+.+.|++.+.||+|+||.||+| ...+++.+|+|.+....     .....+.+|+.+++.+ +|+|++++.+++...  
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            35678999999999999999999 45678889999875421     1234567899999988 699999999998653  


Q ss_pred             ----CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          115 ----RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       115 ----~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                          ...++++||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence                457899999999999998865321 2377888899999999999999998   99999999999999999999999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||++..............|++.|+|||+
T Consensus       154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  182 (272)
T cd06637         154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEV  182 (272)
T ss_pred             cCCCceecccccccCCcccccccccCHhH
Confidence            99999876544444455689999999994

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=2.2e-27  Score=189.07  Aligned_cols=170  Identities=21%  Similarity=0.323  Sum_probs=139.5

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|++|.||+|. ..+++.+++|.+......   .....+.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            4789999999999999999994 457889999998643211   122345689999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      |+||+.+ +|.+++.....  .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 v~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            9999974 89888764332  367888889999999999999998   99999999999999999999999999987544


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........++..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~  174 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDV  174 (291)
T ss_pred             CCCccccccccccccCCcHH
Confidence            33222233456888999994

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=1.4e-27  Score=189.53  Aligned_cols=170  Identities=22%  Similarity=0.388  Sum_probs=143.2

Q ss_pred             CCCCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+|.. .+++.+|+|.+......  ......+.+|+.+++.++|+|++++++++..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc--chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            4688999999999999999954 46889999987543221  12345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+.++++..+.....   .+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++++|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          79 FEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            99999988887765432   277888999999999999999998   999999999999999999999999999987655


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~y~aPE~  171 (286)
T cd07846         153 PGEVYTDYVATRWYRAPEL  171 (286)
T ss_pred             CccccCcccceeeccCcHH
Confidence            4444444578899999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=1.7e-27  Score=195.69  Aligned_cols=169  Identities=20%  Similarity=0.346  Sum_probs=137.8

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC---
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA---  114 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  114 (219)
                      ...++|++.+.||+|+||.||+| ....++.+|+|++......  ......+.+|+.+++.++|+||+++++++...   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC--chhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            45689999999999999999999 4567888999998653322  22345677899999999999999999987543   


Q ss_pred             ---CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          115 ---RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       115 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                         ..++++|||+.+ ++...+..     .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence               357999999965 67666642     266778888999999999999998   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++....... ......+|+.|+|||+
T Consensus       170 fG~a~~~~~~~-~~~~~~~t~~y~aPE~  196 (364)
T cd07875         170 FGLARTAGTSF-MMTPYVVTRYYRAPEV  196 (364)
T ss_pred             CCCccccCCCC-cccCCcccCCcCCHHH
Confidence            99997654332 2234578999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=4.4e-27  Score=185.04  Aligned_cols=171  Identities=25%  Similarity=0.441  Sum_probs=140.3

Q ss_pred             hCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.+.    +...+++|.+....   .......+.+|+..++.++|+||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            467999999999999999999543    24579999876432   22234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++++++|.+++.....  .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||++.
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence            9999999999999999865332  478888999999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCCccc--ccccccccccCCC
Q 039002          197 FLKSDASNWT--EFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~--~~~gt~~y~aPE~  219 (219)
                      ..........  ...+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~  179 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEA  179 (266)
T ss_pred             cccccccceeccCCCCCccccChhh
Confidence            7752222111  1234577999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=3.4e-27  Score=187.19  Aligned_cols=173  Identities=23%  Similarity=0.402  Sum_probs=139.9

Q ss_pred             hCCCCCcceeccccceeEEEEEcC-CC-----cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP-SR-----EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~-~~-----~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++|++.+.||+|+||.||+|... .+     ..+++|.+...   ........+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            468999999999999999999532 22     56899987642   2223445678899999999999999999999998


Q ss_pred             CcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL  181 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili  181 (219)
                      +..++++||+++++|.+++.....             ...+++..+..++.|++.|+.|||+.   +++|+||||+||++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~  157 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLV  157 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEE
Confidence            999999999999999999864321             02367778889999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeccceeeecCCC--CcccccccccccccCCC
Q 039002          182 DLEYEAHVADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       182 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      +.++.++|+|||++.......  .......+++.|+|||+
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA  197 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHH
Confidence            999999999999987653322  11223466788999994

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.95  E-value=1.1e-27  Score=187.88  Aligned_cols=172  Identities=27%  Similarity=0.485  Sum_probs=143.6

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +..+|++.+.||.|+||.||+|....+..+++|.+....    ......+.+|+.+++.++|+|++++++++...+..++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            456789999999999999999976668889999876421    2233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+++++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            9999999999999975332 3477888999999999999999998   99999999999999999999999999997665


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........++..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~  175 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEA  175 (261)
T ss_pred             CccccccCCCCceEecCHHH
Confidence            43322233345678999983

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=2.6e-27  Score=189.47  Aligned_cols=171  Identities=23%  Similarity=0.422  Sum_probs=144.7

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .....+|++.+.||.|++|.||+| ...+++.+++|.+....    ......+.+|+.+++.++|+|++++++.+...+.
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDE   90 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence            334467999999999999999999 56788899999885421    2234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++||+.+++|..++...    .+++.++..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence            99999999999999988642    367889999999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............++..|+|||.
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~  186 (296)
T cd06655         164 QITPEQSKRSTMVGTPYWMAPEV  186 (296)
T ss_pred             hcccccccCCCcCCCccccCcch
Confidence            66544333334578899999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=1.9e-27  Score=188.24  Aligned_cols=174  Identities=19%  Similarity=0.360  Sum_probs=138.0

Q ss_pred             HhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ..++|++.+.||+|+||.||+|...      ++..+|+|.+...   ........+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4578999999999999999998532      3457999987532   112234567889999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccch-------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAA-------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                      ++..+++|||+++++|.+++.....       ...+.+..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence            9999999999999999998864221       11245677888999999999999998   9999999999999999999


Q ss_pred             EEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ++++|||++........  ......+++.|+|||+
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  192 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhH
Confidence            99999999875432211  1112245778999994

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.95  E-value=2.9e-27  Score=185.43  Aligned_cols=171  Identities=19%  Similarity=0.390  Sum_probs=140.9

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ...++|++.++||+|+||.||+|...+++.+|+|.+....     .....+.+|+.+++.++|+|++++++++. .+..+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            3467899999999999999999987788899999876422     22356788999999999999999998864 46789


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++|++.+++|.+++..... ..+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++...
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            99999999999998864332 3477888899999999999999998   9999999999999999999999999999876


Q ss_pred             cCCC-CcccccccccccccCCC
Q 039002          199 KSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      .... .......++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~  174 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEA  174 (260)
T ss_pred             CCCCcccccCCcccccccCHHH
Confidence            5322 22223355678999984

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.4e-27  Score=199.37  Aligned_cols=163  Identities=21%  Similarity=0.295  Sum_probs=136.2

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..+|.+...||+|+||.||+|. ...++.|++|....          ....+|+.+++.++|+||+++++++..++..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            3469999999999999999994 45678899996321          234679999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++|++. +++..++....  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+++...
T Consensus       238 v~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            999995 68888775432  2378899999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCc--ccccccccccccCCC
Q 039002          200 SDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      .....  .....||+.|+|||+
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~  333 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEV  333 (461)
T ss_pred             cccccccccccCCCcCCcCHHH
Confidence            33221  123579999999994

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.95  E-value=3.4e-27  Score=184.88  Aligned_cols=168  Identities=23%  Similarity=0.421  Sum_probs=139.5

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      ++|++.+.||+|+||.||.|....+..+|+|.+....     .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            5688899999999999999977666679999876422     12356788999999999999999999999888899999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.+++|.+++.....  .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||.+......
T Consensus        79 e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          79 EYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            99999999998865322  378888999999999999999998   9999999999999999999999999998765433


Q ss_pred             CCc-ccccccccccccCCC
Q 039002          202 ASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~-~~~~~gt~~y~aPE~  219 (219)
                      ... .....++..|+|||.
T Consensus       154 ~~~~~~~~~~~~~y~~pe~  172 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEV  172 (256)
T ss_pred             ceeecCCCccChhhCCHHH
Confidence            211 112245567999984

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5e-27  Score=185.44  Aligned_cols=168  Identities=28%  Similarity=0.453  Sum_probs=145.1

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||.|++|.||+| ...+++.+++|.+....   .......+.+|+.+++.++|+|++++++.+..+...+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            47889999999999999999 45578899999886432   122335577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|++++++|.+++...    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999999999998753    378888999999999999999998   999999999999999999999999999988765


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+++.|+|||+
T Consensus       151 ~~~~~~~~~~~~~y~~PE~  169 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEV  169 (274)
T ss_pred             cccccccccCCccccChhh
Confidence            5444455688999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.3e-27  Score=194.48  Aligned_cols=164  Identities=20%  Similarity=0.289  Sum_probs=135.9

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ....+|++.+.||+|+||.||+|. ..++..+|+|.....          ....|+.+++.++|+||+++++++...+..
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence            345679999999999999999994 456778999974321          124589999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++. +++..++....  ..+++..+..++.|++.|+.|||..   +++||||||+||+++..+.++|+|||++..
T Consensus       133 ~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             EEEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            99999995 58888775432  2378888999999999999999999   999999999999999999999999999875


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... ......||+.|+|||+
T Consensus       207 ~~~~~-~~~~~~gt~~y~aPE~  227 (357)
T PHA03209        207 PVVAP-AFLGLAGTVETNAPEV  227 (357)
T ss_pred             cccCc-ccccccccccccCCee
Confidence            43222 2234579999999995

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=2.5e-27  Score=186.73  Aligned_cols=166  Identities=25%  Similarity=0.327  Sum_probs=129.8

Q ss_pred             ceeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           48 YCIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      +.||+|+||.||+|...   ....+++|.+...   ........+.+|+..++.++|+||+++++.+...+..+++||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            36899999999999533   2346888876532   12233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccch--hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          125 ERGSLAAILNTDAA--AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       125 ~~~~l~~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      ++++|.+++.....  ....++.....++.|++.|+.|+|+.   +++||||||+||+++.++.++++|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch
Confidence            99999999865322  11235667788999999999999999   99999999999999999999999999986432211


Q ss_pred             --CcccccccccccccCCC
Q 039002          203 --SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 --~~~~~~~gt~~y~aPE~  219 (219)
                        .......+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05042         155 YYITKDCHAVPLRWLAPEL  173 (269)
T ss_pred             heeccCCCCCcccccCHHH
Confidence              11122356678999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=5.2e-27  Score=187.49  Aligned_cols=171  Identities=27%  Similarity=0.345  Sum_probs=142.8

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCc-hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQ-TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +|++.+.||+|++|.||+|. ..+++.+++|.+........ ......+..|+.+++.++|+|++++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            47888999999999999995 55788999999865432211 12234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|++ +++|..++....  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999987543  2378888999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~  173 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPEL  173 (298)
T ss_pred             CCccccccccceeeeCHHH
Confidence            4433344467888999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.95  E-value=4.6e-27  Score=186.84  Aligned_cols=169  Identities=25%  Similarity=0.366  Sum_probs=132.9

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC---CCCccceeEeEEEe-----
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET---RHRNIVKFYGFCSH-----  113 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~-----  113 (219)
                      +|++.+.||+|+||.||+| ...+++.+|+|.+.......  .......+|+.+++.+   +|+||+++++++..     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            5889999999999999999 55678899999886432221  1223345666666555   79999999998854     


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      ....++++|++. +++.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||
T Consensus        79 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          79 ETKVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             CceEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence            345789999996 488888764322 2378888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++....... ......+++.|+|||+
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~y~aPE~  178 (288)
T cd07863         154 LARIYSCQM-ALTPVVVTLWYRAPEV  178 (288)
T ss_pred             ccccccCcc-cCCCccccccccCchH
Confidence            998664332 2234578999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=4.6e-27  Score=186.41  Aligned_cols=170  Identities=23%  Similarity=0.393  Sum_probs=140.8

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||+|. ..++..+++|.+.....   ......+.+|+.+++.++|+|++++++.+...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            58899999999999999995 45788999998865321   122345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.+ ++.+++........+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            99975 8888876543223478888999999999999999998   9999999999999999999999999998765444


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+++.|+|||.
T Consensus       154 ~~~~~~~~~~~~y~~PE~  171 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDV  171 (284)
T ss_pred             ccccccccccccccChHH
Confidence            333334467889999983

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=1e-26  Score=184.08  Aligned_cols=168  Identities=25%  Similarity=0.438  Sum_probs=142.2

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +-|++.+.||.|+||.||+| ...+++.+|+|.+...   ........+.+|+..++.++|+|++++++.+..++..+++
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc---cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            44778899999999999999 4567889999987532   1122345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||++++++..++...    .+++..+..++.+++.++.++|+.   +++|+||+|+||+++.++.++++|||++..+..
T Consensus        81 ~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          81 MEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            9999999999988642    367888889999999999999998   999999999999999999999999999887655


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~y~~PE~  172 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             chhhhccccCCccccChhh
Confidence            4434445678899999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=4.8e-27  Score=185.95  Aligned_cols=173  Identities=26%  Similarity=0.448  Sum_probs=140.9

Q ss_pred             hCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++|.+.+.||+|+||.||+|...      ++..+|+|.++...   .......+.+|+.+++.++|+|++++++++...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            467889999999999999999542      34679999886432   122346788999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccch-----------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA-----------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      ...+++|||+++++|.+++...+.           ...+++..+..++.|++.|+.++|+.   +++|+||||+||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence            999999999999999999865321           12367788889999999999999999   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCC--CcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++++|||++.......  .......+++.|+|||+
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPES  195 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhh
Confidence            9999999999987653221  11123356788999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=2.6e-27  Score=192.70  Aligned_cols=176  Identities=23%  Similarity=0.343  Sum_probs=138.7

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEc-C-----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAEL-P-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGF  110 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~-~-----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~  110 (219)
                      ..+.++|++.+.||+|+||.||+|.. .     +++.||+|++....   .......+.+|+.++.++ +|+||++++++
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            34567899999999999999999942 2     34689999886422   122335677899999999 79999999998


Q ss_pred             EEeC-CcceEEEEecCCCCHHHHhcccch---------------------------------------------------
Q 039002          111 CSHA-RHSFLLCEFLERGSLAAILNTDAA---------------------------------------------------  138 (219)
Q Consensus       111 ~~~~-~~~~lv~e~~~~~~l~~~~~~~~~---------------------------------------------------  138 (219)
                      +... ..+++++||+++++|.+++.....                                                   
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            8654 568899999999999998853211                                                   


Q ss_pred             -------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc--ccccc
Q 039002          139 -------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFA  209 (219)
Q Consensus       139 -------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~  209 (219)
                             ...+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++..+......  .....
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~  236 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  236 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence                   11367888899999999999999998   9999999999999999999999999999876433221  12235


Q ss_pred             cccccccCCC
Q 039002          210 GTYGYVALGI  219 (219)
Q Consensus       210 gt~~y~aPE~  219 (219)
                      ++..|+|||+
T Consensus       237 ~~~~y~aPE~  246 (337)
T cd05054         237 LPLKWMAPES  246 (337)
T ss_pred             CCccccCcHH
Confidence            5678999994

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=7.1e-27  Score=184.01  Aligned_cols=171  Identities=23%  Similarity=0.417  Sum_probs=138.8

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CC---CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~---~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.. .+   ...+++|.++...   .......+.+|+.+++.++||||+++++++..++.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            36788999999999999999953 22   3368999876422   12234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++++++|.+++....  ..+++.+...++.|++.|+.++|+.   +++|+||||+|++++.++.++++|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccc
Confidence            999999999999999986543  2367888899999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCCccc---ccccccccccCCC
Q 039002          197 FLKSDASNWT---EFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~---~~~gt~~y~aPE~  219 (219)
                      ..........   ...++..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~  180 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEA  180 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhH
Confidence            7654332211   1123467999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=7.9e-27  Score=185.36  Aligned_cols=169  Identities=24%  Similarity=0.388  Sum_probs=138.2

Q ss_pred             CCCCcceeccccceeEEEEEc-----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--C
Q 039002           43 DFDAKYCIGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--R  115 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~  115 (219)
                      -|++++.||+|+||.||.+..     .++..+++|.++...   .......+.+|+.+++.++|+|++++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            368899999999999999952     356789999986432   223345688999999999999999999998765  5


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++||+++++|.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            6889999999999999986432  2368888999999999999999999   9999999999999999999999999998


Q ss_pred             eeecCCCCc---ccccccccccccCCC
Q 039002          196 KFLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      ..+......   .....++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~  183 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPEC  183 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHH
Confidence            866433221   123456778999994

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=4.3e-27  Score=184.89  Aligned_cols=170  Identities=21%  Similarity=0.398  Sum_probs=138.3

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +.++|++.++||+|+||.||+|...+...+++|.+....     .....+.+|+.+++.++|+|++++++.+. .+..++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-----cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            457799999999999999999966655679999886421     12346788999999999999999998874 456899


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||.+..+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            9999999999999975321 2367888899999999999999998   99999999999999999999999999997664


Q ss_pred             CCCCcc-cccccccccccCCC
Q 039002          200 SDASNW-TEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~-~~~~gt~~y~aPE~  219 (219)
                      ...... ....++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~  174 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEA  174 (262)
T ss_pred             ccccccccCCcccceecCHhH
Confidence            332211 22345678999994

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=9.7e-27  Score=181.59  Aligned_cols=164  Identities=22%  Similarity=0.383  Sum_probs=133.1

Q ss_pred             ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCC
Q 039002           48 YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLER  126 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  126 (219)
                      +.||+|+||.||+|. ..+++.+|+|.+....   .......+.+|+.+++.++|+||+++++++...+..++++||+.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            368999999999994 4578899999875422   122345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc--
Q 039002          127 GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--  204 (219)
Q Consensus       127 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--  204 (219)
                      ++|.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.........  
T Consensus        78 ~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          78 GDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             CcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99999986433  2367888899999999999999998   9999999999999999999999999998754322111  


Q ss_pred             ccccccccccccCCC
Q 039002          205 WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 ~~~~~gt~~y~aPE~  219 (219)
                      ......+..|+|||+
T Consensus       153 ~~~~~~~~~y~aPE~  167 (252)
T cd05084         153 GGMKQIPVKWTAPEA  167 (252)
T ss_pred             CCCCCCceeecCchh
Confidence            011123456999994

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=5.3e-27  Score=189.15  Aligned_cols=163  Identities=23%  Similarity=0.338  Sum_probs=128.7

Q ss_pred             cceeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CCcceEEE
Q 039002           47 KYCIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHSFLLC  121 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~  121 (219)
                      ..+||+|+||.||+|...   +++.+|+|.+....      ....+.+|+.+++.++||||+++++++..  ....++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999543   56789999885421      22346789999999999999999998854  45688999


Q ss_pred             EecCCCCHHHHhcccc------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe----CCCCcEEEee
Q 039002          122 EFLERGSLAAILNTDA------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL----DLEYEAHVAD  191 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili----~~~~~~kl~d  191 (219)
                      |++. +++..++....      ....+++..+..++.|++.|+.|||+.   +++||||||+||++    +..+.+||+|
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            9985 58877764321      112367788899999999999999999   99999999999999    4567899999


Q ss_pred             ccceeeecCCCC---cccccccccccccCCC
Q 039002          192 FGIAKFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      ||++..+.....   ......||+.|+|||+
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~  186 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPEL  186 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHH
Confidence            999987654322   2234578999999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.95  E-value=8e-27  Score=184.71  Aligned_cols=168  Identities=24%  Similarity=0.406  Sum_probs=142.7

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ..|+..+.||+|+||.||+|. ..++..+|+|.+....   .......+.+|+.+++.++|+|++++++.+..++..+++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            567888999999999999994 5578899999875421   122345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|++.+++|.+++...    .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          81 MEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            9999999999988642    267788888999999999999998   999999999999999999999999999987655


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~y~apE~  172 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             CccccccccCcccccCHhH
Confidence            4433344578889999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=6.7e-27  Score=183.79  Aligned_cols=171  Identities=25%  Similarity=0.375  Sum_probs=141.2

Q ss_pred             CCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCC--chhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD--QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +|++.+.||+|+||.||+|...++..+|+|.+.......  .......+.+|+..++.++|+|++++.+++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            578899999999999999977788899999876432211  112235578899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|++++++|.+++....   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999986543   267788888999999999999998   999999999999999999999999998875432


Q ss_pred             CC------CcccccccccccccCCC
Q 039002          201 DA------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~------~~~~~~~gt~~y~aPE~  219 (219)
                      ..      .......++..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~  179 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEV  179 (265)
T ss_pred             ccccccccccccccCCCccccChhh
Confidence            11      11123468899999994

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=1.1e-26  Score=182.73  Aligned_cols=172  Identities=23%  Similarity=0.372  Sum_probs=139.0

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc-hhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Ccc
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ-TVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  117 (219)
                      .+|++.+.||+|+||.||.| ...++..+++|.+........ ......+.+|+.+++.++|+|++++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999 456788999998753221211 12335678899999999999999999988663  457


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++++++|.+++....   .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999886532   266777888999999999999999   999999999999999999999999999876


Q ss_pred             ecCCC---CcccccccccccccCCC
Q 039002          198 LKSDA---SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~---~~~~~~~gt~~y~aPE~  219 (219)
                      .....   .......++..|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~  180 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEV  180 (265)
T ss_pred             cccccccccccccCCCCccccChhh
Confidence            54221   12234568899999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=4e-27  Score=185.02  Aligned_cols=170  Identities=25%  Similarity=0.418  Sum_probs=139.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..+|++.+.||+|++|.||+|. ...++.+++|.+...     ......+.+|+.+++.++|+|++++++++...+..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            4568889999999999999994 556888999987532     1234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+++++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            9999999999999865332 2367888889999999999999998   99999999999999999999999999988665


Q ss_pred             CCCCcc-cccccccccccCCC
Q 039002          200 SDASNW-TEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~-~~~~gt~~y~aPE~  219 (219)
                      ...... ....+++.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~  176 (263)
T cd05052         156 GDTYTAHAGAKFPIKWTAPES  176 (263)
T ss_pred             cceeeccCCCCCccccCCHHH
Confidence            432111 11234567999994

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=192.36  Aligned_cols=167  Identities=30%  Similarity=0.513  Sum_probs=138.7

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhc--CCCCccceeEeEEEeCC---
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE--TRHRNIVKFYGFCSHAR---  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~---  115 (219)
                      ....++.+.+|+|.||.||+|...+ +.||||++..       .....+..|-.+.+.  ++|+||++++++-....   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccC-ceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            5667788999999999999996654 6999999842       234567777666655  48999999999887665   


Q ss_pred             -cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC------CCCeEecCCCCCCEEeCCCCcEE
Q 039002          116 -HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC------FPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       116 -~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~------~~~i~H~dlkp~nili~~~~~~k  188 (219)
                       .+|||++|.+.|+|.++++.+    ..+|.....++..++.||.|||+-.      .++|+|||||.+|||+..++++.
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence             899999999999999999864    3788999999999999999999743      25799999999999999999999


Q ss_pred             EeeccceeeecCCC--CcccccccccccccCCC
Q 039002          189 VADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      |+|||+|..+....  ......+||..|||||.
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEv  389 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEV  389 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHH
Confidence            99999998876322  22244699999999994

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=1.2e-26  Score=184.59  Aligned_cols=163  Identities=20%  Similarity=0.309  Sum_probs=134.4

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe----CCcceEEEE
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH----ARHSFLLCE  122 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e  122 (219)
                      ...||+|+++.||+|.. +++.||+|.+..... ........+.+|+.++++++||||+++++++.+    ....+++||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            36799999999999976 677999999865322 122234567799999999999999999999876    346889999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+.+|+|.+++....   .+++.....++.+++.|+.|+|...  +++||||||+|++++.++.+|++|||++.......
T Consensus       103 y~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        103 YCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             eCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999997543   3778888999999999999999742  77899999999999999999999999987654332


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                         ....|++.|+|||+
T Consensus       178 ---~~~~~~~~y~aPE~  191 (283)
T PHA02988        178 ---FKNVNFMVYFSYKM  191 (283)
T ss_pred             ---ccccCcccccCHHH
Confidence               23478899999995

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.95  E-value=6.4e-27  Score=183.16  Aligned_cols=168  Identities=23%  Similarity=0.439  Sum_probs=138.1

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .+|++.+.||+|+||.||+|...++..+++|.+....     .....+.+|+.+++.++|+|++++++++...+..++++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            4688999999999999999977667789999875321     12345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++++++|.+++.....  .+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++....+.
T Consensus        79 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          79 EYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             ecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            99999999998864322  367888999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCc-ccccccccccccCCC
Q 039002          202 ASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~-~~~~~gt~~y~aPE~  219 (219)
                      ... .....++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~  172 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEV  172 (256)
T ss_pred             cccccCCCCCCccccCHHH
Confidence            211 111233457999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=2.4e-27  Score=187.68  Aligned_cols=168  Identities=25%  Similarity=0.432  Sum_probs=141.7

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +.|+..+.||+|+||.||+| ...++..+|+|.+....   .......+.+|+.+++.++|+|++++++.+..++..+++
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            34667888999999999999 45677889999875321   122345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||++++++.+++...    .+++..+..++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..+..
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          81 MEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            9999999999988542    367788889999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~  172 (277)
T cd06642         154 TQIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             cchhhhcccCcccccCHHH
Confidence            4433445678899999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=6e-27  Score=186.76  Aligned_cols=171  Identities=25%  Similarity=0.333  Sum_probs=142.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Ccc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  117 (219)
                      .++|++.+.||+|.+|.||+|. ..+++.+++|.++.....  ......+.+|+.+++.++|+|++++++++...  +..
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            3679999999999999999995 457889999998653222  22334567899999999999999999998877  889


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++. ++|.+++.....  .+++.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++..
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceee
Confidence            99999996 488888764322  378888999999999999999998   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............+++.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~  177 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPEL  177 (293)
T ss_pred             ccCCccccccccccccccCchh
Confidence            7655333344567889999994

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=2.7e-27  Score=187.85  Aligned_cols=169  Identities=22%  Similarity=0.354  Sum_probs=139.8

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||+| ...+|+.+++|.+.....  .......+.+|+.+++.++|+|++++++++.+.+..++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            4888999999999999999 456788999998864321  1223345677999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+. +++..++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          79 EYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             ecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            9996 57777765432  2378888999999999999999999   9999999999999999999999999999866544


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+++.|+|||.
T Consensus       153 ~~~~~~~~~~~~y~aPE~  170 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDV  170 (284)
T ss_pred             CCCcCCCccccCCcChHH
Confidence            333344567899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=1.1e-26  Score=182.94  Aligned_cols=173  Identities=25%  Similarity=0.375  Sum_probs=140.1

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      .++++.....||+|+||.||+|. ..++..+++|.+...    .......+.+|+.+++.++|+||+++++++..++..+
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34555566789999999999995 557778999987532    1223456789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEeeccceee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVADFGIAKF  197 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~  197 (219)
                      +++|++++++|.+++.........+...+..++.|++.|+.|||+.   +++|+||||+||+++. .+.++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999986532211126677888899999999999998   9999999999999986 67999999999876


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............+++.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~  180 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEV  180 (268)
T ss_pred             cccCCCccccCCCCccccChhh
Confidence            6443333344568899999994

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.95  E-value=6.2e-27  Score=183.56  Aligned_cols=170  Identities=22%  Similarity=0.391  Sum_probs=139.6

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++.+.||+|++|.||+|...++..+++|.+.....     ....+.+|+.++++++|+|++++++++. .+..++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            4568999999999999999999777777899998864221     2346788999999999999999999875 456899


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++..... ..+++..+..++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999999999864321 2367888999999999999999998   99999999999999999999999999998664


Q ss_pred             CCCCc-ccccccccccccCCC
Q 039002          200 SDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      ..... .....++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~  174 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEA  174 (260)
T ss_pred             CcccccccCCCCCccccChHH
Confidence            33211 122345667999994

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=9.3e-27  Score=182.81  Aligned_cols=172  Identities=30%  Similarity=0.475  Sum_probs=144.4

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|++|.||+|. ..++..+++|.+.....   ......+.+|+..++.++|+|++++++.+...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            479999999999999999995 45778899998754321   12446678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|++.++++.+++........+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++++|||++..+..
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999999999986533223478888899999999999999998   999999999999999999999999999877665


Q ss_pred             CCCc----ccccccccccccCCC
Q 039002          201 DASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~----~~~~~gt~~y~aPE~  219 (219)
                      ....    .....|+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~  177 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEV  177 (267)
T ss_pred             CccccccccccccCChhhcChHH
Confidence            4322    133578899999984

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=6e-27  Score=187.88  Aligned_cols=172  Identities=26%  Similarity=0.417  Sum_probs=136.2

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.. .++.  .+++|.+...   ........+.+|+.++.++ +|+|++++++++...+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            57899999999999999999954 4454  3577766431   1223345677899999999 89999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          117 SFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      .++++||+++++|.+++.....             ...+++.++..++.|++.|+.|||+.   +++|+||||+||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~  159 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE  159 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence            9999999999999999864321             12367888999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++|+|||++........ .....++..|+|||+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~  194 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIES  194 (303)
T ss_pred             CCcEEeCccccCcccchhhh-cccCCCcccccCHHH
Confidence            99999999999864321111 112234567999984

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=1e-26  Score=185.60  Aligned_cols=173  Identities=25%  Similarity=0.398  Sum_probs=140.4

Q ss_pred             hCCCCCcceeccccceeEEEEEcC-----------------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP-----------------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN  103 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~-----------------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n  103 (219)
                      .++|++.+.||+|+||.||+|...                 .+..+++|.+....   .......+.+|+.+++.++|+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence            578999999999999999998432                 12458899876432   1234456788999999999999


Q ss_pred             cceeEeEEEeCCcceEEEEecCCCCHHHHhcccch--------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA--------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       104 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                      ++++++++..++..++++|++.+++|..++.....        ...+++..+..++.|++.|+.|||+.   +++|+|||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk  157 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA  157 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence            99999999999999999999999999999865321        12478888999999999999999998   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++.++++|||++........  ......+++.|+|||+
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWES  203 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHH
Confidence            9999999999999999999876543221  1123456778999994

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=1.5e-26  Score=181.93  Aligned_cols=171  Identities=29%  Similarity=0.450  Sum_probs=140.9

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc-----hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ-----TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      +|.+...||+|++|.||+| ...+++.+++|.+........     ......+.+|+.++++++|+||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999 455778899998865433221     1122457789999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++||+++++|.+++...+   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999996543   267788889999999999999998   99999999999999999999999999988


Q ss_pred             eecCCC------CcccccccccccccCCC
Q 039002          197 FLKSDA------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~------~~~~~~~gt~~y~aPE~  219 (219)
                      ......      .......|+..|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~  183 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEV  183 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhH
Confidence            765321      11123468889999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.95  E-value=6e-27  Score=182.92  Aligned_cols=168  Identities=27%  Similarity=0.429  Sum_probs=144.8

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|++|.||+|.. .++..+++|.+...      .....+.+|+.+++.++|+|++++++.+......++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            57899999999999999999954 45788999987532      114678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++|++.+++|.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+|++|+||+++.++.++++|||++....
T Consensus        76 ~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            999999999999986433  2378888999999999999999998   99999999999999999999999999998776


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........++..|+|||+
T Consensus       151 ~~~~~~~~~~~~~~y~~PE~  170 (256)
T cd06612         151 DTMAKRNTVIGTPFWMAPEV  170 (256)
T ss_pred             cCccccccccCCccccCHHH
Confidence            55434445578899999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=8.3e-27  Score=186.26  Aligned_cols=173  Identities=23%  Similarity=0.388  Sum_probs=138.0

Q ss_pred             hCCCCCcceeccccceeEEEEEcCC---------------CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPS---------------REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV  105 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~---------------~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~  105 (219)
                      .++|++.+.||+|+||.||++....               ...+|+|.+....   .......+.+|+.+++.++|+|++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999985321               2358999886432   122345678899999999999999


Q ss_pred             eeEeEEEeCCcceEEEEecCCCCHHHHhcccch---------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCC
Q 039002          106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAA---------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSS  176 (219)
Q Consensus       106 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  176 (219)
                      ++++++...+..+++|||+.+++|.+++.....         ...+++.....++.+++.|+.|||+.   +++|+||||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp  157 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT  157 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence            999999999999999999999999998854210         11256778889999999999999998   999999999


Q ss_pred             CCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          177 KNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       177 ~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +||+++.++.++++|||++........  ......++..|+|||+
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  202 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES  202 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence            999999999999999999876533221  1122345678999994

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=9.3e-27  Score=185.37  Aligned_cols=172  Identities=26%  Similarity=0.428  Sum_probs=139.6

Q ss_pred             hCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      ..+|.+.+.||+|+||.||++..      .++..+++|.+...    .......+.+|+.++++++|+|++++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            46788999999999999999952      23456889987532    223445688999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccch----------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA----------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE  184 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~  184 (219)
                      +..++++||+.+++|.+++...+.          ...+++..+..++.|++.|+.|+|+.   +++||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            999999999999999999864321          12378888999999999999999998   99999999999999999


Q ss_pred             CcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          185 YEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +.++++|||++........  ......+++.|+|||+
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  193 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  193 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHH
Confidence            9999999999875532211  1122345778999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=6.5e-27  Score=184.94  Aligned_cols=174  Identities=18%  Similarity=0.327  Sum_probs=140.2

Q ss_pred             HhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ..++|++.+.||+|+||.||+|...      ++..+++|.+...   ........+.+|+.+++.++|+|++++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4578999999999999999999532      3367999997532   122334567889999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchh-------hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAA-------QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                      ....++++|++++++|.+++......       ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCC
Confidence            99999999999999999998643211       1256778889999999999999998   9999999999999999999


Q ss_pred             EEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ++|+|||+++.......  ......++..|+|||.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHH
Confidence            99999999875543221  1123356788999984

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-26  Score=183.73  Aligned_cols=167  Identities=28%  Similarity=0.485  Sum_probs=142.6

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC---CCccceeEeEEEeCCcce
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR---HRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~  118 (219)
                      .|++.+.||+|+||.||+|. ..+++.+++|.+.....   ......+.+|+.+++.++   |+|++++++.+..+...+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            57888999999999999994 56788999998764321   123345778899988886   999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++||+.+++|.+++...    .+++.....++.|++.++.|+|+.   +++|+||+|+||+++.++.++++|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          79 IIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            999999999999988542    377888999999999999999998   9999999999999999999999999999877


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........|+..|+|||+
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~  172 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEV  172 (277)
T ss_pred             CCCccccccccCCcceeCHHH
Confidence            655544455689999999994

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=7.6e-27  Score=186.43  Aligned_cols=170  Identities=24%  Similarity=0.449  Sum_probs=144.1

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...++|++.+.||+|+||.||+| ...++..+++|.+...    .......+.+|+.+++.++|||++++++.+...+..
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            34578999999999999999999 4567788999987532    122345678899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++||+.+++|.+++...    .+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~  164 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence            9999999999999988643    256778889999999999999999   999999999999999999999999999876


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............+++.|+|||.
T Consensus       165 ~~~~~~~~~~~~~~~~y~~PE~  186 (293)
T cd06647         165 ITPEQSKRSTMVGTPYWMAPEV  186 (293)
T ss_pred             ccccccccccccCChhhcCchh
Confidence            6554444445578899999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=7.8e-27  Score=182.44  Aligned_cols=171  Identities=23%  Similarity=0.315  Sum_probs=143.0

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|+||.+|.+ ...+++.+++|.+......  ......+.+|+.+++.++|+|++++++++...+..++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC--hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            5889999999999999999 4567889999987643211  223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.+++|.+.+..... ..+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          79 DYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999998864321 2367788899999999999999998   9999999999999999999999999999876544


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........|++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~pe~  172 (256)
T cd08218         155 VELARTCIGTPYYLSPEI  172 (256)
T ss_pred             hhhhhhccCCccccCHHH
Confidence            333334568889999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=7.7e-27  Score=193.73  Aligned_cols=178  Identities=21%  Similarity=0.349  Sum_probs=141.6

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeE
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFY  108 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~  108 (219)
                      .|..+.++|.+.+.||+|+||.||+|.+.      .++.||+|+++....   ......+.+|+.++..+. |+||++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR---SSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC---hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            35566678889999999999999999632      345799999865321   122346788999999997 99999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccch--------------------------------------------------
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAA--------------------------------------------------  138 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------------------------------------------------  138 (219)
                      +++...+..++++||+.+|+|.+++.....                                                  
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            999999999999999999999998854210                                                  


Q ss_pred             ---------------------------------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecC
Q 039002          139 ---------------------------------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRD  173 (219)
Q Consensus       139 ---------------------------------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  173 (219)
                                                                   ...+++.....++.|++.|+.|||+.   +++|+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrd  264 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRD  264 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCccc
Confidence                                                         01245667788899999999999998   999999


Q ss_pred             CCCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          174 VSSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       174 lkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |||+||+++..+.++++|||++........  ......+++.|+|||.
T Consensus       265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  312 (401)
T cd05107         265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES  312 (401)
T ss_pred             CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence            999999999999999999999986543221  1123456788999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=7.3e-27  Score=184.14  Aligned_cols=166  Identities=22%  Similarity=0.314  Sum_probs=129.5

Q ss_pred             ceeccccceeEEEEEcCCC---cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           48 YCIGNGGHASVYRAELPSR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~---~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      +.||+|+||.||+|...++   ..+++|.+....   .......+.+|+.+++.++|||++++++.+......+++|||+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            3689999999999953322   346667654321   1223467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC-
Q 039002          125 ERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA-  202 (219)
Q Consensus       125 ~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-  202 (219)
                      .+++|.+++..... ....+...+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++....... 
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            99999999865321 12245666778899999999999998   99999999999999999999999999875422111 


Q ss_pred             -CcccccccccccccCCC
Q 039002          203 -SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 -~~~~~~~gt~~y~aPE~  219 (219)
                       .......++..|+|||+
T Consensus       155 ~~~~~~~~~~~~y~aPE~  172 (268)
T cd05086         155 IETEDDKCVPLRWLAPEL  172 (268)
T ss_pred             hhcccCCcCcccccCchh
Confidence             11234577889999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=9e-27  Score=183.18  Aligned_cols=171  Identities=24%  Similarity=0.401  Sum_probs=141.6

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc--hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ--TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +|+..+.||+|++|.||+| ...+++.+++|.+........  ......+.+|+.+++.++|+|++++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999 457888999998864332221  1234678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~  198 (219)
                      ++|++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999986533   367888899999999999999999   999999999999998765 6999999998876


Q ss_pred             cCCCC----cccccccccccccCCC
Q 039002          199 KSDAS----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~----~~~~~~gt~~y~aPE~  219 (219)
                      .....    ......++..|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~  179 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEV  179 (268)
T ss_pred             ccccccCCccccccccccceeCHhH
Confidence            54321    1233578899999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-27  Score=189.49  Aligned_cols=166  Identities=30%  Similarity=0.416  Sum_probs=135.4

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHH--hcCCCCccceeEeEEEeC----C
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL--TETRHRNIVKFYGFCSHA----R  115 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l--~~l~h~ni~~~~~~~~~~----~  115 (219)
                      .+.++.+.||+|.||.||+|.|. |+.||||++..       .+..++.+|.++.  ..++|+||..+.+.-..+    .
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecc-------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            55778899999999999999775 56899999853       2334566665544  556999999998776432    4


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhC-----CCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD-----CFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                      ++|||++|.+.|+|.+++...    .++....+.++..++.||.+||..     ..+.|.|||||..|||+.++|.+.|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            689999999999999999763    377788899999999999999962     23679999999999999999999999


Q ss_pred             eccceeeecCCCCc----ccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~  219 (219)
                      |+|+|....+..+.    .+..+||..|||||+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEv  391 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEV  391 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHH
Confidence            99999876654322    255699999999995

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=1.1e-26  Score=185.14  Aligned_cols=180  Identities=26%  Similarity=0.371  Sum_probs=144.7

Q ss_pred             ccHHHHHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           32 ILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        32 ~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      +....+..+.++|++...||+|+||.||+| ...+++.+++|.+...     ......+.+|+.+++++ +|+|++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~   86 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPNVVKFYG   86 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence            333455666899999999999999999999 4567889999987532     11234566788888888 7999999999


Q ss_pred             EEEeC-----CcceEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          110 FCSHA-----RHSFLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       110 ~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      ++...     +..++++||+.+++|.+++.... ....+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.
T Consensus        87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~  163 (291)
T cd06639          87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTT  163 (291)
T ss_pred             EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcC
Confidence            98643     35899999999999999875321 123477888899999999999999998   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++++|||++..............|+..|+|||.
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  199 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  199 (291)
T ss_pred             CCCEEEeecccchhcccccccccCccCCccccChhh
Confidence            999999999998866543323344578899999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=7.9e-27  Score=190.33  Aligned_cols=175  Identities=21%  Similarity=0.356  Sum_probs=136.5

Q ss_pred             HHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEE
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFC  111 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~  111 (219)
                      -+.++|++.+.||+|+||.||+|..      .+++.+|+|.++...   .......+.+|+.++..+ +|+|++++++++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            3467899999999999999999942      346789999986432   122335678899999999 689999999988


Q ss_pred             EeC-CcceEEEEecCCCCHHHHhcccch----------------------------------------------------
Q 039002          112 SHA-RHSFLLCEFLERGSLAAILNTDAA----------------------------------------------------  138 (219)
Q Consensus       112 ~~~-~~~~lv~e~~~~~~l~~~~~~~~~----------------------------------------------------  138 (219)
                      ... ...+++|||+.+|+|.+++.....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 467899999999999998853210                                                    


Q ss_pred             ------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc--
Q 039002          139 ------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--  204 (219)
Q Consensus       139 ------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--  204 (219)
                                  ...+++.+...++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++.........  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  237 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR  237 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence                        01256777888999999999999998   9999999999999999999999999998765332211  


Q ss_pred             ccccccccccccCCC
Q 039002          205 WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 ~~~~~gt~~y~aPE~  219 (219)
                      .....++..|+|||+
T Consensus       238 ~~~~~~~~~y~aPE~  252 (343)
T cd05103         238 KGDARLPLKWMAPET  252 (343)
T ss_pred             cCCCCCCcceECcHH
Confidence            112245567999984

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=1.1e-26  Score=185.09  Aligned_cols=171  Identities=22%  Similarity=0.283  Sum_probs=140.4

Q ss_pred             CCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcc
Q 039002           43 DFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  117 (219)
                      +|++.+.||+|+||.||.|..    .++..+|+|.+..............+.+|+.+++.+ +|+||+.+++.+..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478899999999999999953    367889999886432222223345667899999999 589999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++++++|.+++....   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999886532   367788888889999999999998   999999999999999999999999999876


Q ss_pred             ecCCC-CcccccccccccccCCC
Q 039002          198 LKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ..... .......|+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~  177 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDI  177 (290)
T ss_pred             cccccccccccccCCcccCChhh
Confidence            54322 12234578999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=1.7e-26  Score=183.36  Aligned_cols=170  Identities=27%  Similarity=0.429  Sum_probs=136.5

Q ss_pred             hCCCCCcceeccccceeEEEEEc-----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--  113 (219)
                      ..+|++.+.||+|+||.||+|..     .++..+++|.+...    .......+.+|+.+++.++|+|++++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            35789999999999999999953     35778999997542    22334567889999999999999999998754  


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      ....++++||+++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence            346889999999999999986432  2377888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcc---cccccccccccCCC
Q 039002          194 IAKFLKSDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      ++..........   ....++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  182 (284)
T cd05081         154 LTKVLPQDKEYYKVREPGESPIFWYAPES  182 (284)
T ss_pred             ccccccCCCcceeecCCCCCceEeeCHHH
Confidence            998764432211   11133456899984

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=2.5e-26  Score=178.98  Aligned_cols=164  Identities=24%  Similarity=0.398  Sum_probs=134.3

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCC
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERG  127 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~  127 (219)
                      +.||+|+||.||+|...++..+|+|.+.....   ......+.+|+.+++.++|+|++++++++...+..+++||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            36899999999999777788899998764321   223346788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc-c
Q 039002          128 SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW-T  206 (219)
Q Consensus       128 ~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~-~  206 (219)
                      +|.+++....  ..+.+.....++.+++.++.|+|+.   +++|+||+|+||+++.++.++++|||++.......... .
T Consensus        78 ~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          78 DFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            9999886432  2367888899999999999999998   99999999999999999999999999987543322111 1


Q ss_pred             ccccccccccCCC
Q 039002          207 EFAGTYGYVALGI  219 (219)
Q Consensus       207 ~~~gt~~y~aPE~  219 (219)
                      ...+++.|+|||+
T Consensus       153 ~~~~~~~y~aPE~  165 (250)
T cd05085         153 LKQIPIKWTAPEA  165 (250)
T ss_pred             CCCCcccccCHHH
Confidence            2234567999994

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=8.5e-27  Score=185.60  Aligned_cols=175  Identities=18%  Similarity=0.331  Sum_probs=137.4

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS  112 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  112 (219)
                      ...++|++.+.||+|+||.||+|...      .+..+|+|.+....   .......+.+|+..++.++|+|++++++++.
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34678999999999999999998432      24479999875321   1223345678999999999999999999999


Q ss_pred             eCCcceEEEEecCCCCHHHHhcccch-------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC
Q 039002          113 HARHSFLLCEFLERGSLAAILNTDAA-------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY  185 (219)
Q Consensus       113 ~~~~~~lv~e~~~~~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~  185 (219)
                      ..+..+++|||+.+++|.+++.....       ........+..++.|++.|+.|+|+.   +++|+||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence            99999999999999999999864211       11234567788999999999999998   999999999999999999


Q ss_pred             cEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          186 EAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       186 ~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      .++++|||++........  ......++..|+|||.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~  192 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHH
Confidence            999999999875432211  1122245677999984

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2e-27  Score=203.50  Aligned_cols=172  Identities=23%  Similarity=0.318  Sum_probs=137.5

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEE-E---eC-
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFC-S---HA-  114 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~-~---~~-  114 (219)
                      -+.++.+.|.+|+|+.||.|. ...+..+|+|++..   . ++.....+.+|+.+|+.|+ |+|||.|++.. .   .+ 
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---N-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---C-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            446778999999999999994 44558999999763   2 4567778899999999997 99999999943 1   11 


Q ss_pred             --CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          115 --RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       115 --~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                        -+++|.||||.+|.|.+++.... ...+++..+++|+.++++|+.++|.... +|||||||.+|+|++.+|..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCcc
Confidence              35779999999999999996422 2348899999999999999999999743 6999999999999999999999999


Q ss_pred             cceeeecCCCCcc--------c-ccccccccccCCC
Q 039002          193 GIAKFLKSDASNW--------T-EFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~--------~-~~~gt~~y~aPE~  219 (219)
                      |.+..-.......        . ....|+.|+|||.
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEM  226 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEM  226 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHH
Confidence            9886443222111        1 1256899999993

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=1.7e-26  Score=182.05  Aligned_cols=166  Identities=21%  Similarity=0.308  Sum_probs=131.2

Q ss_pred             ceeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           48 YCIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      +.||+|+||.||+|...   ++..+++|.++...   .......+.+|+.+++.++|+|++++++++.+....+++|||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999543   34568999876432   1223356788999999999999999999999888999999999


Q ss_pred             CCCCHHHHhcccch--hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          125 ERGSLAAILNTDAA--AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       125 ~~~~l~~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      ++++|.+++.....  ....++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            99999999864221  11245566778899999999999998   99999999999999999999999999986543221


Q ss_pred             C--cccccccccccccCCC
Q 039002          203 S--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~--~~~~~~gt~~y~aPE~  219 (219)
                      .  ......++..|+|||+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPEL  173 (269)
T ss_pred             eeecCCCcCCcccccCHhH
Confidence            1  1123467788999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=194.40  Aligned_cols=175  Identities=22%  Similarity=0.300  Sum_probs=147.9

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHAR  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  115 (219)
                      .....+|..+..||+|+||+|.+| +..+.+.+|||+++++..-.+. +.+.-+.|-.+|... +.|++++++..|++-+
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-Dvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-cccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            444578999999999999999999 5567788999999876544332 333345566777665 5789999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .+|.||||+.||+|.-.+..-+.   +.+..++.++.+|+.||.+||++   +|++||||.+|++++.+|.+||+|||.+
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999988865432   66778889999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.-.-......+++|||-|+||||
T Consensus       498 KEni~~~~TTkTFCGTPdYiAPEI  521 (683)
T KOG0696|consen  498 KENIFDGVTTKTFCGTPDYIAPEI  521 (683)
T ss_pred             cccccCCcceeeecCCCcccccce
Confidence            876656666678999999999997

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-26  Score=184.61  Aligned_cols=170  Identities=28%  Similarity=0.404  Sum_probs=141.6

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|++|.||+|. ..+++.+++|.++....  .......+.+|+.+++.++|+|++++++.+..++..+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            478999999999999999994 45788999998864322  122345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+.++.+..+....   ..+++..+..++.+++.|+.|||..   +++|+|++|+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          79 FEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            9999887666655432   2367888999999999999999999   999999999999999999999999999887665


Q ss_pred             CCC-cccccccccccccCCC
Q 039002          201 DAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ... ......++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~  172 (288)
T cd07833         153 RPASPLTDYVATRWYRAPEL  172 (288)
T ss_pred             CccccccCcccccCCcCCch
Confidence            432 2244678899999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=1.4e-26  Score=181.56  Aligned_cols=172  Identities=19%  Similarity=0.378  Sum_probs=141.0

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ....++|++.+.||+|+||.||+|....+..+++|.+...     ......+.+|+.+++.++|+|++++++.+.. ...
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            3456889999999999999999997667778999987532     1233567889999999999999999999877 778


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++||+++++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+..
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceee
Confidence            999999999999999865322 2367788889999999999999998   999999999999999999999999999976


Q ss_pred             ecCCCC-cccccccccccccCCC
Q 039002          198 LKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      +..... ......++..|+|||+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~  174 (260)
T cd05073         152 IEDNEYTAREGAKFPIKWTAPEA  174 (260)
T ss_pred             ccCCCcccccCCcccccccCHhH
Confidence            643221 1122345677999984

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=2.7e-26  Score=180.60  Aligned_cols=172  Identities=23%  Similarity=0.381  Sum_probs=139.4

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc-hhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CCcc
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ-TVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  117 (219)
                      .+|+..+.||+|+||.||+| ...++..+++|.+........ ......+.+|+.+++.++|+|++++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            37899999999999999999 456788999998764332221 2233567789999999999999999998865  3567


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++++++|.+++....   .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999886533   267788888999999999999998   999999999999999999999999999876


Q ss_pred             ecCCC---CcccccccccccccCCC
Q 039002          198 LKSDA---SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~---~~~~~~~gt~~y~aPE~  219 (219)
                      .....   .......++..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~  180 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEV  180 (266)
T ss_pred             cccccccCCccccCCccccccCHHH
Confidence            54321   11233568899999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=9e-27  Score=185.68  Aligned_cols=177  Identities=21%  Similarity=0.347  Sum_probs=141.3

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      +....++|++.+.||+|+||.||++...      ....+++|.+....   .......+.+|+.+++.+ +|+||+++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3445678999999999999999999532      23578999876421   122335578899999999 8999999999


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhccc-------------chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCC
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTD-------------AAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSS  176 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  176 (219)
                      ++...+..+++|||+++++|..++...             .....+++..+..++.|++.|+.|||+.   +++|+||||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp  160 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA  160 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence            999999999999999999999998532             1123477888899999999999999998   999999999


Q ss_pred             CCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          177 KNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       177 ~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +||+++.++.++++|||++..+......  .....++..|+|||.
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  205 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEA  205 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHH
Confidence            9999999999999999999866433211  111234577999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=1.9e-26  Score=183.03  Aligned_cols=169  Identities=26%  Similarity=0.405  Sum_probs=142.4

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||+|. ..++..+++|.+......  ......+.+|+.+++.++|+|++++++++...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            58899999999999999995 557889999998653221  223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++ +++|.+++....  ..+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            999 999999886433  2377888999999999999999998   9999999999999999999999999998876543


Q ss_pred             CC-cccccccccccccCCC
Q 039002          202 AS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~-~~~~~~gt~~y~aPE~  219 (219)
                      .. ......++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~y~aPE~  171 (286)
T cd07832         153 EPRLYSHQVATRWYRAPEL  171 (286)
T ss_pred             CCCccccccCcccccCcee
Confidence            21 1234578999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=4.5e-27  Score=187.73  Aligned_cols=165  Identities=28%  Similarity=0.427  Sum_probs=138.6

Q ss_pred             CCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |.....||+|+||.||++ ...++..+++|.+...    .......+.+|+..++.++|+|++++++.+..++..++++|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            334567999999999999 4567889999987532    12334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      +++++++.+++...    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         100 FLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             CCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            99999999987542    367788899999999999999999   99999999999999999999999999987654443


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......|+..|+|||+
T Consensus       173 ~~~~~~~~~~~y~aPE~  189 (292)
T cd06658         173 PKRKSLVGTPYWMAPEV  189 (292)
T ss_pred             ccCceeecCccccCHHH
Confidence            33344678999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=1.2e-26  Score=185.99  Aligned_cols=175  Identities=21%  Similarity=0.357  Sum_probs=140.0

Q ss_pred             HHhCCCCCcceeccccceeEEEEEc--------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAEL--------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~--------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      ...++|.+...||+|+||.||+|..        .++..+++|.+....   .......+.+|+.+++.+ +|+||+++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            4467889999999999999999952        123468999875321   123345678899999999 8999999999


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCC
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSS  176 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  176 (219)
                      ++...+..+++|||+.+++|.+++.....             ...+++..+..++.|++.|+.|||+.   +++|+||||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence            99999999999999999999999864321             12367778889999999999999998   999999999


Q ss_pred             CCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          177 KNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       177 ~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +||+++.++.++|+|||++.........  .....+++.|+|||+
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEA  210 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchh
Confidence            9999999999999999999876433211  122245678999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=1.3e-26  Score=184.00  Aligned_cols=170  Identities=27%  Similarity=0.380  Sum_probs=140.1

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|+..+.||.|++|.||+| ...+++.+++|.+......  ......+.+|+.+++.++|+|++++++++.+++..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            5888999999999999999 4567889999988643222  123346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+. +++..++..... ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          79 EFLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             eccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9995 588887754322 3477888999999999999999998   9999999999999999999999999998765443


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........+++.|+|||+
T Consensus       154 ~~~~~~~~~~~~y~aPE~  171 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEI  171 (284)
T ss_pred             ccccccccccccccCCeE
Confidence            333333467889999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=7.7e-27  Score=187.49  Aligned_cols=176  Identities=22%  Similarity=0.352  Sum_probs=139.3

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcC--------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELP--------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFY  108 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~--------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  108 (219)
                      ....++|.+.+.||+|+||.||+|...        +...+|+|.+....   .......+.+|+.+++.+ +|+|+++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            444578999999999999999999531        23469999886431   122335677899999999 799999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                      +++...+..++++|++++++|.+++.....             ...+++.++..++.|++.|+.|+|+.   +++|+|||
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlk  167 (307)
T cd05098          91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLA  167 (307)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Cccccccc
Confidence            999999999999999999999999965321             12367888899999999999999998   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCCCcc--cccccccccccCCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDASNW--TEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++.++++|||++..........  ....+++.|+|||+
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  213 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHH
Confidence            999999999999999999987654321111  11234467999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.94  E-value=1.9e-26  Score=183.80  Aligned_cols=172  Identities=27%  Similarity=0.467  Sum_probs=139.6

Q ss_pred             hCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++|.+...||+|+||.||+|..      .++..+++|.+...    .......+.+|+.+++.++|+|++++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            35688899999999999999953      23456888887532    223345678899999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL  181 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili  181 (219)
                      +..+++|||+++++|.+++...+.             ...+++..+..++.|++.|+.|+|++   +++|+||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            999999999999999999864321             12367888999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          182 DLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       182 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +.++.++++|||++........  ......++..|+|||+
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  196 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  196 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHH
Confidence            9999999999999875533221  1123456788999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.4e-26  Score=181.59  Aligned_cols=172  Identities=22%  Similarity=0.446  Sum_probs=142.1

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ...++|++.+.||+|++|.||+|...++..+++|.+....     .....+.+|+.+++.++|+|++++++++......+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            3467899999999999999999976677789999876421     23356788999999999999999999999888999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++|++.+++|.+++..... ..+++..+..++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..+
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             EEEeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence            99999999999999865331 3478888899999999999999999   9999999999999999999999999998766


Q ss_pred             cCCCC-cccccccccccccCCC
Q 039002          199 KSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ..... ......++..|+|||.
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~  175 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEA  175 (261)
T ss_pred             cchhhhhhhccCCCccccCHHH
Confidence            43211 1122234567999983

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=8.6e-27  Score=206.85  Aligned_cols=178  Identities=21%  Similarity=0.331  Sum_probs=140.7

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--C
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--R  115 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~  115 (219)
                      ...++|++...||+|+||.||+| ...++..+|+|.+.....  .......+..|+.+++.++||||++++++|...  +
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            44689999999999999999999 455777899998764322  223446678899999999999999999988543  5


Q ss_pred             cceEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCC----CCeEecCCCCCCEEeCC-------
Q 039002          116 HSFLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCF----PPIVHRDVSSKNLLLDL-------  183 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~----~~i~H~dlkp~nili~~-------  183 (219)
                      .+|++|||+.+++|.+++.... ....+++..++.++.||+.||.|||....    .+|+|+||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            6899999999999999886421 11247889999999999999999998420    15999999999999964       


Q ss_pred             ----------CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 ----------EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                                .+.++|+|||++..+.... ......||+.|+|||+
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEv  212 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPEL  212 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHH
Confidence                      2358999999998664332 2234579999999994

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=6.7e-27  Score=193.98  Aligned_cols=163  Identities=22%  Similarity=0.314  Sum_probs=135.9

Q ss_pred             hCCCCCcceeccccceeEEEEEc---CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ..+|++.+.||+|+||.||++..   ..+..+++|.+...         ....+|+.+++.++|+||+++++++...+..
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            46799999999999999999943   24567899986431         1235799999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++||++. +++..++...   ..+++..+..++.|++.|+.|||..   +++||||||+||+++.++.++|+|||++..
T Consensus       162 ~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            99999985 6888887433   2378889999999999999999998   999999999999999999999999999976


Q ss_pred             ecCCCCc--ccccccccccccCCC
Q 039002          198 LKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +......  .....||+.|+|||+
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~  258 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPEL  258 (392)
T ss_pred             cCcccccccccccccccCccCHhH
Confidence            6543221  224579999999994

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=1.2e-27  Score=204.37  Aligned_cols=175  Identities=23%  Similarity=0.399  Sum_probs=143.6

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC  111 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~  111 (219)
                      ..+..+.+....||+|+||+||+|+..      +...||||.++..   .+.+.+..|.+|+.++..++|+|||+++|+|
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~---a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK---AENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc---ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            344566777899999999999999642      3456999998753   2334567899999999999999999999999


Q ss_pred             EeCCcceEEEEecCCCCHHHHhcccch-----------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEE
Q 039002          112 SHARHSFLLCEFLERGSLAAILNTDAA-----------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLL  180 (219)
Q Consensus       112 ~~~~~~~lv~e~~~~~~l~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nil  180 (219)
                      ..++..++|+||+..|+|..|+....+           +..++..+.+.|+.||+.||.||.++   .++||||-++|+|
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL  635 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence            999999999999999999999964221           12267788999999999999999999   8999999999999


Q ss_pred             eCCCCcEEEeeccceeeecCCC--CcccccccccccccCC
Q 039002          181 LDLEYEAHVADFGIAKFLKSDA--SNWTEFAGTYGYVALG  218 (219)
Q Consensus       181 i~~~~~~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE  218 (219)
                      |+....|||+|||+++..-+..  +-.....-...||+||
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            9999999999999998664322  1111224568899998

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=5.5e-27  Score=187.62  Aligned_cols=167  Identities=28%  Similarity=0.419  Sum_probs=139.5

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ..|+....||+|+||.||+|. ..+++.+++|.+....    ......+.+|+..++.++|||++++++.+..++..+++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            344455689999999999994 5578899999875321    12345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|+++++++..++...    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++..+..
T Consensus        97 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659          97 MEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             EecCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            9999999999877542    367888999999999999999999   999999999999999999999999999876554


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........++..|+|||+
T Consensus       170 ~~~~~~~~~~~~~y~aPE~  188 (297)
T cd06659         170 DVPKRKSLVGTPYWMAPEV  188 (297)
T ss_pred             ccccccceecCccccCHHH
Confidence            4333345678999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=3.1e-26  Score=179.57  Aligned_cols=169  Identities=28%  Similarity=0.476  Sum_probs=145.6

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|++|.||+|. ..+++.+++|++......   .....+.+|+..+..++|+|++++++++...+..+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            478899999999999999994 456889999998653211   3456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|++++++|.+++...   ..+++.....++.|++.++.|+|+ .   +++|+||+|+||+++.++.++++|||.+....
T Consensus        78 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          78 LEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999998654   237888899999999999999999 8   99999999999999999999999999998776


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........++..|+|||.
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~  171 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPER  171 (264)
T ss_pred             cCCCcccceeecccccCHhh
Confidence            55444345578899999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=2.8e-26  Score=180.35  Aligned_cols=159  Identities=26%  Similarity=0.383  Sum_probs=128.7

Q ss_pred             ceeccccceeEEEEEcCC-------------CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           48 YCIGNGGHASVYRAELPS-------------REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~-------------~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      +.||+|+||.||+|....             ...+++|.+...    .......+.+|+.+++.++||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            368999999999996422             225788876532    222345678889999999999999999999998


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc-------E
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE-------A  187 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~-------~  187 (219)
                      ...++++||+.++++..++.....  .+++.....++.|++.|+.|+|+.   +++||||||+||+++.++.       +
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence            999999999999999888764322  367888899999999999999998   9999999999999987654       8


Q ss_pred             EEeeccceeeecCCCCcccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++|||++......    ....++..|+|||.
T Consensus       152 ~l~d~g~~~~~~~~----~~~~~~~~y~aPE~  179 (262)
T cd05077         152 KLSDPGIPITVLSR----QECVERIPWIAPEC  179 (262)
T ss_pred             EeCCCCCCccccCc----ccccccccccChhh
Confidence            99999998755332    23467889999994

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.2e-26  Score=181.36  Aligned_cols=172  Identities=26%  Similarity=0.414  Sum_probs=142.6

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCC--
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHAR--  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~--  115 (219)
                      +.++|++.+.||+|++|.||+|. ..+++.+++|.+....     .....+.+|+.+++.+ +|+|++++++++....  
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            56899999999999999999995 4567789999875421     1335678899999999 7999999999996544  


Q ss_pred             ----cceEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          116 ----HSFLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       116 ----~~~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                          ..++++|++.+++|.+++.... ....+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence                4899999999999999886422 113477888899999999999999998   99999999999999999999999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||++..............++..|+|||+
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEV  184 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhH
Confidence            99998876544444455678999999994

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.2e-26  Score=185.49  Aligned_cols=153  Identities=22%  Similarity=0.253  Sum_probs=131.0

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|++|.||+|. ..+++.+++|.+....... ......+.+|+.+++.++|+||+++++.+...+..+++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            468899999999999999994 4568899999986542221 12445678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|++.+++|.+++.... ...+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          80 MDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            99999999999986432 13478888889999999999999998   99999999999999999999999999887543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=2.7e-26  Score=184.17  Aligned_cols=171  Identities=26%  Similarity=0.331  Sum_probs=139.2

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||++ ...+++.+++|.+...... .......+.+|+.+++.++|+||+++++.+..++..+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            47899999999999999999 4567788999987543211 112335677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||++++++|.+++...+   .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||+++....
T Consensus        80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          80 MEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999986543   367788888899999999999998   999999999999999999999999998864211


Q ss_pred             CCC---------------cccccccccccccCCC
Q 039002          201 DAS---------------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~---------------~~~~~~gt~~y~aPE~  219 (219)
                      ...               ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  187 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV  187 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchh
Confidence            100               0112467888999994

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=2.3e-26  Score=184.51  Aligned_cols=176  Identities=22%  Similarity=0.330  Sum_probs=142.0

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      +....++|++.+.||+|+||.||+|..      .++..+|+|.++...   .......+.+|+.+++++ +|+||+++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            445567899999999999999999942      234579999876421   122345678899999999 7999999999


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV  189 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl  189 (219)
                      .+...+..++++||+.+++|.+++..... ..+++.+...++.+++.|+.|+|+.   +++|+||||+||+++.++.+++
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEE
Confidence            99999999999999999999999864322 2268889999999999999999998   9999999999999999999999


Q ss_pred             eeccceeeecCCCCc--ccccccccccccCCC
Q 039002          190 ADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       190 ~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +|||++.........  .....++..|+|||.
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  214 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPES  214 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhh
Confidence            999999866433211  122345678999994

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=1.7e-26  Score=183.11  Aligned_cols=176  Identities=23%  Similarity=0.420  Sum_probs=143.0

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEE
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCS  112 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~  112 (219)
                      .++..+.+.|++.+.||+|+||.||+| ...+++.+++|.+...     ......+..|+.+++++ +|+|++++++++.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            344456689999999999999999999 4567888999987432     12234567788888888 6999999999985


Q ss_pred             e------CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          113 H------ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       113 ~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                      .      .+..+++|||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence            3      4578999999999999998865322 2367777888999999999999998   9999999999999999999


Q ss_pred             EEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++|+|||++..............|++.|+|||.
T Consensus       160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (282)
T cd06636         160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV  192 (282)
T ss_pred             EEEeeCcchhhhhccccCCCcccccccccCHhh
Confidence            999999998766543333455689999999993

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.94  E-value=1e-27  Score=179.14  Aligned_cols=178  Identities=22%  Similarity=0.307  Sum_probs=146.6

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-  114 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  114 (219)
                      +.+...+|++.+.||+|+|+.|++++ ..++..+|+|++....    ....+..++|+++.++++|||++++++....+ 
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            34456889999999999999999994 6688899999986432    34567789999999999999999998877433 


Q ss_pred             ----CcceEEEEecCCCCHHHHhcccchh-hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039002          115 ----RHSFLLCEFLERGSLAAILNTDAAA-QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV  189 (219)
Q Consensus       115 ----~~~~lv~e~~~~~~l~~~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl  189 (219)
                          ...||++.|...|+|.+.+...... ..+++.+.+.++.+++.|+.++|+... +.+||||||.||+++.++.+++
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEE
Confidence                3489999999999999988653322 358899999999999999999999842 4899999999999999999999


Q ss_pred             eeccceeeecCCC---------CcccccccccccccCCC
Q 039002          190 ADFGIAKFLKSDA---------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       190 ~dfg~~~~~~~~~---------~~~~~~~gt~~y~aPE~  219 (219)
                      .|||.+.......         ..++...+|..|+|||.
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPEL  209 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPEL  209 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchh
Confidence            9999987654211         23455678999999993

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.94  E-value=2.4e-26  Score=186.23  Aligned_cols=168  Identities=18%  Similarity=0.225  Sum_probs=135.2

Q ss_pred             Ccceeccc--cceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           46 AKYCIGNG--GHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        46 ~~~~lg~g--~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      +...||+|  +|+.||++ ...+++.||+|.+......  ......+.+|+.+++.++||||+++++++..++..++++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  67899999 5678899999998643221  2234567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |++++++.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++++||+.+.......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          80 FMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             ccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999999999864321 2377888999999999999999998   99999999999999999999999998654332211


Q ss_pred             Cc-------ccccccccccccCCC
Q 039002          203 SN-------WTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~-------~~~~~gt~~y~aPE~  219 (219)
                      ..       .....++..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~  179 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEV  179 (327)
T ss_pred             ccccccccccccccceecccChHH
Confidence            10       112356778999994

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=3.1e-26  Score=182.72  Aligned_cols=172  Identities=21%  Similarity=0.300  Sum_probs=137.7

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCc---
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARH---  116 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~---  116 (219)
                      ++|++.+.||+|+||.||+|. ..+++.+|+|.+......  ......+.+|+.+++.+. |+|++++++++...+.   
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            478999999999999999994 567889999987653221  123346778999999995 6999999999877665   


Q ss_pred             --ceEEEEecCCCCHHHHhcccch--hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEee
Q 039002          117 --SFLLCEFLERGSLAAILNTDAA--AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVAD  191 (219)
Q Consensus       117 --~~lv~e~~~~~~l~~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~d  191 (219)
                        .++++||+.+ ++.+++.....  ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++. ++.++++|
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence              7999999975 78887754321  12368889999999999999999999   9999999999999998 88999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++..+...........+++.|+|||+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~  182 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEV  182 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHH
Confidence            9999866543332233467888999994

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.2e-26  Score=184.27  Aligned_cols=169  Identities=26%  Similarity=0.413  Sum_probs=141.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||++. ..+++.+|+|.+...   ........+.+|+.+++.++|+|++++++.+...+.+++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec---CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            3678899999999999999994 557888999987542   122345677899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||+++++|..++...+   .+++.....++.+++.++.|+|+..  +++|+||+|+||+++.++.++++|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999999999999886533   3678888899999999999999732  79999999999999999999999999986553


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .....|+..|+|||.
T Consensus       156 ~~~--~~~~~~~~~~~aPE~  173 (284)
T cd06620         156 NSI--ADTFVGTSTYMSPER  173 (284)
T ss_pred             hhc--cCccccCcccCCHHH
Confidence            322  234578999999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.3e-26  Score=179.83  Aligned_cols=167  Identities=24%  Similarity=0.408  Sum_probs=140.7

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++.+.||+|++|.||+|... ++.+++|.+....     .....+.+|+.+++.++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            4578999999999999999999654 6789999986432     134668889999999999999999999998899999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++++++|.+++..... ..+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence            9999999999999865331 2378889999999999999999999   99999999999999999999999999998663


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...   .....+..|+|||+
T Consensus       154 ~~~---~~~~~~~~~~ape~  170 (256)
T cd05039         154 QGQ---DSGKLPVKWTAPEA  170 (256)
T ss_pred             ccc---ccCCCcccccCchh
Confidence            322   12244567999984

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=4e-26  Score=178.35  Aligned_cols=170  Identities=25%  Similarity=0.358  Sum_probs=141.4

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCC-chhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSD-QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +|+..+.||+|++|.||+|. ..++..+++|.+....... .......+.+|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47788999999999999995 4478899999875422111 122345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+++++|.+++....   .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999986543   267788888999999999999998   999999999999999999999999999876644


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .. ......++..|+|||.
T Consensus       155 ~~-~~~~~~~~~~y~~pe~  172 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEV  172 (258)
T ss_pred             cc-cccccCCCcceeCHHH
Confidence            33 2344578899999983

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=195.64  Aligned_cols=172  Identities=23%  Similarity=0.314  Sum_probs=143.1

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc----hhhHHHHHHHHHHHhcCC---CCccceeEeEE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ----TVDQKEFLTEVKALTETR---HRNIVKFYGFC  111 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~----~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~  111 (219)
                      ...+|...+.+|.|+||+|+.| .......|++|.+.+....-+    ......+..|+++|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3456899999999999999999 445566799998865432211    112233567999999997   99999999999


Q ss_pred             EeCCcceEEEEec-CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          112 SHARHSFLLCEFL-ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       112 ~~~~~~~lv~e~~-~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                      ++++.+||+||-. ++.+|.+++....   .+.+.....|+.|++.|+.+||++   +|+|||||-+|+.++.+|-+|++
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            9999999999976 4568899987654   378888999999999999999999   99999999999999999999999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||.+...++.  ....++||..|.|||.
T Consensus       713 dfgsaa~~ksg--pfd~f~gtv~~aapev  739 (772)
T KOG1152|consen  713 DFGSAAYTKSG--PFDVFVGTVDYAAPEV  739 (772)
T ss_pred             eccchhhhcCC--Ccceeeeeccccchhh
Confidence            99998755433  3577899999999995

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=3.2e-26  Score=183.07  Aligned_cols=172  Identities=23%  Similarity=0.375  Sum_probs=135.3

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.. .++.  .+++|.++..   ........+.+|+.+++++ +||||+++++++...+.
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            36899999999999999999954 3443  4688876531   1222345678899999999 79999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccc-------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          117 SFLLCEFLERGSLAAILNTDA-------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      .++++||+++++|.+++....             ....+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~  154 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGE  154 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECC
Confidence            999999999999999986432             112367788899999999999999998   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++|+|||++......... .....+..|+|||+
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~  189 (297)
T cd05089         155 NLASKIADFGLSRGEEVYVKK-TMGRLPVRWMAIES  189 (297)
T ss_pred             CCeEEECCcCCCccccceecc-CCCCcCccccCchh
Confidence            999999999998643221111 11233557999994

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=2.7e-26  Score=180.05  Aligned_cols=170  Identities=22%  Similarity=0.399  Sum_probs=137.3

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++...||+|++|.||+|....+..+++|.+...     ......+.+|+.+++.++|+|++++++++. .+..++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-----TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-----CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            34678999999999999999997666667999987532     123356778999999999999999998875 456899


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            9999999999999865321 2367888899999999999999998   99999999999999999999999999997664


Q ss_pred             CCCC-cccccccccccccCCC
Q 039002          200 SDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      .... ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~  174 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEA  174 (260)
T ss_pred             CCcccccCCCccchhhCCHHH
Confidence            3221 1122345678999984

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=3.1e-26  Score=183.04  Aligned_cols=172  Identities=22%  Similarity=0.386  Sum_probs=137.1

Q ss_pred             hCCCCCcceeccccceeEEEEEcC-----------------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP-----------------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN  103 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~-----------------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n  103 (219)
                      .++|++.+.||+|+||.||++...                 ++..+|+|.+....   .......+.+|+.+++.++|+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCC
Confidence            467999999999999999998422                 23468899876421   2223456788999999999999


Q ss_pred             cceeEeEEEeCCcceEEEEecCCCCHHHHhcccch--------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA--------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       104 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                      |+++++++...+..+++||++.+++|..++.....        ...+++.++..++.|++.|+.|+|+.   +++|+|||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            99999999999999999999999999999865321        11256678899999999999999999   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALG  218 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE  218 (219)
                      |+||+++.++.++++|||++..+.....  ......+++.|+|||
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence            9999999999999999999876533221  112224457789997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.8e-26  Score=180.34  Aligned_cols=170  Identities=24%  Similarity=0.450  Sum_probs=137.7

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCc----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|.. .++.    .+++|......   .......+.+|+.+++.++|+|++++++++.. .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            46789999999999999999953 3333    58888875432   12344567889999999999999999999887 7


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++.+++|.+++.....  .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence            89999999999999999875432  377888999999999999999998   9999999999999999999999999999


Q ss_pred             eeecCCCCcccc--cccccccccCCC
Q 039002          196 KFLKSDASNWTE--FAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~--~~gt~~y~aPE~  219 (219)
                      ............  ..++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALES  182 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHH
Confidence            876543322111  123567999984

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=4.5e-26  Score=178.74  Aligned_cols=169  Identities=30%  Similarity=0.454  Sum_probs=142.4

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||+|. ..++..+++|.++.....  ......+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            58889999999999999994 557889999998654322  234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+++++|.+++....   .+++.....++.+++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          79 EYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             ecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999999986542   266778888999999999999998   9999999999999999999999999998876543


Q ss_pred             CCcc----cccccccccccCCC
Q 039002          202 ASNW----TEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~----~~~~gt~~y~aPE~  219 (219)
                      ....    ....+++.|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~  174 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEV  174 (264)
T ss_pred             CCcccccccCCcCCcCccChhh
Confidence            3221    13467889999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=5.1e-26  Score=180.41  Aligned_cols=170  Identities=22%  Similarity=0.375  Sum_probs=134.2

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCc----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|.+ .++.    .+++|.+...   ........+..|+..++.++|+||+++++++. ..
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence            36788999999999999999954 4444    4777776432   11123345667888889999999999999875 45


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++++++|.+++....  ..+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence            6789999999999999986533  2377888899999999999999998   9999999999999999999999999999


Q ss_pred             eeecCCCC--cccccccccccccCCC
Q 039002          196 KFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +.......  ......++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~  182 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALES  182 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHH
Confidence            86543221  1123456778999984

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=3.4e-26  Score=183.89  Aligned_cols=172  Identities=31%  Similarity=0.378  Sum_probs=139.3

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Cc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RH  116 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~  116 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|.+.......  .......+|+.+++.++|+|++++++++...  +.
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            4678999999999999999999 45678899999986432211  1223456799999999999999999998654  56


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++. +++.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceee
Confidence            899999996 47887776432  2378888999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............+++.|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~  179 (309)
T cd07845         157 TYGLPAKPMTPKVVTLWYRAPEL  179 (309)
T ss_pred             ecCCccCCCCcccccccccChhh
Confidence            77544333233356788999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=9e-27  Score=182.39  Aligned_cols=169  Identities=27%  Similarity=0.384  Sum_probs=142.6

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|+||.||+|. ..+++.+++|.+....... ......+.+|+.+++.++|||++++++.+..+...++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            58899999999999999995 4578899999886432221 123467788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.+++|..++....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        80 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          80 DLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             eCCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999999987542   377888899999999999999998   9999999999999999999999999998765443


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      . ......|+..|+|||+
T Consensus       154 ~-~~~~~~~~~~y~~PE~  170 (258)
T cd05578         154 T-LTTSTSGTPGYMAPEV  170 (258)
T ss_pred             c-cccccCCChhhcCHHH
Confidence            2 2244578889999984

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-28  Score=200.18  Aligned_cols=176  Identities=28%  Similarity=0.336  Sum_probs=150.0

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEcCCCc-EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAELPSRE-VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~-~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .....+.+++.+..||-|+||.|-++...... .+|+|.+++.-.-+ ....+++..|-.+|...+.++|+++|..|.+.
T Consensus       414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            33455678888999999999999999655433 47888876533233 23456788899999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ..+|+.||.|-||.++..+...+.   +...+...++..+++|+.|||+.   +|++|||||+|++++.+|-+|+.|||+
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGF  566 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGF  566 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhh
Confidence            999999999999999999976543   67788889999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |+.+.+..+ ..++||||.|.||||
T Consensus       567 AKki~~g~K-TwTFcGTpEYVAPEI  590 (732)
T KOG0614|consen  567 AKKIGSGRK-TWTFCGTPEYVAPEI  590 (732)
T ss_pred             HHHhccCCc-eeeecCCcccccchh
Confidence            998877654 467999999999997

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.5e-26  Score=178.64  Aligned_cols=172  Identities=23%  Similarity=0.381  Sum_probs=139.6

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCC-CchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Ccc
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPS-DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  117 (219)
                      .+|++.+.||+|++|.||+| ...++..+++|.+...... ........+.+|+.+++.++|+|++++++.+.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999 4567889999987432111 1122345678899999999999999999998664  458


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++++++|.+.+....   .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999886533   267788889999999999999998   999999999999999999999999999986


Q ss_pred             ecCCC---CcccccccccccccCCC
Q 039002          198 LKSDA---SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~---~~~~~~~gt~~y~aPE~  219 (219)
                      .....   .......++..|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~  180 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEV  180 (264)
T ss_pred             cccccccCccccccCCcccccCHhh
Confidence            54321   11234578899999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=8e-26  Score=176.15  Aligned_cols=169  Identities=26%  Similarity=0.415  Sum_probs=145.3

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|.+|.||+| ...+++.+++|.+......  ......+.+|+.++++++|+|++++++++.+.+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            5788999999999999999 4557788999998754322  234467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.+++|.+++....   .+++..+..++.|++.++.++|+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          79 EYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             ecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999999986542   378888999999999999999998   9999999999999999999999999999877655


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........++..|+|||.
T Consensus       153 ~~~~~~~~~~~~y~~pe~  170 (254)
T cd06627         153 SKDDASVVGTPYWMAPEV  170 (254)
T ss_pred             cccccccccchhhcCHhh
Confidence            443345678999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=5.5e-26  Score=180.01  Aligned_cols=170  Identities=22%  Similarity=0.423  Sum_probs=136.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCc----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ..+|++.+.||+|+||.||+|. ..++.    .||+|.+...   ........+.+|+..++.++|+|++++++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            4678999999999999999995 44554    4789987542   222334567889999999999999999999875 4


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++++|++.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence            5789999999999999986532  2377888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcc--cccccccccccCCC
Q 039002          196 KFLKSDASNW--TEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~--~~~~gt~~y~aPE~  219 (219)
                      +.........  ....+++.|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALES  182 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHH
Confidence            8775433221  11234577999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=4.1e-26  Score=178.74  Aligned_cols=172  Identities=23%  Similarity=0.393  Sum_probs=141.1

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CCcceE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHSFL  119 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l  119 (219)
                      +|++.+.||.|+||.||++ ...++..+++|.+.....  .......+..|+.+++.++|+|++++++.+..  +...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            5888999999999999999 456788899998754322  22334567889999999999999999998754  456789


Q ss_pred             EEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhh-----hCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          120 LCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLH-----HDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh-----~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      ++||+++++|.+++.... ....+++..+..++.+++.|+.++|     +.   +++|+||+|+||+++.++.++++|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence            999999999999986531 1234778889999999999999999     66   89999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++..............+++.|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~  181 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQ  181 (265)
T ss_pred             ccccccCCcccccccccCCCccChhh
Confidence            99877554432344578999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=4.7e-26  Score=181.72  Aligned_cols=171  Identities=23%  Similarity=0.353  Sum_probs=137.6

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|.+|.||+|. ..+++.+++|.+......  ......+.+|+.+++.++|+|++++++++...+..+++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc--ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            679999999999999999995 457889999988643211  12335677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~  199 (219)
                      +||+. +++...+..... ...++..+..++.|++.|+.|||+.   +++|+||+|+||+++. ++.++++|||++....
T Consensus        80 ~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             Eeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            99995 577777754322 2246677788999999999999998   9999999999999985 4679999999997654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~  174 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEI  174 (294)
T ss_pred             CCccccccCceeecccCHHH
Confidence            43333334467889999983

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=6.4e-26  Score=178.68  Aligned_cols=171  Identities=24%  Similarity=0.397  Sum_probs=135.4

Q ss_pred             CCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc---
Q 039002           44 FDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH---  116 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---  116 (219)
                      |.+.+.||+|+||.||+|...    .+..+|+|.++.....  ......+.+|+..++.++|+|++++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            567889999999999999532    2467999998653222  2334567889999999999999999998865543   


Q ss_pred             ---ceEEEEecCCCCHHHHhcccc---hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          117 ---SFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       117 ---~~lv~e~~~~~~l~~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                         .++++||+.+++|..++....   ....+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence               789999999999998874321   123478888899999999999999998   99999999999999999999999


Q ss_pred             eccceeeecCCCCc--ccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      |||+++........  .....++..|+|||+
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  186 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIES  186 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhh
Confidence            99999876543221  122245677999984

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.94  E-value=1.6e-26  Score=181.41  Aligned_cols=167  Identities=35%  Similarity=0.566  Sum_probs=132.5

Q ss_pred             CcceeccccceeEEEEEcC-----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           46 AKYCIGNGGHASVYRAELP-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +.+.||.|.||.||+|.+.     .+..|+||.++..   ........+.+|+..+++++||||+++++++...+..+++
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccccccccc
Confidence            4678999999999999544     3557999998542   2223357788999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+++|+|.+++.... ...+++..+..++.|++.|+.|||+.   +++|++|+++||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999999997641 13478889999999999999999998   999999999999999999999999999987632


Q ss_pred             CCC--cccccccccccccCCC
Q 039002          201 DAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ...  ..........|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~  176 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEV  176 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHH
T ss_pred             ccccccccccccccccccccc
Confidence            211  1122356788999983

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=9.6e-28  Score=211.89  Aligned_cols=171  Identities=31%  Similarity=0.450  Sum_probs=144.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +-+++-...||.|.||.||.| ...+|+..|+|.++.....  ......+.+|..++..++|||++++||+-.+.+.++|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            344666788999999999999 7789999999988653222  2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      .||||.+|+|.+++...+.   .++.....+..|++.|+.|||..   +|+|||+||.||+++..|.+|.+|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999976543   44454556678999999999999   99999999999999999999999999998876


Q ss_pred             CCC----CcccccccccccccCCC
Q 039002          200 SDA----SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~----~~~~~~~gt~~y~aPE~  219 (219)
                      .+.    ...+...||+-|||||+
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEv 1409 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEV 1409 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchh
Confidence            543    23466799999999995

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=1.3e-26  Score=181.94  Aligned_cols=168  Identities=27%  Similarity=0.411  Sum_probs=142.1

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|+..+.||+|++|.||+| ...+++.+++|.+.....   ......+.+|+..++.++|+|++++++.+...+..+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC---hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            46888999999999999999 455788899998865321   23446678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|++.+++|.+++....  ..+++.....++.|++.|+.|+|+ .   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999999986532  236788888999999999999999 7   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....  ....++..|+|||+
T Consensus       153 ~~~~--~~~~~~~~y~~PE~  170 (265)
T cd06605         153 NSLA--KTFVGTSSYMAPER  170 (265)
T ss_pred             HHHh--hcccCChhccCHHH
Confidence            3322  12678899999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=3.1e-26  Score=184.56  Aligned_cols=177  Identities=21%  Similarity=0.356  Sum_probs=139.5

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcC--------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCcccee
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELP--------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKF  107 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~--------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  107 (219)
                      +..+.++|.+.+.||+|+||.||+|...        ....+|+|.++...   .......+.+|+.+++.+ +|+||+++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            4455678999999999999999999421        23468899876421   122345677899999999 69999999


Q ss_pred             EeEEEeCCcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC
Q 039002          108 YGFCSHARHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV  174 (219)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  174 (219)
                      ++++...+..++++||+++++|.+++.....             ...+++.....++.|++.|+.|+|+.   +++|+||
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dl  160 (314)
T cd05099          84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDL  160 (314)
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence            9999988999999999999999999864221             12367888889999999999999998   9999999


Q ss_pred             CCCCEEeCCCCcEEEeeccceeeecCCCCcc--cccccccccccCCC
Q 039002          175 SSKNLLLDLEYEAHVADFGIAKFLKSDASNW--TEFAGTYGYVALGI  219 (219)
Q Consensus       175 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~  219 (219)
                      ||+||+++.++.++++|||+++.........  ....++..|+|||.
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  207 (314)
T cd05099         161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEA  207 (314)
T ss_pred             cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHH
Confidence            9999999999999999999997654322111  11234467999983

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=1.8e-26  Score=183.15  Aligned_cols=172  Identities=16%  Similarity=0.257  Sum_probs=137.1

Q ss_pred             CCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           42 NDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .+|++.+.||+|+||.||+|...      ++..+|+|.+....   .......+.+|+.+++.++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            45788899999999999999532      34679999986421   2223456778999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccc-------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          116 HSFLLCEFLERGSLAAILNTDA-------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      ..++++|++.++++..++....             ....+++..+..++.|++.|+.|+|+.   +++||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence            9999999999999999884211             012366777888999999999999998   999999999999999


Q ss_pred             CCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          183 LEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      .++.++++|||+++.......  ......+++.|+|||.
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA  197 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHH
Confidence            999999999999876533221  1123356788999984

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=3.9e-26  Score=181.70  Aligned_cols=174  Identities=26%  Similarity=0.418  Sum_probs=139.4

Q ss_pred             HhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ..++|++...||+|+||.||+|...      ++..+++|.+....   .......+.+|+.++++++|+|++++++++..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            3578999999999999999999532      46689999876421   22234567889999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccc-------------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDA-------------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV  174 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  174 (219)
                      ++..++++|++++++|.+++....                   ....+++..+..++.|++.|+.|+|+.   +++|+||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl  156 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDL  156 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence            999999999999999999986321                   112356778889999999999999998   9999999


Q ss_pred             CCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          175 SSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       175 kp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ||+||+++.++.++++|||++........  ......+++.|+|||.
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES  203 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHH
Confidence            99999999999999999999876533211  1122345677999983

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=4.6e-26  Score=180.59  Aligned_cols=171  Identities=23%  Similarity=0.378  Sum_probs=135.5

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHH-HHhcCCCCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK-ALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|.+......   .....+..|+. .++..+|+|++++++++...+..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            47899999999999999999 5567899999998653221   12234455555 4667789999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++||+. +++.+++.... ....+++..+..++.|++.|+.|+|++.  +++|+||||+||+++.++.++|+|||++..+
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999996 67877765321 1234788899999999999999999853  7999999999999999999999999998865


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... .....++..|+|||.
T Consensus       155 ~~~~~-~~~~~~~~~y~aPE~  174 (283)
T cd06617         155 VDSVA-KTIDAGCKPYMAPER  174 (283)
T ss_pred             ccccc-cccccCCccccChhh
Confidence            43321 123468899999994

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=5.6e-26  Score=179.01  Aligned_cols=171  Identities=26%  Similarity=0.467  Sum_probs=137.9

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCC---cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~---~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.. .++   ..+++|.+....   .......+..|+.+++.++|||++++++++..++.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            35688999999999999999954 333   369999876421   23344678899999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++.+++|.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          80 VMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence            999999999999999886532  2367888899999999999999998   99999999999999999999999999987


Q ss_pred             eecCCCCcc--cccc---cccccccCCC
Q 039002          197 FLKSDASNW--TEFA---GTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~--~~~~---gt~~y~aPE~  219 (219)
                      .........  ....   .+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEA  182 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhH
Confidence            654332211  1111   1356999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=4.1e-26  Score=183.58  Aligned_cols=172  Identities=23%  Similarity=0.349  Sum_probs=137.1

Q ss_pred             CCCCcceeccccceeEEEEEc-C--CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Ccc
Q 039002           43 DFDAKYCIGNGGHASVYRAEL-P--SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHS  117 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~-~--~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  117 (219)
                      +|++.+.||+|++|.||+|.. .  ++..+|+|.+...... .......+.+|+.+++.++|||++++++++...  +..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            478899999999999999954 4  5789999998753211 122335567899999999999999999999888  789


Q ss_pred             eEEEEecCCCCHHHHhcccch--hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC----CCcEEEee
Q 039002          118 FLLCEFLERGSLAAILNTDAA--AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL----EYEAHVAD  191 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~----~~~~kl~d  191 (219)
                      ++++|++.+ ++.+++.....  ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.    ++.++++|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            999999964 66666543211  12367788889999999999999998   9999999999999999    89999999


Q ss_pred             ccceeeecCCCC---cccccccccccccCCC
Q 039002          192 FGIAKFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      ||++..+.....   ......+++.|+|||.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPEL  186 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHH
Confidence            999887644322   1234577899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=7.6e-26  Score=180.22  Aligned_cols=171  Identities=22%  Similarity=0.397  Sum_probs=136.0

Q ss_pred             CCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           43 DFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      +|++.+.||+|+||.||+|...      ....+++|.+....   .......+.+|+.+++.++||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            5788999999999999999431      23468888875422   12234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccc---------------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          117 SFLLCEFLERGSLAAILNTDA---------------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                      .++++||+.+++|.+++....                     ....+++.++..++.|++.|+.|||+.   +++|+|||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik  154 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA  154 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence            999999999999999875321                     012366788899999999999999998   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++.++|+|||++........  ......++..|+|||.
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~  200 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIES  200 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHH
Confidence            9999999999999999999876533221  1122345678999983

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.94  E-value=6e-27  Score=192.97  Aligned_cols=172  Identities=26%  Similarity=0.408  Sum_probs=143.9

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +.+...+.++||+|.||.|.++....+..||+|+++...   .......|.+|+.+|.+++||||++++++|..++.+++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            445667889999999999999988888999999998642   33345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||++.|+|.+++..+-.+. ..-..-..++.||+.|+.||.+.   +++|||+.++|+|++.++.+||+|||.++.+-
T Consensus       613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999998753322 33345567999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc--ccccccccccccCC
Q 039002          200 SDASN--WTEFAGTYGYVALG  218 (219)
Q Consensus       200 ~~~~~--~~~~~gt~~y~aPE  218 (219)
                      +....  ....+-...|||||
T Consensus       689 sg~yy~vqgr~vlpiRwmawE  709 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWE  709 (807)
T ss_pred             cCCceeeecceeeeeeehhHH
Confidence            33221  12245678899998

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=6.5e-26  Score=179.83  Aligned_cols=172  Identities=24%  Similarity=0.443  Sum_probs=138.7

Q ss_pred             hCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      ..+|+...+||+|+||.||++..      .++..+++|.+...    .......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            35788899999999999999942      24557888886532    223445688899999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccch------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      +..++++|++++++|.+++.....            ...+++.++..++.|++.|+.|+|+.   +++|+||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            999999999999999999865321            12367888899999999999999998   999999999999999


Q ss_pred             CCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          183 LEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      .++.++|+|||++........  ......+++.|+|||.
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES  195 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHH
Confidence            999999999999876543211  1122345678999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=3.2e-26  Score=179.11  Aligned_cols=166  Identities=25%  Similarity=0.398  Sum_probs=136.4

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE-eCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS-HARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~  118 (219)
                      ...+|++.+.||+|+||.||++... +..+++|.+...      .....+.+|+.+++.++|+|++++++++. .++..+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            4568999999999999999999654 667899987532      12346788999999999999999999764 556789


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++|++++++|.+++..... ..+++.....++.|++.|+.|+|++   +++|+||||+||+++.++.++++|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence            99999999999999865332 2367888899999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....   ....++..|+|||+
T Consensus       153 ~~~~---~~~~~~~~y~aPE~  170 (256)
T cd05082         153 SSTQ---DTGKLPVKWTAPEA  170 (256)
T ss_pred             cccC---CCCccceeecCHHH
Confidence            4332   22345678999984

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=6.2e-26  Score=180.07  Aligned_cols=168  Identities=25%  Similarity=0.405  Sum_probs=135.0

Q ss_pred             CCC-CCcceeccccceeEEEEE-----cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-
Q 039002           42 NDF-DAKYCIGNGGHASVYRAE-----LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-  114 (219)
Q Consensus        42 ~~y-~~~~~lg~g~~g~V~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  114 (219)
                      ++| ++.+.||+|+||.||++.     ..++..+|+|.+....   .......+.+|+.+++.++|+|++++++++... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345 889999999999998763     2467789999886432   112345677899999999999999999987653 


Q ss_pred             -CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          115 -RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       115 -~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                       ...+++||++.+++|.+++...    .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence             4578999999999999998643    378899999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecCCCCcc---cccccccccccCCC
Q 039002          194 IAKFLKSDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      ++..........   ....++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~  181 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVEC  181 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhH
Confidence            988665332211   12245667899984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.94  E-value=6.1e-26  Score=179.25  Aligned_cols=173  Identities=20%  Similarity=0.358  Sum_probs=139.9

Q ss_pred             hCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++|++...||+|+||.||+|...      +...+++|.+...   ........+.+|+.++++++|+|++++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            367899999999999999999542      3456888876432   1222345688899999999999999999999988


Q ss_pred             CcceEEEEecCCCCHHHHhcccchh------hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEE
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAA------QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~k  188 (219)
                      +..+++||++++++|.+++......      ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEE
Confidence            8999999999999999998654311      1378889999999999999999998   999999999999999999999


Q ss_pred             EeeccceeeecCCC-CcccccccccccccCCC
Q 039002          189 VADFGIAKFLKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ++|||++....... .......+++.|+|||.
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  189 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA  189 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhh
Confidence            99999986543221 12233466788999983

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=4.6e-26  Score=180.29  Aligned_cols=158  Identities=22%  Similarity=0.344  Sum_probs=126.1

Q ss_pred             eeccccceeEEEEEcC-------------------------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc
Q 039002           49 CIGNGGHASVYRAELP-------------------------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN  103 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~~-------------------------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n  103 (219)
                      .||+|+||.||+|...                         ....+++|.+...    .......+.+|+.+++.++|+|
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence            6999999999998531                         1124788876431    1223356778899999999999


Q ss_pred             cceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       104 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      |+++++++...+..++||||+++++|..++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~  152 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR  152 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence            9999999999999999999999999999886432  2367888899999999999999998   9999999999999975


Q ss_pred             CC-------cEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EY-------EAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~-------~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+       .++++|||++......    ....++..|+|||.
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~  191 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPEC  191 (274)
T ss_pred             cCcccCccceeeecCCccccccccc----cccccCCcccCchh
Confidence            43       4799999987644322    22367888999994

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=9.5e-26  Score=176.81  Aligned_cols=162  Identities=24%  Similarity=0.378  Sum_probs=129.1

Q ss_pred             eeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           49 CIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .||+|+||.||+|.+.   ++..+|+|.+....   .......+.+|+.++++++|+||+++++++. .+..+++|||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            4899999999999432   44568999876431   2234456889999999999999999999875 457899999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|.+++....  ..+++..+..++.|++.|+.|+|++   +++|+||||+||+++.++.++++|||++..........
T Consensus        78 ~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          78 GGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999999886432  2378899999999999999999998   99999999999999999999999999987654332211


Q ss_pred             ---cccccccccccCCC
Q 039002          206 ---TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ---~~~~gt~~y~aPE~  219 (219)
                         ....++..|+|||.
T Consensus       153 ~~~~~~~~~~~y~aPE~  169 (257)
T cd05115         153 KARSAGKWPLKWYAPEC  169 (257)
T ss_pred             eccCCCCCCcccCCHHH
Confidence               11123567999983

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=6.6e-26  Score=182.61  Aligned_cols=162  Identities=23%  Similarity=0.351  Sum_probs=127.4

Q ss_pred             ceeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CCcceEEEE
Q 039002           48 YCIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHSFLLCE  122 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e  122 (219)
                      .+||+|+||.||+|...   ++..+|+|.+....      ....+.+|+.+++.++|+|++++++++..  ....++++|
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            57999999999999643   45679999875421      22346789999999999999999998854  456889999


Q ss_pred             ecCCCCHHHHhcccc------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe----CCCCcEEEeec
Q 039002          123 FLERGSLAAILNTDA------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL----DLEYEAHVADF  192 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili----~~~~~~kl~df  192 (219)
                      |+. +++.+++....      ....+++..+..++.|++.|+.|||+.   +++||||||+||++    +..+.++|+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            986 47777664211      112367788889999999999999998   99999999999999    45679999999


Q ss_pred             cceeeecCCCC---cccccccccccccCCC
Q 039002          193 GIAKFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      |+++.......   ......+|+.|+|||+
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~  186 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPEL  186 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHH
Confidence            99987654332   2234578999999994

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=6.9e-26  Score=178.69  Aligned_cols=171  Identities=26%  Similarity=0.381  Sum_probs=139.6

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc------hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ------TVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      +|.+.+.||+|++|.||+| ...+++.+|+|.+..+.....      ....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999 456788999998754221111      111245678999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++.+++|.+++...+   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999986542   377788888999999999999998   9999999999999999999999999998


Q ss_pred             eeecCCCC--cccccccccccccCCC
Q 039002          196 KFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ........  ......++..|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~  181 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEV  181 (272)
T ss_pred             ccccccccccccccccCCccccCHHH
Confidence            76543211  1233468889999983

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=3.1e-26  Score=193.99  Aligned_cols=167  Identities=17%  Similarity=0.234  Sum_probs=129.4

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC------CccceeEeE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH------RNIVKFYGF  110 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~  110 (219)
                      ....++|++.+.||+|+||.||+| ...+++.||+|+++...     ........|+.+++.++|      .+++.++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            334678999999999999999999 45678889999985321     122334456666666644      458888888


Q ss_pred             EEeC-CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCC---
Q 039002          111 CSHA-RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEY---  185 (219)
Q Consensus       111 ~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~---  185 (219)
                      +... +.+++++|++ ++++.+++...+   .+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++   
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence            8765 5788999988 678888876543   37788889999999999999997 5   899999999999998765   


Q ss_pred             -------------cEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          186 -------------EAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       186 -------------~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                                   .+||+|||.+.....   .....+||+.|+|||+
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~  316 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEV  316 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHH
Confidence                         499999998754322   2245689999999995

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-27  Score=184.20  Aligned_cols=176  Identities=24%  Similarity=0.307  Sum_probs=154.0

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHA  114 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  114 (219)
                      +.-.+++|.++..||+|+|.+|.+++ .++.+.+|+|.+++....++. +....+.|-.+.... +||+++-++.+|++.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde-didwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE-DIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc-cchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            34557889999999999999999995 457788999999887666543 445566777766665 799999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ..+|.|.||.++|+|.-.+..++   ++++..+..+...|..|+.|||.+   +|+.||||.+|++++..|.+|++|+|.
T Consensus       324 srlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccch
Confidence            99999999999999988887653   488899999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.-..+....++++|||-|+||||
T Consensus       398 cke~l~~gd~tstfcgtpnyiapei  422 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEI  422 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhh
Confidence            9987777777788999999999996

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=4.2e-27  Score=206.84  Aligned_cols=174  Identities=27%  Similarity=0.429  Sum_probs=138.9

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe---
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH---  113 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---  113 (219)
                      .-+..+|+.+..||+|+||.||++ +.-+|..||||++....   .......+.+|+.++.+++|||+++||..|..   
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            456788999999999999999999 55699999999997643   23345678899999999999999999987721   


Q ss_pred             --------------------------------------------------------------------------------
Q 039002          114 --------------------------------------------------------------------------------  113 (219)
Q Consensus       114 --------------------------------------------------------------------------------  113 (219)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHH
Q 039002          114 ----------------------------A--------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA  157 (219)
Q Consensus       114 ----------------------------~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~  157 (219)
                                                  .        ..+||-||||+...+.+++..+....  .-...+.++.+|++|
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEG  709 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHH
Confidence                                        0        12467788888877777776543211  245678899999999


Q ss_pred             HHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec------------------CCCCcccccccccccccCCC
Q 039002          158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK------------------SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       158 l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~------------------~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.|+|++   +||||||||.||+++.++.+||+|||+|....                  ......+..+||..|+|||.
T Consensus       710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999999   99999999999999999999999999998722                  00112356799999999994

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=2.1e-26  Score=196.30  Aligned_cols=176  Identities=18%  Similarity=0.263  Sum_probs=130.3

Q ss_pred             HhCCCCCcceeccccceeEEEEEcC--CCcEEEEEecCCC-------------CCCCchhhHHHHHHHHHHHhcCCCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELP--SREVVAVKKFHSP-------------LPSDQTVDQKEFLTEVKALTETRHRNI  104 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~--~~~~~aik~~~~~-------------~~~~~~~~~~~~~~e~~~l~~l~h~ni  104 (219)
                      ..++|++.+.||+|+||.||+|..+  .+...+.|.+...             ...........+.+|+.+++.++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998432  2222222211000             000111233456789999999999999


Q ss_pred             ceeEeEEEeCCcceEEEEecCCCCHHHHhcccch--hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA--AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       105 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      +++++++...+..|++++++. +++..++.....  ...........++.|++.||.|||+.   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 567666643211  11123455678899999999999998   999999999999999


Q ss_pred             CCCcEEEeeccceeeecCCCCc-ccccccccccccCCC
Q 039002          183 LEYEAHVADFGIAKFLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      .++.+||+|||++..+...... ....+||+.|+|||+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~  339 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEI  339 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchh
Confidence            9999999999999877544322 234579999999995

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=5e-27  Score=195.16  Aligned_cols=153  Identities=18%  Similarity=0.268  Sum_probs=128.7

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...+-|..++.||-|+||.|.++ +..+...+|+|.+.+...... ....+...|-.+|...+++.++++|..|++++.+
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~r-nQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMR-NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhh-hhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            33444777889999999999999 566777899998754221111 1224456788999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+||+|++||++..++-..+.   +++..+.+++.++.+|+++.|..   |+|||||||+|||||.+|.+||+|||+|.-
T Consensus       705 YFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccc
Confidence            999999999999998866443   67788889999999999999999   999999999999999999999999999875


Q ss_pred             e
Q 039002          198 L  198 (219)
Q Consensus       198 ~  198 (219)
                      +
T Consensus       779 f  779 (1034)
T KOG0608|consen  779 F  779 (1034)
T ss_pred             c
Confidence            4

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.7e-27  Score=206.46  Aligned_cols=172  Identities=24%  Similarity=0.389  Sum_probs=139.3

Q ss_pred             CCCCCcceeccccceeEEEEEcC--CC----cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           42 NDFDAKYCIGNGGHASVYRAELP--SR----EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~--~~----~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ..-.....||+|.||.||.|...  .+    ..||+|.++..   .+.+....|.+|..+|++++||||+++.|++.+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            34456788999999999999532  23    34999988652   23456678999999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccch----hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          116 HSFLLCEFLERGSLAAILNTDAA----AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                      ..+|++||+.+|+|..++...++    ...+.....+.++.+|+.|+.||+++   +.+||||..+|+|++....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999976421    23477889999999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCCC-ccccc-ccccccccCCC
Q 039002          192 FGIAKFLKSDAS-NWTEF-AGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~-~~~~~-~gt~~y~aPE~  219 (219)
                      ||+|+.+....- ..... .-...|||||+
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEs  875 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPES  875 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHH
Confidence            999994432211 11111 23467999994

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.94  E-value=5.4e-26  Score=184.73  Aligned_cols=173  Identities=23%  Similarity=0.368  Sum_probs=137.0

Q ss_pred             hCCCCCcceeccccceeEEEEEc-C-------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-P-------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFC  111 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~-------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~  111 (219)
                      ..+|++.+.||+|+||.||+|.. .       ....+|+|.+...   ........+.+|+.+++++ +|+||+++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            45789999999999999999942 1       1236899987632   1222345678899999999 799999999999


Q ss_pred             EeCCcceEEEEecCCCCHHHHhcccc-------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCC
Q 039002          112 SHARHSFLLCEFLERGSLAAILNTDA-------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN  178 (219)
Q Consensus       112 ~~~~~~~lv~e~~~~~~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~n  178 (219)
                      ...+..++++||+++++|.+++....             ....+++..+..++.|++.|+.|||+.   +++|+||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            99899999999999999999986421             112366788888999999999999998   99999999999


Q ss_pred             EEeCCCCcEEEeeccceeeecCCCCcc--cccccccccccCCC
Q 039002          179 LLLDLEYEAHVADFGIAKFLKSDASNW--TEFAGTYGYVALGI  219 (219)
Q Consensus       179 ili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~  219 (219)
                      |+++.++.++|+|||+++.........  ....++..|+|||+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  207 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEA  207 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHH
Confidence            999999999999999998664332111  11233567999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=4.2e-26  Score=178.26  Aligned_cols=165  Identities=25%  Similarity=0.418  Sum_probs=135.9

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++.+.||+|+||.||+|.. +++.+++|.+...      .....+.+|+.+++.++|+|++++++++... ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            456799999999999999999964 5668999987532      1235678899999999999999999998664 4799


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||+.+++|.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++....
T Consensus        76 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             EEECCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecc
Confidence            9999999999999865432 2367888899999999999999998   99999999999999999999999999987643


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...   .....+..|+|||+
T Consensus       152 ~~~---~~~~~~~~y~~pe~  168 (254)
T cd05083         152 MGV---DNSKLPVKWTAPEA  168 (254)
T ss_pred             ccC---CCCCCCceecCHHH
Confidence            321   22344577999984

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=1e-25  Score=176.12  Aligned_cols=166  Identities=25%  Similarity=0.448  Sum_probs=137.7

Q ss_pred             ceeccccceeEEEEEcC-C---CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEe
Q 039002           48 YCIGNGGHASVYRAELP-S---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~-~---~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      +.||+|+||.||+|... .   +..+++|.+......   .....+.+|+..++.++|+|++++++++......++++|+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46899999999999543 3   778999998653221   1346678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccch------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          124 LERGSLAAILNTDAA------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++++|.+++.....      ...+++.....++.|++.|+.++|+.   +++|+||+|+||+++.++.++++|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence            999999999876411      13478899999999999999999998   999999999999999999999999999987


Q ss_pred             ecCCC--CcccccccccccccCCC
Q 039002          198 LKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      .....  .......+++.|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~  178 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPES  178 (262)
T ss_pred             cccccccccccCCCcCccccCHHH
Confidence            65432  11233467889999993

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=7.1e-26  Score=177.12  Aligned_cols=157  Identities=24%  Similarity=0.417  Sum_probs=128.2

Q ss_pred             ceeccccceeEEEEEcC-CC----------cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           48 YCIGNGGHASVYRAELP-SR----------EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~-~~----------~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      +.||+|+||.||+|... ++          ..+++|.+...    .. ....+.+|+.+++.++|+|++++++++.. +.
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD----HR-DSLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc----hh-hHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            36899999999999543 33          24677765432    11 14667889999999999999999999888 77


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-------cEEE
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-------EAHV  189 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-------~~kl  189 (219)
                      .++++||+++++|.+++.....  .+++..+..++.|++.|+.|||++   +++|+||||+||+++.++       .+++
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence            8999999999999999875432  377888899999999999999998   999999999999999887       7999


Q ss_pred             eeccceeeecCCCCcccccccccccccCCC
Q 039002          190 ADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       190 ~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +|||++......    ....++..|+|||+
T Consensus       150 ~Dfg~a~~~~~~----~~~~~~~~y~aPE~  175 (259)
T cd05037         150 SDPGIPITVLSR----EERVERIPWIAPEC  175 (259)
T ss_pred             CCCCcccccccc----cccccCCCccChhh
Confidence            999998865432    23467788999995

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=9.9e-26  Score=177.72  Aligned_cols=171  Identities=22%  Similarity=0.391  Sum_probs=132.2

Q ss_pred             CCCcceeccccceeEEEEEcC-CCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC------
Q 039002           44 FDAKYCIGNGGHASVYRAELP-SRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA------  114 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~-~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------  114 (219)
                      +.+.+.||+|+||.||+|... .+.  .+|+|.++.....  ......+.+|+.+++.++|+||+++++.+...      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            356789999999999999543 333  5899987653222  23346678899999999999999999977432      


Q ss_pred             CcceEEEEecCCCCHHHHhcccc---hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          115 RHSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                      ...++++||+.+++|..++....   ....+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence            34689999999999998874321   122367888899999999999999998   999999999999999999999999


Q ss_pred             ccceeeecCCCCc--ccccccccccccCCC
Q 039002          192 FGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      ||++.........  .....+++.|+|||+
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  185 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIES  185 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHH
Confidence            9999876433211  122345677999984

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=6e-26  Score=179.82  Aligned_cols=174  Identities=20%  Similarity=0.302  Sum_probs=139.1

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCC-----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe-
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPS-----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH-  113 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-  113 (219)
                      ..++|++.+.||+|+||.||+|....     +..+++|.+...   ........+.+|+.+++.++|+|++++++++.. 
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            35789999999999999999996543     577999987532   223344667889999999999999999998765 


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchh-----hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEE
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAA-----QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~k  188 (219)
                      +...++++|++.+++|..++......     ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence            56789999999999999988643211     3477888999999999999999998   999999999999999999999


Q ss_pred             EeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          189 VADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      ++|||+++.+......  .....++..|+|||+
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~  190 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALES  190 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHH
Confidence            9999999765322111  112345677999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.94  E-value=1.3e-25  Score=175.36  Aligned_cols=170  Identities=22%  Similarity=0.349  Sum_probs=141.2

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||++ ...++..+++|.+......  ......+.+|+.+++.++|+|++++++.+...+..++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT--KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc--cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            5888999999999999999 4557888999988643222  233466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEeeccceeeecC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKS  200 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~  200 (219)
                      |++++++|.+++..... ..+++..+..++.+++.++.|+|++   +++|+||+|+||+++.+ +.++++|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          79 EYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             ecCCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            99999999999865322 2367888899999999999999998   99999999999999855 5689999999987654


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ... .....++..|+|||.
T Consensus       155 ~~~-~~~~~~~~~y~aPE~  172 (256)
T cd08220         155 KSK-AYTVVGTPCYISPEL  172 (256)
T ss_pred             Ccc-ccccccCCcccCchh
Confidence            322 233578899999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=7.4e-26  Score=179.18  Aligned_cols=173  Identities=23%  Similarity=0.364  Sum_probs=137.1

Q ss_pred             hCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++|++.+.||+|++|.||+|...      .+..+++|.+...   ........+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES---CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            467899999999999999999543      4567888977532   1122335678899999999999999999999988


Q ss_pred             CcceEEEEecCCCCHHHHhcccch----hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC---cE
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA----AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY---EA  187 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~---~~  187 (219)
                      +..++++|++.+++|.+++.....    ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence            999999999999999999865431    12377888899999999999999998   999999999999998654   58


Q ss_pred             EEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +++|||+++.......  .......+..|+|||+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA  192 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHH
Confidence            9999999886532211  1112234567999984

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=1e-25  Score=178.71  Aligned_cols=169  Identities=27%  Similarity=0.378  Sum_probs=139.5

Q ss_pred             CCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |++.+.||.|++|.||+| ...++..+++|++......  ......+.+|+.+++.++|+|++++++++.+++..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            678899999999999999 4567889999988643211  2233557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+. +++..++..... ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        79 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          79 FLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             ccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            995 689888865431 2378889999999999999999998   99999999999999999999999999987654333


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~aPE~  170 (283)
T cd07835         154 RTYTHEVVTLWYRAPEI  170 (283)
T ss_pred             cccCccccccCCCCCce
Confidence            22233467889999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=1.3e-25  Score=176.83  Aligned_cols=171  Identities=24%  Similarity=0.452  Sum_probs=137.6

Q ss_pred             hCCCCCcceeccccceeEEEEEcC-CC---cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP-SR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~-~~---~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|+..+.||+|+||.||+|... ++   ..+++|.+....   .......+..|+.+++.++|+|++++.+++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            357888999999999999999543 33   368999875421   12234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++++++|.+++....  ..+++.....++.+++.|+.|+|+.   +++|+|+||+||+++.++.++++|||++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence            999999999999999986532  2367888899999999999999998   99999999999999999999999999988


Q ss_pred             eecCCCCccc---ccccccccccCCC
Q 039002          197 FLKSDASNWT---EFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~---~~~gt~~y~aPE~  219 (219)
                      ..........   ....+..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~  181 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEA  181 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHH
Confidence            6654322111   1123456999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=1e-25  Score=178.79  Aligned_cols=162  Identities=20%  Similarity=0.239  Sum_probs=128.9

Q ss_pred             eeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHH---hcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           49 CIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL---TETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        49 ~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      .||+|+||.||++. ..+++.+|+|.+........ .......+|..++   ...+|+|++.+++.+...+..+++|||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            48999999999994 56788999998864332221 1122233444333   3347999999999999999999999999


Q ss_pred             CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc
Q 039002          125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN  204 (219)
Q Consensus       125 ~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  204 (219)
                      ++++|..++....   .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++........ 
T Consensus        80 ~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          80 NGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            9999998886543   378899999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ccccccccccccCCC
Q 039002          205 WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 ~~~~~gt~~y~aPE~  219 (219)
                       ....|++.|+|||.
T Consensus       153 -~~~~~~~~y~aPE~  166 (279)
T cd05633         153 -HASVGTHGYMAPEV  166 (279)
T ss_pred             -cCcCCCcCccCHHH
Confidence             33578999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=9.1e-26  Score=181.02  Aligned_cols=174  Identities=25%  Similarity=0.399  Sum_probs=138.5

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC-
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR-  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  115 (219)
                      ....++|++.+.||+|+||.||+| ...+++.+|+|.+......  ......+.+|+.+++.++|||++++++++.... 
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc--CCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            344678999999999999999999 4557889999987543211  122344567999999999999999999886554 


Q ss_pred             -------cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEE
Q 039002          116 -------HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       116 -------~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~k  188 (219)
                             ..++++|++. +++.+.+....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK  159 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence                   3499999996 47777775432  2378889999999999999999998   999999999999999999999


Q ss_pred             EeeccceeeecCCCC----cccccccccccccCCC
Q 039002          189 VADFGIAKFLKSDAS----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~  219 (219)
                      |+|||++..+.....    ......++..|+|||+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  194 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL  194 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHH
Confidence            999999986643321    1123467888999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.94  E-value=1.6e-25  Score=175.31  Aligned_cols=162  Identities=25%  Similarity=0.382  Sum_probs=130.9

Q ss_pred             eeccccceeEEEEEc---CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           49 CIGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .||+|+||.||+|.+   .++..+|+|.++...  ........+.+|+.+++.++|+||+++++++. .+..++++|+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            689999999999943   356789999876432  22234466888999999999999999999875 456789999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc-
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN-  204 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-  204 (219)
                      +++|.+++....   .+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++......... 
T Consensus        79 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          79 LGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            999999986532   377888999999999999999998   9999999999999999999999999998866443221 


Q ss_pred             --ccccccccccccCCC
Q 039002          205 --WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 --~~~~~gt~~y~aPE~  219 (219)
                        .....+++.|+|||.
T Consensus       153 ~~~~~~~~~~~y~aPE~  169 (257)
T cd05116         153 KAKTHGKWPVKWYAPEC  169 (257)
T ss_pred             eecCCCCCCccccCHhH
Confidence              111234578999983

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=1.7e-25  Score=176.40  Aligned_cols=169  Identities=24%  Similarity=0.385  Sum_probs=135.6

Q ss_pred             CCCCCcceeccccceeEEEEEcCC----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      .+|.+.+.||+|+||.||+|...+    ...+++|......   .......+.+|+.+++.++|+|++++++++.. +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            568889999999999999995422    3468889875422   12344578889999999999999999998865 557


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++||++++++|.+++....  ..+++..+..++.+++.|+.|+|+.   +++|+||||+||+++..+.++++|||++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            89999999999999986533  2377888899999999999999998   999999999999999999999999999987


Q ss_pred             ecCCCCcc-cccccccccccCCC
Q 039002          198 LKSDASNW-TEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~-~~~~gt~~y~aPE~  219 (219)
                      ........ ....++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~  179 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPES  179 (270)
T ss_pred             cccccceecCCCCccccccChhh
Confidence            65432111 12234567999994

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=1.6e-25  Score=178.10  Aligned_cols=166  Identities=27%  Similarity=0.405  Sum_probs=139.4

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|...+.||+|++|.||++. ..+++.+++|.+...    .......+.+|+.+++.++|+|++++++++...+..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            45556899999999999995 567888999987531    2223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.+++|.+++...    .+++..+..++.|++.|+.++|+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          96 EFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             eccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            999999999988652    367788889999999999999998   9999999999999999999999999988765443


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........|++.|+|||.
T Consensus       169 ~~~~~~~~~~~~y~aPE~  186 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEV  186 (285)
T ss_pred             CcccccccCCccccCHHH
Confidence            333344578999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.94  E-value=1.1e-25  Score=179.72  Aligned_cols=162  Identities=27%  Similarity=0.405  Sum_probs=137.3

Q ss_pred             cceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           47 KYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      ...||+|+||.||++. ..+++.+++|++...    .......+.+|+.+++.++|+|++++++.+...+..+++|||++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3679999999999994 467889999987432    12234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      ++++.+++...    .+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++++|||++..........
T Consensus       101 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657         101 GGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            99999877532    367788889999999999999998   99999999999999999999999999987665443333


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....+++.|+|||+
T Consensus       174 ~~~~~~~~y~~pE~  187 (292)
T cd06657         174 KSLVGTPYWMAPEL  187 (292)
T ss_pred             cccccCccccCHHH
Confidence            45678999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.94  E-value=1.9e-25  Score=174.61  Aligned_cols=169  Identities=21%  Similarity=0.418  Sum_probs=139.0

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .++|++.+.||+|+||.||+|....+..+++|.+.....     ....+.+|+.+++.++|+|++++++++......+++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            357889999999999999999766677899998764221     234577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|++.+++|.+++.....  .+++..+..++.+++.++.++|+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999999999998865322  367788889999999999999998   999999999999999999999999999876543


Q ss_pred             CCCc-ccccccccccccCCC
Q 039002          201 DASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~-~~~~~gt~~y~aPE~  219 (219)
                      .... .....++..|+|||.
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~  172 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEV  172 (256)
T ss_pred             CcccccCCCccchhhcCHhH
Confidence            2211 122345578999984

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=6.1e-26  Score=177.33  Aligned_cols=171  Identities=25%  Similarity=0.349  Sum_probs=140.6

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|+||.||+| ...++..+++|.+.......  .....+.+|+.+++.++|+|++++++.+...+..++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            5788999999999999999 45578889999875432111  23345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEEeeccceeeecC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKFLKS  200 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  200 (219)
                      ||+++++|.+++..... ..+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++ .++++|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          79 EYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999998865322 2367888899999999999999998   999999999999999775 569999999877654


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........|++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~ape~  173 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEI  173 (257)
T ss_pred             CcccccccCCCccccCHHH
Confidence            4333334568899999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=2.3e-25  Score=178.98  Aligned_cols=169  Identities=28%  Similarity=0.441  Sum_probs=138.6

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      +...|++.+.||+|+||.||+|. ..+++.+++|.+...... .......+.+|+.+++.++|+|++++.+++...+..+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            34668999999999999999994 457889999987533212 2223356788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++||+. +++.+++....  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        92 lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          92 LVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence            9999996 56766664322  2377888899999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...    ....+++.|+|||+
T Consensus       166 ~~~----~~~~~~~~y~aPE~  182 (307)
T cd06607         166 SPA----NSFVGTPYWMAPEV  182 (307)
T ss_pred             CCC----CCccCCccccCcee
Confidence            322    34578899999994

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-25  Score=175.43  Aligned_cols=161  Identities=24%  Similarity=0.303  Sum_probs=128.9

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHH-HHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK-ALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|++|.||+| ...+++.+|+|.+........ ........|.. +....+|+|++++++.+..++..++++||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            57899999999999 456788999998754221111 11122334433 3455589999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW  205 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  205 (219)
                      +++|.+++....   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....    .
T Consensus        81 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~  150 (260)
T cd05611          81 GGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N  150 (260)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence            999999986543   367888899999999999999998   999999999999999999999999999875433    2


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      ....+++.|+|||.
T Consensus       151 ~~~~~~~~y~~pe~  164 (260)
T cd05611         151 KKFVGTPDYLAPET  164 (260)
T ss_pred             ccCCCCcCccChhh
Confidence            34578899999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.94  E-value=2.9e-25  Score=173.16  Aligned_cols=172  Identities=24%  Similarity=0.380  Sum_probs=144.5

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||.|++|.||++. ..++..+++|.+.....  .......+.+|+..++.++|+|++++.+.+...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            58889999999999999994 45788999999864322  2234456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          122 EFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |++++++|.+.+.... ....+++..+..++.+++.|+.++|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            9999999999886532 113478888999999999999999998   999999999999999999999999999987655


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........|++.|+|||.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~  174 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPEL  174 (258)
T ss_pred             CcceecceeeeecccChhH
Confidence            4323344578899999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=2.1e-25  Score=176.81  Aligned_cols=162  Identities=20%  Similarity=0.234  Sum_probs=128.9

Q ss_pred             eeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHH---HHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           49 CIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEV---KALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        49 ~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      .||+|+||.||+|. ..+++.+|+|.+........ ........|.   ..++...|++++++.+.+...+..++++||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            47999999999994 55788999998754322211 1111222333   3445567999999999999999999999999


Q ss_pred             CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc
Q 039002          125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN  204 (219)
Q Consensus       125 ~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  204 (219)
                      .+++|..++....   .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++..+..... 
T Consensus        80 ~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          80 NGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            9999998886532   378899999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ccccccccccccCCC
Q 039002          205 WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 ~~~~~gt~~y~aPE~  219 (219)
                       ....|+..|+|||.
T Consensus       153 -~~~~~~~~y~aPE~  166 (278)
T cd05606         153 -HASVGTHGYMAPEV  166 (278)
T ss_pred             -cCcCCCcCCcCcHH
Confidence             34579999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=1.4e-25  Score=175.54  Aligned_cols=164  Identities=24%  Similarity=0.373  Sum_probs=134.1

Q ss_pred             ceeccccceeEEEEEcC--CC--cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEe
Q 039002           48 YCIGNGGHASVYRAELP--SR--EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~--~~--~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      +.||+|++|.||+|...  .+  ..+|+|.+......   .....+.+|+.++++++|+|++++++.+.. ...++++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            36899999999999543  23  35899988653321   345678899999999999999999999988 889999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS  203 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  203 (219)
                      +++++|.+++..... ..+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..+.....
T Consensus        77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999999875432 3478888999999999999999998   999999999999999999999999999987654221


Q ss_pred             c---ccccccccccccCCC
Q 039002          204 N---WTEFAGTYGYVALGI  219 (219)
Q Consensus       204 ~---~~~~~gt~~y~aPE~  219 (219)
                      .   .....++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~y~~pE~  171 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPES  171 (257)
T ss_pred             ceecccCCCCCceecCHHH
Confidence            1   122456788999994

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.7e-25  Score=176.11  Aligned_cols=170  Identities=25%  Similarity=0.384  Sum_probs=138.2

Q ss_pred             CCCCCcceeccccceeEEEEEcC-----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--C
Q 039002           42 NDFDAKYCIGNGGHASVYRAELP-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--A  114 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~  114 (219)
                      .+|++.+.||+|+||.||+|...     +++.+|+|.+......   .....+.+|+.+++.++|+|++++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            56788899999999999999532     4678999998643221   245678899999999999999999999877  5


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ...++++|++++++|.+++.....  .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence            578999999999999999975432  378888999999999999999998   999999999999999999999999999


Q ss_pred             eeeecCCCCc---ccccccccccccCCC
Q 039002          195 AKFLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      +.........   .....++..|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~  183 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPEC  183 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHH
Confidence            9876532211   112244566899983

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=1e-25  Score=178.35  Aligned_cols=164  Identities=24%  Similarity=0.287  Sum_probs=134.3

Q ss_pred             eccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||+|+||.||+| ...+++.+++|.+........ .....+..|+.+++.++|+|++++++.+...+..++++||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR-KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh-hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999 456788999998754221111 123445679999999999999999999999999999999999999


Q ss_pred             HHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccccc
Q 039002          129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF  208 (219)
Q Consensus       129 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  208 (219)
                      |.+++..... ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+...... ......
T Consensus        80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~  154 (277)
T cd05577          80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGR  154 (277)
T ss_pred             HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Cccccc
Confidence            9998865432 2377888899999999999999998   9999999999999999999999999998765432 222334


Q ss_pred             ccccccccCCC
Q 039002          209 AGTYGYVALGI  219 (219)
Q Consensus       209 ~gt~~y~aPE~  219 (219)
                      .++..|+|||+
T Consensus       155 ~~~~~y~~PE~  165 (277)
T cd05577         155 AGTPGYMAPEV  165 (277)
T ss_pred             cCCCCcCCHHH
Confidence            67889999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.6e-25  Score=182.58  Aligned_cols=168  Identities=22%  Similarity=0.373  Sum_probs=138.7

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC-
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR-  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  115 (219)
                      -...++|++.+.||+|+||.||+| ...++..||+|.+.....  .......+.+|+.+++.++|+||+++++++.... 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            334678999999999999999999 566888999998854321  2233456788999999999999999999987553 


Q ss_pred             -----cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          116 -----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       116 -----~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                           ..++++|++ ++++..++...    .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence                 358999998 67888887542    377888999999999999999998   99999999999999999999999


Q ss_pred             eccceeeecCCCCcccccccccccccCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      |||++......   .....+++.|+|||
T Consensus       161 dfg~~~~~~~~---~~~~~~~~~y~aPE  185 (343)
T cd07880         161 DFGLARQTDSE---MTGYVVTRWYRAPE  185 (343)
T ss_pred             ecccccccccC---ccccccCCcccCHH
Confidence            99998765332   23356788999998

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-25  Score=183.10  Aligned_cols=168  Identities=25%  Similarity=0.403  Sum_probs=136.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      .++|++.+.||+|++|.||+| ...+++.||+|.+...   ........+.+|+.+++.++|+|++++++++...     
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF---EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc---ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            478999999999999999999 5668889999988532   1223445677899999999999999999887543     


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ...++++|++. +++...+...    .+++..+..++.|++.|+.+||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          81 NDVYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             ceEEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            34789999996 4777776542    377888899999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCC---cccccccccccccCCC
Q 039002          195 AKFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      +........   ......|++.|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  180 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEI  180 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHH
Confidence            876543321   1133578899999994

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.94  E-value=1.7e-25  Score=177.77  Aligned_cols=172  Identities=26%  Similarity=0.431  Sum_probs=145.4

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ....+.|++.+.||+|++|.||+|.. .++..+++|.+.....     ....+.+|+..++.++|+|++++++.+...+.
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            34567799999999999999999954 4788899998864211     34567889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++.+++|.+++....  ..+++..+..++.+++.|+.++|..   +++|+|++|+||+++.++.++|+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~  164 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAA  164 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhh
Confidence            999999999999999997643  2478888999999999999999998   99999999999999999999999999887


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............++..|+|||+
T Consensus       165 ~~~~~~~~~~~~~~~~~y~~PE~  187 (286)
T cd06614         165 QLTKEKSKRNSVVGTPYWMAPEV  187 (286)
T ss_pred             hhccchhhhccccCCcccCCHhH
Confidence            65544333344568889999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.93  E-value=2.1e-25  Score=175.05  Aligned_cols=162  Identities=31%  Similarity=0.376  Sum_probs=136.0

Q ss_pred             eccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||.|++|.||+|. ..+++.+++|.+....... ......+.+|+.+++.++|+|++++++.+..++..++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            6899999999994 4568899999986432221 2234668899999999999999999999999999999999999999


Q ss_pred             HHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccccc
Q 039002          129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF  208 (219)
Q Consensus       129 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  208 (219)
                      |.+++....   .++...+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++....... .....
T Consensus        80 L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~  152 (262)
T cd05572          80 LWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF  152 (262)
T ss_pred             HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence            999986543   267788888999999999999998   99999999999999999999999999998765432 22335


Q ss_pred             ccccccccCCC
Q 039002          209 AGTYGYVALGI  219 (219)
Q Consensus       209 ~gt~~y~aPE~  219 (219)
                      .+++.|+|||.
T Consensus       153 ~~~~~~~~PE~  163 (262)
T cd05572         153 CGTPEYVAPEI  163 (262)
T ss_pred             cCCcCccChhH
Confidence            78899999984

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=5e-26  Score=179.83  Aligned_cols=171  Identities=26%  Similarity=0.395  Sum_probs=143.0

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l  119 (219)
                      ++|++.+.||+|++|.||+|. ..+++.+++|.+....... ......+.+|+.+++.++ |+||+++++++...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            478999999999999999994 5578899999875422211 223356778999999998 9999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++...+   .+++..+..++.|++.|+.+||+.   +++|+|++|+||+++.++.++++|||++....
T Consensus        80 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          80 VLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999987543   378899999999999999999998   99999999999999999999999999988665


Q ss_pred             CCC--------------------CcccccccccccccCCC
Q 039002          200 SDA--------------------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~--------------------~~~~~~~gt~~y~aPE~  219 (219)
                      ...                    .....+.++..|+|||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~  193 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL  193 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHH
Confidence            432                    12234567889999984

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=4e-25  Score=172.55  Aligned_cols=169  Identities=25%  Similarity=0.418  Sum_probs=137.8

Q ss_pred             CCCcceeccccceeEEEEEcC-C----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           44 FDAKYCIGNGGHASVYRAELP-S----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~-~----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      +++.+.||+|+||.||++... .    +..+|+|.+....   .......+..|+.+++.++|+|++++++++...+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            457789999999999999543 3    3789999986431   1113457788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++|++++++|.+++..... ..+++..+..++.|++.|+.++|+.   +++|+||+|+||+++.++.++++|||++...
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence            99999999999999865332 1178888999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCccc-ccccccccccCCC
Q 039002          199 KSDASNWT-EFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~-~~~gt~~y~aPE~  219 (219)
                      ........ ...+++.|+|||.
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~  175 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPES  175 (258)
T ss_pred             ccccccccccCCCcccccChHH
Confidence            54321111 1236788999984

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=5.9e-26  Score=177.98  Aligned_cols=159  Identities=21%  Similarity=0.337  Sum_probs=128.5

Q ss_pred             ceeccccceeEEEEEc-CCC-------cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           48 YCIGNGGHASVYRAEL-PSR-------EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~-~~~-------~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +.||+|+||.||+|.. ..+       ..+++|.+..    ........+.+|+.+++.++|+|++++++++..++..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence            3689999999999943 222       2477776542    122334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc--------EEEee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE--------AHVAD  191 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~--------~kl~d  191 (219)
                      +|||+.+++|..++.....  .+++.....++.|++.|+.|+|+.   +++||||||+||+++.++.        ++++|
T Consensus        77 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence            9999999999999865432  367888889999999999999998   9999999999999987764        68999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++.....    .....++..|+|||.
T Consensus       152 ~g~~~~~~~----~~~~~~~~~y~aPE~  175 (258)
T cd05078         152 PGISITVLP----KEILLERIPWVPPEC  175 (258)
T ss_pred             cccccccCC----chhccccCCccCchh
Confidence            998865432    234578899999994

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.1e-25  Score=180.12  Aligned_cols=165  Identities=19%  Similarity=0.208  Sum_probs=125.3

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEc-C-CCcEEEEEecCCCCCC-CchhhHHHHHHHHHHHhcCCCCccce-eEeEEEe
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAEL-P-SREVVAVKKFHSPLPS-DQTVDQKEFLTEVKALTETRHRNIVK-FYGFCSH  113 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~-~-~~~~~aik~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~-~~~~~~~  113 (219)
                      ....++|++.+.||+|+||.||+|.. . +++.+|+|++...... ........+.+|+.+++.++|+|++. +++    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            33458899999999999999999954 3 5677899986532110 11223456789999999999999985 443    


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC-CCCCEEeCCCCcEEEeec
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV-SSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-kp~nili~~~~~~kl~df  192 (219)
                      .+..+++|||+.+++|... ..      ..   ...++.+++.++.|+|+.   +++|||| ||+||+++.++.++|+||
T Consensus        90 ~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            2568999999999988632 11      11   135678899999999998   9999999 999999999999999999


Q ss_pred             cceeeecCCCCc--------ccccccccccccCCC
Q 039002          193 GIAKFLKSDASN--------WTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~--------~~~~~gt~~y~aPE~  219 (219)
                      |+++.+......        .....+++.|+|||+
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~  191 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDA  191 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCccc
Confidence            999977543311        134567888999995

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.93  E-value=3e-25  Score=181.69  Aligned_cols=169  Identities=21%  Similarity=0.362  Sum_probs=137.7

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC---
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA---  114 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  114 (219)
                      ...++|++.+.||+|+||.||+| ...+++.+|+|.+.....  .......+.+|+.+++.++|+|++++++++...   
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            35688999999999999999999 556888999998864322  122334567899999999999999999988643   


Q ss_pred             ---CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          115 ---RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       115 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                         ...++++|++. +++...+...     ++...+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence               34799999995 5787776532     66778888999999999999998   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++........ .....+++.|+|||.
T Consensus       162 fg~~~~~~~~~~-~~~~~~~~~y~aPE~  188 (353)
T cd07850         162 FGLARTAGTSFM-MTPYVVTRYYRAPEV  188 (353)
T ss_pred             CccceeCCCCCC-CCCCcccccccCHHH
Confidence            999986644322 234568899999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=1.2e-25  Score=182.85  Aligned_cols=170  Identities=24%  Similarity=0.395  Sum_probs=139.2

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      ..+|++.+.||+|+||.||+| ...+++.|++|.+......  ......+.+|+.+++.++|+|++++++++...     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN--RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            467999999999999999999 5567889999998653222  12334567899999999999999999987644     


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ...++++||+. ++|.+++...+   .+++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            34799999995 68888886543   378888999999999999999998   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +..............++..|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~  179 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPEL  179 (337)
T ss_pred             ccccCCCcccccccccccCccChHH
Confidence            9866443222344578899999983

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=2.1e-25  Score=178.91  Aligned_cols=170  Identities=22%  Similarity=0.425  Sum_probs=134.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCc----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|+..+.||+|+||.||+|. ..++.    .+|+|.+....   .......+.+|+.+++.++|+||+++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4678889999999999999994 34444    47888775421   122234578899999999999999999998754 


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++++|++.+++....  ..+++..+..++.|++.|+.|+|++   +++|+||||+||+++.++.+||+|||++
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence            4678999999999999986532  2367788889999999999999998   9999999999999999999999999999


Q ss_pred             eeecCCCCc--ccccccccccccCCC
Q 039002          196 KFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      .........  .....++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (303)
T cd05110         157 RLLEGDEKEYNADGGKMPIKWMALEC  182 (303)
T ss_pred             ccccCcccccccCCCccccccCCHHH
Confidence            866533221  122345678999984

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-27  Score=199.09  Aligned_cols=171  Identities=27%  Similarity=0.422  Sum_probs=152.1

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      .+.++|+.+..+|.|++|.||++ +..+++..|+|.++.....    .-.-+++|+.+++..+|+||+.|++.+...+.+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d----d~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc----cccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            56789999999999999999999 5778999999998764322    223467899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+.||||.+|+|.+.-..-+.   +++.++..+.+..+.++.|+|+.   +-+|||||-.||++...|.+|+.|||.+..
T Consensus        88 wicMEycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             EEEEEecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhh
Confidence            999999999999987654333   78889999999999999999999   889999999999999999999999999999


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++....+...+.||++|||||+
T Consensus       162 itati~KrksfiGtpywmapEv  183 (829)
T KOG0576|consen  162 ITATIAKRKSFIGTPYWMAPEV  183 (829)
T ss_pred             hhhhhhhhhcccCCccccchhH
Confidence            8887777788999999999995

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=3.2e-25  Score=174.61  Aligned_cols=174  Identities=24%  Similarity=0.429  Sum_probs=138.1

Q ss_pred             CCCCcceeccccceeEEEEEcC--CCcEEEEEecCCCCCCC------chhhHHHHHHHHHHHhc-CCCCccceeEeEEEe
Q 039002           43 DFDAKYCIGNGGHASVYRAELP--SREVVAVKKFHSPLPSD------QTVDQKEFLTEVKALTE-TRHRNIVKFYGFCSH  113 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~~--~~~~~aik~~~~~~~~~------~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~  113 (219)
                      +|++.+.||+|+||.||+|...  .++.+++|.+.......      .......+.+|+.++.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4888999999999999999543  46789999875422111      11233456678887765 799999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                      ++..++++||+++++|.+++.... ....+++..++.++.|++.++.|+|+..  +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999998874321 1234778888999999999999999631  7999999999999999999999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |.+....... ......++..|+|||.
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~  184 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEI  184 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhh
Confidence            9998765433 3345678999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.93  E-value=1.1e-25  Score=182.79  Aligned_cols=170  Identities=26%  Similarity=0.402  Sum_probs=139.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe----CC
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH----AR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~  115 (219)
                      .++|++.+.||+|++|.||+| ...+++.|++|.+.....  .......+.+|+.+++.++|+||+++++++..    ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            378999999999999999999 556788999998864321  12234567789999999999999999988753    34


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++||+. +++..++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence            6899999995 68888886533   278888999999999999999998   9999999999999999999999999999


Q ss_pred             eeecCCCCcc----cccccccccccCCC
Q 039002          196 KFLKSDASNW----TEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~----~~~~gt~~y~aPE~  219 (219)
                      ..........    ....++..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPEL  182 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHH
Confidence            8765432211    23478899999994

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.8e-25  Score=172.42  Aligned_cols=164  Identities=26%  Similarity=0.396  Sum_probs=133.4

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCC
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERG  127 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~  127 (219)
                      +.||+|++|.||+|....++.+++|.+......   .....+.+|+.+++.++|+||+++++++...+..++++|++.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            368999999999996555889999987643221   24456788999999999999999999999999999999999999


Q ss_pred             CHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcc--
Q 039002          128 SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW--  205 (219)
Q Consensus       128 ~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~--  205 (219)
                      ++.+++.....  .+++.....++.+++.++.|+|+.   +++|+||+|+||+++.++.++++|||++..........  
T Consensus        78 ~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          78 SLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            99999854322  367788889999999999999998   99999999999999999999999999987554221111  


Q ss_pred             cccccccccccCCC
Q 039002          206 TEFAGTYGYVALGI  219 (219)
Q Consensus       206 ~~~~gt~~y~aPE~  219 (219)
                      .....+..|+|||+
T Consensus       153 ~~~~~~~~y~~PE~  166 (251)
T cd05041         153 GLKQIPIKWTAPEA  166 (251)
T ss_pred             ccCcceeccCChHh
Confidence            11233567999984

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.93  E-value=2.7e-25  Score=177.81  Aligned_cols=173  Identities=27%  Similarity=0.417  Sum_probs=138.6

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC--
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR--  115 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--  115 (219)
                      ...++|++.+.||+|++|.||+|. ..+++.+++|.+......  ......+.+|+.+++.++|||++++++++....  
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            346789999999999999999995 457889999998643221  123345678999999999999999999886644  


Q ss_pred             --------cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcE
Q 039002          116 --------HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA  187 (219)
Q Consensus       116 --------~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~  187 (219)
                              ..++++|++.+ ++...+....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                    78999999975 6766665432  2377888999999999999999999   99999999999999999999


Q ss_pred             EEeeccceeeecCCCC-cccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      +|+|||++..+..... ......++..|+|||.
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~  188 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPEL  188 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHH
Confidence            9999999987654331 1122356788999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.93  E-value=4.6e-25  Score=174.01  Aligned_cols=164  Identities=26%  Similarity=0.431  Sum_probs=128.6

Q ss_pred             eeccccceeEEEEEc-CCCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEEec
Q 039002           49 CIGNGGHASVYRAEL-PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~-~~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      .||+|+||.||+|.. .++.  .+++|.++..   ........+.+|+.++.++ +|||++++++++...+..+++||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            589999999999954 4443  4678876532   1222345678899999999 7999999999999999999999999


Q ss_pred             CCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          125 ERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       125 ~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                      ++++|.+++.....             ...+++.+...++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence            99999999864321             12367888899999999999999998   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++........ ......+..|+|||+
T Consensus       156 fgl~~~~~~~~~-~~~~~~~~~y~apE~  182 (270)
T cd05047         156 FGLSRGQEVYVK-KTMGRLPVRWMAIES  182 (270)
T ss_pred             CCCccccchhhh-ccCCCCccccCChHH
Confidence            999853221111 111234567999984

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.93  E-value=4.3e-25  Score=173.18  Aligned_cols=164  Identities=24%  Similarity=0.413  Sum_probs=127.8

Q ss_pred             ceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE-eCCcceEEEE
Q 039002           48 YCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS-HARHSFLLCE  122 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e  122 (219)
                      +.||+|+||.||+|...    ....+|+|.+...   ........+.+|+.+++.++|+|++++++++. .++..++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            36899999999999532    2356999987431   12233456778999999999999999999775 4556889999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      ++.+++|.+++....  ....+.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          78 YMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999999986432  2245667788889999999999998   99999999999999999999999999987554321


Q ss_pred             ----CcccccccccccccCCC
Q 039002          203 ----SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ----~~~~~~~gt~~y~aPE~  219 (219)
                          .......++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~  173 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALES  173 (262)
T ss_pred             ceeecccccCcCCccccChhH
Confidence                11122345678999994

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=5.7e-25  Score=170.73  Aligned_cols=167  Identities=31%  Similarity=0.481  Sum_probs=143.0

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||++. ..+++.+++|++.....    .....+.+|+..++.++|++++++.+.+...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999995 45788899999864321    24466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++++++|.+++....  ..+++..+..++.|++.++.++|..   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            9999999999986542  2378888999999999999999998   9999999999999999999999999998876544


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      .. .....++..|+|||+
T Consensus       152 ~~-~~~~~~~~~~~~PE~  168 (253)
T cd05122         152 KA-RNTMVGTPYWMAPEV  168 (253)
T ss_pred             cc-ccceecCCcccCHHH
Confidence            32 345678899999994

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-26  Score=177.35  Aligned_cols=162  Identities=22%  Similarity=0.378  Sum_probs=136.7

Q ss_pred             ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      +.||+|+++.|-.+ ...++..+|||++.+.    ....+.++.+|+.++...+ |+||+++.++|+++...|||+|-+.
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            57999999999988 6789999999998653    2235567899999999985 9999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC---cEEEeeccceeeecCCC
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY---EAHVADFGIAKFLKSDA  202 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~---~~kl~dfg~~~~~~~~~  202 (219)
                      ||+|...+....   .+.+..+..++..|+.||.|||++   +|.|||+||+|||-....   -+||+||.++..+....
T Consensus       160 GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  160 GGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             CchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            999999887543   377888889999999999999999   999999999999986543   47999998876554322


Q ss_pred             -------CcccccccccccccCCC
Q 039002          203 -------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 -------~~~~~~~gt~~y~aPE~  219 (219)
                             ....+++|+..|||||+
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEV  257 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEV  257 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhH
Confidence                   22356789999999995

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.93  E-value=1.5e-25  Score=178.38  Aligned_cols=171  Identities=22%  Similarity=0.293  Sum_probs=139.1

Q ss_pred             CCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcc
Q 039002           43 DFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  117 (219)
                      +|++.+.||+|++|.||++..    .+++.+|+|.++.............+.+|+.++..+ +|+|++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478889999999999999842    356789999876432222223345677899999999 599999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++||+.+++|.+++....   .+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++++|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999886432   367788888899999999999998   999999999999999999999999999876


Q ss_pred             ecCCCCc-ccccccccccccCCC
Q 039002          198 LKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      +...... .....|+..|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~  177 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEV  177 (288)
T ss_pred             cccccccccccccCCccccCHHH
Confidence            5443322 223568899999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=6.8e-25  Score=171.72  Aligned_cols=162  Identities=26%  Similarity=0.384  Sum_probs=129.9

Q ss_pred             ceeccccceeEEEEEc-CC---CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEe
Q 039002           48 YCIGNGGHASVYRAEL-PS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~-~~---~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      +.||+|+||.||+|.. ..   +..+++|.+......   .....+.+|+.+++.++|+|++++++++. .+..++++|+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            4699999999999943 22   267999988643221   23456788999999999999999999876 4568999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS  203 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  203 (219)
                      +.+++|.+++....   .+++..+..++.|++.++.|||+.   +++|+||||+||+++.++.++++|||++........
T Consensus        77 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          77 APLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999999997543   378888999999999999999998   999999999999999999999999999886644332


Q ss_pred             ccc---ccccccccccCCC
Q 039002          204 NWT---EFAGTYGYVALGI  219 (219)
Q Consensus       204 ~~~---~~~gt~~y~aPE~  219 (219)
                      ...   ...++..|+|||.
T Consensus       151 ~~~~~~~~~~~~~y~aPE~  169 (257)
T cd05060         151 YYRATTAGRWPLKWYAPEC  169 (257)
T ss_pred             ccccccCccccccccCHHH
Confidence            111   1123457999983

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=184.33  Aligned_cols=173  Identities=28%  Similarity=0.385  Sum_probs=141.4

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc---hhhHHHHHHHHHHHhcCCCCccceeEeEEE-eCCc
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ---TVDQKEFLTEVKALTETRHRNIVKFYGFCS-HARH  116 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~  116 (219)
                      ++|-.+..||+|+|+.||+| +....+.||+|+-.......+   .-..+.+.+|..+.+.++||.|+++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45667889999999999999 677777899997543222221   223466789999999999999999999996 4466


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC---CCCcEEEeecc
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD---LEYEAHVADFG  193 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~---~~~~~kl~dfg  193 (219)
                      .+-|+|||+|.+|..+++-..   .+++..+..|+.||+.||.||..... +|+|.||||.|||+-   ..|.+||+|||
T Consensus       543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeeecc
Confidence            889999999999999997653   37888999999999999999998754 899999999999984   45899999999


Q ss_pred             ceeeecCCCCc-------ccccccccccccCC
Q 039002          194 IAKFLKSDASN-------WTEFAGTYGYVALG  218 (219)
Q Consensus       194 ~~~~~~~~~~~-------~~~~~gt~~y~aPE  218 (219)
                      +++.+++....       ....+||.+|++||
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPE  650 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPE  650 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcc
Confidence            99988754422       24468999999998

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=4.8e-25  Score=179.17  Aligned_cols=172  Identities=22%  Similarity=0.283  Sum_probs=136.9

Q ss_pred             hCCCCC-cceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCch----------hhHHHHHHHHHHHhcCCCCccceeE
Q 039002           41 TNDFDA-KYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQT----------VDQKEFLTEVKALTETRHRNIVKFY  108 (219)
Q Consensus        41 ~~~y~~-~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~ni~~~~  108 (219)
                      .++|.. .+.||+|+||.||+| ...+++.+|+|.+.........          .....+.+|+.+++.++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 577999999999999 4567889999988643222110          0112467899999999999999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEE
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~k  188 (219)
                      +++...+..+++||++. +++.+++....   .+++.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            99999999999999996 58888886432   377888899999999999999998   999999999999999999999


Q ss_pred             EeeccceeeecCC--------------CCcccccccccccccCCC
Q 039002          189 VADFGIAKFLKSD--------------ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~--------------~~~~~~~~gt~~y~aPE~  219 (219)
                      ++|||.+.....+              ........+++.|+|||+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  204 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL  204 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChh
Confidence            9999998766511              111223356888999994

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=4.8e-25  Score=175.42  Aligned_cols=170  Identities=26%  Similarity=0.352  Sum_probs=138.0

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Ccce
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSF  118 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~  118 (219)
                      ++|+..+.||.|++|.||+|. ..+++.+++|.+....   .......+.+|+.+++.++|+||+++++++...  +.++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            468889999999999999994 4578889999876421   123456688999999999999999999988643  4689


Q ss_pred             EEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          119 LLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++|||+++++|.+++.... ....++...+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            9999999999988764311 122367788889999999999999998   999999999999999999999999999876


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ......  ....++..|+|||.
T Consensus       155 ~~~~~~--~~~~~~~~y~~pE~  174 (287)
T cd06621         155 LVNSLA--GTFTGTSFYMAPER  174 (287)
T ss_pred             cccccc--ccccCCccccCHHH
Confidence            543322  23467888999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=5.5e-25  Score=174.25  Aligned_cols=165  Identities=24%  Similarity=0.298  Sum_probs=133.7

Q ss_pred             CCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeC--CcceE
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHA--RHSFL  119 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~l  119 (219)
                      |++.+.||+|+||.||+| ...++..+|+|.++......   ......+|+..++.+. |+|++++++++.+.  +..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            678899999999999999 45678899999886532111   1223457888888885 99999999999887  88999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++||+. +++.+.+....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++. +.++|+|||++....
T Consensus        78 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          78 VFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             EEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            999996 57777775432  2378889999999999999999999   9999999999999999 999999999998765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... ....++..|+|||+
T Consensus       151 ~~~~~-~~~~~~~~y~aPE~  169 (282)
T cd07831         151 SKPPY-TEYISTRWYRAPEC  169 (282)
T ss_pred             cCCCc-CCCCCCcccCChhH
Confidence            43322 33568899999993

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=6.2e-25  Score=174.19  Aligned_cols=168  Identities=26%  Similarity=0.418  Sum_probs=138.7

Q ss_pred             CCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--CcceEE
Q 039002           44 FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLL  120 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv  120 (219)
                      |++.+.||+|++|.||+|. ..+++.+++|.+....  ........+.+|+.+++.++|+|++++++++...  +..+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            6788999999999999995 4568889999987543  1223345677899999999999999999999887  889999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+++ ++..++....  ..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        79 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          79 FEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             eccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            999964 8888875432  2377888899999999999999998   999999999999999999999999999987755


Q ss_pred             CCC-cccccccccccccCCC
Q 039002          201 DAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ... ......++..|+|||.
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~  172 (287)
T cd07840         153 RNSADYTNRVITLWYRPPEL  172 (287)
T ss_pred             CCcccccccccccccCCcee
Confidence            431 1233467888999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=2.8e-25  Score=180.66  Aligned_cols=170  Identities=27%  Similarity=0.450  Sum_probs=137.6

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeC--C
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHA--R  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--~  115 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.+++|++......  ......+.+|+.+++.+ +|+||+++++++...  .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc--chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            35789999999999999999994 457888999987542211  12234567899999999 999999999988653  3


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++. ++|..++...    .+.+.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            6899999996 5888887643    366778888999999999999998   9999999999999999999999999998


Q ss_pred             eeecCCCC-----cccccccccccccCCC
Q 039002          196 KFLKSDAS-----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~-----~~~~~~gt~~y~aPE~  219 (219)
                      ........     ......|+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  183 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEI  183 (337)
T ss_pred             hccccccccccCcchhcccccccccCcee
Confidence            86643321     2233578999999994

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.93  E-value=1e-24  Score=175.96  Aligned_cols=167  Identities=27%  Similarity=0.427  Sum_probs=137.2

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ..|+..+.||+|+||.||+|. ..++..+++|.+...... .......+.+|+.+++.++|+|++++++++..++..+++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            447888999999999999995 557889999987543222 122335678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+.+ ++.+.+....  ..+++..+..++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus       104 ~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         104 MEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             EeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            999964 7777664322  2377888899999999999999998   999999999999999999999999998865432


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .    ....+++.|+|||+
T Consensus       178 ~----~~~~~~~~y~aPE~  192 (317)
T cd06635         178 A----NSFVGTPYWMAPEV  192 (317)
T ss_pred             c----ccccCCccccChhh
Confidence            2    34578899999994

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.93  E-value=1e-24  Score=172.02  Aligned_cols=166  Identities=19%  Similarity=0.336  Sum_probs=133.8

Q ss_pred             HHHHHHhCCCCCccee--ccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeE
Q 039002           35 DEIVKATNDFDAKYCI--GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGF  110 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~l--g~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~  110 (219)
                      .+.....++|++.+.+  |+|+||.||++ ...++..+++|.+.......         .|+.....+ +|+|++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEE
Confidence            3445556788888777  99999999999 45678889999875421110         022222222 79999999999


Q ss_pred             EEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEE
Q 039002          111 CSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHV  189 (219)
Q Consensus       111 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl  189 (219)
                      +...+..+++|||+++++|.+++....   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++ .+++
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence            999999999999999999999987643   378899999999999999999999   999999999999999888 9999


Q ss_pred             eeccceeeecCCCCcccccccccccccCCC
Q 039002          190 ADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       190 ~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +|||++......    ....++..|+|||+
T Consensus       152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~  177 (267)
T PHA03390        152 CDYGLCKIIGTP----SCYDGTLDYFSPEK  177 (267)
T ss_pred             ecCccceecCCC----ccCCCCCcccChhh
Confidence            999998765433    23478899999994

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=1e-24  Score=169.97  Aligned_cols=169  Identities=28%  Similarity=0.401  Sum_probs=143.8

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--CcceE
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFL  119 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l  119 (219)
                      +|+..+.||+|++|.||+|. ..+++.+++|.+......  ......+.+|+..+++++|+|++++++.+...  +..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            47788999999999999995 447889999988653222  23456778899999999999999999999888  88999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ++|++++++|.+++....   .+++..+..++.+++.++.|+|+.   +++|+|++|+||+++.++.++|+|||.+....
T Consensus        79 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999999987543   478888999999999999999998   99999999999999999999999999998776


Q ss_pred             CCCC--cccccccccccccCCC
Q 039002          200 SDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ....  ......++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~  174 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEV  174 (260)
T ss_pred             cccccccccCCCCCccccCHhh
Confidence            5542  1344678899999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=6.6e-25  Score=179.16  Aligned_cols=172  Identities=25%  Similarity=0.414  Sum_probs=139.5

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ..+....++|++.+.||+|+||.||+| ...+++.||+|++......  ......+.+|+.+++.++|+||+++++++..
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            345556789999999999999999999 4567889999998653221  2233557789999999999999999998854


Q ss_pred             C------CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcE
Q 039002          114 A------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA  187 (219)
Q Consensus       114 ~------~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~  187 (219)
                      .      +..+++++++ ++++.+++...    .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence            3      3467888877 77898877542    377888899999999999999999   99999999999999999999


Q ss_pred             EEeeccceeeecCCCCcccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +|+|||++......   .....++..|+|||+
T Consensus       160 kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~  188 (345)
T cd07877         160 KILDFGLARHTDDE---MTGYVATRWYRAPEI  188 (345)
T ss_pred             EEeccccccccccc---ccccccCCCccCHHH
Confidence            99999998754322   234578899999983

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.93  E-value=2.5e-25  Score=174.29  Aligned_cols=163  Identities=26%  Similarity=0.384  Sum_probs=135.2

Q ss_pred             eccccceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||+|+||.||++.. .+++.+++|.+....... ......+.+|+.+++.++|+|++++++.+..++..++++|++.+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            68999999999954 468899999886432211 2344567889999999999999999999999999999999999999


Q ss_pred             HHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC-----
Q 039002          129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS-----  203 (219)
Q Consensus       129 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-----  203 (219)
                      |.+++...+   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++........     
T Consensus        80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          80 LASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            999987543   378888999999999999999998   999999999999999999999999999875543311     


Q ss_pred             ---cccccccccccccCCC
Q 039002          204 ---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       204 ---~~~~~~gt~~y~aPE~  219 (219)
                         ......++..|+|||.
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~  172 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEV  172 (265)
T ss_pred             ccccccCcccCccccCHHH
Confidence               2234567889999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=3.2e-25  Score=179.74  Aligned_cols=168  Identities=26%  Similarity=0.420  Sum_probs=140.1

Q ss_pred             CCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC-----c
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR-----H  116 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~  116 (219)
                      +|++.+.||+|++|.||+|. ..+++.+++|.+....  ........+.+|+.+++.++|+|++++++++...+     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            58889999999999999995 4568899999886532  11234466788999999999999999999987765     7


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++. +++.+++....   .+++..+..++.+++.|+.+||+.   +++|+||||+||+++.++.++++|||++.
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            899999996 58888886543   378888899999999999999999   99999999999999999999999999998


Q ss_pred             eecCCC---CcccccccccccccCCC
Q 039002          197 FLKSDA---SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~---~~~~~~~gt~~y~aPE~  219 (219)
                      ......   .......++..|+|||+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~  177 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPEL  177 (330)
T ss_pred             eecccccccccccccccccCcCCcee
Confidence            776543   12344578899999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=5.6e-25  Score=174.37  Aligned_cols=167  Identities=28%  Similarity=0.427  Sum_probs=137.4

Q ss_pred             CCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceEEE
Q 039002           44 FDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      |++.+.||+|++|.||+|.. .+++.+++|++......   .......+|+..++.++ |+|++++++++..++..+++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            67789999999999999954 46788999987643221   12233456889999998 999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++ ++++.+.+.... ...+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            999 778988886543 12478889999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      .. .....++..|+|||+
T Consensus       153 ~~-~~~~~~~~~~~aPE~  169 (283)
T cd07830         153 PP-YTDYVSTRWYRAPEI  169 (283)
T ss_pred             CC-cCCCCCcccccCcee
Confidence            22 233568889999994

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=7.3e-25  Score=177.76  Aligned_cols=169  Identities=25%  Similarity=0.386  Sum_probs=138.0

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe-CC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH-AR  115 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~  115 (219)
                      ....++|++.+.||+|+||.||+| ...+++.+|+|++......  ......+.+|+.+++.++|||++++++++.. .+
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            345688999999999999999999 5668889999987643222  1234567789999999999999999998865 56


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++ ++++..++...    .+++.....++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            788999998 56888877542    256677778899999999999999   9999999999999999999999999998


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .....   ......++..|+|||+
T Consensus       156 ~~~~~---~~~~~~~~~~y~aPE~  176 (328)
T cd07856         156 RIQDP---QMTGYVSTRYYRAPEI  176 (328)
T ss_pred             cccCC---CcCCCcccccccCcee
Confidence            75432   2234567889999994

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-26  Score=176.10  Aligned_cols=168  Identities=24%  Similarity=0.308  Sum_probs=136.9

Q ss_pred             HHHhCCCCCc-ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEe-
Q 039002           38 VKATNDFDAK-YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSH-  113 (219)
Q Consensus        38 ~~~~~~y~~~-~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-  113 (219)
                      ...+++|++. ++||-|-.|+|-.+ ...+++.+|+|.+.         +...+.+|+++.-.. .|+||+.+.++|.+ 
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---------DSPKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---------cCHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            3456778765 67999999999999 66789999999874         223456788765444 59999999998854 


Q ss_pred             ---CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcE
Q 039002          114 ---ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEA  187 (219)
Q Consensus       114 ---~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~  187 (219)
                         ...+.+|||.+.||.|...+...+. ..++++.+..|+.||..|+.|||+.   +|.|||+||+|+|...   +..+
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcce
Confidence               3457899999999999999987654 3488999999999999999999999   9999999999999974   3578


Q ss_pred             EEeeccceeeecCCCCcccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |++|||+|+.-.. .....+.+-||+|.|||+
T Consensus       204 KLtDfGFAK~t~~-~~~L~TPc~TPyYvaPev  234 (400)
T KOG0604|consen  204 KLTDFGFAKETQE-PGDLMTPCFTPYYVAPEV  234 (400)
T ss_pred             EecccccccccCC-CccccCCcccccccCHHH
Confidence            9999999986543 334567799999999985

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.7e-25  Score=183.34  Aligned_cols=172  Identities=21%  Similarity=0.300  Sum_probs=142.0

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~  117 (219)
                      .....|+++++||+|+.+.||++...+.+.+|+|++...  ..+......+.+|+.+|.+++ |.+|++++++-..++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            334569999999999999999998887788999987643  233445677899999999996 89999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+|||+= ..+|..+++....  ..+.-.+..++.|++.++.++|..   ||||.||||.|+|+ .+|.+||+|||+|..
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             EEEeecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            9999965 5699999975432  133236778899999999999999   99999999999987 678999999999987


Q ss_pred             ecCCCCcc--cccccccccccCCC
Q 039002          198 LKSDASNW--TEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~--~~~~gt~~y~aPE~  219 (219)
                      +.......  ...+||+-||+||.
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEA  532 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEA  532 (677)
T ss_pred             cCccccceeeccccCcccccCHHH
Confidence            76554332  34599999999993

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=5.9e-25  Score=173.96  Aligned_cols=168  Identities=27%  Similarity=0.377  Sum_probs=139.9

Q ss_pred             CCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |+..+.||+|.+|.||+|. ..+++.+++|.+....  ........+..|+.+++.++|+|++++++++.+.+..++++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            5678899999999999995 4568899999986543  122234567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      ++. ++|.+++....  ..+++..+..++.+++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            997 58999987542  2378889999999999999999999   99999999999999999999999999998765443


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......++..|+|||+
T Consensus       153 ~~~~~~~~~~~~~aPE~  169 (282)
T cd07829         153 RTYTHEVVTLWYRAPEI  169 (282)
T ss_pred             cccCccccCcCcCChHH
Confidence            33333466788999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.92  E-value=5e-25  Score=171.95  Aligned_cols=170  Identities=24%  Similarity=0.359  Sum_probs=141.0

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      +|++.+.||+|++|.||++ ...+++.+++|.+......  ......+.+|+.+++.++|+||+++++++......++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            5888999999999999999 5567889999988643222  223456678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          122 EFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |++++++|..++..... ...+++..+..++.+++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            99999999998865221 13367788889999999999999998   999999999999999999999999999876654


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..  .....+++.|+|||+
T Consensus       156 ~~--~~~~~~~~~~~~Pe~  172 (256)
T cd08530         156 NM--AKTQIGTPHYMAPEV  172 (256)
T ss_pred             CC--cccccCCccccCHHH
Confidence            42  223468889999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=1.5e-24  Score=171.77  Aligned_cols=168  Identities=30%  Similarity=0.416  Sum_probs=139.5

Q ss_pred             CCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |++.+.||+|++|.||+|. ..+++.+++|.+......  ......+.+|+.+++.++|+|++++++++..++..++++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            6778899999999999995 457888999988653322  1234567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+.+ ++.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        79 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          79 FMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             ccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            9965 8877775432  2478888999999999999999999   99999999999999999999999999998775543


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......++..|+|||.
T Consensus       153 ~~~~~~~~~~~~~~PE~  169 (283)
T cd05118         153 RPYTHYVVTRWYRAPEL  169 (283)
T ss_pred             ccccCccCcccccCcHH
Confidence            22234568889999984

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.92  E-value=8.1e-25  Score=175.59  Aligned_cols=171  Identities=25%  Similarity=0.412  Sum_probs=134.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|++.+.||+|++|.||+|. ..+++.+++|.+......+  .....+.+|+.+++.++|+||+++++.+....    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            5899999999999999999994 5578899999875432221  12234578999999999999999998875433    


Q ss_pred             ----cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          116 ----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       116 ----~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                          .+++++||+.+ ++...+....  ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence                46899999865 6666554322  2478889999999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCCCc-----------ccccccccccccCCC
Q 039002          192 FGIAKFLKSDASN-----------WTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~-----------~~~~~gt~~y~aPE~  219 (219)
                      ||++.........           .....+++.|+|||.
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL  197 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHH
Confidence            9998765432211           122356888999993

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.9e-24  Score=168.18  Aligned_cols=163  Identities=26%  Similarity=0.352  Sum_probs=137.0

Q ss_pred             eccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||+|++|.||++. ..+++.+++|.+....... ......+..|+.+++.++|+|++++++.+..++..+++||++++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            6899999999994 4568899999876533221 2234567889999999999999999999999999999999999999


Q ss_pred             HHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccccc
Q 039002          129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF  208 (219)
Q Consensus       129 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  208 (219)
                      |.+++....   .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+.............
T Consensus        80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            999987543   367888899999999999999998   99999999999999999999999999998765543333456


Q ss_pred             ccccccccCCC
Q 039002          209 AGTYGYVALGI  219 (219)
Q Consensus       209 ~gt~~y~aPE~  219 (219)
                      .++..|+|||.
T Consensus       154 ~~~~~~~~Pe~  164 (250)
T cd05123         154 CGTPEYLAPEV  164 (250)
T ss_pred             cCCccccChHH
Confidence            78899999984

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.92  E-value=2.4e-24  Score=174.91  Aligned_cols=168  Identities=27%  Similarity=0.399  Sum_probs=132.9

Q ss_pred             CCCCcceeccccceeEEEEE-cCC--CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeC----
Q 039002           43 DFDAKYCIGNGGHASVYRAE-LPS--REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHA----  114 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~-~~~--~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~----  114 (219)
                      +|++.+.||+|+||.||++. ..+  +..+|+|.+.....  .......+.+|+.+++.+ +|+||+++++.+...    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            47888999999999999995 445  77899998764221  122345677899999999 599999999875432    


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ...+++++++. ++|..++....   .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||+
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            45778889885 68888886432   377888899999999999999998   999999999999999999999999999


Q ss_pred             eeeecCCCC----cccccccccccccCCC
Q 039002          195 AKFLKSDAS----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~----~~~~~~gt~~y~aPE~  219 (219)
                      +..+.....    ......|++.|+|||+
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~  180 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEI  180 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHH
Confidence            986653221    1233578999999994

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.92  E-value=1.3e-24  Score=172.92  Aligned_cols=170  Identities=27%  Similarity=0.383  Sum_probs=134.3

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l  119 (219)
                      ++|+....||+|+||.||++ ...+++.+|+|.+.....   ......+.+|+..+.++. |+||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            46677889999999999999 556788999998764221   133456788999999996 9999999999999899999


Q ss_pred             EEEecCCCCHHHHhc---ccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILN---TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      ++|++. +++.++..   ... ...+++..+..++.+++.|+.|+|+..  +++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~e~~~-~~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          81 CMELMD-ISLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEeccc-CCHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            999985 45544332   111 123778889999999999999999742  89999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+..+... ....|++.|+|||.
T Consensus       157 ~~~~~~~~-~~~~~~~~y~aPE~  178 (288)
T cd06616         157 QLVDSIAK-TRDAGCRPYMAPER  178 (288)
T ss_pred             HhccCCcc-ccccCccCccCHHH
Confidence            65443322 33468899999994

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.92  E-value=6.8e-24  Score=170.97  Aligned_cols=165  Identities=28%  Similarity=0.427  Sum_probs=135.2

Q ss_pred             CCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |...+.||+|+||.||+|. ..++..+++|.+...... .......+.+|+.+++.++|+|++++++++.+....++++|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            6667889999999999994 557889999987543222 22233567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+. +++.+++....  ..+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++++|||++.....  
T Consensus       102 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         102 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            995 57777765432  2377888889999999999999998   999999999999999999999999998864321  


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                        .....|+..|+|||+
T Consensus       174 --~~~~~~~~~y~aPE~  188 (313)
T cd06633         174 --ANSFVGTPYWMAPEV  188 (313)
T ss_pred             --CCCccccccccChhh
Confidence              234578999999994

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=2.1e-24  Score=173.58  Aligned_cols=167  Identities=28%  Similarity=0.446  Sum_probs=136.4

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ..|+..+.||+|++|.||+|. ..++..+++|.+....... ......+.+|+.+++.++|+|++++.+++...+..+++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            447778899999999999994 5577889999875422111 22335677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +||+. +++.+.+....  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99996 57777664332  2367788889999999999999998   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .    ....+++.|+|||.
T Consensus       168 ~----~~~~~~~~y~aPE~  182 (308)
T cd06634         168 A----NXFVGTPYWMAPEV  182 (308)
T ss_pred             c----ccccCCccccCHHH
Confidence            2    23478899999983

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.92  E-value=2.3e-24  Score=174.79  Aligned_cols=166  Identities=19%  Similarity=0.251  Sum_probs=130.7

Q ss_pred             ceeccc--cceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           48 YCIGNG--GHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        48 ~~lg~g--~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      ..||+|  +||.||++. ..+++.||+|.+......  ....+.+.+|+.+++.++|+||+++++++..++..++++|++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            456776  899999994 568899999997643222  223466788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc
Q 039002          125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN  204 (219)
Q Consensus       125 ~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  204 (219)
                      .++++.+++..... ..+++..+..++.|++.||.|+|+.   +++||||||+||+++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          82 AYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             cCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99999998865332 2367888889999999999999998   9999999999999999999999999754322111110


Q ss_pred             -------ccccccccccccCCC
Q 039002          205 -------WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 -------~~~~~gt~~y~aPE~  219 (219)
                             .....++..|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~  179 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPEL  179 (328)
T ss_pred             ccccccccccccCccCccChhh
Confidence                   011235667999995

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=2.7e-24  Score=175.36  Aligned_cols=165  Identities=24%  Similarity=0.391  Sum_probs=133.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|.+.+.||+|+||.||+|. ..+++.+|+|.+......  ......+.+|+.+++.++|+||+++++++....    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            3789999999999999999994 567889999988653222  223355788999999999999999999986543    


Q ss_pred             --cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          116 --HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       116 --~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                        ..++++|++. .++......     .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++++|||
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             CceEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence              4689999985 467665431     267788888999999999999998   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++......   .....+++.|+|||.
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~  185 (342)
T cd07879         163 LARHADAE---MTGYVVTRWYRAPEV  185 (342)
T ss_pred             CCcCCCCC---CCCceeeecccChhh
Confidence            98754322   234577899999994

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.92  E-value=4.7e-25  Score=167.37  Aligned_cols=169  Identities=22%  Similarity=0.372  Sum_probs=137.1

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~  118 (219)
                      .++.+++..||.|+-|.|+++. ..+|...|||.+..   .......+++++.+.++.+.+ .|.|++.+|+|..+..++
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r---t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR---TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc---cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            4455667889999999999995 45788999999875   334456677888888766654 799999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +-||.+. ..+..+++.-.  ..+++.-.-.+...++.||.||-++.  +++|||+||+|||+|..|.+|+||||++-.+
T Consensus       168 IcMelMs-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  168 ICMELMS-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HHHHHHH-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence            9999884 35555554321  23677777788889999999999884  8999999999999999999999999999888


Q ss_pred             cCCCCcccccccccccccCC
Q 039002          199 KSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE  218 (219)
                      .++... +..+|.+.|||||
T Consensus       243 vdSkAh-trsAGC~~YMaPE  261 (391)
T KOG0983|consen  243 VDSKAH-TRSAGCAAYMAPE  261 (391)
T ss_pred             eccccc-ccccCCccccCcc
Confidence            766543 3348999999999

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.92  E-value=1.5e-24  Score=170.06  Aligned_cols=173  Identities=21%  Similarity=0.282  Sum_probs=135.1

Q ss_pred             CCCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCC-chhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           43 DFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSD-QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +|.+.+.||+|+||.||++.. ..+...++|.++...... .......+..|+.+++.++|||++++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            488899999999999999943 334445555443211111 112234566789999999999999999999988999999


Q ss_pred             EEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++++++.+++.... ....+++..+..++.|++.|+.|+|+.   +++|+|++|+|++++. +.++++|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999998875321 123478888999999999999999998   9999999999999974 679999999998775


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~  176 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEA  176 (260)
T ss_pred             CCcccccCCCCCcCccCHHH
Confidence            54444445678899999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=6.6e-24  Score=167.38  Aligned_cols=171  Identities=27%  Similarity=0.402  Sum_probs=132.0

Q ss_pred             CCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           44 FDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      |.+.+.||+|+||.||+|..    .++..+|+|.+......  ......+.+|+.+++.++|||++++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            56788999999999999953    24678999988653322  223456788999999999999999999886532    


Q ss_pred             --cceEEEEecCCCCHHHHhcccc---hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          116 --HSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       116 --~~~lv~e~~~~~~l~~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                        ..+++++++.++++..++....   ....+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence              2368889999999988764221   112367788899999999999999998   99999999999999999999999


Q ss_pred             eccceeeecCCCC--cccccccccccccCCC
Q 039002          191 DFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |||++........  ......+++.|++||.
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  186 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALES  186 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhH
Confidence            9999886543221  1122345677889883

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=3.3e-24  Score=171.32  Aligned_cols=172  Identities=26%  Similarity=0.386  Sum_probs=135.3

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcC-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      ...++|++.+.||+|++|.||+|... ++..+|+|.+....   .......+.+|+..+.+. .|+|++++++++.....
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            34678999999999999999999554 58899999986432   112334456677666566 59999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++. +++..++....  ..+++..+..++.|++.|+.|+|+..  +++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccch
Confidence            999999985 47777665422  23778888899999999999999731  89999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+...... ....+++.|+|||.
T Consensus       164 ~~~~~~~~-~~~~~~~~y~aPE~  185 (296)
T cd06618         164 RLVDSKAK-TRSAGCAAYMAPER  185 (296)
T ss_pred             hccCCCcc-cCCCCCccccCHhh
Confidence            66443322 23467889999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-24  Score=181.13  Aligned_cols=164  Identities=27%  Similarity=0.436  Sum_probs=136.1

Q ss_pred             CcceeccccceeEEEEEcC---CCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           46 AKYCIGNGGHASVYRAELP---SRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~~~---~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +...||.|.||.||+|.+.   .|+  .||||..+.++..+   ..+.|+.|+.+++.++||||+++.|++.. ...|||
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d---~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD---DTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh---hHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            3467999999999999432   233  48999887654443   35789999999999999999999999866 569999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||.++.|.|..++....  ..++......++.|++.|+.|||+.   +++||||-.+|||++....+|++|||+++.+.+
T Consensus       469 mEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            99999999999997654  3478888899999999999999999   899999999999999999999999999998766


Q ss_pred             CCCcccc-cccccccccCC
Q 039002          201 DASNWTE-FAGTYGYVALG  218 (219)
Q Consensus       201 ~~~~~~~-~~gt~~y~aPE  218 (219)
                      ..-..++ ..-..-|||||
T Consensus       544 ~~yYkaS~~kLPIKWmaPE  562 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPE  562 (974)
T ss_pred             cchhhccccccceeecCcc
Confidence            5432222 23346699999

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.92  E-value=7.7e-24  Score=167.99  Aligned_cols=168  Identities=27%  Similarity=0.406  Sum_probs=134.0

Q ss_pred             CCCcceeccccceeEEEEEcC-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC---CCCccceeEeEEEeCCc---
Q 039002           44 FDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET---RHRNIVKFYGFCSHARH---  116 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~---  116 (219)
                      |++.+.||+|+||.||+|... +++.+|+|.+......  ......+.+|+.+++++   +|+|++++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            678899999999999999654 5889999998653321  12234455677766555   69999999999988776   


Q ss_pred             --ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          117 --SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       117 --~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                        .++++|++. +++.+++..... ..+++..+..++.|++.|+.|||+.   +++|+|++|+||+++.++.++++|||+
T Consensus        79 ~~~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          79 LKLTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             ceeEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence              899999996 478887764322 2478899999999999999999998   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +..+..... .....++..|+|||+
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~~PE~  177 (287)
T cd07838         154 ARIYSFEMA-LTSVVVTLWYRAPEV  177 (287)
T ss_pred             ceeccCCcc-cccccccccccChHH
Confidence            987654322 233457888999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.92  E-value=2.1e-24  Score=169.92  Aligned_cols=165  Identities=25%  Similarity=0.384  Sum_probs=130.2

Q ss_pred             eeccccceeEEEEEcCC-------CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           49 CIGNGGHASVYRAELPS-------REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~~~-------~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .||+|+||.||+|...+       +..+++|.+....   .......+.+|+.+++.++|+||+++++++...+..++++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            68999999999995432       2468888875321   1123456788999999999999999999999989999999


Q ss_pred             EecCCCCHHHHhcccch----hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-----cEEEeec
Q 039002          122 EFLERGSLAAILNTDAA----AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-----EAHVADF  192 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-----~~kl~df  192 (219)
                      |++++++|.+++.....    ...+++.++..++.|++.|+.|+|+.   +++|+||+|+||+++.++     .++++||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence            99999999999864211    12367788899999999999999998   999999999999999877     8999999


Q ss_pred             cceeeecCCCC--cccccccccccccCCC
Q 039002          193 GIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |++........  ......++..|+|||+
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPES  184 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHH
Confidence            99876532211  1122345678999994

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.92  E-value=4.2e-24  Score=172.00  Aligned_cols=166  Identities=17%  Similarity=0.231  Sum_probs=130.2

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCC
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLER  126 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  126 (219)
                      .+.+|.|+++.|+++. .+++.+|+|++.....  .......+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus         7 ~~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           7 GKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hHhhcCCceEEEEEec-CCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3444445555455443 3788999999865321  223446788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC---
Q 039002          127 GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS---  203 (219)
Q Consensus       127 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---  203 (219)
                      +++.+++..... ..+++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||.+........   
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999999875322 2367788889999999999999999   999999999999999999999999998876543221   


Q ss_pred             ----cccccccccccccCCC
Q 039002          204 ----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       204 ----~~~~~~gt~~y~aPE~  219 (219)
                          ......++..|+|||+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~  179 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEV  179 (314)
T ss_pred             ccccccccccccccccCHHH
Confidence                1123457788999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.92  E-value=6.3e-25  Score=186.10  Aligned_cols=187  Identities=23%  Similarity=0.463  Sum_probs=149.2

Q ss_pred             CCcccccccHHHHHHH---------hCCCCCcceeccccceeEEEEEcC-C---CcEEEEEecCCCCCCCchhhHHHHHH
Q 039002           25 IPPEVGKILYDEIVKA---------TNDFDAKYCIGNGGHASVYRAELP-S---REVVAVKKFHSPLPSDQTVDQKEFLT   91 (219)
Q Consensus        25 ~~~~~~~~~~~~~~~~---------~~~y~~~~~lg~g~~g~V~~~~~~-~---~~~~aik~~~~~~~~~~~~~~~~~~~   91 (219)
                      ..-++++..|++....         -+...+.+.||.|.||.|++|+.+ .   ...||||.++....   ......|+.
T Consensus       603 ~k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt---ekqrrdFL~  679 (996)
T KOG0196|consen  603 TKTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT---EKQRRDFLS  679 (996)
T ss_pred             ceeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc---HHHHhhhhh
Confidence            4455666655543222         233466789999999999999643 2   23599999986432   334577999


Q ss_pred             HHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEe
Q 039002           92 EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVH  171 (219)
Q Consensus        92 e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  171 (219)
                      |+.+|.+++||||+++.|+......+.|++||+++|+|+.|+....  .++...+...+..+|+.|+.||.++   +.+|
T Consensus       680 EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVH  754 (996)
T KOG0196|consen  680 EASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVH  754 (996)
T ss_pred             hhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchh
Confidence            9999999999999999999999999999999999999999997654  3488889999999999999999999   9999


Q ss_pred             cCCCCCCEEeCCCCcEEEeeccceeeecCCCC-ccccccc--ccccccCCC
Q 039002          172 RDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS-NWTEFAG--TYGYVALGI  219 (219)
Q Consensus       172 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~g--t~~y~aPE~  219 (219)
                      |||-.+|||++.+-.+|++|||+++.+.+... ..++.-|  ...|-|||.
T Consensus       755 RDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEA  805 (996)
T KOG0196|consen  755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEA  805 (996)
T ss_pred             hhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhH
Confidence            99999999999999999999999998865542 2222222  256899983

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-25  Score=161.29  Aligned_cols=176  Identities=22%  Similarity=0.356  Sum_probs=140.8

Q ss_pred             HHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhc-CCCCccceeEeEEEeC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNIVKFYGFCSHA  114 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~  114 (219)
                      +..+.++......||+|++|.|-+- ...+|+..|+|.+.....   .+.+.+.++|+.+... ..-|.++.+||.....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            4444555666788999999999888 456899999999876443   3345667888886544 4689999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcc-cchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          115 RHSFLLCEFLERGSLAAILNT-DAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      +.+||-||.++ .++..+-.. .......++...-+++..++.|+.|||++.  .++|||+||+|||++.+|++|+||||
T Consensus       118 gdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  118 GDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             ccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence            99999999994 477665542 111234788888899999999999999984  89999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++-.+.++... +.-+|...|||||.
T Consensus       195 IsG~L~dSiAk-t~daGCkpYmaPEr  219 (282)
T KOG0984|consen  195 ISGYLVDSIAK-TMDAGCKPYMAPER  219 (282)
T ss_pred             cceeehhhhHH-HHhcCCCccCChhh
Confidence            99888776543 33488999999994

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=2.1e-25  Score=165.42  Aligned_cols=163  Identities=21%  Similarity=0.373  Sum_probs=138.2

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeC--C
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHA--R  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~  115 (219)
                      ..++|++.+++|+|-++.||.| ...+.+.+++|.+++       ...+.+.+|+.+|..+. ||||++++++..+.  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            4678999999999999999999 567888999999874       34467889999999997 99999999999765  3


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEeeccc
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVADFGI  194 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~dfg~  194 (219)
                      ..-|++|+..+.+...+...      ++...+..++.+++.||.|||++   ||+|||+||+|++++. ...++++|+|+
T Consensus       109 tpaLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             CchhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecch
Confidence            46799999998888776643      56677889999999999999999   9999999999999995 47899999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |.++- +....+..+.+.+|..||.
T Consensus       180 AEFYH-p~~eYnVRVASRyfKGPEL  203 (338)
T KOG0668|consen  180 AEFYH-PGKEYNVRVASRYFKGPEL  203 (338)
T ss_pred             HhhcC-CCceeeeeeehhhcCCchh
Confidence            98774 3444566788888889983

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=1.2e-23  Score=192.17  Aligned_cols=160  Identities=25%  Similarity=0.490  Sum_probs=129.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ...+...+.||+|+||.||+|. ..++..||+|++.....     .   ...|+..+++++||||+++++++.+.+..++
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----I---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----c---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            4567778899999999999995 46888999998753211     1   1236888999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||+++++|.+++..      +++..+..++.|++.|+.|+|..+..+++|||+||+||+++.++..++. ||.+....
T Consensus       761 v~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            9999999999999853      6788899999999999999995433489999999999999988887765 65544322


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..    ....+|+.|+|||+
T Consensus       834 ~~----~~~~~t~~y~aPE~  849 (968)
T PLN00113        834 TD----TKCFISSAYVAPET  849 (968)
T ss_pred             cC----CCccccccccCccc
Confidence            11    22378899999995

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=2.6e-24  Score=175.51  Aligned_cols=167  Identities=23%  Similarity=0.403  Sum_probs=137.7

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc--
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH--  116 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--  116 (219)
                      ..++|++...||+|++|.||+|. ..++..+++|.+......  ......+.+|+.+++.++|+|++++.+++...+.  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch--hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            35789999999999999999995 457888999987643211  2233556789999999999999999988765544  


Q ss_pred             ----ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          117 ----SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       117 ----~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                          .++++|++ +++|.+++...    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence                89999998 66998888642    378888999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |++......   .....++..|+|||.
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~  186 (343)
T cd07851         163 GLARHTDDE---MTGYVATRWYRAPEI  186 (343)
T ss_pred             ccccccccc---ccCCcccccccCHHH
Confidence            998765433   234477889999983

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.91  E-value=3.9e-24  Score=174.41  Aligned_cols=167  Identities=24%  Similarity=0.368  Sum_probs=134.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      .++|++.+.||.|+||.||+| ...+++.+++|++....    ......+.+|+.+++.++|+|++++++.+...     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            478999999999999999999 56678899999875432    12345678899999999999999998776543     


Q ss_pred             ---------CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-C
Q 039002          115 ---------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-E  184 (219)
Q Consensus       115 ---------~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~  184 (219)
                               ...++++||+. +++..++...    .+++..+..++.|++.|+.|||+.   +++|+||||+||+++. +
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~  151 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence                     35789999996 5888777532    377888999999999999999998   9999999999999984 5


Q ss_pred             CcEEEeeccceeeecCCCCc---ccccccccccccCCC
Q 039002          185 YEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ~~~kl~dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      +.++++|||.+.........   .....++..|+|||.
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  189 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL  189 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHH
Confidence            67899999999866432211   122367889999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.91  E-value=1.1e-23  Score=168.41  Aligned_cols=172  Identities=22%  Similarity=0.294  Sum_probs=120.2

Q ss_pred             hCCCCCcceeccccceeEEEEEcC-C---CcEEEEEecCCCCCCCchhh-------HHHHHHHHHHHhcCCCCccceeEe
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP-S---REVVAVKKFHSPLPSDQTVD-------QKEFLTEVKALTETRHRNIVKFYG  109 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~-~---~~~~aik~~~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~  109 (219)
                      .++|++.+.||+|+||.||+|... +   +..+++|.............       ......+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            368999999999999999999543 3   34566664322111000000       011123344556778999999998


Q ss_pred             EEEeCC----cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC
Q 039002          110 FCSHAR----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY  185 (219)
Q Consensus       110 ~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~  185 (219)
                      .+....    ..+++++++. .++.+.+....   ..++..+..++.|++.|+.|+|+.   +++||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            765543    2367777763 35666554322   145677788999999999999998   999999999999999999


Q ss_pred             cEEEeeccceeeecCCC-------CcccccccccccccCCC
Q 039002          186 EAHVADFGIAKFLKSDA-------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       186 ~~kl~dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~  219 (219)
                      .++|+|||+++.+....       .......||+.|+|||+
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~  204 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDA  204 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHH
Confidence            99999999998764322       11233579999999984

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=169.31  Aligned_cols=170  Identities=29%  Similarity=0.395  Sum_probs=133.7

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ++.+.+..||.|.||.|++- ..+.|+..|||+++....   ...+.+++.|.....+- +-|||+++||+...++.-|+
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            44556788999999999998 677899999999976432   34567788888866555 57999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc--hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDA--AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      -||.+. .++..+-+.-.  ....+++.-...+..-.+.||.||-..  +.|+|||+||+|||++..|.+|+||||++-.
T Consensus       141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHh
Confidence            999994 46655543211  112356666666777788999999876  4899999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCC
Q 039002          198 LKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      +.++-.. +.-+|...|||||
T Consensus       218 Lv~SiAk-T~daGCrpYmAPE  237 (361)
T KOG1006|consen  218 LVDSIAK-TVDAGCRPYMAPE  237 (361)
T ss_pred             HHHHHHh-hhccCCccccChh
Confidence            7655432 3348999999999

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.8e-26  Score=173.30  Aligned_cols=173  Identities=25%  Similarity=0.421  Sum_probs=137.6

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe---
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH---  113 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---  113 (219)
                      ....+.|+-+.++|+|+||.||+|+ ..+++.||+|++--+  ...........+|+.+|..++|+|++.+.+.|.+   
T Consensus        13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme--neKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh--ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            4445778888999999999999994 557778898875321  2234456677899999999999999988887743   


Q ss_pred             -----CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEE
Q 039002          114 -----ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       114 -----~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~k  188 (219)
                           ....++|+.+|+. +|..+++.-  ..+++...+..++.+++.|+.|+|+.   .|+|||+|+.|++|+.+|.++
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEE
Confidence                 2347899999965 788777642  24578889999999999999999999   999999999999999999999


Q ss_pred             EeeccceeeecCCCC----cccccccccccccCC
Q 039002          189 VADFGIAKFLKSDAS----NWTEFAGTYGYVALG  218 (219)
Q Consensus       189 l~dfg~~~~~~~~~~----~~~~~~gt~~y~aPE  218 (219)
                      |+|||+++.+..+..    ..+..+-|.+|++||
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppE  198 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE  198 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHH
Confidence            999999976653321    123446699999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.3e-23  Score=175.89  Aligned_cols=177  Identities=18%  Similarity=0.247  Sum_probs=126.5

Q ss_pred             HhCCCCCcceeccccceeEEEEEc-----------------CCCcEEEEEecCCCCCCCchh----------hHHHHHHH
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAEL-----------------PSREVVAVKKFHSPLPSDQTV----------DQKEFLTE   92 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~-----------------~~~~~~aik~~~~~~~~~~~~----------~~~~~~~e   92 (219)
                      ..++|++.++||+|+||.||+|..                 ..++.||+|++..........          .......|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999942                 234579999986422110000          01123346


Q ss_pred             HHHHhcCCCCcc-----ceeEeEEEe--------CCcceEEEEecCCCCHHHHhcccch---------------------
Q 039002           93 VKALTETRHRNI-----VKFYGFCSH--------ARHSFLLCEFLERGSLAAILNTDAA---------------------  138 (219)
Q Consensus        93 ~~~l~~l~h~ni-----~~~~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~~~---------------------  138 (219)
                      +.++..++|.++     +++.++|..        .+..|+|+||+++++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     566666642        3568999999999999998863210                     


Q ss_pred             hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc-ccccccccccccC
Q 039002          139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN-WTEFAGTYGYVAL  217 (219)
Q Consensus       139 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~gt~~y~aP  217 (219)
                      ...+.+..+..++.|++.++.|+|..   +++||||||+||+++.++.++|+|||++......... ...-.+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            01134566778899999999999998   9999999999999999999999999998755332211 1112347899999


Q ss_pred             CC
Q 039002          218 GI  219 (219)
Q Consensus       218 E~  219 (219)
                      |.
T Consensus       380 E~  381 (507)
T PLN03224        380 EE  381 (507)
T ss_pred             hh
Confidence            94

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.1e-24  Score=177.85  Aligned_cols=174  Identities=27%  Similarity=0.467  Sum_probs=146.0

Q ss_pred             HHHHHHHhCCCCCcceeccccceeEEEEEcC-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE
Q 039002           34 YDEIVKATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS  112 (219)
Q Consensus        34 ~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  112 (219)
                      .+.|.....+.....+||-|.||.||.|.|+ ...-||||.++.     +......|+.|+.+|+.++|||+++++++|.
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            3677777788888899999999999999665 445699998863     2334578999999999999999999999999


Q ss_pred             eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          113 HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       113 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                      .....|||+||+..|+|.+++..... ..++.-..+.++.||..|+.||..+   ++|||||-.+|+|++.+..+|+.||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence            99999999999999999999986543 3356666778899999999999998   8999999999999999999999999


Q ss_pred             cceeeecCCCCcccccccc---cccccCC
Q 039002          193 GIAKFLKSDASNWTEFAGT---YGYVALG  218 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt---~~y~aPE  218 (219)
                      |++++++...  .+..+|.   +-|-|||
T Consensus       410 GLsRlMtgDT--YTAHAGAKFPIKWTAPE  436 (1157)
T KOG4278|consen  410 GLSRLMTGDT--YTAHAGAKFPIKWTAPE  436 (1157)
T ss_pred             chhhhhcCCc--eecccCccCcccccCcc
Confidence            9999886543  2333443   4488888

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=2.2e-23  Score=179.38  Aligned_cols=168  Identities=20%  Similarity=0.235  Sum_probs=116.9

Q ss_pred             HhCCCCCcceeccccceeEEEEEc-CC----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeE----
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAEL-PS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGF----  110 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~-~~----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~----  110 (219)
                      ..++|++.+.||+|+||.||+|.. .+    +..+|+|++....      .......+  .++...+.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            568899999999999999999954 45    6889999875311      11111111  1112222222222111    


Q ss_pred             --EEeCCcceEEEEecCCCCHHHHhcccchhhc-----------------cCHHHHHHHHHHHHHHHHhhhhCCCCCeEe
Q 039002          111 --CSHARHSFLLCEFLERGSLAAILNTDAAAQE-----------------LGWSQRMSVIKGVADALSYLHHDCFPPIVH  171 (219)
Q Consensus       111 --~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~-----------------l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  171 (219)
                        .......++++||+.+++|.+++........                 .....+..++.|++.||.|+|+.   +|+|
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH  278 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH  278 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence              2355679999999999999998864321100                 11233557889999999999998   9999


Q ss_pred             cCCCCCCEEeCC-CCcEEEeeccceeeecCCCC-cccccccccccccCC
Q 039002          172 RDVSSKNLLLDL-EYEAHVADFGIAKFLKSDAS-NWTEFAGTYGYVALG  218 (219)
Q Consensus       172 ~dlkp~nili~~-~~~~kl~dfg~~~~~~~~~~-~~~~~~gt~~y~aPE  218 (219)
                      |||||+|||++. ++.+||+|||+++.+..... ....+++++.|+|||
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE  327 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE  327 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChH
Confidence            999999999985 58999999999986543221 224568899999999

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.90  E-value=4.2e-23  Score=159.99  Aligned_cols=149  Identities=19%  Similarity=0.168  Sum_probs=122.1

Q ss_pred             ccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCCHHH
Q 039002           53 GGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAA  131 (219)
Q Consensus        53 g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~  131 (219)
                      |.+|.||++ +..+++.+|+|.+....         ...+|...+....|||++++++.+...+..+++|||+.+++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            789999999 56788899999986421         11234444455579999999999999999999999999999999


Q ss_pred             HhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcccccccc
Q 039002          132 ILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT  211 (219)
Q Consensus       132 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt  211 (219)
                      ++....   .+++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||.+......   .....++
T Consensus        75 ~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~  145 (237)
T cd05576          75 HISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVE  145 (237)
T ss_pred             HHHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcC
Confidence            886532   377888899999999999999998   9999999999999999999999999987655432   2234567


Q ss_pred             cccccCCC
Q 039002          212 YGYVALGI  219 (219)
Q Consensus       212 ~~y~aPE~  219 (219)
                      ..|+|||.
T Consensus       146 ~~y~aPE~  153 (237)
T cd05576         146 NMYCAPEV  153 (237)
T ss_pred             ccccCCcc
Confidence            78999994

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-23  Score=165.62  Aligned_cols=166  Identities=20%  Similarity=0.274  Sum_probs=137.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC--C----ccceeEeEEEe
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH--R----NIVKFYGFCSH  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----ni~~~~~~~~~  113 (219)
                      .++|.+...+|+|+||+|..+ ...++..||+|++++.     ....+...-|+.++.++.+  |    -++.+.+||.-
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            678999999999999999999 5666788999998752     3355666779999999942  2    36778889999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC----------
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL----------  183 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~----------  183 (219)
                      .++.+||+|.+ |.++.+++..+.- ..++...+..+..|++.++.+||+.   +++|.||||+||++-.          
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence            99999999988 6699999987543 3478899999999999999999999   9999999999999832          


Q ss_pred             ----------CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 ----------EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                                +-.++++|||.|.+-....   .+.+.|..|+|||+
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEV  280 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEV  280 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchh
Confidence                      1247999999998765443   56789999999996

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=6.4e-23  Score=153.62  Aligned_cols=145  Identities=21%  Similarity=0.193  Sum_probs=107.8

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchh----------------------hHHHHHHHHHHHhcCCCCcc
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----------------------DQKEFLTEVKALTETRHRNI  104 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~ni  104 (219)
                      ...||+|++|.||+|...+|+.||+|.++.........                      ......+|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46899999999999976789999999987643221110                      01123458999999987776


Q ss_pred             ceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhh-hhCCCCCeEecCCCCCCEEeCC
Q 039002          105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       105 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dlkp~nili~~  183 (219)
                      ........  ...+++|||++++++.......   ..++...+..++.|++.++.++ |+.   +++||||||+||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            44333222  2348999999887665443222   2367788899999999999999 687   999999999999998 


Q ss_pred             CCcEEEeeccceeeecC
Q 039002          184 EYEAHVADFGIAKFLKS  200 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~  200 (219)
                      ++.++++|||++.....
T Consensus       153 ~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         153 DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CCcEEEEEccccccCCC
Confidence            57899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-23  Score=175.76  Aligned_cols=173  Identities=23%  Similarity=0.349  Sum_probs=138.8

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcC--CCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELP--SRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~--~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      .++.++..+.++||+|+||.|++|.|.  .|+  .||||.++.....   .....|.+|+..|.+++|+|++++||+..+
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            344456667899999999999999654  444  5999998765433   266789999999999999999999999988


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                       ....+|+|+++.|+|.+.+..... ..+.......++.||+.|+.||..+   ++|||||-.+|+++.....+||+|||
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~-~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKK-AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccc-cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence             678899999999999999876221 2356677888999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCccc--c-cccccccccCC
Q 039002          194 IAKFLKSDASNWT--E-FAGTYGYVALG  218 (219)
Q Consensus       194 ~~~~~~~~~~~~~--~-~~gt~~y~aPE  218 (219)
                      +.+.+........  . .--...|.|||
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPE  285 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPE  285 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHh
Confidence            9987764432211  0 11234578887

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=4.7e-22  Score=149.20  Aligned_cols=145  Identities=21%  Similarity=0.202  Sum_probs=109.2

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCch----------------------hhHHHHHHHHHHHhcCCCCcc
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQT----------------------VDQKEFLTEVKALTETRHRNI  104 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~ni  104 (219)
                      ...||+|++|.||+|...+|+.||+|.+.........                      ........|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999997668999999998764321100                      001223578899999999887


Q ss_pred             ceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCC
Q 039002          105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       105 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~  183 (219)
                      .....+...  ..+++|||++++++.......   ..++......++.+++.++.++|+ .   +++|+||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            555444433  248999999887543322111   125567788899999999999999 8   999999999999998 


Q ss_pred             CCcEEEeeccceeeecC
Q 039002          184 EYEAHVADFGIAKFLKS  200 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~  200 (219)
                      ++.++++|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            89999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-23  Score=175.80  Aligned_cols=166  Identities=23%  Similarity=0.437  Sum_probs=134.4

Q ss_pred             CCCcceeccccceeEEEE-EcCCCc----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      .+..++||+|+||.||+| +.+.|+    +||+|.+...   .......+++.|+..|.+++|+|++++++++.... +.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            344689999999999999 566654    5888877532   12234567899999999999999999999998766 88


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ||++|++.|+|.++++.++.  .+.....+.+..||++||.|||.+   +++||||-++|+|+.....+|+.|||+++.+
T Consensus       774 lvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            99999999999999987653  367788889999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCccccc--ccccccccCC
Q 039002          199 KSDASNWTEF--AGTYGYVALG  218 (219)
Q Consensus       199 ~~~~~~~~~~--~gt~~y~aPE  218 (219)
                      ..........  .-.+.|||-|
T Consensus       849 ~~d~~ey~~~~gK~pikwmale  870 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALE  870 (1177)
T ss_pred             CcccccccccccccCcHHHHHH
Confidence            6554433222  2234466654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=2.4e-21  Score=147.99  Aligned_cols=168  Identities=32%  Similarity=0.514  Sum_probs=139.7

Q ss_pred             CCCcceeccccceeEEEEEcC-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |.+.+.||+|++|.||+|... +++.+++|.+......   .....+.+|+..++.++|+|++++++.+...+..++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence            567789999999999999544 5888999998653222   134567889999999999999999999999899999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      ++.+++|.+++......  +++.....++.+++.++.++|+.   +++|+|++|+|++++..+.++++|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       78 YCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             ccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            99999999998754321  56788889999999999999998   99999999999999999999999999998775542


Q ss_pred             -CcccccccccccccCCC
Q 039002          203 -SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 -~~~~~~~gt~~y~aPE~  219 (219)
                       .......++..|++||.
T Consensus       153 ~~~~~~~~~~~~~~~pe~  170 (225)
T smart00221      153 AALLKTVKGTPFYLAPEV  170 (225)
T ss_pred             cccccceeccCCcCCHhH
Confidence             12234577888999983

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.2e-24  Score=164.01  Aligned_cols=167  Identities=26%  Similarity=0.375  Sum_probs=132.2

Q ss_pred             CCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----Ccc
Q 039002           44 FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----RHS  117 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~  117 (219)
                      .+-...||-|+||.||.+ +-++|+.|++|++.+...  .-...+.+.+|+.++.-++|.|+...+++.+-.     .+.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq--~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ--NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHH--HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            345678999999999999 556899999999754322  223456789999999999999999998887543     346


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+++|.+.. +|...+-+   ++.++.+.+..++.||+.|+.|||+.   +|.||||||-|.++..+-.+||||||+++.
T Consensus       133 YV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            788888843 77666643   23467777788889999999999999   999999999999999999999999999986


Q ss_pred             ecCCC-CcccccccccccccCCC
Q 039002          198 LKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      .+... ...+-.+-|.+|+|||+
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEi  228 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPEL  228 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHH
Confidence            65332 22233477899999996

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-21  Score=169.71  Aligned_cols=177  Identities=25%  Similarity=0.413  Sum_probs=141.2

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEcC----C----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccce
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAELP----S----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVK  106 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~~----~----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~  106 (219)
                      .|.....+..+.+.+|.|.||.|++|...    .    ...||+|..+.....   ...+.+..|+.+++.+ +|+|++.
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~  366 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVN  366 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhh
Confidence            45556666677789999999999999421    1    346999998764322   3456788999999999 6999999


Q ss_pred             eEeEEEeCCcceEEEEecCCCCHHHHhcccc-----hh--------hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecC
Q 039002          107 FYGFCSHARHSFLLCEFLERGSLAAILNTDA-----AA--------QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRD  173 (219)
Q Consensus       107 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  173 (219)
                      +.+++...+.+++++||+..|+|..++...+     ..        ..++....+.++.||+.|++||++.   +++|||
T Consensus       367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRD  443 (609)
T KOG0200|consen  367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRD  443 (609)
T ss_pred             heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchh
Confidence            9999999999999999999999999997654     00        1277788899999999999999999   999999


Q ss_pred             CCCCCEEeCCCCcEEEeeccceeeecCCCCcc-ccccc--ccccccCC
Q 039002          174 VSSKNLLLDLEYEAHVADFGIAKFLKSDASNW-TEFAG--TYGYVALG  218 (219)
Q Consensus       174 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~g--t~~y~aPE  218 (219)
                      |-.+|||+..+..+||+|||+|+......... ..-.+  ...|||||
T Consensus       444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApE  491 (609)
T KOG0200|consen  444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPE  491 (609)
T ss_pred             hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHH
Confidence            99999999999999999999998654433221 11122  34499998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.87  E-value=1.2e-20  Score=141.93  Aligned_cols=162  Identities=34%  Similarity=0.569  Sum_probs=134.2

Q ss_pred             eccccceeEEEEEcC-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCC
Q 039002           50 IGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGS  128 (219)
Q Consensus        50 lg~g~~g~V~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~  128 (219)
                      ||+|.+|.||++... +++.+++|.+.......   ....+.+|+..++.++|++++++++++......++++|++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999554 58889999986532111   23567889999999999999999999999999999999999899


Q ss_pred             HHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEeeccceeeecCCCCcccc
Q 039002          129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVADFGIAKFLKSDASNWTE  207 (219)
Q Consensus       129 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~~~~~~~~  207 (219)
                      |..++....  ..+++.....++.+++.++.++|..   +++|+|++|.||+++. .+.++++|||.+............
T Consensus        78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            999986531  1367788889999999999999999   9999999999999998 899999999999876554322334


Q ss_pred             cccccccccCCC
Q 039002          208 FAGTYGYVALGI  219 (219)
Q Consensus       208 ~~gt~~y~aPE~  219 (219)
                      ..+...|++||.
T Consensus       153 ~~~~~~~~~pe~  164 (215)
T cd00180         153 IVGTPAYMAPEV  164 (215)
T ss_pred             ccCCCCccChhH
Confidence            567888999983

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-21  Score=151.66  Aligned_cols=165  Identities=19%  Similarity=0.331  Sum_probs=135.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~  118 (219)
                      --.|++.++||+|+||.++.| ..-+++.||||.=.  .    ......+.-|....+.|. -+.|..+|.+...+-.-.
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--r----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--R----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecc--c----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            357999999999999999999 67789999999621  1    112234667888888885 589999988888888888


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-----cEEEeecc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-----EAHVADFG  193 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-----~~kl~dfg  193 (219)
                      ||+|.+ |.+|.+++.-.  ...++..+++-++.|++.-++++|++   .+|.|||||+|+||++.+     .+.++|||
T Consensus       101 LVidLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhhhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence            999988 78999998644  34688899999999999999999999   999999999999998654     48899999


Q ss_pred             ceeeecCCCCcc-------cccccccccccC
Q 039002          194 IAKFLKSDASNW-------TEFAGTYGYVAL  217 (219)
Q Consensus       194 ~~~~~~~~~~~~-------~~~~gt~~y~aP  217 (219)
                      +|+.+.++.++.       .+..||..||+-
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEe
Confidence            999998776543       456899999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.86  E-value=5.8e-22  Score=169.18  Aligned_cols=163  Identities=26%  Similarity=0.381  Sum_probs=127.0

Q ss_pred             CCcceeccccc-eeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEEE
Q 039002           45 DAKYCIGNGGH-ASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        45 ~~~~~lg~g~~-g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      .--+.+|.|+. +.||+|... ++.||||++-.       .....+.+|+..|+.- +||||+++|+.-.+.++.||..|
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC-CceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            33466888875 568899654 45899998742       2334568999999988 59999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchh-hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CC--cEEEeecccee
Q 039002          123 FLERGSLAAILNTDAAA-QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EY--EAHVADFGIAK  196 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~--~~kl~dfg~~~  196 (219)
                      .| ..+|.+++...+.. .....-..+.+..|++.|+.+||+.   +|+||||||+||||+.   ++  +++|+|||+++
T Consensus       584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            99 56999999763111 1111133467789999999999998   9999999999999986   34  67899999999


Q ss_pred             eecCCCCc---ccccccccccccCCC
Q 039002          197 FLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      .+....+.   .....||-+|+|||.
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~  685 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQ  685 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHH
Confidence            88654432   345689999999994

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.6e-21  Score=144.70  Aligned_cols=165  Identities=21%  Similarity=0.330  Sum_probs=133.9

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC-CccceeEeEEEeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKFYGFCSHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~  117 (219)
                      ..++|+++++||.|+||.+|.| ...+|+.||+|.=.      ..+....+.-|..+.+.+++ ..|+.+..+......-
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es------~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES------SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeec------ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            4689999999999999999999 67889999999733      22344556778898888876 5777777777788888


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEeeccc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVADFGI  194 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~dfg~  194 (219)
                      .+||+.. |.+|.+++...  ...++..+++-++-|++.-++|+|.+   +.+||||||+|.|++-   ..++-++|||+
T Consensus        87 vlVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             eeeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence            8999988 78999988643  24478889999999999999999999   8999999999999973   35788999999


Q ss_pred             eeeecCCCCcc-------ccccccccccc
Q 039002          195 AKFLKSDASNW-------TEFAGTYGYVA  216 (219)
Q Consensus       195 ~~~~~~~~~~~-------~~~~gt~~y~a  216 (219)
                      ++.+.+..+..       ...+||..|.+
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehh
Confidence            99876544322       34578888754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.86  E-value=4.7e-22  Score=153.74  Aligned_cols=166  Identities=22%  Similarity=0.358  Sum_probs=134.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  113 (219)
                      ..+|..+..+|.|.- .|..+ +.-.+++|++|++..+...  ....+++.+|..++..++|+|+++++.+|.-      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            466778888998887 56666 5567889999998876433  3455678899999999999999999999943      


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      ...+|+|||++. .++...+..     .+...++.+++.|+++|+.++|+.   +|+||||||+||++..+..+||.|||
T Consensus        93 ~~e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   93 FQEVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHhHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            245899999994 588887763     256678889999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +|..-... =-.+..+.|..|.|||+
T Consensus       164 ~ar~e~~~-~~mtpyVvtRyyrapev  188 (369)
T KOG0665|consen  164 LARTEDTD-FMMTPYVVTRYYRAPEV  188 (369)
T ss_pred             hhcccCcc-cccCchhheeeccCchh
Confidence            99743222 12245688899999996

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-21  Score=148.70  Aligned_cols=149  Identities=22%  Similarity=0.400  Sum_probs=123.2

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe-EEEeC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG-FCSHA  114 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~-~~~~~  114 (219)
                      ..-.+.|.+.+.+|+|.||++.+++ .++.+.+++|-+..+     ......|.+|...--.+ .|.||+.-|+ .|++.
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            4455889999999999999999995 557778999987543     23556788898876666 4889987655 67888


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC--CCCcEEEeec
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD--LEYEAHVADF  192 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~--~~~~~kl~df  192 (219)
                      +.++.++|+++.|+|..-+...+    +.+..-..++.|++.|+.|+|+.   +++|||||.+||||-  ..-++|+|||
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence            88999999999999998876543    66777788999999999999999   999999999999995  3458999999


Q ss_pred             cceeee
Q 039002          193 GIAKFL  198 (219)
Q Consensus       193 g~~~~~  198 (219)
                      |.....
T Consensus       168 G~t~k~  173 (378)
T KOG1345|consen  168 GLTRKV  173 (378)
T ss_pred             cccccc
Confidence            987643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.85  E-value=1.4e-20  Score=144.94  Aligned_cols=156  Identities=29%  Similarity=0.481  Sum_probs=130.9

Q ss_pred             cceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCCHHHH
Q 039002           54 GHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAI  132 (219)
Q Consensus        54 ~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~  132 (219)
                      +||.||+|.. .+++.+++|.+.......   ....+.+|+..++.++|+|++++++.+......++++|++.+++|..+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK---KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            4789999954 468899999986532211   146788899999999999999999999998999999999999999999


Q ss_pred             hcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccccccccc
Q 039002          133 LNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTY  212 (219)
Q Consensus       133 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~  212 (219)
                      +.....   +++.....++.+++.++.++|..   +++|+|++|+||+++.++.++++|||.+....... ......++.
T Consensus        78 ~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  150 (244)
T smart00220       78 LKKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP  150 (244)
T ss_pred             HHhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence            865332   67788899999999999999998   99999999999999999999999999998775542 224457888


Q ss_pred             ccccCCC
Q 039002          213 GYVALGI  219 (219)
Q Consensus       213 ~y~aPE~  219 (219)
                      .|++||.
T Consensus       151 ~~~~pE~  157 (244)
T smart00220      151 EYMAPEV  157 (244)
T ss_pred             CCCCHHH
Confidence            9999983

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=4.5e-20  Score=139.75  Aligned_cols=138  Identities=18%  Similarity=0.268  Sum_probs=103.5

Q ss_pred             CCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-----CCCccceeEeEEEeCC---c
Q 039002           45 DAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-----RHRNIVKFYGFCSHAR---H  116 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~---~  116 (219)
                      .-...||+|++|.||. ...++. .+||.+....    ......+.+|+.+++.+     +||||+++++++.++.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcC-eEEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            3457899999999996 333443 4688875421    12345688999999999     5799999999998873   4


Q ss_pred             ce-EEEEe--cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHH-HhhhhCCCCCeEecCCCCCCEEeCCC----CcEE
Q 039002          117 SF-LLCEF--LERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL-SYLHHDCFPPIVHRDVSSKNLLLDLE----YEAH  188 (219)
Q Consensus       117 ~~-lv~e~--~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~lh~~~~~~i~H~dlkp~nili~~~----~~~k  188 (219)
                      ++ +|+||  +.+++|.++++...    +++.  ..++.+++.++ .|||+.   +|+||||||+||+++..    +.++
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence            34 78999  55799999996532    3333  34567777777 899999   99999999999999743    3799


Q ss_pred             Eee-ccceee
Q 039002          189 VAD-FGIAKF  197 (219)
Q Consensus       189 l~d-fg~~~~  197 (219)
                      |+| ||....
T Consensus       150 LiDg~G~~~~  159 (210)
T PRK10345        150 VCDNIGESTF  159 (210)
T ss_pred             EEECCCCcce
Confidence            999 565544

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.85  E-value=2.7e-21  Score=158.09  Aligned_cols=168  Identities=23%  Similarity=0.277  Sum_probs=138.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC------CccceeEeEEEe
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH------RNIVKFYGFCSH  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~~~~  113 (219)
                      .+.|.+..-.|+|-|+.|..| ....+..||||++.+..     .-.+.=+.|+.+|++|+.      -++++++..|..
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            366888899999999999999 55667799999997531     122334679999999952      378899999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEeec
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADF  192 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~df  192 (219)
                      .+++|+|+|.+ ..+|...++..+....+....+..++.|+..||..|-.+   +++|.||||+|||+... ..+|||||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence            99999999988 569999998766545577788899999999999999998   99999999999999965 67899999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |.|.+....  ..+..+-+..|.||||
T Consensus       582 GSA~~~~en--eitPYLVSRFYRaPEI  606 (752)
T KOG0670|consen  582 GSASFASEN--EITPYLVSRFYRAPEI  606 (752)
T ss_pred             ccccccccc--cccHHHHHHhccCcce
Confidence            999876433  2345677888999997

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=8.8e-21  Score=158.17  Aligned_cols=162  Identities=24%  Similarity=0.323  Sum_probs=130.8

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHH-hcCCCCccceeEeEEEeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL-TETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ..++|.+...+|.|+|+.|..+ ...+++..++|++....        ....+|+.++ ..-+|+|++++.+.+.++.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCcee
Confidence            3678999999999999999998 56678889999986431        1123456444 444799999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe-CCCCcEEEeecccee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL-DLEYEAHVADFGIAK  196 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili-~~~~~~kl~dfg~~~  196 (219)
                      |+|||.+.++-+.+.+.....   .. ..+..++.+++.|+.|||++   +++||||||+|||+ +..|.++|+|||+++
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence            999999998877776654321   22 55667899999999999998   99999999999999 588999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .....   ....+-|..|.|||.
T Consensus       465 ~~~~~---~~tp~~t~~y~APEv  484 (612)
T KOG0603|consen  465 ELERS---CDTPALTLQYVAPEV  484 (612)
T ss_pred             hCchh---hcccchhhcccChhh
Confidence            77654   234467889999994

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.1e-19  Score=140.58  Aligned_cols=154  Identities=20%  Similarity=0.206  Sum_probs=112.8

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE--cCCCcEEEEEecCCCCCCCch--------------------hhHHHHHHHHH
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQT--------------------VDQKEFLTEVK   94 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~--~~~~~~~aik~~~~~~~~~~~--------------------~~~~~~~~e~~   94 (219)
                      +....-.|++.+.||+|++|.||+|.  ..+|+.||+|.++........                    .....+..|+.
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            34433458899999999999999997  568999999998653211000                    01123467999


Q ss_pred             HHhcCCCC--ccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC-eEe
Q 039002           95 ALTETRHR--NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP-IVH  171 (219)
Q Consensus        95 ~l~~l~h~--ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H  171 (219)
                      +++.+.+.  .+++++++    ...+++||++.+.++........   .........++.|++.++.++|..   + ++|
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH  172 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVH  172 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEe
Confidence            99999753  33444432    23589999999877765542221   134445678889999999999999   8 999


Q ss_pred             cCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          172 RDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       172 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      +|+||+||+++ +++++++|||.+.....+
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence            99999999999 889999999998865443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=2.7e-19  Score=136.32  Aligned_cols=142  Identities=13%  Similarity=0.159  Sum_probs=113.9

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHH------HHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE------FLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++|++.+.+|+|+||.||.++. ++..+++|.+.+...... .....      +.+|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~-~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTE-RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchH-HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            58899999999999999999855 466899999876543332 22222      46889999999999999998886533


Q ss_pred             --------CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          115 --------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       115 --------~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                              +..+++|||++|.+|.++..       .+.    ....+++.++..+|+.   +++|+|++|.|++++.+| 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence                    35789999999999977632       222    2345889999999999   999999999999999888 


Q ss_pred             EEEeeccceeeec
Q 039002          187 AHVADFGIAKFLK  199 (219)
Q Consensus       187 ~kl~dfg~~~~~~  199 (219)
                      ++++|||......
T Consensus       173 i~liDfg~~~~~~  185 (232)
T PRK10359        173 LRIIDLSGKRCTA  185 (232)
T ss_pred             EEEEECCCccccc
Confidence            9999999877553

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=8.6e-19  Score=133.49  Aligned_cols=139  Identities=17%  Similarity=0.325  Sum_probs=112.0

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCc----hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEe
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ----TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      +.||+|++|.||+|.. .+..+++|..........    ......+.+|+.++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999966 566788897654322211    11224567899999999999988877777777889999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++++|.+++...      .. ....++.+++.++.++|..   +++|+|++|.||+++ .+.++++|||.+...
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999887532      12 5677889999999999999   999999999999999 789999999998753

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=5.1e-18  Score=127.03  Aligned_cols=137  Identities=12%  Similarity=0.067  Sum_probs=102.9

Q ss_pred             CCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceEEEEe
Q 039002           45 DAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      .+...|++|.||.|+.+.. .+..++.+.+..............+.+|+.+++.+. ++++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998866 455667665543211101111124678999999995 4789999886    346999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC-CCCCEEeCCCCcEEEeeccceeeec
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV-SSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-kp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +.|.+|......          ....++.|++.++.++|+.   +++|||| ||.||+++.+|.++|+|||++....
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            999888654321          1134567889999999999   9999999 7999999999999999999998544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=1.3e-18  Score=140.88  Aligned_cols=167  Identities=21%  Similarity=0.328  Sum_probs=127.4

Q ss_pred             CCCCcceeccccceeEEEEEc-CCC-cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC----CccceeEeEE-EeCC
Q 039002           43 DFDAKYCIGNGGHASVYRAEL-PSR-EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH----RNIVKFYGFC-SHAR  115 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~-~~~-~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----~ni~~~~~~~-~~~~  115 (219)
                      +|.+.+.||+|+||.||.|.. .++ ..+|+|.-.......   . ..+..|..++..+..    +++..+.+.. ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            899999999999999999953 333 467777654321111   1 145668888888762    6888898888 4777


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-----CcEEEe
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-----YEAHVA  190 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-----~~~kl~  190 (219)
                      ..|+||+.+ |.+|.++..... ...++..+...++.|++.+|.++|+.   +++||||||.|++++..     ..+.+.
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence            889999988 789999886554 35588899999999999999999999   99999999999999865     358999


Q ss_pred             eccceeeec---CCC-------CcccccccccccccCC
Q 039002          191 DFGIAKFLK---SDA-------SNWTEFAGTYGYVALG  218 (219)
Q Consensus       191 dfg~~~~~~---~~~-------~~~~~~~gt~~y~aPE  218 (219)
                      |||+++.+.   ...       .....+.||..|.++.
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~  207 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN  207 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHH
Confidence            999998332   111       1123456999998763

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=3.7e-18  Score=128.89  Aligned_cols=135  Identities=16%  Similarity=0.326  Sum_probs=105.5

Q ss_pred             eeccccceeEEEEEcCCCcEEEEEecCCCCCCCc----hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           49 CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ----TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      .||+|++|.||+|.+ ++..+++|..........    ......+.+|+.+++.+.|+++.....++...+..+++||++
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999974 456788888543221111    112355678999999998887666655566667789999999


Q ss_pred             CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       125 ~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++++.+++....       .   .++.+++.++.++|+.   +++|+|++|.|++++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999988764321       0   6778999999999999   999999999999999 889999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=2.6e-18  Score=129.73  Aligned_cols=142  Identities=18%  Similarity=0.149  Sum_probs=107.2

Q ss_pred             CCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCch------------------hhHHHHHHHHHHHhcCCCCc-
Q 039002           43 DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQT------------------VDQKEFLTEVKALTETRHRN-  103 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~------------------~~~~~~~~e~~~l~~l~h~n-  103 (219)
                      -|.+.+.||+|+||.||+|...+++.+|+|.+.........                  ........|+..+..+.+++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            37788999999999999998778999999987543211000                  01123567888888887764 


Q ss_pred             -cceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          104 -IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       104 -i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                       ++..++    ....+++|||++++++......         .....++.+++.++.++|..   +++|+||+|.||+++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence             344433    2456899999999888665321         22346778899999999998   999999999999999


Q ss_pred             CCCcEEEeeccceeeecC
Q 039002          183 LEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~  200 (219)
                      .++.++++|||.+.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999965544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.78  E-value=6.5e-19  Score=140.67  Aligned_cols=145  Identities=26%  Similarity=0.431  Sum_probs=124.9

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEE
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFC  111 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~  111 (219)
                      +......|.++++||.|.|+.||++. ..   .+..+|+|.+...      ..+.++..|+.+|..+. +.||+.+.+++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t------s~p~ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT------SSPSRILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc------cCchHHHHHHHHHHHhccchhhhcchhhh
Confidence            45556779999999999999999993 33   5668999998642      23456788999999995 89999999999


Q ss_pred             EeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEe
Q 039002          112 SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVA  190 (219)
Q Consensus       112 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~  190 (219)
                      ..++++.+|+||.++....++...      ++...+..++..+..||.++|..   ||+|||+||.|++.+.. ++-.|+
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence            999999999999999999888754      55677888899999999999999   99999999999999954 888999


Q ss_pred             ecccee
Q 039002          191 DFGIAK  196 (219)
Q Consensus       191 dfg~~~  196 (219)
                      |||+|.
T Consensus       176 DFgLA~  181 (418)
T KOG1167|consen  176 DFGLAQ  181 (418)
T ss_pred             echhHH
Confidence            999987

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=5e-18  Score=146.08  Aligned_cols=142  Identities=19%  Similarity=0.337  Sum_probs=109.7

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEec-CCCCCC---CchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKF-HSPLPS---DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~-~~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ..|...+.||+|+||.||+|.+.... +++|+. ......   +.......+.+|+.+++.++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34566789999999999999665443 333332 211111   1112235577899999999999998887777777788


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++|||+++++|.+++.           ....++.+++.++.++|+.   +++|||+||+||++ .++.++++|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999988764           2346778999999999998   99999999999999 678999999999986


Q ss_pred             ec
Q 039002          198 LK  199 (219)
Q Consensus       198 ~~  199 (219)
                      ..
T Consensus       477 ~~  478 (535)
T PRK09605        477 SD  478 (535)
T ss_pred             CC
Confidence            43

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.76  E-value=2.4e-17  Score=131.62  Aligned_cols=170  Identities=32%  Similarity=0.510  Sum_probs=137.7

Q ss_pred             CCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC-ccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR-NIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |.+...||.|+|+.||.+...  ..+++|.+........ .....+.+|+..++.+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            677889999999999999554  6788888765432221 2356788899999999988 79999999977777899999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEEeeccceeeecCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKFLKSD  201 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~  201 (219)
                      ++.++++.+++........+.......++.|++.++.++|..   +++|||+||+|++++..+ .++++|||.+..+...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999997765432101367788889999999999999999   999999999999999888 7999999999866544


Q ss_pred             CC------cccccccccccccCCC
Q 039002          202 AS------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~------~~~~~~gt~~y~aPE~  219 (219)
                      ..      ......|+..|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~  179 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEV  179 (384)
T ss_pred             CccccccccccccccccccCCHHH
Confidence            32      2356689999999983

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.8e-18  Score=139.50  Aligned_cols=135  Identities=24%  Similarity=0.397  Sum_probs=111.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-----C---CccceeEeEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-----H---RNIVKFYGFC  111 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~ni~~~~~~~  111 (219)
                      .++|-+.++||.|-|++||+| +....+.||+|..+.     .....+...-||.+|+.++     |   .+|+++++.|
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            367889999999999999999 556677899999863     2345667788999999883     2   4799999999


Q ss_pred             E----eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC
Q 039002          112 S----HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE  184 (219)
Q Consensus       112 ~----~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~  184 (219)
                      .    ++.++++|+|++ |.+|..+|....- +.++...+..|+.||+.||.|||..|  +|+|.||||+|||+...
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence            5    456899999999 6688888865322 33888999999999999999999997  99999999999999644

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=1.4e-16  Score=119.05  Aligned_cols=141  Identities=23%  Similarity=0.221  Sum_probs=97.2

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhH--------------------HHHHHHHHHHhcCCCCc--c
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQ--------------------KEFLTEVKALTETRHRN--I  104 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~h~n--i  104 (219)
                      .+.||+|+||.||+|...+++.||+|.+............                    .....|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5679999999999997778889999987653322111110                    00134555555554332  3


Q ss_pred             ceeEeEEEeCCcceEEEEecCCCCHHH-HhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeC
Q 039002          105 VKFYGFCSHARHSFLLCEFLERGSLAA-ILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       105 ~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~  182 (219)
                      .+.++.    ...+++|||++++.+.. .+....    . ......++.+++.++.++|. .   +++|+|++|+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            344432    34689999998854321 111100    1 14466788999999999999 7   999999999999999


Q ss_pred             CCCcEEEeeccceeeecC
Q 039002          183 LEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~  200 (219)
                       ++.++++|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999976654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.1e-16  Score=114.75  Aligned_cols=135  Identities=20%  Similarity=0.193  Sum_probs=107.9

Q ss_pred             CcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC--CccceeEeEEEeCCcceEEEEe
Q 039002           46 AKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH--RNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      +.+.||+|.++.||++...+ ..+++|.......      ...+.+|+..++.+++  .++++++.+....+..++++|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999997654 6789998754321      3457788999999976  5888998888887889999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +.+.++..+          +......++.+++.++..+|.....+++|+|++|.|++++..+.++++|||.+..
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            987666433          2244456678899999999986433699999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=6.1e-17  Score=139.81  Aligned_cols=168  Identities=18%  Similarity=0.228  Sum_probs=125.8

Q ss_pred             CCcceeccccceeEEEE-EcCCCcEEEEEecCCC--CCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           45 DAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSP--LPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .....+|.|++|.|+.+ +....+..+.|.+...  ...........+..|+.+-..++|+|++.....+.......-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999977777 4444444555544311  11122222233667888888999999988777776665555559


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |||++ +|..++...+   .+....+-.++.|++.|+.|+|+.   ++.|||+|++|+++...|.+||+|||.+..+.-+
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99998 9999987642   256667788899999999999999   9999999999999999999999999998877544


Q ss_pred             CCc----ccccccccccccCCC
Q 039002          202 ASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~----~~~~~gt~~y~aPE~  219 (219)
                      .+.    ...++|+..|+|||.
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~  495 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEV  495 (601)
T ss_pred             cchhhhhhcCcccCCcCcCccc
Confidence            332    345799999999995

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.66  E-value=9.9e-17  Score=127.70  Aligned_cols=178  Identities=19%  Similarity=0.259  Sum_probs=134.5

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeE
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY  108 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~  108 (219)
                      .++.....+++....+-+|+||.||.|.|.      +.+.+.+|.++...   .......++.|...+..+.|+|+..+.
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            345556677888888999999999999443      23346677765422   223345678899999999999999999


Q ss_pred             eEEEe-CCcceEEEEecCCCCHHHHhc-----ccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          109 GFCSH-ARHSFLLCEFLERGSLAAILN-----TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       109 ~~~~~-~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      +++.. ....++.+.+...|+|..++.     .....+.+.-.+.+.++.|+..|+.|+|..   +++|.||-.+|++|+
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            98865 467888999998999999986     222334456667788999999999999999   999999999999999


Q ss_pred             CCCcEEEeeccceeeecC-CCCcc-cccccccccccCC
Q 039002          183 LEYEAHVADFGIAKFLKS-DASNW-TEFAGTYGYVALG  218 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~-~~~~~-~~~~gt~~y~aPE  218 (219)
                      +.-++|++|-.+++.+-. +-.+. ...-....||+||
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE  468 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE  468 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence            999999999998876532 12221 1123356688887

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=3.5e-16  Score=138.69  Aligned_cols=167  Identities=21%  Similarity=0.228  Sum_probs=123.0

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC---CCccceeEeEEEeCC
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR---HRNIVKFYGFCSHAR  115 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~  115 (219)
                      -....|.+.+.+|+|+||.||+|...+++.+|+|.=+++....-  .   +  -.+++.+|+   -+.|..+..+....+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf--Y---I--~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF--Y---I--CLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee--e---e--hHHHHHhhchhhhcchHHHHHHHccCC
Confidence            33567888999999999999999776799999998766543321  1   0  112233333   234556666666677


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-------CCcEE
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-------EYEAH  188 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-------~~~~k  188 (219)
                      ..+|++||.+.|+|.+++...   ..+.+.-...++.|++..+..+|+.   +|||+||||+|.++-.       ...++
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             cceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            789999999999999999743   2377788889999999999999999   9999999999999943       23589


Q ss_pred             EeeccceeeecCCC--CcccccccccccccCC
Q 039002          189 VADFGIAKFLKSDA--SNWTEFAGTYGYVALG  218 (219)
Q Consensus       189 l~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE  218 (219)
                      |+|||.+..++--.  ......++|-.|=++|
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~E  873 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIE  873 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHH
Confidence            99999998775322  2334456666655554

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=2.9e-15  Score=116.15  Aligned_cols=140  Identities=15%  Similarity=0.221  Sum_probs=101.4

Q ss_pred             ceec-cccceeEEEEEcCCCcEEEEEecCCCCC-----C----CchhhHHHHHHHHHHHhcCCCCcc--ceeEeEEEeC-
Q 039002           48 YCIG-NGGHASVYRAELPSREVVAVKKFHSPLP-----S----DQTVDQKEFLTEVKALTETRHRNI--VKFYGFCSHA-  114 (219)
Q Consensus        48 ~~lg-~g~~g~V~~~~~~~~~~~aik~~~~~~~-----~----~~~~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~~-  114 (219)
                      ..|| .|+.|.||.+... +..+++|.+.....     .    ........+.+|+.++..+.|+++  ++.+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4576 6777888888654 55788887743210     0    011233557889999999988775  5666654332 


Q ss_pred             Cc---ceEEEEecCC-CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          115 RH---SFLLCEFLER-GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       115 ~~---~~lv~e~~~~-~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                      ..   .++++|++++ .+|.+++...    .++..    .+.+++.++.++|+.   +|+|+||||.|||++.++.++++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence            22   3599999987 6888887542    13322    356889999999999   99999999999999988999999


Q ss_pred             eccceeeec
Q 039002          191 DFGIAKFLK  199 (219)
Q Consensus       191 dfg~~~~~~  199 (219)
                      |||.+....
T Consensus       185 Dfg~~~~~~  193 (239)
T PRK01723        185 DFDRGELRT  193 (239)
T ss_pred             ECCCcccCC
Confidence            999988654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.62  E-value=3.2e-16  Score=140.75  Aligned_cols=112  Identities=11%  Similarity=0.037  Sum_probs=79.3

Q ss_pred             CccceeEeEE-------EeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC
Q 039002          102 RNIVKFYGFC-------SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV  174 (219)
Q Consensus       102 ~ni~~~~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  174 (219)
                      .||..++++|       ......+.++|++ +++|.+++....  ..+++..+..++.||+.||.|||++   +|+||||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDl  106 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNV  106 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            4666677766       2224566778877 669999996432  2378889999999999999999998   9999999


Q ss_pred             CCCCEEeCCC-------------------CcEEEeeccceeeecCCC----------------CcccccccccccccCCC
Q 039002          175 SSKNLLLDLE-------------------YEAHVADFGIAKFLKSDA----------------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       175 kp~nili~~~-------------------~~~kl~dfg~~~~~~~~~----------------~~~~~~~gt~~y~aPE~  219 (219)
                      ||+|||++..                   +.+|++|||+++......                ......+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999654                   445666666654321100                00011368899999995

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.58  E-value=1.9e-16  Score=132.53  Aligned_cols=159  Identities=24%  Similarity=0.258  Sum_probs=127.3

Q ss_pred             eeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceEEEEe
Q 039002           49 CIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      .+|+|+||.|++++.    ..+..+++|..+.........  .....|..++...+ |+.++++...+++.+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~--~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR--THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc--cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            378999999998842    345678888765432222111  14456778888887 99999999999999999999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS  203 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  203 (219)
                      ..+|.+...++....   ..+.....+...++.++.++|..   +++++|+|++||+++.+|.+++.|||+.+.......
T Consensus        79 ~rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            999998887765433   45566677778899999999998   999999999999999999999999999987654432


Q ss_pred             cccccccccccccCCC
Q 039002          204 NWTEFAGTYGYVALGI  219 (219)
Q Consensus       204 ~~~~~~gt~~y~aPE~  219 (219)
                      .    +||..||||||
T Consensus       153 ~----cgt~eymApEI  164 (612)
T KOG0603|consen  153 A----CGTYEYRAPEI  164 (612)
T ss_pred             c----ccchhhhhhHh
Confidence            2    89999999996

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=4.8e-14  Score=118.24  Aligned_cols=145  Identities=22%  Similarity=0.244  Sum_probs=96.3

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhh------------------------------------HHHHH
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVD------------------------------------QKEFL   90 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~------------------------------------~~~~~   90 (219)
                      .+.||.|++|.||+|...+|+.||||..++.....-..+                                    .-.+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            467999999999999988999999999865321100000                                    00134


Q ss_pred             HHHHHHhcCC----CCccceeEeEE-EeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHH-HHHhhhhC
Q 039002           91 TEVKALTETR----HRNIVKFYGFC-SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD-ALSYLHHD  164 (219)
Q Consensus        91 ~e~~~l~~l~----h~ni~~~~~~~-~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~lh~~  164 (219)
                      +|+..+..+.    +.+-+.+..++ ...+..+++|||++|.++.+.......  ..   ....++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            4555555542    22222322222 223457899999999999876542111  11   12334444444 45677887


Q ss_pred             CCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       165 ~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                         +++|+|++|.||++..+|+++++|||++..+.
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=1.6e-13  Score=116.86  Aligned_cols=148  Identities=17%  Similarity=0.187  Sum_probs=92.6

Q ss_pred             CCCCCcceeccccceeEEEEEcCC-CcEEEEEecCCCCCCC--------------------c------h----hhHHH--
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPS-REVVAVKKFHSPLPSD--------------------Q------T----VDQKE--   88 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~-~~~~aik~~~~~~~~~--------------------~------~----~~~~~--   88 (219)
                      .+|+. +.||.|++|.||+|...+ |+.||||..++.....                    .      .    .....  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            44666 799999999999997766 9999999987542100                    0      0    01111  


Q ss_pred             ----HHHHHHHHhcCC----CCccceeEeEEE-eCCcceEEEEecCCCCHHHHhc--ccc-hhhccCHHHHHHHHHHHHH
Q 039002           89 ----FLTEVKALTETR----HRNIVKFYGFCS-HARHSFLLCEFLERGSLAAILN--TDA-AAQELGWSQRMSVIKGVAD  156 (219)
Q Consensus        89 ----~~~e~~~l~~l~----h~ni~~~~~~~~-~~~~~~lv~e~~~~~~l~~~~~--~~~-~~~~l~~~~~~~i~~~i~~  156 (219)
                          +.+|+..+.++.    +.+.+.+..++. -....+|+|||+.|+++.+.-.  ..+ ....+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                234444444442    333333333332 2345779999999999977432  111 01112222233333443  


Q ss_pred             HHHhhhhCCCCCeEecCCCCCCEEeCCCC----cEEEeeccceeeecC
Q 039002          157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEY----EAHVADFGIAKFLKS  200 (219)
Q Consensus       157 ~l~~lh~~~~~~i~H~dlkp~nili~~~~----~~kl~dfg~~~~~~~  200 (219)
                           ...   +++|+|++|.||+++.+|    ++++.|||++..++.
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 334   999999999999999887    999999999987643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=2.4e-11  Score=90.82  Aligned_cols=143  Identities=18%  Similarity=0.175  Sum_probs=97.3

Q ss_pred             cceeccccceeEEEEEcCC-------CcEEEEEecCCCCCCC---------c---------hhhH----HHHHHHHHHHh
Q 039002           47 KYCIGNGGHASVYRAELPS-------REVVAVKKFHSPLPSD---------Q---------TVDQ----KEFLTEVKALT   97 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~-------~~~~aik~~~~~~~~~---------~---------~~~~----~~~~~e~~~l~   97 (219)
                      ...||.|--+.||.|...+       +..+|+|.++.....-         +         ....    ....+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999995442       4689999875422110         0         0001    12237999999


Q ss_pred             cCCC--CccceeEeEEEeCCcceEEEEecCCCCHHH-HhcccchhhccCHHHHHHHHHHHHHHHHhh-hhCCCCCeEecC
Q 039002           98 ETRH--RNIVKFYGFCSHARHSFLLCEFLERGSLAA-ILNTDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRD  173 (219)
Q Consensus        98 ~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~d  173 (219)
                      ++..  -++++.+++    ..-+|+||++.+..+.. .++..    .++......+..+++.++..+ |..   +++|+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            8854  466666654    56789999997643321 12211    133344556678999999988 777   999999


Q ss_pred             CCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          174 VSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       174 lkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.||++. ++.+.++|||.+.....+
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence            999999996 578999999998766544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=4.6e-12  Score=92.98  Aligned_cols=131  Identities=21%  Similarity=0.200  Sum_probs=91.4

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCcc-ceeEeEEEeCCcceEEEEecC
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI-VKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .+.++.|.++.||++... +..+++|.......     ....+..|+..++.+.+.++ ++++...  .+..+++||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence            467889999999999755 56799998654221     11234568888888754443 4555443  334689999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC--CCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC--FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +.++... .       ..   ....+.+++.++..+|...  ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus        75 G~~l~~~-~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE-D-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc-c-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            8776532 0       10   1234568899999999872  11259999999999999 67899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.33  E-value=3.2e-13  Score=119.56  Aligned_cols=167  Identities=22%  Similarity=0.194  Sum_probs=121.8

Q ss_pred             CCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      ++...+.||.+.|=+|.+|+.+.|. +++|.+-+..+.-.-..-....+|+. .+.+++||...+.-+..+....|++-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777899999999999999887775 88888755432222112223344555 666689999998877777778888888


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |.. .+|.+.++....   +......-|+.|++.|+.-+|..   +|+|+|||.+|||+..=+.+-|+||..-+..-.+.
T Consensus       102 yvk-hnLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHh-hhhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            884 589999876543   44555667889999999999999   99999999999999988889999997544322222


Q ss_pred             C---ccccccc----ccccccCC
Q 039002          203 S---NWTEFAG----TYGYVALG  218 (219)
Q Consensus       203 ~---~~~~~~g----t~~y~aPE  218 (219)
                      .   ....+..    -..|+|||
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPE  197 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPE  197 (1431)
T ss_pred             CCcccceEEEecCCceeeecChH
Confidence            1   1222222    24588998

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.32  E-value=6.8e-13  Score=101.69  Aligned_cols=167  Identities=17%  Similarity=0.261  Sum_probs=123.6

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .++..+..+|.+...|..|+|+|+.+..| +|.+.-.  .-.....+.|.+|.-.++.+.||||..+++.|.+..++.++
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr--~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQGNDIV-AKILNVR--EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccccCcchh-hhhhhhh--hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            34456678899999999999988766443 3544321  11123345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe--eccceeee
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA--DFGIAKFL  198 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~--dfg~~~~~  198 (219)
                      ..|++.|+|+..+..... --+...+.++++..++.|+.|||+... -|...-|+..+++++++.+.+|.  |--++  +
T Consensus       266 sq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfs--f  341 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFS--F  341 (448)
T ss_pred             eeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceee--e
Confidence            999999999999976543 235667889999999999999999752 24455688999999998776653  32222  1


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...     ...-+|.||+||.
T Consensus       342 qe~-----gr~y~pawmspea  357 (448)
T KOG0195|consen  342 QEV-----GRAYSPAWMSPEA  357 (448)
T ss_pred             ecc-----ccccCcccCCHHH
Confidence            111     1256788999983

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=6.7e-11  Score=86.26  Aligned_cols=136  Identities=21%  Similarity=0.315  Sum_probs=99.2

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCC----CchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEe
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPS----DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      ..+++|+-+.++.+.+.+. .+.+|.-.+....    +......+..+|+.++.+++.-.+....-++.+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            3578999999999966443 3566643222211    2223335567899999998766665555566677788999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +.|..+.+.+...          ...++..+-.-+.-||..   +|+|+||.++|+++...+ +.++|||++.+-
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9998888777543          134456667778889999   999999999999997665 999999999754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.31  E-value=2.3e-11  Score=95.70  Aligned_cols=166  Identities=20%  Similarity=0.251  Sum_probs=97.2

Q ss_pred             CCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC----------CccceeEeEE--
Q 039002           45 DAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH----------RNIVKFYGFC--  111 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~ni~~~~~~~--  111 (219)
                      .....||.|+++.||.+ ...+++.+|+|.+..+. .......+.+.+|.-....+.+          -.++..++..  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            34578999999999999 66789999999876544 2222334555555543333222          1112112221  


Q ss_pred             -------EeC---C-----cceEEEEecCCCCHHHHhcccch----hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEec
Q 039002          112 -------SHA---R-----HSFLLCEFLERGSLAAILNTDAA----AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHR  172 (219)
Q Consensus       112 -------~~~---~-----~~~lv~e~~~~~~l~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~  172 (219)
                             ...   +     +.+++|+.+ .++|.+++..-..    ...+.......+..|++..+.++|+.   +++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                   111   1     235667766 4688777653111    01123344456678999999999999   99999


Q ss_pred             CCCCCCEEeCCCCcEEEeeccceeeecCCCCcccccccccccccCC
Q 039002          173 DVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       173 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      ||+|+|++++.+|.+.|+||+..........+   ...+..|.+||
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe  212 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPE  212 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChh
Confidence            99999999999999999999977654332221   12335566665

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=1e-12  Score=113.76  Aligned_cols=173  Identities=24%  Similarity=0.315  Sum_probs=132.7

Q ss_pred             HhCCCCCcceeccccceeEEEEEc-C-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAEL-P-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARH  116 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~-~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  116 (219)
                      +...|.+...||+|.|+.|-.... . ....++.+.+....  ...........|..+-+.+. |+|++..++...+.+.
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            467888999999999999888743 2 33356677665432  12223344455777767776 9999999999999999


Q ss_pred             ceEEEEecCCCCHHHHh-cccchhhccCHHHHHHHHHHHHHHHHhhh-hCCCCCeEecCCCCCCEEeCCCC-cEEEeecc
Q 039002          117 SFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEY-EAHVADFG  193 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg  193 (219)
                      .++.+++..++++...+ .....  ..+....-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ .+++.|||
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             cccccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence            99999999999888877 33221  2444556778899999999999 76   999999999999999999 99999999


Q ss_pred             ceeeecC-CCCc--cccccc-ccccccCCC
Q 039002          194 IAKFLKS-DASN--WTEFAG-TYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~-~~~~--~~~~~g-t~~y~aPE~  219 (219)
                      +|..+.. ....  ....+| ++.|+|||.
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~  200 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEH  200 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCccc
Confidence            9988765 3222  244588 999999995

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=1.3e-11  Score=99.21  Aligned_cols=112  Identities=24%  Similarity=0.341  Sum_probs=81.9

Q ss_pred             CCCccceeEeEEEe---------------------------CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHH
Q 039002          100 RHRNIVKFYGFCSH---------------------------ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK  152 (219)
Q Consensus       100 ~h~ni~~~~~~~~~---------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~  152 (219)
                      +||||+.++++|.+                           +..+|++|.... .+|..++....    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            69999999998843                           234678888763 48888876532    44566677889


Q ss_pred             HHHHHHHhhhhCCCCCeEecCCCCCCEEeC--CC--CcEEEeeccceeeecCC------CCcccccccccccccCCC
Q 039002          153 GVADALSYLHHDCFPPIVHRDVSSKNLLLD--LE--YEAHVADFGIAKFLKSD------ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       153 ~i~~~l~~lh~~~~~~i~H~dlkp~nili~--~~--~~~kl~dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~  219 (219)
                      |+++|+.|||.+   ++.|||+|.+||++.  .+  ..++++|||+|---+..      .+.....-|....|||||
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            999999999999   999999999999995  33  35789999987532221      111223356667899996

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=5.6e-10  Score=81.36  Aligned_cols=149  Identities=19%  Similarity=0.257  Sum_probs=105.4

Q ss_pred             CcceeccccceeEEEEEcCCCcEEEEEecCCCCCC----CchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           46 AKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPS----DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      ....+-||+-+.|+++.+. |+.+.||.-......    +......+..+|+..+.++.--.|....-++.+...-+|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678899999999999654 556677753221111    12223355678999998887666666666677777889999


Q ss_pred             EecCC-CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC---cEEEeeccceee
Q 039002          122 EFLER-GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY---EAHVADFGIAKF  197 (219)
Q Consensus       122 e~~~~-~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~---~~kl~dfg~~~~  197 (219)
                      ||+++ .++.+++......... ......++..+-..+.-||..   +++|+||.++||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 4777777653322211 122256778888899999999   999999999999997554   458999999864


Q ss_pred             ec
Q 039002          198 LK  199 (219)
Q Consensus       198 ~~  199 (219)
                      ..
T Consensus       166 s~  167 (229)
T KOG3087|consen  166 SR  167 (229)
T ss_pred             cc
Confidence            43

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=4.8e-10  Score=83.47  Aligned_cols=131  Identities=24%  Similarity=0.310  Sum_probs=82.8

Q ss_pred             eEEEEEcCCCcEEEEEecCCCCCCC----------------------chhhHHHHHHHHHHHhcCCCC--ccceeEeEEE
Q 039002           57 SVYRAELPSREVVAVKKFHSPLPSD----------------------QTVDQKEFLTEVKALTETRHR--NIVKFYGFCS  112 (219)
Q Consensus        57 ~V~~~~~~~~~~~aik~~~~~~~~~----------------------~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~  112 (219)
                      .||.|..+++..+|+|..+....+-                      .........+|+..|.++..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3889988888899999876532111                      111124457899999999765  566666442 


Q ss_pred             eCCcceEEEEecC--CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHh-hhhCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039002          113 HARHSFLLCEFLE--RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY-LHHDCFPPIVHRDVSSKNLLLDLEYEAHV  189 (219)
Q Consensus       113 ~~~~~~lv~e~~~--~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-lh~~~~~~i~H~dlkp~nili~~~~~~kl  189 (219)
                         .-.|+|||++  +.++..+....     +.......++.+++..+.. +|..   +++|+|+.+.||+++.+ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               4579999998  65554443322     1122344556677775544 5777   99999999999999877 9999


Q ss_pred             eeccceeeecC
Q 039002          190 ADFGIAKFLKS  200 (219)
Q Consensus       190 ~dfg~~~~~~~  200 (219)
                      +|||.+.....
T Consensus       148 IDf~qav~~~~  158 (188)
T PF01163_consen  148 IDFGQAVDSSH  158 (188)
T ss_dssp             --GTTEEETTS
T ss_pred             EecCcceecCC
Confidence            99999876553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=2.4e-10  Score=97.26  Aligned_cols=124  Identities=19%  Similarity=0.233  Sum_probs=99.0

Q ss_pred             EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhc
Q 039002           62 ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE  141 (219)
Q Consensus        62 ~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~  141 (219)
                      ...++.+|.+..++....    .......+-+..++.++||||+++++.+...+..|||+|.+.  +|...++..+    
T Consensus        33 ~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----  102 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----  102 (690)
T ss_pred             eeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----
Confidence            456777888887764321    233445677889999999999999999999999999999983  6766665432    


Q ss_pred             cCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       142 l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                        ...+...+.||+.||.|||+.+  +++|+++..+.++++..|+-||++|.++....
T Consensus       103 --~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  103 --KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             --HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence              3445556789999999998765  89999999999999999999999998875443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.19  E-value=5.9e-11  Score=87.54  Aligned_cols=75  Identities=24%  Similarity=0.194  Sum_probs=62.4

Q ss_pred             CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCccc
Q 039002          127 GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT  206 (219)
Q Consensus       127 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  206 (219)
                      |+|.+++...+  ..+++..+..++.|++.|+.|+|+.   +      ||+||+++.++.+++  ||++.......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            57888886432  2388999999999999999999997   5      999999999999998  99998765432    


Q ss_pred             ccccccccccCCC
Q 039002          207 EFAGTYGYVALGI  219 (219)
Q Consensus       207 ~~~gt~~y~aPE~  219 (219)
                       ..||+.|+|||+
T Consensus        64 -~~g~~~y~aPE~   75 (176)
T smart00750       64 -SRVDPYFMAPEV   75 (176)
T ss_pred             -CCCcccccChHH
Confidence             268899999995

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.17  E-value=4.7e-11  Score=99.86  Aligned_cols=119  Identities=27%  Similarity=0.485  Sum_probs=96.4

Q ss_pred             HhcCCCCccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCe-EecCC
Q 039002           96 LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI-VHRDV  174 (219)
Q Consensus        96 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i-~H~dl  174 (219)
                      |+.+.|.|+.++++.+.++...+++.++|..|+|.+.+....  ..+.+.....++..++.|+.|+|..   +| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            356789999999999999999999999999999999997633  3477778888999999999999998   55 99999


Q ss_pred             CCCCEEeCCCCcEEEeeccceeeecC--CCCcccccccccccccCCC
Q 039002          175 SSKNLLLDLEYEAHVADFGIAKFLKS--DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       175 kp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~  219 (219)
                      +..|++++..+.+|++|||+......  .........-...|.|||.
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPel  122 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPEL  122 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHH
Confidence            99999999999999999999876632  1111111233455778873

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.15  E-value=2.6e-11  Score=107.38  Aligned_cols=135  Identities=30%  Similarity=0.390  Sum_probs=89.2

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcC-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ....++|..++.+..|++|.||.++.+ +.+.+|+|.-+      +.    .+.+.  ++....+|              
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk------q~----lilRn--ilt~a~np--------------  132 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK------QN----LILRN--ILTFAGNP--------------  132 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcccc------cc----hhhhc--cccccCCc--------------
Confidence            344578999999999999999999544 67778885422      11    11111  22222233              


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                       |.|      |+-...++.-+.   ++        .+.+.+++|+|+-   +|+|||+||+|.+|..-|.+|++|||+.+
T Consensus       133 -fvv------gDc~tllk~~g~---lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk  191 (1205)
T KOG0606|consen  133 -FVV------GDCATLLKNIGP---LP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK  191 (1205)
T ss_pred             -cee------chhhhhcccCCC---Cc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence             332      333344432211   22        1226789999998   99999999999999999999999999977


Q ss_pred             eecCCCC-c--------------ccccccccccccCCC
Q 039002          197 FLKSDAS-N--------------WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~-~--------------~~~~~gt~~y~aPE~  219 (219)
                      ...-... +              ....+|||.|+||||
T Consensus       192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            4321111 0              133589999999996

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=1e-09  Score=83.76  Aligned_cols=143  Identities=19%  Similarity=0.237  Sum_probs=95.8

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC--CccceeEeEEEeC---CcceEEEE
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH--RNIVKFYGFCSHA---RHSFLLCE  122 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~---~~~~lv~e  122 (219)
                      +.|+.|..+.+|++...+|+.+++|........   .....+.+|+..++.+.+  .++.+++.+....   +..+++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            568899999999997666678999987543211   122356788999998875  3456777776553   36789999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhC--------------------------------------
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD--------------------------------------  164 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------------------------------------  164 (219)
                      ++++.++......    ..++......++.+++..+..+|+.                                      
T Consensus        81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9988766554320    0122333334444444444444421                                      


Q ss_pred             ---------------CCCCeEecCCCCCCEEeCC--CCcEEEeeccceee
Q 039002          165 ---------------CFPPIVHRDVSSKNLLLDL--EYEAHVADFGIAKF  197 (219)
Q Consensus       165 ---------------~~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~  197 (219)
                                     ....++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           0136799999999999998  56788999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=8.6e-10  Score=92.65  Aligned_cols=169  Identities=24%  Similarity=0.268  Sum_probs=126.9

Q ss_pred             CCCCCcceecc--ccceeEEEEE---cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCC
Q 039002           42 NDFDAKYCIGN--GGHASVYRAE---LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHAR  115 (219)
Q Consensus        42 ~~y~~~~~lg~--g~~g~V~~~~---~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~  115 (219)
                      ..+.+...+|.  |.+|.+|.+.   ..++..+|+|+-+.+....  ....+-.+|+...++++ |+|.++.+..+...+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p--~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP--LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc--cccccccchhhcccccCccccccccCcccccCC
Confidence            44667788999  9999999994   4577789988754433221  12223356777777774 899999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHH----HHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEe
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD----ALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVA  190 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~  190 (219)
                      ..|+-+|.|. .++..+...-.  ..++....+..+.+...    |+.++|..   .++|-|+||.|++...+ ..++++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            9999999995 67777765432  22566777777778888    99999999   99999999999999988 788999


Q ss_pred             eccceeeecCCCCc-----ccccccccccccCC
Q 039002          191 DFGIAKFLKSDASN-----WTEFAGTYGYVALG  218 (219)
Q Consensus       191 dfg~~~~~~~~~~~-----~~~~~gt~~y~aPE  218 (219)
                      |||+...+.+..=.     .-...|...|++||
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke  298 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE  298 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChh
Confidence            99998877644311     11125667788887

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.97  E-value=2.5e-08  Score=78.48  Aligned_cols=145  Identities=21%  Similarity=0.147  Sum_probs=94.4

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCC--ch-----hhHHHHHHHHHHHhcCCCCccc--eeEeEEEe-----
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD--QT-----VDQKEFLTEVKALTETRHRNIV--KFYGFCSH-----  113 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~--~~-----~~~~~~~~e~~~l~~l~h~ni~--~~~~~~~~-----  113 (219)
                      +.+-......|.++.+ .|+.+.+|.........  ..     .....+.+|...+..+...+|.  ...++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3344444445666654 45689999764321000  00     0011367888888888544443  33444432     


Q ss_pred             CCcceEEEEecCCC-CHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-------CC
Q 039002          114 ARHSFLLCEFLERG-SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-------EY  185 (219)
Q Consensus       114 ~~~~~lv~e~~~~~-~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-------~~  185 (219)
                      ....++|||++++. ++.+++..... ..........++.+++..+.-+|+.   +++|+|+++.|||++.       ++
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999875 78888753211 1133445567888999999999999   9999999999999975       46


Q ss_pred             cEEEeeccceee
Q 039002          186 EAHVADFGIAKF  197 (219)
Q Consensus       186 ~~kl~dfg~~~~  197 (219)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999998854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.95  E-value=1.2e-10  Score=96.49  Aligned_cols=97  Identities=22%  Similarity=0.398  Sum_probs=80.5

Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .++|.|++|...+|.+|+.........++.....++.|++.++.|   +   +.+|+|+||.||+...+..++|.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999755544556677788889999999999   5   8899999999999999999999999998


Q ss_pred             eeecCCC------CcccccccccccccCC
Q 039002          196 KFLKSDA------SNWTEFAGTYGYVALG  218 (219)
Q Consensus       196 ~~~~~~~------~~~~~~~gt~~y~aPE  218 (219)
                      .......      ..-+.-+||..||+||
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPE  432 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPE  432 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHH
Confidence            8765443      1113358999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.90  E-value=1.5e-09  Score=91.15  Aligned_cols=153  Identities=25%  Similarity=0.264  Sum_probs=119.7

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-c-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-L-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSH  113 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  113 (219)
                      -...+.+|..+..||.+.|+.|+... . .++..+++|.+.+....... + ..-..|+.+...+ .|.+.+.++..|..
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-D-IFSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-h-hcchhhhhHhhHhhcccccCCCCCCccc
Confidence            35567789999999999999999984 3 46678999987665443321 1 1124556655555 48888898888888


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEeec
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADF  192 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~df  192 (219)
                      .++.++-.|+|.+++....+..   ...+.+...+.+..|++.++.++|..   .++|+|++|+||++.++ +..++.||
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccc
Confidence            8888899999999888776632   23467778888999999999999998   89999999999999986 77889999


Q ss_pred             cceee
Q 039002          193 GIAKF  197 (219)
Q Consensus       193 g~~~~  197 (219)
                      |.+..
T Consensus       412 ~~~t~  416 (524)
T KOG0601|consen  412 GCWTR  416 (524)
T ss_pred             ccccc
Confidence            98864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=4.7e-08  Score=75.65  Aligned_cols=141  Identities=21%  Similarity=0.166  Sum_probs=96.1

Q ss_pred             CCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCC----------------c--hhhHHHHHHHHHHHhcCCCC--c
Q 039002           44 FDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD----------------Q--TVDQKEFLTEVKALTETRHR--N  103 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~----------------~--~~~~~~~~~e~~~l~~l~h~--n  103 (219)
                      ..+.++||-|--+.||.|..+.|..+++|.=+....+-                .  ......+.+|...|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            46678999999999999988889999999632211110                0  01123457899999888655  6


Q ss_pred             cceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       104 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      +++.+++    +.-.++||++.+-.|...--.        -...-.++..|++-+.-.-..   |++|+|+++-||+++.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~--------~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRLD--------VENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccCc--------ccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            6666655    445799999988766543310        111223333344444433355   9999999999999999


Q ss_pred             CCcEEEeeccceeeec
Q 039002          184 EYEAHVADFGIAKFLK  199 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~  199 (219)
                      +|.+.++||-.+....
T Consensus       238 dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         238 DGDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCCEEEEeCcccccCC
Confidence            9999999998765443

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1.6e-07  Score=70.71  Aligned_cols=142  Identities=18%  Similarity=0.183  Sum_probs=97.1

Q ss_pred             eccccceeEEEEEcCCCcEEEEEecCCCCCCC-c-hhhHHHHHHHHHHHhcCCCCc--cceeEeEEE---eC--CcceEE
Q 039002           50 IGNGGHASVYRAELPSREVVAVKKFHSPLPSD-Q-TVDQKEFLTEVKALTETRHRN--IVKFYGFCS---HA--RHSFLL  120 (219)
Q Consensus        50 lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~---~~--~~~~lv  120 (219)
                      -|+|+.+.|+....... .+.+|+-.+..... . .-....+.+|+..+..+...+  +++.. ++.   .+  -..+||
T Consensus        26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            35688888998765444 68888754211110 0 123466889999999886433  33333 221   11  236799


Q ss_pred             EEecCC-CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc--EEEeeccceee
Q 039002          121 CEFLER-GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE--AHVADFGIAKF  197 (219)
Q Consensus       121 ~e~~~~-~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~  197 (219)
                      +|.+++ -+|.+++..... ...+......++.+++..+.-+|+.   ++.|+|+.+.||+++.+|.  +.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997754 588888754321 1234555678889999999999999   9999999999999987676  89999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=2.2e-07  Score=70.55  Aligned_cols=107  Identities=22%  Similarity=0.284  Sum_probs=79.8

Q ss_pred             HHHHHHHHHHhcCCCC--ccceeEeEEEeC----CcceEEEEecCC-CCHHHHhcccchhhccCHHHHHHHHHHHHHHHH
Q 039002           87 KEFLTEVKALTETRHR--NIVKFYGFCSHA----RHSFLLCEFLER-GSLAAILNTDAAAQELGWSQRMSVIKGVADALS  159 (219)
Q Consensus        87 ~~~~~e~~~l~~l~h~--ni~~~~~~~~~~----~~~~lv~e~~~~-~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~  159 (219)
                      ....+|...+..+...  ..++..++....    ...++++|++++ .+|.+++.....   ........++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            4567788877777543  344555555442    235899999987 478888864221   334456678889999999


Q ss_pred             hhhhCCCCCeEecCCCCCCEEeCCCC---cEEEeeccceeeec
Q 039002          160 YLHHDCFPPIVHRDVSSKNLLLDLEY---EAHVADFGIAKFLK  199 (219)
Q Consensus       160 ~lh~~~~~~i~H~dlkp~nili~~~~---~~kl~dfg~~~~~~  199 (219)
                      -+|+.   +++|+|+++.|||++.++   .+.++||+.+....
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999   999999999999999887   88999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1.9e-07  Score=79.54  Aligned_cols=144  Identities=22%  Similarity=0.233  Sum_probs=89.9

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhh------------------------------------HHHHHH
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVD------------------------------------QKEFLT   91 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~------------------------------------~~~~~~   91 (219)
                      ..|+.++-|.||+|...+|+.||||..++.....-..+                                    .-.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999999999999999876442211111                                    001234


Q ss_pred             HHHHHhcCC-----CCccceeEe-EEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC
Q 039002           92 EVKALTETR-----HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC  165 (219)
Q Consensus        92 e~~~l~~l~-----h~ni~~~~~-~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~  165 (219)
                      |...+.+++     .+++ ++-. +++-.+.-.++|||+.|-.+.+.......  ....+.+.....++.  +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHhc-
Confidence            555554442     2333 3322 23334557899999999888887432111  122222222111111  1112223 


Q ss_pred             CCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       166 ~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                        +++|.|..|-|+++..+|++.+.|||....+.
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              88999999999999999999999999987654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.54  E-value=1.2e-06  Score=73.29  Aligned_cols=139  Identities=16%  Similarity=0.207  Sum_probs=102.4

Q ss_pred             ceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC----CcceEEEEecCC-CC
Q 039002           55 HASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA----RHSFLLCEFLER-GS  128 (219)
Q Consensus        55 ~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----~~~~lv~e~~~~-~~  128 (219)
                      ....|++ ...+|..|++|++......    .......=++..+++.|+|++.+.++|.+.    ..+.+|++|.++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~----~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQ----STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccccc----CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            3567788 4568889999998432111    111122346778999999999999998732    347789998764 67


Q ss_pred             HHHHhccc------------chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          129 LAAILNTD------------AAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       129 l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      |.++.-..            ......++...|.++.|+..||.++|+.   |+..+-|.+.+|++..+.+++|+..|+..
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence            77654211            1112367888999999999999999999   99999999999999988899998888776


Q ss_pred             eecC
Q 039002          197 FLKS  200 (219)
Q Consensus       197 ~~~~  200 (219)
                      .+..
T Consensus       442 vl~~  445 (655)
T KOG3741|consen  442 VLQE  445 (655)
T ss_pred             eecC
Confidence            5543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.53  E-value=1.2e-07  Score=74.97  Aligned_cols=97  Identities=22%  Similarity=0.350  Sum_probs=78.0

Q ss_pred             HHHHhcCCCCccceeEeEEEeC-----CcceEEEEecCCCCHHHHhcc-cchhhccCHHHHHHHHHHHHHHHHhhhhCCC
Q 039002           93 VKALTETRHRNIVKFYGFCSHA-----RHSFLLCEFLERGSLAAILNT-DAAAQELGWSQRMSVIKGVADALSYLHHDCF  166 (219)
Q Consensus        93 ~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~  166 (219)
                      +..+-.+.|.||++++.+|.+.     ....+++||+..|++..++++ ..+...+......+++-||+.|+.|||++..
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            4455566799999999998543     447789999999999999975 2233335566667888999999999999764


Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEe
Q 039002          167 PPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       167 ~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                       .++|+++..+.+++..+|-+|+.
T Consensus       198 -piihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  198 -PIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             -ccccCCcchhheeecCCceEEec
Confidence             79999999999999988888864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.49  E-value=2.5e-06  Score=65.48  Aligned_cols=163  Identities=21%  Similarity=0.224  Sum_probs=99.7

Q ss_pred             ccccccHHHHHHHhCCCCCcc---eeccccceeEEEEEcCCCcEEEEEecCCCCCCCch--------------------h
Q 039002           28 EVGKILYDEIVKATNDFDAKY---CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQT--------------------V   84 (219)
Q Consensus        28 ~~~~~~~~~~~~~~~~y~~~~---~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~--------------------~   84 (219)
                      .+++.+.+.+....+...+..   .|++|--+.||+|...++..+|+|+++........                    .
T Consensus        31 v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l  110 (268)
T COG1718          31 VFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL  110 (268)
T ss_pred             hhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence            344455555555455554443   45667788999998788889999998653221111                    0


Q ss_pred             hHHHHHHHHHHHhcCC--CCccceeEeEEEeCCcceEEEEecCCC-CHHHHhcccchhhccCHHHHHHHHHHHHHHHHhh
Q 039002           85 DQKEFLTEVKALTETR--HRNIVKFYGFCSHARHSFLLCEFLERG-SLAAILNTDAAAQELGWSQRMSVIKGVADALSYL  161 (219)
Q Consensus        85 ~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l  161 (219)
                      ......+|+..|+.+.  +-.+++-+.+    .+..|+||++... .-.-.++.-    .+.......+..++++.+.-|
T Consensus       111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l  182 (268)
T COG1718         111 VFAWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRL  182 (268)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHH
Confidence            0112345666666663  2333444433    2357999998543 111111110    122223455566777777666


Q ss_pred             hh-CCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          162 HH-DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       162 h~-~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      -. .   +++|+||+.=|||+. ++.+.++|+|.+.....+.
T Consensus       183 ~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp~  220 (268)
T COG1718         183 YKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHPN  220 (268)
T ss_pred             HHhc---CcccccchhhheEEE-CCeEEEEECccccccCCCc
Confidence            55 5   899999999999999 8999999999987665443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.44  E-value=9.1e-06  Score=62.57  Aligned_cols=140  Identities=13%  Similarity=0.168  Sum_probs=81.3

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC--ccceeEeEEEeCCcceEEEEecC
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR--NIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      ..||+|..+.||+.   .+..+++|......      ......+|.+.++.+..-  .+.+.+.+....+...++||++.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999974   23456778764311      223457799988888543  35677877777777889999998


Q ss_pred             CCC-HHHHhcc-------------------cc-hhhccCHHHHH-HHHH----------HHHHH-HHhhhhC-CCCCeEe
Q 039002          126 RGS-LAAILNT-------------------DA-AAQELGWSQRM-SVIK----------GVADA-LSYLHHD-CFPPIVH  171 (219)
Q Consensus       126 ~~~-l~~~~~~-------------------~~-~~~~l~~~~~~-~i~~----------~i~~~-l~~lh~~-~~~~i~H  171 (219)
                      |.+ +......                   +. .....+..... .+..          .+... ..++... ....++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            853 1111100                   00 00000100000 0000          00111 1111111 1125689


Q ss_pred             cCCCCCCEEeCCCCcEEEeeccceee
Q 039002          172 RDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       172 ~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +|+.|.|++++.++ +.++||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=4.2e-06  Score=63.46  Aligned_cols=140  Identities=16%  Similarity=0.173  Sum_probs=86.7

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHH------HHHHHHHHhcCCCC---ccceeEeEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE------FLTEVKALTETRHR---NIVKFYGFC  111 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~---ni~~~~~~~  111 (219)
                      .++|...+.+-......|.+.+.. ++.+.+|..++.... .......      ..+.+..+..++..   ....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            477888888888877777777554 468888876542211 1111111      12344444444332   222322222


Q ss_pred             Ee-----CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          112 SH-----ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       112 ~~-----~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                      .-     ....+++|||++|..+.+...       ++.    .+...+.+++.-+|..   |+.|+|..|.|+++..+ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-c
Confidence            21     133568999999977755432       221    1334566788999998   99999999999999854 5


Q ss_pred             EEEeeccceee
Q 039002          187 AHVADFGIAKF  197 (219)
Q Consensus       187 ~kl~dfg~~~~  197 (219)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=2.7e-06  Score=72.56  Aligned_cols=146  Identities=20%  Similarity=0.189  Sum_probs=86.6

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhh---------------------------HH------HHHHHH
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVD---------------------------QK------EFLTEV   93 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~---------------------------~~------~~~~e~   93 (219)
                      -+.||.-+.+.||+|+.++|+.||||.-++.....-..+                           .+      .|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            367999999999999999999999998765331110000                           01      123444


Q ss_pred             HHHhcC----CCCc---cceeEeEE-EeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC
Q 039002           94 KALTET----RHRN---IVKFYGFC-SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC  165 (219)
Q Consensus        94 ~~l~~l----~h~n---i~~~~~~~-~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~  165 (219)
                      +...++    +|-+   -+.+-.++ .-.....|+|||++|..+.+.-.-..  ..+....+...+.+...-+-+.  . 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~--~-  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFK--T-  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHh--c-
Confidence            444333    3334   11222222 22245689999999976665432111  1133333333333322222222  2 


Q ss_pred             CCCeEecCCCCCCEEeCC----CCcEEEeeccceeeec
Q 039002          166 FPPIVHRDVSSKNLLLDL----EYEAHVADFGIAKFLK  199 (219)
Q Consensus       166 ~~~i~H~dlkp~nili~~----~~~~kl~dfg~~~~~~  199 (219)
                        |.+|.|-.|-||++..    ++++.+-|||+...+.
T Consensus       321 --GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 --GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             --CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence              8899999999999983    5789999999987654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.33  E-value=6.1e-06  Score=60.21  Aligned_cols=130  Identities=18%  Similarity=0.208  Sum_probs=85.8

Q ss_pred             CCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccc-eeEeEEEeCCcceEEEEe
Q 039002           45 DAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV-KFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv~e~  123 (219)
                      ++.+.|++|.+|.||+|.+..+ .+|+|.-+.+      .....+..|++++..+.-.++. ++|.+.    .-++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRD------SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc-eEEEEEecCC------cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence            4568899999999999987655 7788875432      2446678899999988765554 444443    33555999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC-CCCEEeCCCCcEEEeeccceeee
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS-SKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk-p~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +.|.+|..+.....      -.+.    ..+++..--|-..   +|-|..+. |...++-.++.+-|+||..|++-
T Consensus        94 i~G~~L~~~~~~~~------rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          94 IDGRPLGKLEIGGD------RKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hcCcchhhhhhccc------HHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            99888877664211      1111    2334442233333   77777764 55555556669999999998743

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=0.00012  Score=55.03  Aligned_cols=138  Identities=19%  Similarity=0.299  Sum_probs=89.7

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCc------------hhhHHHHHHHHHHHhcCC------CCccceeE
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ------------TVDQKEFLTEVKALTETR------HRNIVKFY  108 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~------------~~~~~~~~~e~~~l~~l~------h~ni~~~~  108 (219)
                      ...||+|+.-.||.  ++.....+||..........            ........+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999998884  45555678888765430000            011234455655554444      78999999


Q ss_pred             eEEEeCCcceEEEEecCC------CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          109 GFCSHARHSFLLCEFLER------GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~------~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      |+.+++--.-+++|.+..      .+|.+++....    ++. ...   ..+-+-..++-+.   +|+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence            999999888999997632      46777775432    322 222   2333444667776   899999999999997


Q ss_pred             CC--C--cEEEee-ccceee
Q 039002          183 LE--Y--EAHVAD-FGIAKF  197 (219)
Q Consensus       183 ~~--~--~~kl~d-fg~~~~  197 (219)
                      ..  +  .+.++| ||....
T Consensus       153 ~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             ecCCCceEEEEEeCCCCccc
Confidence            43  2  467777 676544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.12  E-value=0.00011  Score=56.32  Aligned_cols=78  Identities=15%  Similarity=0.234  Sum_probs=53.4

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC--ccceeEeEEEe---CCcceEEE
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR--NIVKFYGFCSH---ARHSFLLC  121 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~---~~~~~lv~  121 (219)
                      ++.++.|..+.||.....+ ..+++|....      ......+.+|..+++.+...  .+.+++.....   ....+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            3578899999999997766 4889998642      12345667888888887533  35666664422   33468999


Q ss_pred             EecCCCCHHH
Q 039002          122 EFLERGSLAA  131 (219)
Q Consensus       122 e~~~~~~l~~  131 (219)
                      +++++.++..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9998877766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.11  E-value=0.00014  Score=56.53  Aligned_cols=75  Identities=20%  Similarity=0.179  Sum_probs=49.8

Q ss_pred             eccccc-eeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceEEEEecCCC
Q 039002           50 IGNGGH-ASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFLLCEFLERG  127 (219)
Q Consensus        50 lg~g~~-g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~  127 (219)
                      |..|.. +.||+....+ ..+.+|......       ...+.+|+.+++.+. +-.+.+++.+....+..+++||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-CcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            444444 7889986544 577788754321       123456888887774 345667787777667789999999887


Q ss_pred             CHHHH
Q 039002          128 SLAAI  132 (219)
Q Consensus       128 ~l~~~  132 (219)
                      ++...
T Consensus        78 ~l~~~   82 (244)
T cd05150          78 PAAAL   82 (244)
T ss_pred             cHhHh
Confidence            66543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.10  E-value=2.6e-05  Score=58.24  Aligned_cols=104  Identities=21%  Similarity=0.247  Sum_probs=78.3

Q ss_pred             HHHHHHhcCCC-CccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCe
Q 039002           91 TEVKALTETRH-RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI  169 (219)
Q Consensus        91 ~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  169 (219)
                      .|.-++..+.+ +++++++|+|..    ++++|+...+++......-......+|..+..++.++++.+.++++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47788888876 699999999833    6789998766553210000000125789999999999999999998544368


Q ss_pred             EecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          170 VHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       170 ~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      .-.|++++|+-+..+|++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88999999999999999999999866543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.03  E-value=0.00015  Score=66.13  Aligned_cols=79  Identities=19%  Similarity=0.288  Sum_probs=53.8

Q ss_pred             cceeccccceeEEEEEcCCC---cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCcc--ceeEeEEEeC---Ccc
Q 039002           47 KYCIGNGGHASVYRAELPSR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNI--VKFYGFCSHA---RHS  117 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~---~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--~~~~~~~~~~---~~~  117 (219)
                      ...++.|.++.+|+.....+   ..+++|+......   ......+.+|+.+++.+. |.++  ++++.++.+.   +..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~---~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL---LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc---CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            57788999999999865543   3577776532111   112235678999999995 6654  6777776553   568


Q ss_pred             eEEEEecCCCC
Q 039002          118 FLLCEFLERGS  128 (219)
Q Consensus       118 ~lv~e~~~~~~  128 (219)
                      |+|||++++..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            99999998753

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.76  E-value=0.0013  Score=54.80  Aligned_cols=80  Identities=19%  Similarity=0.182  Sum_probs=52.9

Q ss_pred             cceeccccceeEEEEEcCCC-cEEEEEecCCCCCC--Cc-hhhHHHHHHHHHHHhcCC---CCccceeEeEEEeCCcceE
Q 039002           47 KYCIGNGGHASVYRAELPSR-EVVAVKKFHSPLPS--DQ-TVDQKEFLTEVKALTETR---HRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~-~~~aik~~~~~~~~--~~-~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+.||.|.++.||++...+| +.++||.-.+....  .. .....+...|...|+.+.   ...+++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46789999999999977666 47999985422111  11 123345666778777763   2456777766  4455789


Q ss_pred             EEEecCCCC
Q 039002          120 LCEFLERGS  128 (219)
Q Consensus       120 v~e~~~~~~  128 (219)
                      +||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999987643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.63  E-value=0.0012  Score=50.98  Aligned_cols=30  Identities=30%  Similarity=0.350  Sum_probs=25.5

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      .++|+|+.+.|++++..+..-++||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            589999999999998765567999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.62  E-value=3.9e-05  Score=66.12  Aligned_cols=155  Identities=16%  Similarity=0.118  Sum_probs=99.8

Q ss_pred             CCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc-cceeEeEEEeCCcceEEEEe
Q 039002           45 DAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN-IVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e~  123 (219)
                      .....+++++++++++.+--..+....+.+..     .    ....-++++|.+++||| .+.+++-+..+...++.+++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----T----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeecc-----c----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            34456778899988887422111222333321     1    23445789999999999 66667777777888999999


Q ss_pred             cCCC-CHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          124 LERG-SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       124 ~~~~-~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      +..+ +.........  ..+..-+...+...-+.++.++|+.   .-+|+|    |++..+ +..+..+|+.+..++...
T Consensus       316 ~s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hcCCccccccCChhh--Hhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc
Confidence            9776 2322221110  1122333444555667788889876   457877    665544 788999999988776554


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                       ..++..+++.++|||.
T Consensus       386 -~~~t~~~~~~~~~pev  401 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEV  401 (829)
T ss_pred             -ccccCCCCCCCCCchh
Confidence             3456789999999983

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.62  E-value=1e-05  Score=72.85  Aligned_cols=148  Identities=21%  Similarity=0.258  Sum_probs=96.3

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      .-+++.+.+.+-.|.++.++.+. ...+-..+.+..... ......+.+....+-..+....+|.++.....+-.....+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~a-p~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLA-PKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccc-hhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            44667778888889999998873 333322222221110 0000011122223333333445566666655555667789


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      |++++..++++...+...++   ........+...++.+.++||..   .+.|+|++|.|.+....|..++.+||.
T Consensus       881 L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence            99999999999888876543   22233444556788899999997   689999999999999999999999873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.53  E-value=0.003  Score=48.66  Aligned_cols=74  Identities=14%  Similarity=0.098  Sum_probs=45.0

Q ss_pred             cceeccccceeEEEEEcCC--CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC-CccceeEeEEEeCCcceEEEEe
Q 039002           47 KYCIGNGGHASVYRAELPS--REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~--~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      .+.|..|-.+.+|+....+  ++.+.+|...... ...    ....+|+.+++.+.. .-.++++..+.    -.+++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~----~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELI----IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cce----ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEe
Confidence            3567778888999997654  5678888764321 110    112357777777743 33445554332    2489999


Q ss_pred             cCCCCH
Q 039002          124 LERGSL  129 (219)
Q Consensus       124 ~~~~~l  129 (219)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            987554

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.49  E-value=0.00011  Score=58.99  Aligned_cols=140  Identities=12%  Similarity=0.089  Sum_probs=90.3

Q ss_pred             CCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCC----------------chhh--HHHHHHHHHHHhcCCC-C-
Q 039002           43 DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD----------------QTVD--QKEFLTEVKALTETRH-R-  102 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~----------------~~~~--~~~~~~e~~~l~~l~h-~-  102 (219)
                      -+.+.++||-|--+.+|.+-.+.|.+.++|.=+....+.                .+..  .-.+.+|+..|+.+.. . 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            467789999999999999988888888887522211110                0111  1224678888888853 2 


Q ss_pred             ccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       103 ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      .+++.++.    +.-++|||++.+-++...-.....      .++.   ..++.-+--|...   |+||+|.+-=||++.
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~------~~ly---~~lm~~Iv~la~~---GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDP------PTLY---DDLMGLIVRLANH---GLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeecCCh------HHHH---HHHHHHHHHHHHc---CceecccchheeEEe
Confidence            23344333    455789999988888765432211      1122   2222222334444   999999999999999


Q ss_pred             CCCcEEEeeccceeee
Q 039002          183 LEYEAHVADFGIAKFL  198 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~  198 (219)
                      .++.++++||-.+...
T Consensus       237 dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVST  252 (465)
T ss_pred             cCCCEEEeechHhhcc
Confidence            9999999999765433

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.33  E-value=0.003  Score=50.47  Aligned_cols=142  Identities=24%  Similarity=0.214  Sum_probs=77.5

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC--ccceeEeE------EEeCCcce
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR--NIVKFYGF------CSHARHSF  118 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~------~~~~~~~~  118 (219)
                      .+.+..|....+|+....++ .+++|....    .   ....+..|+.++..+.+.  .+.+.+..      ...++..+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~----~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK----V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC----C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            45677777788998865444 688887642    1   122345577777777432  23343331      13345678


Q ss_pred             EEEEecCCCCHHH--------H---hcc-cchhhc----------cCHHHHH----------HHHHHHHHHHHhhhh---
Q 039002          119 LLCEFLERGSLAA--------I---LNT-DAAAQE----------LGWSQRM----------SVIKGVADALSYLHH---  163 (219)
Q Consensus       119 lv~e~~~~~~l~~--------~---~~~-~~~~~~----------l~~~~~~----------~i~~~i~~~l~~lh~---  163 (219)
                      .++++++|.++..        .   +.. +.....          ..|....          .....+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999998754321        0   000 000000          0011000          001112223333332   


Q ss_pred             -CCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          164 -DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       164 -~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                       ....+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence             111268999999999999987777899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.26  E-value=0.0034  Score=49.15  Aligned_cols=138  Identities=14%  Similarity=0.084  Sum_probs=71.7

Q ss_pred             eeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCcc-ceeEeEEEeCCcceEEEEecCCC
Q 039002           49 CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI-VKFYGFCSHARHSFLLCEFLERG  127 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~  127 (219)
                      .+..|..+.+|+... ++..+++|.........    .....+|...++.+....+ ++++...    .-++++|+++|.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL----GVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccc----cCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCc
Confidence            345677888998863 45577888653321110    0123567888887754323 3444332    247899999875


Q ss_pred             CHHHH--------------hc---ccc-hhhccCHH-HHHHHHHHH---------HHHHHhhhhC-----CCCCeEecCC
Q 039002          128 SLAAI--------------LN---TDA-AAQELGWS-QRMSVIKGV---------ADALSYLHHD-----CFPPIVHRDV  174 (219)
Q Consensus       128 ~l~~~--------------~~---~~~-~~~~l~~~-~~~~i~~~i---------~~~l~~lh~~-----~~~~i~H~dl  174 (219)
                      ++...              +.   ... ........ ....+..++         ...+..+...     ....++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            54321              11   000 00001111 111111111         1111111111     0125899999


Q ss_pred             CCCCEEeCCCCcEEEeecccee
Q 039002          175 SSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       175 kp~nili~~~~~~kl~dfg~~~  196 (219)
                      .|.|++++.++ +.++||+.+.
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccC
Confidence            99999998876 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.13  E-value=0.0045  Score=50.77  Aligned_cols=145  Identities=21%  Similarity=0.228  Sum_probs=89.4

Q ss_pred             CCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCc--------------------hh--hHHHHHHHHHHHhcCCCC
Q 039002           45 DAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ--------------------TV--DQKEFLTEVKALTETRHR  102 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~--------------------~~--~~~~~~~e~~~l~~l~h~  102 (219)
                      .+-..|..|--.-||.|...+|..+|||+++.......                    ..  ....+-.|+..|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            34466788888899999888898999999865321110                    00  012234577778777655


Q ss_pred             ccceeEeEEEeCCcceEEEEecCCCCHHH--HhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEE
Q 039002          103 NIVKFYGFCSHARHSFLLCEFLERGSLAA--ILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLL  180 (219)
Q Consensus       103 ni~~~~~~~~~~~~~~lv~e~~~~~~l~~--~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nil  180 (219)
                      .|.-.-.+..-  .-.|||+++.. +-+.  .++.    ..++...+..+-.+++.-+.-|-..|  +++|.||+--|+|
T Consensus       227 GIP~PePIlLk--~hVLVM~FlGr-dgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L  297 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLGR-DGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL  297 (520)
T ss_pred             CCCCCCceeee--cceEeeeeccC-CCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence            44332222221  23589999853 2211  1111    12443444455566777776665554  8999999999999


Q ss_pred             eCCCCcEEEeeccceeeec
Q 039002          181 LDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       181 i~~~~~~kl~dfg~~~~~~  199 (219)
                      +. +|.+.++|-+.+....
T Consensus       298 yh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  298 YH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             EE-CCEEEEEEccccccCC
Confidence            84 5788899988765443

>PRK05231 homoserine kinase; Provisional

Probab=97.11  E-value=0.019  Score=46.47  Aligned_cols=29  Identities=24%  Similarity=0.338  Sum_probs=25.3

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +++|+|+.|.|++++.+...-++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            79999999999999866556899999875

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.05  E-value=0.015  Score=43.80  Aligned_cols=129  Identities=23%  Similarity=0.359  Sum_probs=80.6

Q ss_pred             CCCCCcceeccccc-eeEEEEEcCCCcEEEEEecCC---CCC-------CCch-------hhHHHHHHHHH---HHhcCC
Q 039002           42 NDFDAKYCIGNGGH-ASVYRAELPSREVVAVKKFHS---PLP-------SDQT-------VDQKEFLTEVK---ALTETR  100 (219)
Q Consensus        42 ~~y~~~~~lg~g~~-g~V~~~~~~~~~~~aik~~~~---~~~-------~~~~-------~~~~~~~~e~~---~l~~l~  100 (219)
                      ++++.++.||.|.- |.||+++... ..+|+|.++.   ...       ....       .....+..|.+   .|+...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g-~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDG-RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECC-eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78899999999999 9999997654 4899998211   110       0000       11223445544   444445


Q ss_pred             CCcc--ceeEeEEEeC------------------CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHh
Q 039002          101 HRNI--VKFYGFCSHA------------------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY  160 (219)
Q Consensus       101 h~ni--~~~~~~~~~~------------------~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  160 (219)
                      +.++  ++.+||..-.                  ....||.|+.+...            .+....+    .++..-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~~----~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRDI----PQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhHH----HHHHHHHHH
Confidence            5566  8889988321                  01235666654422            1222333    455666777


Q ss_pred             hhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       161 lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      +|..   +|+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            8988   9999999999985     3477899853

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.04  E-value=0.014  Score=46.37  Aligned_cols=30  Identities=27%  Similarity=0.429  Sum_probs=25.3

Q ss_pred             CeEecCCCCCCEEeCCCCcE-EEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDLEYEA-HVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~-kl~dfg~~~~  197 (219)
                      .++|+|+.+.|++++.++++ -|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            58999999999999975654 5999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.03  E-value=0.025  Score=45.59  Aligned_cols=143  Identities=20%  Similarity=0.194  Sum_probs=76.1

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC--ccceeEeEE------EeCCcce
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR--NIVKFYGFC------SHARHSF  118 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~------~~~~~~~  118 (219)
                      ...++.|....+|+....++ .+++|......      ....+..|+.++..+...  ++++++...      ...+..+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~------~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV------KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC------CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            45677777788998865555 57788764311      112334566666666322  234443321      2245678


Q ss_pred             EEEEecCCCCHH-----H------H---hcccchh--hc-------cCHHHHH------------HHHHHHHHHHHhhhh
Q 039002          119 LLCEFLERGSLA-----A------I---LNTDAAA--QE-------LGWSQRM------------SVIKGVADALSYLHH  163 (219)
Q Consensus       119 lv~e~~~~~~l~-----~------~---~~~~~~~--~~-------l~~~~~~------------~i~~~i~~~l~~lh~  163 (219)
                      +++++++|.++.     .      .   +......  ..       -.|....            .....+...+.++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999998774321     0      0   0000000  00       0011000            001112223333422


Q ss_pred             ----CCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          164 ----DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       164 ----~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                          ....+++|+|+.+.|++++.++.+.++||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                112389999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.92  E-value=0.015  Score=46.59  Aligned_cols=30  Identities=27%  Similarity=0.293  Sum_probs=26.7

Q ss_pred             CCeEecCCCCCCEEeCCC----CcEEEeecccee
Q 039002          167 PPIVHRDVSSKNLLLDLE----YEAHVADFGIAK  196 (219)
Q Consensus       167 ~~i~H~dlkp~nili~~~----~~~kl~dfg~~~  196 (219)
                      ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            368999999999999874    889999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=96.83  E-value=0.014  Score=48.77  Aligned_cols=159  Identities=18%  Similarity=0.225  Sum_probs=97.0

Q ss_pred             CcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEE------EeCCc-
Q 039002           46 AKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFC------SHARH-  116 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~------~~~~~-  116 (219)
                      ....||+|+-+.+|.. +..   .++.|++..+.....       .+.+..|.+. .||-+..-..|=      -+.+. 
T Consensus        15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~-------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ-------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCccccCCccceeeecchhh---chhheeecCCCchHH-------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            4568999999999865 332   245577765432211       1223334444 455433211111      11222 


Q ss_pred             ceEEEEecCC-CCHHHHhccc---chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          117 SFLLCEFLER-GSLAAILNTD---AAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       117 ~~lv~e~~~~-~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                      .-+.|..+.+ ..+.++.+..   .....+.|...++....++.+...+|..   |-.=+|++++|+|+++++.++++|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence            4456666554 3444444321   1112366888899999999999999998   8889999999999999999999875


Q ss_pred             cceeeecCCCCcccccccccccccCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      ..-..- ....-....+|...|.+||
T Consensus       162 Dsfqi~-~ng~~~~cpVg~~eftPPE  186 (637)
T COG4248         162 DSFQIN-ANGTLHLCPVGVSEFTPPE  186 (637)
T ss_pred             cceeec-cCCceEecccCccccCCHH
Confidence            432211 1222223458888999998

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.55  E-value=0.083  Score=44.29  Aligned_cols=78  Identities=17%  Similarity=0.190  Sum_probs=48.7

Q ss_pred             CcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCch---hhHHHHHHHHHHHhcCC---CCccceeEeEEEeCCcceE
Q 039002           46 AKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQT---VDQKEFLTEVKALTETR---HRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~---~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..+.||.|....||+...+ +..++||+-.+.......   ....+...|...|+.+.   ...+++++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3568899999999998654 346888975422111111   12233344566665553   247778877765  44678


Q ss_pred             EEEecCC
Q 039002          120 LCEFLER  126 (219)
Q Consensus       120 v~e~~~~  126 (219)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999865

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.48  E-value=0.027  Score=43.22  Aligned_cols=103  Identities=13%  Similarity=0.072  Sum_probs=62.5

Q ss_pred             EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHH
Q 039002           68 VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR  147 (219)
Q Consensus        68 ~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~  147 (219)
                      +..+|++.......   -..-+..+..++.++.  .|+++..-  ++-.+-++.|.|-....            .   ..
T Consensus        87 ~L~lKKi~slp~~~---~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~---~~  144 (308)
T PF07387_consen   87 PLFLKKIRSLPCCI---NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------N---FS  144 (308)
T ss_pred             hhhhhhccCCCccc---chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------c---hh
Confidence            45666664322111   1123456677777664  45555422  33456799999854211            0   01


Q ss_pred             HHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       148 ~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      -.+..+ +.++.-.|+... +.+|+|..|+||+-+..|-+|+.|-+.
T Consensus       145 N~i~ag-i~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  145 NFITAG-IKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHh-HHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhh
Confidence            111111 346677785443 789999999999999999999999874

The function of this family is unknown.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.40  E-value=0.1  Score=42.27  Aligned_cols=31  Identities=32%  Similarity=0.523  Sum_probs=27.7

Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       167 ~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ..++|+|..+.|++++..+.+-+.||+.+..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            3689999999999999888899999998863

>PLN02236 choline kinase

Probab=96.37  E-value=0.044  Score=45.03  Aligned_cols=30  Identities=20%  Similarity=0.431  Sum_probs=26.2

Q ss_pred             CeEecCCCCCCEEeCC-CCcEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDL-EYEAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~-~~~~kl~dfg~~~~  197 (219)
                      .++|+|+++.||+++. ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6799999999999986 47899999998763

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.09  E-value=0.15  Score=42.12  Aligned_cols=76  Identities=14%  Similarity=0.151  Sum_probs=46.3

Q ss_pred             eeccccceeEEEEEcCCC-cEEEEEecCCCCC---CCchhhHHHHHHHHHHHhcCCC--C-ccceeEeEEEeCCcceEEE
Q 039002           49 CIGNGGHASVYRAELPSR-EVVAVKKFHSPLP---SDQTVDQKEFLTEVKALTETRH--R-NIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~~~~-~~~aik~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h--~-ni~~~~~~~~~~~~~~lv~  121 (219)
                      .||.|....||++..+++ +.++||.-.+-..   ..-.....+...|...|+....  | .++++|.+  +.....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            578999999999976554 5799997532111   1112233445567777766531  2 45555433  445566899


Q ss_pred             EecCC
Q 039002          122 EFLER  126 (219)
Q Consensus       122 e~~~~  126 (219)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            98854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=96.01  E-value=0.0057  Score=53.47  Aligned_cols=47  Identities=21%  Similarity=0.442  Sum_probs=40.5

Q ss_pred             HHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       152 ~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      .+++.|+.|+|..-  +++|+++.|++|.+...|..|++.|+++.....
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~  152 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG  152 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCC
Confidence            34558999999873  799999999999999999999999999875543

>PRK10593 hypothetical protein; Provisional

Probab=95.89  E-value=0.095  Score=42.12  Aligned_cols=77  Identities=18%  Similarity=0.119  Sum_probs=53.6

Q ss_pred             CcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC---CccceeEeEEEe---CCcceE
Q 039002           46 AKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH---RNIVKFYGFCSH---ARHSFL  119 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~---~~~~~l  119 (219)
                      -.+.||.|..+.||.....+++ +.+|..+. .     .....+..|...++.+..   -.++++++++..   .+..++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN-PMPLMARS-F-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC-EEEEEecc-c-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            3567999999999988655553 55565432 0     012356779998988853   367788877754   366899


Q ss_pred             EEEecCCCCH
Q 039002          120 LCEFLERGSL  129 (219)
Q Consensus       120 v~e~~~~~~l  129 (219)
                      +||++.+.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999988655

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.30  E-value=0.18  Score=41.11  Aligned_cols=29  Identities=31%  Similarity=0.376  Sum_probs=25.3

Q ss_pred             CeEecCCCCCCEEeCC-CCcEEEeecccee
Q 039002          168 PIVHRDVSSKNLLLDL-EYEAHVADFGIAK  196 (219)
Q Consensus       168 ~i~H~dlkp~nili~~-~~~~kl~dfg~~~  196 (219)
                      -+.|+|+.+.||+++. ++.++++||..|.
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            3699999999999974 5789999999875

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.09  E-value=0.26  Score=41.27  Aligned_cols=78  Identities=19%  Similarity=0.140  Sum_probs=48.9

Q ss_pred             cceeccccceeEEEEEcCC-CcEEEEEecCCCCC--CCchhhHHHHHHHHHHHhcCC---CCccceeEeEEEeCCcceEE
Q 039002           47 KYCIGNGGHASVYRAELPS-REVVAVKKFHSPLP--SDQTVDQKEFLTEVKALTETR---HRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~-~~~~aik~~~~~~~--~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .+.||.|.-..||++...+ ++.++||.-.+-..  .+-.....+...|...|+...   ...++++|.+  +.....++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5689999999999996542 56799997532111  111334456667888887663   2245556544  44455678


Q ss_pred             EEecCC
Q 039002          121 CEFLER  126 (219)
Q Consensus       121 ~e~~~~  126 (219)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            887753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.55  E-value=0.27  Score=39.38  Aligned_cols=74  Identities=23%  Similarity=0.271  Sum_probs=45.6

Q ss_pred             CcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC---CCccceeEeEEEeCCcceEEEE
Q 039002           46 AKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR---HRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      -...++-|..+.+|+.. .+++.+.+|.-..       .....+..|+.-|+.+.   .-.+++++++....+..||++|
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~-------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE-------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG-------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh-------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            35678888899999887 5666888887531       12234566888777773   4567888988887778899999


Q ss_pred             ecCCC
Q 039002          123 FLERG  127 (219)
Q Consensus       123 ~~~~~  127 (219)
                      +++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            98654

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=94.30  E-value=2.7  Score=39.88  Aligned_cols=29  Identities=31%  Similarity=0.550  Sum_probs=24.8

Q ss_pred             CeEecCCCCCCEEeCCCC--cEE-Eeecccee
Q 039002          168 PIVHRDVSSKNLLLDLEY--EAH-VADFGIAK  196 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~--~~k-l~dfg~~~  196 (219)
                      .++|+|+++.||+++.++  ++. |+|||-+.
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            699999999999999775  555 99999765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.22  E-value=0.21  Score=41.24  Aligned_cols=70  Identities=20%  Similarity=0.339  Sum_probs=48.4

Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .|+++++. |+++. .++.      -.+.+...++++.+..+.-+...  +..-|||+.-.||+++ +|.+.|+||.+++
T Consensus       301 ~yl~~kdh-gt~is-~ik~------~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         301 LYLHFKDH-GTPIS-IIKA------DRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEecC-Cceee-eeec------ccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence            45566655 44442 2221      23566777777766555545443  3778999999999999 9999999999998


Q ss_pred             e
Q 039002          197 F  197 (219)
Q Consensus       197 ~  197 (219)
                      .
T Consensus       370 l  370 (488)
T COG5072         370 L  370 (488)
T ss_pred             c
Confidence            3

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.03  E-value=1  Score=34.93  Aligned_cols=74  Identities=20%  Similarity=0.256  Sum_probs=46.4

Q ss_pred             ceeccccceeEEEEEcCCC-cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC---CccceeEeEEEeCCcceEEEEe
Q 039002           48 YCIGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH---RNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~-~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      +.+.-|.....|..  .+| ..+-+|.-.       ......+..|+.-|+.+.-   -.+.+++.+-.+.+..|+|+||
T Consensus        22 ~~v~gG~inea~~v--~dg~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~   92 (286)
T COG3001          22 EEVSGGDINEAWRL--RDGTDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY   92 (286)
T ss_pred             cccCCccccceeEe--ecCCcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence            34444444444433  333 357777532       2233456677777776643   4577788888888999999999


Q ss_pred             cCCCCHH
Q 039002          124 LERGSLA  130 (219)
Q Consensus       124 ~~~~~l~  130 (219)
                      ++-+++.
T Consensus        93 L~~~~~d   99 (286)
T COG3001          93 LPTGPLD   99 (286)
T ss_pred             ccCCCCC
Confidence            8765544

>PTZ00384 choline kinase; Provisional

Probab=93.15  E-value=0.62  Score=38.91  Aligned_cols=74  Identities=19%  Similarity=0.138  Sum_probs=42.7

Q ss_pred             cceeccccceeEEEEEcCCC--c-----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC-ccceeEeEEEeCCcce
Q 039002           47 KYCIGNGGHASVYRAELPSR--E-----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR-NIVKFYGFCSHARHSF  118 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~--~-----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~  118 (219)
                      .+.|..|-.+.+|++...++  .     .|.++.....    . ...-...+|+.+++.+... --.++++.+.    -+
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g  125 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DF  125 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----C-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence            45565688889999864432  1     2444443211    0 1111224588888888544 4456666663    26


Q ss_pred             EEEEecCCCCH
Q 039002          119 LLCEFLERGSL  129 (219)
Q Consensus       119 lv~e~~~~~~l  129 (219)
                      ++.||++|.++
T Consensus       126 ~l~efIeGr~l  136 (383)
T PTZ00384        126 TIQEWVEGNTM  136 (383)
T ss_pred             EEEEEeccccC
Confidence            88999887544

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.96  E-value=0.096  Score=39.04  Aligned_cols=29  Identities=24%  Similarity=0.219  Sum_probs=25.2

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ..+|+|+.|.|+++..+| ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            469999999999998777 88999998863

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.88  E-value=0.28  Score=39.36  Aligned_cols=28  Identities=32%  Similarity=0.427  Sum_probs=24.9

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +++|+|+.+.|++++. +.+.++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            7899999999999987 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.57  E-value=0.11  Score=39.44  Aligned_cols=30  Identities=27%  Similarity=0.515  Sum_probs=21.5

Q ss_pred             CeEecCCCCCCEEe-CCCCcEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLL-DLEYEAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili-~~~~~~kl~dfg~~~~  197 (219)
                      .+.|+|+.+.||++ ..++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57999999999999 7889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.24  E-value=0.21  Score=37.50  Aligned_cols=30  Identities=17%  Similarity=0.490  Sum_probs=25.5

Q ss_pred             CeEecCCCCCCEEeCCCC-----cEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDLEY-----EAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~-----~~kl~dfg~~~~  197 (219)
                      .++|+|+.+.|+++..++     .+.++||..+..
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            689999999999998543     689999998764

subfamily of choline kinases

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=90.95  E-value=0.22  Score=39.40  Aligned_cols=29  Identities=28%  Similarity=0.284  Sum_probs=26.9

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++|+|+.|.|++.+.++.+.++||.-|.
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCC
Confidence            58999999999999999999999998775

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=90.90  E-value=0.072  Score=36.64  Aligned_cols=30  Identities=33%  Similarity=0.241  Sum_probs=26.8

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCC
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHS   76 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~   76 (219)
                      ...|+.|+.|.||+|...+|+.||||..++
T Consensus        16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP   45 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKDGEEVAVKVQRP   45 (119)
T ss_pred             cchhhheehhhheeeeecccchhhhhhcch
Confidence            468999999999999998899999998764

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=90.77  E-value=0.24  Score=40.48  Aligned_cols=28  Identities=32%  Similarity=0.518  Sum_probs=25.3

Q ss_pred             eEecCCCCCCEEeCCCCc-EEEeecccee
Q 039002          169 IVHRDVSSKNLLLDLEYE-AHVADFGIAK  196 (219)
Q Consensus       169 i~H~dlkp~nili~~~~~-~kl~dfg~~~  196 (219)
                      ++|+|+.|.||+++.+.. +.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998875 8899999875

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.44  E-value=0.18  Score=40.64  Aligned_cols=30  Identities=27%  Similarity=0.353  Sum_probs=27.3

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++|+|+.++|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            789999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=90.25  E-value=0.09  Score=44.75  Aligned_cols=74  Identities=26%  Similarity=0.463  Sum_probs=56.2

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      .....++|+....+|.|+||.|+.+. ..++-.+|||.+..+.   ......+..+|..-+.++.|+++++++..|..
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn---~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN---REESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccc---hhhhhhhhhccccchhhhcccchhhheeceec
Confidence            45556889999999999999999994 4455578999875432   22344566778888999999999999887754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	219
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-26
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-19
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-04
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-04
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 64/183 (34%), Positives = 97/183 (53%), Gaps = 5/183 (2%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           E+  A+++F  K  +G GG   VY+  L    +VAVK+          +   +F TEV+ 
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL---QFQTEVEM 88
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGV 154
           ++   HRN+++  GFC       L+  ++  GS+A+ L     +Q  L W +R  +  G 
Sbjct: 89  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 148
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK-SDASNWTEFAGTYG 213
           A  L+YLH  C P I+HRDV + N+LLD E+EA V DFG+AK +   D        GT G
Sbjct: 149 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 214 YVA 216
           ++A
Sbjct: 209 HIA 211

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 63/183 (34%), Positives = 96/183 (52%), Gaps = 5/183 (2%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           E+  A+++F  K  +G GG   VY+  L    +VAVK+          +   +F TEV+ 
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL---QFQTEVEM 80
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGV 154
           ++   HRN+++  GFC       L+  ++  GS+A+ L     +Q  L W +R  +  G 
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK-SDASNWTEFAGTYG 213
           A  L+YLH  C P I+HRDV + N+LLD E+EA V DFG+AK +   D        G  G
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIG 200
Query: 214 YVA 216
           ++A
Sbjct: 201 HIA 203

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/196 (35%), Positives = 102/196 (52%), Gaps = 21/196 (10%)
Query: 33  LYDEIVKATNDFDAKYC-------IGNGGHASVYRAELPSREVVAVK-----KFHSPLPS 80
           LY +     +D D  +C       IG G   +V+RAE    +V AVK      FH+    
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHA---- 75
Query: 81  DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ 140
            + V+  EFL EV  +   RH NIV F G  +   +  ++ E+L RGSL  +L+   A +
Sbjct: 76  -ERVN--EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
           +L   +R+S+   VA  ++YLH+   PPIVHRD+ S NLL+D +Y   V DFG+++   S
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 201 DASNWTEFAGTYGYVA 216
                   AGT  ++A
Sbjct: 192 XFLXSKXAAGTPEWMA 207

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/179 (36%), Positives = 98/179 (54%), Gaps = 14/179 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELPSREVVAVK-----KFHSPLPSDQTVDQKEFLTEVKALT 97
           D + K  IG G   +V+RAE    +V AVK      FH+     + V+  EFL EV  + 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHA-----ERVN--EFLREVAIMK 89
Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
             RH NIV F G  +   +  ++ E+L RGSL  +L+   A ++L   +R+S+   VA  
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++YLH+   PPIVHR++ S NLL+D +Y   V DFG+++   S   +    AGT  ++A
Sbjct: 150 MNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 25  IPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV 84
           +P E  ++   ++ +ATN+FD K+ IG+G    VY+  L     VA+K+  +P   + + 
Sbjct: 22  VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTP---ESSQ 77
Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAA-ILNTDAAAQELG 143
             +EF TE++ L+  RH ++V   GFC       L+ +++E G+L   +  +D     + 
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           W QR+ +  G A  L YLH      I+HRDV S N+LLD  +   + DFGI+K  K    
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTEL 192
Query: 204 NWTEF----AGTYGYV 215
           + T       GT GY+
Sbjct: 193 DQTHLXXVVKGTLGYI 208

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 25  IPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV 84
           +P E  ++   ++ +ATN+FD K+ IG+G    VY+  L     VA+K+  +P   + + 
Sbjct: 22  VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTP---ESSQ 77
Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAA-ILNTDAAAQELG 143
             +EF TE++ L+  RH ++V   GFC       L+ +++E G+L   +  +D     + 
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           W QR+ +  G A  L YLH      I+HRDV S N+LLD  +   + DFGI+K  K    
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTEL 192
Query: 204 NWTEF----AGTYGYV 215
             T       GT GY+
Sbjct: 193 GQTHLXXVVKGTLGYI 208

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 36  EIVKATNDFDAKYC------IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           E+   TN+FD +        +G GG   VY+  + +   VAVKK  + +       +++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
             E+K + + +H N+V+  GF S      L+  ++  GSL   L+       L W  R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTE 207
           + +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  A     + 
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 208 FAGTYGYVA 216
             GT  Y+A
Sbjct: 195 IVGTTAYMA 203

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 36  EIVKATNDFDAKYC------IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           E+   TN+FD +        +G GG   VY+  + +   VAVKK  + +       +++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
             E+K + + +H N+V+  GF S      L+  ++  GSL   L+       L W  R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTE 207
           + +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  A       
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 208 FAGTYGYVA 216
             GT  Y+A
Sbjct: 195 IVGTTAYMA 203

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 36  EIVKATNDFDAKYC------IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           E+   TN+FD +        +G GG   VY+  + +   VAVKK  + +       +++F
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 71
Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
             E+K + + +H N+V+  GF S      L+  ++  GSL   L+       L W  R  
Sbjct: 72  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 131
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTE 207
           + +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  A       
Sbjct: 132 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 208 FAGTYGYVA 216
             GT  Y+A
Sbjct: 189 IVGTTAYMA 197

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 36  EIVKATNDFDAKYC------IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           E+   TN+FD +         G GG   VY+  + +   VAVKK  + +       +++F
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 68
Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
             E+K   + +H N+V+  GF S      L+  +   GSL   L+       L W  R  
Sbjct: 69  DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCK 128
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTE 207
           + +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  A     + 
Sbjct: 129 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 208 FAGTYGYVA 216
             GT  Y A
Sbjct: 186 IVGTTAYXA 194

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 91/172 (52%), Gaps = 12/172 (6%)
Query: 50  IGNGGHASVYRAEL--PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    V R  L  P ++   VA+K         Q   ++EFL+E   + +  H NI+
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ---RREFLSEASIMGQFEHPNII 80
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G  +++    +L EF+E G+L + L  +    +    Q + +++G+A  + YL    
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVIQLVGMLRGIASGMRYLAEMS 138
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVAL 217
           +   VHRD++++N+L++      V+DFG+++FL+ ++S+ TE +   G + +
Sbjct: 139 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 12/172 (6%)
Query: 50  IGNGGHASVYRAEL--PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    V R  L  P ++   VA+K         Q   ++EFL+E   + +  H NI+
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ---RREFLSEASIMGQFEHPNII 78
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G  +++    +L EF+E G+L + L  +    +    Q + +++G+A  + YL    
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVIQLVGMLRGIASGMRYLAEMS 136
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVAL 217
           +   VHRD++++N+L++      V+DFG+++FL+ ++S+ T  +   G + +
Sbjct: 137 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPI 185

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 118
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 61
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 120
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 63
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 122
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 123 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 60
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 119
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 120 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 72
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 73  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 131
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 132 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 178

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 60
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 119
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 120 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 118
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 64
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 123
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 61
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 120
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 61
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 120
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 59
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 64/119 (53%), Gaps = 5/119 (4%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           Q+ FL EVK +    H N++KF G     +    + E+++ G+L  I+   +   +  WS
Sbjct: 51  QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWS 108
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
           QR+S  K +A  ++YLH      I+HRD++S N L+       VADFG+A+ +  + + 
Sbjct: 109 QRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 10/178 (5%)
Query: 26  PPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELP-SREV-VAVKKFHSPLPSDQT 83
           P   G+    EI  +    +     G+ G     R  +P  R+V VA+K   +     Q 
Sbjct: 35  PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ- 93
Query: 84  VDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELG 143
             +++FL+E   + +  H NI++  G  +  R + ++ E++E GSL   L T     +  
Sbjct: 94  --RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFT 149
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             Q + +++GV   + YL    +   VHRD++++N+L+D      V+DFG+++ L+ D
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 10/178 (5%)
Query: 26  PPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELP-SREV-VAVKKFHSPLPSDQT 83
           P   G+    EI  +    +     G+ G     R  +P  R+V VA+K   +     Q 
Sbjct: 35  PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ- 93
Query: 84  VDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELG 143
             +++FL+E   + +  H NI++  G  +  R + ++ E++E GSL   L T     +  
Sbjct: 94  --RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFT 149
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             Q + +++GV   + YL    +   VHRD++++N+L+D      V+DFG+++ L+ D
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 305
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 364
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
            ++ A+ YL    F   +HR+++++N L+   +   VADFG+++ +  D   +T  AG
Sbjct: 365 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAG 417

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKE 266
Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 325
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
            ++ A+ YL    F   +HR+++++N L+   +   VADFG+++ +  D 
Sbjct: 326 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 51  GNGGHASVYRAELP-SREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           G  G       +LP  RE+ VA+K   S     Q   +++FL+E   + +  H N++   
Sbjct: 44  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNVIHLE 100
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G  + +    ++ EF+E GSL + L  +    +    Q + +++G+A  + YL    +  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNY-- 156
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVAL 217
            VHRD++++N+L++      V+DFG+++FL+ D S+ T  +   G + +
Sbjct: 157 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 204

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            D   K+ +G G +  VY        + VAVK        + T++ +EFL E   + E +
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 65
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 124
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           L    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            D   K+ +G G +  VY        + VAVK        + T++ +EFL E   + E +
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 65
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 124
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           L    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +D++ +  IG+G  A V  A   P +E VA+K+ +  L   QT    E L E++A+++  
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQT-SMDELLKEIQAMSQCH 66
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-----LGWSQRMSVIKGVA 155
           H NIV +Y         +L+ + L  GS+  I+    A  E     L  S   ++++ V 
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
           + L YLH +     +HRDV + N+LL  +    +ADFG++ FL +
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLAT 168

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +D++ +  IG+G  A V  A   P +E VA+K+ +  L   QT    E L E++A+++  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQT-SMDELLKEIQAMSQCH 71
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-----LGWSQRMSVIKGVA 155
           H NIV +Y         +L+ + L  GS+  I+    A  E     L  S   ++++ V 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
           + L YLH +     +HRDV + N+LL  +    +ADFG++ FL +
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    F   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 159 GMKYLSDMGF---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+A+ L+ D
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDD 200

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 13/157 (8%)
Query: 50  IGNGGHASVYRAELPS----REV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           IG G    VY+  L +    +EV VA+K   +     Q VD   FL E   + +  H NI
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD---FLGEAGIMGQFSHHNI 108
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           ++  G  S  +   ++ E++E G+L   L       E    Q + +++G+A  + YL + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM 166
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            D   K+ +G G    VY        + VAVK        + T++ +EFL E   + E +
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 65
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ Y
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEY 124
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           L    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 125 LEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 32  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 88
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 146
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 147 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 71
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 129
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 130 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 42  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 98
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 156
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 157 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 42  NDFDAKYCIGNGGHASVYRAEL----PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
            D   K  +G G    V+ AE     P+++  +VAVK    P        +K+F  E + 
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAEL 70
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT---DA----------AAQEL 142
           LT  +H +IVKFYG C       ++ E+++ G L   L     DA          A  EL
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           G SQ + +   +A  + YL    F   VHRD++++N L+       + DFG+++
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+ + L+ D
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 25/156 (16%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    V++A+L + E VAVK F  P+   Q+  Q E+  EV +L   +H NI++F G  +
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIF--PIQDKQSW-QNEY--EVYSLPGMKHENILQFIG--A 86
Query: 113 HARHS------FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC- 165
             R +      +L+  F E+GSL+  L  +  +    W++   + + +A  L+YLH D  
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS----WNELCHIAETMARGLAYLHEDIP 142
Query: 166 ------FPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
                  P I HRD+ SKN+LL     A +ADFG+A
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 86/169 (50%), Gaps = 10/169 (5%)
Query: 51  GNGGHASVYRAELP-SREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           G  G       +LP  RE+ VA+K   S     Q   +++FL+E   + +  H N++   
Sbjct: 18  GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNVIHLE 74
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G  + +    ++ EF+E GSL + L  +    +    Q + +++G+A  + YL    +  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNY-- 130
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVAL 217
            VHR ++++N+L++      V+DFG+++FL+ D S+ T  +   G + +
Sbjct: 131 -VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 69
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+  RG +   L   +   E    QR +  I  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE----QRTATYITELANA 125
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 178

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 50  IGNGGHASVYRAELPS-REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V+   L +   +VAVK     LP D    + +FL E + L +  H NIV+  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G C+  +  +++ E ++ G     L T+ A   L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +HRD++++N L+  +    ++DFG+++
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 50  IGNGGHASVYRAELPS-REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V+   L +   +VAVK     LP D    + +FL E + L +  H NIV+  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G C+  +  +++ E ++ G     L T+ A   L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +HRD++++N L+  +    ++DFG+++
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 71
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E +E GSL + L    A  +    Q + +++G+A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 129
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 130 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 42  NDFDAKYCIGNGGHASVYRAE----LPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
            D   K+ +G G    V+ AE    LP ++  +VAVK       S +    ++F  E + 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAEL 96
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT------------DAAAQELG 143
           LT  +H++IV+F+G C+  R   ++ E++  G L   L +            D A   LG
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             Q ++V   VA  + YL    F   VHRD++++N L+       + DFG+++
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 50  IGNGGHASVYRAELPS-REV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G  G     R ++P  RE+ VA+K   +     Q   +++FL+E   + +  H NI+  
Sbjct: 18  VGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNIIHL 74
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
            G  +  +   ++ E++E GSL A L  +     +   Q + +++G+   + YL    + 
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSY- 131
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 132 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E +E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL    +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 42  NDFDAKYCIGNGGHASVYRAE----LPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
            D   K+ +G G    V+ AE    LP ++  +VAVK       S +    ++F  E + 
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAEL 67
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT------------DAAAQELG 143
           LT  +H++IV+F+G C+  R   ++ E++  G L   L +            D A   LG
Sbjct: 68  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 127
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             Q ++V   VA  + YL    F   VHRD++++N L+       + DFG+++
Sbjct: 128 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 120
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  TE  GT  Y+
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYL 173

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 50  IGNGGHASVYRAELP-SREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G  G     R ++P  RE+ VA+K   +     Q   +++FL+E   + +  H NI+  
Sbjct: 24  VGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNIIHL 80
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
            G  +  +   ++ E++E GSL A L  +     +   Q + +++G+   + YL    + 
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSY- 137
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 138 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 42  NDFDAKYCIGNGGHASVYRAE----LPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
            D   K+ +G G    V+ AE    LP ++  +VAVK       S +    ++F  E + 
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAEL 73
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT------------DAAAQELG 143
           LT  +H++IV+F+G C+  R   ++ E++  G L   L +            D A   LG
Sbjct: 74  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 133
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
             Q ++V   VA  + YL    F   VHRD++++N L+       + DFG+++ + S
Sbjct: 134 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 187

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 15/195 (7%)
Query: 26  PP--EVGKILYDEIVKATND-FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSD 81
           PP  ++ K+  D + K   + FD    +G G + SVY+A    + ++VA+K+   P+ SD
Sbjct: 10  PPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESD 67
Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE 141
                +E + E+  + +    ++VK+YG        +++ E+   GS++ I+      + 
Sbjct: 68  L----QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKT 121
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           L   +  ++++     L YLH   F   +HRD+ + N+LL+ E  A +ADFG+A  L   
Sbjct: 122 LTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDX 178
Query: 202 ASNWTEFAGTYGYVA 216
            +      GT  ++A
Sbjct: 179 MAKRNXVIGTPFWMA 193

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 8/176 (4%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           A  DF+    +G G   +VY A    R+ +   K       ++   + +   EV+  +  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
           RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 119
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           Y H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 120 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 170

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+     V+A  K    + +    + ++++ E+  L    H NIVK   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKV---IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
              +  + ++L EF   G++ A++      + L  SQ   V K   DAL+YLH +    I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+ + N+L  L+ +  +ADFG++            F GT  ++A
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 203

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+     V+A  K    + +    + ++++ E+  L    H NIVK   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKV---IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
              +  + ++L EF   G++ A++      + L  SQ   V K   DAL+YLH +    I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+ + N+L  L+ +  +ADFG++            F GT  ++A
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMA 203

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+     V+A  K    + +    + ++++ E+  L    H NIVK   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKV---IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
              +  + ++L EF   G++ A++      + L  SQ   V K   DAL+YLH +    I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+ + N+L  L+ +  +ADFG++            F GT  ++A
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMA 203

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    V   +   +  VAVK     +  + ++ + EF  E + + +  H  +VKFYG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK-----MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            CS     +++ E++  G L   L +     E   SQ + +   V + +++L    F   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLESHQF--- 125
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L+D +    V+DFG+ +++  D
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 10/174 (5%)
Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           DFD    +G G   +VY A E  S+ ++A+K           V+  +   EV+  +  RH
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH-QLRREVEIQSHLRH 71
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYC 128
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 129 HSKR---VIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYL 177

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 79/162 (48%), Gaps = 10/162 (6%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            D   K+ +G G +  VY        + VAVK        + T++ +EFL E   + E +
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 86
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H N+V+  G C+     +++ E++  G+L   L  +   +E+     + +   ++ A+ Y
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLR-ECNREEVTAVVLLYMATQISSAMEY 145
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           L    F   +HRD++++N L+   +   VADFG+++ +  D 
Sbjct: 146 LEKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT 184

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K     +  + ++ + EF+ E K +    H  +V+ YG
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 126
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 158

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K     +  + ++ + EF+ E K +    H  +V+ YG
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K     +  + ++ + EF+ E K +    H  +V+ YG
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 78  VCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 132
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 164

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K     +  + ++ + EF+ E K +    H  +V+ YG
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKF---HSPLPSDQTVDQKEFLTEVKA 95
           A N+ + +  IG GG   V++  L   + VVA+K      S   ++     +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           ++   H NIVK YG   +     ++ EF+  G L   L     A  + WS ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYE-----AHVADFGIAK 196
             + Y+ +   PPIVHRD+ S N+ L    E     A VADFG+++
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K     +  + ++ + EF+ E K +    H  +V+ YG
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 125
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 157

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 120
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T+  GT  Y+
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYL 173

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K     +  + ++ + EF+ E K +    H  +V+ YG
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 126
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 158

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 65
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 121
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T+  GT  Y+
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYL 174

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T+  GT  Y+
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYL 173

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 69
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+  RG +   L   +   E    QR +  I  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE----QRTATYITELANA 125
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYL 178

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 69
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 125
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T+  GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYL 178

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K     +  + ++ + EF+ E K +    H  +V+ YG
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 121
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQ--KEFLTEVKALTETRHRNIVKF 107
           IG GG   VYRA     EV      H P   D+ + Q  +    E K     +H NI+  
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDP---DEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL--GWSQRMSVIKGVADALSYLHHDC 165
            G C    +  L+ EF   G L  +L+      ++   W+ +      +A  ++YLH + 
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEA 125
Query: 166 FPPIVHRDVSSKNLLLDLEYE--------AHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             PI+HRD+ S N+L+  + E          + DFG+A+  +   +     AG Y ++A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGAYAWMA 182

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 11/165 (6%)
Query: 40  ATN-DFDAKYCIGNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           ATN   D     G  G     R +LPS++   VA+K         Q   +++FL E   +
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIM 100
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            +  H NI++  G  + ++   ++ E +E GSL + L    A  +    Q + +++G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIAS 158
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            + YL        VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 159 GMKYLSDMG---AVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 122 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYL 173

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 68
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 125
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 126 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 177

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DFD    +G G   +VY A E  ++ ++A+K         + V+  +   E++  +  R
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLR 73
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H NI++ Y +    +  +L+ EF  RG L   L       E    +  + ++ +ADAL Y
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHY 130
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
            H      ++HRD+  +NLL+  + E  +ADFG
Sbjct: 131 CHER---KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 67
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 124
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 125 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 176

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 63
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 120
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 121 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 172

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 50  IGNGGHASVYRAELP-SREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G  G     R ++P  RE+ VA+K   +     Q   +++FL+E   + +  H NI+  
Sbjct: 39  VGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNIIHL 95
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
            G  +  +   ++ E++E GSL A L  +     +   Q + +++G+   + YL      
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMS-- 151
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 152 -AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 120
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 173

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
             +DFD    +G G   +VY A E  ++ ++A+K         + V+  +   E++  + 
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSH 70
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ Y +    +  +L+ EF  RG L   L       E    +  + ++ +ADAL
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADAL 127
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
            Y H      ++HRD+  +NLL+  + E  +ADFG
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 67
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 123
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 176

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKF---HSPLPSDQTVDQKEFLTEVKA 95
           A N+ + +  IG GG   V++  L   + VVA+K      S   ++     +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           ++   H NIVK YG   +     ++ EF+  G L   L     A  + WS ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYE-----AHVADFGIAK 196
             + Y+ +   PPIVHRD+ S N+ L    E     A VADFG ++
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 69
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 125
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 178

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 65
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 121
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +    + +S  T  +GT  Y+
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYL 174

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+     +++ VA+K        +  + +++F+ E + + +  H  +V+ YG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCF 166
            C       L+ EF+E G L+  L T     AA+ L     + +   V + ++YL   C 
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 124
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             ++HRD++++N L+       V+DFG+ +F+  D   +T   GT
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGT 165

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 81
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 137
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 138 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 190

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 90
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 146
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 199

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 69
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 125
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S  T   GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYL 178

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 67
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 124
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S   +  GT  Y+
Sbjct: 125 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYL 176

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+     +++ VA+K        + ++ + +F+ E + + +  H  +V+ YG
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI-----KEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCF 166
            C       L+ EF+E G L+  L T     AA+ L     + +   V + ++YL   C 
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 143
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             ++HRD++++N L+       V+DFG+ +F+  D   +T   GT
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGT 184

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+     +++ VA+K        +  + +++F+ E + + +  H  +V+ YG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCF 166
            C       L+ EF+E G L+  L T     AA+ L     + +   V + ++YL   C 
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 123
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             ++HRD++++N L+       V+DFG+ +F+  D   +T   GT
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGT 164

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 10/174 (5%)
Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           DFD    +G G   +VY A E  S+ ++A+K           V+  +   EV+  +  RH
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH-QLRREVEIQSHLRH 71
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYC 128
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 129 HSKR---VIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYL 177

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+     +++ VA+K        +  + +++F+ E + + +  H  +V+ YG
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCF 166
            C       L+ EF+E G L+  L T     AA+ L     + +   V + ++YL   C 
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 126
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             ++HRD++++N L+       V+DFG+ +F+  D   +T   GT
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGT 167

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+     +++ VA+K        +  + +++F+ E + + +  H  +V+ YG
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCF 166
            C       L+ EF+E G L+  L T     AA+ L     + +   V + ++YL   C 
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 121
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             ++HRD++++N L+       V+DFG+ +F+  D   +T   GT
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGT 162

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           ND   +  IG G    V +A +     R   A+K+       D   D ++F  E++ L +
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 81
Query: 99  T-RHRNIVKFYGFCSHARHSFLLCEFLERGSL------AAILNTDAA-------AQELGW 144
              H NI+   G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            Q +     VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           ND   +  IG G    V +A +     R   A+K+       D   D ++F  E++ L +
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 71
Query: 99  T-RHRNIVKFYGFCSHARHSFLLCEFLERGSL------AAILNTDAA-------AQELGW 144
              H NI+   G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 72  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 131
Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            Q +     VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++
Sbjct: 132 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 67
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 123
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +A+FG +  + + +S  T   GT  Y+
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYL 176

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 122 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYL 173

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 51  GNGGHASVYRAELP-SREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           G  G     R +LP  RE+ VA+K         Q   +++FL E   + +  H NI+   
Sbjct: 33  GEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNIIHLE 89
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G  + ++   ++ E++E GSL   L  +    +    Q + +++G++  + YL    +  
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDG--QFTVIQLVGMLRGISAGMKYLSDMGY-- 145
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 67
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 124
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 125 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYL 176

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 75/153 (49%), Gaps = 10/153 (6%)
Query: 51  GNGGHASVYRAELPSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           G  G     R +LP +    VA+K         Q   +++FL E   + +  H N+V   
Sbjct: 54  GEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ---RRDFLCEASIMGQFDHPNVVHLE 110
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G  +  +   ++ EF+E G+L A L       +    Q + +++G+A  + YL    +  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDG--QFTVIQLVGMLRGIAAGMRYLADMGY-- 166
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            VHRD++++N+L++      V+DFG+++ ++ D
Sbjct: 167 -VHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKF---HSPLPSDQTVDQKEFLTEVKA 95
           A N+ + +  IG GG   V++  L   + VVA+K      S   ++     +EF  EV  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           ++   H NIVK YG   +     ++ EF+  G L   L     A  + WS ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYE-----AHVADFGIAK 196
             + Y+ +   PPIVHRD+ S N+ L    E     A VADF +++
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 122 SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYL 173

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 90
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 146
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S   +  GT  Y+
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYL 199

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 66
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 122
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +A+FG +  + + +S  T   GT  Y+
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYL 175

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 66
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 122
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 123 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYL 175

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 67
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 123
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYL 176

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 6/179 (3%)
Query: 43  DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR 102
           D++  Y IG G +    +    S   + V K      S    +++  ++EV  L E +H 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWK-ELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 103 NIVKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGVADALS 159
           NIV++Y       ++  +++ E+ E G LA+++      ++ L     + V+  +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 160 YLHH--DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             H   D    ++HRD+   N+ LD +    + DFG+A+ L  D     EF GT  Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 65
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV-IKGVADA 157
            RH NI++ YG+   A   +L+ E+   G++   L   +   E    QR +  I  +A+A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANA 121
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LSY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYL 174

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 6/179 (3%)
Query: 43  DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR 102
           D++  Y IG G +    +    S   + V K      S    +++  ++EV  L E +H 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWK-ELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 103 NIVKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGVADALS 159
           NIV++Y       ++  +++ E+ E G LA+++      ++ L     + V+  +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 160 YLHH--DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             H   D    ++HRD+   N+ LD +    + DFG+A+ L  D S    F GT  Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 6/179 (3%)
Query: 43  DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR 102
           D++  Y IG G +    +    S   + V K      S    +++  ++EV  L E +H 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWK-ELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 103 NIVKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGVADALS 159
           NIV++Y       ++  +++ E+ E G LA+++      ++ L     + V+  +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 160 YLHH--DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             H   D    ++HRD+   N+ LD +    + DFG+A+ L  D S    F GT  Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           ND   +  IG G    V +A +     R   A+K+       D   D ++F  E++ L +
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 78
Query: 99  T-RHRNIVKFYGFCSHARHSFLLCEFLERGSL------AAILNTDAA-------AQELGW 144
              H NI+   G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 79  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 138
Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            Q +     VA  + YL    F   +HR+++++N+L+   Y A +ADFG+++
Sbjct: 139 QQLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 43  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L   A A+ +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 99  PYGSLRDYLQ--AHAERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 153
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 154 NRVKIGDFGLTKVLPQD 170

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 10/177 (5%)
Query: 40  ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           A  DF+    +G G   +VY A E  S+ ++A+K           V+  +   EV+  + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSH 64
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            RH NI++ YG+   +   +L+ E+   G++   L   +   E    +  + I  +A+AL
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANAL 121
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           SY H      ++HRD+  +NLLL    E  +ADFG +  + + +S      GT  Y+
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYL 173

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + S A    ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 141
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +HRD+ S N+ L  +    + DFG+A    ++ S W+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWS 174

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 23/163 (14%)
Query: 50  IGNGGHASVYRAEL----PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G    V+ AE     P ++  +VAVK       SD    +K+F  E + LT  +H +
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNA--RKDFHREAELLTNLQHEH 76
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSL----------AAILNTDAAAQELGWSQRMSVIKG 153
           IVKFYG C       ++ E+++ G L          A ++       EL  SQ + + + 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +A  + YL    F   VHRD++++N L+       + DFG+++
Sbjct: 137 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 29/184 (15%)
Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFL--TEVKALTETRHRNIVK 106
           C+G G +  V+R      E VAVK F S        D+K +   TE+      RH NI+ 
Sbjct: 15  CVGKGRYGEVWRGSWQG-ENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 107 FYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           F      +RHS    +L+  + E GSL   L        L     + ++  +A  L++LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 122
Query: 163 HDCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA-----GTY 212
            + F     P I HRD+ SKN+L+    +  +AD G+A  + S ++N  +       GT 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTK 181
Query: 213 GYVA 216
            Y+A
Sbjct: 182 RYMA 185

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 24/167 (14%)
Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFL--TEVKALTETRHRNIVK 106
           C+G G +  V+R      E VAVK F S        D+K +   TE+      RH NI+ 
Sbjct: 15  CVGKGRYGEVWRGSWQG-ENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 107 FYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           F      +RHS    +L+  + E GSL   L        L     + ++  +A  L++LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 122
Query: 163 HDCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
            + F     P I HRD+ SKN+L+    +  +AD G+A  + S ++N
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTN 168

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 29/184 (15%)
Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFL--TEVKALTETRHRNIVK 106
           C+G G +  V+R      E VAVK F S        D+K +   TE+      RH NI+ 
Sbjct: 44  CVGKGRYGEVWRGSWQG-ENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 95
Query: 107 FYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           F      +RHS    +L+  + E GSL   L        L     + ++  +A  L++LH
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 151
Query: 163 HDCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA-----GTY 212
            + F     P I HRD+ SKN+L+    +  +AD G+A  + S ++N  +       GT 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTK 210
Query: 213 GYVA 216
            Y+A
Sbjct: 211 RYMA 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 88  YSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 141
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +HRD+ S N+ L  +    + DFG+A    ++ S W+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWS 174

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+      +A  K    + +    + ++++ E++ L    H  IVK  G
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKV---IETKSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 110 FCSHARHSFLLCEFLERGSLAAI-LNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
              H    +++ EF   G++ AI L  D    E    Q   V + + +AL++LH      
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSKR--- 129
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGI-AKFLKSDASNWTEFAGTYGYVA 216
           I+HRD+ + N+L+ LE +  +ADFG+ AK LK+       F GT  ++A
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMA 177

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHSFLLCEFL 124
           E VAVK        +   D K+   E++ L    H NIVK+ G C+        L+ EFL
Sbjct: 51  EQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L  +    ++   Q++     +   + YL    +   VHRD++++N+L++ E
Sbjct: 108 PSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESE 162
Query: 185 YEAHVADFGIAKFLKSDASNWT 206
           ++  + DFG+ K +++D    T
Sbjct: 163 HQVKIGDFGLTKAIETDKEXXT 184

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 71
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +HRD+ S N+ L  +    + DFG+A    ++ S W+
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWS 158

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHSFLLCEFL 124
           E VAVK        +   D K+   E++ L    H NIVK+ G C+        L+ EFL
Sbjct: 39  EQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 95
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L  +    ++   Q++     +   + YL    +   VHRD++++N+L++ E
Sbjct: 96  PSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESE 150
Query: 185 YEAHVADFGIAKFLKSDASNWT 206
           ++  + DFG+ K +++D    T
Sbjct: 151 HQVKIGDFGLTKAIETDKEXXT 172

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G   +VY A ++ + + VA+++ +      Q   ++  + E+  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +++ E+L  GSL  ++ T+    E    Q  +V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---Q 136
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++HRD+ S N+LL ++    + DFG    +  + S  +E  GT  ++A
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMA 184

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    VY+A+      +A  K    + +    + ++++ E++ L    H  IVK  G
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKV---IETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 110 FCSHARHSFLLCEFLERGSLAAI-LNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
              H    +++ EF   G++ AI L  D    E    Q   V + + +AL++LH      
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSKR--- 137
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGI-AKFLKSDASNWTEFAGTYGYVA 216
           I+HRD+ + N+L+ LE +  +ADFG+ AK LK+       F GT  ++A
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMA 185

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 75
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 76  YSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 129
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 174

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 99
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 153
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +HRD+ S N+ L  +    + DFG+A    ++ S W+
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWS 186

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            + + +  +G G    V +A+  +++V A+K+  S        ++K F+ E++ L+   H
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES------ESERKAFIVELRQLSRVNH 61
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NIVK YG C +     L+ E+ E GSL  +L+          +  MS     +  ++YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASN 204
           H      ++HRD+   NLLL        + DFG A  +++  +N
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN 163

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+     +++ VA+K        +  + +++F+ E + + +  H  +V+ YG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCF 166
            C       L+ EF+E G L+  L T     AA+ L     + +   V + ++YL     
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE--- 121
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             ++HRD++++N L+       V+DFG+ +F+  D   +T   GT
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGT 164

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 91
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 92  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 145
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +HRD+ S N+ L  +    + DFG+A    ++ S W+
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLA----TEKSRWS 178

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ EFL
Sbjct: 43  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFL 98
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 99  PYGSLREYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 153
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 154 NRVKIGDFGLTKVLPQD 170

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            + + +  +G G    V +A+  +++V A+K+  S        ++K F+ E++ L+   H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES------ESERKAFIVELRQLSRVNH 60
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NIVK YG C +     L+ E+ E GSL  +L+          +  MS     +  ++YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASN 204
           H      ++HRD+   NLLL        + DFG A  +++  +N
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN 162

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 71
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + S A    ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 170

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 71
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 125
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 170

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 76
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 130
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 175

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 76
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 130
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 175

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++CE++ +GSL   L  +   + L   Q + +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 73
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 74  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 127
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 172

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 98
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 99  YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 152
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 197

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 99
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      E+   + + + +  A  + YLH      I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---I 153
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           +HRD+ S N+ L  +    + DFG+A  +KS  S   +F    G +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSI 198

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 58  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 114 PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 168
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 169 NRVKIGDFGLTKVLPQD 185

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 58  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 114 PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 168
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 169 NRVKIGDFGLTKVLPQD 185

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 40  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 96  PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 150
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 151 NRVKIGDFGLTKVLPQD 167

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 40  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 96  PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 150
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 151 NRVKIGDFGLTKVLPQD 167

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 43  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 99  PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 153
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 154 NRVKIGDFGLTKVLPQD 170

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 13/138 (9%)
Query: 67  EVVAVKKF-HSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEF 123
           EVVAVKK  HS   +++ +  ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+
Sbjct: 44  EVVAVKKLQHS---TEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 98
Query: 124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL 183
           L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ 
Sbjct: 99  LPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVEN 153
Query: 184 EYEAHVADFGIAKFLKSD 201
           E    + DFG+ K L  D
Sbjct: 154 ENRVKIGDFGLTKVLPQD 171

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 38  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 93
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 94  PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 148
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 149 NRVKIGDFGLTKVLPQD 165

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 13/138 (9%)
Query: 67  EVVAVKKF-HSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEF 123
           EVVAVKK  HS   +++ +  ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+
Sbjct: 39  EVVAVKKLQHS---TEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 93
Query: 124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL 183
           L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ 
Sbjct: 94  LPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVEN 148
Query: 184 EYEAHVADFGIAKFLKSD 201
           E    + DFG+ K L  D
Sbjct: 149 ENRVKIGDFGLTKVLPQD 166

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 47  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 102
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 103 PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 157
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 158 NRVKIGDFGLTKVLPQD 174

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 13/138 (9%)
Query: 67  EVVAVKKF-HSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEF 123
           EVVAVKK  HS   +++ +  ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+
Sbjct: 71  EVVAVKKLQHS---TEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL 183
           L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ 
Sbjct: 126 LPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVEN 180
Query: 184 EYEAHVADFGIAKFLKSD 201
           E    + DFG+ K L  D
Sbjct: 181 ENRVKIGDFGLTKVLPQD 198

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 40  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 96  PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 150
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 151 NRVKIGDFGLTKVLPQD 167

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 45  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 100
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 101 PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 155
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 156 NRVKIGDFGLTKVLPQD 172

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 46  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 101
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++ E
Sbjct: 102 PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENE 156
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 157 NRVKIGDFGLTKVLPQD 173

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 12/168 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G   +VY A ++ + + VA+++ +      Q   ++  + E+  + E ++ NIV + 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +++ E+L  GSL  ++ T+    E    Q  +V +    AL +LH +    
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---Q 137
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 185

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 12/168 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G   +VY A ++ + + VA+++ +      Q   ++  + E+  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +++ E+L  GSL  ++ T+    E    Q  +V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---Q 136
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 12/168 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G   +VY A ++ + + VA+++ +      Q   ++  + E+  + E ++ NIV + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +++ E+L  GSL  ++ T+    E    Q  +V +    AL +LH +    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---Q 136
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 184

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 86  QKEFL-TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ-ELG 143
           ++E L  EV  + + +H N+V+ Y         ++L EFL+ G+L     TD  +Q  L 
Sbjct: 85  RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL-----TDIVSQVRLN 139
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             Q  +V + V  AL+YLH      ++HRD+ S ++LL L+    ++DFG    +  D  
Sbjct: 140 EEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196
Query: 204 NWTEFAGTYGYVA 216
                 GT  ++A
Sbjct: 197 KRKXLVGTPYWMA 209

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 87/185 (47%), Gaps = 16/185 (8%)
Query: 37  IVKATNDFDAKYC----IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
           I+ +  D   KY     IG G   +VY A ++ + + VA+++ +      Q   ++  + 
Sbjct: 12  IIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIIN 67
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E+  + E ++ NIV +          +++ E+L  GSL  ++ T+    E    Q  +V 
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVC 123
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           +    AL +LH +    ++HR++ S N+LL ++    + DFG    +  + S  +   GT
Sbjct: 124 RECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 180
Query: 212 YGYVA 216
             ++A
Sbjct: 181 PYWMA 185

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G +  VY+A+    E  A+KK    L  +        + E+  L E +H NIVK Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
                +   L+ E L++  L  +L+      E   ++  S +  + + ++Y H      +
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDRR---V 121
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y A
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G +  VY+A+    E  A+KK    L  +        + E+  L E +H NIVK Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
                +   L+ E L++  L  +L+      E   ++  S +  + + ++Y H      +
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDRR---V 121
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y A
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 7/175 (4%)
Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           DF     +G G  A VYRAE + +   VA+K           + Q+    EVK   + +H
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKH 70
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            +I++ Y +   + + +L+ E    G +   L      +    ++    +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYL 128
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H      I+HRD++  NLLL       +ADFG+A  LK          GT  Y++
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           ++  +DF+    +G G    V +A   L SR   A+KK         T+     L+EV  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSR-YYAIKKIRHTEEKLSTI-----LSEVML 55
Query: 96  LTETRHRNIVKFYGFCSHARH-------------SFLLCEFLERGSLAAILNTDAAAQEL 142
           L    H+ +V++Y      R+              F+  E+ E G+L  +++++   Q+ 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK------ 196
               R+   + + +ALSY+H      I+HRD+   N+ +D      + DFG+AK      
Sbjct: 116 DEYWRL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 197 -FLKSDAS-------NWTEFAGTYGYVA 216
             LK D+        N T   GT  YVA
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVA 198

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 9/167 (5%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G GG ++VY AE     + VA+K    P P ++    K F  EV   ++  H+NIV   
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                    +L+ E++E  +L+  + +      L     ++    + D + + H      
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---MR 131
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA-GTYGY 214
           IVHRD+  +N+L+D      + DFGIAK L   +   T    GT  Y
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+     +   VAVK      P   +V  + FL E   +   +H  +V+ Y 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSV--QAFLEEANLMKTLQHDKLVRLYA 74
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ EF+ +GSL   L +D   + L   + +     +A+ ++Y+    +   
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 130
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDN 162

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      V + K   P P       + F  EV  L +TRH NI+ F G
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQF----QAFRNEVAVLRKTRHVNILLFMG 99
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +    + ++ ++ E  SL   L+      ++   Q + + +  A  + YLH      I
Sbjct: 100 YMTKDNLA-IVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---I 153
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIA 195
           +HRD+ S N+ L       + DFG+A
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLA 179

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKLNHQN 109
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKLNHQN 95
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G +  VY+A+    E  A+KK    L  +        + E+  L E +H NIVK Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
                +   L+ E L++  L  +L+      E   ++  S +  + + ++Y H      +
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDRR---V 121
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y A
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 79/175 (45%), Gaps = 14/175 (8%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 11  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 63
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 64  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIA 121
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +   WT   G
Sbjct: 122 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN--EWTARQG 171

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 15/179 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           +   ++DF  K  +G G +  V  A   P+ E+VA+KK     P D+ +     L E+K 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTD----AAAQELGWSQRMSVI 151
           L   +H NI+  +        SF    F E   +  ++ TD     + Q L        I
Sbjct: 63  LKHFKHENIITIFNI--QRPDSFE--NFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
                A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   A++ +E  G
Sbjct: 119 YQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           EVVAVKK    L        ++F  E++ L   +H NIVK+ G C  A  R+  L+ E+L
Sbjct: 41  EVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 96
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L      + +   + +     +   + YL    +   +HR+++++N+L++ E
Sbjct: 97  PYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRNLATRNILVENE 151
Query: 185 YEAHVADFGIAKFLKSD 201
               + DFG+ K L  D
Sbjct: 152 NRVKIGDFGLTKVLPQD 168

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 109
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 33/178 (18%)
Query: 50  IGNGGHASVYRAELPSR------EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           IG G    V++A  P         +VAVK       +D    Q +F  E   + E  + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAEFDNPN 111
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN---------------------TDAAAQEL 142
           IVK  G C+  +   LL E++  G L   L                      +      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
             ++++ + + VA  ++YL    F   VHRD++++N L+       +ADFG+++ + S
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 17/171 (9%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G  A+V+R     + ++ A+K F++ +   + VD +  + E + L +  H+NIVK +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQ--MREFEVLKKLNHKNIVKLF 73
Query: 109 GFC--SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
                +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  +  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 167 PPIVHRDVSSKNLLL----DLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
             IVHR++   N++     D +    + DFG A+ L+ D     +F   YG
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYG 177

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 15/179 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           +   ++DF  K  +G G +  V  A   P+ E+VA+KK     P D+ +     L E+K 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTD----AAAQELGWSQRMSVI 151
           L   +H NI+  +        SF    F E   +  ++ TD     + Q L        I
Sbjct: 63  LKHFKHENIITIFNI--QRPDSFE--NFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
                A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   A++ +E  G
Sbjct: 119 YQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 86
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 87  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 147 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 15/179 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           +   ++DF  K  +G G +  V  A   P+ E+VA+KK     P D+ +     L E+K 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKI 62
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTD----AAAQELGWSQRMSVI 151
           L   +H NI+  +        SF    F E   +  ++ TD     + Q L        I
Sbjct: 63  LKHFKHENIITIFNI--QRPDSFE--NFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
                A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   A++ +E  G
Sbjct: 119 YQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 135
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 94
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +GNG    V+         VA+K          T+  + FL E + + + +H  +V+ Y 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKP-----GTMSPESFLEEAQIMKKLKHDKLVQLYA 71
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  D   + L     + +   VA  ++Y+    +   
Sbjct: 72  VVSE-EPIYIVTEYMNKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 126
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ S N+L+       +ADFG+A+ ++ +
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDN 158

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 95
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 111
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 112 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 172 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 94
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 112
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 113 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 173 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 5/111 (4%)
Query: 87  KEFLTEVKALTETRHRNIVKFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWS 145
           + FL E   +T+ RH N+V+  G     +   +++ E++ +GSL   L +   +  LG  
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGD 108
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             +     V +A+ YL  + F   VHRD++++N+L+  +  A V+DFG+ K
Sbjct: 109 CLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 101
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 102 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 162 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 65
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 66  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 119
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L  + +N  EF GT  Y++
Sbjct: 120 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRSYMS 174

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 26/158 (16%)
Query: 52  NGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC 111
            G    V++A+L   + VAVK F  PL   Q+   +    E+ +    +H N+++F    
Sbjct: 25  RGRFGCVWKAQL-MNDFVAVKIF--PLQDKQSWQSER---EIFSTPGMKHENLLQF--IA 76
Query: 112 SHARHS------FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  R S      +L+  F ++GSL   L  +     + W++   V + ++  LSYLH D 
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDV 132
Query: 166 --------FPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
                    P I HRD  SKN+LL  +  A +ADFG+A
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VYSEQ--DELDFLMEALIISKFNHQN 109
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 5/109 (4%)
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           FL E   +T+ RH N+V+  G     +   +++ E++ +GSL   L +   +  LG    
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCL 104
Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +     V +A+ YL  + F   VHRD++++N+L+  +  A V+DFG+ K
Sbjct: 105 LKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 95
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+++ N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLAAANILVGENLVCKVADFGLARLIEDN 167

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 5/109 (4%)
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           FL E   +T+ RH N+V+  G     +   +++ E++ +GSL   L +   +  LG    
Sbjct: 61  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCL 119
Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +     V +A+ YL  + F   VHRD++++N+L+  +  A V+DFG+ K
Sbjct: 120 LKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 17/171 (9%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G  A+V+R     + ++ A+K F++ +   + VD +  + E + L +  H+NIVK +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQ--MREFEVLKKLNHKNIVKLF 73
Query: 109 GFC--SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
                +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  +  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 167 PPIVHRDVSSKNLLL----DLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
             IVHR++   N++     D +    + DFG A+ L+ D     +F   YG
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVXLYG 177

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 5/109 (4%)
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           FL E   +T+ RH N+V+  G     +   +++ E++ +GSL   L +   +  LG    
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCL 291
Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +     V +A+ YL  + F   VHRD++++N+L+  +  A V+DFG+ K
Sbjct: 292 LKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    VY  ++      PS   VAVK     + S+Q  D+ +FL E   +++  H+N
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQ--DELDFLMEALIISKFNHQN 121
Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILN----TDAAAQELGWSQRMSVIKGVADALS 159
           IV+  G    +   F+L E +  G L + L       +    L     + V + +A    
Sbjct: 122 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA---DFGIAK 196
           YL  + F   +HRD++++N LL       VA   DFG+A+
Sbjct: 182 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 7   EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 59
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 60  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIA 117
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 118 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 160

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/152 (22%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+     +   VAVK      P   +V  + FL E   +   +H  +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSV--QAFLEEANLMKTLQHDKLVRLYA 75
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++ +GSL   L +D   + L   + +     +A+ ++Y+    +   
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 131
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDN 163

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 50  IGNGGHASVYRAEL--PSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V R E   PS + V+V  K   P    Q     +F+ EV A+    HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            YG         ++ E    GSL   L        LG   R +V   VA+ + YL    F
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +HRD++++NLLL       + DFG+ + L  +
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 67  MKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 50  IGNGGHASVYRAEL--PSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V R E   PS + V+V  K   P    Q     +F+ EV A+    HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            YG         ++ E    GSL   L        LG   R +V   VA+ + YL    F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +HRD++++NLLL       + DFG+ + L  +
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 50  IGNGGHASVYRAEL--PSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V R E   PS + V+V  K   P    Q     +F+ EV A+    HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            YG         ++ E    GSL   L        LG   R +V   VA+ + YL    F
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +HRD++++NLLL       + DFG+ + L  +
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 168

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 50  IGNGGHASVYRAEL--PSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V R E   PS + V+V  K   P    Q     +F+ EV A+    HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            YG         ++ E    GSL   L        LG   R +V   VA+ + YL    F
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +HRD++++NLLL       + DFG+ + L  +
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 50  IGNGGHASVYRAEL--PSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V R E   PS + V+V  K   P    Q     +F+ EV A+    HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            YG         ++ E    GSL   L        LG   R +V   VA+ + YL    F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +HRD++++NLLL       + DFG+ + L  +
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 50  IGNGGHASVYRAEL--PSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V R E   PS + V+V  K   P    Q     +F+ EV A+    HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            YG         ++ E    GSL   L        LG   R +V   VA+ + YL    F
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +HRD++++NLLL       + DFG+ + L  +
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 3   EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 55
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 56  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 113
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 114 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 156

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 50  IGNGGHASVYRAEL--PSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G    V R E   PS + V+V  K   P    Q     +F+ EV A+    HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            YG         ++ E    GSL   L        LG   R +V   VA+ + YL    F
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +HRD++++NLLL       + DFG+ + L  +
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 168

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 118
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 119 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171
Query: 213 GYVA 216
            YVA
Sbjct: 172 PYVA 175

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 29/184 (15%)
Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFL--TEVKALTETRHRNIVK 106
           C+G G +  V+R  L   E VAVK F S        D++ +   TE+      RH NI+ 
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSS-------RDEQSWFRETEIYNTVLLRHDNILG 66
Query: 107 FYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           F      +R+S    +L+  + E GSL   L        L  + R++V    A  L++LH
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL--ALRLAV--SAACGLAHLH 122
Query: 163 HDCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA-----GTY 212
            + F     P I HRD  S+N+L+    +  +AD G+A  + S  S++ +       GT 
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTK 181
Query: 213 GYVA 216
            Y+A
Sbjct: 182 RYMA 185

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 118
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 119 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 213 GYVA 216
            YVA
Sbjct: 172 PYVA 175

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 118
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 119 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 213 GYVA 216
            YVA
Sbjct: 172 PYVA 175

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 118
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 119 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 213 GYVA 216
            YVA
Sbjct: 172 PYVA 175

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 118
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 119 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 213 GYVA 216
            YVA
Sbjct: 172 PYVA 175

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 5   EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 57
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 58  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIA 115
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 116 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 158

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 11  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 63
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 64  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIA 121
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 122 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 164

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 118
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 119 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 213 GYVA 216
            YVA
Sbjct: 172 PYVA 175

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G   +VY A E  S  +VA+K         + V+  +   E++      
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEH-QLRREIEIQAHLH 81
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H NI++ Y +    R  +L+ E+  RG L   L       E    +  ++++ +ADAL Y
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDE---QRTATIMEELADALMY 138
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
            H      ++HRD+  +NLLL L+ E  +ADFG
Sbjct: 139 CHGK---KVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 7/125 (5%)
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E++ L   RH +I+K Y   S     F++ E++  G L   +      +E+   +   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLF 117
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           + +  A+ Y H      +VHRD+  +N+LLD    A +ADFG++  + SD     +  G+
Sbjct: 118 QQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSCGS 173
Query: 212 YGYVA 216
             Y A
Sbjct: 174 PNYAA 178

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 75/179 (41%), Gaps = 16/179 (8%)
Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L    H
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN---H 62
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGVADALS 159
            N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV     
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV---- 117
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVA 216
           YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT  YVA
Sbjct: 118 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VA+K          T+  + FL E + + + RH  +V+ Y 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  +   + L   Q + +   +A  ++Y+    +   
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 118
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 119 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 213 GYVA 216
            YVA
Sbjct: 172 PYVA 175

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VA+K          T+  + FL E + + + RH  +V+ Y 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  +   + L   Q + +   +A  ++Y+    +   
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VA+K          T+  + FL E + + + RH  +V+ Y 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  +   + L   Q + +   +A  ++Y+    +   
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 384
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDN 416

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G +  V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFL-TEVKALTETRHRNIV 105
           +G GG A  Y   ++ ++EV A K     +P    +   QKE + TE+       + ++V
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 89
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       +++ E   R SL  +     A  E    +    ++     + YLH++ 
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNNR 146
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + +  + DFG+A  ++ D     +  GT  Y+A
Sbjct: 147 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 194

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 40/208 (19%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           ++  +DF+    +G G    V +A   L SR   A+KK         T+     L+EV  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSR-YYAIKKIRHTEEKLSTI-----LSEVML 55
Query: 96  LTETRHRNIVKFYGFCSHARH-------------SFLLCEFLERGSLAAILNTDAAAQEL 142
           L    H+ +V++Y      R+              F+  E+ E  +L  +++++   Q+ 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK------ 196
               R+   + + +ALSY+H      I+HRD+   N+ +D      + DFG+AK      
Sbjct: 116 DEYWRL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 197 -FLKSDAS-------NWTEFAGTYGYVA 216
             LK D+        N T   GT  YVA
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVA 198

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 83/183 (45%), Gaps = 21/183 (11%)
Query: 44  FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTE-TR 100
           F+    +GNG +  VY+   + + ++ A+K        D T D++E +  E+  L + + 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTGDEEEEIKQEINMLKKYSH 79
Query: 101 HRNIVKFYGFCSHAR------HSFLLCEFLERGSLAAIL-NTDAAAQELGWSQRMSVIKG 153
           HRNI  +YG              +L+ EF   GS+  ++ NT     +  W     + + 
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICRE 137
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +   LS+LH      ++HRD+  +N+LL    E  + DFG++  L         F GT  
Sbjct: 138 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 214 YVA 216
           ++A
Sbjct: 195 WMA 197

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 85  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 139
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 171

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 12/171 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKF---HSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G  A+VY+A +  + ++VA+KK    H     D     +  L E+K L E  H NI+
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
                  H  +  L+ +F+E   L  I+  ++    L  S   + +      L YLH   
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              I+HRD+   NLLLD      +ADFG+AK   S    +     T  Y A
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRA 180

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 84  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 138
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 170

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 78  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 132
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 164

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 86  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 140
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 172

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 136
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 168

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFL-TEVKALTETRHRNIV 105
           +G GG A  Y   ++ ++EV A K     +P    +   QKE + TE+       + ++V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       +++ E   R SL  +     A  E    +    ++     + YLH++ 
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNNR 162
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + +  + DFG+A  ++ D     +  GT  Y+A
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 77  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 131
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 163

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 71  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 125
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 157

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/186 (20%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            DF+   C+G GG   V+ A+    +   A+K+   P   ++ + +++ + EVKAL +  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLE 61
Query: 101 HRNIVKFYGF------------CSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           H  IV+++               S   + ++  +   + +L   +N     +E   S  +
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
            +   +A+A+ +LH      ++HRD+   N+   ++    V DFG+   +  D    T  
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 209 AGTYGY 214
                Y
Sbjct: 179 TPMPAY 184

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 59  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VA+K          T+  + FL E + + + RH  +V+ Y 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  +   + L   Q + +   +A  ++Y+    +   
Sbjct: 247 VVSE-EPIYIVGEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 301
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 136
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 168

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/152 (21%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 81  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 135
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 167

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE----FLTEVKALT 97
           NDFD    +G G    V    +  RE    + +   +   + +  K+     +TE + L 
Sbjct: 8   NDFDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  +   G  +
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEI 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y
Sbjct: 118 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 174
Query: 215 VA 216
           +A
Sbjct: 175 LA 176

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE----FLTEVKALT 97
           NDFD    +G G    V    +  RE    + +   +   + +  K+     +TE + L 
Sbjct: 5   NDFDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  +   G  +
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEI 114
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 215 VA 216
           +A
Sbjct: 172 LA 173

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE----FLTEVKALT 97
           NDFD    +G G    V    +  RE    + +   +   + +  K+     +TE + L 
Sbjct: 5   NDFDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  +   G  +
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEI 114
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 215 VA 216
           +A
Sbjct: 172 LA 173

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE----FLTEVKALT 97
           NDFD    +G G    V    +  RE    + +   +   + +  K+     +TE + L 
Sbjct: 10  NDFDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  +   G  +
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEI 119
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y
Sbjct: 120 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 176
Query: 215 VA 216
           +A
Sbjct: 177 LA 178

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 12  EVLHIQ-LNRLDGSIPPEVGKILYDEIVKATND------FDAKYCIGNGGHASVYRAELP 64
           E L+ Q ++ +  S  P    ++ D  +  +N       F+ +  +G G  + VYR +  
Sbjct: 16  ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQK 75
Query: 65  -SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF 123
            +++  A+K         +TVD+K   TE+  L    H NI+K            L+ E 
Sbjct: 76  GTQKPYALKVLK------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129
Query: 124 LERGSLAAILNTDAAAQELGWSQR--MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL 181
           +  G L      D   ++  +S+R     +K + +A++YLH +    IVHRD+  +NLL 
Sbjct: 130 VTGGEL-----FDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLY 181
Query: 182 DL---EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                +    +ADFG++K ++      T   GT GY A
Sbjct: 182 ATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYCA 218

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE----FLTEVKALT 97
           NDFD    +G G    V    +  RE    + +   +   + +  K+     +TE + L 
Sbjct: 5   NDFDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  +   G  +
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEI 114
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 215 VA 216
           +A
Sbjct: 172 LA 173

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE----FLTEVKALT 97
           NDFD    +G G    V    +  RE    + +   +   + +  K+     +TE + L 
Sbjct: 5   NDFDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  +   G  +
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEI 114
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 215 VA 216
           +A
Sbjct: 172 LA 173

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE----FLTEVKALT 97
           NDFD    +G G    V    +  RE    + +   +   + +  K+     +TE + L 
Sbjct: 5   NDFDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            TRH  +    Y F +H R  F++ E+   G L   L     ++E  +++  +   G  +
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHL-----SRERVFTEERARFYGAEI 114
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             AL YLH      +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 215 VA 216
           +A
Sbjct: 172 LA 173

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/119 (23%), Positives = 60/119 (50%), Gaps = 10/119 (8%)
Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE--- 141
           ++ EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E   
Sbjct: 93  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 152
Query: 142 ----LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
                  S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 153 VLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 76/185 (41%), Gaps = 18/185 (9%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKA 95
           V    D+D    +G G +  V  A    + E VAVK         + VD  E +  E+  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKG 153
                H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ G
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAG 117
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGT 211
           V     YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT
Sbjct: 118 VV----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 212 YGYVA 216
             YVA
Sbjct: 171 LPYVA 175

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/116 (23%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT-------DAAAQ 140
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +       +    
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 4   EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 56
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S      ++ E++ +GSL   L  +   + L   Q + +   +A
Sbjct: 57  MKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIA 114
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 115 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 157

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 7/125 (5%)
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E++ L   RH +I+K Y   S     F++ E++  G L   +      +E+   +   + 
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLF 117
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           + +  A+ Y H      +VHRD+  +N+LLD    A +ADFG++  + SD        G+
Sbjct: 118 QQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGS 173
Query: 212 YGYVA 216
             Y A
Sbjct: 174 PNYAA 178

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/150 (21%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 130
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           +HRD+ + N+L+       +ADFG+A+ ++
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 44  FDAKYCIGNGGHASVYRAELPS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           F  K  +G+G    V+  E  S    R +  + K  S +P +Q         E++ L   
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ------IEAEIEVLKSL 77
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGS-LAAILNTDAAAQELGWSQRMSVIKGVADAL 158
            H NI+K +       + +++ E  E G  L  I++  A  + L       ++K + +AL
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAH----VADFGIAKFLKSDASNWTEFAGTYGY 214
           +Y H      +VH+D+  +N+L   +   H    + DFG+A+  KSD  + T  AGT  Y
Sbjct: 138 AYFHSQH---VVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALY 192
Query: 215 VA 216
           +A
Sbjct: 193 MA 194

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 75/184 (40%), Gaps = 16/184 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           V    D+D    +G G    V  A    + E VAVK        D   + K+ +   K L
Sbjct: 2   VPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGV 154
               H N+VKFYG        +L  E+   G L   +  D    E   +QR    ++ GV
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGV 117
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTY 212
                YLH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT 
Sbjct: 118 V----YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 213 GYVA 216
            YVA
Sbjct: 171 PYVA 174

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +G L   L  +   + L   Q + +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/116 (23%), Positives = 58/116 (50%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT-------DAAAQ 140
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +       +    
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 11/169 (6%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G +  V +     +  +VA+KKF      D  + +K  + E+K L + RH N+V   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 109 GFCSHARHSFLLCEFLERGSLAAI-LNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
             C   +  +L+ EF++   L  + L  +    ++       +I G+    S+       
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH------- 143
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            I+HRD+  +N+L+       + DFG A+ L +    + +   T  Y A
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 62
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 116
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 62
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 116
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 62
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 116
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 62
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 116
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           EI + +   + K  +G G    V+         VA+K          T+  + FL E + 
Sbjct: 14  EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQV 66
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           + + RH  +V+ Y   S     +++ E++ +G L   L  +   + L   Q + +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIA 124
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             ++Y+    +   VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 125 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN 167

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 62
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 63  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 116
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 171

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 81
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 82  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 135
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 136 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 190

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFL-TEVKALTETRHRNIV 105
           +G GG A  Y   ++ ++EV A K     +P    +   QKE + TE+       + ++V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       +++ E   R SL  +     A  E    +    ++     + YLH++ 
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNNR 162
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + +  + DFG+A  ++ D        GT  Y+A
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIA 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 89
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 90  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 143
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 144 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 198

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 42  NDFDAKYCIGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++ +  PS  V+A K  H  +   +   + + + E++ L E  
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 124
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILNTDAAAQE--LGWSQRMSVIKGVADA 157
              IV FYG F S    S  + E ++ GSL  +L       E  LG    ++VIKG    
Sbjct: 125 SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 178
Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y++
Sbjct: 179 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 233

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFL-TEVKALTETRHRNIV 105
           +G GG A  Y   ++ ++EV A K     +P    +   QKE + TE+       + ++V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVV 105
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       +++ E   R SL  +     A  E    +    ++     + YLH++ 
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNNR 162
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + +  + DFG+A  ++ D        GT  Y+A
Sbjct: 163 ---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIA 210

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 65/149 (43%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  REV    K       + T  QK F  EV+ +    H NIVK
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAI--KIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVK 75
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  S  + +  A+ Y H    
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQYCHQK-- 130
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 131 -RIVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 65/149 (43%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  REV    K       + T  QK F  EV+ +    H NIVK
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAI--KIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVK 78
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  S  + +  A+ Y H    
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQYCHQK-- 133
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 134 -RIVHRDLKAENLLLDADMNIKIADFGFS 161

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFLT-EVKALTETRHRNIV 105
           +G GG A  +  ++  ++EV A K     +P    +   Q+E ++ E+       H+++V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 80
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRNR 137
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIA 185

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFLT-EVKALTETRHRNIV 105
           +G GG A  +  ++  ++EV A K     +P    +   Q+E ++ E+       H+++V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 80
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRNR 137
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIA 185

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 65/128 (50%), Gaps = 9/128 (7%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D + +
Sbjct: 112 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 206 TEFAGTYG 213
              A T+G
Sbjct: 169 K--AQTHG 174

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 11/173 (6%)
Query: 47  KYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +  +G G +  VY     S +V +A+K+    +P   +   +    E+      +H+NIV
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIV 68
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           ++ G  S      +  E +  GSL+A+L +     +          K + + L YLH + 
Sbjct: 69  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 127
Query: 166 FPPIVHRDVSSKNLLLDLEYEA--HVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              IVHRD+   N+L++  Y     ++DFG +K L         F GT  Y+A
Sbjct: 128 --QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 177

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 125
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D +
Sbjct: 126 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFLT-EVKALTETRHRNIV 105
           +G GG A  +  ++  ++EV A K     +P    +   Q+E ++ E+       H+++V
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 84
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH + 
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRNR 141
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 142 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIA 189

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 7/114 (6%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++      
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNI 472
Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D
Sbjct: 473 IELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRAD 523

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 27  PEVGKILY-DEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKF-HSPLPSDQT 83
           P+V ++ + D+  K  +D      IG+G   +VY A ++ + EVVA+KK  +S   S++ 
Sbjct: 41  PDVAELFFKDDPEKLFSDLRE---IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 97
Query: 84  VDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELG 143
              ++ + EV+ L + RH N +++ G       ++L+ E+   GS + +L  +   + L 
Sbjct: 98  --WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQ 152
Query: 144 WSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
             +  +V  G    L+YLH H+    ++HRDV + N+LL       + DFG A  +    
Sbjct: 153 EVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207
Query: 203 SNWTEFAGTYGYVA 216
                F GT  ++A
Sbjct: 208 ---NXFVGTPYWMA 218

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/152 (22%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+ A       VAVK      P   +V+   FL E   +   +H  +VK + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANVMKTLQHDKLVKLHA 77
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ EF+ +GSL   L +D  +++    + +     +A+ ++++    +   
Sbjct: 78  VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY--- 132
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDN 164

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D +
Sbjct: 128 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D +
Sbjct: 128 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 7/114 (6%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR 147
           E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++      
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNI 471
Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D
Sbjct: 472 IELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D +
Sbjct: 112 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/116 (24%), Positives = 57/116 (49%), Gaps = 10/116 (8%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE------ 141
           EFL E   + E    ++V+  G  S  + + ++ E + RG L + L +     E      
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 142 -LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               S+ + +   +AD ++YL+ + F   VHRD++++N  +  ++   + DFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 16/144 (11%)
Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLERG 127
           VAVK   S   +D+   ++  ++E+K ++   +H NIV   G C+H     ++ E+   G
Sbjct: 71  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 127
Query: 128 SLAAILNTDAAA-------QELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNL 179
            L   L   A A       + L     +     VA  +++L   +C    +HRDV+++N+
Sbjct: 128 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNV 183
Query: 180 LLDLEYEAHVADFGIAKFLKSDAS 203
           LL   + A + DFG+A+ + +D++
Sbjct: 184 LLTNGHVAKIGDFGLARDIMNDSN 207

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A + S  ++VAVKK        +   ++E L  EV  + + +H N+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALS LH     
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 136
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 184

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/152 (20%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ E++E GSL   L T +  + L  ++ + +   +A+ ++++    +   
Sbjct: 72  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY--- 126
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HR++ + N+L+       +ADFG+A+ ++ +
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDN 158

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A + S  ++VAVKK        +   ++E L  EV  + + +H N+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 86
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALS LH     
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 140
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 141 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 188

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A + S  ++VAVKK        +   ++E L  EV  + + +H N+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 93
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALS LH     
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 147
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 148 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 195

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 27  PEVGKILY-DEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKF-HSPLPSDQT 83
           P+V ++ + D+  K  +D      IG+G   +VY A ++ + EVVA+KK  +S   S++ 
Sbjct: 2   PDVAELFFKDDPEKLFSDLRE---IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 84  VDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELG 143
              ++ + EV+ L + RH N +++ G       ++L+ E+   GS + +L  +   + L 
Sbjct: 59  --WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQ 113
Query: 144 WSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
             +  +V  G    L+YLH H+    ++HRDV + N+LL       + DFG A  +    
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168
Query: 203 SNWTEFAGTYGYVA 216
                F GT  ++A
Sbjct: 169 ---NXFVGTPYWMA 179

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 44  FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKE--FLTEVKALTETR 100
           +D +  +G G  + V  AE   ++++VA+K       + + ++ KE     E+  L + +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIK 74
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS--VIKGVADAL 158
           H NIV          H +L+ + +  G L      D   ++  +++R +  +I  V DA+
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGEL-----FDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 159 SYLHHDCFPPIVHRDVSSKNLL---LDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
            YLH      IVHRD+  +NLL   LD + +  ++DFG++K ++   S  +   GT GYV
Sbjct: 130 KYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYV 185
Query: 216 A 216
           A
Sbjct: 186 A 186

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 105
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D +
Sbjct: 106 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 117
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D +
Sbjct: 118 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 16/144 (11%)
Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLERG 127
           VAVK   S   +D+   ++  ++E+K ++   +H NIV   G C+H     ++ E+   G
Sbjct: 79  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 128 SLAAILNTDAAA-------QELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNL 179
            L   L   A A       + L     +     VA  +++L   +C    +HRDV+++N+
Sbjct: 136 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNV 191
Query: 180 LLDLEYEAHVADFGIAKFLKSDAS 203
           LL   + A + DFG+A+ + +D++
Sbjct: 192 LLTNGHVAKIGDFGLARDIMNDSN 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 71/157 (45%), Gaps = 10/157 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+ A       VAVK      P   +V+   FL E   +   +H  +VK + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANVMKTLQHDKLVKLHA 244
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ EF+ +GSL   L +D  +++    + +     +A+ ++++    +   
Sbjct: 245 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY--- 299
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +HRD+ + N+L+       +ADFG+A+        WT
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT 336

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           + E L E   + +  +  IV+  G C  A    L+ E  E G L   L  +   ++    
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 107
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
             + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K L++D +
Sbjct: 108 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 11/173 (6%)
Query: 47  KYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +  +G G +  VY     S +V +A+K+    +P   +   +    E+      +H+NIV
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           ++ G  S      +  E +  GSL+A+L +     +          K + + L YLH + 
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 166 FPPIVHRDVSSKNLLLDLEYEA--HVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              IVHRD+   N+L++  Y     ++DFG +K L         F GT  Y+A
Sbjct: 142 --QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFLT-EVKALTETRHRNIV 105
           +G GG A  +  ++  ++EV A K     +P    +   Q+E ++ E+       H+++V
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH + 
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRN- 134
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A + S  ++VAVKK        +   ++E L  EV  + + +H N+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 91
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALS LH     
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 145
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 146 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 193

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL--LCEFL 124
           E+VAVK   +          K+   E+  L    H +I+K+ G C  A  + L  + E++
Sbjct: 61  EMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L   +    +G +Q +   + + + ++YLH   +   +HRD++++N+LLD +
Sbjct: 118 PLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDND 170
Query: 185 YEAHVADFGIAK 196
               + DFG+AK
Sbjct: 171 RLVKIGDFGLAK 182

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFLT-EVKALTETRHRNIV 105
           +G GG A  +  ++  ++EV A K     +P    +   Q+E ++ E+       H+++V
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH + 
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRNR 161
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD--QKEFLT-EVKALTETRHRNIV 105
           +G GG A  +  ++  ++EV A K     +P    +   Q+E ++ E+       H+++V
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 102
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
            F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH + 
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRNR 159
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 160 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 207

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 40/208 (19%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           ++  +DF+    +G G    V +A   L SR   A+KK         T+     L+EV  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSR-YYAIKKIRHTEEKLSTI-----LSEVXL 55
Query: 96  LTETRHRNIVKFYGFCSHARHS-------------FLLCEFLERGSLAAILNTDAAAQEL 142
           L    H+ +V++Y      R+              F+  E+ E  +L  +++++   Q+ 
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK------ 196
               R+   + + +ALSY+H      I+HR++   N+ +D      + DFG+AK      
Sbjct: 116 DEYWRL--FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 197 -FLKSDAS-------NWTEFAGTYGYVA 216
             LK D+        N T   GT  YVA
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVA 198

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/152 (22%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+ A       VAVK      P   +V+   FL E   +   +H  +VK + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA--FLAEANVMKTLQHDKLVKLHA 250
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +     +++ EF+ +GSL   L +D  +++    + +     +A+ ++++    +   
Sbjct: 251 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY--- 305
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 57/125 (45%), Gaps = 7/125 (5%)
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E++ L   RH +I+K Y   S     F++ E++  G L   +  +    E    +   + 
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRLF 122
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           + +   + Y H      +VHRD+  +N+LLD    A +ADFG++  + SD        G+
Sbjct: 123 QQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSCGS 178
Query: 212 YGYVA 216
             Y A
Sbjct: 179 PNYAA 183

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A + S  ++VAVKK        +   ++E L  EV  + + +H N+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 136
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALS LH     
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 190
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 191 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 238

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 59/119 (49%), Gaps = 7/119 (5%)
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H +I+        +   FL+ + + +G L   L    A  E    +  S+++ + +A+S+
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEAVSF 215
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI 219
           LH +    IVHRD+  +N+LLD   +  ++DFG +  L+       E  GT GY+A  I
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELCGTPGYLAPEI 270

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 12/170 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  +EV       + L S      ++   EV+ +    H NIVK
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL---QKLFREVRIMKVLNHPNIVK 77
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y H    
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQYCHQKF- 133
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             IVHRD+ ++NLLLD +    +ADFG +    +  +   EF G+  Y A
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAA 180

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 69  VAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERG 127
           VAVKK        +   ++E L  EV  + +  H N+V  Y         +++ EFLE G
Sbjct: 73  VAVKKMDL-----RKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGG 127
Query: 128 SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA 187
           +L  I+      +E    Q  +V   V  ALSYLH+     ++HRD+ S ++LL  +   
Sbjct: 128 ALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRI 180
Query: 188 HVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++DFG    +  +        GT  ++A
Sbjct: 181 KLSDFGFCAQVSKEVPKRKXLVGTPYWMA 209

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 44  FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKE--FLTEVKALTETR 100
           +D +  +G G  + V  AE   ++++VA+K       + + ++ KE     E+  L + +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIK 74
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS--VIKGVADAL 158
           H NIV          H +L+ + +  G L      D   ++  +++R +  +I  V DA+
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGEL-----FDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 159 SYLHHDCFPPIVHRDVSSKNLL---LDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
            YLH      IVHRD+  +NLL   LD + +  ++DFG++K ++   S  +   GT GYV
Sbjct: 130 KYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYV 185
Query: 216 A 216
           A
Sbjct: 186 A 186

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V+         VA+K      P + + +   FL E + + + RH  +V+ Y 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMSPEA--FLQEAQVMKKLRHEKLVQLYA 247
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             S     +++ E++ +GSL   L  +   + L   Q + +   +A  ++Y+    +   
Sbjct: 248 VVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY--- 302
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           VHRD+ + N+L+       VADFG+ + ++ +
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDN 334

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V + +  PS  ++A K  H  +   +   + + + E++ L E  
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 72
Query: 101 HRNIVKFYG-FCSHARHSFLLCEFLERGSLAAILN-TDAAAQELGWSQRMSVIKGVADAL 158
              IV FYG F S    S  + E ++ GSL  +L       +E+     ++V++G+A  L
Sbjct: 73  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA-YL 130
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              H      I+HRDV   N+L++   E  + DFG++  L    +N   F GT  Y+A
Sbjct: 131 REKHQ-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMA 181

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 44  FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKE--FLTEVKALTETR 100
           +D +  +G G  + V  AE   ++++VA+K       + + ++ KE     E+  L + +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKEALEGKEGSMENEIAVLHKIK 74
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS--VIKGVADAL 158
           H NIV          H +L+ + +  G L      D   ++  +++R +  +I  V DA+
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGEL-----FDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 159 SYLHHDCFPPIVHRDVSSKNLL---LDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
            YLH      IVHRD+  +NLL   LD + +  ++DFG++K ++   S  +   GT GYV
Sbjct: 130 KYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYV 185
Query: 216 A 216
           A
Sbjct: 186 A 186

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 74/148 (50%), Gaps = 20/148 (13%)
Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLERG 127
           VAVK   S   +D   +++  ++E+K ++   +H NIV   G C+H     ++ E+   G
Sbjct: 79  VAVKMLKSTAHAD---EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 128 SL-------AAILNTDAA----AQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVS 175
            L       + +L TD A       L     +     VA  +++L   +C    +HRDV+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVA 191
Query: 176 SKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           ++N+LL   + A + DFG+A+ + +D++
Sbjct: 192 ARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 44  FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKE--FLTEVKALTETR 100
           +D +  +G G  + V  AE   ++++VA+K       + + ++ KE     E+  L + +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKEGSMENEIAVLHKIK 74
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS--VIKGVADAL 158
           H NIV          H +L+ + +  G L      D   ++  +++R +  +I  V DA+
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGEL-----FDRIVEKGFYTERDASRLIFQVLDAV 129
Query: 159 SYLHHDCFPPIVHRDVSSKNLL---LDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
            YLH      IVHRD+  +NLL   LD + +  ++DFG++K ++   S  +   GT GYV
Sbjct: 130 KYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYV 185
Query: 216 A 216
           A
Sbjct: 186 A 186

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 30/153 (19%)
Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCE----- 122
           VAVK   S   +D   +++  ++E+K ++   +H NIV   G C+H     ++ E     
Sbjct: 79  VAVKMLKSTAHAD---EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 123 ----FLERGSLA-------AILNTDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIV 170
               FL R S         AI N+ A+ ++L     +     VA  +++L   +C    +
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDL-----LHFSSQVAQGMAFLASKNC----I 186
Query: 171 HRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           HRDV+++N+LL   + A + DFG+A+ + +D++
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 12/176 (6%)
Query: 43  DFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           ++  +  IG G  A V  A   L  REV    K       + T  QK F  EV+ +    
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAV--KIIDKTQLNPTSLQKLF-REVRIMKILN 72
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H NIVK +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQY 129
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            H      IVHRD+ ++NLLLD +    +ADFG +    +  +    F G+  Y A
Sbjct: 130 CHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF-TVGNKLDTFCGSPPYAA 181

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 11/167 (6%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V++     + ++VA+KKF      D  V +K  L E++ L + +H N+V   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFP 167
                 R   L+ E+ +   L  +   D   + +      S+      A+++ H H+C  
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKHNC-- 123
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
             +HRDV  +N+L+       + DFG A+ L   +  + +   T  Y
Sbjct: 124 --IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 20/180 (11%)
Query: 44  FDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE--FLTEVKALTETRH 101
           F+ K  +G G  + V  AE    E    K F       + +  KE     E+  L + +H
Sbjct: 24  FEFKETLGTGAFSEVVLAE----EKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR--MSVIKGVADALS 159
            NIV          H +L+ + +  G L      D   ++  ++++   ++I+ V DA+ 
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGEL-----FDRIVEKGFYTEKDASTLIRQVLDAVY 134
Query: 160 YLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           YLH      IVHRD+  +NLL    D E +  ++DFG++K ++      +   GT GYVA
Sbjct: 135 YLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYVA 190

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQKEFL-TEVKALTETRHRNIVKF 107
           IG G    V  A + S  ++VAVKK        +   ++E L  EV  + + +H N+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 213
Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y         +++ EFLE G+L  I+      +E    Q  +V   V  ALS LH     
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG-- 267
Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++HRD+ S ++LL  +    ++DFG    +  +        GT  ++A
Sbjct: 268 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 315

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++  +  +++VVA+K        D+  D ++   E+  L++     + K+Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 91
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L        L  +Q  ++++ +   L YLH +    
Sbjct: 92  GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 144
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL    E  +ADFG+A  L         F GT  ++A
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 192

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE 141
           Q  D++  L EV+ L +  H NI+K Y F     + +L+ E    G L   + +     E
Sbjct: 72  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 131
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFL 198
           +  ++   +I+ V   ++Y+H +    IVHRD+  +NLLL+ + +     + DFG++   
Sbjct: 132 VDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 185
Query: 199 KSDASNWTEFAGTYGYVA 216
           ++ +    +  GT  Y+A
Sbjct: 186 EA-SKKMKDKIGTAYYIA 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE 141
           Q  D++  L EV+ L +  H NI+K Y F     + +L+ E    G L   + +     E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFL 198
           +  ++   +I+ V   ++Y+H +    IVHRD+  +NLLL+ + +     + DFG++   
Sbjct: 126 VDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 199 KSDASNWTEFAGTYGYVA 216
           ++ +    +  GT  Y+A
Sbjct: 180 EA-SKKMKDKIGTAYYIA 196

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 8/175 (4%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 61
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NIVK           +L+ EFL +  L   ++  +A   +      S +  +   LS+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA-SALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H      ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G  + V R  ++P+ +  A K  ++   S +  D ++   E +     +H NIV+ +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR--DHQKLEREARICRLLKHPNIVRLH 69
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-VIKGVADALSYLHHDCFP 167
              S     +L+ + +  G L      D  A+E       S  I+ + +++++ H +   
Sbjct: 70  DSISEEGFHYLVFDLVTGGELF----EDIVAREYYSEADASHCIQQILESVNHCHLNG-- 123
Query: 168 PIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            IVHRD+  +NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++
Sbjct: 124 -IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE 141
           Q  D++  L EV+ L +  H NI+K Y F     + +L+ E    G L   + +     E
Sbjct: 89  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 148
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFL 198
           +  ++   +I+ V   ++Y+H +    IVHRD+  +NLLL+ + +     + DFG++   
Sbjct: 149 VDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 202
Query: 199 KSDASNWTEFAGTYGYVA 216
           ++ +    +  GT  Y+A
Sbjct: 203 EA-SKKMKDKIGTAYYIA 219

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE 141
           Q  D++  L EV+ L +  H NI+K Y F     + +L+ E    G L   + +     E
Sbjct: 90  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 149
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFL 198
           +  ++   +I+ V   ++Y+H +    IVHRD+  +NLLL+ + +     + DFG++   
Sbjct: 150 VDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 203
Query: 199 KSDASNWTEFAGTYGYVA 216
           ++ +    +  GT  Y+A
Sbjct: 204 EA-SKKMKDKIGTAYYIA 220

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++  +  +++VVA+K        D+  D ++   E+  L++     + K+Y
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSSYVTKYY 87
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L     A      Q  +++K +   L YLH +    
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---K 140
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL  + +  +ADFG+A  L         F GT  ++A
Sbjct: 141 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 188

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  +EV AVK       +  ++  ++   EV+ +    H NIVK
Sbjct: 21  TIGKGNFAKVKLARHILTGKEV-AVKIIDKTQLNSSSL--QKLFREVRIMKVLNHPNIVK 77
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y H    
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQYCHQKF- 133
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++  +  +++VVA+K        D+  D ++   E+  L++     + K+Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 71
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L        L  +Q  ++++ +   L YLH +    
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 124
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL    E  +ADFG+A  L         F GT  ++A
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 172

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  +EV AVK       +  ++  ++   EV+ +    H NIVK
Sbjct: 21  TIGKGNFAKVKLARHILTGKEV-AVKIIDKTQLNSSSL--QKLFREVRIMKVLNHPNIVK 77
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y H    
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQYCHQKF- 133
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G  + V R  ++P+ +  A K  ++   S +  D ++   E +     +H NIV+ +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR--DHQKLEREARICRLLKHPNIVRLH 69
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-VIKGVADALSYLHHDCFP 167
              S     +L+ + +  G L      D  A+E       S  I+ + +++++ H +   
Sbjct: 70  DSISEEGFHYLVFDLVTGGELF----EDIVAREYYSEADASHCIQQILESVNHCHLNG-- 123
Query: 168 PIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            IVHRD+  +NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++
Sbjct: 124 -IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  +EV AVK       +  ++  ++   EV+ +    H NIVK
Sbjct: 21  TIGKGNFAKVKLARHILTGKEV-AVKIIDKTQLNSSSL--QKLFREVRIMKVLNHPNIVK 77
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y H    
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQYCHQKF- 133
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  +EV AVK       +  ++  ++   EV+ +    H NIVK
Sbjct: 14  TIGKGNFAKVKLARHILTGKEV-AVKIIDKTQLNSSSL--QKLFREVRIMKVLNHPNIVK 70
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y H    
Sbjct: 71  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKE---KEARAKFRQIVSAVQYCHQKF- 126
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFS 153

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++  +  +++VVA+K        D+  D ++   E+  L++     + K+Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 86
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L        L  +Q  ++++ +   L YLH +    
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEK--- 139
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL    E  +ADFG+A  L         F GT  ++A
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 187

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 11/168 (6%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++  +  +++VVA+K        D+  D ++   E+  L++     + K+Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 71
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G        +++ E+L  GS   +L        L  +Q  ++++ +   L YLH +    
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 124
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL    E  +ADFG+A  L         F GT  ++A
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 172

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 65
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 125 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 175

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 14/181 (7%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
              S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y 
Sbjct: 119 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 171
Query: 216 A 216
           A
Sbjct: 172 A 172

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 68
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 128 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 68
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 128 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 61
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 121 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 30  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 144
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 145 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 60
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 120 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 56  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 170
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 171 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 61
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 121 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 60
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 120 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 150
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 151 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 61
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 121 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 57  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 171
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 172 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 14/151 (9%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNIVKF 107
           +G G +  V+++ +  + EVVAVKK      +  + D +    E+  LTE + H NIV  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGHENIVNL 74
Query: 108 YGF--CSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
                  + R  +L+ +++E    A I      A  L    +  V+  +   + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVI-----RANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              ++HRD+   N+LL+ E    VADFG+++
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 35  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 149
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 150 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 26/190 (13%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA--ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
            + T+D+     +G G  + V R   + P++E    ++  KK  +        D ++   
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR-------DHQKLER 79
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-V 150
           E +     +H NIV+ +   S     +L+ + +  G L      D  A+E       S  
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHC 135
Query: 151 IKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWT 206
           I  + ++++++H HD    IVHRD+  +NLLL  + +     +ADFG+A  ++ +   W 
Sbjct: 136 IHQILESVNHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 207 EFAGTYGYVA 216
            FAGT GY++
Sbjct: 192 GFAGTPGYLS 201

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 37  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 152 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 33  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 147
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 37  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 152 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  +RH  +    Y F +H R  F++ E+   G L   L     ++E  +S+  
Sbjct: 58  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-----SRERVFSEDR 111
Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +   
Sbjct: 112 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 169
Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 170 XFCGTPEYLA 179

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G +  VY+A+     +VA+K+    L ++        + E+  L E  H NIV    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
                R   L+ EF+E+  L  +L+ +     L  SQ    +  +   +++ H      I
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQHR---I 140
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+  +NLL++ +    +ADFG+A+       ++T    T  Y A
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  +RH  +    Y F +H R  F++ E+   G L   L     ++E  +S+  
Sbjct: 56  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-----SRERVFSEDR 109
Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +   
Sbjct: 110 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 167
Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 168 XFCGTPEYLA 177

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G +  VY+A+     +VA+K+    L ++        + E+  L E  H NIV    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
                R   L+ EF+E+  L  +L+ +     L  SQ    +  +   +++ H      I
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQHR---I 140
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+  +NLL++ +    +ADFG+A+       ++T    T  Y A
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  +RH  +    Y F +H R  F++ E+   G L   L     ++E  +S+  
Sbjct: 57  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-----SRERVFSEDR 110
Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +   
Sbjct: 111 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 168
Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 169 XFCGTPEYLA 178

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 12/132 (9%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           E+VAVK   +          K+   E+  L    H +I+K+ G C     +   L+ E++
Sbjct: 44  EMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L        +G +Q +   + + + ++YLH   +   +HR+++++N+LLD +
Sbjct: 101 PLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQHY---IHRNLAARNVLLDND 153
Query: 185 YEAHVADFGIAK 196
               + DFG+AK
Sbjct: 154 RLVKIGDFGLAK 165

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 11/168 (6%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    VY+  +  ++EVVA+K        D+  D ++   E+  L++     I +++
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYF 83
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G    +   +++ E+L  GS   +L      +    +   ++++ +   L YLH +    
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSER--- 136
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +HRD+ + N+LL  + +  +ADFG+A  L         F GT  ++A
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 184

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 13/137 (9%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SHARHSF-LLCEFLE 125
           +VAVK+     P DQ   Q++F  E++ L       IVK+ G      R S  L+ E+L 
Sbjct: 42  LVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 97
Query: 126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLE 184
            G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L++ E
Sbjct: 98  SGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESE 151
Query: 185 YEAHVADFGIAKFLKSD 201
               +ADFG+AK L  D
Sbjct: 152 AHVKIADFGLAKLLPLD 168

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  +EV       + L S      ++   EV+ +    H NIVK
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL---QKLFREVRIMKVLNHPNIVK 77
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y H    
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIVSAVQYCHQKF- 133
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 13/137 (9%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SHARHSF-LLCEFLE 125
           +VAVK+     P DQ   Q++F  E++ L       IVK+ G      R S  L+ E+L 
Sbjct: 41  LVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 96
Query: 126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLE 184
            G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L++ E
Sbjct: 97  SGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESE 150
Query: 185 YEAHVADFGIAKFLKSD 201
               +ADFG+AK L  D
Sbjct: 151 AHVKIADFGLAKLLPLD 167

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 13/137 (9%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SHARHSF-LLCEFLE 125
           +VAVK+     P DQ   Q++F  E++ L       IVK+ G      R S  L+ E+L 
Sbjct: 54  LVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLE 184
            G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L++ E
Sbjct: 110 SGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESE 163
Query: 185 YEAHVADFGIAKFLKSD 201
               +ADFG+AK L  D
Sbjct: 164 AHVKIADFGLAKLLPLD 180

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 121 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 22/176 (12%)
Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVD----QKEFLTEVKALTETRHRNI 104
           C    GH+        + +V+   +F     SD   +     +E   E+  L    H NI
Sbjct: 55  CKEKNGHSE------KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI 108
Query: 105 VKFYGFCSHARHSFLLCEFLERGSL-AAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           +K +      ++ +L+ EF E G L   I+N      +       +++K +   + YLH 
Sbjct: 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHK 164
Query: 164 DCFPPIVHRDVSSKNLLLDLE---YEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                IVHRD+  +N+LL+ +       + DFG++ F   D     +  GT  Y+A
Sbjct: 165 ---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIA 216

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 12/132 (9%)
Query: 67  EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFL 124
           E+VAVK   +          K+   E+  L    H +I+K+ G C     +   L+ E++
Sbjct: 44  EMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE 184
             GSL   L        +G +Q +   + + + ++YLH   +   +HR+++++N+LLD +
Sbjct: 101 PLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQHY---IHRNLAARNVLLDND 153
Query: 185 YEAHVADFGIAK 196
               + DFG+AK
Sbjct: 154 RLVKIGDFGLAK 165

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G + +V++A+   + E+VA+K+    L  D        L E+  L E +H+NIV+ +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                 +   L+ EF ++         D+   +L      S +  +   L + H      
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           ++HRD+  +NLL++   E  +ADFG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  +RH  +    Y F +H R  F++ E+   G L   L     ++E  +S+  
Sbjct: 199 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-----SRERVFSEDR 252
Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +   
Sbjct: 253 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 310
Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 311 TFCGTPEYLA 320

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 121 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 60
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 120 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI 219
               I+HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y A  I
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEI 193

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 121 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 139
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI 219
               I+HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y A  I
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEI 189

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 90  LTEVKALTETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           LTE + L  +RH  +    Y F +H R  F++ E+   G L   L     ++E  +S+  
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-----SRERVFSEDR 249
Query: 149 SVIKG--VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +   G  +  AL YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +   
Sbjct: 250 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 207 EFAGTYGYVA 216
            F GT  Y+A
Sbjct: 308 TFCGTPEYLA 317

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 62
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 122 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 12/172 (6%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAELPSREV---VAVKKFHSPLPSDQTVDQKEFLTEVK 94
           +K  N   A   +G G   SV +     R+    VA+K         +  D +E + E +
Sbjct: 6   LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREAQ 62
Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
            + +  +  IV+  G C  A    L+ E    G L   L      +E+  S    ++  V
Sbjct: 63  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQV 119
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           +  + YL    F   VHRD++++N+LL   + A ++DFG++K L +D S +T
Sbjct: 120 SMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 119 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI 219
               I+HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y A  I
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEI 193

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 60
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 120 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 118 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 11  LEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVA 70
           L  +HI L+ L+   P  V  + +  I  ++        IG G    VY   L   +   
Sbjct: 3   LNTVHIDLSALN---PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG-- 57
Query: 71  VKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIVKFYGFCSHARHS-FLLCEFLE 125
            KK H  + S   +    +  +FLTE   + +  H N++   G C  +  S  ++  +++
Sbjct: 58  -KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 116
Query: 126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY 185
            G L   +  +     +     +     VA  + +L    F   VHRD++++N +LD ++
Sbjct: 117 HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKF 171
Query: 186 EAHVADFGIAK 196
              VADFG+A+
Sbjct: 172 TVKVADFGLAR 182

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 118 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 118 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 139
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 118 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 23  GSIPPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSP 77
           GS+  E       E+ K   +   +Y     +G+G + SV  A +  +   VAVKK   P
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKP 70
Query: 78  LPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF----LERGSLAAIL 133
             S   +  K    E++ L   +H N++      + AR    L EF    L    + A L
Sbjct: 71  FQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFNDVYLVTHLMGADL 125
Query: 134 NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
           N     Q+L       +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 194 IAK 196
           +A+
Sbjct: 183 LAR 185

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 11/136 (8%)
Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGW 144
           D ++   E +     +H NIV+ +   S   H +L+ + +  G L      D  A+E   
Sbjct: 64  DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF----EDIVAREYYS 119
Query: 145 SQRMS-VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKS 200
               S  I+ + +A+ + H      +VHRD+  +NLLL  + +     +ADFG+A  ++ 
Sbjct: 120 EADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEG 176
Query: 201 DASNWTEFAGTYGYVA 216
           +   W  FAGT GY++
Sbjct: 177 EQQAWFGFAGTPGYLS 192

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 11  LEVLHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVA 70
           L  +HI L+ L+   P  V  + +  I  ++        IG G    VY   L   +   
Sbjct: 3   LNTVHIDLSALN---PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG-- 57
Query: 71  VKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIVKFYGFCSHARHS-FLLCEFLE 125
            KK H  + S   +    +  +FLTE   + +  H N++   G C  +  S  ++  +++
Sbjct: 58  -KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 116
Query: 126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY 185
            G L   +  +     +     +     VA  + +L    F   VHRD++++N +LD ++
Sbjct: 117 HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKF 171
Query: 186 EAHVADFGIAK 196
              VADFG+A+
Sbjct: 172 TVKVADFGLAR 182

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 23  GSIPPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSP 77
           GS+  E       E+ K   +   +Y     +G+G + SV  A +  +   VAVKK   P
Sbjct: 1   GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 78  LPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF----LERGSLAAIL 133
             S   +  K    E++ L   +H N++      + AR    L EF    L    + A L
Sbjct: 61  FQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFNDVYLVTHLMGADL 115
Query: 134 NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
           N     Q+L       +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG
Sbjct: 116 NNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFG 172
Query: 194 IAK 196
           +A+
Sbjct: 173 LAR 175

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 60
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 120 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 163
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 98  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 153
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 154 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 62
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 122 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 97  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 211
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 119 FCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 60
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 120 FCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 23  GSIPPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSP 77
           GS+  E       E+ K   +   +Y     +G+G + SV  A +  +   VAVKK   P
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 70
Query: 78  LPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF----LERGSLAAIL 133
             S   +  K    E++ L   +H N++      + AR    L EF    L    + A L
Sbjct: 71  FQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFNDVYLVTHLMGADL 125
Query: 134 NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
           N     Q+L       +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 194 IAK 196
           +A+
Sbjct: 183 LAR 185

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 60
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 120 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 163
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 43  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + +L   
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 157
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 158 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 23  GSIPPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSP 77
           GS+  E       E+ K   +   +Y     +G+G + SV  A +  +   VAVKK   P
Sbjct: 11  GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 70
Query: 78  LPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF----LERGSLAAIL 133
             S   +  K    E++ L   +H N++      + AR    L EF    L    + A L
Sbjct: 71  FQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFNDVYLVTHLMGADL 125
Query: 134 NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
           N     Q+L       +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 194 IAK 196
           +A+
Sbjct: 183 LAR 185

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI 219
               I+HRD+   NL ++ + E  + DFG+A   +  A   T +  T  Y A  I
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEI 200

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 107 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 162
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI 219
               I+HRD+   NL ++ + E  + DFG+A   +  A   T +  T  Y A  I
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEI 200

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 23  GSIPPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSP 77
           GS+  E       E+ K   +   +Y     +G+G + SV  A +  +   VAVKK   P
Sbjct: 1   GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 78  LPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF----LERGSLAAIL 133
             S   +  K    E++ L   +H N++      + AR    L EF    L    + A L
Sbjct: 61  FQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFNDVYLVTHLMGADL 115
Query: 134 NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
           N     Q+L       +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG
Sbjct: 116 NNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 172
Query: 194 IAK 196
           +A+
Sbjct: 173 LAR 175

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 153 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV----DQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +    KK H  + S   +    +  +FLTE   + +  H N++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +     +     +     VA  + +L   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 150
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            F   VHRD++++N +LD ++   VADFG+A+
Sbjct: 151 KF---VHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI 219
               I+HRD+   NL ++ + E  + DFG+A   +  A   T +  T  Y A  I
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEI 200

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 99  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 154
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 155 --ADIIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 11/149 (7%)
Query: 49  CIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G  A V  A   L  +EV AVK       +  ++  ++   EV+      H NIVK
Sbjct: 21  TIGKGNFAKVKLARHILTGKEV-AVKIIDKTQLNSSSL--QKLFREVRIXKVLNHPNIVK 77
Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +      +  +L+ E+   G +   L      +E    +  +  + +  A+ Y H    
Sbjct: 78  LFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKE---KEARAKFRQIVSAVQYCHQKF- 133
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             IVHRD+ ++NLLLD +    +ADFG +
Sbjct: 134 --IVHRDLKAENLLLDADXNIKIADFGFS 160

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 149
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 24/151 (15%)
Query: 69  VAVKKFHSPLPSDQTVDQKE-FLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLER 126
           VAVK     L S    D+KE  ++E+K ++   +H NIV   G C+H     ++ E+   
Sbjct: 79  VAVKM----LKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 127 GSLAAILN-------------TDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHR 172
           G L   L              +    ++L     +     VA  +++L   +C    +HR
Sbjct: 135 GDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHR 190
Query: 173 DVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           DV+++N+LL   + A + DFG+A+ + +D++
Sbjct: 191 DVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 71/161 (44%), Gaps = 13/161 (8%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQK--EFLTEVKALTETRHRNIVKF 107
           +G G   SV    L   +  ++K     +  D +  ++  EFL+E   + +  H N+++ 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 108 YGFCSHAR-----HSFLLCEFLERGSLAAIL---NTDAAAQELGWSQRMSVIKGVADALS 159
            G C            ++  F++ G L   L     +   + +     +  +  +A  + 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
           YL +  F   +HRD++++N +L  +    VADFG++K + S
Sbjct: 162 YLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSP-----LPSDQTVDQKEFLTEV 93
           AT+ ++    IG G + +VY+A  P S   VA+K    P     LP   TV +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 94  KALTETRHRNIVKFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           +A     H N+V+    C+ +R        L+ E +++  L   L+  A    L      
Sbjct: 61  EAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIK 115
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
            +++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+ 
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTE--VKALTETRHRNIVKF 107
           IG G + +VY+  L  R V AVK F          +++ F+ E  +  +    H NI +F
Sbjct: 21  IGRGRYGAVYKGSLDERPV-AVKVF-------SFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 108 Y----GFCSHARHSFLLC-EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
                   +  R  +LL  E+   GSL   L+   +     W     +   V   L+YLH
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLH 128
Query: 163 HDC------FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +        P I HRD++S+N+L+  +    ++DFG++  L  +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSP-----LPSDQTVDQKEFLTEV 93
           AT+ ++    IG G + +VY+A  P S   VA+K    P     LP   TV +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 94  KALTETRHRNIVKFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           +A     H N+V+    C+ +R        L+ E +++  L   L+  A    L      
Sbjct: 61  EAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIK 115
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
            +++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+ 
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSP-----LPSDQTVDQKEFLTEV 93
           AT+ ++    IG G + +VY+A  P S   VA+K    P     LP   TV +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 94  KALTETRHRNIVKFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           +A     H N+V+    C+ +R        L+ E +++  L   L+  A    L      
Sbjct: 61  EAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIK 115
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
            +++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+ 
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 13/179 (7%)
Query: 23  GSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSD 81
           GS P    + L   I +    +     +G+G + SV  A +  +   VAVKK   P  S 
Sbjct: 1   GSRPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS- 59
Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF----LERGSLAAILNTDA 137
             +  K    E++ L   +H N++      + AR    L EF    L    + A LN   
Sbjct: 60  -IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIV 115
Query: 138 AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             Q+L       +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 116 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL    L   ++  A       L  S    +++G+A
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 121 FCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+ K    L ++        + E+  L E  H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR--LDTETEGVPSTAIREISLLKELNH 61
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 121 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+ K    L ++        + E+  L E  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR--LDTETEGVPSTAIREISLLKELNH 60
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 120 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 111 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 166
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 85  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 140
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 111 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 166
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 167 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 59
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL    L   ++  A       L  S    +++G+A
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 119 FCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRAELPSREV---VAVKKFHSPLPSDQTVDQKEFLTEV 93
            +K  N   A   +G G   SV +     R+    VA+K         +  D +E + E 
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREA 387
Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
           + + +  +  IV+  G C  A    L+ E    G L   L      +E+  S    ++  
Sbjct: 388 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQ 444
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
           V+  + YL    F   VHR+++++N+LL   + A ++DFG++K L +D S +T
Sbjct: 445 VSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 99  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 154
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 155 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 149
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 150 --ADIIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 14/177 (7%)
Query: 35  DEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD--QTVDQKEFLTE 92
           ++++     F     +G G   SV  A+L   +   VK     L +D   + D +EFL E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 93  VKALTETRHRNIVKFYGFCSHARHS------FLLCEFLERGSLAAILNTDAAAQE---LG 143
              + E  H ++ K  G    +R         ++  F++ G L A L      +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
               +  +  +A  + YL    F   +HRD++++N +L  +    VADFG+++ + S
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 139
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 145
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 163
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 164 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 150
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 151 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 85  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 140
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 141 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 148
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 149 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 87  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 142
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 143 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 58
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL +  L   ++  A       L  S    +++G+A
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 118 FCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 149
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL    L   ++  A       L  S    +++G+A
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 121 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 145
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 146 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE 141
           Q  D++  L EV+ L +  H NI K Y F     + +L+ E    G L   + +     E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFL 198
           +  ++   +I+ V   ++Y H +    IVHRD+  +NLLL+ + +     + DFG++   
Sbjct: 126 VDAAR---IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 199 KSDASNWTEFAGTYGYVA 216
           ++ +    +  GT  Y+A
Sbjct: 180 EA-SKKXKDKIGTAYYIA 196

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 107 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 162
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 163 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 60
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ EFL    L   ++  A       L  S    +++G+A
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 120 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 69  VAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCEFLERG 127
           VAVK   S   +D+   ++  ++E+K ++   +H NIV   G C+H     ++ E+   G
Sbjct: 64  VAVKMLKSTAHADE---KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 120
Query: 128 SLAAILNTDAAA--------------------QELGWSQRMSVIKGVADALSYL-HHDCF 166
            L   L   A A                    + L     +     VA  +++L   +C 
Sbjct: 121 DLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC- 179
Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
              +HRDV+++N+LL   + A + DFG+A+ + +D++
Sbjct: 180 ---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 63/144 (43%), Gaps = 24/144 (16%)
Query: 83  TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-------AAILNT 135
           T    + L EV  L    H NI+K Y F    R+ +L+ E  + G L             
Sbjct: 77  TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV 136
Query: 136 DAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LEYEA--HVADF 192
           DAA           +IK V   ++YLH      IVHRD+  +NLLL+  E +A   + DF
Sbjct: 137 DAAV----------IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 193 GIAKFLKSDASNWTEFAGTYGYVA 216
           G++   + +     E  GT  Y+A
Sbjct: 184 GLSAVFE-NQKKMKERLGTAYYIA 206

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G + +V++A+   + E+VA+K+    L  D        L E+  L E +H+NIV+ +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                 +   L+ EF ++         D+   +L      S +  +   L + H      
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           ++HRD+  +NLL++   E  +A+FG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 149
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 150 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 13/137 (9%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SHARHSF-LLCEFLE 125
           +VAVK+     P DQ   Q++F  E++ L       IVK+ G      R    L+ E+L 
Sbjct: 38  LVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLP 93
Query: 126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLE 184
            G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L++ E
Sbjct: 94  SGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESE 147
Query: 185 YEAHVADFGIAKFLKSD 201
               +ADFG+AK L  D
Sbjct: 148 AHVKIADFGLAKLLPLD 164

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 12/138 (8%)
Query: 83  TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL 142
           T +    L EV  L +  H NI+K Y F    R+ +L+ E    G L    +     Q+ 
Sbjct: 62  TSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKF 118
Query: 143 GWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFL 198
                  ++K V    +YLH H+    IVHRD+  +NLLL+ +       + DFG++   
Sbjct: 119 SEVDAAVIMKQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF 174
Query: 199 KSDASNWTEFAGTYGYVA 216
           +       E  GT  Y+A
Sbjct: 175 EV-GGKMKERLGTAYYIA 191

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 25/178 (14%)
Query: 50  IGNGGHASVYR-AELPSREVVAVKKFHSPLPSDQTVD---QKEFLTEVKALTETRH-RNI 104
           IG G + SV +    PS +++AVK+  S      TVD   QK+ L ++  +  +     I
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRS------TVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 105 VKFYGFCSHARHSFLLCEFLERG------SLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
           V+FYG        ++  E +          + ++L+ D   +E+     ++ +K    AL
Sbjct: 84  VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLD-DVIPEEILGKITLATVK----AL 138
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           ++L  +    I+HRD+   N+LLD      + DFGI+  L  D+   T  AG   Y+A
Sbjct: 139 NHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMA 193

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 11/151 (7%)
Query: 50  IGNGGHASV---YRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G + SV   Y A L  R+ VAVKK   P  S   +  +    E++ L   +H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQS--LIHARRTYRELRLLKHLKHENVIG 91
Query: 107 FYGFCSHARHSFLLCE-FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
                + A       E +L    + A LN    +Q L       ++  +   L Y+H   
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              I+HRD+   N+ ++ + E  + DFG+A+
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 14/181 (7%)
Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           T+++     IG G  + V R  +L +    A K  ++   S +  D ++   E +     
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSAR--DHQKLEREARICRLL 60
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-VIKGVADAL 158
           +H NIV+ +   S     +L+ + +  G L      D  A+E       S  I+ + +A+
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELF----EDIVAREYYSEADASHCIQQILEAV 116
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWTEFAGTYGYV 215
            + H      +VHRD+  +NLLL  + +     +ADFG+A  ++ D   W  FAGT GY+
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYL 173
Query: 216 A 216
           +
Sbjct: 174 S 174

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 90/186 (48%), Gaps = 19/186 (10%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVK 94
            K ++++D K  +G G  + V R    +  +    +F + + + + +  ++F     E +
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREAR 80
Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-VIKG 153
              + +H NIV+ +         +L+ + +  G L      D  A+E       S  I+ 
Sbjct: 81  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQ 136
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWTEFAG 210
           + ++++Y H +    IVHR++  +NLLL  + +     +ADFG+A  + +D+  W  FAG
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAG 192
Query: 211 TYGYVA 216
           T GY++
Sbjct: 193 TPGYLS 198

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 90/186 (48%), Gaps = 19/186 (10%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVK 94
            K ++++D K  +G G  + V R    +  +    +F + + + + +  ++F     E +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREAR 57
Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-VIKG 153
              + +H NIV+ +         +L+ + +  G L      D  A+E       S  I+ 
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQ 113
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWTEFAG 210
           + ++++Y H +    IVHR++  +NLLL  + +     +ADFG+A  + +D+  W  FAG
Sbjct: 114 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAG 169
Query: 211 TYGYVA 216
           T GY++
Sbjct: 170 TPGYLS 175

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 47  KYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNI 104
           +  +  GG A VY A+ + S    A+K+    L S++    +  + EV  + + + H NI
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKR----LLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 105 VKFYGFCSHA----------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
           V+F   CS A          +  FLL   L +G L   L    +   L     + +    
Sbjct: 89  VQF---CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             A+ ++H    PPI+HRD+  +NLLL  +    + DFG A
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 90/186 (48%), Gaps = 19/186 (10%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVK 94
            K ++++D K  +G G  + V R    +  +    +F + + + + +  ++F     E +
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREAR 56
Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-VIKG 153
              + +H NIV+ +         +L+ + +  G L      D  A+E       S  I+ 
Sbjct: 57  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQ 112
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWTEFAG 210
           + ++++Y H +    IVHR++  +NLLL  + +     +ADFG+A  + +D+  W  FAG
Sbjct: 113 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAG 168
Query: 211 TYGYVA 216
           T GY++
Sbjct: 169 TPGYLS 174

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSP--------LPSDQTVDQKEFL 90
           AT+ ++    IG G + +VY+A  P S   VA+K    P        LP   TV +   L
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPI-STVREVALL 65
Query: 91  TEVKALTETRHRNIVKFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWS 145
             ++A     H N+V+    C+ +R        L+ E +++  L   L+  A    L   
Sbjct: 66  RRLEAF---EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAE 120
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
               +++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+ 
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 90/186 (48%), Gaps = 19/186 (10%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVK 94
            K ++++D K  +G G  + V R    +  +    +F + + + + +  ++F     E +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREAR 57
Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS-VIKG 153
              + +H NIV+ +         +L+ + +  G L      D  A+E       S  I+ 
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQ 113
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKSDASNWTEFAG 210
           + ++++Y H +    IVHR++  +NLLL  + +     +ADFG+A  + +D+  W  FAG
Sbjct: 114 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAG 169
Query: 211 TYGYVA 216
           T GY++
Sbjct: 170 TPGYLS 175

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 20/194 (10%)
Query: 34  YDEIVKATNDFDAKYCIGNG--GHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
           +D      ++++    IGNG  G  S  R  L  ++V A+KK   P   D   + K  L 
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQV-AIKKI--PNAFDVVTNAKRTLR 102
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDA-----AAQELGWSQ 146
           E+K L   +H NI+         R +    EF     +  ++ +D      ++Q L    
Sbjct: 103 ELKILKHFKHDNIIAIKDIL---RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 159
Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN-- 204
               +  +   L Y+H      ++HRD+   NLL++   E  + DFG+A+ L +  +   
Sbjct: 160 VRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 216
Query: 205 --WTEFAGTYGYVA 216
              TE+  T  Y A
Sbjct: 217 YFMTEYVATRWYRA 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN    +Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+ +
Sbjct: 144 --ADIIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 20/194 (10%)
Query: 34  YDEIVKATNDFDAKYCIGNG--GHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
           +D      ++++    IGNG  G  S  R  L  ++V A+KK   P   D   + K  L 
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQV-AIKKI--PNAFDVVTNAKRTLR 103
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDA-----AAQELGWSQ 146
           E+K L   +H NI+         R +    EF     +  ++ +D      ++Q L    
Sbjct: 104 ELKILKHFKHDNIIAIKDIL---RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 160
Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN-- 204
               +  +   L Y+H      ++HRD+   NLL++   E  + DFG+A+ L +  +   
Sbjct: 161 VRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 217
Query: 205 --WTEFAGTYGYVA 216
              TE+  T  Y A
Sbjct: 218 YFMTEYVATRWYRA 231

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/132 (22%), Positives = 59/132 (44%), Gaps = 9/132 (6%)
Query: 87  KEFLTEVKALTETRHRNIVKFYGFCSHAR--HSFLLCEFLERGSLAAILNTDAAAQELGW 144
           ++   E+  L +  H N+VK           H +++ E + +G +  +      +++   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
                +IKG+     YLH+     I+HRD+   NLL+  +    +ADFG++   K   + 
Sbjct: 141 FYFQDLIKGI----EYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 205 WTEFAGTYGYVA 216
            +   GT  ++A
Sbjct: 194 LSNTVGTPAFMA 205

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 57/131 (43%), Gaps = 10/131 (7%)
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
            L EV  L +  H NI+K Y F    R+ +L+ E    G L    +     Q+       
Sbjct: 51  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKFSEVDAA 107
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFLKSDASNW 205
            ++K V    +YLH      IVHRD+  +NLLL+ +       + DFG++   +      
Sbjct: 108 VIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKM 163
Query: 206 TEFAGTYGYVA 216
            E  GT  Y+A
Sbjct: 164 KERLGTAYYIA 174

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 92  EVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           E++ L    H +IVK+ G C     +   L+ E++  GSL   L        +G +Q + 
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLL 115
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             + + + ++YLH   +   +HR ++++N+LLD +    + DFG+AK
Sbjct: 116 FAQQICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 92  EVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           E++ L    H +IVK+ G C     +   L+ E++  GSL   L        +G +Q + 
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLL 116
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             + + + ++YLH   +   +HR ++++N+LLD +    + DFG+AK
Sbjct: 117 FAQQICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + D+G+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 66/136 (48%), Gaps = 11/136 (8%)
Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGW 144
           D ++   E +     +H NIV+ +   S   H +L+ + +  G L      D  A+E   
Sbjct: 53  DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF----EDIVAREYYS 108
Query: 145 SQRMS-VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA---HVADFGIAKFLKS 200
               S  I+ + +A+ + H      +VHR++  +NLLL  + +     +ADFG+A  ++ 
Sbjct: 109 EADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 201 DASNWTEFAGTYGYVA 216
           +   W  FAGT GY++
Sbjct: 166 EQQAWFGFAGTPGYLS 181

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 12/169 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G GG + V+ A +L     VAVK   + L  D +   + F  E +      H  IV  Y
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 109 ----GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
                        +++ E+++  +L  I++T+     +   + + VI     AL++ H +
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 135
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
               I+HRDV   N+++       V DFGIA+ +    ++ T+ A   G
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 65/145 (44%), Gaps = 10/145 (6%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G    VY         VA++     +  D     K F  EV A  +TRH N+V F G
Sbjct: 41  IGKGRFGQVYHGRWHGE--VAIRLID--IERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C    H  ++    +  +L +++       ++  +++++  + +   + YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA--QEIVKGMGYLHAKG---I 151
Query: 170 VHRDVSSKNLLLDLEYEAHVADFGI 194
           +H+D+ SKN+  D   +  + DFG+
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGL 175

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 12/169 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G GG + V+ A +L     VAVK   + L  D +   + F  E +      H  IV  Y
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 109 GFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
                   +    +++ E+++  +L  I++T+     +   + + VI     AL++ H +
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN 135
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
               I+HRDV   N+++       V DFGIA+ +    ++ T+ A   G
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 50  IGNGGHASV---YRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G + SV   Y A L  R+ VAVKK   P  S   +  +    E++ L   +H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQS--LIHARRTYRELRLLKHLKHENVIG 91
Query: 107 FYGFCSHARHSFLLCE-FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
                + A       E +L    + A LN     Q L       ++  +   L Y+H   
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              I+HRD+   N+ ++ + E  + DFG+A+
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           + +++ F     +GNG +A+VY+    +  V VA+K+    L S++       + E+  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTA-IREISLM 57
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR---MSVIK- 152
            E +H NIV+ Y          L+ EF++       L     ++ +G + R   ++++K 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKY 112
Query: 153 ---GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               +   L++ H +    I+HRD+  +NLL++   +  + DFG+A+
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 9/121 (7%)
Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
           L+   H  I++ +G    A+  F++ +++E G L ++L     +Q             V 
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVC 116
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
            AL YLH      I++RD+  +N+LLD      + DFG AK++  D +      GT  Y+
Sbjct: 117 LALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT--YXLCGTPDYI 170
Query: 216 A 216
           A
Sbjct: 171 A 171

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 50  IGNGGHASV---YRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G + SV   Y A L  R+ VAVKK   P  S   +  +    E++ L   +H N++ 
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQS--LIHARRTYRELRLLKHLKHENVIG 83
Query: 107 FYGFCSHARHSFLLCE-FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
                + A       E +L    + A LN     Q L       ++  +   L Y+H   
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              I+HRD+   N+ ++ + E  + DFG+A+
Sbjct: 144 ---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 12/178 (6%)
Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           ++ ++    +G GG + V+ A +L     VAVK   + L  D +   + F  E +     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAAL 69
Query: 100 RHRNIVKFYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            H  IV  Y        +    +++ E+++  +L  I++T+     +   + + VI    
Sbjct: 70  NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
            AL++ H +    I+HRDV   N+++       V DFGIA+ +    ++ T+ A   G
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 61/137 (44%), Gaps = 14/137 (10%)
Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA----- 139
           +++E   EV  L   +H NIV++          +++ ++ E G L   +N          
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125
Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           Q L W  ++ +      AL ++H      I+HRD+ S+N+ L  +    + DFGIA+ L 
Sbjct: 126 QILDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 200 SDASNWTEFAGTYGYVA 216
           S         GT  Y++
Sbjct: 177 STVELARACIGTPYYLS 193

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN      +L       +I  +   L Y+H  
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS- 139
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           Q     E+  L   RH +I+K Y          ++ E+        I+  D  +++    
Sbjct: 48  QGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---- 103
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           +     + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++  + +D +  
Sbjct: 104 EARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFL 159
Query: 206 TEFAGTYGYVA 216
               G+  Y A
Sbjct: 160 KTSCGSPNYAA 170

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 14/178 (7%)
Query: 43  DFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 60
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVADAL 158
            NIVK           +L+ E + +  L   ++  A       L  S    +++G+A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           S+        ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 120 SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 46/191 (24%)
Query: 29  VGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE 88
           +G+  + ++VKAT    A +  G  G+ +V         V  +K+  SP       + ++
Sbjct: 31  LGEGEFGKVVKAT----AFHLKGRAGYTTV--------AVKMLKENASP------SELRD 72
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------- 134
            L+E   L +  H +++K YG CS      L+ E+ + GSL   L               
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 135 ---------TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY 185
                     D  A  +G    +S    ++  + YL       +VHRD++++N+L+    
Sbjct: 133 SRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGR 187
Query: 186 EAHVADFGIAK 196
           +  ++DFG+++
Sbjct: 188 KMKISDFGLSR 198

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           Q     E+  L   RH +I+K Y          ++ E+        I+  D  +++    
Sbjct: 52  QGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---- 107
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           +     + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++  + +D +  
Sbjct: 108 EARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFL 163
Query: 206 TEFAGTYGYVA 216
               G+  Y A
Sbjct: 164 KTSCGSPNYAA 174

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 79/178 (44%), Gaps = 12/178 (6%)
Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           ++ ++    +G GG + V+ A +L     VAVK   + L  D +   + F  E +     
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAAL 86
Query: 100 RHRNIVKFY----GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            H  IV  Y             +++ E+++  +L  I++T+     +   + + VI    
Sbjct: 87  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 143
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
            AL++ H +    I+HRDV   N+++       V DFGIA+ +    ++ T+ A   G
Sbjct: 144 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           Q     E+  L   RH +I+K Y          ++ E+        I+  D  +++    
Sbjct: 58  QGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---- 113
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           +     + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++  + +D +  
Sbjct: 114 EARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFL 169
Query: 206 TEFAGTYGYVA 216
               G+  Y A
Sbjct: 170 KTSCGSPNYAA 180

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 79/178 (44%), Gaps = 12/178 (6%)
Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           ++ ++    +G GG + V+ A +L     VAVK   + L  D +   + F  E +     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAAL 69
Query: 100 RHRNIVKFY----GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            H  IV  Y             +++ E+++  +L  I++T+     +   + + VI    
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
            AL++ H +    I+HRDV   N+++       V DFGIA+ +    ++ T+ A   G
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
           Q     E+  L   RH +I+K Y          ++ E+        I+  D  +++    
Sbjct: 57  QGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ---- 112
Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           +     + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++  + +D +  
Sbjct: 113 EARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFL 168
Query: 206 TEFAGTYGYVA 216
               G+  Y A
Sbjct: 169 KTSCGSPNYAA 179

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 36  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 150
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 151 F---VHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 36  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 150
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 151 F---VHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 35  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 89
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 90  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 149
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 150 F---VHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 33  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 87
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 88  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 147
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 148 F---VHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 46/191 (24%)
Query: 29  VGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE 88
           +G+  + ++VKAT    A +  G  G+ +V         V  +K+  SP       + ++
Sbjct: 31  LGEGEFGKVVKAT----AFHLKGRAGYTTV--------AVKMLKENASP------SELRD 72
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------- 134
            L+E   L +  H +++K YG CS      L+ E+ + GSL   L               
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 135 ---------TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY 185
                     D  A  +G    +S    ++  + YL       +VHRD++++N+L+    
Sbjct: 133 SRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGR 187
Query: 186 EAHVADFGIAK 196
           +  ++DFG+++
Sbjct: 188 KMKISDFGLSR 198

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 12/178 (6%)
Query: 44  FDAKYCIGNGGHASVYRAE----LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           F+    +G GG+  V++        + ++ A+K     +      D      E   L E 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 100 RHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
           +H  IV   Y F +  +  +L+ E+L  G L   L  +    E         +  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMAL 134
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +LH      I++RD+  +N++L+ +    + DFG+ K    D +    F GT  Y+A
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMA 189

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 46/191 (24%)
Query: 29  VGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE 88
           +G+  + ++VKAT    A +  G  G+ +V         V  +K+  SP       + ++
Sbjct: 31  LGEGEFGKVVKAT----AFHLKGRAGYTTV--------AVKMLKENASP------SELRD 72
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------- 134
            L+E   L +  H +++K YG CS      L+ E+ + GSL   L               
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 135 ---------TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY 185
                     D  A  +G    +S    ++  + YL       +VHRD++++N+L+    
Sbjct: 133 SRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGR 187
Query: 186 EAHVADFGIAK 196
           +  ++DFG+++
Sbjct: 188 KMKISDFGLSR 198

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 36  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 150
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 151 F---VHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 36  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 150
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHRD++++N ++  ++   + DFG+ +
Sbjct: 151 F---VHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYXQRT-LREIKILLRFRHENIIGIN 91
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 70/171 (40%), Gaps = 10/171 (5%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 107
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                     +   +L    + A L      Q L        +  +   L Y+H      
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVA 216
           ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 12/178 (6%)
Query: 44  FDAKYCIGNGGHASVYRAE----LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           F+    +G GG+  V++        + ++ A+K     +      D      E   L E 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 100 RHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
           +H  IV   Y F +  +  +L+ E+L  G L   L  +    E         +  ++ AL
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMAL 134
Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +LH      I++RD+  +N++L+ +    + DFG+ K    D +    F GT  Y+A
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           ++ ++    +G GG + V+ A +L     VAVK   + L  D +   + F  E +     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAAL 69
Query: 100 RHRNIVKFY----GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            H  IV  Y             +++ E+++  +L  I++T+     +   + + VI    
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADAC 126
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
            AL++ H +    I+HRDV   N+L+       V DFGIA+ +    ++  + A   G
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIG 181

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 40  ATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           +  +F     IG G +  VY+A    + EVVA+KK    L ++        + E+  L E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKE 61
Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ---ELGWSQRMSVIKGVA 155
             H NIVK           +L+ E +++  L   ++  A       L  S    +++G+A
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              S+        ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 121 FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 132
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L              +    ++L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 193 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DF +A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 91
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA-------------QELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   ++L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 91
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA-------------QELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   ++L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  +  FG+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 68/165 (41%), Gaps = 23/165 (13%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFL--TEVKALTETRHRNIVKF 107
           IG G +  V+  +    E VAVK F        T ++  +   TE+      RH NI+ F
Sbjct: 45  IGKGRYGEVWMGKWRG-EKVAVKVFF-------TTEEASWFRETEIYQTVLMRHENILGF 96
Query: 108 YGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                    S    +L+ ++ E GSL   L +      L     + +       L +LH 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHT 152
Query: 164 DCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           + F     P I HRD+ SKN+L+       +AD G+A    SD +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 84
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L              +    ++L    
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 145 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 26/189 (13%)
Query: 39  KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           K   DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYV 57
Query: 99  TRHRNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           TR R++         VK Y         +    + + G L   +    +  E     R  
Sbjct: 58  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFY 115
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTE 207
             + +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    
Sbjct: 116 TAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 171
Query: 208 FAGTYGYVA 216
           F GT  YV+
Sbjct: 172 FVGTAQYVS 180

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 91
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA-------------QELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   ++L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 26/189 (13%)
Query: 39  KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           K   DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYV 56
Query: 99  TRHRNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           TR R++         VK Y         +    + + G L   +    +  E     R  
Sbjct: 57  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFY 114
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTE 207
             + +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    
Sbjct: 115 TAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 170
Query: 208 FAGTYGYVA 216
           F GT  YV+
Sbjct: 171 FVGTAQYVS 179

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 83
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L              +    ++L    
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 144 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 17/182 (9%)
Query: 24  SIPPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPL 78
           S PP        E+ K   +  A Y     +G+G + +V  A +  +   VA+KK + P 
Sbjct: 3   SPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF 62
Query: 79  PSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA 138
            S+  +  K    E++ L   RH N++   G          L +F +   +   + TD  
Sbjct: 63  QSE--LFAKRAYRELRLLKHMRHENVI---GLLDVFTPDETLDDFTDFYLVMPFMGTDLG 117
Query: 139 A----QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI 194
                ++LG  +   ++  +   L Y+H      I+HRD+   NL ++ + E  + DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 195 AK 196
           A+
Sbjct: 175 AR 176

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 80
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA-------------QELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   ++L    
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 141 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 87
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 142
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 87
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 142
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 91
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L              +    ++L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 152 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 32/171 (18%)
Query: 50  IGNGGHASVYRAEL-------PSREV-VAVKKFHSPLPSDQT-VDQKEFLTEVKALTET- 99
           +G G    V  AE        P+R   VAVK     L SD T  D  + ++E++ +    
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 76
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA-------------QELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   ++L    
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    VA  + YL    C    +HRD++++N+L+  +    +ADFG+A+
Sbjct: 137 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  + ++ S   +AVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + A     L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 117 DVFTPATS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 172
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + DFG+A+
Sbjct: 173 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 26/189 (13%)
Query: 39  KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           K   DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYV 55
Query: 99  TRHRNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           TR R++         VK Y         +    + + G L   +    +  E     R  
Sbjct: 56  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFY 113
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTE 207
             + +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    
Sbjct: 114 TAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 169
Query: 208 FAGTYGYVA 216
           F GT  YV+
Sbjct: 170 FVGTAQYVS 178

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 87
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 142
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 26/189 (13%)
Query: 39  KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           K   DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYV 54
Query: 99  TRHRNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           TR R++         VK Y         +    + + G L   +    +  E     R  
Sbjct: 55  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFY 112
Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTE 207
             + +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    
Sbjct: 113 TAE-IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 168
Query: 208 FAGTYGYVA 216
           F GT  YV+
Sbjct: 169 FVGTAQYVS 177

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + D G+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + D G+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET--RHRNIVKF 107
           IG G    V+R +    EV AVK F S        +++ +  E +       RH NI+ F
Sbjct: 37  IGKGRFGEVWRGKWRGEEV-AVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 88
Query: 108 YGFCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
               +    ++    L+ ++ E GSL   LN      E      + +    A  L++LH 
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 144
Query: 164 DCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           +       P I HRD+ SKN+L+       +AD G+A
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 91
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 95
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 150
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 151 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 87
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 142
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 87
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 142
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 143 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  +   VAVKK   P  S   +  K    E++ L   +H N++   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 109 GFCSHARHSFLLCEF----LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              + AR    L EF    L    + A LN     Q+L       +I  +   L Y+H  
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 143
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               I+HRD+   NL ++ + E  + D G+A+
Sbjct: 144 --ADIIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET--RHRNIVKF 107
           IG G    V+R +    EV AVK F S        +++ +  E +       RH NI+ F
Sbjct: 50  IGKGRFGEVWRGKWRGEEV-AVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 101
Query: 108 YGFCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
               +    ++    L+ ++ E GSL   LN      E      + +    A  L++LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 157
Query: 164 DCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           +       P I HRD+ SKN+L+       +AD G+A
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 89
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 144
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 145 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 81/197 (41%), Gaps = 48/197 (24%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 37  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 87
Query: 102 RNI---------VKFYGFC-----------SHARHSFLLCEFLERGSLAAILNTDAAAQE 141
           R++         VK Y FC           S+A++  LL    + GS          A+ 
Sbjct: 88  RDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE- 145
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--K 199
                       +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +
Sbjct: 146 ------------IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 190
Query: 200 SDASNWTEFAGTYGYVA 216
           S  +    F GT  YV+
Sbjct: 191 SKQARANXFVGTAQYVS 207

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET--RHRNIVKF 107
           IG G    V+R +    EV AVK F S        +++ +  E +       RH NI+ F
Sbjct: 14  IGKGRFGEVWRGKWRGEEV-AVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 65
Query: 108 YGFCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
               +    ++    L+ ++ E GSL   LN      E      + +    A  L++LH 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 121
Query: 164 DCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           +       P I HRD+ SKN+L+       +AD G+A
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET--RHRNIVKF 107
           IG G    V+R +    EV AVK F S        +++ +  E +       RH NI+ F
Sbjct: 17  IGKGRFGEVWRGKWRGEEV-AVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 68
Query: 108 YGFCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
               +    ++    L+ ++ E GSL   LN      E      + +    A  L++LH 
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 124
Query: 164 DCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           +       P I HRD+ SKN+L+       +AD G+A
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET--RHRNIVKF 107
           IG G    V+R +    EV AVK F S        +++ +  E +       RH NI+ F
Sbjct: 12  IGKGRFGEVWRGKWRGEEV-AVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 63
Query: 108 YGFCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
               +    ++    L+ ++ E GSL   LN      E      + +    A  L++LH 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 119
Query: 164 DCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           +       P I HRD+ SKN+L+       +AD G+A
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGG----HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G     H  +Y +       VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 73
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 74  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 130
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 131 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQK---EFLTEVKALTETRHRNIV 105
           +G+G   +VY+   +P  E V +      L  ++T   K   EF+ E   +    H ++V
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G C       L+ + +  G L   ++       +G    ++    +A  + YL    
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR 160
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
              +VHRD++++N+L+       + DFG+A+ L+ D   +    G
Sbjct: 161 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 23/157 (14%)
Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET--RHRNIVKF 107
           IG G    V+R +    EV AVK F S        +++ +  E +       RH NI+ F
Sbjct: 11  IGKGRFGEVWRGKWRGEEV-AVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 62
Query: 108 YGFCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
               +    ++    L+ ++ E GSL   LN      E      + +    A  L++LH 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 118
Query: 164 DCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           +       P I HRD+ SKN+L+       +AD G+A
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 58/128 (45%), Gaps = 11/128 (8%)
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E+  L + +H NIV          H +L+ + +  G L   +       E   S    VI
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VI 112
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADFGIAKFLKSDASNWTEF 208
           + V  A+ YLH +    IVHRD+  +NLL    +   +  + DFG++K  ++   +    
Sbjct: 113 QQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-- 167
Query: 209 AGTYGYVA 216
            GT GYVA
Sbjct: 168 CGTPGYVA 175

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 20/176 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 107
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 162
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVA 216
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A
Sbjct: 163 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 85
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 140
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 85
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 140
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 46/196 (23%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 82
Query: 102 RNIV-------------------KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL 142
           R+++                   K Y   S+A++  LL    + GS          A+  
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE-- 140
Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KS 200
                      +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S
Sbjct: 141 -----------IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186
Query: 201 DASNWTEFAGTYGYVA 216
             +    F GT  YV+
Sbjct: 187 KQARANSFVGTAQYVS 202

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 92
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 147
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 93
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 148
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 149 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 84
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 139
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 140 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 91
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGG----HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G     H  +Y +       VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 73
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 74  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESK 130
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 131 RF---VHRDIAARNVLVSATDCVKLGDFGLSRYME 162

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 9/181 (4%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           VKA +D +    +G G +  V +   +PS +++AVK+  + + S +   QK  L ++   
Sbjct: 4   VKA-DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDIS 59
Query: 97  TETRHRNI-VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
             T      V FYG        ++  E ++              Q +       +   + 
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
            AL +LH      ++HRDV   N+L++   +  + DFGI+ +L  D +   + AG   Y+
Sbjct: 120 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYM 176
Query: 216 A 216
           A
Sbjct: 177 A 177

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/151 (20%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 37  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 91
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 92  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 151
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHR+++++N ++  ++   + DFG+ +
Sbjct: 152 F---VHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQK---EFLTEVKALTETRHRNIV 105
           +G+G   +VY+   +P  E V +      L  ++T   K   EF+ E   +    H ++V
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G C       L+ + +  G L   ++       +G    ++    +A  + YL    
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR 137
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
              +VHRD++++N+L+       + DFG+A+ L+ D   +    G
Sbjct: 138 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
           A+    H +IV+  G C  +    L+ ++L  GSL   +     A  LG    ++    +
Sbjct: 86  AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQI 142
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           A  + YL       +VHR+++++N+LL    +  VADFG+A  L  D
Sbjct: 143 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 186

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 33  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 83
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 84  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 141
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 142 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 198 TAQYVS 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/151 (20%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 53  GGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS 112
           G    + + E  +R  VAVK  +    S    ++ EFL E   +      ++V+  G  S
Sbjct: 36  GNARDIIKGEAETR--VAVKTVNE---SASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 90
Query: 113 HARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSYLHHDC 165
             + + ++ E +  G L + L +       +         + + +   +AD ++YL+   
Sbjct: 91  KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK 150
Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           F   VHR+++++N ++  ++   + DFG+ +
Sbjct: 151 F---VHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGG----HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G     H  +Y +       VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 73
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 74  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESK 130
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 131 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G    V++    S E     VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 101
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 102 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 158
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 159 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 190

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 13/194 (6%)
Query: 24  SIPPEVGKILYDEIVKATND-FDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ 82
           S+PP     ++DE      D F+    IG G    V   +    + +   K+ +     +
Sbjct: 1   SMPP-----VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE 55
Query: 83  TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL 142
             + +    E++ +    H  +V  +         F++ + L  G L   L  +   +E 
Sbjct: 56  RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE 115
Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
             + ++ + + V  AL YL +     I+HRD+   N+LLD     H+ DF IA  L  + 
Sbjct: 116 --TVKLFICELVM-ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168
Query: 203 SNWTEFAGTYGYVA 216
           +  T  AGT  Y+A
Sbjct: 169 TQITTMAGTKPYMA 182

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 82
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 140
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 197 TAQYVS 202

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G    V++    S E     VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 73
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 74  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 130
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 131 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 33  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 83
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 84  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 141
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 142 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 198 TAQYVS 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G    V++    S E     VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 78
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 135
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 136 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 167

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 82
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 140
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 197 TAQYVS 202

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G    V++    S E     VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 70
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 71  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 127
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 128 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 159

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 6/107 (5%)
Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
           A+    H +IV+  G C  +    L+ ++L  GSL   +     A  LG    ++    +
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQI 124
Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           A  + YL       +VHR+++++N+LL    +  VADFG+A  L  D
Sbjct: 125 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  S E VA+KK   P  S+  +  K    E+  L   +H N++   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLL 107
Query: 109 GFCSHAR-----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
              + A      + F L     +  L  I+  + + +++ +     ++  +   L Y+H 
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHS 162
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
                +VHRD+   NL ++ + E  + DFG+A+
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G    V++    S E     VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 75
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 76  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 132
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 133 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 164

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G    V++    S E     VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 76
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 77  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 133
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 134 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 165

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLAFRHENIIGIN 89
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 144
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 145 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 82
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 140
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 197 TAQYVS 202

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 35  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 85
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 86  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 143
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 144 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 200 TAQYVS 205

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 82
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 140
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 197 TAQYVS 202

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLAFRHENIIGIN 89
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 144
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 145 AN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 82
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 140
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 141 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 197 TAQYVS 202

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 60/138 (43%), Gaps = 14/138 (10%)
Query: 80  SDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA 139
           S + V ++E   EV  L E RH NI+  +    +     L+ E +  G L   L   A  
Sbjct: 67  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEK 123
Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN-LLLDLEY---EAHVADFGIA 195
           + L   +    +K + D + YLH      I H D+  +N +LLD         + DFGIA
Sbjct: 124 ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180
Query: 196 KFLKSDASNWTEFAGTYG 213
              K +A N  EF   +G
Sbjct: 181 H--KIEAGN--EFKNIFG 194

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGG----HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G     H  +Y +       VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 453
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESK 510
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 511 RF---VHRDIAARNVLVSATDCVKLGDFGLSRYME 542

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 30  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 80
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 138
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 139 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 195 TAQYVS 200

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 30  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 80
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 138
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 139 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 195 TAQYVS 200

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 60/138 (43%), Gaps = 14/138 (10%)
Query: 80  SDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA 139
           S + V ++E   EV  L E RH NI+  +    +     L+ E +  G L   L   A  
Sbjct: 53  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEK 109
Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN-LLLDLEY---EAHVADFGIA 195
           + L   +    +K + D + YLH      I H D+  +N +LLD         + DFGIA
Sbjct: 110 ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 166
Query: 196 KFLKSDASNWTEFAGTYG 213
              K +A N  EF   +G
Sbjct: 167 H--KIEAGN--EFKNIFG 180

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 49  CIGNGG----HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           CIG G     H  +Y +       VA+K   +   SD    +++FL E   + +  H +I
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSV--REKFLQEALTMRQFDHPHI 453
Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK  G  +     +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESK 510
Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
            F   VHRD++++N+L+       + DFG++++++
Sbjct: 511 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 542

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           F      +++  H+++V  YG C     + L+ EF++ GSL   L  +     + W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL 181
            V K +A A+ +L  +    ++H +V +KN+LL
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILL 146

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 30  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 80
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 138
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 139 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 195 TAQYVS 200

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 60/138 (43%), Gaps = 14/138 (10%)
Query: 80  SDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAA 139
           S + V ++E   EV  L E RH NI+  +    +     L+ E +  G L   L   A  
Sbjct: 46  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEK 102
Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN-LLLDLEY---EAHVADFGIA 195
           + L   +    +K + D + YLH      I H D+  +N +LLD         + DFGIA
Sbjct: 103 ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
Query: 196 KFLKSDASNWTEFAGTYG 213
              K +A N  EF   +G
Sbjct: 160 H--KIEAGN--EFKNIFG 173

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 71/174 (40%), Gaps = 10/174 (5%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 91
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                     +   ++ +  +   L      Q L        +  +   L Y+H      
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
           ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 26/186 (13%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR 
Sbjct: 14  EDFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRE 64
Query: 102 RNI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           R++         VK Y         +    + + G L   +    +  E     R    +
Sbjct: 65  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE 122
Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAG 210
            +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F G
Sbjct: 123 -IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 211 TYGYVA 216
           T  YV+
Sbjct: 179 TAQYVS 184

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAGT 211
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 212 YGYVA 216
             YV+
Sbjct: 196 AQYVS 200

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 26/185 (14%)
Query: 43  DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR 102
           DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR R
Sbjct: 30  DFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRER 80
Query: 103 NI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
           ++         VK Y         +    + + G L   +    +  E     R    + 
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE- 137
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAGT 211
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 212 YGYVA 216
             YV+
Sbjct: 195 AQYVS 199

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 75/170 (44%), Gaps = 15/170 (8%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           VK  ++++ K+ IG G +  VY A +  + + VA+KK +     +  +D K  L E+  L
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMF--EDLIDCKRILREITIL 81
Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTD-----AAAQELGWSQRMSVI 151
              +   I++ +           L +F E   +  I ++D          L      +++
Sbjct: 82  NRLKSDYIIRLHDLIIPED----LLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTIL 137
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             +     ++H      I+HRD+   N LL+ +    + DFG+A+ + SD
Sbjct: 138 YNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSD 184

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 14/180 (7%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
           + F+    +G G    V+  +  S    R++ A+K       + +  D+     E   L 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA--TLKVRDRVRTKMERDILV 81
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
           E  H  IVK  Y F +  +  +L+ +FL  G L   L+ +    E         +  +A 
Sbjct: 82  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELAL 137
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL +LH      I++RD+  +N+LLD E    + DFG++K           F GT  Y+A
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA++K  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 91
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVALGI 219
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A  I
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 26/185 (14%)
Query: 43  DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR 102
           DF     +G G  ++V  A    RE+   +++     + + ++++  + E K    TR R
Sbjct: 30  DFKFGKILGEGSFSTVVLA----RELATSREY-----AIKILEKRHIIKENKVPYVTRER 80
Query: 103 NI---------VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
           ++         VK Y         +    + + G L   +    +  E     R    + 
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYTAE- 137
Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL--KSDASNWTEFAGT 211
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L  +S  +    F GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 212 YGYVA 216
             YV+
Sbjct: 195 AQYVS 199

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 14/180 (7%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
           + F+    +G G    V+  +  S    R++ A+K       + +  D+     E   L 
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA--TLKVRDRVRTKMERDILV 82
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
           E  H  IVK  Y F +  +  +L+ +FL  G L   L+ +    E         +  +A 
Sbjct: 83  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELAL 138
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL +LH      I++RD+  +N+LLD E    + DFG++K           F GT  Y+A
Sbjct: 139 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 146 LVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 205 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 14/180 (7%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
           + F+    +G G    V+  +  S    R++ A+K       + +  D+     E   L 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA--TLKVRDRVRTKMERDILV 81
Query: 98  ETRHRNIVKF-YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
           E  H  IVK  Y F +  +  +L+ +FL  G L   L+ +    E         +  +A 
Sbjct: 82  EVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELAL 137
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL +LH      I++RD+  +N+LLD E    + DFG++K           F GT  Y+A
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 24/153 (15%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCE---- 122
            VAVK      PS    +++  ++E+K L+    H NIV   G C+    + ++ E    
Sbjct: 78  TVAVKMLK---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 134
Query: 123 -----FLERGSLAAILNTDAAA------QELGWSQRMSVIKGVADALSYL-HHDCFPPIV 170
                FL R   + I +  + A        L     +S    VA  +++L   +C    +
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----I 190
Query: 171 HRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           HRD++++N+LL       + DFG+A+ +K+D++
Sbjct: 191 HRDLAARNILLTHGRITKICDFGLARHIKNDSN 223

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/193 (21%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 43  DFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           DF     IG+GG   V++A+  +  +  V  +  ++   +++         EVKAL +  
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---------EVKALAKLD 62
Query: 101 HRNIVKFYGFC-----------------SHARHSFLLCEFLERGSLAAILNTDAAAQELG 143
           H NIV + G C                 S  +  F+  EF ++G+L   +      ++L 
Sbjct: 63  HVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLD 120
Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
               + + + +   + Y+H      +++RD+   N+ L    +  + DFG+   LK+D  
Sbjct: 121 KVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 204 NWTEFAGTYGYVA 216
                 GT  Y++
Sbjct: 178 R-XRSKGTLRYMS 189

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           F      +++  H+++V  YG C     + L+ EF++ GSL   L  +     + W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL 181
            V K +A A+ +L  +    ++H +V +KN+LL
Sbjct: 117 EVAKQLAWAMHFLEENT---LIHGNVCAKNILL 146

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 151 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 148 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 8   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 63
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 64  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 120
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A+ ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 121 VQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 171

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  S E VA+KK   P  S+  +  K    E+  L   +H N++   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLL 89
Query: 109 GFCSHAR-----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
              + A      + F L     +  L  I+    + +++ +     ++  +   L Y+H 
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHS 144
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
                +VHRD+   NL ++ + E  + DFG+A+
Sbjct: 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++A    + + VA+KK    + +++       L E+K L   +H N+V   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 109 GFCSHARHSFLLC--------EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
             C      +  C        +F E   LA +L+       L   +R  V++ + + L Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 8/125 (6%)
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E+  L   RH +I+K Y   +      ++ E+        I+      ++ G        
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEG----RRFF 114
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++  + +D +      G+
Sbjct: 115 QQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGS 170
Query: 212 YGYVA 216
             Y A
Sbjct: 171 PNYAA 175

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++A    + + VA+KK    + +++       L E+K L   +H N+V   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 109 GFCSHARHSFLLC--------EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
             C      +  C        +F E   LA +L+       L   +R  V++ + + L Y
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 24/153 (15%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCE---- 122
            VAVK      PS    +++  ++E+K L+    H NIV   G C+    + ++ E    
Sbjct: 78  TVAVKMLK---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 134
Query: 123 -----FLERGSLAAILNTDAAA------QELGWSQRMSVIKGVADALSYL-HHDCFPPIV 170
                FL R   + I +  + A        L     +S    VA  +++L   +C    +
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----I 190
Query: 171 HRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           HRD++++N+LL       + DFG+A+ +K+D++
Sbjct: 191 HRDLAARNILLTHGRITKICDFGLARDIKNDSN 223

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 8   LSHLEVLHIQLNRLDGSIPPEVGKIL-YDEIVKATNDFDAKYC--IGNGGHASVYRAELP 64
           +S+  +  ++LN LD   P +V K+L  D       +     C  IGNG    V++A+L 
Sbjct: 5   MSNAPLNGVKLNPLDD--PNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 65  SREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVK----FYGFCSHARHSF- 118
             + VA+KK          +  K F   E++ +   +H N+V     FY         F 
Sbjct: 63  ESDEVAIKK---------VLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 119 -LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK----GVADALSYLHHDCFPPIVHRD 173
            L+ E++       +        +L  +  M +IK     +  +L+Y+H      I HRD
Sbjct: 114 NLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRD 166
Query: 174 VSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           +  +NLLLD       + DFG AK L +   N +     Y
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY 206

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 47/206 (22%)
Query: 43  DFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           DF     IG+GG   V++A+  +  +  V  +  ++   +++         EVKAL +  
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER---------EVKALAKLD 63
Query: 101 HRNIVKFYGFC------------------------------SHARHSFLLCEFLERGSLA 130
           H NIV + G C                              S  +  F+  EF ++G+L 
Sbjct: 64  HVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 131 AILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA 190
             +      ++L     + + + +   + Y+H      ++HRD+   N+ L    +  + 
Sbjct: 123 QWIEK-RRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 191 DFGIAKFLKSDASNWTEFAGTYGYVA 216
           DFG+   LK+D    T   GT  Y++
Sbjct: 179 DFGLVTSLKNDGKR-TRSKGTLRYMS 203

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 24/153 (15%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCE---- 122
            VAVK      PS    +++  ++E+K L+    H NIV   G C+    + ++ E    
Sbjct: 55  TVAVKMLK---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 111
Query: 123 -----FLERGSLAAILNTDAAA------QELGWSQRMSVIKGVADALSYL-HHDCFPPIV 170
                FL R   + I +  + A        L     +S    VA  +++L   +C    +
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----I 167
Query: 171 HRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           HRD++++N+LL       + DFG+A+ +K+D++
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++A    + + VA+KK    + +++       L E+K L   +H N+V   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 109 GFCSHARHSFLLC--------EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
             C      +  C        +F E   LA +L+       L   +R  V++ + + L Y
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 139
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 24/153 (15%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCE---- 122
            VAVK      PS    +++  ++E+K L+    H NIV   G C+    + ++ E    
Sbjct: 71  TVAVKMLK---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 127
Query: 123 -----FLERGSLAAILNTDAAA------QELGWSQRMSVIKGVADALSYL-HHDCFPPIV 170
                FL R   + I +  + A        L     +S    VA  +++L   +C    +
Sbjct: 128 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----I 183
Query: 171 HRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           HRD++++N+LL       + DFG+A+ +K+D++
Sbjct: 184 HRDLAARNILLTHGRITKICDFGLARDIKNDSN 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 9/181 (4%)
Query: 38  VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
           VKA +D +    +G G +  V +   +PS +++AVK+  + + S +   QK  L ++   
Sbjct: 48  VKA-DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDIS 103
Query: 97  TETRHRNI-VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
             T      V FYG        ++  E ++              Q +       +   + 
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 163
Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
            AL +LH      ++HRDV   N+L++   +  + DFGI+ +L  D+   T  AG   Y+
Sbjct: 164 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDAGCKPYM 220
Query: 216 A 216
           A
Sbjct: 221 A 221

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 25/158 (15%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G +  VY+A +  + E VA+K+    L  ++       + EV  L E +HRNI++  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG----VADALSYLH-H 163
               H     L+ E+ E   L   ++ +           M VIK     + + +++ H  
Sbjct: 100 SVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVS-------MRVIKSFLYQLINGVNFCHSR 151
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAH-----VADFGIAK 196
            C    +HRD+  +NLLL +   +      + DFG+A+
Sbjct: 152 RC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN-------------TDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L   L                   +++ +  
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 147 RMSVIKGVADALSYL-HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            +S    +A  + YL    C    +HRD++++N+L+       +ADFG+A+
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 4/175 (2%)
Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F  +  IG G  + VYRA  L     VA+KK       D    + + + E+  L +  H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA-RADCIKEIDLLKQLNH 91
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            N++K+Y          ++ E  + G L+ ++      + L   +  +V K      S L
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER--TVWKYFVQLCSAL 149
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            H     ++HRD+   N+ +       + D G+ +F  S  +      GT  Y++
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 69
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 126
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 24/153 (15%)
Query: 68  VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLCE---- 122
            VAVK      PS    +++  ++E+K L+    H NIV   G C+    + ++ E    
Sbjct: 73  TVAVKMLK---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 129
Query: 123 -----FLERGSLAAILNTDAAA------QELGWSQRMSVIKGVADALSYL-HHDCFPPIV 170
                FL R   + I +  + A        L     +S    VA  +++L   +C    +
Sbjct: 130 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----I 185
Query: 171 HRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS 203
           HRD++++N+LL       + DFG+A+ +K+D++
Sbjct: 186 HRDLAARNILLTHGRITKICDFGLARDIKNDSN 218

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 36  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 91
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 92  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 148
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 149 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 199

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 69
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    ++ + +  G L   +        +G    ++  
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWC 126
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/117 (21%), Positives = 59/117 (50%), Gaps = 9/117 (7%)
Query: 88  EFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAA------ILNTDAAAQE 141
           +F  E++ +T+ ++   +   G  ++    +++ E++E  S+        +L+ +     
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF- 147
Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
           +       +IK V ++ SY+H++    I HRDV   N+L+D      ++DFG ++++
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 18  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 73
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 130
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 69
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 126
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V++A    + + VA+KK    + +++       L E+K L   +H N+V   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 109 GFCSHARHSFLLC--------EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
             C      +  C        +F E   LA +L+       L   +R  V++ + + L Y
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           +H +    I+HRD+ + N+L+  +    +ADFG+A+
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 69
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 126
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 15  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 70
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    ++ + +  G L   +        +G    ++  
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWC 127
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 178

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 68
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 125
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 66
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 123
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 68
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    ++ + +  G L   +        +G    ++  
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWC 125
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 66
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 123
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 66
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    ++ + +  G L   +        +G    ++  
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWC 123
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 12  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 67
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    ++ + +  G L   +        +G    ++  
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWC 124
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 5   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 60
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 117
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 17  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 72
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 73  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 129
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 130 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 180

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 66
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHK--DNIGSQYLLNWC 123
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 72/180 (40%), Gaps = 15/180 (8%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSRE-VVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-T 99
            DFD    IG G +A V    L   + + A+K     L +D   D     TE     + +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWVQTEKHVFEQAS 67
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE---LGWSQRMSVIKGVAD 156
            H  +V  +         F + E++  G L   +       E     +S  +S+      
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ 121
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL+YLH      I++RD+   N+LLD E    + D+G+ K         + F GT  Y+A
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 178

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 79
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 140 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 188

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 21  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 76
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 77  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 133
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 134 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 184

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 82
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 143 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 191

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 91
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                ++HRD+   NLLL+   +  + DFG+A+    D
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 37  IVKATNDFDAKYCIGNGGHASVYRA-ELPSRE----VVAVKKFHSPLPSDQTVDQKEFLT 91
           I+K T +F     +G+G   +VY+   +P  E     VA+K+      +      KE L 
Sbjct: 12  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 67
Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVI 151
           E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++  
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHK--DNIGSQYLLNWC 124
Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
             +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +
Sbjct: 125 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 175

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A     +V VA+KK  SP    QT  Q+  L E+K L   RH NI+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYCQRT-LREIKILLRFRHENIIGIN 92
Query: 109 GFC-----SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                      +  +++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 147
Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                ++HRD+   NLLL+   +  + DFG+A+    D
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 44  FDAKYCIGNGGHAS-VYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RH 101
           F  K  +G+G   + VYR    +R+V AVK+    LP   +   +E    V+ L E+  H
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDV-AVKRI---LPECFSFADRE----VQLLRESDEH 77
Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELG--WSQRMSVIKGVADALS 159
            N++++  FC+     F   +++     AA L      ++      + +++++     L+
Sbjct: 78  PNVIRY--FCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 160 YLHHDCFPPIVHRDVSSKNLLLDL-----EYEAHVADFGIAKFL---KSDASNWTEFAGT 211
           +LH      IVHRD+   N+L+ +     + +A ++DFG+ K L   +   S  +   GT
Sbjct: 133 HLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 212 YGYVA 216
            G++A
Sbjct: 190 EGWIA 194

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 72/180 (40%), Gaps = 15/180 (8%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSRE-VVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-T 99
            DFD    IG G +A V    L   + + A+K     L +D   D     TE     + +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWVQTEKHVFEQAS 63
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE---LGWSQRMSVIKGVAD 156
            H  +V  +         F + E++  G L   +       E     +S  +S+      
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ 117
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL+YLH      I++RD+   N+LLD E    + D+G+ K         + F GT  Y+A
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 174

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 51/119 (42%), Gaps = 9/119 (7%)
Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H NIVK +       H+FL+ E L  G L   +       E   ++   +++ +  A+S+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSH 121
Query: 161 LHHDCFPPIVHRDVSSKNLLLDLE---YEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +H      +VHRD+  +NLL   E    E  + DFG A+    D         T  Y A
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 97
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 158 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 206

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 90
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 86
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 147 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 195

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G    V +  +  +++  AVK  +    S +  D    L EV+ L +  H NI+K +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKA--SAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                +   +++ E    G L    +     +         +IK V   ++Y+H      
Sbjct: 88  EILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 169 IVHRDVSSKNLLL---DLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           IVHRD+  +N+LL   + + +  + DFG++   + + +   +  GT  Y+A
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIA 191

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G    V +  +  +++  AVK  +    S +  D    L EV+ L +  H NI+K +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKA--SAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                +   +++ E    G L    +     +         +IK V   ++Y+H      
Sbjct: 88  EILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 169 IVHRDVSSKNLLL---DLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           IVHRD+  +N+LL   + + +  + DFG++   + + +   +  GT  Y+A
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIA 191

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 72/180 (40%), Gaps = 15/180 (8%)
Query: 42  NDFDAKYCIGNGGHASVYRAELPSRE-VVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-T 99
            DFD    IG G +A V    L   + + A+K     L +D   D     TE     + +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWVQTEKHVFEQAS 78
Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE---LGWSQRMSVIKGVAD 156
            H  +V  +         F + E++  G L   +       E     +S  +S+      
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ 132
Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL+YLH      I++RD+   N+LLD E    + D+G+ K         + F GT  Y+A
Sbjct: 133 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 54/128 (42%), Gaps = 8/128 (6%)
Query: 90  LTEVKALTETR-HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           L EV  L +   H NI++           FL+ + +++G L   L       E    + M
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 117
Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
             +  V  AL  L+      IVHRD+  +N+LLD +    + DFG +  L        E 
Sbjct: 118 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 170
Query: 209 AGTYGYVA 216
            GT  Y+A
Sbjct: 171 CGTPSYLA 178

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 21/172 (12%)
Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           IGNG    VY+A+L  S E+VA+KK          +  K F   E++ + +  H NIV+ 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 90
Query: 108 -YGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            Y F S           L+ +++         +   A Q L        +  +  +L+Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-HVADFGIAKFLKSDASNWTEFAGTY 212
           H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	219
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-60
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-51
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-48
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-48
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-44
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-40
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-36
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-36
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-24
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-22
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-22
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-22
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-21
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-20
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-19
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-19
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-18
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-18
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-18
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-16
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-16
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-13
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-06
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-10
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-09
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-09
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-09
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-09
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-09
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-08
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-08
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-04
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-04
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  189 bits (483), Expect = 9e-60
 Identities = 63/185 (34%), Positives = 98/185 (52%), Gaps = 5/185 (2%)

Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
             E+  A+++F  K  +G GG   VY+  L    +VAVK+        Q  +  +F TEV
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGE-LQFQTEV 78

Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLA-AILNTDAAAQELGWSQRMSVIK 152
           + ++   HRN+++  GFC       L+  ++  GS+A  +     +   L W +R  +  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN-WTEFAGT 211
           G A  L+YLH  C P I+HRDV + N+LLD E+EA V DFG+AK +    ++  T   GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 212 YGYVA 216
            G++A
Sbjct: 199 IGHIA 203

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  168 bits (427), Expect = 2e-51
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 10/198 (5%)

Query: 22  DGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSD 81
              +P E  ++   ++ +ATN+FD K+ IG+G    VY+  L     VA+K+      S 
Sbjct: 19  SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SS 76

Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLA-AILNTDAAAQ 140
           Q +  +EF TE++ L+  RH ++V   GFC       L+ +++E G+L   +  +D    
Sbjct: 77  QGI--EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134

Query: 141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK-FLK 199
            + W QR+ +  G A  L YLH      I+HRDV S N+LLD  +   + DFGI+K   +
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191

Query: 200 SDASNW-TEFAGTYGYVA 216
            D ++  T   GT GY+ 
Sbjct: 192 LDQTHLSTVVKGTLGYID 209

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  160 bits (407), Expect = 2e-48
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 23/196 (11%)

Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
            + +   +           G    V++A+L +  V AVK F       Q     +   EV
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIF-----PIQDKQSWQNEYEV 69

Query: 94  KALTETRHRNIVKFYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
            +L   +H NI++F G            +L+  F E+GSL+  L        + W++   
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCH 125

Query: 150 VIKGVADALSYLHHDCF-------PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           + + +A  L+YLH D         P I HRD+ SKN+LL     A +ADFG+A   ++  
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 203 SNW--TEFAGTYGYVA 216
           S        GT  Y+A
Sbjct: 186 SAGDTHGQVGTRRYMA 201

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  160 bits (406), Expect = 2e-48
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 16/193 (8%)

Query: 34  YDEIVKATNDFDAKYC------IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQ- 86
           + E+   TN+FD +        +G GG   VY+  + +  V AVKK  + +  D T ++ 
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMV--DITTEEL 73

Query: 87  -KEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
            ++F  E+K + + +H N+V+  GF S      L+  ++  GSL   L+       L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS-- 203
            R  + +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  A   
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190

Query: 204 NWTEFAGTYGYVA 216
             +   GT  Y+A
Sbjct: 191 MTSRIVGTTAYMA 203

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  159 bits (405), Expect = 3e-48
 Identities = 61/167 (36%), Positives = 91/167 (54%), Gaps = 4/167 (2%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G   +V+RAE    +V AVK         + V   EFL EV  +   RH NIV F G
Sbjct: 45  IGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERV--NEFLREVAIMKRLRHPNIVLFMG 101

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
             +   +  ++ E+L RGSL  +L+   A ++L   +R+S+   VA  ++YLH+   PPI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           VHR++ S NLL+D +Y   V DFG+++   S   +    AGT  ++A
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  149 bits (378), Expect = 9e-45
 Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 15/175 (8%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG GG   VYRA     EV AVK        D +   +    E K     +H NI+   G
Sbjct: 15  IGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C    +  L+ EF   G L  +L+     + +     ++    +A  ++YLH +   PI
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 170 VHRDVSSKNLLLDLEYEAH--------VADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+ S N+L+  + E          + DFG+A+            AG Y ++A
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMA 182

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  148 bits (376), Expect = 5e-44
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 13/176 (7%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            + + +  +G G    V +A+  +++V A+K+  S        ++K F+ E++ L+   H
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIESES------ERKAFIVELRQLSRVNH 60

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NIVK YG C +     L+ E+ E GSL  +L+          +  MS     +  ++YL
Sbjct: 61  PNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYE-AHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H      ++HRD+   NLLL        + DFG A  +++     T   G+  ++A
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMA 171

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  144 bits (366), Expect = 9e-43
 Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 17/176 (9%)

Query: 50  IGNGGHASVYRAELPSR-EVVAVKKFHSPLPSDQTVDQ---KEFLTEVKALTETRHRNIV 105
           IG GG   V++  L     VVA+K         +T      +EF  EV  ++   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           K YG   +     ++ EF+  G L   L     A  + WS ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN-Q 141

Query: 166 FPPIVHRDVSSKNLLLDLEYE-----AHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            PPIVHRD+ S N+ L    E     A VADFG+++         +   G + ++A
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNFQWMA 194

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  138 bits (351), Expect = 1e-40
 Identities = 30/169 (17%), Positives = 66/169 (39%), Gaps = 12/169 (7%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +       +++      ++  VK       S +    ++F  E   L    H N++   G
Sbjct: 18  LNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKS--RDFNEECPRLRIFSHPNVLPVLG 74

Query: 110 FCSH--ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
            C    A H  L+  ++  GSL  +L+ +     +  SQ +     +A  +++LH    P
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            I    ++S+++++D +  A ++   +    +S             +VA
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVA 176

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  138 bits (349), Expect = 8e-40
 Identities = 47/204 (23%), Positives = 76/204 (37%), Gaps = 33/204 (16%)

Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
             E     ++      IG G + +VY+  L  R V AVK F          +++ F+ E 
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFA-------NRQNFINEK 56

Query: 94  K--ALTETRHRNIVKFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQ 146
               +    H NI +F                L+ E+   GSL   L+         W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVS 112

Query: 147 RMSVIKGVADALSYLHHD------CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
              +   V   L+YLH +        P I HRD++S+N+L+  +    ++DFG++  L  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 201 DASNWTEF--------AGTYGYVA 216
           +                GT  Y+A
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMA 196

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  135 bits (341), Expect = 1e-38
 Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 15/172 (8%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G    VY         VA++       ++  +  K F  EV A  +TRH N+V F G
Sbjct: 41  IGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQL--KAFKREVMAYRQTRHENVVLFMG 96

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C    H  ++    +  +L +++    A   L  ++   + + +   + YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAK-----FLKSDASNWTEFAGTYGYVA 216
           +H+D+ SKN+  D   +  + DFG+                    G   ++A
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  132 bits (334), Expect = 7e-38
 Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 27/183 (14%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK--ALTETRHRNIVK 106
           C+G G +  V+R       V AVK F S        D+K +  E +       RH NI+ 
Sbjct: 15  CVGKGRYGEVWRGSWQGENV-AVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66

Query: 107 FYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           F      +RHS    +L+  + E GSL   L        L     + ++  +A  L++LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLH 122

Query: 163 HDCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS----NWTEFAGTYG 213
            + F     P I HRD+ SKN+L+    +  +AD G+A       +          GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 214 YVA 216
           Y+A
Sbjct: 183 YMA 185

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  129 bits (327), Expect = 9e-37
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 10/163 (6%)

Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G      +     + EV+ +K+        Q    + FL EVK +    H N++KF 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ----RTFLKEVKVMRCLEHPNVLKFI 73

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G     +    + E+++ G+L  I+ +     +  WSQR+S  K +A  ++YLH      
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           I+HRD++S N L+       VADFG+A+ +  + +        
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (326), Expect = 2e-36
 Identities = 50/204 (24%), Positives = 79/204 (38%), Gaps = 30/204 (14%)

Query: 26  PPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVD 85
           P  V + +  +I            IG G +  V+  +    +V AVK F +    ++   
Sbjct: 28  PLLVQRTIAKQIQMVK-------QIGKGRYGEVWMGKWRGEKV-AVKVFFTT---EEASW 76

Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQE 141
            +E  TE+      RH NI+ F         S    +L+ ++ E GSL   L +      
Sbjct: 77  FRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TT 130

Query: 142 LGWSQRMSVIKGVADALSYLHHDCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           L     + +       L +LH + F     P I HRD+ SKN+L+       +AD G+A 
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190

Query: 197 FLKSDASNW----TEFAGTYGYVA 216
              SD +          GT  Y+ 
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMP 214

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  127 bits (322), Expect = 3e-36
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 12/169 (7%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G   +VY+ +      VAVK  +   P+ Q +  + F  EV  L +TRH NI+ F G
Sbjct: 32  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
           + +  + + ++ ++ E  SL   L+      +    + + + +  A  + YLH      I
Sbjct: 88  YSTAPQLA-IVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLK--SDASNWTEFAGTYGYVA 216
           +HRD+ S N+ L  +    + DFG+A      S +  + + +G+  ++A
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (320), Expect = 2e-35
 Identities = 47/183 (25%), Positives = 73/183 (39%), Gaps = 27/183 (14%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTE--VKALTETRHRNIVK 106
            IG G    V+R +    EV AVK F S        +++ +  E  +      RH NI+ 
Sbjct: 49  SIGKGRFGEVWRGKWRGEEV-AVKIFSSR-------EERSWFREAEIYQTVMLRHENILG 100

Query: 107 FYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           F    +    +    +L+ ++ E GSL   LN       +     + +    A  L++LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLH 156

Query: 163 HDCF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS----NWTEFAGTYG 213
            +       P I HRD+ SKN+L+       +AD G+A    S             GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 214 YVA 216
           Y+A
Sbjct: 217 YMA 219

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 98.9 bits (247), Expect = 3e-25
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 11/166 (6%)

Query: 49  CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
            +G G +  VY   +L ++  +A+K+   P    +         E+      +H+NIV++
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLH--EEIALHKHLKHKNIVQY 84

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
            G  S      +  E +  GSL+A+L +     +          K + + L YLH +   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142

Query: 168 PIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGT 211
            IVHRD+   N+L++  Y   +  +DFG +K L         F GT
Sbjct: 143 -IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGT 186

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 98.1 bits (245), Expect = 2e-24
 Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 9/153 (5%)

Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    V+   L +    VAVK     LP D    + +FL E + L +  H NIV+  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G C+  +  +++ E ++ G     L T+     L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKCC-- 234

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +HRD++++N L+  +    ++DFG+++     
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEADG 266

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 95.9 bits (239), Expect = 4e-24
 Identities = 41/200 (20%), Positives = 81/200 (40%), Gaps = 31/200 (15%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            DF+   C+G GG   V+ A+        A+K+   P   ++ + +++ + EVKAL +  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLE 61

Query: 101 HRNIVKFYGF---------CSHARHSFLLC---EFLERGSLAAILNTDAAAQELGWSQRM 148
           H  IV+++              +     L    +   + +L   +N     +E   S  +
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD------- 201
            +   +A+A+ +LH      ++HRD+   N+   ++    V DFG+   +  D       
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 202 -----ASNWTEFAGTYGYVA 216
                 +  T   GT  Y++
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.4 bits (235), Expect = 2e-23
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 15/198 (7%)

Query: 18  LNRLDGSIPPEVGKILYDEIVKATN---DFDAKYCIGNGGHASVYRA-ELPSREVVAVKK 73
           L  +    PP       DE          FD    +G G + SVY+A    + ++VA+K+
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61

Query: 74  FHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL 133
                      D +E + E+  + +    ++VK+YG        +++ E+   GS++ I+
Sbjct: 62  V------PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII 115

Query: 134 NTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG 193
                 + L   +  ++++     L YLH       +HRD+ + N+LL+ E  A +ADFG
Sbjct: 116 RL--RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG 170

Query: 194 IAKFLKSDASNWTEFAGT 211
           +A  L    +      GT
Sbjct: 171 VAGQLTDTMAKRNTVIGT 188

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 92.6 bits (231), Expect = 4e-23
 Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG+G    V+     +++ VA+K        +  + +++F+ E + + +  H  +V+ YG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C       L+ EF+E G L+  L T            + +   V + ++YL   C    
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV--- 125

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L+       V+DFG+ +F+  D
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 92.0 bits (229), Expect = 1e-22
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 13/171 (7%)

Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETR 100
            F     IG G    V++  +  +++VVA+K     +  ++  D+ E +  E+  L++  
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI----IDLEEAEDEIEDIQQEITVLSQCD 78

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
              + K+YG        +++ E+L  GS   +L        L  +Q  ++++ +   L Y
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDY 134

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           LH +     +HRD+ + N+LL    E  +ADFG+A  L         F GT
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 182

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 91.6 bits (228), Expect = 2e-22
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 17/181 (9%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +D++ +  IG+G  A V  A   P +E VA+K+    L   QT    E L E++A+++  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQT-SMDELLKEIQAMSQCH 71

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-----NTDAAAQELGWSQRMSVIKGVA 155
           H NIV +Y         +L+ + L  GS+  I+       +  +  L  S   ++++ V 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE-----FAG 210
           + L YLH +     +HRDV + N+LL  +    +ADFG++ FL +            F G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 211 T 211
           T
Sbjct: 189 T 189

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 90.7 bits (226), Expect = 2e-22
 Identities = 39/152 (25%), Positives = 76/152 (50%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G+G    V   +   +  VAVK        + ++ + EF  E + + +  H  +VKFYG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            CS     +++ E++  G L   L +    + L  SQ + +   V + +++L    F   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L+D +    V+DFG+ +++  D
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 90.7 bits (226), Expect = 3e-22
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 10/152 (6%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           +G G    V   +   +  VA+K        + ++ + EF+ E K +    H  +V+ YG
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
            C+  R  F++ E++  G L   L            Q + + K V +A+ YL    F   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +HRD++++N L++ +    V+DFG+++++  D
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.4 bits (225), Expect = 4e-22
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 10/153 (6%)

Query: 50  IGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G +  VY        + VAVK        + T++ +EFL E   + E +H N+V+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
           G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ YL    F  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +HRD++++N L+   +   VADFG+++ +  D
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 90.9 bits (226), Expect = 5e-22
 Identities = 34/174 (19%), Positives = 61/174 (35%), Gaps = 15/174 (8%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            +     +G GG + V   E L      A+K+       D+    +E   E        H
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR----EEAQREADMHRLFNH 85

Query: 102 RNIVKFYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQR--MSVIKGVA 155
            NI++   +C   R +    +LL  F +RG+L   +           ++   + ++ G+ 
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGIC 144

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
             L  +H        HRD+   N+LL  E +  + D G             +  
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 90.6 bits (225), Expect = 6e-22
 Identities = 45/197 (22%), Positives = 72/197 (36%), Gaps = 22/197 (11%)

Query: 22  DGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPS 80
           +G +  E  K +  E  +  +    +  +G G    V+R  +  +    AVKK    +  
Sbjct: 38  EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR 97

Query: 81  DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ 140
            +         E+ A        IV  YG         +  E LE GSL  ++       
Sbjct: 98  VE---------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP 148

Query: 141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLK 199
           E    + +  +    + L YLH      I+H DV + N+LL  +   A + DFG A  L+
Sbjct: 149 E---DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202

Query: 200 SDASNWTE-----FAGT 211
            D    +        GT
Sbjct: 203 PDGLGKSLLTGDYIPGT 219

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 92.1 bits (229), Expect = 6e-22
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 10/154 (6%)

Query: 49  CIGNGGHASVYRAELPSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
            +G G +  VY        + VAVK        + T++ +EFL E   + E +H N+V+ 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
            G C+     +++ EF+  G+L   L      QE+     + +   ++ A+ YL    F 
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF- 339

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             +HR+++++N L+   +   VADFG+++ +  D
Sbjct: 340 --IHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 89.7 bits (223), Expect = 7e-22
 Identities = 41/192 (21%), Positives = 77/192 (40%), Gaps = 30/192 (15%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            DF     IG+GG   V++A+     +   +K+           + ++   EVKAL +  
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAEREVKALAKLD 62

Query: 101 HRNIVKFYGF-------------CSHARHSFLLC---EFLERGSLAAILNTDAAAQELGW 144
           H NIV + G               S    +  L    EF ++G+L   +      ++L  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDK 121

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
              + + + +   + Y+H      +++RD+   N+ L    +  + DFG+   LK+D   
Sbjct: 122 VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 205 WTEFAGTYGYVA 216
                GT  Y++
Sbjct: 179 TR-SKGTLRYMS 189

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 89.7 bits (223), Expect = 8e-22
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 16/174 (9%)

Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
              +     IG G   +VY A ++ + + VA+++    L       ++  + E+  + E 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQP--KKELIINEILVMREN 74

Query: 100 RHRNIVKFYGFCSHARHSFL--LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
           ++ NIV +    S+     L  + E+L  GSL  ++        +   Q  +V +    A
Sbjct: 75  KNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQA 128

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           L +LH +    ++HRD+ S N+LL ++    + DFG    +  + S  +   GT
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 90.5 bits (225), Expect = 1e-21
 Identities = 38/176 (21%), Positives = 69/176 (39%), Gaps = 7/176 (3%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
             +     IG G        +         +K+ +    S +  +++E   EV  L   +
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK--EREESRREVAVLANMK 81

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H NIV++          +++ ++ E G L   +N           Q +     +  AL +
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKH 140

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +H      I+HRD+ S+N+ L  +    + DFGIA+ L S         GT  Y++
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 43/182 (23%), Positives = 84/182 (46%), Gaps = 13/182 (7%)

Query: 34  YDEIVKATN---DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEF 89
           Y+ + +  +    ++    +G+G    VY+A    +  + A K     + +    + +++
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV----IETKSEEELEDY 63

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           + E++ L    H  IVK  G   H    +++ EF   G++ AI+      + L   Q   
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQV 121

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           V + + +AL++LH      I+HRD+ + N+L+ LE +  +ADFG++            F 
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178

Query: 210 GT 211
           GT
Sbjct: 179 GT 180

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 88.9 bits (221), Expect = 1e-21
 Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 16/170 (9%)

Query: 49  CIGNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
            IG G   +VY+  +  +   VA  +     L      +++ F  E + L   +H NIV+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS---ERQRFKEEAEMLKGLQHPNIVR 89

Query: 107 FYG----FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           FY          +   L+ E +  G+L   L      + +      S  + +   L +LH
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 163 HDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKFLKSDASNWTEFAGT 211
               PPI+HRD+   N+ +        + D G+A   ++  +      GT
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGT 193

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 16/171 (9%)

Query: 44  FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR 102
            D+   IG G    V  A E  S   VAVK     L   Q   ++    EV  + + +H 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQ--RRELLFNEVVIMRDYQHF 102

Query: 103 NIVKFYGFCSHARHSFL--LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           N+V+ Y   S+     L  L EFL+ G+L  I++       L   Q  +V + V  AL+Y
Sbjct: 103 NVVEMYK--SYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAY 156

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           LH      ++HRD+ S ++LL L+    ++DFG    +  D        GT
Sbjct: 157 LHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 204

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 88.9 bits (221), Expect = 2e-21
 Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 10/182 (5%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            D++  Y IG G +    +       +++  K+      ++   +++  ++EV  L E +
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELK 63

Query: 101 HRNIVKFYGFCSHARHSFLLC---EFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGVAD 156
           H NIV++Y      R +  L    E+ E G LA+++      ++ L     + V+  +  
Sbjct: 64  HPNIVRYYD-RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 157 ALSYLH--HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
           AL   H   D    ++HRD+   N+ LD +    + DFG+A+ L  D S    F GT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 215 VA 216
           ++
Sbjct: 183 MS 184

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 89.6 bits (222), Expect = 3e-21
 Identities = 31/181 (17%), Positives = 63/181 (34%), Gaps = 16/181 (8%)

Query: 41  TNDFDAKYCIGNGGH--ASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
              ++    IG G     +V  A   P+ E V V++    L +           E+    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
              H NIV +          +++  F+  GS   ++ T      +       +++GV  A
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKA 140

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL-------KSDASNWTEFAG 210
           L Y+HH      VHR V + ++L+ ++ + +++       +       +           
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 211 T 211
            
Sbjct: 198 V 198

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 89.9 bits (223), Expect = 4e-21
 Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 25/176 (14%)

Query: 49  CIGNGGHASVYRAE---LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           CI +GG   +Y A    +  R V  +K       S     Q   + E + L E  H +IV
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPV-VLKGLV---HSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 106 KFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           + + F  H         +++ E++   SL          Q+L  ++ ++ +  +  ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           LH      +V+ D+  +N++L  E +  + D G    + S         GT G+ A
Sbjct: 198 LHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQA 245

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 87.7 bits (218), Expect = 5e-21
 Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 11/170 (6%)

Query: 50  IGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G GG ++VY AE  + + +V A+K    P    +   ++ F  EV   ++  H+NIV  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSM 76

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
                     +L+ E++E  +L+  + +      L     ++    + D + + H     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM--- 130

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA-GTYGYVA 216
            IVHRD+  +N+L+D      + DFGIAK L   +   T    GT  Y +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 88.4 bits (219), Expect = 7e-21
 Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +DF+    +G G    V++    PS  V+A K  H  +       + + + E++ L E  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECN 89

Query: 101 HRNIVKFYGFCSHARHSFL------LC-EFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
              IV FYG       +F       +C E ++ GSL  +L       E        V   
Sbjct: 90  SPYIVGFYG-------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIA 139

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           V   L+YL       I+HRDV   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 195

Query: 214 YVA 216
           Y++
Sbjct: 196 YMS 198

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 87.7 bits (218), Expect = 7e-21
 Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 22/175 (12%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G GG A  +   +  ++EV A K    S L      ++     E+       H+++V F
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 106

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS------VIKGVADALSYL 161
           +GF       F++ E   R SL  +             + ++       ++ +     YL
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYYLRQIVLGCQYL 157

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 158 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 87.5 bits (217), Expect = 8e-21
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 14/174 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G  A+V+R     + ++ A+K F++             + E + L +  H+NIVK +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLF 73

Query: 109 GF--CSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
                +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  +  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132

Query: 167 PPIVHRDVSSKNLLLDLEYEAH----VADFGIAKFLKSDASNWTEFAGTYGYVA 216
             IVHR++   N++  +  +      + DFG A+ L+ D   +    GT  Y+ 
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLH 183

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 87.3 bits (217), Expect = 8e-21
 Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 13/171 (7%)

Query: 50  IGNGGHASVYRAELPSRE-VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G GG   VY AE   RE +VA+K     L SD    +     E +     +  ++V  +
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF-RTRMQREARTAGRLQEPHVVPIH 100

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
            F       ++    +    LAA+L        L   + +++++ +  AL   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE---FAGTYGYVA 216
             HRDV  +N+L+  +  A++ DFGIA          T+     GT  Y+A
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMA 203

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 88.1 bits (218), Expect = 9e-21
 Identities = 34/202 (16%), Positives = 64/202 (31%), Gaps = 28/202 (13%)

Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAE------LPSREVVAVKKFHSPLPSDQTVDQKEF 89
           E    +      + +G G  A VY A         +++   +K      P +  +  +  
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL- 117

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQ--R 147
              ++ L  +     +KFY        S L+ E    G+L   +N      E    Q   
Sbjct: 118 ---MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH-----------VADFGIAK 196
           +S    +   +  +H      I+H D+   N +L   +              + D G + 
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 197 FLKSDASN--WTEFAGTYGYVA 216
            +K       +T    T G+  
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQC 253

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 88.2 bits (219), Expect = 1e-20
 Identities = 32/153 (20%), Positives = 69/153 (45%), Gaps = 10/153 (6%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
            +G G    V+ A       VAVK          ++  + FL E   +   +H  +VK +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
              +     +++ EF+ +GSL   L +D    +    + +     +A+ ++++    +  
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 36/172 (20%), Positives = 68/172 (39%), Gaps = 6/172 (3%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            +F  +  IG G  + VYRA  L     VA+KK       D    + + + E+  L +  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLN 90

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGVADALS 159
           H N++K+Y          ++ E  + G L+ ++      +  +           +  AL 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
           ++H      ++HRD+   N+ +       + D G+ +F  S  +      GT
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 199

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 12/156 (7%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG+G    V    L         VA+K   +     Q   +++FL+E   + +  H NI+
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ---RRDFLSEASIMGQFDHPNII 113

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G  +  R + ++ E++E GSL   L T     +    Q + +++GV   + YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +   VHRD++++N+L+D      V+DFG+++ L+ D
Sbjct: 172 Y---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 86.5 bits (215), Expect = 1e-20
 Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 22/175 (12%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVK-KFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G GG A  +   +  ++EV A K    S L      ++     E+       H+++V F
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 80

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS------VIKGVADALSYL 161
           +GF       F++ E   R SL  +             + ++       ++ +     YL
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYYLRQIVLGCQYL 131

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  Y+A
Sbjct: 132 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 88.4 bits (219), Expect = 1e-20
 Identities = 36/153 (23%), Positives = 70/153 (45%), Gaps = 10/153 (6%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
            +G G    V+         VA+K          T+  + FL E + + + RH  +V+ Y
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
              S     +++ E++ +GSL   L  +   + L   Q + +   +A  ++Y+    +  
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY-- 384

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDN 416

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 87.9 bits (218), Expect = 2e-20
 Identities = 36/153 (23%), Positives = 70/153 (45%), Gaps = 10/153 (6%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
            +G G    V+         VA+K          T+  + FL E + + + RH  +V+ Y
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
              S     +++ E++ +GSL   L  +   + L   Q + +   +A  ++Y+    +  
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY-- 301

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            VHRD+ + N+L+       VADFG+A+ ++ +
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.8 bits (213), Expect = 2e-20
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 15/159 (9%)

Query: 50  IGNGGHASVYRAELP-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G    V           + E VAVK      P        +   E++ L    H NI
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHENI 85

Query: 105 VKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           VK+ G C+    +   L+ EFL  GSL   L  +    ++   Q++     +   + YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG 143

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +   VHRD++++N+L++ E++  + DFG+ K +++D
Sbjct: 144 SRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 86.3 bits (214), Expect = 2e-20
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 17/179 (9%)

Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
              F+    +GNG +  VY+   + + ++ A+K     +  D   +++E   E+  L + 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGD---EEEEIKQEINMLKKY 77

Query: 100 -RHRNIVKFYG------FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
             HRNI  +YG              +L+ EF   GS+  ++        L       + +
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICR 136

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
            +   LS+LH      ++HRD+  +N+LL    E  + DFG++  L         F GT
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 85.3 bits (212), Expect = 2e-20
 Identities = 32/153 (20%), Positives = 72/153 (47%), Gaps = 10/153 (6%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
            +G G    V+         VAVK          ++    FL E   + + +H+ +V+ Y
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
              +     +++ E++E GSL   L T  +  +L  ++ + +   +A+ ++++    +  
Sbjct: 75  AVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +HRD+ + N+L+       +ADFG+A+ ++ +
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 86.2 bits (214), Expect = 3e-20
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 16/159 (10%)

Query: 50  IGNGGHASVYRAELP-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G   SV           +  +VAVK+    L       Q++F  E++ L       I
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ----LQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 105 VKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           VK+ G           L+ E+L  G L   L    A   L  S+ +     +   + YL 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 144

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                  VHRD++++N+L++ E    +ADFG+AK L  D
Sbjct: 145 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLD 180

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 85.9 bits (213), Expect = 6e-20
 Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 12/156 (7%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G    V    L         VA+K         Q   +++FL E   + +  H NI+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           +  G  + ++   ++ E++E GSL + L    A  +    Q + +++G+A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +   VHRD++++N+L++      V+DFG+ + L+ D
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 84.6 bits (210), Expect = 7e-20
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 16/159 (10%)

Query: 50  IGNGGHASVYRAELP-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G   SV           + EVVAVKK    L        ++F  E++ L   +H NI
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 105 VKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           VK+ G C  A      L+ E+L  GSL   L      + +   + +     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 131

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +   +HRD++++N+L++ E    + DFG+ K L  D
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 167

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.0 bits (211), Expect = 1e-19
 Identities = 40/213 (18%), Positives = 75/213 (35%), Gaps = 35/213 (16%)

Query: 24  SIPPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFH-SP 77
            I    G IL  ++      F+  Y     IG G  + V R     + +  AVK    + 
Sbjct: 4   GISGGGGGIL--DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61

Query: 78  LPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL---LCE----F---LERG 127
             S   +  ++   E       +H +IV+     S     ++     +        ++R 
Sbjct: 62  FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121

Query: 128 SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYE 186
               + +   A+           ++ + +AL Y H ++    I+HRDV    +LL  +  
Sbjct: 122 DAGFVYSEAVASH---------YMRQILEALRYCHDNN----IIHRDVKPHCVLLASKEN 168

Query: 187 AH---VADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +    +  FG+A  L           GT  ++A
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 84.7 bits (210), Expect = 1e-19
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASVYRAEL----PSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           IG G    VY+  L      +EV VA+K   +     Q   + +FL E   + +  H NI
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDFLGEAGIMGQFSHHNI 108

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           ++  G  S  +   ++ E++E G+L   L       E    Q + +++G+A  + YL + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +   VHRD++++N+L++      V+DFG+++ L+ D
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.8 bits (208), Expect = 1e-19
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 12/155 (7%)

Query: 50  IGNGGHASVYRAELPSREV---VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G   +V +     ++V   VAVK   +        D  E L E   + +  +  IV+
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 82

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
             G C       L+ E  E G L   L  +   + +     + ++  V+  + YL    F
Sbjct: 83  MIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              VHRD++++N+LL  ++ A ++DFG++K L++D
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 85.6 bits (212), Expect = 1e-19
 Identities = 41/191 (21%), Positives = 78/191 (40%), Gaps = 38/191 (19%)

Query: 43  DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT----EVKALTE 98
            F  K  +G+G   ++    +     VAVK+              E  +    EV+ L E
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-----------LPECFSFADREVQLLRE 73

Query: 99  -TRHRNIVKFYGFCSHARHSFL---LCEFLERGSLA-AILNTDAAAQELGWSQRMSVIKG 153
              H N+++++      +  ++   LC      +L   +   D A   L   + +++++ 
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELCA----ATLQEYVEQKDFAHLGL---EPITLLQQ 126

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLL-----DLEYEAHVADFGIAKFLKSDAS---NW 205
               L++LH      IVHRD+   N+L+       + +A ++DFG+ K L          
Sbjct: 127 TTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183

Query: 206 TEFAGTYGYVA 216
           +   GT G++A
Sbjct: 184 SGVPGTEGWIA 194

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 85.4 bits (212), Expect = 1e-19
 Identities = 43/192 (22%), Positives = 80/192 (41%), Gaps = 32/192 (16%)

Query: 41  TNDFDAKYC----IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
              F  +Y     +G G  + V R  ++ + +  A              D ++   E + 
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMII--NTKKLSARDHQKLEREARI 63

Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLA-AILN------TDAAAQELGWSQRM 148
               +H NIV+ +   S   H +L+ + +  G L   I+        DA+          
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------- 113

Query: 149 SVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDASN 204
             I+ + +A+ + H       +VHR++  +NLLL  + +     +ADFG+A  ++ +   
Sbjct: 114 HCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 205 WTEFAGTYGYVA 216
           W  FAGT GY++
Sbjct: 170 WFGFAGTPGYLS 181

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 84.9 bits (210), Expect = 1e-19
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 14/174 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G  A+V+R     + ++ A+K F++             + E + L +  H+NIVK +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLF 73

Query: 109 GF--CSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
                +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  +  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132

Query: 167 PPIVHRDVSSKNLLLDLEYEAH----VADFGIAKFLKSDASNWTEFAGTYGYVA 216
             IVHR++   N++  +  +      + DFG A+ L+ D   +    GT  Y+ 
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLH 183

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 83.8 bits (208), Expect = 1e-19
 Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 12/158 (7%)

Query: 47  KYCIGNGGHASVYRAEL--PSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
              +G G   SV +       +++ VA+K         +  D +E + E + + +  +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPY 71

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           IV+  G C       L+ E    G L   L      +E+  S    ++  V+  + YL  
Sbjct: 72  IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE 128

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
             F   VHRD++++N+LL   + A ++DFG++K L +D
Sbjct: 129 KNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 83.8 bits (208), Expect = 1e-19
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 17/176 (9%)

Query: 50  IGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G GG + V+ A      R+V AVK   + L  D +   + F  E +      H  IV  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77

Query: 108 Y--GF--CSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           Y  G          +++ E+++  +L  I++T+     +   + + VI     AL++ H 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ 134

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA---GTYGYVA 216
           +    I+HRDV   N+++       V DFGIA+ +    ++ T+ A   GT  Y++
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.0 bits (208), Expect = 1e-19
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 16/159 (10%)

Query: 50  IGNGGHASVYRAELP-----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G   SV           + EVVAVKK    L        ++F  E++ L   +H NI
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 105 VKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           VK+ G C  A      L+ E+L  GSL   L      + +   + +     +   + YL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 162

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +   +HRD++++N+L++ E    + DFG+ K L  D
Sbjct: 163 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 198

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 84.4 bits (209), Expect = 1e-19
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 14/161 (8%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TRHRNIVKF 107
           +  GG A VY A+ + S    A+K+  S          +  + EV  + + + H NIV+F
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN----RAIIQEVCFMKKLSGHPNIVQF 91

Query: 108 YGFCSHARHS-------FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
               S  +         FLL   L +G L   L    +   L     + +      A+ +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +H    PPI+HRD+  +NLLL  +    + DFG A  +   
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.9 bits (208), Expect = 2e-19
 Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 17/159 (10%)

Query: 50  IGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G G    V           + E+VAVK             +  +  E+  L    H +I
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 105 VKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           +K+ G C  A  +   L+ E++  GSL   L        +G +Q +   + + + ++YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH 151

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              +   +HRD++++N+LLD +    + DFG+AK +   
Sbjct: 152 AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.7 bits (205), Expect = 3e-19
 Identities = 33/168 (19%), Positives = 66/168 (39%), Gaps = 25/168 (14%)

Query: 50  IGNGGHASVYRAEL--------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +G G    +++                V +K     L        + F      +++  H
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKV----LDKAHRNYSESFFEAASMMSKLSH 71

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
           +++V  YG C     + L+ EF++ GSL   L  +     +    ++ V K +A A+ +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFL 129

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAH--------VADFGIAKFLKSD 201
             +     +H +V +KN+LL  E +          ++D GI+  +   
Sbjct: 130 EENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 84.2 bits (208), Expect = 3e-19
 Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 12/155 (7%)

Query: 50  IGNGGHASVYRAEL--PSREV-VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G G   SV +       +++ VA+K         +  D +E + E + + +  +  IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
             G C       L+ E    G L   L      +E+  S    ++  V+  + YL    F
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNF 457

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              VHR+++++N+LL   + A ++DFG++K L +D
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 82.4 bits (204), Expect = 6e-19
 Identities = 40/210 (19%), Positives = 80/210 (38%), Gaps = 21/210 (10%)

Query: 14  LHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKK 73
           +H   +   G              VK    +     IG+GG + V++     +++ A+K 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVK-GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 59

Query: 74  FHSPLPSDQTVDQKEFLTEVKALTETRHRN--IVKFYGFCSHARHSFLLCEFLERGSLAA 131
               L          +  E+  L + +  +  I++ Y +    ++ +++ E      L +
Sbjct: 60  V--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNS 116

Query: 132 ILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV- 189
            L    +       +R S  K + +A+  +H H     IVH D+   N L+    +  + 
Sbjct: 117 WLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV---DGMLK 166

Query: 190 -ADFGIAKFLKSDASNW--TEFAGTYGYVA 216
             DFGIA  ++ D ++       GT  Y+ 
Sbjct: 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 81.5 bits (202), Expect = 7e-19
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTET 99
            DF+    +G G   +VY A E  S+ ++A+K    + L       Q     EV+  +  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 66

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS------VIKG 153
           RH NI++ YG+   A   +L+ E+   G++   L             +         I  
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---------LSKFDEQRTATYITE 117

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +    S  S  T+  GT  
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLD 172

Query: 214 YVA 216
           Y+ 
Sbjct: 173 YLP 175

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 82.0 bits (203), Expect = 8e-19
 Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 25/184 (13%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET- 99
           ND +    +G+G    V++     +  V+AVK+       +   + K  L ++  + ++ 
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE---ENKRILMDLDVVLKSH 81

Query: 100 RHRNIVKFYGFCSHARHSFL------LC-EFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
               IV+ +G       +F+      +  E +   +            E        +  
Sbjct: 82  DCPYIVQCFG-------TFITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTV 131

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTY 212
            +  AL YL       ++HRDV   N+LLD   +  + DFGI+  L  D       AG  
Sbjct: 132 AIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCA 188

Query: 213 GYVA 216
            Y+A
Sbjct: 189 AYMA 192

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 81.6 bits (202), Expect = 1e-18
 Identities = 45/205 (21%), Positives = 73/205 (35%), Gaps = 40/205 (19%)

Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
            +DF+    +G G    V +A         A+KK                L+EV  L   
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-----RHTEEKLSTILSEVMLLASL 59

Query: 100 RHRNIVKFYGFCSHARHSFLLC-------------EFLERGSLA-AILNTDAAAQELGWS 145
            H+ +V++Y      R+                  E+ E G+L   I + +   Q     
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR---D 116

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
           +   + + + +ALSY+H      I+HRD+   N+ +D      + DFG+AK +       
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 206 --------------TEFAGTYGYVA 216
                         T   GT  YVA
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVA 198

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 82.1 bits (203), Expect = 1e-18
 Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 10/154 (6%)

Query: 44  FDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQ-KEFLTEVKALTETRH 101
           F     IG+G   +VY A ++ + EVVA+KK        Q+ ++ ++ + EV+ L + RH
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            N +++ G       ++L+ E+    +   +       QE    +  +V  G    L+YL
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---VEIAAVTHGALQGLAYL 170

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           H      ++HRDV + N+LL       + DFG A
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 81.0 bits (201), Expect = 1e-18
 Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 23/176 (13%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKK-FHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G  A VYRA  + +   VA+K      +     V +     EVK   + +H +I++ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILEL 76

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRMSVIKGVADALSY 160
           Y +   + + +L+ E    G +   L         + A            +  +   + Y
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH---------FMHQIITGMLY 127

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           LH      I+HRD++  NLLL       +ADFG+A  LK          GT  Y++
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 81.8 bits (202), Expect = 1e-18
 Identities = 35/173 (20%), Positives = 72/173 (41%), Gaps = 16/173 (9%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH--RNIVK 106
            IG+GG + V++     +++ A+K     L          +  E+  L + +     I++
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDC 165
            Y +    ++ +++ E      L + L    +       +R S  K + +A+  +H H  
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 175

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE--FAGTYGYVA 216
              IVH D+   N L+  +    + DFGIA  ++ D ++  +    G   Y+ 
Sbjct: 176 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 80.7 bits (200), Expect = 2e-18
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G    V   +    +V AVK              + FL E   +T+ RH N+V+  G
Sbjct: 29  IGKGEFGDVMLGDYRGNKV-AVKCIK------NDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 110 FCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                +   +++ E++ +GSL   L +      LG    +     V +A+ YL  + F  
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            VHRD++++N+L+  +  A V+DFG+ K
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 81.3 bits (201), Expect = 2e-18
 Identities = 36/175 (20%), Positives = 72/175 (41%), Gaps = 20/175 (11%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH--RNIVK 106
            IG+GG + V++     +++ A+K     L          +  E+  L + +     I++
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDC 165
            Y +    ++ +++ E      L + L    +       +R S  K + +A+  +H H  
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 128

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNW--TEFAGTYGYVA 216
              IVH D+   N L+    +  +   DFGIA  ++ D ++       GT  Y+ 
Sbjct: 129 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.8 bits (200), Expect = 2e-18
 Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 38/199 (19%)

Query: 39  KATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVK-----KFHSPLPSDQTVDQKE 88
            +T+ F   Y     +G G  + V R    P+ +  AVK        S    +    ++ 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 89  FLTEVKALTE-TRHRNIVKFYGFCSHARHSFL---LCE----F---LERGSLAAILNTDA 137
            L EV  L + + H NI++           FL   L +    F    E+ +L     ++ 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-----SEK 124

Query: 138 AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
             +++        ++ + + +  LH      IVHRD+  +N+LLD +    + DFG +  
Sbjct: 125 ETRKI--------MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 198 LKSDASNWTEFAGTYGYVA 216
           L        E  GT  Y+A
Sbjct: 174 LDPG-EKLREVCGTPSYLA 191

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.8 bits (197), Expect = 3e-18
 Identities = 17/149 (11%), Positives = 42/149 (28%), Gaps = 12/149 (8%)

Query: 49  CIGNGGHASVYRA--ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
             G       ++A      R+V A+            V  +E L+    L+      + +
Sbjct: 38  FHGGVPPLQFWQALDTALDRQV-ALTFVDPQGVLPDDV-LQETLSRTLRLSRIDKPGVAR 95

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
                       ++ E++  GSL  +               +  ++ +A A    H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA-- 148

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             +         + + ++ +  +A     
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATM 176

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.0 bits (198), Expect = 3e-18
 Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 11/156 (7%)

Query: 50  IGNGGHASVYRAELPSREV----VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G+G    V R E  +       VAVK     + S       +F+ EV A+    HRN++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA-MDDFIREVNAMHSLDHRNLI 84

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           + YG         ++ E    GSL   L                    VA+ + YL    
Sbjct: 85  RLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           F   +HRD++++NLLL       + DFG+ + L  +
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 81.7 bits (201), Expect = 3e-18
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 17/177 (9%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G GG   V R     + E VA+K+    L      +++ +  E++ + +  H N+V   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSAR 78

Query: 109 ------GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
                    +      L  E+ E G L   LN       L      +++  ++ AL YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +    I+HRD+  +N++L    +     + D G AK L       TEF GT  Y+A
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLA 191

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 80.4 bits (199), Expect = 4e-18
 Identities = 32/158 (20%), Positives = 64/158 (40%), Gaps = 16/158 (10%)

Query: 50  IGNGGHASVYRAELPSRE-----VVAVKKFHSPLPSDQTVDQK-EFLTEVKALTETRHRN 103
           +G+G   +VY+             VA+K+    L    +     E L E   +    + +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKE----LREATSPKANKEILDEAYVMASVDNPH 78

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           + +  G C       L+ + +  G L   +        +G    ++    +A  ++YL  
Sbjct: 79  VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED 135

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                 VHRD++++N+L+       + DFG+AK L ++
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 80.5 bits (199), Expect = 5e-18
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 21/166 (12%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTV-DQKEFLTEVKALTETRHR 102
           +G+G    VY  ++      PS   VAVK     LP   +  D+ +FL E   +++  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAIL----NTDAAAQELGWSQRMSVIKGVADAL 158
           NIV+  G    +   F+L E +  G L + L       +    L     + V + +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV---ADFGIAKFLKSD 201
            YL  + F   +HRD++++N LL       V    DFG+A+ +   
Sbjct: 195 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 80.0 bits (198), Expect = 5e-18
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 21/166 (12%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTV-DQKEFLTEVKALTETRHR 102
           +G+G    VY  ++      PS   VAVK     LP   +  D+ +FL E   +++  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAIL----NTDAAAQELGWSQRMSVIKGVADAL 158
           NIV+  G    +   F+L E +  G L + L       +    L     + V + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV---ADFGIAKFLKSD 201
            YL  + F   +HRD++++N LL       V    DFG+A+ +   
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 79.5 bits (197), Expect = 5e-18
 Identities = 47/195 (24%), Positives = 75/195 (38%), Gaps = 42/195 (21%)

Query: 41  TNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           T +    +      G+G  + V+   +  + ++ A+K                   E+  
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI----KKSPAFRDSSLENEIAV 59

Query: 96  LTETRHRNIVKFYGFCSHARHSFL---LCE----F---LERGSLAAILNTDAAAQELGWS 145
           L + +H NIV          H +L   L      F   LERG       T+  A  +   
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-----TEKDASLV--- 111

Query: 146 QRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLL-DLEYEAHV--ADFGIAKFLKSD 201
                I+ V  A+ YLH +     IVHRD+  +NLL    E  + +   DFG++K  ++ 
Sbjct: 112 -----IQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161

Query: 202 ASNWTEFAGTYGYVA 216
               +   GT GYVA
Sbjct: 162 -GIMSTACGTPGYVA 175

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 80.5 bits (199), Expect = 7e-18
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 12/149 (8%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
            IG G    V   +    +V AVK     + +D T   + FL E   +T+ RH N+V+  
Sbjct: 200 TIGKGEFGDVMLGDYRGNKV-AVKC----IKNDAT--AQAFLAEASVMTQLRHSNLVQLL 252

Query: 109 GFCSHARHSFLL-CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           G     +    +  E++ +GSL   L +      LG    +     V +A+ YL  + F 
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             VHRD++++N+L+  +  A V+DFG+ K
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.7 bits (197), Expect = 7e-18
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 35/199 (17%)

Query: 35  DEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKE 88
           + ++ A+  F   Y     +G G  + V R     +    A K  +   L +    D ++
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQK 74

Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLA-AILN------TDAAAQE 141
              E +   + +H NIV+ +         +L+ + +  G L   I+        DA+   
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--- 131

Query: 142 LGWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKF 197
                    I+ + ++++Y H +     IVHR++  +NLLL  + +     +ADFG+A  
Sbjct: 132 -------HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 198 LKSDASNWTEFAGTYGYVA 216
           +  D+  W  FAGT GY++
Sbjct: 181 VN-DSEAWHGFAGTPGYLS 198

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 79.3 bits (196), Expect = 8e-18
 Identities = 39/176 (22%), Positives = 64/176 (36%), Gaps = 11/176 (6%)

Query: 43  DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE-TR 100
            F     +G+G +  V++        + AVK+  S  P     D+   L EV +  +  +
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H   V+           +L  E     SL       A    L  +Q    ++    AL++
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--AWGASLPEAQVWGYLRDTLLALAH 172

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           LH      +VH DV   N+ L       + DFG+   L +  +      G   Y+A
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMA 224

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 25/164 (15%)

Query: 50  IGNGGHASVYRAELPSRE------VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G    V+ AE  +        +VAVK     L       +++F  E + LT  +H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTMLQHQH 104

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAIL------------NTDAAAQELGWSQRMSVI 151
           IV+F+G C+  R   ++ E++  G L   L              D A   LG  Q ++V 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
             VA  + YL    F   VHRD++++N L+       + DFG++
Sbjct: 165 SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMS 205

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 35/193 (18%)

Query: 39  KATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
              +     + +    G G  + VYR  +  +++  A+K         +TVD+K   TE+
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL------KKTVDKKIVRTEI 99

Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------TDAAAQELGWSQ 146
             L    H NI+K            L+ E +  G L   I+        DAA        
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------- 151

Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL-DLEYEAHV--ADFGIAKFLKSDAS 203
               +K + +A++YLH +    IVHRD+  +NLL      +A +  ADFG++K ++    
Sbjct: 152 --DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-V 205

Query: 204 NWTEFAGTYGYVA 216
                 GT GY A
Sbjct: 206 LMKTVCGTPGYCA 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 78.5 bits (194), Expect = 1e-17
 Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 25/186 (13%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK-ALTET 99
            D      IG G + SV +    PS +++AVK+  S +      +QK+ L ++   +  +
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSS 78

Query: 100 RHRNIVKFYGFCSHARHSFL------LC-EFLERGSLAAILNTDAAAQELGWSQRM--SV 150
               IV+FYG       +        +C E +   S         +  +    + +   +
Sbjct: 79  DCPYIVQFYG-------ALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKI 130

Query: 151 IKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAG 210
                 AL++L  +    I+HRD+   N+LLD      + DFGI+  L    +  T  AG
Sbjct: 131 TLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAG 187

Query: 211 TYGYVA 216
              Y+A
Sbjct: 188 CRPYMA 193

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 79.4 bits (196), Expect = 1e-17
 Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 32/201 (15%)

Query: 34  YDEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFH----SPLPSDQTV 84
            D+          +Y +    G+G    V  A E  + + VA++       +   + +  
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 182

Query: 85  DQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL------AAILNTDAA 138
                 TE++ L +  H  I+K   F   A   +++ E +E G L         L     
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATC 241

Query: 139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIA 195
                          +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG +
Sbjct: 242 K---------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

Query: 196 KFLKSDASNWTEFAGTYGYVA 216
           K L  + S      GT  Y+A
Sbjct: 290 KILG-ETSLMRTLCGTPTYLA 309

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 77.6 bits (192), Expect = 2e-17
 Identities = 36/158 (22%), Positives = 64/158 (40%), Gaps = 17/158 (10%)

Query: 50  IGNGGHASVYRAELPSREV----VAVKKFHSPLPSDQTVDQK-EFLTEVKALTETRHRNI 104
           +G G    VY     + +     VAVK        D T+D K +F++E   +    H +I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKT----CKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 105 VKFYGFCSHARHSFLL-CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           VK  G          +  E    G L   L  +     L     +     +  A++YL  
Sbjct: 76  VKLIGIIE--EEPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES 131

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                 VHRD++ +N+L+       + DFG++++++ +
Sbjct: 132 INC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 78.6 bits (194), Expect = 2e-17
 Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 37/198 (18%)

Query: 39  KATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVK----KFHSPLPSDQTVDQKEF 89
            A  +F  KY     IG G  + V R     +    AVK          P      ++  
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 90  LTEVKALTE-TRHRNIVKFYGFCSHARHSFL---LCE----F---LERGSLAAILNTDAA 138
             E   L +   H +I+        +   FL   L      F    E+ +L     ++  
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL-----SEKE 201

Query: 139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
            + +        ++ + +A+S+LH +    IVHRD+  +N+LLD   +  ++DFG +  L
Sbjct: 202 TRSI--------MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250

Query: 199 KSDASNWTEFAGTYGYVA 216
           +       E  GT GY+A
Sbjct: 251 EPG-EKLRELCGTPGYLA 267

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 77.6 bits (192), Expect = 2e-17
 Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 33/192 (17%)

Query: 41  TNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           +  F   Y +    G G  + V R     +    A K            D ++   E + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII--NTKKLSARDFQKLEREARI 58

Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLA-AILN------TDAAAQELGWSQRM 148
             + +H NIV+ +         +L+ + +  G L   I+        DA+          
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---------- 108

Query: 149 SVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDASN 204
             I+ + ++++Y H +     IVHR++  +NLLL  + +     +ADFG+A  +  D+  
Sbjct: 109 HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEA 163

Query: 205 WTEFAGTYGYVA 216
           W  FAGT GY++
Sbjct: 164 WHGFAGTPGYLS 175

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 77.3 bits (191), Expect = 2e-17
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    V++    S E     VA+K   +         +++FL E   + +  H +IV
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPHIV 79

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           K  G  +     +++ E    G L + L        L  +  +     ++ AL+YL    
Sbjct: 80  KLIGVITENPV-WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR 136

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           F   VHRD++++N+L+       + DFG++++++   
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 77.3 bits (191), Expect = 3e-17
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 33/192 (17%)

Query: 41  TNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVK 94
              F  +Y I    G G    V +  +  +++  AVK  + +   +    D    L EV+
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVE 73

Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILNT------DAAAQELGWSQR 147
            L +  H NI+K +     +   +++ E    G L   I+        DAA         
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------- 124

Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDASN 204
             +IK V   ++Y+H      IVHRD+  +N+LL+ + +     + DFG++   + + + 
Sbjct: 125 -RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TK 179

Query: 205 WTEFAGTYGYVA 216
             +  GT  Y+A
Sbjct: 180 MKDRIGTAYYIA 191

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 76.9 bits (190), Expect = 5e-17
 Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 17/159 (10%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G   SV    L   +     VAVK       S +  + +EFL+E   + +  H N++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVI 99

Query: 106 KFYGFCS-----HARHSFLLCEFLERGSLAAIL---NTDAAAQELGWSQRMSVIKGVADA 157
           +  G C            ++  F++ G L   L     +   + +     +  +  +A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           + YL +  F   +HRD++++N +L  +    VADFG++K
Sbjct: 160 MEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSK 195

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 77.9 bits (192), Expect = 5e-17
 Identities = 42/196 (21%), Positives = 80/196 (40%), Gaps = 47/196 (23%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLT----EVKALTET-RHRNI 104
           +G G   +V          VAVK+              +F      E+K LTE+  H N+
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM-----------LIDFCDIALMEIKLLTESDDHPNV 71

Query: 105 VKFYGFCSHARHSFL---LCEFLERGSLAAIL----NTDAAAQELGWSQRMSVIKGVADA 157
           +++Y   +  R  ++   LC      +L  ++     +D   +       +S+++ +A  
Sbjct: 72  IRYYCSETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH-------------VADFGIAKFLKSDASN 204
           +++LH      I+HRD+  +N+L+                    ++DFG+ K L S  S+
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 205 WT----EFAGTYGYVA 216
           +       +GT G+ A
Sbjct: 185 FRTNLNNPSGTSGWRA 200

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 77.0 bits (190), Expect = 5e-17
 Identities = 32/157 (20%), Positives = 64/157 (40%), Gaps = 14/157 (8%)

Query: 50  IGNGGHASVYRAELPSRE-----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G+G   +VY+             VA+K+      +      KE L E   +    + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
            +  G C       L+ + +  G L   +        +G    ++    +A  ++YL   
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                VHRD++++N+L+       + DFG+AK L ++
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.9 bits (190), Expect = 6e-17
 Identities = 43/199 (21%), Positives = 74/199 (37%), Gaps = 40/199 (20%)

Query: 36  EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL 90
           ++ + +  F   Y     IG G ++   R     +    AVK            D  E  
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPTE-- 64

Query: 91  TEVKAL-TETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------TDAAAQEL 142
            E++ L    +H NI+         ++ +++ E ++ G L   IL        +A+A   
Sbjct: 65  -EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA--- 120

Query: 143 GWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAH----VADFGIAKF 197
                  V+  +   + YLH       +VHRD+   N+L   E        + DFG AK 
Sbjct: 121 -------VLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 198 LKSDASNWTEFAGTYGYVA 216
           L+++         T  +VA
Sbjct: 170 LRAENGLLMTPCYTANFVA 188

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 77.4 bits (191), Expect = 8e-17
 Identities = 48/204 (23%), Positives = 77/204 (37%), Gaps = 38/204 (18%)

Query: 37  IVKATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVK---------KFHSPLPSDQ 82
           + K        Y      G+G +  V    E       A+K           +S    + 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 83  TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------T 135
               +E   E+  L    H NI+K +      ++ +L+ EF E G L   I+N       
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 136 DAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADF 192
           DAA          +++K +   + YLH      IVHRD+  +N+LL   +      + DF
Sbjct: 147 DAA----------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF 193

Query: 193 GIAKFLKSDASNWTEFAGTYGYVA 216
           G++ F   D     +  GT  Y+A
Sbjct: 194 GLSSFFSKD-YKLRDRLGTAYYIA 216

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 76.2 bits (188), Expect = 1e-16
 Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 18/160 (11%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           +G G   SV  A+L   +     VAVK   + + +    D +EFL E   + E  H ++ 
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88

Query: 106 KFYGFCS------HARHSFLLCEFLERGSLAAIL---NTDAAAQELGWSQRMSVIKGVAD 156
           K  G               ++  F++ G L A L           L     +  +  +A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
            + YL    F   +HRD++++N +L  +    VADFG+++
Sbjct: 149 GMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSR 185

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 77.0 bits (190), Expect = 1e-16
 Identities = 51/195 (26%), Positives = 78/195 (40%), Gaps = 31/195 (15%)

Query: 37  IVKATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT 91
           I          Y      G+G +  V    +  +    A+K       S  T    + L 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII--RKTSVSTSSNSKLLE 85

Query: 92  EVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------TDAAAQELGW 144
           EV  L    H NI+K Y F    R+ +L+ E  + G L   I++       DAA      
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA------ 139

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSD 201
                +IK V   ++YLH      IVHRD+  +NLLL+ + +     + DFG++   ++ 
Sbjct: 140 ----VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 202 ASNWTEFAGTYGYVA 216
                E  GT  Y+A
Sbjct: 193 -KKMKERLGTAYYIA 206

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 75.4 bits (186), Expect = 1e-16
 Identities = 42/185 (22%), Positives = 78/185 (42%), Gaps = 24/185 (12%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK-ALTET 99
           +D +    +G G +  V +   +PS +++AVK+  + + S    +QK  L ++  ++   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ---EQKRLLMDLDISMRTV 63

Query: 100 RHRNIVKFYGFCSHARHSFL------LC-EFLERGSLAAIL-NTDAAAQELGWSQRMSVI 151
                V FYG       +        +C E ++  SL           Q +       + 
Sbjct: 64  DCPFTVTFYG-------ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGT 211
             +  AL +LH      ++HRDV   N+L++   +  + DFGI+ +L  D +     AG 
Sbjct: 116 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGC 172

Query: 212 YGYVA 216
             Y+A
Sbjct: 173 KPYMA 177

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 75.4 bits (186), Expect = 1e-16
 Identities = 37/193 (19%), Positives = 72/193 (37%), Gaps = 31/193 (16%)

Query: 41  TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE- 98
           T +F     IG+G   SV++  +     + A+K+  S  P   +VD++  L EV A    
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 67

Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGVADA 157
            +H ++V+++   +   H  +  E+   GSLA  ++ +         ++   ++  V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLD-------------------LEYEAHVADFGIAKFL 198
           L Y+H      +VH D+   N+ +                     +    + D G    +
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 199 KSDASNWTEFAGT 211
            S         G 
Sbjct: 185 SSPQV----EEGD 193

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +      AVK  +         +  +FLTE   + +  H N++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG---EVSQFLTEGIIMKDFSHPNVL 153

Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +           +     VA  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            F   VHRD++++N +LD ++   VADFG+A+ +   
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.9 bits (186), Expect = 2e-16
 Identities = 19/198 (9%), Positives = 45/198 (22%), Gaps = 39/198 (19%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +  G  + V+   ++   E  A+K F     + ++ + +       A       +  +  
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS-ELERLHEATFAAARLLGESPEEAR 128

Query: 109 GFCSHAR--------------------------HSFLLCEFLERGSLAAILNTDAAAQE- 141
                                            +  LL        L  + +T       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 142 ---LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
               G      +   +    + L       +VH   +  NL +  +    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL--- 241

Query: 199 KSDASNWTEFAGTYGYVA 216
               +     +    Y  
Sbjct: 242 WKVGTRGPASSVPVTYAP 259

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 75.0 bits (185), Expect = 2e-16
 Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    VY   L   +      AVK  +         +  +FLTE   + +  H N++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG---EVSQFLTEGIIMKDFSHPNVL 89

Query: 106 KFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G C  +  S  ++  +++ G L   +  +           +     VA  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            F   VHRD++++N +LD ++   VADFG+A+ +   
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 35/157 (22%), Positives = 63/157 (40%), Gaps = 14/157 (8%)

Query: 50  IGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G+G   +V++          +  V +K              +     + A+    H +I
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIE---DKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           V+  G C       L+ ++L  GSL   +        LG    ++    +A  + YL   
Sbjct: 78  VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
                VHR+++++N+LL    +  VADFG+A  L  D
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 25/165 (15%)

Query: 50  IGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTE-TRHRNI 104
           IG G    V +A +     R   A+K+    +    +  D ++F  E++ L +   H NI
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKR----MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 105 VKFYGFCSHARHSFLLCEFLERGSL-------------AAILNTDAAAQELGWSQRMSVI 151
           +   G C H  + +L  E+   G+L              A    ++ A  L   Q +   
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
             VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++
Sbjct: 149 ADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR 190

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 75.0 bits (185), Expect = 2e-16
 Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 26/165 (15%)

Query: 50  IGNGGHASVYRAELPSRE------VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G    V+ AE  +        +VAVK     L       +K+F  E + LT  +H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKA----LKDPTLAARKDFQREAELLTNLQHEH 78

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSL-------------AAILNTDAAAQELGWSQRMSV 150
           IVKFYG C       ++ E+++ G L                     A  ELG SQ + +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 151 IKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
              +A  + YL    F   VHRD++++N L+       + DFG++
Sbjct: 139 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMS 180

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 74.6 bits (184), Expect = 3e-16
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTET 99
           +DFD    +G G   +VY A E  ++ ++A+K    S L  +    Q     E++  +  
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHL 71

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS------VIKG 153
           RH NI++ Y +    +  +L+ EF  RG L   L             R         ++ 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---------HGRFDEQRSATFMEE 122

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +ADAL Y H      ++HRD+  +NLL+  + E  +ADFG +    S     T   GT  
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRT-MCGTLD 177

Query: 214 YVA 216
           Y+ 
Sbjct: 178 YLP 180

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 31/197 (15%)

Query: 35  DEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEF 89
            E +     F  +Y I    G G    V +  +  +++  AVK       S +  D    
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI--NKASAKNKDTSTI 68

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------TDAAAQEL 142
           L EV+ L +  H NI+K +     +   +++ E    G L   I+        DAA    
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---- 124

Query: 143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL-DLEYEAH--VADFGIAKFLK 199
                  +IK V   ++Y+H      IVHRD+  +N+LL   E +    + DFG++   +
Sbjct: 125 ------RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 200 SDASNWTEFAGTYGYVA 216
            + +   +  GT  Y+A
Sbjct: 176 QN-TKMKDRIGTAYYIA 191

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 75.5 bits (186), Expect = 3e-16
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 32/196 (16%)

Query: 37  IVKATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKEFL 90
           +  +T  F  +Y      G G    V    +  + +  AVK      +      D++  L
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLL 74

Query: 91  TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------TDAAAQELG 143
            EV+ L +  H NI+K Y F     + +L+ E    G L   I++       DAA     
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----- 129

Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL-DLEYEAHV--ADFGIAKFLKS 200
                 +I+ V   ++Y+H +    IVHRD+  +NLLL     +A++   DFG++   ++
Sbjct: 130 -----RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181

Query: 201 DASNWTEFAGTYGYVA 216
                 +  GT  Y+A
Sbjct: 182 S-KKMKDKIGTAYYIA 196

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 74.6 bits (184), Expect = 3e-16
 Identities = 34/166 (20%), Positives = 72/166 (43%), Gaps = 21/166 (12%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTV-DQKEFLTEVKALTETRHR 102
           +G G    VY               VA+K     +    ++ ++ EFL E   + E    
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKT----VNEAASMRERIEFLNEASVMKEFNCH 88

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAIL-------NTDAAAQELGWSQRMSVIKGVA 155
           ++V+  G  S  + + ++ E + RG L + L         +        S+ + +   +A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           D ++YL+ + F   VHRD++++N ++  ++   + DFG+ + +   
Sbjct: 149 DGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 74.5 bits (183), Expect = 5e-16
 Identities = 43/227 (18%), Positives = 81/227 (35%), Gaps = 52/227 (22%)

Query: 39  KATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKEFLTE 92
            +  +   KY +    G G +  V  A E  +R + A+K  + + +      D +   TE
Sbjct: 19  GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL----------------------- 129
           V+ + +  H NI + Y      ++  L+ E    G L                       
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 130 ------------AAILNTDAAAQELGWSQRM--SVIKGVADALSYLHHDCFPPIVHRDVS 175
                          ++    + +    +++  ++++ +  AL YLH+     I HRD+ 
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIK 195

Query: 176 SKNLLLDLEYEAHV--ADFGIAKFLKS----DASNWTEFAGTYGYVA 216
            +N L        +   DFG++K        +    T  AGT  +VA
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 74.9 bits (184), Expect = 6e-16
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    V++    S E     VA+K   +         +++FL E   + +  H +IV
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPHIV 454

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC 165
           K  G  +     +++ E    G L + L        L  +  +     ++ AL+YL    
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR 511

Query: 166 FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
           F   VHRD++++N+L+       + DFG++++++   
Sbjct: 512 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.5 bits (181), Expect = 8e-16
 Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 28/181 (15%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFH----SPLPSDQTVDQKEFLTEVKALTETRHRNI 104
           +G+G    V  A E  + + VA+K       +   + +        TE++ L +  H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 105 VKFYGFCSHARHSFLLCEFLERGSL------AAILNTDAAAQELGWSQRMSVIKGVADAL 158
           +K   F   A   +++ E +E G L         L                    +  A+
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 127

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDASNWTEFAGTYGYV 215
            YLH +    I+HRD+  +N+LL  + E     + DFG +K L  + S      GT  Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYL 183

Query: 216 A 216
           A
Sbjct: 184 A 184

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 73.5 bits (181), Expect = 1e-15
 Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 26/171 (15%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTE-TRH 101
           +G G    V  A         +   VAVK     L S     +++  ++E+K ++   +H
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKM----LKSTAHADEKEALMSELKIMSHLGQH 109

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-----------NTDAAAQELGWSQRMSV 150
            NIV   G C+H     ++ E+   G L   L               A         +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 151 IKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
              VA  +++L        +HRDV+++N+LL   + A + DFG+A+ + +D
Sbjct: 170 SSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 72.6 bits (179), Expect = 1e-15
 Identities = 42/197 (21%), Positives = 69/197 (35%), Gaps = 41/197 (20%)

Query: 39  KATNDFDAKYCIGN----GGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEV 93
               D +  Y + N    G    V  A +  +R   A KK    +P     D   F  E+
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK----IPKYFVEDVDRFKQEI 57

Query: 94  KALTETRHRNIVKFYGFCSHARHSFL---LCE----F---LERGSLAAILNTDAAAQELG 143
           + +    H NI++ Y         +L   LC     F   + +         ++ A  + 
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF-----RESDAARI- 111

Query: 144 WSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLK 199
                  +K V  A++Y H  +    + HRD+  +N L   +       + DFG+A   K
Sbjct: 112 -------MKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160

Query: 200 SDASNWTEFAGTYGYVA 216
                     GT  YV+
Sbjct: 161 PG-KMMRTKVGTPYYVS 176

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 33/194 (17%), Positives = 74/194 (38%), Gaps = 25/194 (12%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVK-------------KFHSPLPSDQTVDQKE 88
           ND+     +  G    +   E    +  A+K                +           +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 89  FLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           F  E++ +T+ ++   +   G  ++    +++ E++E  S+           +  ++  +
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFI 148

Query: 149 S------VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA 202
                  +IK V ++ SY+H+     I HRDV   N+L+D      ++DFG ++++    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-- 204

Query: 203 SNWTEFAGTYGYVA 216
                  GTY ++ 
Sbjct: 205 KKIKGSRGTYEFMP 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 30/174 (17%), Positives = 64/174 (36%), Gaps = 31/174 (17%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQK-EFLTEVKALTETRHR 102
           +G      VY+  L         + VA+K     L        + EF  E       +H 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT----LKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSL-------------AAILNTDAAAQELGWSQRMS 149
           N+V   G  +  +   ++  +   G L              +  +       L     + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 150 VIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           ++  +A  + YL  HH     +VH+D++++N+L+  +    ++D G+ + + + 
Sbjct: 133 LVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 71.5 bits (176), Expect = 4e-15
 Identities = 36/157 (22%), Positives = 60/157 (38%), Gaps = 13/157 (8%)

Query: 50  IGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV 105
           IG G    VY  E   +       A+K         +    + FL E   +    H N++
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 106 KFYGFCSHAR-HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              G          +L  ++  G L   + +    +       +S    VA  + YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            F   VHRD++++N +LD  +   VADFG+A+ +   
Sbjct: 144 KF---VHRDLAARNCMLDESFTVKVADFGLARDILDR 177

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.0 bits (177), Expect = 5e-15
 Identities = 39/175 (22%), Positives = 74/175 (42%), Gaps = 30/175 (17%)

Query: 50  IGNGGHASVYRAELP--------SREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTE-T 99
           +G G    V  AE              VAVK     L SD T  D  + ++E++ +    
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 132

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSL-------------AAILNTDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L              +   +    ++L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +S    VA  + YL        +HRD++++N+L+  +    +ADFG+A+ +   
Sbjct: 193 LVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 72.2 bits (177), Expect = 6e-15
 Identities = 35/209 (16%), Positives = 71/209 (33%), Gaps = 31/209 (14%)

Query: 22  DGSIPPEVGKILYDEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFHS 76
           D  +     +     +    +     Y I    G G    V+R  E  +    A K    
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--- 189

Query: 77  PLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL------- 129
            + +    D++    E++ ++  RH  +V  +          ++ EF+  G L       
Sbjct: 190 -VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 248

Query: 130 AAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV 189
              ++ D A +          ++ V   L ++H +     VH D+  +N++   +    +
Sbjct: 249 HNKMSEDEAVE---------YMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296

Query: 190 --ADFGIAKFLKSDASNWTEFAGTYGYVA 216
              DFG+   L     +     GT  + A
Sbjct: 297 KLIDFGLTAHLDPK-QSVKVTTGTAEFAA 324

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 70.8 bits (174), Expect = 9e-15
 Identities = 36/175 (20%), Positives = 73/175 (41%), Gaps = 30/175 (17%)

Query: 50  IGNGGHASVYRAELP--------SREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTE-T 99
           +G G    V  AE              VAVK     L  D T  D  + ++E++ +    
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 98

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSL-------------AAILNTDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L              +        +++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +S    +A  + YL        +HRD++++N+L+       +ADFG+A+ + + 
Sbjct: 159 LVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNI 210

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 70.8 bits (174), Expect = 9e-15
 Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 39/177 (22%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTETRHR 102
           IG G    V++A            +VAVK     L  + +   Q +F  E   + E  + 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKM----LKEEASADMQADFQREAALMAEFDNP 110

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSL---------------------AAILNTDAAAQE 141
           NIVK  G C+  +   LL E++  G L                          +      
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 142 LGWSQRMSVIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
           L  ++++ + + VA  ++YL          VHRD++++N L+       +ADFG+++
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR 222

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 70.3 bits (173), Expect = 1e-14
 Identities = 36/182 (19%), Positives = 72/182 (39%), Gaps = 39/182 (21%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTV-DQKEFLTEVKALTETRHR 102
           +G G    V +A             VAVK     L  + +  + ++ L+E   L +  H 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKM----LKENASPSELRDLLSEFNVLKQVNHP 86

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSL---------------------AAILNTDAAAQE 141
           +++K YG CS      L+ E+ + GSL                      +        + 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 142 LGWSQRMSVIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           L     +S    ++  + YL         +VHRD++++N+L+    +  ++DFG+++ + 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

Query: 200 SD 201
            +
Sbjct: 202 EE 203

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 35/209 (16%), Positives = 74/209 (35%), Gaps = 33/209 (15%)

Query: 24  SIPPEVGKILYDEIVKATNDFDAKY------CIGNGGHASVYRA-ELPSREVVAVKKFHS 76
            IP       +  +       ++ Y       +G G    V++  E  +   +A K    
Sbjct: 65  DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI--- 121

Query: 77  PLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL------- 129
            + +    D++E   E+  + +  H N+++ Y          L+ E+++ G L       
Sbjct: 122 -IKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE 180

Query: 130 AAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV 189
           +  L                 +K + + + ++H      I+H D+  +N+L        +
Sbjct: 181 SYNLTELDTI---------LFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQI 228

Query: 190 --ADFGIAKFLKSDASNWTEFAGTYGYVA 216
              DFG+A+  K          GT  ++A
Sbjct: 229 KIIDFGLARRYKPR-EKLKVNFGTPEFLA 256

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 38/215 (17%), Positives = 72/215 (33%), Gaps = 33/215 (15%)

Query: 17  QLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSREVVAV 71
           ++N  D        K +   +          Y I    G+G    V+R  E  +  V   
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 72  KKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-- 129
           K     + +   +D+     E+  + +  H  ++  +          L+ EFL  G L  
Sbjct: 82  KF----INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 137

Query: 130 -----AAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDL 183
                   ++                ++   + L ++H H     IVH D+  +N++ + 
Sbjct: 138 RIAAEDYKMSEAEVIN---------YMRQACEGLKHMHEHS----IVHLDIKPENIMCET 184

Query: 184 EYEAHV--ADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +  + V   DFG+A  L  D         T  + A
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAA 218

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 69.9 bits (172), Expect = 2e-14
 Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 9/159 (5%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V++     + ++VA+KKF      D  V +K  L E++ L + +H N+V   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFL--ESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                 R   L+ E+ +  ++   L  D   + +      S+      A+++ H      
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE 207
            +HRDV  +N+L+       + DFG A+ L   +  + +
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 36/177 (20%), Positives = 73/177 (41%), Gaps = 34/177 (19%)

Query: 50  IGNGGHASVYRAEL--------PSREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTE-T 99
           +G G    V  AE              VAVK     L  D T  D  + ++E++ +    
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 144

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSL-------------AAILNTDAAAQELGWSQ 146
           +H+NI+   G C+     +++ E+  +G+L              +        +++ +  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 147 RMSVIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +S    +A  + YL          +HRD++++N+L+       +ADFG+A+ + + 
Sbjct: 205 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNI 256

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 43/197 (21%), Positives = 74/197 (37%), Gaps = 38/197 (19%)

Query: 41  TNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFH--SPLPSDQTVDQKEFLTEV 93
               +  Y I    G+G  A V +  E  +    A K         S + V ++E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFL----------ERGSLAAILNTDAAAQELG 143
             L +  H NI+  +    +     L+ E +          ++ SL     ++  A    
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-----SEEEATSF- 120

Query: 144 WSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH----VADFGIAKFLK 199
                  IK + D ++YLH      I H D+  +N++L  +        + DFG+A  ++
Sbjct: 121 -------IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 200 SDASNWTEFAGTYGYVA 216
            D   +    GT  +VA
Sbjct: 171 -DGVEFKNIFGTPEFVA 186

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 43/200 (21%), Positives = 76/200 (38%), Gaps = 41/200 (20%)

Query: 41  TNDFDAKY-----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK 94
           +  F+  Y      +G G HA V     L + +  AVK     +       +     EV+
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKI----IEKQPGHIRSRVFREVE 62

Query: 95  ALTE-TRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------TDAAAQELGWSQ 146
            L +   HRN+++   F       +L+ E +  GS+ + I         +A+        
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------- 115

Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDAS 203
              V++ VA AL +LH      I HRD+  +N+L +   +     + DF +   +K +  
Sbjct: 116 ---VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 204 -------NWTEFAGTYGYVA 216
                        G+  Y+A
Sbjct: 170 CSPISTPELLTPCGSAEYMA 189

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 34/147 (23%), Positives = 66/147 (44%), Gaps = 9/147 (6%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G +  V +     +  +VA+KKF      D  + +K  + E+K L + RH N+V   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFL--ESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
             C   +  +L+ EF++  ++   L  +     L +      +  + + + + H      
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIA 195
           I+HRD+  +N+L+       + DFG A
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFA 171

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 68.8 bits (169), Expect = 3e-14
 Identities = 45/187 (24%), Positives = 79/187 (42%), Gaps = 20/187 (10%)

Query: 41  TNDFDAKYC----IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE-FLTEVK 94
               D  +     +G+G    V+   E  S     +K     +  D++    E    E++
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT----INKDRSQVPMEQIEAEIE 72

Query: 95  ALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILNTDAAAQELGWSQRMSVIKG 153
            L    H NI+K +       + +++ E  E G L   I++  A  + L       ++K 
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132

Query: 154 VADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDASNWTEFA 209
           + +AL+Y H       +VH+D+  +N+L           + DFG+A+  KSD  + T  A
Sbjct: 133 MMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA 187

Query: 210 GTYGYVA 216
           GT  Y+A
Sbjct: 188 GTALYMA 194

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 69.3 bits (169), Expect = 4e-14
 Identities = 29/201 (14%), Positives = 54/201 (26%), Gaps = 40/201 (19%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-------- 100
           +G     +   A    + E   V   +           K+   EV  L   R        
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN-AIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 101 --------------HRNIVKFYGFCSHARHSFLLCEFL-------ERGSLAAILNTDAAA 139
                              K        R  ++L  F           +   +L + ++ 
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 140 QE-LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
            + L    R+ +   V   L+ LHH     +VH  +   +++LD      +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259

Query: 199 KSDASNWTEFAGTYG---YVA 216
           +  AS  +     +      A
Sbjct: 260 RDGASAVSPIGRGFAPPETTA 280

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 68.9 bits (169), Expect = 4e-14
 Identities = 45/195 (23%), Positives = 70/195 (35%), Gaps = 39/195 (20%)

Query: 41  TNDFDAKY-------CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTE 92
            + F   Y        +G G  +   +     S +  AVK             +     E
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK-------IISKRMEANTQKE 55

Query: 93  VKALTE-TRHRNIVKFYGFCSHARHSFLLCEFLERGSL-AAILN------TDAAAQELGW 144
           + AL     H NIVK +       H+FL+ E L  G L   I        T+A+      
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY----- 110

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSD 201
                +++ +  A+S++H      +VHRD+  +NLL   E +     + DFG A+    D
Sbjct: 111 -----IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 202 ASNWTEFAGTYGYVA 216
                    T  Y A
Sbjct: 163 NQPLKTPCFTLHYAA 177

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.4 bits (168), Expect = 5e-14
 Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 29/174 (16%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQT-VDQKEFLTEVKALTE-TRH 101
           +G G    V  A+        +   VAVK     L    T  + +  ++E+K L     H
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 90

Query: 102 RNIVKFYGFCSHA-RHSFLLCEFLERGSL-------------AAILNTDAAAQELGWSQR 147
            N+V   G C+       ++ EF + G+L               +   D     L     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 148 MSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           +     VA  + +L        +HRD++++N+LL  +    + DFG+A+ +  D
Sbjct: 151 ICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 68.1 bits (167), Expect = 9e-14
 Identities = 46/189 (24%), Positives = 76/189 (40%), Gaps = 22/189 (11%)

Query: 41  TNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFH--SPLPSDQTVDQKEFLTEV 93
               +  Y I    G+G  A V +  E  +    A K         S + V ++E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQR--MSVI 151
             L +  H N++  +    +     L+ E +  G L      D  AQ+   S+    S I
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-----FDFLAQKESLSEEEATSFI 121

Query: 152 KGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH----VADFGIAKFLKSDASNWTE 207
           K + D ++YLH      I H D+  +N++L  +        + DFG+A  ++ D   +  
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN 177

Query: 208 FAGTYGYVA 216
             GT  +VA
Sbjct: 178 IFGTPEFVA 186

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 43/189 (22%), Positives = 68/189 (35%), Gaps = 34/189 (17%)

Query: 43  DFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
           +   KY I    G G    V+R  E  S++    K         +  DQ     E+  L 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILN 56

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSL-------AAILNTDAAAQELGWSQRMSV 150
             RHRNI+  +          ++ EF+    +       A  LN              S 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---------SY 107

Query: 151 IKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTE 207
           +  V +AL +LH H+    I H D+  +N++      + +   +FG A+ LK    N+  
Sbjct: 108 VHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRL 162

Query: 208 FAGTYGYVA 216
                 Y A
Sbjct: 163 LFTAPEYYA 171

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 66.8 bits (164), Expect = 1e-13
 Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 38/195 (19%)

Query: 43  DFDAKYCI----GNGGHASVYRA-ELPSREVVAVK--KFHSPLPSDQTVDQKEFLTEVKA 95
             +  Y +    G+G  A V +  +  + +  A K  K      S + V ++E   EV  
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFL----------ERGSLAAILNTDAAAQELGWS 145
           L E RH NI+  +    +     L+ E +          E+ SL     T+  A +    
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL-----TEDEATQF--- 113

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL-DLEYEAH---VADFGIAKFLKSD 201
                +K + D + YLH      I H D+  +N++L D         + DFGIA  +++ 
Sbjct: 114 -----LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165

Query: 202 ASNWTEFAGTYGYVA 216
            + +    GT  +VA
Sbjct: 166 -NEFKNIFGTPEFVA 179

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 67.3 bits (165), Expect = 1e-13
 Identities = 43/198 (21%), Positives = 74/198 (37%), Gaps = 40/198 (20%)

Query: 41  TNDFDAKYCI----GNGGHASVYRA-ELPSREVVAVKKFH--SPLPSDQTVDQKEFLTEV 93
             + D  Y      G+G  A V +  E  +    A K         S + V +++   EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 94  KALTETRHRNIVKFYGFCSHARHSFLLCEFL----------ERGSLAAILNTDAAAQELG 143
             L E +H N++  +    +     L+ E +          E+ SL     T+  A E  
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL-----TEEEATEF- 119

Query: 144 WSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLL-DLEYEAH---VADFGIAKFL 198
                  +K + + + YLH       I H D+  +N++L D         + DFG+A  +
Sbjct: 120 -------LKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168

Query: 199 KSDASNWTEFAGTYGYVA 216
               + +    GT  +VA
Sbjct: 169 DFG-NEFKNIFGTPEFVA 185

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 23/197 (11%), Positives = 58/197 (29%), Gaps = 37/197 (18%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFH-SPLPSDQTVDQKE------------------- 88
           +G     +   A +  + E   V   + +  P    + Q +                   
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 89  ----FLTEVKALTETRHRNIVKFYG-FCSHARHSFLLCEFLERGSLA----AILNTDAAA 139
               F+     + + + + +++           S        + +L      +L+  +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           + L    R+ +   V   L+ LHH     +VH  +   +++LD      +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 200 SDASNWTEFAGTYGYVA 216
           +        + + G+  
Sbjct: 258 AR----VVSSVSRGFEP 270

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 40/193 (20%), Positives = 68/193 (35%), Gaps = 35/193 (18%)

Query: 41  TNDFDAKY-----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK 94
                  Y      +G G +  V       + +  A+K  +         D  +   EV 
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---------DSPKARQEVD 73

Query: 95  ALT-ETRHRNIVKFYGFC---SHARHSFLLC-EFLERGSL-AAILNTDAAAQELGWSQRM 148
                +   +IV          H +   L+  E +E G L + I        +  +++R 
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTERE 129

Query: 149 --SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDAS 203
              +++ +  A+ +LH      I HRDV  +NLL   + +     + DFG AK    +A 
Sbjct: 130 AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185

Query: 204 NWTEFAGTYGYVA 216
                  T  YVA
Sbjct: 186 -LQTPCYTPYYVA 197

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.5 bits (163), Expect = 2e-13
 Identities = 36/158 (22%), Positives = 71/158 (44%), Gaps = 23/158 (14%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALTETRHRN 103
           +GNG +A+VY+     +   VA+K+          +D +E      + E+  + E +H N
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIREISLMKELKHEN 64

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA----DALS 159
           IV+ Y          L+ EF++   L   ++             ++++K         L+
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYMD-SRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
           + H +    I+HRD+  +NLL++   +  + DFG+A+ 
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 30/175 (17%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTV-DQKEFLTEVKALTE-TRH 101
           +G G    V  A         +   VAVK     L     + +++  ++E+K L+    H
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKM----LKPSAHLTEREALMSELKVLSYLGNH 86

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSL---------------AAILNTDAAAQELGWSQ 146
            NIV   G C+    + ++ E+   G L                +    +     L    
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
            +S    VA  +++L        +HRD++++N+LL       + DFG+A+ +K+D
Sbjct: 147 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKND 198

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 66.1 bits (162), Expect = 4e-13
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 20/154 (12%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALTETRHRN 103
           +G G +A+VY+     +  +VA+K+          ++ +E      + EV  L + +H N
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           IV  +      +   L+ E+L++  L   L  D     +        +  +   L+Y H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
                ++HRD+  +NLL++   E  +ADFG+A+ 
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARA 149

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 66.1 bits (162), Expect = 4e-13
 Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 16/154 (10%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALTETRHRN 103
           +G G  A+VY+A +  + ++VA+KK           + K+      L E+K L E  H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKL----GHRSEAKDGINRTALREIKLLQELSHPN 73

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           I+       H  +  L+ +F+E   L  I+     +  L  S   + +      L YLH 
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
                I+HRD+   NLLLD      +ADFG+AK 
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 65.4 bits (160), Expect = 7e-13
 Identities = 37/198 (18%), Positives = 74/198 (37%), Gaps = 33/198 (16%)

Query: 37  IVKATNDFDAKYCI-----GNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL 90
             ++  +F+  Y +     G G  A V +     + +  A K             + E L
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEIL 76

Query: 91  TEVKALTETRHR-NIVKFYGFCSHARHSFLLCEFLERGSL--------AAILNTDAAAQE 141
            E+  L   +    ++  +    +     L+ E+   G +        A +++ +   + 
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR- 135

Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFL 198
                   +IK + + + YLH +    IVH D+  +N+LL   Y      + DFG+++ +
Sbjct: 136 --------LIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 199 KSDASNWTEFAGTYGYVA 216
                   E  GT  Y+A
Sbjct: 185 GHA-CELREIMGTPEYLA 201

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 65.3 bits (160), Expect = 7e-13
 Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 27/160 (16%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEF------LTEVKALTETRHR 102
           +G G +  VY+A +  + E VA+K+          ++ +E       + EV  L E +HR
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVSLLKELQHR 93

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           NI++      H     L+ E+ E   L   ++      ++      S +  + + +++ H
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCH 149

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAH-----VADFGIAKF 197
                  +HRD+  +NLLL +   +      + DFG+A+ 
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 65.4 bits (160), Expect = 7e-13
 Identities = 37/176 (21%), Positives = 65/176 (36%), Gaps = 39/176 (22%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTV-DQKEFLTEVKALTE-TRH 101
           +G+G    V  A             VAVK     L       +++  ++E+K +T+   H
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKM----LKEKADSSEREALMSELKMMTQLGSH 108

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSL--------------------AAILNTDAAAQE 141
            NIV   G C+ +   +L+ E+   G L                       L  +     
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 142 LGWSQRMSVIKGVADALSYL--HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           L +   +     VA  + +L          VHRD++++N+L+       + DFG+A
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLA 219

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 64.5 bits (158), Expect = 1e-12
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 18/152 (11%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALTETRHRNI 104
           IG G +  VY+A+    E  A+KK    L  +      E      + E+  L E +H NI
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKE-----DEGIPSTTIREISILKELKHSNI 62

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           VK Y      +   L+ E L++  L  +L  D     L      S +  + + ++Y H  
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 165 CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
               ++HRD+  +NLL++ E E  +ADFG+A+
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLAR 148

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 43/201 (21%), Positives = 75/201 (37%), Gaps = 45/201 (22%)

Query: 38  VKATNDFDAKYC----IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTE 92
           +K     D        +G G +  V +     ++E  A+K            D  +   E
Sbjct: 54  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARRE 104

Query: 93  VKALTE-TRHRNIVKFYGFC----SHARHSFLLCEFLERGSL-AAILN--------TDAA 138
           V+     ++  +IV+         +  +   ++ E L+ G L + I +         +A+
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164

Query: 139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIA 195
                      ++K + +A+ YLH      I HRDV  +NLL   +       + DFG A
Sbjct: 165 E----------IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211

Query: 196 KFLKSDASNWTEFAGTYGYVA 216
           K   S  ++ T    T  YVA
Sbjct: 212 KETTSH-NSLTTPCYTPYYVA 231

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 63.7 bits (156), Expect = 2e-12
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 18/153 (11%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALTETRHRN 103
           IG G +  VY+A    + EVVA+KK    L ++      E      + E+  L E  H N
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIR--LDTE-----TEGVPSTAIREISLLKELNHPN 63

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           IVK           +L+ EFL +  L   ++  +A   +      S +  +   L++ H 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHS 121

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
                ++HRD+  +NLL++ E    +ADFG+A+
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 63.3 bits (155), Expect = 3e-12
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE------FLTEVKALTETRHR 102
           IG G + +V++A    + E+VA+K+          +D  +       L E+  L E +H+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--------LDDDDEGVPSSALREICLLKELKHK 61

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
           NIV+ +      +   L+ EF ++  L      D+   +L      S +  +   L + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
                 ++HRD+  +NLL++   E  +A+FG+A+ 
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 63.4 bits (154), Expect = 3e-12
 Identities = 23/150 (15%), Positives = 54/150 (36%), Gaps = 15/150 (10%)

Query: 79  PSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAA 138
           P            +++ +     +N V      S   + ++  +   + +L   +N   +
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 139 AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL 198
            ++      + +   +A+A+ +LH      ++HRD+   N+   ++    V DFG+   +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214

Query: 199 KSDAS------------NWTEFAGTYGYVA 216
             D                T   GT  Y++
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 45.6 bits (108), Expect = 4e-06
 Identities = 22/145 (15%), Positives = 51/145 (35%), Gaps = 9/145 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            DF+   C+G GG   V+ A+        A+K+   P   ++ + +++ + EVKAL +  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLE 62

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H  IV+++             E  E        +   ++     +  + + +     +  
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR-----MDP 117

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEY 185
                    +        L + ++ 
Sbjct: 118 FSTKNTVGQLQPSSPKVYLYIQMQL 142

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 63.3 bits (155), Expect = 3e-12
 Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 20/154 (12%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKE------FLTEVKALTETRHRN 103
           +G G +  VY+A+     +VA+K+          +D ++       + E+  L E  H N
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR--------LDAEDEGIPSTAIREISLLKELHHPN 80

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           IV         R   L+ EF+E+  L  +L  D     L  SQ    +  +   +++ H 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
                I+HRD+  +NLL++ +    +ADFG+A+ 
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARA 168

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 63.3 bits (154), Expect = 4e-12
 Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 31/166 (18%)

Query: 50  IGNGGHASVYRA---ELPSREVVAVKKFHS---PLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G G +  VY+A   +    +  A+K+       + +           E+  L E +H N
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---------CREIALLRELKHPN 79

Query: 104 IVKFYG-FCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRM--SVIKGVA---- 155
           ++     F SHA    +LL ++ E   L  I+    A++      ++   ++K +     
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH----VADFGIAKF 197
           D + YLH +    ++HRD+   N+L+  E        +AD G A+ 
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 60.5 bits (147), Expect = 3e-11
 Identities = 40/183 (21%), Positives = 68/183 (37%), Gaps = 33/183 (18%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVK-----KFHSPLPSDQTVDQKEFLTEVKALTETRHRN 103
           +G+G    V+ A      + V VK     K       +     K  L E+  L+   H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL----GWSQRMS------VIKG 153
           I+K      +     L+ E    G             +L        R+       + + 
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSG------------LDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG 213
           +  A+ YL       I+HRD+  +N+++  ++   + DFG A +L+     +T F GT  
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIE 194

Query: 214 YVA 216
           Y A
Sbjct: 195 YCA 197

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.8 bits (148), Expect = 3e-11
 Identities = 40/211 (18%), Positives = 66/211 (31%), Gaps = 35/211 (16%)

Query: 22  DGSIPPEVGKILYDEIV-KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLP 79
            GS+         DE   K  + F  +   G G   +V    E  +   VA+KK      
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---- 57

Query: 80  SDQTVDQKEFLTEVKALTETRHRNIVK-FYGFCSHARHSF------LLCEFLERGSLAAI 132
                 +   L  ++ L    H NIV+    F +            ++ E++   +L   
Sbjct: 58  -QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC 115

Query: 133 LNTDAAAQELGWSQRMSV--IKG----VADALSYLHHDCFPPIVHRDVSSKNLLLDLE-Y 185
                               IK     +  ++  LH      + HRD+   N+L++    
Sbjct: 116 CRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADG 169

Query: 186 EAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              + DFG AK L     N         Y+ 
Sbjct: 170 TLKLCDFGSAKKLSPSEPN-VA------YIC 193

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 59.9 bits (146), Expect = 6e-11
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 31/164 (18%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKK--FHSPLPSDQTVDQKE-F----LTEVKALTETRH 101
           IG G    V++A    + + VA+KK    +         +KE F    L E+K L   +H
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMEN---------EKEGFPITALREIKILQLLKH 75

Query: 102 RNIVKFYGFCSHARHS--------FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
            N+V     C              +L+ +F E   LA +L       +   S+   V++ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQM 132

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
           + + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A+ 
Sbjct: 133 LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 59.2 bits (144), Expect = 8e-11
 Identities = 44/176 (25%), Positives = 67/176 (38%), Gaps = 26/176 (14%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQ--TVDQKEFLTEVKALTETRHRNIVK 106
           IG G  A V  A  + +   VA+K     +   Q      ++   EV+ +    H NIVK
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKI----IDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG------VADALSY 160
            +      +  +L+ E+   G +   L             RM   +       +  A+ Y
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVA---------HGRMKEKEARSKFRQIVSAVQY 129

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            H      IVHRD+ ++NLLLD +    +ADFG +            F G   Y A
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAA 181

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 33/170 (19%)

Query: 50  IGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IGNG    VY+A+L  S E+VA+KK           D++    E++ + +  H NIV+  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 109 GFCSHARHSF------LLCEFLERGSLAAILNTDAAAQELGWSQRMSV--IKG----VAD 156
            F   +          L+ +++   ++  +    + A      Q + V  +K     +  
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFR 167

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASN 204
           +L+Y+H       I HRD+  +NLLLD +     + DFG AK L     N
Sbjct: 168 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 24/61 (39%), Positives = 30/61 (49%), Gaps = 6/61 (9%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           AL YL        I+HRD+   N+LLD     H+ DF IA  L  +    T  AGT  Y+
Sbjct: 127 ALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181

Query: 216 A 216
           A
Sbjct: 182 A 182

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 58.7 bits (143), Expect = 1e-10
 Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 19/160 (11%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVKALTE---TRHR 102
           IG G + +VY+A +  S   VA+K     +P+         ++   EV  L       H 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 103 NIVKFYGFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
           N+V+    C+ +R        L+ E +++  L   L+  A    L       +++     
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLRG 132

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF 197
           L +LH +C   IVHRD+  +N+L+       +ADFG+A+ 
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 38/185 (20%), Positives = 62/185 (33%), Gaps = 35/185 (18%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFH-SPLPSDQTVDQKEFLT-EVKAL----TETRHR 102
           +G GG  +V+    L  R  VA+K    + +     +        EV  L        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL----GWSQRMS------VIK 152
            +++   +        L+ E                 Q+L         +          
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPA------------QDLFDYITEKGPLGEGPSRCFFG 146

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKFLKSDASNWTEFAGT 211
            V  A+ + H      +VHRD+  +N+L+DL    A + DFG    L      +T+F GT
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGT 201

Query: 212 YGYVA 216
             Y  
Sbjct: 202 RVYSP 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 57.6 bits (140), Expect = 3e-10
 Identities = 44/195 (22%), Positives = 71/195 (36%), Gaps = 44/195 (22%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEF---LTEVKALT 97
            DF     +G G  ++V  A EL +    A+K     L     + + +      E   ++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 85

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-------NTDA---AAQELGWSQR 147
              H   VK Y         +    + + G L   +        T      A+       
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE------- 138

Query: 148 MSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASN 204
                 +  AL YLH       I+HRD+  +N+LL+   + H+   DFG AK L  ++  
Sbjct: 139 ------IVSALEYLHGKG----IIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQ 186

Query: 205 ---WTEFAGTYGYVA 216
               + F GT  YV+
Sbjct: 187 ARANS-FVGTAQYVS 200

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 57.1 bits (138), Expect = 7e-10
 Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 17/153 (11%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A +   + VVA+KK       +  +D K  L E+  L    H ++VK  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKRILREIAILNRLNHDHVVKVL 118

Query: 109 G-FCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH- 162
                     F    ++ E  +      +  T      L      +++  +   + Y+H 
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHS 174

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
                 I+HRD+   N L++ +    V DFG+A
Sbjct: 175 AG----ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 56.6 bits (137), Expect = 9e-10
 Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 24/185 (12%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKE---FLTEVKALT 97
           +DF+    IG G  + V   ++  + +V A+K     +     + + E   F  E   L 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI----MNKWDMLKRGEVSCFREERDVLV 116

Query: 98  ETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV--IKGV 154
               R I +  + F     + +L+ E+   G L  +L+             M+   +  +
Sbjct: 117 NGDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSK----FGERIPAEMARFYLAEI 171

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTE-FAGT 211
             A+  +H       VHRD+   N+LLD     H+  ADFG    L++D +  +    GT
Sbjct: 172 VMAIDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGT 226

Query: 212 YGYVA 216
             Y++
Sbjct: 227 PDYLS 231

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 30/202 (14%)

Query: 26  PPEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPS 80
           PP        E+ K   +  A Y     +G+G + +V  A +  +   VA+KK + P   
Sbjct: 5   PPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-- 62

Query: 81  DQTVDQKEFLTEVKALTETRHRNIVKFY------GFCSHARHSFLLCEFLERGSLAAILN 134
              +  K    E++ L   RH N++                  +L+  F+    L  ++ 
Sbjct: 63  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK 121

Query: 135 TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI 194
                ++LG  +   ++  +   L Y+H      I+HRD+   NL ++ + E  + DFG+
Sbjct: 122 H----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174

Query: 195 AKFLKSDASNWTEFAGTYGYVA 216
           A   +   S  T       YV 
Sbjct: 175 A---RQADSEMTG------YVV 187

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 55.3 bits (134), Expect = 2e-09
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 11/169 (6%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G    V   E   +   VAVK  +   + S   V + +   E++ L   RH +I+K 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y   S     F++ E++  G L   +        +   +   + + +  A+ Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRHM-- 131

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +VHRD+  +N+LLD    A +ADFG++  +       T   G+  Y A
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAA 178

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 36/187 (19%), Positives = 71/187 (37%), Gaps = 23/187 (12%)

Query: 36  EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL 90
           E+  +T     +Y     IG+G    V  A +      VA+KK   P         K   
Sbjct: 52  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAY 109

Query: 91  TEVKALTETRHRNIVKFY------GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGW 144
            E+  +    H+NI+               +  +L+ E ++  +L  ++       EL  
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDH 163

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
            +   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+   +    
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FM 219

Query: 205 WTEFAGT 211
            T +  T
Sbjct: 220 MTPYVVT 226

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 28/167 (16%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK-FY 108
           IGNG    V++A+L   + VA+KK           D++    E++ +   +H N+V    
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKA 99

Query: 109 GFCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG----VADALS 159
            F S+          L+ E++      A  +     Q +     M +IK     +  +L+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLA 155

Query: 160 YLH-HDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASN 204
           Y+H       I HRD+  +NLLLD       + DFG AK L +   N
Sbjct: 156 YIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 27/174 (15%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G+G + SV  A +  S E VA+KK   P      +  K    E+  L   +H N++   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 109 G-FCSHARHS-----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
             F   +        +L+  F++   L  I+       +    +   ++  +   L Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH 143

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                 +VHRD+   NL ++ + E  + DFG+A   +   +  T       YV 
Sbjct: 144 S---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTG------YVV 185

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 54.7 bits (132), Expect = 4e-09
 Identities = 39/185 (21%), Positives = 68/185 (36%), Gaps = 37/185 (20%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVK---KFHSPLPSDQTVDQKEFLT-EVKALTETRHR-- 102
           +G+GG  SVY    +     VA+K   K    +     +     +  EV  L +      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEK--DRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQEL----GWSQRMS------VIK 152
            +++   +        L+ E  E              Q+L         +          
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPV------------QDLFDFITERGALQEELARSFFW 156

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKFLKSDASNWTEFAGT 211
            V +A+ + H+     ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT
Sbjct: 157 QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGT 211

Query: 212 YGYVA 216
             Y  
Sbjct: 212 RVYSP 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 54.7 bits (132), Expect = 4e-09
 Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 28/186 (15%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKE---FLTEVKALT 97
            D++    IG G    V       +R+V A+K     L   + + + +   F  E   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWEERDIMA 124

Query: 98  ETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV--IKGV 154
                 +V+ FY F    R+ +++ E++  G L  ++            ++ +      V
Sbjct: 125 FANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLM------SNYDVPEKWARFYTAEV 177

Query: 155 ADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTE-FAG 210
             AL  +H        +HRDV   N+LLD     H+  ADFG    +  +     +   G
Sbjct: 178 VLALDAIHSMG----FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVG 231

Query: 211 TYGYVA 216
           T  Y++
Sbjct: 232 TPDYIS 237

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 54.7 bits (132), Expect = 4e-09
 Identities = 44/179 (24%), Positives = 66/179 (36%), Gaps = 33/179 (18%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G            ++E+VAVK     +     +D+     E+      RH NIV+F 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKY----IERGAAIDENVQ-REIINHRSLRHPNIVRFK 82

Query: 109 GFCSHARHSFLLCEFLERGSL------AAILNTDAAA---QELGWSQRMSVIKGVADALS 159
                  H  ++ E+   G L      A   + D A    Q+L               +S
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------------LSGVS 130

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAH--VADFGIAKFLKSDASNWTEFAGTYGYVA 216
           Y H      I HRD+  +N LLD        + DFG +K     +   +   GT  Y+A
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIA 185

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 54.2 bits (131), Expect = 5e-09
 Identities = 43/192 (22%), Positives = 71/192 (36%), Gaps = 43/192 (22%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEF---LTEVKALT 97
           + FD    +G G    V   +   S    A+K     L   + V  K+    L E + L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI----LDKQKVVKLKQIEHTLNEKRILQ 96

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-------NTDA---AAQELGWSQR 147
                 +VK         + +++ E++  G + + L          A   AAQ       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ------- 149

Query: 148 MSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASN 204
                 +     YLH  D    +++RD+  +NLL+D   + ++   DFG AK  +     
Sbjct: 150 ------IVLTFEYLHSLD----LIYRDLKPENLLID--QQGYIQVTDFGFAK--RVKGRT 195

Query: 205 WTEFAGTYGYVA 216
           WT   GT   +A
Sbjct: 196 WT-LCGTPEALA 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 53.7 bits (130), Expect = 6e-09
 Identities = 33/162 (20%), Positives = 64/162 (39%), Gaps = 27/162 (16%)

Query: 50  IGNGGHASVYRA--ELPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKALTE---T 99
           IG G +  V++A         VA+K+    + +      +E      + EV  L      
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVR--VQTG-----EEGMPLSTIREVAVLRHLETF 71

Query: 100 RHRNIVK----FYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
            H N+V+         +       L+ E +++  L   L+       +       ++  +
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDMMFQL 129

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK 196
              L +LH      +VHRD+  +N+L+    +  +ADFG+A+
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 53.9 bits (130), Expect = 7e-09
 Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 24/192 (12%)

Query: 36  EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL 90
           E+ K   +   +Y     +G+G + SV  A +  +   VAVKK   P      +  K   
Sbjct: 19  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTY 76

Query: 91  TEVKALTETRHRNIVKFYGFC--SHARHSF----LLCEFLERGSLAAILNTDAAAQELGW 144
            E++ L   +H N++        + +   F    L+   +    L  I+      Q+L  
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC----QKLTD 131

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
                +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG+A   +  A  
Sbjct: 132 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE 185

Query: 205 WTEFAGTYGYVA 216
            T +  T  Y A
Sbjct: 186 MTGYVATRWYRA 197

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 53.8 bits (130), Expect = 8e-09
 Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 25/155 (16%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKF 107
           +G G ++ V+ A  + + E V VK           V +K+   E+K L   R   NI+  
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITL 96

Query: 108 YGFCSHARHSF---LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-H 163
                    S    L+ E +       +       Q L        +  +  AL Y H  
Sbjct: 97  AD-IVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM 149

Query: 164 DCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKF 197
                I+HRDV   N+++D E+ +  + D+G+A+F
Sbjct: 150 G----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 53.4 bits (129), Expect = 8e-09
 Identities = 49/181 (27%), Positives = 69/181 (38%), Gaps = 34/181 (18%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           +G G +  V  A    + E VAVK     +   + VD  E +  E+       H N+VKF
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI----VDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 108 YGFCSHARHSFLLCEFLERGSL------AAILNTDAAA---QELGWSQRMSVIKGVADAL 158
           YG        +L  E+   G L         +    A     +L        + GV    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--------MAGV---- 118

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW---TEFAGTYGYV 215
            YLH      I HRD+  +NLLLD      ++DFG+A   + +           GT  YV
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYV 174

Query: 216 A 216
           A
Sbjct: 175 A 175

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 54.0 bits (130), Expect = 8e-09
 Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 11/169 (6%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G    V   +   +   VAVK  +   + S   V +     E++ L   RH +I+K 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y   S     F++ E++  G L   +        L   +   + + +   + Y H     
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            +VHRD+  +N+LLD    A +ADFG++  +       T   G+  Y A
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAA 183

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.1 bits (128), Expect = 9e-09
 Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 46/182 (25%)

Query: 38  VKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTE 92
           +K     D        +G G +  V +     ++E  A+K            D  +   E
Sbjct: 10  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARRE 60

Query: 93  VKALTE-TRHRNIVKFYGFC----SHARHSFLLCEFLERGSL-AAILN--------TDAA 138
           V+     ++  +IV+         +  +   ++ E L+ G L + I +         +A+
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120

Query: 139 AQELGWSQRMSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGI 194
                      ++K + +A+ YLH  +    I HRDV  +NLL   +       + DFG 
Sbjct: 121 E----------IMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF 166

Query: 195 AK 196
           AK
Sbjct: 167 AK 168

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 39/192 (20%), Positives = 69/192 (35%), Gaps = 32/192 (16%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVK------------KFHSPLPSDQTVDQKEFLT----- 91
           IG G +  V  A         A+K                P P          +      
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 92  -----EVKALTETRHRNIVKFYGFCSHA--RHSFLLCEFLERGSLAAILNTDAAAQELGW 144
                E+  L +  H N+VK           H +++ E + +G +  +      +++   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
                +IKG+     YLH+     I+HRD+   NLL+  +    +ADFG++   K   + 
Sbjct: 141 FYFQDLIKGI----EYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 205 WTEFAGTYGYVA 216
            +   GT  ++A
Sbjct: 194 LSNTVGTPAFMA 205

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 26/176 (14%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A +  ++  VA+KK     P +     +  L E+K L   RH NI+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91

Query: 109 G-FCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
               +          ++ + +E   L  +L T    Q L        +  +   L Y+H 
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVA 216
                ++HRD+   NLLL+   +  + DFG+A+    D  +    TE      YVA
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE------YVA 193

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 23/184 (12%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEF---LTEVKALT 97
           N F     +G GG   V   ++  + ++ A KK    L   +   +K     L E + L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK----LEKKRIKKRKGEAMALNEKQILE 239

Query: 98  ETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
           +   R +V   Y + +      +L   +  G L   +       + G+ +  +V     +
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVL-TLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEI 295

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGTY 212
              L  LH +    IV+RD+  +N+LLD     H+  +D G+A  +    +      GT 
Sbjct: 296 CCGLEDLHRER---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTIKG-RVGTV 349

Query: 213 GYVA 216
           GY+A
Sbjct: 350 GYMA 353

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 34/174 (19%), Positives = 67/174 (38%), Gaps = 19/174 (10%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G    V  A +      VA+KK   P         K    E+  +    H+NI+   
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLL 90

Query: 109 ------GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
                       +  +++ E ++  +L  ++       EL   +   ++  +   + +LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 144

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                 I+HRD+   N+++  +    + DFG+A+   +     T +  T  Y A
Sbjct: 145 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRA 194

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 23/184 (12%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEF---LTEVKALT 97
           N+F+    +G G    V   +   +    A+K     L  +  V + E    LTE + L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTENRVLQ 203

Query: 98  ETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
            +RH  +    Y F +H R  F++ E+   G L   L+     +E  +S+  +   G  +
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLS-----RERVFSEDRARFYGAEI 257

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGTY 212
             AL YLH +    +V+RD+  +NL+LD   + H+   DFG+ K    D +    F GT 
Sbjct: 258 VSALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMKTFCGTP 313

Query: 213 GYVA 216
            Y+A
Sbjct: 314 EYLA 317

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 51.9 bits (125), Expect = 3e-08
 Identities = 49/181 (27%), Positives = 69/181 (38%), Gaps = 34/181 (18%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLT-EVKALTETRHRNIVKF 107
           +G G +  V  A    + E VAVK     +   + VD  E +  E+       H N+VKF
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKI----VDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 108 YGFCSHARHSFLLCEFLERGSL------AAILNTDAAA---QELGWSQRMSVIKGVADAL 158
           YG        +L  E+   G L         +    A     +L        + GV    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--------MAGV---- 118

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW---TEFAGTYGYV 215
            YLH      I HRD+  +NLLLD      ++DFG+A   + +           GT  YV
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYV 174

Query: 216 A 216
           A
Sbjct: 175 A 175

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 51.5 bits (124), Expect = 4e-08
 Identities = 40/210 (19%), Positives = 69/210 (32%), Gaps = 55/210 (26%)

Query: 36  EIVKATNDFDAKY----CIGNGGHASVYRAELPSREVVAVKKFHSPL-------PSDQTV 84
           +++   +   + Y     I +G + +V          VA+K+  + +           + 
Sbjct: 12  DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSF 71

Query: 85  DQKEFLTEVKALTETRHRNIVKFYG-FCSHARHSF----LLCEFLERGSLAAILNTDAAA 139
             K  L E++ L    H NI+     F      +     L+ E +          TD A 
Sbjct: 72  LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR---------TDLAQ 122

Query: 140 QELGWSQRMSVIKGVADALSYLHHDCF-------------PPIVHRDVSSKNLLLDLEYE 186
                     VI      +S  H   F               +VHRD+   N+LL    +
Sbjct: 123 ----------VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172

Query: 187 AHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             + DF +A+   +D +N T       YV 
Sbjct: 173 ITICDFNLAREDTAD-ANKTH------YVT 195

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 41/184 (22%), Positives = 81/184 (44%), Gaps = 20/184 (10%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEF---LTEVKALT 97
           + F     +G GG   V+  ++  + ++ A KK    L   +   +K +   + E K L 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK----LNKKRLKKRKGYQGAMVEKKILA 240

Query: 98  ETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG--V 154
           +   R IV   Y F +      ++   +  G +   +  +      G+ +  ++     +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVM-TIMNGGDIRYHIY-NVDEDNPGFQEPRAIFYTAQI 298

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGTY 212
              L +LH      I++RD+  +N+LLD   + +V  +D G+A  LK+  +    +AGT 
Sbjct: 299 VSGLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 213 GYVA 216
           G++A
Sbjct: 354 GFMA 357

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 51.1 bits (123), Expect = 5e-08
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 21/177 (11%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G +  V  A   P+ E+VA+KK     P D+ +     L E+K L   +H NI+  +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHENIITIF 75

Query: 109 G-FCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                 +  +F    ++ E ++   L  +++T    Q L        I     A+  LH 
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQT-DLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG 130

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYG----YVA 216
                ++HRD+   NLL++   +  V DFG+A+ +   A++ +E  G       +VA
Sbjct: 131 ---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 26/186 (13%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKE---FLTEVKALT 97
            DF+    IG G    V   +L  + +V A+K     L   + + + E   F  E   L 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREERDVLV 129

Query: 98  ETRHRNIVK-FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV--IKGV 154
               + I    Y F     + +L+ ++   G L  +L+      E    + M+   +  +
Sbjct: 130 NGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEM 184

Query: 155 ADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTE-FAG 210
             A+  +H        VHRD+   N+L+D     H+  ADFG    L  D +  +    G
Sbjct: 185 VIAIDSVHQLH----YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVG 238

Query: 211 TYGYVA 216
           T  Y++
Sbjct: 239 TPDYIS 244

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 50.7 bits (122), Expect = 7e-08
 Identities = 35/168 (20%), Positives = 62/168 (36%), Gaps = 28/168 (16%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G +  V       +    AVK      L      +      E++ L   RH+N+++ 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK-KEIQLLRRLRHKNVIQL 71

Query: 108 YGFCSHA--RHSFLLCEFLERGSLAAILNTDAAAQEL---GWSQRMSVIKGVA------D 156
                +   +  +++ E+   G            QE+      +R  V +         D
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGM-----------QEMLDSVPEKRFPVCQAHGYFCQLID 120

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
            L YLH      IVH+D+   NLLL       ++  G+A+ L   A++
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 50.2 bits (121), Expect = 1e-07
 Identities = 50/192 (26%), Positives = 77/192 (40%), Gaps = 43/192 (22%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEF---LTEVKALT 97
            DF     +G G    V+      +    A+K     L  +  V  K+      E   L+
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRLKQVEHTNDERLMLS 61

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-------NTDA---AAQELGWSQR 147
              H  I++ +G    A+  F++ +++E G L ++L       N  A   AA+       
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------- 114

Query: 148 MSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASN 204
                 V  AL YLH  D    I++RD+  +N+LLD     H+   DFG AK        
Sbjct: 115 ------VCLALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVT 160

Query: 205 WTEFAGTYGYVA 216
           +T   GT  Y+A
Sbjct: 161 YT-LCGTPDYIA 171

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 50.1 bits (120), Expect = 1e-07
 Identities = 34/207 (16%), Positives = 59/207 (28%), Gaps = 58/207 (28%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK-F 107
           +G G    V    ++ S +  A+KK           D +    E+  +    H NI+K  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKV--------LQDPRYKNRELDIMKVLDHVNIIKLV 66

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS------------------ 149
             F +         +  +  +     N              S                  
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 150 VIKGVAD-------------------ALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHV 189
           V+K                       A+ ++H      I HRD+  +NLL++ +     +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183

Query: 190 ADFGIAKFLKSDASNWTEFAGTYGYVA 216
            DFG AK L     +         Y+ 
Sbjct: 184 CDFGSAKKLIPSEPS-VA------YIC 203

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 49.6 bits (119), Expect = 2e-07
 Identities = 39/186 (20%), Positives = 70/186 (37%), Gaps = 37/186 (19%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G GG+  V+ A +    + VA+KK    +        K  L E+K +    H NIVK +
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKK----IVLTDPQSVKHALREIKIIRRLDHDNIVKVF 74

Query: 109 ----------GFCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
                          +        ++ E++E   LA +L        L        +  +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQL 129

Query: 155 ADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASN---WTEFAG 210
              L Y+H      ++HRD+   NL ++ E     + DFG+A+ +    S+    +E   
Sbjct: 130 LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE--- 183

Query: 211 TYGYVA 216
               + 
Sbjct: 184 ---GLV 186

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 37/175 (21%), Positives = 69/175 (39%), Gaps = 21/175 (12%)

Query: 42  NDF--DAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK 94
            +      Y     IG G +  VY A +  + + VA+KK +     +  +D K  L E+ 
Sbjct: 20  KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREIT 77

Query: 95  ALTETRHRNIVKFYG-FCSHARHSF----LLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
            L   +   I++ Y          F    ++ E  +   L  +  T      L      +
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP---IFLTEEHIKT 133

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
           ++  +    +++H      I+HRD+   N LL+ +    V DFG+A+ + S+   
Sbjct: 134 ILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.5 bits (117), Expect = 2e-07
 Identities = 28/199 (14%), Positives = 47/199 (23%), Gaps = 42/199 (21%)

Query: 40  ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLP----SDQTVDQKEFLTEVKA 95
            T        IG G    V++        VA+K      P           +E L E+  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 96  LTE---------TRHRNIVKFYGF--CSHARHSFLLCEFL----ERGSLAAILNTDAAAQ 140
             E          R    +          +    LL  +      +GS     +     Q
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 141 --------------------ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLL 180
                                   +   S++  +  +L+           HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194

Query: 181 LDLEYEAHVADFGIAKFLK 199
           L       +      K   
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 48.8 bits (117), Expect = 3e-07
 Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 30/178 (16%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G    V  A    +++ VA+K      L       + E   E+  L   RH +I+K 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74

Query: 108 YGFCSHARHSFLLCEF---------LERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
           Y   +      ++ E+         +E+  +     T+   +     Q +        A+
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYIVEKKRM-----TEDEGRRFFQ-QIIC-------AI 121

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            Y H      IVHRD+  +NLLLD      +ADFG++  +       T   G+  Y A
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 175

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.2 bits (115), Expect = 5e-07
 Identities = 38/172 (22%), Positives = 67/172 (38%), Gaps = 37/172 (21%)

Query: 50  IGNGGHASVYRAE---------LPSREVVAVK--KFHSPLPSDQTVDQKEF----LTEVK 94
                   +Y A           P ++  ++K       L ++Q   Q+      + + K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 95  ALTETRHRNIVKFYGFCSH-ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKG 153
            L  T    I    GF  H  ++ FL+   L R SL + L+             +S  + 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP-------KHVLS-ERS 160

Query: 154 VA-------DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK 196
           V        DAL +LH + +   VH +V+++N+ +D E ++ V  A +G A 
Sbjct: 161 VLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.8 bits (114), Expect = 7e-07
 Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 39/173 (22%)

Query: 50  IGNGGHASVYRAELPSREVVAVK---------KFHSPLPSD----QTVDQKEFLTEVKAL 96
           IG GG   +Y A++ S E V              + PL ++    Q   + E + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 97  TETRHRNIVKFYGFCSH----ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
            + ++  + K++G   H      + F++ +      L  I   +        ++R S  K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN--------AKRFS-RK 152

Query: 153 GVA-------DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK 196
            V        D L Y+H   +   VH D+ + NLLL+ +    V   D+G+A 
Sbjct: 153 TVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 47.6 bits (113), Expect = 1e-06
 Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 9/62 (14%)

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGTYGY 214
            L ++H+     +V+RD+   N+LLD     HV  +D G+A        +     GT+GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPH--ASVGTHGY 356

Query: 215 VA 216
           +A
Sbjct: 357 MA 358

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 38/171 (22%), Positives = 64/171 (37%), Gaps = 38/171 (22%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVK------KFHSPLPSD----QTVDQKEFLTEVKALTE 98
           IG+GG   +Y A      E  A        + + PL S+    Q V +K+ + +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 99  TRHRNIVKFYGFCSHA----RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGV 154
             +  I  FYG          + F++ E L    L  I            +        V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISG---------QNGTFK-KSTV 153

Query: 155 A-------DALSYLHHDCFPPIVHRDVSSKNLLLDLEYE--AHVADFGIAK 196
                   D L Y+H + +   VH D+ + NLLL  +     ++AD+G++ 
Sbjct: 154 LQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 2e-06
 Identities = 37/214 (17%), Positives = 64/214 (29%), Gaps = 70/214 (32%)

Query: 22  DGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVA--VKKFHSPLP 79
              IP  +  +++ +++K+                     +L    +V    K+    +P
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVN--------------KLHKYSLVEKQPKESTISIP 429

Query: 80  SDQTVDQKEFLTEVKALTETRHRNIVKFYG------------------FCSH-ARHSFLL 120
               ++ K  L    AL    HR+IV  Y                   F SH   H    
Sbjct: 430 -SIYLELKVKLENEYAL----HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH-LKN 483

Query: 121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLL 180
            E  ER +L  ++  D       + ++    K        + HD         +   N L
Sbjct: 484 IEHPERMTLFRMVFLD-----FRFLEQ----K--------IRHDSTAWNASGSIL--NTL 524

Query: 181 LDLE-YEAHVAD---------FGIAKFLKSDASN 204
             L+ Y+ ++ D           I  FL     N
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN 558

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 43.8 bits (104), Expect = 2e-05
 Identities = 25/67 (37%), Positives = 40/67 (59%), Gaps = 11/67 (16%)

Query: 154 VADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDASNWTEFA 209
           +A AL YLH  +    IV+RD+  +N+LLD   + H+   DFG+ K  ++ +++  T F 
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLD--SQGHIVLTDFGLCKENIEHNSTTST-FC 200

Query: 210 GTYGYVA 216
           GT  Y+A
Sbjct: 201 GTPEYLA 207

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 43.4 bits (103), Expect = 2e-05
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 42/193 (21%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEF---LTEVKALT 97
           NDFD    +G G    V       +    A+K     L  +  + + E    +TE + L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI----LRKEVIIAKDEVAHTVTESRVLQ 60

Query: 98  ETRHRNIVK-FYGFCSHARHSFLLCEFLERGSL------AAILNTDAA---AQELGWSQR 147
            TRH  +    Y F +H R  F++ E+   G L        +   + A     E      
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAE------ 113

Query: 148 MSVIKGVADALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDAS 203
                 +  AL YLH  D    +V+RD+  +NL+LD   + H+   DFG+ K  +   A+
Sbjct: 114 ------IVSALEYLHSRD----VVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGAT 161

Query: 204 NWTEFAGTYGYVA 216
             T F GT  Y+A
Sbjct: 162 MKT-FCGTPEYLA 173

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 42.7 bits (101), Expect = 4e-05
 Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 10/64 (15%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTE-FAGTY 212
           AL +LH       I++RD+  +N+LLD     HV   DFG++K   +D +     F GT 
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 213 GYVA 216
            Y+A
Sbjct: 225 EYMA 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 42.2 bits (100), Expect = 5e-05
 Identities = 25/64 (39%), Positives = 34/64 (53%), Gaps = 11/64 (17%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDASNWTEFAGTY 212
            L +LH       IV+RD+   N+LLD   + H+  ADFG+ K  +  DA   T F GT 
Sbjct: 130 GLQFLHSKG----IVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNT-FCGTP 182

Query: 213 GYVA 216
            Y+A
Sbjct: 183 DYIA 186

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 41.8 bits (99), Expect = 7e-05
 Identities = 21/63 (33%), Positives = 34/63 (53%), Gaps = 9/63 (14%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGTYG 213
           AL +LH       I++RD+  +N++L+  ++ HV   DFG+ K    D +    F GT  
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186

Query: 214 YVA 216
           Y+A
Sbjct: 187 YMA 189

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 41.8 bits (99), Expect = 8e-05
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 11/64 (17%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDASNWTEFAGTY 212
           AL +LH       I++RD+   N+LLD  +E H   ADFG+ K  + +  +  T F GT 
Sbjct: 136 ALMFLHDKG----IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTAT-FCGTP 188

Query: 213 GYVA 216
            Y+A
Sbjct: 189 DYIA 192

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 41.9 bits (98), Expect = 8e-05
 Identities = 22/65 (33%), Positives = 32/65 (49%), Gaps = 7/65 (10%)

Query: 154 VADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGT 211
           +A  L +L       I++RD+   N++LD   E H+  ADFG+ K    D      F GT
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGT 505

Query: 212 YGYVA 216
             Y+A
Sbjct: 506 PDYIA 510

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.4 bits (98), Expect = 9e-05
 Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 11/64 (17%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDASNWTEFAGTY 212
           AL +LH       I++RD+  +N+LLD   E H+   DFG++K  +  +   ++ F GT 
Sbjct: 138 ALDHLHSLG----IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYS-FCGTV 190

Query: 213 GYVA 216
            Y+A
Sbjct: 191 EYMA 194

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 11/64 (17%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDASNWTEFAGTY 212
           AL+YLH       I++RD+   N+LLD   E H+   D+G+ K  L+   +  T F GT 
Sbjct: 122 ALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 174

Query: 213 GYVA 216
            Y+A
Sbjct: 175 NYIA 178

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 11/64 (17%)

Query: 157 ALSYLH-HDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDASNWTEFAGTY 212
           AL+YLH       I++RD+   N+LLD   E H+   D+G+ K  L+   +  T F GT 
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 217

Query: 213 GYVA 216
            Y+A
Sbjct: 218 NYIA 221

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 40.6 bits (96), Expect = 2e-04
 Identities = 8/30 (26%), Positives = 13/30 (43%)

Query: 3   SEVGLLSHLEVLHIQLNRLDGSIPPEVGKI 32
             +  L +L  +    NR+ G+IP   G  
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSF 172

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 39.4 bits (93), Expect = 5e-04
 Identities = 7/29 (24%), Positives = 14/29 (48%)

Query: 3   SEVGLLSHLEVLHIQLNRLDGSIPPEVGK 31
             +  L+ L  L+I    + G+IP  + +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 39/188 (20%), Positives = 67/188 (35%), Gaps = 38/188 (20%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G    ++    L + + VA+K       + Q  D+       K L       I   Y
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTY---KLLAGCTG--IPNVY 72

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA-------DALSYL 161
            F     H+ L+ + L   SL  +L+           ++ S +K VA         +  +
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SLEDLLDL--------CGRKFS-VKTVAMAAKQMLARVQSI 122

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEA-----HVADFGIAKFLKSDASNW-------TEFA 209
           H       V+RD+   N L+           +V DFG+ KF +   +            +
Sbjct: 123 HEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179

Query: 210 GTYGYVAL 217
           GT  Y+++
Sbjct: 180 GTARYMSI 187

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 22/154 (14%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKF 107
           +G G +  V+++ +  + EVVAVKK         + D +    E+  LTE   H NIV  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 108 Y------GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
                        R  +L+ +++E   L A++        L    +  V+  +   + YL
Sbjct: 75  LNVLRADND----RDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYL 125

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA 195
           H      ++HRD+   N+LL+ E    VADFG++
Sbjct: 126 HS---GGLLHRDMKPSNILLNAECHVKVADFGLS 156

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.3 bits (94), Expect = 2e-04
 Identities = 26/141 (18%), Positives = 49/141 (34%), Gaps = 23/141 (16%)

Query: 50  IGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTV-DQKEFLTEVKALTE-TRH 101
           +G G    V  A+        +   VAVK     L    T  + +  ++E+K L     H
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 85

Query: 102 RNIVKFYGFCSHARHSFLLC-EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
            N+V   G C+      ++  EF + G+L+  L           S+R   +        +
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARF 135

Query: 161 LHHDCFPPIVHRDVSSKNLLL 181
                +   +  D+  +   +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSI 156

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 40.3 bits (95), Expect = 3e-04
 Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 9/63 (14%)

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAK-FLKSDASNWTEFAGTYG 213
            L +L       I++RD+   N++LD   E H+  ADFG+ K  +    +  T F GT  
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 186

Query: 214 YVA 216
           Y+A
Sbjct: 187 YIA 189

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 33/163 (20%), Positives = 57/163 (34%), Gaps = 37/163 (22%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVK--KFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIV 105
           IG G    +   + L + E VA+K     S  P            E +   +      I 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--------LHLEYRFYKQLGSGDGIP 68

Query: 106 KFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA-------DAL 158
           + Y F    +++ ++ E L   SL  + +           +  S +K V          +
Sbjct: 69  QVYYFGPCGKYNAMVLELLGP-SLEDLFDLC--------DRTFS-LKTVLMIAIQLISRM 118

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEA-----HVADFGIAK 196
            Y+H       ++RDV  +N L+           H+ DF +AK
Sbjct: 119 EYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 39.6 bits (92), Expect = 5e-04
 Identities = 38/183 (20%), Positives = 71/183 (38%), Gaps = 36/183 (19%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G    +Y    + + E VA+K  +      Q + + +     + L       I    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIY---RILQGGTG--IPNVR 69

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA-------DALSYL 161
            F     ++ L+ + L   SL  + N          S+++S +K V        + + ++
Sbjct: 70  WFGVEGDYNVLVMDLLGP-SLEDLFNFC--------SRKLS-LKTVLMLADQMINRVEFV 119

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAH---VADFGIAKFLKSDASNW-------TEFAGT 211
           H   F   +HRD+   N L+ L   A+   + DFG+AK  +  +++            GT
Sbjct: 120 HSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

Query: 212 YGY 214
             Y
Sbjct: 177 ARY 179

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 38.8 bits (90), Expect = 7e-04
 Identities = 29/181 (16%), Positives = 54/181 (29%), Gaps = 37/181 (20%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQK------EFLTEVKALTETRHR 102
            +G G  ++V+           VK       S + V +K       F            R
Sbjct: 97  LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 156

Query: 103 NIVKFYGFCSHARHSF----LLCEFLERGSLAAILNTDAAA--QELGWSQRMSVIKGVAD 156
            + K  G      +++    +L E ++   L  +   +       +         +G   
Sbjct: 157 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG--- 213

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA---------KFLKSDASNWTE 207
                       IVH D+S  N+L+  E    + DF  +         + L+ D  N   
Sbjct: 214 ------------IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIIT 260

Query: 208 F 208
           +
Sbjct: 261 Y 261

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	219
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.98
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.98
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.98
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.98
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.98
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.98
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.97
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.96
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.95
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.95
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.95
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.95
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.95
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.53
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.25
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.03
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.0
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.91
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.45
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.45
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.43
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.34
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.04
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.04
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.02
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.9
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.73
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.83
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.73
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.21
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.18
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.72
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.11
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.72
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.22

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-43  Score=283.47  Aligned_cols=173  Identities=22%  Similarity=0.309  Sum_probs=144.2

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++++.||+|+||.||+| ...+++.||||.+.....  .......+.+|+.+++.++||||+++++++.+++.+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            578999999999999999999 567899999999865432  23345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      |||||++|+|.+++..... ..+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       101 VmEy~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEeCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999965332 2367888999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+||+.|||||+
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~  196 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEI  196 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHH
T ss_pred             CCcccccccCCCccccCHHH
Confidence            43333345689999999994

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-43  Score=281.64  Aligned_cols=168  Identities=27%  Similarity=0.389  Sum_probs=149.2

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ...|++.++||+|+||.||+| ...+|+.||||++.....    .....+.+|+.+++.++||||++++++|.+++.+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            356999999999999999999 566899999999864321    123457889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      |||||++|+|.+++...    .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       149 vmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            99999999999998642    388999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+||+.|||||+
T Consensus       222 ~~~~~~~~~~GTp~YmAPEv  241 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPEL  241 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHH
T ss_pred             CCCCcccccccCcCcCCHHH
Confidence            66555667899999999994

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.5e-43  Score=278.23  Aligned_cols=171  Identities=23%  Similarity=0.350  Sum_probs=148.6

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| +..+++.||+|.+...... .......+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            57999999999999999999 5678999999998532111 112345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||||.+|+|.+++...+   .+++..+..++.|++.|+.|||++   +|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999997543   388999999999999999999999   999999999999999999999999999998754


Q ss_pred             CC--CcccccccccccccCCC
Q 039002          201 DA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ..  .....++||+.|||||+
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEv  205 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPEL  205 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHH
T ss_pred             CCCcccccCcccCcccCCHHH
Confidence            32  23356799999999994

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=283.84  Aligned_cols=168  Identities=27%  Similarity=0.389  Sum_probs=149.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+.|++.++||+|+||.||+| ...+|+.||||++.....    .....+.+|+.+++.++||||++++++|.+.+.+||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            456999999999999999999 567899999999865322    223457899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      |||||.+|+|.+++...    .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       226 VmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            99999999999998643    388899999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+||+.|||||+
T Consensus       299 ~~~~~~~~~~GTp~YmAPEv  318 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPEL  318 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHH
T ss_pred             CCCccccccccCcCcCCHHH
Confidence            66555667899999999994

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-41  Score=266.40  Aligned_cols=171  Identities=22%  Similarity=0.350  Sum_probs=132.7

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+....... ......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            35899999999999999999994 5689999999986543332 234567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +||||+ +|+|.+.+...+   .+++..+..++.|++.|+.|+|++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        90 ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             EEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             EEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeec
Confidence            999999 679999886543   388999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .... .....+||+.|||||+
T Consensus       163 ~~~~-~~~~~~GT~~Y~APE~  182 (275)
T 3hyh_A          163 TDGN-FLKTSCGSPNYAAPEV  182 (275)
T ss_dssp             -------------CTTSCHHH
T ss_pred             CCCC-ccCCeeECcccCChhh
Confidence            5432 2345799999999994

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.8e-41  Score=267.51  Aligned_cols=173  Identities=23%  Similarity=0.445  Sum_probs=136.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|++++.||+|+||.||+| ...+++.||+|++...   ........+.+|+.+++.++||||++++++|.+.+    
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~   80 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK   80 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC---SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence            457999999999999999999 5668999999998643   22334567889999999999999999999997544    


Q ss_pred             --------cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcE
Q 039002          116 --------HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA  187 (219)
Q Consensus       116 --------~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~  187 (219)
                              .+|++||||.+|+|.+++..........+..+..++.|++.|+.|||++   +|+||||||+|||++.+|.+
T Consensus        81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence                    3689999999999999997655434455666788999999999999999   99999999999999999999


Q ss_pred             EEeeccceeeecCCCCc------------ccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDASN------------WTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~  219 (219)
                      ||+|||+|+.+......            ....+||+.|||||+
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~  201 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ  201 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHH
Confidence            99999999877543211            133589999999994

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.6e-42  Score=271.80  Aligned_cols=170  Identities=25%  Similarity=0.321  Sum_probs=139.5

Q ss_pred             CCCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           42 NDFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ++|++.+.||+|+||.||+|+.    .+++.||+|.+.......  .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            5799999999999999999953    357789999986432221  1223567899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |+|||||++|+|.+++...+   .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            99999999999999997543   388999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........+||+.|||||+
T Consensus       176 ~~~~~~~~~~~~GT~~YmAPE~  197 (304)
T 3ubd_A          176 SIDHEKKAYSFCGTVEYMAPEV  197 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHH
T ss_pred             ccCCCccccccccCcccCCHHH
Confidence            6555444566799999999994

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-40  Score=261.55  Aligned_cols=168  Identities=22%  Similarity=0.366  Sum_probs=141.0

Q ss_pred             CCC-CCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe----CC
Q 039002           42 NDF-DAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH----AR  115 (219)
Q Consensus        42 ~~y-~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~  115 (219)
                      ++| ++.++||+|+||.||+| ...++..||+|.+.....  .......+.+|+.+++.++||||++++++|.+    .+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            444 67778999999999999 566888999999864322  22344678899999999999999999999865    34


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeC-CCCcEEEeec
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLD-LEYEAHVADF  192 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~-~~~~~kl~df  192 (219)
                      .+|+|||||++|+|.+++....   .+++..+..++.|++.||.|||++   +  |+||||||+|||++ .+|.+||+||
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeC
Confidence            5899999999999999997543   378899999999999999999998   6  99999999999997 4799999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |+|+.....  .....+||+.|||||+
T Consensus       177 Gla~~~~~~--~~~~~~GTp~YmAPE~  201 (290)
T 3fpq_A          177 GLATLKRAS--FAKAVIGTPEFMAPEM  201 (290)
T ss_dssp             TGGGGCCTT--SBEESCSSCCCCCGGG
T ss_pred             cCCEeCCCC--ccCCcccCccccCHHH
Confidence            999754332  3356799999999995

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=264.10  Aligned_cols=173  Identities=24%  Similarity=0.367  Sum_probs=141.8

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      |....+++++.++||+|+||.||+|.+..  .||||.++...  ........+.+|+.++++++||||+++++++. .+.
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~  105 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN  105 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence            44556789999999999999999997654  58999986432  22334567899999999999999999999875 467


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      ++||||||++|+|.+++....  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCce
Confidence            899999999999999986533  2388999999999999999999998   99999999999999999999999999998


Q ss_pred             eecCCC--CcccccccccccccCCC
Q 039002          197 FLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ......  ......+||+.|||||+
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~  205 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEV  205 (307)
T ss_dssp             C------------CCCCTTSCCHHH
T ss_pred             ecccCCcceeecccccCCCccCHHH
Confidence            764322  22345689999999994

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.8e-40  Score=266.96  Aligned_cols=164  Identities=26%  Similarity=0.309  Sum_probs=139.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+.|++.++||+|+||.||+| ...+|+.||||+++....         ..+|+.+++.++||||+++++++.+++.+||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456788889999999999999 567899999999864321         1369999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~  198 (219)
                      ||||+++|+|.+++...+   .+++..+..++.|++.||.|||++   +|+||||||+|||++.+| .+||+|||+|+.+
T Consensus       128 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            999999999999997543   388999999999999999999999   999999999999999987 6999999999977


Q ss_pred             cCCCC-----cccccccccccccCCC
Q 039002          199 KSDAS-----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~-----~~~~~~gt~~y~aPE~  219 (219)
                      .....     ....++||+.|||||+
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~  227 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEV  227 (336)
T ss_dssp             ------------CCCCCCGGGCCHHH
T ss_pred             cCCCcccceecCCccccCccccCHHH
Confidence            54321     1234689999999994

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.3e-40  Score=263.38  Aligned_cols=172  Identities=26%  Similarity=0.424  Sum_probs=143.3

Q ss_pred             hCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++|.+.+.||+|+||.||+|.+.      ++..||||.++..    .....+.+.+|+.++++++||||+++++++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            357888999999999999999642      4678999998642    233456789999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccch----------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA----------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE  184 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~  184 (219)
                      +..+||||||++|+|.+++...+.          ...+++..+..++.|++.|+.|||++   +|+||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            999999999999999999965321          23488999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          185 YEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +.+||+|||+++........  .....||+.|||||+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~  201 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  201 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHH
Confidence            99999999999865433221  123479999999994

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.4e-40  Score=262.28  Aligned_cols=173  Identities=17%  Similarity=0.277  Sum_probs=143.8

Q ss_pred             hCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .+++++.++||+|+||.||+|.+      .+++.||||.++...   .....+.+.+|+.++++++||||+++++++.+.
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            45677889999999999999964      246789999986532   223446789999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL  181 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili  181 (219)
                      +..++|||||++|+|.+++.....             ...+++..+..++.|++.||.|||++   +|+||||||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            999999999999999999854211             12378899999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeccceeeecCCC--CcccccccccccccCCC
Q 039002          182 DLEYEAHVADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       182 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      +.++.+||+|||+++......  ......+||+.|||||+
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~  218 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEA  218 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHH
Confidence            999999999999998664322  22244689999999994

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.4e-40  Score=263.38  Aligned_cols=172  Identities=26%  Similarity=0.443  Sum_probs=137.9

Q ss_pred             hCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      ..+|.+.++||+|+||.||+|.+.      +++.||||.++..    .......+.+|+.++++++||||+++++++.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            356777889999999999999643      4778999998642    233456789999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccch------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAA------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      +..+|||||+++|+|.+++.....            ...+++..+..++.|++.||.|||+.   +|+||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            999999999999999999865321            12378999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          183 LEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      .++.+||+|||+++.......  .....+||+.|||||+
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~  231 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES  231 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhh
Confidence            999999999999987643321  2234689999999994

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=258.97  Aligned_cols=169  Identities=25%  Similarity=0.413  Sum_probs=142.7

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------C
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------A  114 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~  114 (219)
                      ++|++++.||+|+||.||+| +..+|+.||||+++...  ........+.+|+.+|+.++||||+++++++..      .
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            57999999999999999999 56789999999986532  223345677899999999999999999998754      3


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +.+|+||||+. |+|.+++...+   .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            67899999995 68999887643   388999999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCC----CcccccccccccccCCC
Q 039002          195 AKFLKSDA----SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~----~~~~~~~gt~~y~aPE~  219 (219)
                      |+.+....    ......+||+.|||||+
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv  233 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPEL  233 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHH
T ss_pred             eeecccCccccccccccceeChHhcCHHH
Confidence            98764321    22345799999999994

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-38  Score=256.03  Aligned_cols=180  Identities=21%  Similarity=0.327  Sum_probs=148.4

Q ss_pred             HHHHHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC-Cccce
Q 039002           34 YDEIVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVK  106 (219)
Q Consensus        34 ~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~  106 (219)
                      .++|..+.++|++.+.||+|+||.||+|.+.      .++.||+|.+....   .......+.+|+.++++++| |||++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            3567888899999999999999999999532      24579999986432   22345678899999999965 89999


Q ss_pred             eEeEEEeC-CcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEec
Q 039002          107 FYGFCSHA-RHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHR  172 (219)
Q Consensus       107 ~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~  172 (219)
                      ++++|... +.++||||||++|+|.+++.....             ...+++..+..++.|++.||.|||++   +|+||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            99998664 568999999999999999965321             12378889999999999999999999   99999


Q ss_pred             CCCCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          173 DVSSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       173 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ||||+|||++.++.+||+|||+|+.+.....  .....+||+.|||||+
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~  258 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  258 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHH
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHH
Confidence            9999999999999999999999987654332  2234689999999994

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-37  Score=248.87  Aligned_cols=168  Identities=28%  Similarity=0.339  Sum_probs=133.8

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----cc
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----HS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~  117 (219)
                      .+|.+.++||+|+||.||+|.+ +|+.||||++...     .........|+..+..++||||+++++++...+    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~-----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            3577889999999999999976 5789999998531     112222234666667889999999999997654    57


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC-----CCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC-----FPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                      ||||||+++|+|.+++...    .+++..+..++.|++.|+.|+|+..     ..+|+||||||+|||++.++.+||+||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            9999999999999999653    3788899999999999999999751     238999999999999999999999999


Q ss_pred             cceeeecCCCCc----ccccccccccccCCC
Q 039002          193 GIAKFLKSDASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~----~~~~~gt~~y~aPE~  219 (219)
                      |+++........    ....+||+.|||||+
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~  183 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHH
T ss_pred             CCCccccCCCCceeeecccccccccccCHHH
Confidence            999887654322    133589999999994

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.2e-38  Score=269.46  Aligned_cols=171  Identities=20%  Similarity=0.235  Sum_probs=143.4

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHH---HHHHHhcCCCCccceeEeEEEeCC
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ..++|++.+.||+|+||.||+| ...+|+.||+|.+....... ......+.+   ++.+++.++||||++++++|.+.+
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~-~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch-hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            3578999999999999999999 56789999999985321110 111122333   356677889999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .+|+||||++||+|.+++...+   .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccccee
Confidence            9999999999999999997643   388999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.+....  ..+++||+.|||||+
T Consensus       340 ~~~~~~~--~~t~~GTp~YmAPEv  361 (689)
T 3v5w_A          340 CDFSKKK--PHASVGTHGYMAPEV  361 (689)
T ss_dssp             EECSSCC--CCSCCSCGGGCCHHH
T ss_pred             eecCCCC--CCCccCCcCccCHHH
Confidence            8775443  345799999999994

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-36  Score=248.06  Aligned_cols=166  Identities=27%  Similarity=0.351  Sum_probs=139.5

Q ss_pred             HHhCCCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEe
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSH  113 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  113 (219)
                      ...++|++.+.||+|+||.||+|..    .+++.||+|.+...      .....+.+|+.+++.+ +||||++++++|.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            3457899999999999999999942    35678999988542      1234578899999988 69999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEeec
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADF  192 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~df  192 (219)
                      .+.+|+||||+++++|.+++..      +++..+..++.|++.|+.|||++   +|+||||||+|||++.+ +.+||+||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCEEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            9999999999999999998842      77888999999999999999999   99999999999999876 89999999


Q ss_pred             cceeeecCCCC----------------------------cccccccccccccCCC
Q 039002          193 GIAKFLKSDAS----------------------------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~  219 (219)
                      |+|+.......                            .....+||+.|+|||+
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~  217 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEV  217 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence            99986543211                            1234589999999994

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-36  Score=259.97  Aligned_cols=169  Identities=20%  Similarity=0.364  Sum_probs=147.2

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++.+.||+|+||.||+| ...+|+.||+|.+...    .......+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            468999999999999999999 5678999999998642    22345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC--CcEEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE--YEAHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~--~~~kl~dfg~~~~  197 (219)
                      +|||+.+|+|.+++....  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.
T Consensus       232 v~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            999999999999886432  2378899999999999999999999   99999999999999854  8999999999998


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +... ......+||+.|||||+
T Consensus       307 ~~~~-~~~~~~~GT~~y~APEv  327 (573)
T 3uto_A          307 LDPK-QSVKVTTGTAEFAAPEV  327 (573)
T ss_dssp             CCTT-SEEEEECSSGGGCCHHH
T ss_pred             ccCC-CceeeeEECccccCHHH
Confidence            7543 33455789999999994

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.4e-33  Score=223.16  Aligned_cols=169  Identities=22%  Similarity=0.423  Sum_probs=148.5

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+....    ......+.+|+.+++.++||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            45789999999999999999994 5788899999986422    123456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++|||+.+++|.+++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999998653    377888999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........||+.|+|||+
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~  187 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEV  187 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHH
T ss_pred             CCcccccCCccCCcCccChhh
Confidence            665555566789999999984

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.4e-34  Score=230.77  Aligned_cols=172  Identities=24%  Similarity=0.307  Sum_probs=147.1

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            4789999999999999999994 567899999998532100 11233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+++++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.+|.+||+|||+++...
T Consensus        83 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999886532   378889999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+||+.|+|||+
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~  176 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEV  176 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGG
T ss_pred             cCCCcccccccChhhCChhh
Confidence            44444566799999999995

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.6e-34  Score=234.65  Aligned_cols=174  Identities=25%  Similarity=0.327  Sum_probs=146.9

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      ...++|++.+.||+|+||.||+|. ..+++.+|+|.++....... .....+.+|..++..+ +||||+++++++.+.+.
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            346789999999999999999994 56788999999865432222 2234467788888776 89999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +++||||+.+|+|..++....   .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+|.+||+|||+++
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence            999999999999999887543   378899999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............+||+.|+|||+
T Consensus       202 ~~~~~~~~~~~~~gt~~Y~aPE~  224 (396)
T 4dc2_A          202 EGLRPGDTTSTFCGTPNYIAPEI  224 (396)
T ss_dssp             CCCCTTCCBCCCCBCGGGCCHHH
T ss_pred             ecccCCCccccccCCcccCCchh
Confidence            65444445566799999999994

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-33  Score=227.32  Aligned_cols=171  Identities=25%  Similarity=0.413  Sum_probs=148.3

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|.+.....  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            3588999999999999999999 457899999999865322  2234466789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +||||+++++|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        91 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             EEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            9999999999999986543   378889999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ... ......+||+.|+|||+
T Consensus       165 ~~~-~~~~~~~gt~~y~aPE~  184 (328)
T 3fe3_A          165 TVG-GKLDAFCGAPPYAAPEL  184 (328)
T ss_dssp             SSS-CGGGTTSSSGGGCCHHH
T ss_pred             CCC-CccccccCCcceeCccc
Confidence            433 23456789999999994

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.9e-34  Score=232.40  Aligned_cols=174  Identities=24%  Similarity=0.344  Sum_probs=140.9

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      ...++|++.+.||+|+||.||+|. ..+++.||+|.++..... .......+.+|..+++.+ +||||+++++++.+.+.
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            446899999999999999999994 567899999998532111 112335567899999888 79999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +|+||||+.+++|..++....   .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+|.+||+|||+++
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence            999999999999999986543   378899999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............+||+.|+|||+
T Consensus       173 ~~~~~~~~~~~~~gt~~y~aPE~  195 (353)
T 3txo_A          173 EGICNGVTTATFCGTPDYIAPEI  195 (353)
T ss_dssp             CSCC---------CCGGGCCHHH
T ss_pred             ecccCCccccccCCCcCeEChhh
Confidence            65444444456789999999994

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-33  Score=228.05  Aligned_cols=172  Identities=26%  Similarity=0.333  Sum_probs=147.5

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+....... ......+.+|..+++.+ +||||+++++++.+.+..+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            4689999999999999999995 5678899999986543222 23445677899999887 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++|||+.+++|..++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.+|.+||+|||+++..
T Consensus        87 lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999999999999886532   378899999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+||+.|+|||+
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~  181 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEI  181 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHH
T ss_pred             cCCCCcccccCCCccccCccc
Confidence            444444456789999999994

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.4e-33  Score=222.33  Aligned_cols=173  Identities=22%  Similarity=0.432  Sum_probs=142.8

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+....   .......+.+|+.+++.++||||+++++++...+    
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            4679999999999999999995 5588999999986532   2234567889999999999999999999986543    


Q ss_pred             -----------------------------------------------------cceEEEEecCCCCHHHHhcccchhhcc
Q 039002          116 -----------------------------------------------------HSFLLCEFLERGSLAAILNTDAAAQEL  142 (219)
Q Consensus       116 -----------------------------------------------------~~~lv~e~~~~~~l~~~~~~~~~~~~l  142 (219)
                                                                           ..+++||++.+++|.+++.........
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 278999999999999999875544445


Q ss_pred             CHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC------------ccccccc
Q 039002          143 GWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS------------NWTEFAG  210 (219)
Q Consensus       143 ~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~g  210 (219)
                      .+..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++........            ......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            6667889999999999999999   999999999999999999999999999987765421            1233579


Q ss_pred             ccccccCCC
Q 039002          211 TYGYVALGI  219 (219)
Q Consensus       211 t~~y~aPE~  219 (219)
                      |+.|+|||+
T Consensus       239 t~~y~aPE~  247 (332)
T 3qd2_B          239 TKLYMSPEQ  247 (332)
T ss_dssp             CGGGSCHHH
T ss_pred             CcCccChHH
Confidence            999999984

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.7e-33  Score=225.73  Aligned_cols=173  Identities=23%  Similarity=0.341  Sum_probs=136.1

Q ss_pred             hCCCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|..    .+++.+|+|.++.............+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            47899999999999999999954    57889999998754322222334556789999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999986532   377888899999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............+||+.|+|||+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~  192 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEI  192 (327)
T ss_dssp             ---------CTTSSCCTTSCHHH
T ss_pred             ccccCCccccccCCCcCccCHhh
Confidence            65444433455689999999984

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-33  Score=229.49  Aligned_cols=176  Identities=24%  Similarity=0.340  Sum_probs=145.6

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHA  114 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  114 (219)
                      .....++|++.+.||+|+||.||+|. ..+++.||+|.++..... .......+..|..++..+ +||||+++++++.+.
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            34567899999999999999999995 567889999998542110 011234567788888876 899999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..+++|||+.+|+|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.+|.+||+|||+
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence            99999999999999999986532   378899999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++............+||+.|+|||+
T Consensus       165 a~~~~~~~~~~~~~~gt~~y~aPE~  189 (345)
T 1xjd_A          165 CKENMLGDAKTNTFCGTPDYIAPEI  189 (345)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHH
T ss_pred             hhhcccCCCcccCCCCCcccCChhh
Confidence            9865444444456789999999994

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1e-32  Score=218.69  Aligned_cols=170  Identities=22%  Similarity=0.337  Sum_probs=145.3

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|.+.....  .......+.+|+.+++.++||||+++++++.+++..+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            68999999999999999999 456788999999875432  223446678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||++.+ ++...+....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            999975 5555554322  2378899999999999999999999   999999999999999999999999999988766


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........||+.|+|||+
T Consensus       154 ~~~~~~~~~~t~~y~aPE~  172 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDV  172 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHH
T ss_pred             ccccccCCccccCCcChHH
Confidence            5555566789999999983

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.2e-33  Score=222.02  Aligned_cols=178  Identities=34%  Similarity=0.471  Sum_probs=141.0

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .+....++|++.+.||+|+||.||+|.. +++.+|+|.+.....  .......+.+|+.+++.++||||+++++++...+
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3455667899999999999999999965 577899999865432  2334466889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeCCCCcEEEeecc
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      ..+++|||+.+++|.+++........+++..+..++.|++.|+.|||+.   +  ++||||||+||+++.++.++|+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            9999999999999999997655444588899999999999999999998   8  9999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++..............||+.|+|||+
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~  210 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEV  210 (309)
T ss_dssp             -----------------CCTTSCHHH
T ss_pred             CCccccccccccccCCCCccccChhh
Confidence            99865544333445689999999984

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-32  Score=218.63  Aligned_cols=170  Identities=27%  Similarity=0.460  Sum_probs=145.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+..    ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            468899999999999999999 456788999998753    233455678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            999999999999997532  2378899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcc--------------cccccccccccCCC
Q 039002          200 SDASNW--------------TEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~--------------~~~~gt~~y~aPE~  219 (219)
                      ......              ....||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM  193 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHH
Confidence            432211              14579999999983

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-33  Score=229.35  Aligned_cols=171  Identities=23%  Similarity=0.372  Sum_probs=146.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            478999999999999999999 5667889999987532111 11233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|..++....   .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+|.++|+|||++..+.
T Consensus        93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            999999999999987543   378899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .. ......+||+.|+|||+
T Consensus       167 ~~-~~~~~~~gt~~Y~aPE~  185 (384)
T 4fr4_A          167 RE-TQITTMAGTKPYMAPEM  185 (384)
T ss_dssp             TT-CCBCCCCSCGGGCCGGG
T ss_pred             CC-CceeccCCCccccCCee
Confidence            43 23356789999999995

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-32  Score=224.23  Aligned_cols=172  Identities=25%  Similarity=0.345  Sum_probs=147.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc--hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ--TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+........  ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999 556789999999865432211  12346688999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC----cEEEeecc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY----EAHVADFG  193 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~----~~kl~dfg  193 (219)
                      +++|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++    .++|+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999997543   378899999999999999999999   999999999999998776    79999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++....... .....+||+.|+|||+
T Consensus       165 ~a~~~~~~~-~~~~~~gt~~y~aPE~  189 (361)
T 2yab_A          165 LAHEIEDGV-EFKNIFGTPEFVAPEI  189 (361)
T ss_dssp             SCEECCTTC-CCCCCCSCGGGCCHHH
T ss_pred             CceEcCCCC-ccccCCCCccEECchH
Confidence            998775432 2345689999999984

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-33  Score=234.73  Aligned_cols=175  Identities=21%  Similarity=0.261  Sum_probs=145.6

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...++|++.+.||+|+||.||+|. ..+++.+|+|.+...... .......+.+|..++..++||||+++++++.+.+.+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            345789999999999999999995 556888999987531100 001112367899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++||||+.+|+|.+++....  ..+++..+..++.|++.|+.|||+.   +|+||||||+|||++.+|.+||+|||+++.
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            99999999999999997532  2378899999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCc-ccccccccccccCCC
Q 039002          198 LKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      ....... ....+||+.|+|||+
T Consensus       225 ~~~~~~~~~~~~~GT~~Y~APE~  247 (437)
T 4aw2_A          225 LMEDGTVQSSVAVGTPDYISPEI  247 (437)
T ss_dssp             CCTTSCEECCSCCSCGGGCCHHH
T ss_pred             cccCCCcccccccCCcCeeChHH
Confidence            6544332 234689999999994

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-33  Score=234.17  Aligned_cols=174  Identities=21%  Similarity=0.284  Sum_probs=145.4

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ....++|++.+.||+|+||.||+|. ..+++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3456789999999999999999994 567889999987531100 00112336789999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +++||||+++|+|.+++...    .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+|.+||+|||+++
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            99999999999999988643    378888999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCC-cccccccccccccCCC
Q 039002          197 FLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ....... .....+||+.|+|||+
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~  240 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEV  240 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHH
T ss_pred             eeccCCcccccCCcCCccccCHHH
Confidence            7654432 2235689999999994

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-32  Score=219.67  Aligned_cols=171  Identities=25%  Similarity=0.342  Sum_probs=143.5

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .++|++.+.||+|+||.||+|...+++.+|+|++.....  .......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            488999999999999999999777789999999865322  222345678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||++.+ ++.+.+....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999974 7877776533  2378888999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........||+.|+|||+
T Consensus       172 ~~~~~~~~~~t~~y~aPE~  190 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDV  190 (311)
T ss_dssp             CCC---CCCCCCTTCCHHH
T ss_pred             CcccccCCcccCCcCCHHH
Confidence            5444455689999999993

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.6e-33  Score=229.63  Aligned_cols=173  Identities=25%  Similarity=0.317  Sum_probs=138.6

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHH-HhcCCCCccceeEeEEEeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA-LTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.+|+|.+........ .....+.+|..+ ++.++||||+++++++.+.+..
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            35789999999999999999994 56788999999865322211 122345566665 5778999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      |++|||+.+++|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.+|.+||+|||+++.
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            99999999999999886533   377888899999999999999999   999999999999999999999999999986


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........+||+.|+|||+
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~  210 (373)
T 2r5t_A          189 NIEHNSTTSTFCGTPEYLAPEV  210 (373)
T ss_dssp             GBCCCCCCCSBSCCCCCCCHHH
T ss_pred             cccCCCccccccCCccccCHHH
Confidence            5444444556799999999994

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-33  Score=232.42  Aligned_cols=177  Identities=22%  Similarity=0.245  Sum_probs=147.3

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .....++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|..++..++|+||+++++++.+.+
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            34456889999999999999999995 568899999998531100 0112234678999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .+|+||||+++|+|.+++...+  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.+|.+||+|||++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhh
Confidence            9999999999999999996532  2378888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCc-ccccccccccccCCC
Q 039002          196 KFLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      +........ ....+||+.|+|||+
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~  234 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEI  234 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHH
T ss_pred             eeccCCCccccceeccccCcCCHHH
Confidence            877544322 234689999999994

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6e-33  Score=225.95  Aligned_cols=174  Identities=22%  Similarity=0.295  Sum_probs=146.0

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      ...++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+..|..++..+ +||||+++++++.+.+.
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            346899999999999999999995 456888999998542110 112335567899999888 79999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .|++|||+++|+|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.+|.+||+|||+++
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            999999999999999986533   378899999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............+||+.|+|||+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~  192 (353)
T 2i0e_A          170 ENIWDGVTTKTFCGTPDYIAPEI  192 (353)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHH
T ss_pred             ccccCCcccccccCCccccChhh
Confidence            65444444456789999999994

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-32  Score=217.97  Aligned_cols=173  Identities=23%  Similarity=0.332  Sum_probs=141.1

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc----------------------hhhHHHHHHHHHHH
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ----------------------TVDQKEFLTEVKAL   96 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~----------------------~~~~~~~~~e~~~l   96 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|.+........                      ......+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3588999999999999999999 456788999999865322111                      01124578899999


Q ss_pred             hcCCCCccceeEeEEEe--CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC
Q 039002           97 TETRHRNIVKFYGFCSH--ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV  174 (219)
Q Consensus        97 ~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  174 (219)
                      +.++||||+++++++.+  .+..+++||++.+++|.++...    ..+++..+..++.|++.|+.|||+.   +++|+||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            99999999999999986  5678999999999998876543    2378889999999999999999999   9999999


Q ss_pred             CCCCEEeCCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          175 SSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       175 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||+||+++.++.++|+|||++..............||+.|+|||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  208 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES  208 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGG
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhh
Confidence            999999999999999999999877655444455689999999994

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-32  Score=229.34  Aligned_cols=171  Identities=23%  Similarity=0.363  Sum_probs=146.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+.....  .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            477999999999999999999 567889999999865322  22344567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC---CCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD---LEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~  196 (219)
                      +||++.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++   .++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999886543   378889999999999999999999   999999999999998   45789999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............||+.|+|||+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~  184 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEV  184 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHH
T ss_pred             EecCCCceeecccCCcccCCHHH
Confidence            77665554556789999999994

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-32  Score=217.57  Aligned_cols=172  Identities=25%  Similarity=0.387  Sum_probs=142.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+...... .......+.+|+..++.++||||+++++++...+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc-cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            468999999999999999999 4668889999998654322 23445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+++++|.+++...+   .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++....
T Consensus        89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999987543   378899999999999999999999   99999999999999999999999999997654


Q ss_pred             CCC-CcccccccccccccCCC
Q 039002          200 SDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ... .......||+.|+|||.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~  183 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQ  183 (294)
T ss_dssp             ------------CCSSCCHHH
T ss_pred             cccccccCccccCccccCHhH
Confidence            332 12234579999999983

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.7e-32  Score=217.07  Aligned_cols=165  Identities=28%  Similarity=0.422  Sum_probs=144.4

Q ss_pred             CCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  122 (219)
                      |+..+.||+|+||.||+|. ..+++.||+|.+....    ......+.+|+.+++.++|+||+++++++...+..+++||
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            6677899999999999995 4588999999986432    2234567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCC
Q 039002          123 FLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA  202 (219)
Q Consensus       123 ~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  202 (219)
                      |+.+++|.+++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus       123 ~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          123 FLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             CCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             cCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence            99999999998642    378899999999999999999998   99999999999999999999999999998776554


Q ss_pred             CcccccccccccccCCC
Q 039002          203 SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       203 ~~~~~~~gt~~y~aPE~  219 (219)
                      .......||+.|+|||+
T Consensus       196 ~~~~~~~gt~~y~aPE~  212 (321)
T 2c30_A          196 PKRKSLVGTPYWMAPEV  212 (321)
T ss_dssp             CCBCCCCSCGGGCCHHH
T ss_pred             cccccccCCccccCHhh
Confidence            44456789999999984

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-33  Score=221.81  Aligned_cols=169  Identities=24%  Similarity=0.358  Sum_probs=144.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            578999999999999999999 4568899999997532110 11233567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.+|.+||+|||+++...
T Consensus        84 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             EECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999997543   378888999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..   ....+||+.|+|||+
T Consensus       158 ~~---~~~~~gt~~y~aPE~  174 (318)
T 1fot_A          158 DV---TYTLCGTPDYIAPEV  174 (318)
T ss_dssp             SC---BCCCCSCTTTCCHHH
T ss_pred             Cc---cccccCCccccCHhH
Confidence            33   235689999999984

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-31  Score=211.53  Aligned_cols=187  Identities=29%  Similarity=0.521  Sum_probs=156.5

Q ss_pred             cccccHHHHHHHhCCCCCc------ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC
Q 039002           29 VGKILYDEIVKATNDFDAK------YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR  102 (219)
Q Consensus        29 ~~~~~~~~~~~~~~~y~~~------~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~  102 (219)
                      ...+.++++...+++|...      +.||+|+||.||+|.. +++.+|+|++..............+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3556777888888888776      8999999999999976 57789999986543333334456788999999999999


Q ss_pred             ccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       103 ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      ||+++++++...+..+++||++++++|.+++........+++..+..++.|++.|+.|||+.   +++|+||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            99999999999999999999999999999987543333478889999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          183 LEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      .++.++|+|||++.........  .....||+.|+|||.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~  206 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA  206 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHH
Confidence            9999999999999876543221  233579999999983

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.5e-32  Score=218.11  Aligned_cols=188  Identities=34%  Similarity=0.623  Sum_probs=156.8

Q ss_pred             cccccHHHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeE
Q 039002           29 VGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY  108 (219)
Q Consensus        29 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~  108 (219)
                      +..++..++....++|++.+.||+|+||.||+|...+++.||+|.+.......   ....+.+|+.+++.++|+||++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG---GELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch---HHHHHHHHHHHHHhccCCCccceE
Confidence            34566788889999999999999999999999987788899999986533221   223578899999999999999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcE
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEA  187 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~  187 (219)
                      +++.+.+..+++||++.+++|.+++..... ...+++..+..++.|++.|+.|||+.+..+++|+||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            999999999999999999999999975432 2237888999999999999999999755589999999999999999999


Q ss_pred             EEeeccceeeecCCCCc-ccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      +|+|||++......... .....||+.|+|||+
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY  206 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHH
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHH
Confidence            99999999877543322 234569999999984

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.98  E-value=1.9e-32  Score=220.48  Aligned_cols=170  Identities=26%  Similarity=0.388  Sum_probs=143.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+......   .....+.+|+.+++.++|+||+++++++...+..++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            578999999999999999999 4568889999998543221   223457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++..+.
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999999886543   378899999999999999999999   99999999999999999999999999998764


Q ss_pred             CCC--CcccccccccccccCCC
Q 039002          200 SDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .......||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~  178 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPEL  178 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHH
T ss_pred             cCCcccccCCCccCcCccCcHH
Confidence            332  22245689999999984

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=7e-32  Score=217.01  Aligned_cols=168  Identities=24%  Similarity=0.320  Sum_probs=145.5

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+...     ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            478999999999999999999 5567889999988632     2234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC--CCcEEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL--EYEAHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~  197 (219)
                      +|||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.  ++.++|+|||++..
T Consensus        79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            999999999999996543  2378899999999999999999999   9999999999999986  78999999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.... ......||+.|+|||+
T Consensus       154 ~~~~~-~~~~~~gt~~y~aPE~  174 (321)
T 1tki_A          154 LKPGD-NFRLLFTAPEYYAPEV  174 (321)
T ss_dssp             CCTTC-EEEEEESCGGGSCHHH
T ss_pred             CCCCC-ccccccCChhhcCcHH
Confidence            75432 3345689999999984

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=4.2e-32  Score=217.79  Aligned_cols=173  Identities=22%  Similarity=0.358  Sum_probs=131.5

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+.....   ......+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            35789999999999999999995 45788999999865321   223356788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccc---hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          119 LLCEFLERGSLAAILNTDA---AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ++||++. ++|.+++....   ....+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999997 59988886422   112377888899999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..............||+.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~  179 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDV  179 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHH
T ss_pred             eecCCCcccCCCCcccccccCchH
Confidence            877654444455689999999994

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.98  E-value=2e-32  Score=222.69  Aligned_cols=169  Identities=21%  Similarity=0.252  Sum_probs=145.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            4789999999999999999994 567899999997532110 11233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.+|.++|+|||+++...
T Consensus       119 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence            999999999999987533   378889999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..   ....+||+.|+|||+
T Consensus       193 ~~---~~~~~gt~~y~aPE~  209 (350)
T 1rdq_E          193 GR---TWTLCGTPEALAPEI  209 (350)
T ss_dssp             SC---BCCCEECGGGCCHHH
T ss_pred             CC---cccccCCccccCHHH
Confidence            43   235689999999984

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.98  E-value=3.4e-32  Score=218.50  Aligned_cols=177  Identities=34%  Similarity=0.571  Sum_probs=149.8

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ++....++|++.+.||+|+||.||+|...+++.||+|++....    ......+.+|+.+++.++||||+++++++...+
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            3455678999999999999999999987788999999876431    223466889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          116 HSFLLCEFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ..+++|||+.+++|.+++..... ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999998865331 12378889999999999999999998   999999999999999999999999999


Q ss_pred             eeeecCCCC--cccccccccccccCCC
Q 039002          195 AKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +........  ......||+.|+|||+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~  212 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEY  212 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHH
T ss_pred             ccccccccccccccccCCCccccCHHH
Confidence            987543221  1234579999999983

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.98  E-value=2.1e-32  Score=216.58  Aligned_cols=170  Identities=26%  Similarity=0.386  Sum_probs=140.3

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      ++|++.+.||+|+||.||+|...+++.+|+|++....  ........+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS--GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc--cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            6899999999999999999976788999999986532  12223356789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      |++.+ ++.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             ECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            99975 8888886532  2377888999999999999999999   9999999999999999999999999999866544


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      ........||+.|+|||+
T Consensus       154 ~~~~~~~~~t~~y~aPE~  171 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDV  171 (288)
T ss_dssp             --------CCCTTCCHHH
T ss_pred             ccccccccccccccCchh
Confidence            433445688999999983

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.98  E-value=4.8e-32  Score=220.48  Aligned_cols=176  Identities=20%  Similarity=0.268  Sum_probs=145.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCC-CCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLP-SDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+..... .........+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            367999999999999999999 566889999998743110 011113456789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc---EEEeeccc
Q 039002          119 LLCEFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGI  194 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~---~kl~dfg~  194 (219)
                      ++|||+.+++|.+.+..... ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.   ++|+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999887754321 12367888999999999999999999   9999999999999986554   99999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.............+||+.|+|||+
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~  204 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEV  204 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHH
Confidence            9887655443455689999999994

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.98  E-value=1.1e-31  Score=215.46  Aligned_cols=172  Identities=26%  Similarity=0.397  Sum_probs=144.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC--cc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR--HS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~  117 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+....   .......+.+|+.+++.++||||+++++++...+  ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS---FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG---GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            367999999999999999999 45578899999986422   1223456778999999999999999999997665  67


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe----CCCCcEEEeecc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL----DLEYEAHVADFG  193 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili----~~~~~~kl~dfg  193 (219)
                      +++|||+.+++|.+++........+++..+..++.|++.|+.|||+.   +++|+||||+||++    +..+.+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            99999999999999997654434478899999999999999999999   99999999999998    677889999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++........ .....||+.|+|||+
T Consensus       162 ~a~~~~~~~~-~~~~~gt~~y~aPE~  186 (319)
T 4euu_A          162 AARELEDDEQ-FVSLYGTEEYLHPDM  186 (319)
T ss_dssp             TCEECCTTCC-BCCCCSCGGGCCHHH
T ss_pred             CceecCCCCc-eeecccCCCccCHHH
Confidence            9987755432 344679999999983

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.98  E-value=1.1e-31  Score=214.36  Aligned_cols=171  Identities=22%  Similarity=0.353  Sum_probs=139.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|++....  ........+.+|+.+++.++|+||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence            4789999999999999999994 5678899999886532  223345667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.++++..++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        80 v~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EEECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            999999999988876543   378888999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........||+.|+|||+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~  173 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPEL  173 (311)
T ss_dssp             ------------GGGCCHHH
T ss_pred             CcccccCCCcCCccccChHH
Confidence            55444455689999999983

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=1.2e-31  Score=219.52  Aligned_cols=173  Identities=21%  Similarity=0.371  Sum_probs=143.7

Q ss_pred             hCCCCCcceeccccceeEEEEEc--------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL--------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFC  111 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~--------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~  111 (219)
                      .++|++.+.||+|+||.||+|..        .++..||+|.++..   ........+.+|+.+++.+ +||||+++++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            46788999999999999999953        24557999998643   2333456788999999999 899999999999


Q ss_pred             EeCCcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCC
Q 039002          112 SHARHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN  178 (219)
Q Consensus       112 ~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~n  178 (219)
                      ...+..+++|||+.+++|.+++.....             ...+++..+..++.|++.|+.|||+.   +++||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            999999999999999999999975321             12367888899999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          179 LLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       179 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |+++.++.+||+|||+++.......  ......+|+.|+|||+
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  276 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA  276 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHH
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhH
Confidence            9999999999999999987654322  1233467889999993

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=214.40  Aligned_cols=171  Identities=23%  Similarity=0.336  Sum_probs=145.8

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc--hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ--TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ++|++.+.||+|+||.||+| ...+++.+|+|.+........  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            56899999999999999999 456788999999865432211  123466889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC----cEEEeeccc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY----EAHVADFGI  194 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~----~~kl~dfg~  194 (219)
                      ++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++    .++|+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999997543   378889999999999999999999   999999999999998877    899999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +....... ......||+.|+|||+
T Consensus       165 a~~~~~~~-~~~~~~gt~~y~aPE~  188 (326)
T 2y0a_A          165 AHKIDFGN-EFKNIFGTPEFVAPEI  188 (326)
T ss_dssp             CEECCTTS-CCCCCCSCTTTCCHHH
T ss_pred             CeECCCCC-ccccccCCcCcCCcee
Confidence            98775432 2345689999999984

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.97  E-value=1.8e-32  Score=221.69  Aligned_cols=170  Identities=22%  Similarity=0.359  Sum_probs=143.6

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            5789999999999999999994 578899999987532111 11123467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+ +|++.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        87 v~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999 678888876532   378899999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .. ......+||+.|+|||+
T Consensus       160 ~~-~~~~~~~gt~~y~aPE~  178 (336)
T 3h4j_B          160 DG-NFLKTSCGSPNYAAPEV  178 (336)
T ss_dssp             TS-BTTCCCTTSTTTSCGGG
T ss_pred             CC-cccccccCCcCcCCHHH
Confidence            33 22345689999999994

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=5.4e-33  Score=232.79  Aligned_cols=173  Identities=23%  Similarity=0.303  Sum_probs=136.9

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|.+....... ......+.+|+.+++.++||||+++++++...+..+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            3467999999999999999999 56688999999985421111 122345678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +||||+.+++|.+++....   .+++..+..++.|++.||.|||+ .   +|+||||||+||+++.++.+||+|||+++.
T Consensus       225 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            9999999999999886533   37888999999999999999998 7   999999999999999999999999999986


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........+||+.|+|||+
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~  320 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEV  320 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHH
T ss_pred             ccCCCcccccccCCccccCHhh
Confidence            5444444456789999999984

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.97  E-value=8.2e-32  Score=220.01  Aligned_cols=170  Identities=24%  Similarity=0.406  Sum_probs=145.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+......  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            467999999999999999999 5567889999998654322  2344567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC---CcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE---YEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~  196 (219)
                      +||++.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.+   +.+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999886543   378889999999999999999999   99999999999999865   459999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...... ......||+.|+|||+
T Consensus       180 ~~~~~~-~~~~~~gt~~y~aPE~  201 (362)
T 2bdw_A          180 EVNDSE-AWHGFAGTPGYLSPEV  201 (362)
T ss_dssp             CCTTCC-SCCCSCSCTTTCCHHH
T ss_pred             EecCCc-ccccCCCCccccCHHH
Confidence            765432 2345689999999984

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=3.9e-32  Score=231.71  Aligned_cols=175  Identities=21%  Similarity=0.288  Sum_probs=147.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            4678999999999999999995 567899999998532111 11223567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +|||+.+++|..++..... ...+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+|.+||+|||+++.+
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999998865321 12478889999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+||+.|+|||+
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~  360 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPEL  360 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHH
T ss_pred             cCCCcccccccCCccccChhh
Confidence            655444455699999999994

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=7.6e-32  Score=226.45  Aligned_cols=170  Identities=22%  Similarity=0.359  Sum_probs=130.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|++....  ........+.+|+.+++.++|+||+++++++...     
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            367999999999999999999 56688999999986532  2334456788999999999999999999999433     


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +.+|++||++ +++|..++....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence            5689999998 578988886542   378899999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCC---------------------------cccccccccccccCCC
Q 039002          195 AKFLKSDAS---------------------------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~  219 (219)
                      ++.......                           .....+||+.|+|||+
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  254 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL  254 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHH
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHH
Confidence            987643211                           1234578999999993

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=1.1e-31  Score=219.13  Aligned_cols=167  Identities=23%  Similarity=0.300  Sum_probs=135.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+.....     ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            578999999999999999999 456888999999864321     22457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc--EEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE--AHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~  197 (219)
                      +|||+.+++|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.  +||+|||+++.
T Consensus        94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            999999999999886533   378899999999999999999999   9999999999999987654  99999999875


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... ......||+.|+|||+
T Consensus       168 ~~~~~-~~~~~~gt~~y~aPE~  188 (361)
T 3uc3_A          168 SVLHS-QPKSTVGTPAYIAPEV  188 (361)
T ss_dssp             --------------CTTSCHHH
T ss_pred             ccccC-CCCCCcCCCCcCChhh
Confidence            43322 2244589999999984

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=2e-31  Score=222.50  Aligned_cols=170  Identities=24%  Similarity=0.391  Sum_probs=141.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|++....  ........+.+|+.+++.++|+||+++++++...     
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            478999999999999999999 56678899999987532  2334456788999999999999999999999766     


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..|+|||++. ++|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            56899999985 59999987542   378899999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCC----------------------cccccccccccccCCC
Q 039002          195 AKFLKSDAS----------------------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~----------------------~~~~~~gt~~y~aPE~  219 (219)
                      ++.......                      .....+||+.|+|||+
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  222 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL  222 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHH
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence            987654321                      1245689999999993

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=5.2e-32  Score=236.94  Aligned_cols=174  Identities=22%  Similarity=0.288  Sum_probs=146.7

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      ...++|++.+.||+|+||.||+| ...+++.||+|.++..... .......+..|..++..+ +|++|+.+++++.+.+.
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            35678999999999999999999 4567889999998632111 112234567888888887 79999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +|+||||+.+|+|..++...+   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.+|.+||+|||+++
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence            999999999999999987543   378899999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........++||+.|+|||+
T Consensus       491 ~~~~~~~~~~~~~GT~~Y~APE~  513 (674)
T 3pfq_A          491 ENIWDGVTTKTFCGTPDYIAPEI  513 (674)
T ss_dssp             ECCCTTCCBCCCCSCSSSCCHHH
T ss_pred             ccccCCcccccccCCCcccCHhh
Confidence            75544444566799999999994

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=8.1e-32  Score=219.21  Aligned_cols=182  Identities=20%  Similarity=0.326  Sum_probs=148.2

Q ss_pred             ccHHHHHHHhCCCCCcceeccccceeEEEEE------cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCcc
Q 039002           32 ILYDEIVKATNDFDAKYCIGNGGHASVYRAE------LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNI  104 (219)
Q Consensus        32 ~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~------~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni  104 (219)
                      .....|....++|++.+.||+|+||.||+|.      ..+++.||+|.+...   ........+.+|+.+++.+ +||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHHHHHHHHHHhhcCCcce
Confidence            3455677788999999999999999999995      235678999998643   2233446688999999999 78999


Q ss_pred             ceeEeEEEeCCc-ceEEEEecCCCCHHHHhcccch---------------------------------------------
Q 039002          105 VKFYGFCSHARH-SFLLCEFLERGSLAAILNTDAA---------------------------------------------  138 (219)
Q Consensus       105 ~~~~~~~~~~~~-~~lv~e~~~~~~l~~~~~~~~~---------------------------------------------  138 (219)
                      +++++++...+. .+++|||+.+++|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999987654 8999999999999999965321                                             


Q ss_pred             ------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          139 ------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       139 ------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                                        ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              11177888999999999999999999   999999999999999999999999999986543


Q ss_pred             CCC--cccccccccccccCCC
Q 039002          201 DAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ...  ......||+.|+|||+
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHH
T ss_pred             cccchhccccCCCceeEChhh
Confidence            322  2234578899999993

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=3.3e-31  Score=213.37  Aligned_cols=171  Identities=25%  Similarity=0.437  Sum_probs=140.3

Q ss_pred             hCCCCCcceeccccceeEEEEEc-C---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-P---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.. .   .+..||+|.++...   .......+.+|+.+++.++||||+++++++...+.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            45688899999999999999954 2   34469999986432   23345678899999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             cEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            999999999999999996532  2378899999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcc---cccccccccccCCC
Q 039002          197 FLKSDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      .........   ....+|+.|+|||+
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~  225 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEA  225 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHH
T ss_pred             ccccCccceeeccCCCCcccccCHhH
Confidence            775433221   22345778999984

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=7.4e-32  Score=230.86  Aligned_cols=174  Identities=21%  Similarity=0.267  Sum_probs=146.7

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            4567999999999999999999 4568999999997532110 1123355788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +||||+++|+|.+++...+. ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+|.+||+|||+++..
T Consensus       261 lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999998865432 2378899999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .... .....+||+.|+|||+
T Consensus       337 ~~~~-~~~~~~GT~~Y~APEv  356 (576)
T 2acx_A          337 PEGQ-TIKGRVGTVGYMAPEV  356 (576)
T ss_dssp             CTTC-CEECCCSCGGGCCHHH
T ss_pred             ccCc-cccccCCCccccCHHH
Confidence            5432 2344689999999994

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=4.8e-31  Score=217.17  Aligned_cols=169  Identities=20%  Similarity=0.341  Sum_probs=144.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+...    .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            467999999999999999999 5568889999998642    12234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC--CCcEEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL--EYEAHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~  197 (219)
                      +|||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.  .+.++|+|||++..
T Consensus       126 v~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            999999999999986542  2378899999999999999999999   9999999999999974  47899999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... ......||+.|+|||+
T Consensus       201 ~~~~~-~~~~~~gt~~y~aPE~  221 (387)
T 1kob_A          201 LNPDE-IVKVTTATAEFAAPEI  221 (387)
T ss_dssp             CCTTS-CEEEECSSGGGCCHHH
T ss_pred             cCCCc-ceeeeccCCCccCchh
Confidence            65432 2344589999999984

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=7.7e-32  Score=215.62  Aligned_cols=172  Identities=24%  Similarity=0.389  Sum_probs=137.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc--
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS--  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~--  117 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++...+..  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT-SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC-CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            4789999999999999999994 578889999998764332 233445678999999999999999999998766544  


Q ss_pred             --eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          118 --FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       118 --~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                        +++|||+.+++|.+++...+   .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence              99999999999999986543   378889999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC---cccccccccccccCCC
Q 039002          196 KFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      ..+.....   ......||+.|+|||+
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~  190 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQ  190 (311)
T ss_dssp             ------------------CCTTCCHHH
T ss_pred             ccccccccccccccccCcCcccCCHHH
Confidence            87654322   2234579999999984

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=1.1e-31  Score=226.03  Aligned_cols=171  Identities=22%  Similarity=0.352  Sum_probs=146.4

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4789999999999999999995 558999999998532100 11233567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        94 v~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999997543   378899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .. ......+||+.|+|||+
T Consensus       168 ~~-~~~~~~~gt~~y~aPE~  186 (476)
T 2y94_A          168 DG-EFLRTSCGSPNYAAPEV  186 (476)
T ss_dssp             TT-CCBCCCCSCSTTCCHHH
T ss_pred             cc-ccccccCCCcCeEChhh
Confidence            43 22345689999999984

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=4.4e-31  Score=206.69  Aligned_cols=169  Identities=23%  Similarity=0.416  Sum_probs=144.6

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .++|++.+.||+|+||.||+|...++..+|+|.+....     .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            47899999999999999999987788889999986432     2335678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||++++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            99999999999986543  2378899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCc-ccccccccccccCCC
Q 039002          201 DASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~-~~~~~gt~~y~aPE~  219 (219)
                      .... .....+|+.|+|||.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~  176 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEV  176 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHH
T ss_pred             hhhhcccCCCcCcccCCHHH
Confidence            4321 123356778999983

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=6.4e-33  Score=224.14  Aligned_cols=166  Identities=16%  Similarity=0.190  Sum_probs=133.0

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCC----CchhhHHHHHHHHHHHhcCC---------CCcccee
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPS----DQTVDQKEFLTEVKALTETR---------HRNIVKF  107 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------h~ni~~~  107 (219)
                      .++|++.+.||+|+||.||+|.. +++.||+|.+......    ........+.+|+.+++.++         |+|++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999965 6789999998754321    11223356788888888886         6666665


Q ss_pred             EeEE-----------------Ee-------------CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHH
Q 039002          108 YGFC-----------------SH-------------ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA  157 (219)
Q Consensus       108 ~~~~-----------------~~-------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~  157 (219)
                      .+++                 .+             .+..++||||+.+|++.+.+..    ..+++..+..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            5543                 32             6789999999999876655533    237889999999999999


Q ss_pred             HHhhh-hCCCCCeEecCCCCCCEEeCCCC--------------------cEEEeeccceeeecCCCCccccccccccccc
Q 039002          158 LSYLH-HDCFPPIVHRDVSSKNLLLDLEY--------------------EAHVADFGIAKFLKSDASNWTEFAGTYGYVA  216 (219)
Q Consensus       158 l~~lh-~~~~~~i~H~dlkp~nili~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~a  216 (219)
                      |.||| +.   +|+||||||+|||++.++                    .+||+|||+++.....     ..+||+.|+|
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999 88   999999999999999887                    8999999999877543     3489999999


Q ss_pred             CCC
Q 039002          217 LGI  219 (219)
Q Consensus       217 PE~  219 (219)
                      ||+
T Consensus       246 PE~  248 (336)
T 2vuw_A          246 EDL  248 (336)
T ss_dssp             SGG
T ss_pred             hhh
Confidence            995

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=3.1e-31  Score=212.26  Aligned_cols=169  Identities=22%  Similarity=0.264  Sum_probs=137.0

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ++|++.+.||+|+||.||+|. ..+++.||+|++......  .........|+..+..+ +|+||+++++++..++..++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC--hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            679999999999999999995 558899999987653322  22333445555555444 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++ ++++.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 678888876533  2488999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ... ......||+.|+|||+
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~  227 (311)
T 3p1a_A          209 TAG-AGEVQEGDPRYMAPEL  227 (311)
T ss_dssp             -------CCCCCGGGCCGGG
T ss_pred             cCC-CCcccCCCccccCHhH
Confidence            433 2244579999999995

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=1.8e-31  Score=217.94  Aligned_cols=170  Identities=18%  Similarity=0.256  Sum_probs=140.5

Q ss_pred             HhCCCCCcceeccccceeEEEE------EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC---CCccceeEeE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA------ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR---HRNIVKFYGF  110 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~------~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~  110 (219)
                      ..++|++.+.||+|+||.||+|      ...+++.||+|.+...       ....+.+|+..++.++   |+|+++++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            3467999999999999999999      3456888999998642       2335667777777776   8999999999


Q ss_pred             EEeCCcceEEEEecCCCCHHHHhcccc--hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-----
Q 039002          111 CSHARHSFLLCEFLERGSLAAILNTDA--AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-----  183 (219)
Q Consensus       111 ~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-----  183 (219)
                      +...+..++||||+.+|+|.+++....  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            999999999999999999999996421  123488899999999999999999998   9999999999999988     


Q ss_pred             ------CCcEEEeeccceeeecCC--CCcccccccccccccCCC
Q 039002          184 ------EYEAHVADFGIAKFLKSD--ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ------~~~~kl~dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~  219 (219)
                            ++.+||+|||+++.+...  .......+||+.|+|||+
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~  256 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM  256 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHH
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHH
Confidence                  899999999999876422  222345689999999994

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=3.9e-31  Score=212.95  Aligned_cols=160  Identities=26%  Similarity=0.357  Sum_probs=123.4

Q ss_pred             cceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcceEEEEec
Q 039002           47 KYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      .+.||+|+||.||+| ...+++.||+|.+..       .......+|+..++.+. ||||+++++++.+.+..+++||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~   88 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL   88 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh-------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence            378999999999999 556788999999853       23356678999999997 999999999999999999999999


Q ss_pred             CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC---cEEEeeccceeeecCC
Q 039002          125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY---EAHVADFGIAKFLKSD  201 (219)
Q Consensus       125 ~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~---~~kl~dfg~~~~~~~~  201 (219)
                      .+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++   .++|+|||++......
T Consensus        89 ~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           89 NGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999997543   378899999999999999999999   999999999999998665   8999999999876655


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      .......+||+.|+|||+
T Consensus       163 ~~~~~~~~~t~~y~aPE~  180 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPEL  180 (325)
T ss_dssp             ------------------
T ss_pred             CCcccccCCCcCccCHHH
Confidence            444456689999999995

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=4.8e-31  Score=217.17  Aligned_cols=173  Identities=18%  Similarity=0.226  Sum_probs=146.0

Q ss_pred             hCCCCCcceeccc--cceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           41 TNDFDAKYCIGNG--GHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g--~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      .++|++.+.||+|  +||.||+|. ..+++.||+|.+.....  .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            5789999999999  999999994 56889999999865322  223446678899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++||||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.+..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            999999999999999865422 2378889999999999999999999   999999999999999999999999998875


Q ss_pred             ecCCCC-------cccccccccccccCCC
Q 039002          198 LKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                      ......       ......||+.|+|||+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEV  206 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHH
T ss_pred             eccccccccccccccccccccccccCHHH
Confidence            532211       1123478999999984

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=3.9e-31  Score=217.69  Aligned_cols=170  Identities=26%  Similarity=0.451  Sum_probs=133.0

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCC--
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHAR--  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~--  115 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|++....  ........+.+|+.+++.+. |+||+++++++...+  
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            3589999999999999999999 56788999999986432  22344566789999999997 999999999997554  


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      .+|+||||+. ++|..++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            6899999997 5898888642    377888889999999999999999   9999999999999999999999999999


Q ss_pred             eeecCC---------------------CCcccccccccccccCCC
Q 039002          196 KFLKSD---------------------ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~---------------------~~~~~~~~gt~~y~aPE~  219 (219)
                      +.+...                     .......+||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  201 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI  201 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHH
Confidence            876431                     111244689999999994

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=209.35  Aligned_cols=175  Identities=26%  Similarity=0.426  Sum_probs=133.6

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            345789999999999999999994 568889999997532100 112235678899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            99999999999999987532  2378889999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............||+.|+|||.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~  183 (278)
T 3cok_A          162 LKMPHEKHYTLCGTPNYISPEI  183 (278)
T ss_dssp             CC--------------------
T ss_pred             ccCCCCcceeccCCCCcCCcch
Confidence            7644433345689999999994

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=6.8e-31  Score=208.33  Aligned_cols=172  Identities=23%  Similarity=0.393  Sum_probs=147.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            4779999999999999999994 557888999987543222 22345667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        93 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999999886532   378889999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........||+.|+|||.
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~  186 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEV  186 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHH
T ss_pred             cCccccccccCCCCcCCcch
Confidence            54444455689999999983

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=4.3e-31  Score=216.56  Aligned_cols=171  Identities=22%  Similarity=0.423  Sum_probs=133.3

Q ss_pred             hCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|...    ++..||+|.++...   .......+.+|+.+++.++||||+++++++...+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            357999999999999999999543    56779999986432   23345678899999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            999999999999999997543  2478889999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcc---cccccccccccCCC
Q 039002          197 FLKSDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      .........   ....+++.|+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~  221 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEA  221 (373)
T ss_dssp             ------------------CTTSCHHH
T ss_pred             ccccCCccceeccCCCcCCCccChhh
Confidence            765432211   12245678999984

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=3.6e-31  Score=218.55  Aligned_cols=172  Identities=26%  Similarity=0.398  Sum_probs=144.5

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC--cc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR--HS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~  117 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+....   .......+.+|+.+++.++||||+++++++...+  ..
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS---FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG---GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            357999999999999999999 45678899999986422   1223456778999999999999999999998755  67


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe----CCCCcEEEeecc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL----DLEYEAHVADFG  193 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili----~~~~~~kl~dfg  193 (219)
                      +++|||+.+++|.+++........+++..+..++.|++.|+.|||+.   +++||||||+||++    +..+.+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            99999999999999997654434488899999999999999999999   99999999999999    677789999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++....... ......||+.|+|||+
T Consensus       162 ~a~~~~~~~-~~~~~~gt~~y~aPE~  186 (396)
T 4eut_A          162 AARELEDDE-QFVSLYGTEEYLHPDM  186 (396)
T ss_dssp             GCEECCCGG-GSSCSSSCCTTCCHHH
T ss_pred             CceEccCCC-ccccccCCccccCHHH
Confidence            998765433 2244679999999983

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=4e-31  Score=216.96  Aligned_cols=177  Identities=23%  Similarity=0.374  Sum_probs=145.8

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      +.|....++|++.+.||+|+||.||+|.. .+++.||+|.++...   .......+.+|+.+++.++||||+++++++..
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            34455567899999999999999999954 578899999986431   22233457789999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      .+..+++||++++++|.+++...+  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            999999999999999999987533  2378889999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCc--ccccccccccccCCC
Q 039002          194 IAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +++........  .....+++.|+|||.
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~  286 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEA  286 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHH
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhH
Confidence            99865432111  112245778999983

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=6.2e-31  Score=212.53  Aligned_cols=172  Identities=23%  Similarity=0.398  Sum_probs=148.2

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||++ ...+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            467999999999999999999 4567889999987643222 22345667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus       119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999999886532   378889999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........||+.|+|||+
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~  212 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEV  212 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHH
T ss_pred             cCcccccccCCCccccCHHH
Confidence            54444456789999999984

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=1.4e-31  Score=215.85  Aligned_cols=174  Identities=22%  Similarity=0.344  Sum_probs=135.5

Q ss_pred             HHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .....++|++.+.||+|+||.||+| ...+++.||+|.+.....  .......+.+|+.+++.++||||+++++++.+.+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            3556788999999999999999999 566888999999865422  2223455678999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-----CCCcEEEe
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-----LEYEAHVA  190 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-----~~~~~kl~  190 (219)
                      ..+++|||+. ++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++     ..+.++|+
T Consensus       107 ~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          107 RLHLIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             EEEEEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             EEEEEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEEC
Confidence            9999999997 59999886543   378889999999999999999999   999999999999994     44569999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||++..............||+.|+|||+
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~  208 (329)
T 3gbz_A          180 DFGLARAFGIPIRQFTHEIITLWYRPPEI  208 (329)
T ss_dssp             CTTHHHHHC-----------CCTTCCHHH
T ss_pred             cCCCccccCCcccccCCCcCCccccCHHH
Confidence            99999876544444455688999999994

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=8.9e-32  Score=212.21  Aligned_cols=175  Identities=22%  Similarity=0.395  Sum_probs=144.2

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      ..+....++|++.+.||+|+||.||+|...++..||+|.+....     .....+.+|+.+++.++|+||+++++++...
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            34445567899999999999999999988888889999986432     2235678999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             CCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence            99999999999999999997532  2378899999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCC-CcccccccccccccCCC
Q 039002          195 AKFLKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      +....... .......+|+.|+|||+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (283)
T 3gen_A          167 SRYVLDDEYTSSVGSKFPVRWSPPEV  192 (283)
T ss_dssp             GGGBCCHHHHSTTSTTSCGGGCCHHH
T ss_pred             cccccccccccccCCccCcccCCHHH
Confidence            97654321 11123456788999984

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=2e-31  Score=215.51  Aligned_cols=174  Identities=21%  Similarity=0.361  Sum_probs=146.1

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc----hhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ----TVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ...++|++.+.||+|+||.||+| ...+++.||+|.+........    ......+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            34578999999999999999999 467888999999875432221    0122345679999999999999999999999


Q ss_pred             CCcceEEEEecCCC-CHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          114 ARHSFLLCEFLERG-SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       114 ~~~~~lv~e~~~~~-~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                      .+..+++||++..| ++.+++....   .+++..+..++.|++.|+.|||..   +++||||||+||+++.++.++|+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999998766 9999987543   378889999999999999999999   9999999999999999999999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |++........ .....||+.|+|||+
T Consensus       175 g~a~~~~~~~~-~~~~~gt~~y~aPE~  200 (335)
T 3dls_A          175 GSAAYLERGKL-FYTFCGTIEYCAPEV  200 (335)
T ss_dssp             TTCEECCTTCC-BCEECSCGGGCCHHH
T ss_pred             ccceECCCCCc-eeccCCCccccChhh
Confidence            99987654432 344689999999984

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=4.1e-31  Score=213.14  Aligned_cols=172  Identities=22%  Similarity=0.395  Sum_probs=140.5

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|.+....  ........+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            3578999999999999999999 45678899999986432  22334456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++||++.++++..+.....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus       101 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            9999999988888765432   378889999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........||+.|+|||+
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~  195 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPEL  195 (331)
T ss_dssp             ---------CCCCCTTCCHHH
T ss_pred             cCCccccCCCcCCccccCccc
Confidence            654444455689999999983

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=4.4e-31  Score=214.10  Aligned_cols=166  Identities=22%  Similarity=0.322  Sum_probs=140.7

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  117 (219)
                      ..++|++.+.||+|+||.||+| ...+++.+|+|.+.....        ...+|+.++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            3578999999999999999999 556788999999864321        123577777777 799999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC----CcEEEeecc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE----YEAHVADFG  193 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~----~~~kl~dfg  193 (219)
                      +++|||+.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++||||||+||++...    +.+||+|||
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            99999999999999886543   378899999999999999999999   99999999999998533    359999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.............+||+.|+|||+
T Consensus       166 ~a~~~~~~~~~~~~~~gt~~y~aPE~  191 (342)
T 2qr7_A          166 FAKQLRAENGLLMTPCYTANFVAPEV  191 (342)
T ss_dssp             TCEECBCTTCCBCCSSCCSSCCCHHH
T ss_pred             CcccCcCCCCceeccCCCccccCHHH
Confidence            99987665544556789999999994

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=2.5e-31  Score=208.27  Aligned_cols=170  Identities=22%  Similarity=0.402  Sum_probs=144.1

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++.+.||+|+||.||+|...++..+|+|.+....     .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            346899999999999999999987778889999986432     233568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccc
Confidence            999999999999996543  2378888999999999999999999   99999999999999999999999999997654


Q ss_pred             CCC-CcccccccccccccCCC
Q 039002          200 SDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ... .......+|+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~  178 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEV  178 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHH
T ss_pred             ccccccccCcccccccCCHHH
Confidence            321 11233467788999984

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=8.8e-31  Score=211.11  Aligned_cols=167  Identities=19%  Similarity=0.290  Sum_probs=142.2

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+.....      ...+.+|+.+++.+ +|+||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            3789999999999999999994 57888999998864321      12367899999999 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc-----EEEeecc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE-----AHVADFG  193 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~-----~kl~dfg  193 (219)
                      ++||++ +++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.     ++|+|||
T Consensus        82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             EEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            999999 899999987532  3488899999999999999999999   9999999999999998887     9999999


Q ss_pred             ceeeecCCCCc-------ccccccccccccCCC
Q 039002          194 IAKFLKSDASN-------WTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~  219 (219)
                      +++.+......       .....||+.|+|||+
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  188 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINT  188 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHH
Confidence            99977544321       245689999999984

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=215.73  Aligned_cols=169  Identities=22%  Similarity=0.329  Sum_probs=133.9

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+|. ..+++.||+|.+.......   ....+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc---cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            689999999999999999994 5588899999986432111   111234689999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||++. +++.+++...+  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             ecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            99997 58888886543  2377888999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........||+.|+|||+
T Consensus       153 ~~~~~~~~~~t~~y~aPE~  171 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDI  171 (324)
T ss_dssp             ----------CGGGCCHHH
T ss_pred             CccccccccCcccccChhh
Confidence            4444455688999999983

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.7e-32  Score=220.34  Aligned_cols=173  Identities=21%  Similarity=0.293  Sum_probs=143.4

Q ss_pred             hCCCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|..    .+++.||+|.++.............+.+|+.+++.+ +|+||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999954    478899999986422111112223456789999999 6999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++|||+.+++|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999986532   378888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC-cccccccccccccCCC
Q 039002          196 KFLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      +.+..... .....+||+.|+|||+
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~  231 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDI  231 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHH
T ss_pred             eecccCCCCcccCcccCcCccChhh
Confidence            87643322 2234689999999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2e-30  Score=206.40  Aligned_cols=169  Identities=25%  Similarity=0.425  Sum_probs=147.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+.|++.+.||+|+||.||+| ...+++.||+|.+.....   ......+.+|+.+++.++|+||+++++++...+..++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            467999999999999999999 466788999999865322   2234678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        98 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence            99999999999998642    378889999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........||+.|+|||+
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~  190 (303)
T 3a7i_A          171 DTQIKRNTFVGTPFWMAPEV  190 (303)
T ss_dssp             TTBCCBCCCCSCGGGCCHHH
T ss_pred             ccccccCccCCCcCccCHHH
Confidence            55444456689999999984

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=1e-30  Score=210.02  Aligned_cols=171  Identities=24%  Similarity=0.349  Sum_probs=145.7

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCc--hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQ--TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ++|++.+.||+|+||.||+|. ..+++.+|+|.+........  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            679999999999999999994 56788999999865432221  123466889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC----cEEEeeccc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY----EAHVADFGI  194 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~----~~kl~dfg~  194 (219)
                      ++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++    .++|+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999997543   367888999999999999999999   999999999999999887    799999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +....... ......||+.|+|||+
T Consensus       166 ~~~~~~~~-~~~~~~gt~~y~aPE~  189 (321)
T 2a2a_A          166 AHEIEDGV-EFKNIFGTPEFVAPEI  189 (321)
T ss_dssp             CEECCTTC-CCCCCCSCGGGCCHHH
T ss_pred             ceecCccc-cccccCCCCCccCccc
Confidence            98765433 2344579999999983

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=1.2e-30  Score=221.62  Aligned_cols=173  Identities=23%  Similarity=0.388  Sum_probs=143.1

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc---------hhhHHHHHHHHHHHhcCCCCccceeEe
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ---------TVDQKEFLTEVKALTETRHRNIVKFYG  109 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~ni~~~~~  109 (219)
                      ..++|++.+.||+|+||.||+| ...+++.+|+|.+........         ......+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999 456788999999865332211         123466889999999999999999999


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC---c
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY---E  186 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~---~  186 (219)
                      ++.+.+..++||||+.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999886532   378899999999999999999999   999999999999998775   6


Q ss_pred             EEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++|+|||++....... .....+||+.|+|||+
T Consensus       188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~  219 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEV  219 (504)
T ss_dssp             EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHH
T ss_pred             EEEEECCCCEEcCCCC-ccccccCCcCCCCHHH
Confidence            9999999998775432 2345689999999984

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=1e-30  Score=205.56  Aligned_cols=168  Identities=24%  Similarity=0.335  Sum_probs=144.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...++..+|+|++.....    .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            467999999999999999999 456778899999864321    234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe---CCCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~  196 (219)
                      +||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||++   +.++.++|+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999886532   378889999999999999999999   99999999999999   778899999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...... ......||+.|+|||+
T Consensus       158 ~~~~~~-~~~~~~~t~~y~aPE~  179 (277)
T 3f3z_A          158 RFKPGK-MMRTKVGTPYYVSPQV  179 (277)
T ss_dssp             ECCTTS-CBCCCCSCTTTCCHHH
T ss_pred             eccCcc-chhccCCCCCccChHH
Confidence            765433 2345689999999983

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=9.3e-31  Score=221.82  Aligned_cols=170  Identities=26%  Similarity=0.393  Sum_probs=139.8

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..++..+|+|.+........  ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS--SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C--TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch--HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3569999999999999999994 56888999999865432222  24567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC---CcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE---YEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~  196 (219)
                      ||||+.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++..   +.+||+|||++.
T Consensus       114 v~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999998886432   378888999999999999999999   99999999999999754   559999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+.... .....+||+.|+|||+
T Consensus       188 ~~~~~~-~~~~~~gt~~y~aPE~  209 (494)
T 3lij_A          188 VFENQK-KMKERLGTAYYIAPEV  209 (494)
T ss_dssp             ECBTTB-CBCCCCSCTTTCCHHH
T ss_pred             ECCCCc-cccccCCCcCeeCHHH
Confidence            776443 2345689999999984

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=1.5e-30  Score=205.01  Aligned_cols=170  Identities=22%  Similarity=0.368  Sum_probs=142.6

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+......  ......+.+|+..+..+ +||||+++++++.+.+..+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT--SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            4679999999999999999994 558899999998754322  23446678899999998 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchh-hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-------------
Q 039002          119 LLCEFLERGSLAAILNTDAAA-QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-------------  184 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-------------  184 (219)
                      ++||++++++|.+++...... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999753221 2378889999999999999999999   99999999999999844             


Q ss_pred             ------CcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          185 ------YEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ------~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                            ..++|+|||.+.......    ...||+.|+|||+
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~  201 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEV  201 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHH
T ss_pred             cccCCceEEEEcccccccccCCcc----ccCCCccccChhH
Confidence                  479999999998765432    3469999999984

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.3e-31  Score=213.81  Aligned_cols=175  Identities=29%  Similarity=0.387  Sum_probs=138.9

Q ss_pred             HHhCCCCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCCc-hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQ-TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|.+........ ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3468899999999999999999954 5788999999864322111 1122457789999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++.+ ++..++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999975 8888886543  2367788899999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+...........||+.|+|||+
T Consensus       161 ~~~~~~~~~~~~~~t~~y~aPE~  183 (346)
T 1ua2_A          161 SFGSPNRAYTHQVVTRWYRAPEL  183 (346)
T ss_dssp             TTTSCCCCCCCSCCCCTTCCHHH
T ss_pred             eccCCcccCCcccccccccCchH
Confidence            76555444455689999999983

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=1.8e-30  Score=206.22  Aligned_cols=164  Identities=29%  Similarity=0.443  Sum_probs=135.8

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhc--CCCCccceeEeEEEe----C
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE--TRHRNIVKFYGFCSH----A  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~----~  114 (219)
                      .++|++.+.||+|+||.||+|.. +++.||+|.+..       .....+.+|..++..  ++||||+++++++..    .
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc-------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            47899999999999999999966 678899999753       123344556666555  799999999998754    2


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhh--------hCCCCCeEecCCCCCCEEeCCCCc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH--------HDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                      +..+++|||+.+++|.+++...    .+++..+..++.|++.|+.|||        ..   +++||||||+||+++.++.
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred             ceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence            4589999999999999999643    3788899999999999999999        77   9999999999999999999


Q ss_pred             EEEeeccceeeecCCCCc----ccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~  219 (219)
                      +||+|||++.........    .....||+.|+|||+
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  188 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV  188 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHH
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhh
Confidence            999999999877654332    133489999999994

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=5.7e-31  Score=208.87  Aligned_cols=170  Identities=26%  Similarity=0.417  Sum_probs=138.3

Q ss_pred             hCCCCCcceeccccceeEEEEEc-----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  114 (219)
                      .++|++.+.||+|+||.||+|.+     .+++.||+|++...    .......+.+|+.+++.++||||+++++++... 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            47899999999999999999963     36788999998642    233446788999999999999999999998543 


Q ss_pred             -CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          115 -RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       115 -~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                       ...+++||++++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence             56899999999999999997543  2378889999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCC---cccccccccccccCCC
Q 039002          194 IAKFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      ++........   ......++..|+|||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  188 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPES  188 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHH
Confidence            9987654321   1233467788999983

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=5.2e-31  Score=213.11  Aligned_cols=177  Identities=24%  Similarity=0.383  Sum_probs=145.5

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeE
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGF  110 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  110 (219)
                      +....++|++.+.||+|+||.||+|..      .+++.||+|.++...   .......+.+|+.+++.++||||++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            344568899999999999999999954      345789999986432   23345678899999999999999999999


Q ss_pred             EEeCCcceEEEEecCCCCHHHHhcccch---------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCe
Q 039002          111 CSHARHSFLLCEFLERGSLAAILNTDAA---------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPI  169 (219)
Q Consensus       111 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  169 (219)
                      +...+..+++|||+.+++|.+++.....                     ...+++..+..++.|++.|+.|||+.   ++
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            9999999999999999999999865321                     13478888999999999999999999   99


Q ss_pred             EecCCCCCCEEeCCCCcEEEeeccceeeecCCC--CcccccccccccccCCC
Q 039002          170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       170 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      +|+||||+||+++.++.++|+|||++.......  .......+|+.|+|||.
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            999999999999999999999999987654321  12234578899999983

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.7e-30  Score=212.57  Aligned_cols=166  Identities=23%  Similarity=0.393  Sum_probs=136.5

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|++....  ........+.+|+.+++.++||||+++++++...+    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            578999999999999999999 55789999999986542  22334567889999999999999999999997653    


Q ss_pred             --cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          116 --HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       116 --~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                        ..+++||++ +++|.+++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence              469999999 78999988642    378888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++.....   ....++|+.|+|||+
T Consensus       174 ~a~~~~~~---~~~~~~t~~y~aPE~  196 (367)
T 1cm8_A          174 LARQADSE---MTGYVVTRWYRAPEV  196 (367)
T ss_dssp             TCEECCSS---CCSSCSCGGGCCTHH
T ss_pred             cccccccc---cCcCcCCCCcCCHHH
Confidence            99876433   244689999999984

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.3e-30  Score=214.30  Aligned_cols=176  Identities=22%  Similarity=0.355  Sum_probs=145.5

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEc--------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAEL--------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFY  108 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~--------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  108 (219)
                      ....++|++.+.||+|+||.||+|..        ..+..+|+|.++..   ........+.+|+.+++.+ +||||++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            34457899999999999999999953        23357999998653   2233446788999999999 899999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                      +++...+..+++||++.+++|.+++.....             ...+++..+..++.|++.|+.|||+.   +++|||||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  218 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA  218 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence            999999999999999999999999975321             12378899999999999999999999   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCC--CcccccccccccccCCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++.+||+|||++.......  .......+|+.|+|||+
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  264 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  264 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHH
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHH
Confidence            999999999999999999998665332  12233467889999984

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=1.7e-30  Score=204.00  Aligned_cols=171  Identities=26%  Similarity=0.377  Sum_probs=145.7

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+.....   ......+.+|+.+++.++|+||+++++++...+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            35789999999999999999994 55788999999854221   223466789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +++|++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..+
T Consensus        82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            9999999999999886532   378889999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCC--CcccccccccccccCCC
Q 039002          199 KSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ....  .......|++.|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~  178 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPEL  178 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGG
T ss_pred             CCCcchhcccCCccccCccChHH
Confidence            4332  12244679999999994

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=1.8e-30  Score=204.71  Aligned_cols=170  Identities=24%  Similarity=0.405  Sum_probs=144.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+.....  .......+.+|+.+++.++|+||+++++++...+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            478999999999999999999 456788999999864322  22334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc---EEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~---~kl~dfg~~~  196 (219)
                      +||++.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.   ++|+|||++.
T Consensus        83 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999988886532   378889999999999999999999   9999999999999986654   9999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...... ......||+.|+|||+
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~  178 (284)
T 3kk8_A          157 EVNDSE-AWHGFAGTPGYLSPEV  178 (284)
T ss_dssp             ECCSSC-BCCCSCSCGGGCCHHH
T ss_pred             EcccCc-cccCCCCCcCCcCchh
Confidence            765433 2345689999999984

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=1.2e-30  Score=204.38  Aligned_cols=172  Identities=27%  Similarity=0.415  Sum_probs=130.9

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .++|++.+.||+|+||.||+|... +..+|+|.+..............+.+|+.+++.++||||+++++++...+..+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            578999999999999999999654 7789999986543333333456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC--------CCcEEEeec
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL--------EYEAHVADF  192 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~--------~~~~kl~df  192 (219)
                      ||++.+++|.+++...    .+++..+..++.|++.|+.|||+....+++|+||||+||+++.        ++.++|+||
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999998642    3788889999999999999999982111899999999999986        678999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |++........  ....||+.|+|||.
T Consensus       161 g~~~~~~~~~~--~~~~~~~~y~aPE~  185 (271)
T 3dtc_A          161 GLAREWHRTTK--MSAAGAYAWMAPEV  185 (271)
T ss_dssp             CC---------------CCGGGSCHHH
T ss_pred             Ccccccccccc--cCCCCccceeCHHH
Confidence            99986654332  24579999999983

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=3.3e-30  Score=204.19  Aligned_cols=172  Identities=25%  Similarity=0.361  Sum_probs=141.3

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|.....||+|+||.||+|. ..++..||+|.+....    ......+.+|+.+++.++||||+++++++...+..++
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            3556667799999999999994 6678899999986431    2234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~  198 (219)
                      +||++++++|.+++........+++..+..++.|++.|+.|||+.   +++|+||||+||+++. ++.++|+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999999999987543222356778888999999999999999   9999999999999987 899999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........|++.|+|||+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~  194 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEI  194 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHH
T ss_pred             CCCCCcccccCCCccccChhh
Confidence            544333445689999999984

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=7.6e-31  Score=213.25  Aligned_cols=166  Identities=27%  Similarity=0.428  Sum_probs=128.3

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+....      ....+.+|+.+++.++||||+++++++...+..++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            4669999999999999999995 5578899999986421      22456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~dfg~~~  196 (219)
                      +|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.   ++.++|+|||++.
T Consensus       126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999987543   378889999999999999999999   9999999999999975   7899999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...... ......||+.|+|||+
T Consensus       200 ~~~~~~-~~~~~~gt~~y~aPE~  221 (349)
T 2w4o_A          200 IVEHQV-LMKTVCGTPGYCAPEI  221 (349)
T ss_dssp             --------------CGGGSCHHH
T ss_pred             ccCccc-ccccccCCCCccCHHH
Confidence            664332 2244689999999984

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=1.9e-30  Score=206.35  Aligned_cols=171  Identities=24%  Similarity=0.366  Sum_probs=141.4

Q ss_pred             hCCCCCcceeccccceeEEEEE-----cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-----LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  114 (219)
                      ...|++.+.||+|+||.||+|.     ..+++.||+|.+....   .......+.+|+.+++.++|+||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            3568999999999999999996     3467899999987532   122346678999999999999999999999876 


Q ss_pred             -CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          115 -RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       115 -~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                       +..+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence             66899999999999999985432  2378889999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCC---cccccccccccccCCC
Q 039002          194 IAKFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      ++........   ......||..|+|||.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  200 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPEC  200 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHH
T ss_pred             ccccccCCCcceeccCCCCCCccccCCee
Confidence            9987764432   1234578888999983

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=8.4e-31  Score=212.93  Aligned_cols=167  Identities=28%  Similarity=0.444  Sum_probs=141.3

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +.|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++...+..+++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            458899999999999999994 578889999998643222 223345678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+. |++.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99996 67877775322  2378889999999999999999999   999999999999999999999999999976533


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .    ....||+.|+|||+
T Consensus       207 ~----~~~~gt~~y~aPE~  221 (348)
T 1u5q_A          207 A----NSFVGTPYWMAPEV  221 (348)
T ss_dssp             B----CCCCSCGGGCCHHH
T ss_pred             C----CcccCCcceeCHhh
Confidence            2    34689999999983

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=5e-31  Score=221.82  Aligned_cols=168  Identities=21%  Similarity=0.354  Sum_probs=134.6

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC----
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA----  114 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----  114 (219)
                      ..++|++.+.||+|+||.||+| ...+++.||+|++....  ........+.+|+.+++.++||||+++++++...    
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            3578999999999999999999 56688899999986432  1233456778999999999999999999999654    


Q ss_pred             --CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          115 --RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       115 --~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                        +.+++||||+.+ ++.+.+..     .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+||
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence              356999999975 56666543     277888899999999999999999   9999999999999999999999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |+++...... .....+||+.|+|||+
T Consensus       209 G~a~~~~~~~-~~~~~~gt~~y~aPE~  234 (464)
T 3ttj_A          209 GLARTAGTSF-MMTPYVVTRYYRAPEV  234 (464)
T ss_dssp             CCC-----CC-CC----CCCTTCCHHH
T ss_pred             EeeeecCCCc-ccCCCcccccccCHHH
Confidence            9998765432 2345689999999994

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=1.8e-30  Score=207.43  Aligned_cols=175  Identities=22%  Similarity=0.392  Sum_probs=145.2

Q ss_pred             HHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS  112 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  112 (219)
                      ...++|++.+.||+|+||.||+|..      .++..||+|.+...   ........+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3457899999999999999999953      34578999998642   22334467889999999999999999999999


Q ss_pred             eCCcceEEEEecCCCCHHHHhcccch---------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEe
Q 039002          113 HARHSFLLCEFLERGSLAAILNTDAA---------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVH  171 (219)
Q Consensus       113 ~~~~~~lv~e~~~~~~l~~~~~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  171 (219)
                      ..+..+++||++.+++|.+++.....                     ...+++..+..++.|++.|+.|||+.   +++|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence            99999999999999999999965321                     12377888999999999999999999   9999


Q ss_pred             cCCCCCCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          172 RDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       172 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +||||+||+++.++.++|+|||++.........  .....+|+.|+|||.
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            999999999999999999999999876543321  123467788999983

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=2.2e-30  Score=212.35  Aligned_cols=163  Identities=20%  Similarity=0.326  Sum_probs=134.0

Q ss_pred             cceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           47 KYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .+.||+|+||.||+| ...+++.||+|.+...    .......+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            567999999999999 4567899999998642    22345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe--CCCCcEEEeeccceeeecCCCC
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL--DLEYEAHVADFGIAKFLKSDAS  203 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~~~~~  203 (219)
                      +++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||++  +.++.++|+|||++..+.... 
T Consensus       170 ~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          170 GGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             TCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            999998886432  2378888999999999999999999   99999999999999  566899999999998775433 


Q ss_pred             cccccccccccccCCC
Q 039002          204 NWTEFAGTYGYVALGI  219 (219)
Q Consensus       204 ~~~~~~gt~~y~aPE~  219 (219)
                      .....+||+.|+|||+
T Consensus       244 ~~~~~~gt~~y~aPE~  259 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEV  259 (373)
T ss_dssp             BCCCCCSSCTTCCHHH
T ss_pred             ccccccCCCcEeChhh
Confidence            2344579999999994

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.6e-31  Score=215.10  Aligned_cols=181  Identities=25%  Similarity=0.333  Sum_probs=142.8

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCC-CCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLP-SDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ++....++|++.+.||+|+||.||+| ...++..+|+|.+..... .........+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            44556688999999999999999999 556788999998753210 0012234678899999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccch-------------------------------------hhccCHHHHHHHHHHHHH
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAA-------------------------------------AQELGWSQRMSVIKGVAD  156 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~  156 (219)
                      .+..++||||+++++|.+++.....                                     ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999998852100                                     111345667789999999


Q ss_pred             HHHhhhhCCCCCeEecCCCCCCEEeCCCC--cEEEeeccceeeecCCCC----cccccccccccccCCC
Q 039002          157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEY--EAHVADFGIAKFLKSDAS----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       157 ~l~~lh~~~~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~  219 (219)
                      |+.|||+.   +++|+||||+||+++.++  .++|+|||++..+.....    ......||+.|+|||+
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  245 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV  245 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHH
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchh
Confidence            99999999   999999999999998766  899999999987654322    1245689999999983

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=5.7e-31  Score=218.88  Aligned_cols=173  Identities=23%  Similarity=0.312  Sum_probs=134.4

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCC----chhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSD----QTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ...++|++.+.||+|+||.||+| ...+++.||+|.+.......    .......+.+|+.+++.++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34589999999999999999999 56678899999975422111    11112246789999999999999999999854


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC---cEEEe
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY---EAHVA  190 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~---~~kl~  190 (219)
                       +..+++|||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++   .+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence             55899999999999998886543   378899999999999999999999   999999999999997544   59999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||+++...... .....+||+.|+|||+
T Consensus       285 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~  312 (419)
T 3i6u_A          285 DFGHSKILGETS-LMRTLCGTPTYLAPEV  312 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTT
T ss_pred             ecccceecCCCc-cccccCCCCCccCcee
Confidence            999998664332 2345689999999995

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1.7e-30  Score=208.84  Aligned_cols=170  Identities=31%  Similarity=0.465  Sum_probs=140.6

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc---
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH---  116 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---  116 (219)
                      ..++|++.+.||+|+||.||+|... ++.||+|.+...     ........+|+..++.++||||+++++++.....   
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            3578999999999999999999654 678999998531     2233445668889999999999999999987543   


Q ss_pred             -ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC-------CCCeEecCCCCCCEEeCCCCcEE
Q 039002          117 -SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC-------FPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       117 -~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-------~~~i~H~dlkp~nili~~~~~~k  188 (219)
                       .+++|||+++++|.+++...    .+++..+..++.|++.|+.|||+..       ..+++||||||+||+++.++.+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence             69999999999999999653    3788999999999999999999751       12799999999999999999999


Q ss_pred             EeeccceeeecCCCC--cccccccccccccCCC
Q 039002          189 VADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |+|||+++.+.....  ......||+.|+|||+
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  204 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV  204 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhh
Confidence            999999987764432  2233589999999994

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=5.7e-30  Score=202.25  Aligned_cols=169  Identities=29%  Similarity=0.462  Sum_probs=140.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhH---HHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQ---KEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+............   ..+.+|+.+++.++|+||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            478999999999999999999 4568889999998654333222111   56789999999999999999999986554 


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeCCCCc-----EEE
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLDLEYE-----AHV  189 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~~~~~-----~kl  189 (219)
                       +++||++.+++|.+.+....  ..+++..+..++.|++.|+.|||+.   +  ++|+||||+||+++.++.     ++|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             79999999999988886533  2378889999999999999999998   8  999999999999988776     999


Q ss_pred             eeccceeeecCCCCcccccccccccccCCC
Q 039002          190 ADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       190 ~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +|||++.....   ......||+.|+|||.
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~  197 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPET  197 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGG
T ss_pred             CCCCccccccc---cccccCCCccccCchh
Confidence            99999975433   2345689999999994

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=4.9e-31  Score=223.13  Aligned_cols=170  Identities=22%  Similarity=0.425  Sum_probs=142.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+......  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            367999999999999999999 4568889999997532111  1234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC---CCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD---LEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~  196 (219)
                      +||++.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++   .++.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999998886532   378899999999999999999999   999999999999995   45679999999997


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+.... .....+||+.|+|||+
T Consensus       173 ~~~~~~-~~~~~~gt~~y~aPE~  194 (486)
T 3mwu_A          173 CFQQNT-KMKDRIGTAYYIAPEV  194 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGG
T ss_pred             ECCCCC-ccCCCcCCCCCCCHHH
Confidence            654432 2345689999999995

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=8.6e-31  Score=212.33  Aligned_cols=169  Identities=20%  Similarity=0.319  Sum_probs=139.1

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC--CccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH--RNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+|...+++.||+|.+....  ........+.+|+.+++.++|  +||+++++++...+..+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            45699999999999999999977888899999986532  223344678899999999976  99999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++|| +.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++ ++.+||+|||++..+
T Consensus        86 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            9999 55789999987543   378888999999999999999999   999999999999996 688999999999876


Q ss_pred             cCCCC--cccccccccccccCCC
Q 039002          199 KSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      .....  .....+||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~  180 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEA  180 (343)
T ss_dssp             ------------CCCCSSCCHHH
T ss_pred             CcccccccCCCCcCCcCcCCHHH
Confidence            54322  1234689999999994

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=2.5e-30  Score=210.00  Aligned_cols=171  Identities=25%  Similarity=0.378  Sum_probs=140.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  113 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|++......  ......+.+|+.+++.++|+||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            4789999999999999999994 568899999998654322  2234567789999999999999999999976      


Q ss_pred             --CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          114 --ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       114 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                        .+..++|||++.+ ++...+....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence              4568999999975 7777665432  2378899999999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCC----CcccccccccccccCCC
Q 039002          192 FGIAKFLKSDA----SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~----~~~~~~~gt~~y~aPE~  219 (219)
                      ||++..+....    .......||+.|+|||+
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  199 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL  199 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHH
T ss_pred             chhcccccccccccccccCCcccccCccCchh
Confidence            99998765322    22244578999999993

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=1e-30  Score=206.68  Aligned_cols=171  Identities=25%  Similarity=0.379  Sum_probs=139.6

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...++..+|+|.+.....   ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            67999999999999999999 456788999999865321   22346678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC---CCCcEEEeecccee
Q 039002          121 CEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD---LEYEAHVADFGIAK  196 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~  196 (219)
                      ||++.+++|.+.+.... ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++   .++.++|+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999999999885431 123478889999999999999999999   999999999999994   55789999999997


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+.... ......||+.|+|||+
T Consensus       176 ~~~~~~-~~~~~~~t~~y~aPE~  197 (285)
T 3is5_A          176 LFKSDE-HSTNAAGTALYMAPEV  197 (285)
T ss_dssp             C-----------CTTGGGCCHHH
T ss_pred             ecCCcc-cCcCcccccCcCChHH
Confidence            665432 2244689999999983

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=3.2e-30  Score=210.79  Aligned_cols=175  Identities=26%  Similarity=0.399  Sum_probs=147.4

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCc----hhhHHHHHHHHHHHhcC-CCCccceeEeEE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQ----TVDQKEFLTEVKALTET-RHRNIVKFYGFC  111 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~  111 (219)
                      ....++|++.+.||+|+||.||+|. ..+|+.||||.+........    ......+.+|+.+++.+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            4455789999999999999999995 45799999998865332211    11235567899999999 799999999999


Q ss_pred             EeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          112 SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       112 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                      ...+..+++|||+.+++|.+++...   ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.+|.++|+|
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999998643   2378889999999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++..+.... ......||+.|+|||+
T Consensus       244 fG~~~~~~~~~-~~~~~~gt~~y~aPE~  270 (365)
T 2y7j_A          244 FGFSCHLEPGE-KLRELCGTPGYLAPEI  270 (365)
T ss_dssp             CTTCEECCTTC-CBCCCCSCGGGCCHHH
T ss_pred             cCcccccCCCc-ccccCCCCCCccChhh
Confidence            99998765432 2345689999999994

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=8.4e-31  Score=214.36  Aligned_cols=174  Identities=24%  Similarity=0.369  Sum_probs=142.0

Q ss_pred             HhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ..++|++.+.||+|+||.||+|..      .++..||+|.+...   ........+.+|+.+++.++||||+++++++..
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            356789999999999999999963      24668999998642   223344567889999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccch----hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC---c
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAA----AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY---E  186 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~---~  186 (219)
                      .+..++||||+.+++|.+++.....    ...+++..++.++.|++.|+.|||+.   +++||||||+||+++.+|   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999965321    12377888999999999999999999   999999999999999555   5


Q ss_pred             EEEeeccceeeecCCC--CcccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      +||+|||+++......  .......||+.|+|||+
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  257 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA  257 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHH
Confidence            9999999997553221  22234578899999983

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=2.7e-30  Score=206.35  Aligned_cols=176  Identities=20%  Similarity=0.325  Sum_probs=135.4

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++...+..+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            45789999999999999999994 568889999998653222 2334567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          119 LLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++||++.+++|.+++.... ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            9999999999999986422 123377888999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............|++.|+|||.
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~  207 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPER  207 (310)
T ss_dssp             -------------CCSSCCHHH
T ss_pred             ecCCCccccccCCCeeEeChHH
Confidence            6554443445689999999983

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=2e-30  Score=207.26  Aligned_cols=176  Identities=23%  Similarity=0.329  Sum_probs=138.9

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .....++|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+.+++.++||||+++++++...+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            34556899999999999999999995 557889999998643222 2233466889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             eEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccC
Confidence            9999999999999999987532   378889999999999999999999   9999999999999999999999999998


Q ss_pred             eeecCCC-CcccccccccccccCCC
Q 039002          196 KFLKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ....... .......|++.|+|||+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~  206 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPER  206 (309)
T ss_dssp             ---------------CCGGGCCGGG
T ss_pred             ccccccccccccccCCCcCccCHHH
Confidence            7665432 22234579999999994

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.5e-30  Score=210.61  Aligned_cols=178  Identities=22%  Similarity=0.358  Sum_probs=144.7

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeE
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFY  108 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  108 (219)
                      ++....++|++.+.||+|+||.||+|..      .++..||+|.+....   .......+.+|+.+++.+ +||||++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            3455678899999999999999999953      245679999986432   122345688999999999 899999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccchh--------------------hccCHHHHHHHHHHHHHHHHhhhhCCCCC
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAAA--------------------QELGWSQRMSVIKGVADALSYLHHDCFPP  168 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~  168 (219)
                      +++...+..+++||++++++|.+++......                    ..+++..+..++.|++.|+.|||+.   +
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  192 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---S  192 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            9999999999999999999999999754321                    2267888999999999999999999   9


Q ss_pred             eEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       169 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      ++|+||||+||+++.++.++|+|||++.........  .....+|+.|+|||.
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  245 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  245 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence            999999999999999999999999999876543321  233467889999983

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=9.3e-31  Score=221.22  Aligned_cols=171  Identities=24%  Similarity=0.427  Sum_probs=145.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+....... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            367999999999999999999 45688999999986543222 2345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe---CCCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~  196 (219)
                      +||++.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++||||||+||++   +.++.++|+|||++.
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999886543   378889999999999999999999   99999999999999   466899999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+.... .....+||+.|+|||+
T Consensus       178 ~~~~~~-~~~~~~gt~~y~aPE~  199 (484)
T 3nyv_A          178 HFEASK-KMKDKIGTAYYIAPEV  199 (484)
T ss_dssp             HBCCCC-SHHHHTTGGGTCCHHH
T ss_pred             Eccccc-ccccCCCCccccCcee
Confidence            765433 2345689999999984

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=5.1e-31  Score=211.84  Aligned_cols=181  Identities=24%  Similarity=0.410  Sum_probs=141.3

Q ss_pred             ccccHHHHHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCcccee
Q 039002           30 GKILYDEIVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKF  107 (219)
Q Consensus        30 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  107 (219)
                      ..+....+....++|++.+.||+|+||.||+|. ..+++.||+|.+....     .....+.+|+.+++.+ +|+||+++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~   86 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATY   86 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeee
Confidence            333334445567899999999999999999995 5688899999986421     1235678899999998 79999999


Q ss_pred             EeEEEe------CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe
Q 039002          108 YGFCSH------ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL  181 (219)
Q Consensus       108 ~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili  181 (219)
                      ++++..      .+..+++||++.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||++
T Consensus        87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~  162 (326)
T 2x7f_A           87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLL  162 (326)
T ss_dssp             EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEE
T ss_pred             eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEE
Confidence            999976      4678999999999999999975432 3478888999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          182 DLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       182 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.++.++|+|||++..............||+.|+|||+
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  200 (326)
T 2x7f_A          163 TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV  200 (326)
T ss_dssp             CTTCCEEECCCTTTC-------------CCGGGCCHHH
T ss_pred             cCCCCEEEeeCcCceecCcCccccccccCCccccChhh
Confidence            99999999999999876544333445689999999983

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=4.9e-30  Score=208.92  Aligned_cols=169  Identities=24%  Similarity=0.274  Sum_probs=143.0

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-----CCccceeEeEE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-----HRNIVKFYGFC  111 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~~~  111 (219)
                      ....++|++.+.||+|+||.||+| ...+++.||+|.+..     .......+..|+.+++.+.     |+||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            334578999999999999999999 456888999999853     2234456677999999886     99999999999


Q ss_pred             EeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC--------
Q 039002          112 SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL--------  183 (219)
Q Consensus       112 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~--------  183 (219)
                      ...+..+++||++ +++|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.        
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence            9999999999999 8899999975432 2378888999999999999999999   9999999999999975        


Q ss_pred             -----------------CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 -----------------EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 -----------------~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                                       ++.++|+|||++......   .....||+.|+|||+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~  230 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEV  230 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHH
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHH
Confidence                             789999999999865432   235689999999994

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=3.8e-30  Score=202.79  Aligned_cols=171  Identities=25%  Similarity=0.373  Sum_probs=141.8

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCc--hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQ--TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ++|++.+.||+|+||.||+|. ..+++.+|+|.+........  ......+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            568999999999999999994 55788999998865432221  123567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC----cEEEeeccc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY----EAHVADFGI  194 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~----~~kl~dfg~  194 (219)
                      ++||++.+++|.+++...   ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++    .++|+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999998643   2378899999999999999999999   999999999999998876    899999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +....... ......|++.|+|||.
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~aPE~  182 (283)
T 3bhy_A          159 AHKIEAGN-EFKNIFGTPEFVAPEI  182 (283)
T ss_dssp             CEECC---------CCCGGGCCHHH
T ss_pred             ceeccCCC-cccccCCCcCccCcce
Confidence            98765432 2244579999999983

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=2e-30  Score=214.37  Aligned_cols=165  Identities=24%  Similarity=0.332  Sum_probs=129.8

Q ss_pred             hCCCCCc-ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHH-hcCCCCccceeEeEEEe----
Q 039002           41 TNDFDAK-YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL-TETRHRNIVKFYGFCSH----  113 (219)
Q Consensus        41 ~~~y~~~-~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~----  113 (219)
                      .++|.+. +.||+|+||.||+| ...+++.||+|.+..         ...+.+|+.++ +..+|+||+++++++..    
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---------chhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            4567666 68999999999999 566888999999852         12456788776 45589999999999875    


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEe
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVA  190 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~  190 (219)
                      .+.+++||||+.+|+|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.   ++.+||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence            5678999999999999999975432 3478899999999999999999998   9999999999999997   7899999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||+++...... .....+||+.|+|||+
T Consensus       207 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~  234 (400)
T 1nxk_A          207 DFGFAKETTSHN-SLTTPCYTPYYVAPEV  234 (400)
T ss_dssp             CCTTCEECC------------CTTCCGGG
T ss_pred             ecccccccCCCC-ccccCCCCCCccCHhh
Confidence            999998765332 2345689999999995

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=7.1e-31  Score=206.73  Aligned_cols=170  Identities=28%  Similarity=0.466  Sum_probs=140.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...++..+|+|.+..... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            578999999999999999999 566788899998743111 111234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++++++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999886532   378888999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .....|++.|+|||.
T Consensus       161 ~~~--~~~~~~~~~y~aPE~  178 (279)
T 3fdn_A          161 SSR--RTDLCGTLDYLPPEM  178 (279)
T ss_dssp             ---------CCCCTTCCHHH
T ss_pred             ccc--ccccCCCCCccCHhH
Confidence            322  234589999999983

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.97  E-value=1.9e-30  Score=206.01  Aligned_cols=172  Identities=27%  Similarity=0.379  Sum_probs=142.6

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+......  ......+.+|+.+++.++|+||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   79 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccc--hhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEE
Confidence            4789999999999999999994 557889999998643221  2233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++. ++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        80 v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  154 (299)
T 2r3i_A           80 VFEFLH-QDLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  154 (299)
T ss_dssp             EEECCS-EEHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             EEEccc-CCHHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence            999997 699998865422 2377888899999999999999999   99999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+|+.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~  174 (299)
T 2r3i_A          155 VPVRTYTHEVVTLWYRAPEI  174 (299)
T ss_dssp             CCSBCTTSCBCCCTTCCHHH
T ss_pred             CCccccCcccccccccCcHH
Confidence            44434445678999999983

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=4.1e-30  Score=205.51  Aligned_cols=171  Identities=26%  Similarity=0.430  Sum_probs=141.3

Q ss_pred             HHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ....++|++.+.||+|+||.||+|. ..+++.||+|.+....      ....+.+|+.+++.++||||+++++++...+.
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            4456789999999999999999994 5578899999986421      23457889999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||..   +++|+||||+||+++.++.++|+|||++.
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccch
Confidence            999999999999999986322  2378889999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .............|++.|+|||+
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~  196 (314)
T 3com_A          174 QLTDTMAKRNTVIGTPFWMAPEV  196 (314)
T ss_dssp             ECBTTBSCBCCCCSCGGGCCHHH
T ss_pred             hhhhhccccCccCCCCCccChhh
Confidence            87655444456689999999984

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=4.9e-30  Score=205.27  Aligned_cols=169  Identities=23%  Similarity=0.377  Sum_probs=136.5

Q ss_pred             hCCCCCc-ceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcc
Q 039002           41 TNDFDAK-YCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        41 ~~~y~~~-~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  117 (219)
                      .+.|++. +.||+|+||.||+|. ..+++.||+|.+....    ......+.+|+.+++.+ +||||+++++++.+.+..
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            3678885 789999999999995 5678899999986432    22345678899999885 799999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc---EEEeeccc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADFGI  194 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~---~kl~dfg~  194 (219)
                      +++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.   ++|+|||+
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            99999999999999986532   378888999999999999999999   9999999999999997765   99999999


Q ss_pred             eeeecCCCC-------cccccccccccccCCC
Q 039002          195 AKFLKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                      +........       .....+||+.|+|||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  192 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEV  192 (316)
T ss_dssp             CC-------------------CCSGGGCCHHH
T ss_pred             ccccccCCccccccccccccccCCcCccChHH
Confidence            876542211       1123469999999994

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=2e-30  Score=213.73  Aligned_cols=168  Identities=20%  Similarity=0.318  Sum_probs=138.9

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC--CCccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR--HRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+|++.+.||+|+||.||+|...+++.||+|.+.....  .......+.+|+.+++.++  |+||+++++++...+..++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            34999999999999999999777788999999865322  2334567889999999996  5999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|| +.+++|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++ ++.+||+|||++..+.
T Consensus       134 v~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             EEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            999 56889999987543   367788889999999999999999   999999999999995 5899999999998765


Q ss_pred             CCCC--cccccccccccccCCC
Q 039002          200 SDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ....  .....+||+.|+|||+
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~  227 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEA  227 (390)
T ss_dssp             --------CCSCCCGGGCCHHH
T ss_pred             CCCccccCCCCCcCCCccChHH
Confidence            3322  1234689999999994

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=5e-30  Score=207.03  Aligned_cols=176  Identities=20%  Similarity=0.358  Sum_probs=144.1

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEc--------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAEL--------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFY  108 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~--------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~  108 (219)
                      ....++|++.+.||+|+||.||+|..        .++..||+|.+....   .......+.+|+.+++.+ +||||++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            34468899999999999999999953        346689999986432   233456688999999999 899999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                      +++...+..+++||++.+++|.+++.....             ...+++..+..++.|++.|+.|||+.   +++|+|||
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  184 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA  184 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence            999999999999999999999999975431             12377888999999999999999999   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++.++|+|||++........  ......+|+.|+|||+
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  230 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA  230 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHH
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHH
Confidence            9999999999999999999987654322  1123467788999983

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=2.1e-30  Score=219.69  Aligned_cols=175  Identities=23%  Similarity=0.394  Sum_probs=146.0

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEc-CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .|.....+|++.+.||+|+||.||+|.. .++..||+|.++...     .....+.+|+.+++.++||||+++++++...
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3444567788999999999999999954 457889999986421     2346788999999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..++|||++.+++|.+++..... ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence            999999999999999999975332 3478888999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCC-cccccccccccccCCC
Q 039002          195 AKFLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ++....... ......+++.|+|||+
T Consensus       365 a~~~~~~~~~~~~~~~~~~~y~aPE~  390 (495)
T 1opk_A          365 SRLMTGDTYTAHAGAKFPIKWTAPES  390 (495)
T ss_dssp             EECCTTCCEECCTTCCCCGGGCCHHH
T ss_pred             ceeccCCceeecCCCcCCcceeCHhH
Confidence            987643321 1122356788999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=4.1e-30  Score=205.18  Aligned_cols=173  Identities=25%  Similarity=0.363  Sum_probs=138.3

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCC-chhhHHHHHHHHHHHhcC---CCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSD-QTVDQKEFLTEVKALTET---RHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+....... .......+.+|+..++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            5799999999999999999995 5678899999986432111 111223456677776666   4999999999998765


Q ss_pred             -----cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          116 -----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       116 -----~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                           ..++++|++. ++|.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence                 4789999996 599999876432 2378899999999999999999999   99999999999999999999999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||++....... ......||+.|+|||+
T Consensus       163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~  190 (308)
T 3g33_A          163 DFGLARIYSYQM-ALTPVVVTLWYRAPEV  190 (308)
T ss_dssp             SCSCTTTSTTCC-CSGGGGCCCSSCCHHH
T ss_pred             eCccccccCCCc-ccCCccccccccCchH
Confidence            999997654332 2345689999999984

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=8.3e-30  Score=205.11  Aligned_cols=170  Identities=25%  Similarity=0.339  Sum_probs=143.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-----cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE--e
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-----LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS--H  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~  113 (219)
                      .++|++.+.||+|+||.||+|.     ..+++.||+|.+...    .......+.+|+.+++.++|+||+++++++.  .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            4689999999999999999996     346788999998642    2334466889999999999999999999886  4


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      .+..+++|||+++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence            566899999999999999997532  2378899999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCC---cccccccccccccCCC
Q 039002          194 IAKFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      ++........   ......+|+.|+|||+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPES  201 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHH
T ss_pred             cceecccCCccceeeccCCccccccCHHH
Confidence            9987654332   1233468888999983

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=8.7e-31  Score=208.26  Aligned_cols=172  Identities=25%  Similarity=0.406  Sum_probs=140.0

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...++|++.+.||+|+||.||+|. ..+++.+|+|.+....    ......+.+|+.+++.++||||+++++++...+..
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            345789999999999999999995 4578899999986431    22346678899999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++||++++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            99999999999999886422  2378889999999999999999999   999999999999999999999999998754


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ............||+.|+|||+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~  188 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEV  188 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHH
T ss_pred             ccccccccccccCChhhcCCee
Confidence            3322222234579999999983

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=1e-30  Score=209.68  Aligned_cols=179  Identities=21%  Similarity=0.365  Sum_probs=146.2

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeE
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY  108 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~  108 (219)
                      +++....++|++.+.||+|+||.||+|...      +++.||+|.+...   ........+.+|+.+++.++|+||++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            445556788999999999999999999432      4678999998642   2223445678999999999999999999


Q ss_pred             eEEEeCCcceEEEEecCCCCHHHHhcccchh-------hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe
Q 039002          109 GFCSHARHSFLLCEFLERGSLAAILNTDAAA-------QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL  181 (219)
Q Consensus       109 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili  181 (219)
                      +++.+.+..+++||++.+++|.+++......       ..+++..+..++.|++.|+.|||+.   +++|+||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            9999999999999999999999998653221       2357788899999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          182 DLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       182 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +.++.++|+|||++........  ......+|+.|+|||+
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            9999999999999876543221  1123467889999983

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=1.7e-30  Score=218.08  Aligned_cols=175  Identities=19%  Similarity=0.375  Sum_probs=145.8

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      +.|....++|++.+.||+|+||.||+|...++..||+|.++...     .....+.+|+.+++.++||||+++++++. .
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            34556678899999999999999999987778889999986421     23467889999999999999999999986 5


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..+++||++.+|+|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             CccEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            679999999999999999975432 2477888899999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCC-CcccccccccccccCCC
Q 039002          195 AKFLKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ++...... .......+++.|+|||+
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~  356 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEA  356 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHH
T ss_pred             ceEcCCCceeccCCCcccccccCHHH
Confidence            98654321 11122356788999984

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=2.7e-30  Score=206.27  Aligned_cols=176  Identities=23%  Similarity=0.354  Sum_probs=146.2

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGF  110 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~  110 (219)
                      ....++|++.+.||+|+||.||+|..      .+++.||+|.+...   ........+.+|+.+++.+ +||||++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            34467899999999999999999952      35678999998643   2223446788999999999 89999999999


Q ss_pred             EEeCCcceEEEEecCCCCHHHHhcccchh---------------hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          111 CSHARHSFLLCEFLERGSLAAILNTDAAA---------------QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       111 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                      +...+..+++||++.+++|.+++......               ..+++..+..++.|++.|+.|||+.   +++|+|||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence            99999999999999999999998754311               1378889999999999999999999   99999999


Q ss_pred             CCCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          176 SKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++.++|+|||++.........  .....+|+.|+|||+
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  218 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES  218 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHH
Confidence            99999999999999999999876544321  123467889999983

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=3.8e-30  Score=206.57  Aligned_cols=177  Identities=24%  Similarity=0.377  Sum_probs=128.9

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcC-CCc---EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELP-SRE---VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~-~~~---~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ....++|++.+.||+|+||.||+|... ++.   .||+|.+......  ......+.+|+.+++.++||||+++++++..
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA--SSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC--HHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            445678999999999999999999644 332   7999998654322  2345678899999999999999999999987


Q ss_pred             CCcc------eEEEEecCCCCHHHHhcccch---hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC
Q 039002          114 ARHS------FLLCEFLERGSLAAILNTDAA---AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE  184 (219)
Q Consensus       114 ~~~~------~lv~e~~~~~~l~~~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~  184 (219)
                      .+..      ++++|++.+++|.+++.....   ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence            7655      999999999999999864321   11378889999999999999999999   99999999999999999


Q ss_pred             CcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          185 YEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +.++|+|||++........  ......+++.|+|||.
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALES  210 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchh
Confidence            9999999999987643321  1123456788999983

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=1.2e-30  Score=206.29  Aligned_cols=166  Identities=20%  Similarity=0.350  Sum_probs=140.1

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCC-------cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSR-------EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS  112 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~-------~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  112 (219)
                      .++|++.+.||+|+||.||+|. ..++       ..+|+|.+...    .......+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            4678999999999999999994 3333       46999987532    2334567889999999999999999999999


Q ss_pred             eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc------
Q 039002          113 HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE------  186 (219)
Q Consensus       113 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~------  186 (219)
                      +.+..+++|||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.      
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence            9999999999999999999997543  2378888999999999999999999   9999999999999998876      


Q ss_pred             --EEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          187 --AHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 --~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                        ++|+|||++.....    .....||+.|+|||.
T Consensus       158 ~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~  188 (289)
T 4fvq_A          158 PFIKLSDPGISITVLP----KDILQERIPWVPPEC  188 (289)
T ss_dssp             CEEEECCCCSCTTTSC----HHHHHHTTTTSCHHH
T ss_pred             ceeeeccCcccccccC----ccccCCcCcccCHHH
Confidence              99999999864322    234578999999983

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.5e-30  Score=204.10  Aligned_cols=170  Identities=26%  Similarity=0.455  Sum_probs=143.8

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..++..+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            4789999999999999999994 557888999987532110 11223567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            999999999999986543   378888999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .....|++.|+|||.
T Consensus       166 ~~~--~~~~~~~~~y~aPE~  183 (284)
T 2vgo_A          166 SLR--RRTMCGTLDYLPPEM  183 (284)
T ss_dssp             SSC--BCCCCSCGGGCCHHH
T ss_pred             ccc--cccccCCCCcCCHHH
Confidence            332  244689999999983

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=4e-30  Score=202.71  Aligned_cols=170  Identities=21%  Similarity=0.344  Sum_probs=130.1

Q ss_pred             hCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|...    .+..+|+|.+...   ........+.+|+..++.++||||+++++++ ..+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence            478999999999999999999542    2456999987642   2233456788999999999999999999998 4567


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            899999999999999986532  2378888999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc-ccccccccccccCCC
Q 039002          197 FLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      ........ .....+++.|+|||.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~  188 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPES  188 (281)
T ss_dssp             --------------CCGGGCCHHH
T ss_pred             ccCcccccccccCCCcccccChhh
Confidence            76543221 123356788999983

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=1.7e-29  Score=200.48  Aligned_cols=174  Identities=25%  Similarity=0.374  Sum_probs=146.1

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCc-----hhhHHHHHHHHHHHhcCC-CCccceeEeEE
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQ-----TVDQKEFLTEVKALTETR-HRNIVKFYGFC  111 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~  111 (219)
                      ...++|++.+.||+|+||.||+| ...+++.||+|.+........     ......+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34688999999999999999999 456788999999865321110     122355778999999995 99999999999


Q ss_pred             EeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          112 SHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       112 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                      ...+..+++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999986532   378889999999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++....... ......|++.|+|||+
T Consensus       168 fg~~~~~~~~~-~~~~~~~~~~y~aPE~  194 (298)
T 1phk_A          168 FGFSCQLDPGE-KLREVCGTPSYLAPEI  194 (298)
T ss_dssp             CTTCEECCTTC-CBCCCCSCGGGCCHHH
T ss_pred             ccchhhcCCCc-ccccccCCccccCHHH
Confidence            99998765432 2345689999999983

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=4.2e-30  Score=202.23  Aligned_cols=173  Identities=19%  Similarity=0.380  Sum_probs=144.2

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      |....++|++.+.||+|+||.||+|...++..+|+|.+....     .....+.+|+.+++.++|+||+++++++. .+.
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            344457899999999999999999987777789999986422     23456789999999999999999999986 456


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cEEEEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            8999999999999999975432 2478889999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCC-cccccccccccccCCC
Q 039002          197 FLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ....... ......+++.|+|||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~  181 (279)
T 1qpc_A          158 LIEDNEYTAREGAKFPIKWTAPEA  181 (279)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHH
T ss_pred             cccCcccccccCCCCccCccChhh
Confidence            7654321 1123456788999983

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=8.2e-30  Score=213.72  Aligned_cols=169  Identities=25%  Similarity=0.388  Sum_probs=140.4

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC-
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR-  115 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  115 (219)
                      |....++|++.+.||+|+||.||+|... ++.||+|.++...      ....+.+|+.+++.++||||+++++++...+ 
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            3445678999999999999999999664 6689999987531      3356889999999999999999999987665 


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++|||+.+++|.+++...+. ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            78999999999999999975432 2257888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +......   ....+++.|+|||+
T Consensus       337 ~~~~~~~---~~~~~~~~y~aPE~  357 (450)
T 1k9a_A          337 KEASSTQ---DTGKLPVKWTAPEA  357 (450)
T ss_dssp             EECC---------CCCTTTSCHHH
T ss_pred             ccccccc---cCCCCCcceeCHHH
Confidence            8653322   22367889999984

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=2e-29  Score=202.21  Aligned_cols=168  Identities=24%  Similarity=0.385  Sum_probs=139.9

Q ss_pred             CCC-CCcceeccccceeEEEEEc-----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-
Q 039002           42 NDF-DAKYCIGNGGHASVYRAEL-----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-  114 (219)
Q Consensus        42 ~~y-~~~~~lg~g~~g~V~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-  114 (219)
                      ++| ++.+.||+|+||.||++.+     .+++.||+|.+...   ........+.+|+.+++.++||||+++++++.+. 
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            344 8999999999999988843     36788999998753   2233456688999999999999999999999874 


Q ss_pred             -CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          115 -RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       115 -~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                       ...+++||++.+++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             CceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence             5689999999999999999753    278889999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCc---ccccccccccccCCC
Q 039002          194 IAKFLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      ++.........   .....+|+.|+|||+
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~  208 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPEC  208 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHH
T ss_pred             ccccccccccccccccCCCCCceeeChHH
Confidence            99877544321   233468888999984

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=1.9e-30  Score=211.45  Aligned_cols=169  Identities=27%  Similarity=0.390  Sum_probs=142.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...++..+|+|.+...   ........+.+|+.+++.++|+||+++++++...+..++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc---cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            467999999999999999999 4568889999998653   223345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +|||+.+++|.+++....   .+++..+..++.+++.|+.|||+..  +++|+||||+||+++.++.++|+|||++....
T Consensus       109 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999996543   3778889999999999999999831  79999999999999999999999999987554


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .....||+.|+|||+
T Consensus       184 ~~~--~~~~~gt~~y~aPE~  201 (360)
T 3eqc_A          184 DSM--ANSFVGTRSYMSPER  201 (360)
T ss_dssp             HHC------CCCCTTCCHHH
T ss_pred             ccc--ccCCCCCCCeECHHH
Confidence            322  234589999999984

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=1.3e-30  Score=204.96  Aligned_cols=174  Identities=25%  Similarity=0.420  Sum_probs=142.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CCcc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  117 (219)
                      .++|++.+.||+|+||.||+| ...+++.+|+|.+.....  .......+.+|+.+++.++||||+++++++..  .+..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            578999999999999999999 456888999999865332  23345678899999999999999999998854  5678


Q ss_pred             eEEEEecCCCCHHHHhcccch-hhccCHHHHHHHHHHHHHHHHhhhhCCCCC-----eEecCCCCCCEEeCCCCcEEEee
Q 039002          118 FLLCEFLERGSLAAILNTDAA-AQELGWSQRMSVIKGVADALSYLHHDCFPP-----IVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~-----i~H~dlkp~nili~~~~~~kl~d  191 (219)
                      +++|||+++++|.+++..... ...+++..+..++.|++.|+.|||..   +     ++|+||||+||+++.++.++|+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            999999999999999865322 12378889999999999999999998   7     99999999999999999999999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++..............|++.|+|||.
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~  187 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQ  187 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHH
T ss_pred             CchheeeccccccccccCCCccccChHH
Confidence            9998766544332344578999999983

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=3e-30  Score=202.70  Aligned_cols=171  Identities=23%  Similarity=0.349  Sum_probs=136.5

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+..... ........+.+|+..++.++|+||+++++++...+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4789999999999999999995 45788999998753210 011233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999986532   378888999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ... ......|++.|+|||.
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~  181 (276)
T 2h6d_A          163 DGE-FLRTSCGSPNYAAPEV  181 (276)
T ss_dssp             C--------------CCTGG
T ss_pred             CCc-ceecccCCccccCHHH
Confidence            332 2234578999999994

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=2.8e-30  Score=206.46  Aligned_cols=180  Identities=21%  Similarity=0.335  Sum_probs=146.3

Q ss_pred             HHHHHHHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccce
Q 039002           34 YDEIVKATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVK  106 (219)
Q Consensus        34 ~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~  106 (219)
                      ...+....++|++.+.||+|+||.||+|..      .+++.||+|.+....   .......+.+|+.+++.+ +||||++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeee
Confidence            445666778999999999999999999952      356789999986432   223445678999999999 6899999


Q ss_pred             eEeEEEeCC-cceEEEEecCCCCHHHHhcccchh-------------hccCHHHHHHHHHHHHHHHHhhhhCCCCCeEec
Q 039002          107 FYGFCSHAR-HSFLLCEFLERGSLAAILNTDAAA-------------QELGWSQRMSVIKGVADALSYLHHDCFPPIVHR  172 (219)
Q Consensus       107 ~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~  172 (219)
                      +++++...+ ..+++||++.+++|.+++......             ..+++..+..++.|++.|+.|||+.   +++|+
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999987654 589999999999999999754321             1167788899999999999999999   99999


Q ss_pred             CCCCCCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          173 DVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       173 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      ||||+||+++.++.++|+|||++.........  .....+|+.|+|||+
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  221 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHH
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchh
Confidence            99999999999999999999999866433221  233567889999983

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.96  E-value=4.9e-30  Score=204.40  Aligned_cols=167  Identities=25%  Similarity=0.393  Sum_probs=140.5

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+.....    .....+.+|+.+++.++||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            4678999999999999999994 55888999999864321    123457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe---CCCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~  196 (219)
                      +||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||++   +.++.++|+|||++.
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999886432   378888999999999999999999   99999999999999   678899999999987


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .....  ......||+.|+|||+
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~  178 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEV  178 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTT
T ss_pred             ecCCC--ccccccCCCCccChHH
Confidence            54322  2234579999999995

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=1.6e-30  Score=218.11  Aligned_cols=175  Identities=21%  Similarity=0.390  Sum_probs=140.7

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      +.|....++|++.+.||+|+||.||+|....+..||+|.++...     .....+.+|+.+++.++||||+++++++.. 
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            34555667899999999999999999987777789999986432     133568899999999999999999999866 


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..+++||++.+++|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             CceEEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence            678999999999999999975321 2378889999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCC-cccccccccccccCCC
Q 039002          195 AKFLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ++....... ......+++.|+|||.
T Consensus       327 a~~~~~~~~~~~~~~~~~~~y~aPE~  352 (452)
T 1fmk_A          327 ARLIEDNEYTARQGAKFPIKWTAPEA  352 (452)
T ss_dssp             TC--------------CCGGGSCHHH
T ss_pred             ceecCCCceecccCCcccccccCHhH
Confidence            987643321 1223456788999983

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.96  E-value=2.5e-29  Score=199.34  Aligned_cols=167  Identities=20%  Similarity=0.320  Sum_probs=141.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+.....      ...+.+|+..++.+ +|+|++.+++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            4679999999999999999994 57888999998854321      12356789999999 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc-----EEEeecc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE-----AHVADFG  193 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~-----~kl~dfg  193 (219)
                      ++||++ +++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.     ++|+|||
T Consensus        83 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            999999 899999997543  2378899999999999999999998   9999999999999987765     9999999


Q ss_pred             ceeeecCCCC-------cccccccccccccCCC
Q 039002          194 IAKFLKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                      ++........       ......||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  189 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINT  189 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchh
Confidence            9987765432       1245679999999984

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.96  E-value=2.8e-30  Score=203.99  Aligned_cols=172  Identities=25%  Similarity=0.415  Sum_probs=145.3

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...++|++.+.||+|+||.||+|. ..++..+|+|.+...     ......+.+|+.+++.++|+||+++++++...+..
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            346789999999999999999994 556888999998642     22446688999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++||++.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999999999975332 3378888999999999999999999   999999999999999999999999999986


Q ss_pred             ecCCCC-cccccccccccccCCC
Q 039002          198 LKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ...... ......+|+.|+|||+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~  183 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPES  183 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHH
T ss_pred             ccCCccccccCCccccCcCChhh
Confidence            654332 1233467788999983

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.4e-30  Score=223.75  Aligned_cols=161  Identities=19%  Similarity=0.203  Sum_probs=123.5

Q ss_pred             eccccceeEEEE-EcCCCcEEEEEecCCCCCCC------chhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEE
Q 039002           50 IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSD------QTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        50 lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .+.|++|.+..+ +.-.|+.+++|.+.......      .....+.+.+|+.+|+++ +|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            344555544444 23357789999886543221      122235688999999999 6999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||++|++|.+.+...+.   ++..   .|+.||+.||.|+|++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999976543   4433   5789999999999999   9999999999999999999999999999977665


Q ss_pred             CCcccccccccccccCCC
Q 039002          202 ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~~~~~~gt~~y~aPE~  219 (219)
                      .......+||+.|+|||.
T Consensus       393 ~~~~~t~vGTp~YmAPE~  410 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNEL  410 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHH
T ss_pred             CccccCceechhhccHHH
Confidence            555566799999999983

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=1.2e-29  Score=207.08  Aligned_cols=170  Identities=25%  Similarity=0.404  Sum_probs=142.5

Q ss_pred             HHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC---
Q 039002           39 KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA---  114 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---  114 (219)
                      ...++|++.+.||+|+||.||+| ...++..||+|.+...   ........+.+|+.+++.++||||+++++++...   
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            33578999999999999999999 4567888999998642   2233446788999999999999999999999654   


Q ss_pred             --CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          115 --RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       115 --~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                        ...++++|++. ++|.+++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+||
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  172 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  172 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeC
Confidence              36899999996 5898888643    378889999999999999999999   9999999999999999999999999


Q ss_pred             cceeeecCCCCc---ccccccccccccCCC
Q 039002          193 GIAKFLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      |++.........   ....+||+.|+|||+
T Consensus       173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  202 (364)
T 3qyz_A          173 GLARVADPDHDHTGFLTEYVATRWYRAPEI  202 (364)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCHHH
T ss_pred             cceEecCCCCCccccccccccccCCCCCHH
Confidence            999876543221   234589999999983

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=5e-30  Score=206.71  Aligned_cols=177  Identities=23%  Similarity=0.348  Sum_probs=145.2

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCC-----cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSR-----EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~-----~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      +....++|++.+.||+|+||.||+|. ..++     ..+|+|.+....   .......+.+|+.+++.+ +||||+++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            44556889999999999999999995 3333     479999986432   223446688999999999 8999999999


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhcccch-----------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCC
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTDAA-----------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN  178 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~n  178 (219)
                      ++...+..+++||++++++|.+++.....           ...+++..+..++.|++.|+.|||+.   +++|+||||+|
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  194 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN  194 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence            99999999999999999999999865321           12367888999999999999999999   99999999999


Q ss_pred             EEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          179 LLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       179 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      |+++.++.++|+|||++.........  .....+|+.|+|||.
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  237 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES  237 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHH
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHH
Confidence            99999999999999999866443321  133467889999983

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.96  E-value=9.3e-30  Score=201.39  Aligned_cols=168  Identities=21%  Similarity=0.352  Sum_probs=140.0

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe----CCc
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH----ARH  116 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~  116 (219)
                      ..|++.+.||+|+||.||+| ...++..+|+|.+......  ......+.+|+.+++.++||||+++++++..    ...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            34788889999999999999 5567888999988643222  2345667899999999999999999999865    355


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeC-CCCcEEEeecc
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLD-LEYEAHVADFG  193 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~-~~~~~kl~dfg  193 (219)
                      .+++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +  ++|+||||+||+++ .++.++|+|||
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            899999999999999996532   377888999999999999999998   7  99999999999998 78999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.......  .....||+.|+|||+
T Consensus       178 ~~~~~~~~~--~~~~~~t~~y~aPE~  201 (290)
T 1t4h_A          178 LATLKRASF--AKAVIGTPEFMAPEM  201 (290)
T ss_dssp             GGGGCCTTS--BEESCSSCCCCCGGG
T ss_pred             Ccccccccc--cccccCCcCcCCHHH
Confidence            996543332  244679999999994

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.8e-30  Score=202.88  Aligned_cols=170  Identities=22%  Similarity=0.402  Sum_probs=143.6

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++.+.||+|+||.||+|...++..+|+|.+....     .....+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            346889999999999999999977778889999986432     123567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccc
Confidence            999999999999986532  2377888999999999999999999   99999999999999999999999999987653


Q ss_pred             CCC-CcccccccccccccCCC
Q 039002          200 SDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ... .......+++.|+|||.
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~  176 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEV  176 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHH
T ss_pred             cccccccccccccccccChhh
Confidence            221 11123467788999983

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=1.1e-29  Score=208.03  Aligned_cols=167  Identities=20%  Similarity=0.354  Sum_probs=131.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|++....  ........+.+|+.+++.++||||+++++++...+    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            588999999999999999999 56678899999986532  22334466789999999999999999999997654    


Q ss_pred             --cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          116 --HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       116 --~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                        ..+++||++.+ ++.+.+..     .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence              67999999964 77777742     267888899999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++....... ......||+.|+|||+
T Consensus       173 ~a~~~~~~~-~~~~~~gt~~y~aPE~  197 (371)
T 2xrw_A          173 LARTAGTSF-MMTPYVVTRYYRAPEV  197 (371)
T ss_dssp             C-----------------CTTCCHHH
T ss_pred             ccccccccc-ccCCceecCCccCHHH
Confidence            998664332 2244689999999984

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=2e-29  Score=202.82  Aligned_cols=162  Identities=23%  Similarity=0.369  Sum_probs=139.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEe--CCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSH--ARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~  116 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+...       ....+.+|+.+++.++ |+||+++++++..  ...
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            467999999999999999999 5678889999998631       2356788999999997 9999999999987  567


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEEeeccce
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIA  195 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg~~  195 (219)
                      .+++||++.++++.+++..      +++..+..++.|++.|+.|||+.   +++||||||+||+++.++ .++|+|||++
T Consensus       108 ~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            8999999999999988743      67788899999999999999999   999999999999999776 8999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....... ......|++.|+|||+
T Consensus       179 ~~~~~~~-~~~~~~~~~~y~aPE~  201 (330)
T 3nsz_A          179 EFYHPGQ-EYNVRVASRYFKGPEL  201 (330)
T ss_dssp             EECCTTC-CCCSCCSCGGGCCHHH
T ss_pred             eEcCCCC-ccccccccccccChhh
Confidence            8765433 2345689999999983

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=5.3e-30  Score=203.36  Aligned_cols=169  Identities=26%  Similarity=0.461  Sum_probs=136.2

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  113 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+..     .......+.+|+.+++.++||||+++++++..      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            4679999999999999999995 56888999999853     22344667899999999999999999998865      


Q ss_pred             -------CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc
Q 039002          114 -------ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE  186 (219)
Q Consensus       114 -------~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~  186 (219)
                             .+..+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence                   356789999999999999997533  2367788889999999999999999   9999999999999999999


Q ss_pred             EEEeeccceeeecCC--------------CCcccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSD--------------ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~--------------~~~~~~~~gt~~y~aPE~  219 (219)
                      ++|+|||++......              ........||+.|+|||+
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV  201 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence            999999998765422              112234579999999983

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=1.2e-29  Score=200.89  Aligned_cols=171  Identities=25%  Similarity=0.438  Sum_probs=132.9

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ...++|++.+.||+|+||.||+|....  .+|+|.++....  .......+.+|+.+++.++|+||++++++. ..+..+
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            346789999999999999999997543  599999865432  233456788999999999999999999965 556789


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            9999999999999986443  2378888999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCC--CcccccccccccccCCC
Q 039002          199 KSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ....  .......||+.|+|||.
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~  193 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEV  193 (289)
T ss_dssp             -------------CCCTTCCHHH
T ss_pred             ccccccccccccCCCccccCchh
Confidence            4321  22234579999999983

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.96  E-value=1e-29  Score=207.18  Aligned_cols=180  Identities=22%  Similarity=0.304  Sum_probs=139.4

Q ss_pred             cHHHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCc-------hhhHHHHHHHHHHHhcCCCCccc
Q 039002           33 LYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ-------TVDQKEFLTEVKALTETRHRNIV  105 (219)
Q Consensus        33 ~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~  105 (219)
                      ...++....++|++.+.||+|+||.||+|...++..||+|++........       ......+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            34567778899999999999999999999777799999999865332211       11236688999999999999999


Q ss_pred             eeEeEEEeC-----CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEE
Q 039002          106 KFYGFCSHA-----RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLL  180 (219)
Q Consensus       106 ~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nil  180 (219)
                      ++++++...     ...+++||++. +++.+.+....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            999998543     35799999997 58888776432  2378889999999999999999999   9999999999999


Q ss_pred             eCCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          181 LDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       181 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++.++|+|||++....... ......||+.|+|||+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~  204 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPEL  204 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHHH
T ss_pred             EcCCCCEEEEecCccccccccc-ccceecccceecCcHH
Confidence            9999999999999997554332 2244689999999983

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=4e-30  Score=206.88  Aligned_cols=170  Identities=24%  Similarity=0.387  Sum_probs=135.4

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcE----EEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREV----VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~----~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|. ..+++.    +++|.+......   .....+.+|+..++.++|+||+++++++. .+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            4689999999999999999995 445544    788876543211   12234567899999999999999999886 46


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence            6899999999999999987543  2377888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC--cccccccccccccCCC
Q 039002          196 KFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +.......  ......++..|+|||.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~  188 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALES  188 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHH
T ss_pred             cccCcccccccccCCCCcccccChHH
Confidence            87644322  1234567889999983

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=9e-30  Score=199.12  Aligned_cols=168  Identities=17%  Similarity=0.234  Sum_probs=142.1

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--Ccc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--RHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  117 (219)
                      ..++|++.+.||+|+||.||+|... ++.+|+|.+.....  .......+.+|+.+++.++||||+++++++.+.  +..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            3578999999999999999999764 77899999875422  233446788999999999999999999999877  788


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      +++||++++++|.+++..... ..+++..+..++.|++.|+.|||+.   +  ++|+||||+||+++.++.++++|||++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             EeeecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccce
Confidence            999999999999999976432 2378899999999999999999998   7  999999999999999999999999987


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .....     ....||+.|+|||.
T Consensus       161 ~~~~~-----~~~~~t~~y~aPE~  179 (271)
T 3kmu_A          161 FSFQS-----PGRMYAPAWVAPEA  179 (271)
T ss_dssp             CTTSC-----TTCBSCGGGSCHHH
T ss_pred             eeecc-----cCccCCccccChhh
Confidence            54222     23478999999984

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=8e-30  Score=202.96  Aligned_cols=174  Identities=20%  Similarity=0.280  Sum_probs=138.4

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE--eCCcc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS--HARHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~  117 (219)
                      .++|++.+.||+|+||.||+|. ..+++.+|+|.+..............+.+|+.+++.++|+||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4889999999999999999995 56788999999854211111123466889999999999999999999984  45678


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++||++.++ +.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999765 6666654222 3478889999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCC--CcccccccccccccCCC
Q 039002          198 LKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      .....  .......||+.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~  182 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEI  182 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHH
T ss_pred             cCccccccccccCCCCCCCcChhh
Confidence            65322  12234579999999983

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=4.2e-30  Score=206.99  Aligned_cols=170  Identities=22%  Similarity=0.443  Sum_probs=134.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcE----EEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREV----VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~----~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|. ..+++.    +|+|.+....   .......+.+|+.+++.++||||+++++++...+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            3679999999999999999995 445543    5888775322   2234467889999999999999999999998754


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                       .++++|++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence             789999999999999986543  2378888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcc--cccccccccccCCC
Q 039002          196 KFLKSDASNW--TEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~--~~~~gt~~y~aPE~  219 (219)
                      +.........  ....+|+.|+|||+
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHH
T ss_pred             eEccCCcccccccCCCccccccChHH
Confidence            8765433221  23456889999983

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=1.5e-29  Score=208.03  Aligned_cols=169  Identities=20%  Similarity=0.280  Sum_probs=135.1

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC--
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA--  114 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--  114 (219)
                      ....++|++.+.||+|+||.||+| ...+++.||+|++......        ..+|+.+++.++|+||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence            345688999999999999999999 5678999999998643211        13589999999999999999998543  


Q ss_pred             ------------------------------------CcceEEEEecCCCCHHHHhccc-chhhccCHHHHHHHHHHHHHH
Q 039002          115 ------------------------------------RHSFLLCEFLERGSLAAILNTD-AAAQELGWSQRMSVIKGVADA  157 (219)
Q Consensus       115 ------------------------------------~~~~lv~e~~~~~~l~~~~~~~-~~~~~l~~~~~~~i~~~i~~~  157 (219)
                                                          ...+++|||++ ++|.+.+... .....+++..+..++.|++.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                                33789999997 5877766531 112347888999999999999


Q ss_pred             HHhhhhCCCCCeEecCCCCCCEEeC-CCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          158 LSYLHHDCFPPIVHRDVSSKNLLLD-LEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       158 l~~lh~~~~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.|||+.   +++||||||+||+++ .++.+||+|||+++.+..... .....||+.|+|||+
T Consensus       154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~  212 (383)
T 3eb0_A          154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPEL  212 (383)
T ss_dssp             HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHH
T ss_pred             HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHH
Confidence            9999998   999999999999997 679999999999987654432 344688999999983

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=2.4e-30  Score=205.64  Aligned_cols=178  Identities=28%  Similarity=0.456  Sum_probs=127.2

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      ++....++|++.+.||+|+||.||+|. ..+++.||+|.+.....   ......+.+|+..++.++||||+++++++...
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESS
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            345567899999999999999999995 45788999998854321   12335677899999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccc-----hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039002          115 RHSFLLCEFLERGSLAAILNTDA-----AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV  189 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl  189 (219)
                      +..+++||++.+++|.+++....     ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence            99999999999999999886311     112378889999999999999999999   9999999999999999999999


Q ss_pred             eeccceeeecCCC-----CcccccccccccccCCC
Q 039002          190 ADFGIAKFLKSDA-----SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       190 ~dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~  219 (219)
                      +|||++.......     .......||+.|+|||+
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV  197 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHH
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence            9999987554321     11234579999999983

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.96  E-value=4.5e-30  Score=206.21  Aligned_cols=171  Identities=24%  Similarity=0.336  Sum_probs=137.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCC----CchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPS----DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+......    ........+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999 5567889999998643211    11112234678999999999999999999987655


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc---EEEeec
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVADF  192 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~---~kl~df  192 (219)
                       .+++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.   ++|+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence             899999999999999886543   378888999999999999999999   9999999999999987654   999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |++....... ......||+.|+|||+
T Consensus       162 g~~~~~~~~~-~~~~~~gt~~y~aPE~  187 (322)
T 2ycf_A          162 GHSKILGETS-LMRTLCGTPTYLAPEV  187 (322)
T ss_dssp             TTCEECCCCH-HHHHHHSCCTTCCHHH
T ss_pred             ccceeccccc-ccccccCCcCccCchh
Confidence            9998764332 2234578999999983

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=6.7e-30  Score=209.02  Aligned_cols=166  Identities=25%  Similarity=0.419  Sum_probs=124.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|++....  ........+.+|+.+++.++|+||+++++++...     
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            488999999999999999999 56788999999986532  2233456778999999999999999999998654     


Q ss_pred             -CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          115 -RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       115 -~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                       ...++++|++ +++|.+++...    .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence             5679999999 67888887642    378889999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++.....   .....||+.|+|||+
T Consensus       178 ~a~~~~~~---~~~~~~t~~y~aPE~  200 (367)
T 2fst_X          178 LARHTADE---MTGYVATRWYRAPEI  200 (367)
T ss_dssp             ----------------CCCTTCCHHH
T ss_pred             cccccccc---CCCcCcCcCccChHH
Confidence            99865433   234689999999983

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=4.3e-30  Score=208.19  Aligned_cols=172  Identities=21%  Similarity=0.409  Sum_probs=144.7

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCch-------------hhHHHHHHHHHHHhcCCCCcccee
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQT-------------VDQKEFLTEVKALTETRHRNIVKF  107 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~  107 (219)
                      .++|++.+.||+|+||.||+|.. +++.||+|.+.........             .....+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999999966 8889999997542211110             011678899999999999999999


Q ss_pred             EeEEEeCCcceEEEEecCCCCHHHH------hcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEE
Q 039002          108 YGFCSHARHSFLLCEFLERGSLAAI------LNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLL  180 (219)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nil  180 (219)
                      ++++.+.+..+++||++.+++|.++      +.... ...+++..+..++.|++.|+.|||+ .   +++|+||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999988      54321 1347889999999999999999999 8   9999999999999


Q ss_pred             eCCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          181 LDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       181 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++.++|+|||++......  ......|++.|+|||+
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~  221 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEF  221 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGG
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchh
Confidence            999999999999999876543  2344689999999994

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=202.50  Aligned_cols=167  Identities=28%  Similarity=0.435  Sum_probs=131.4

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      .++|++.+.||+|+||.||+|... ++.+|+|.+...      .....+.+|+.+++.++||||+++++++.  +..+++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence            367889999999999999999664 678999998531      23456789999999999999999999876  458999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc-EEEeeccceeeec
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE-AHVADFGIAKFLK  199 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~-~kl~dfg~~~~~~  199 (219)
                      |||+++++|.+++........++...+..++.|++.|+.|||+....+++|+||||+||+++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999976443334677888899999999999999932118999999999999998876 7999999997654


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...   ....||+.|+|||+
T Consensus       158 ~~~---~~~~gt~~y~aPE~  174 (307)
T 2eva_A          158 THM---TNNKGSAAWMAPEV  174 (307)
T ss_dssp             ----------CCTTSSCHHH
T ss_pred             ccc---ccCCCCCceEChhh
Confidence            322   33479999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=1.2e-29  Score=199.70  Aligned_cols=166  Identities=25%  Similarity=0.434  Sum_probs=140.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  113 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+....        ..+.+|+.+++.++||||+++++++..      
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3679999999999999999995 4588899999986421        234679999999999999999998854      


Q ss_pred             ----------CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          114 ----------ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       114 ----------~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                                ....+++||++++++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                      3458999999999999999965322 3478888999999999999999999   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++|+|||++........ .....||+.|+|||.
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~  192 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQ  192 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHH
T ss_pred             CCCEEECcchhheecccccc-ccccCCcccccChhh
Confidence            99999999999987654432 234579999999983

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=1.3e-29  Score=209.18  Aligned_cols=167  Identities=24%  Similarity=0.282  Sum_probs=132.1

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc----
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH----  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----  116 (219)
                      ..+|++.+.||+|+||.||+|....+..+|+|++......        ..+|+.+++.++|+||+++++++...+.    
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3569999999999999999997665556899987542211        1258999999999999999999965443    


Q ss_pred             --ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-CCCcEEEeecc
Q 039002          117 --SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LEYEAHVADFG  193 (219)
Q Consensus       117 --~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-~~~~~kl~dfg  193 (219)
                        .+++|||+.++.+............+++..+..++.|++.|+.|||+.   +++||||||+||+++ .++.+||+|||
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence              789999997644333332111123478888999999999999999999   999999999999999 78999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++.+..... .....||+.|+|||+
T Consensus       188 ~a~~~~~~~~-~~~~~~t~~y~aPE~  212 (394)
T 4e7w_A          188 SAKILIAGEP-NVSYICSRYYRAPEL  212 (394)
T ss_dssp             TCEECCTTCC-CCSSCSCGGGCCHHH
T ss_pred             CcccccCCCC-CcccccCcCccCHHH
Confidence            9987654332 245688999999983

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=2.4e-29  Score=199.64  Aligned_cols=173  Identities=23%  Similarity=0.378  Sum_probs=138.6

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEE-Ee
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SH  113 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~  113 (219)
                      ....+|++.+.||+|+||.||+|...    ....+|+|.+...   ........+.+|+.+++.++||||+++++++ ..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS   98 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence            33466889999999999999999532    2235899987642   2333456788999999999999999999985 45


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      .+..+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccc
Confidence            568899999999999999996533  2367888899999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCC----CcccccccccccccCCC
Q 039002          194 IAKFLKSDA----SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~----~~~~~~~gt~~y~aPE~  219 (219)
                      ++.......    .......+|+.|+|||.
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALES  203 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHH
T ss_pred             ccccccccchhccccccCCCCCccccChHH
Confidence            998664322    11233467889999983

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=3.4e-30  Score=211.38  Aligned_cols=170  Identities=15%  Similarity=0.142  Sum_probs=132.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHH---HHHhcCCCCccceeE-------e
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEV---KALTETRHRNIVKFY-------G  109 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~ni~~~~-------~  109 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+....... ......+.+|+   ..++.++||||++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            4668889999999999999996 4678999999986432222 22446678899   555666899999998       6


Q ss_pred             EEEeCCc-----------------ceEEEEecCCCCHHHHhcccchh----hccCHHHHHHHHHHHHHHHHhhhhCCCCC
Q 039002          110 FCSHARH-----------------SFLLCEFLERGSLAAILNTDAAA----QELGWSQRMSVIKGVADALSYLHHDCFPP  168 (219)
Q Consensus       110 ~~~~~~~-----------------~~lv~e~~~~~~l~~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~  168 (219)
                      ++...+.                 .+++||++ +|+|.+++......    ..+++..+..++.|++.||.|||+.   +
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            6655532                 78999999 67999999753221    1123477788999999999999999   9


Q ss_pred             eEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       169 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++||||||+||+++.++.+||+|||+++....   .....+| +.|+|||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~  273 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPEL  273 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhh
Confidence            99999999999999999999999999985332   2345577 99999994

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.4e-29  Score=197.34  Aligned_cols=170  Identities=24%  Similarity=0.352  Sum_probs=140.3

Q ss_pred             hCCCCCcc-eeccccceeEEEEEc---CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKY-CIGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~-~lg~g~~g~V~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|.+.. .||+|+||.||+|..   .++..||+|.+...   ........+.+|+.+++.++||||+++++++ ..+.
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            45677776 999999999999953   35778999998653   2234556788999999999999999999999 5567


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccccee
Confidence            999999999999999986432  2378899999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc---ccccccccccccCCC
Q 039002          197 FLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      ........   .....+|+.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPEC  184 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHH
T ss_pred             eeccCcceeeccccccccccccCHHH
Confidence            77543321   123356889999984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=3.2e-29  Score=203.45  Aligned_cols=168  Identities=27%  Similarity=0.455  Sum_probs=139.2

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+..   .........+.+|+.+++.++|+||+++++++...     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc---cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            4789999999999999999994 56788999999853   22333455678999999999999999999988654     


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ...++++|++. ++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            67899999996 5898888642    378889999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCC----------cccccccccccccCCC
Q 039002          195 AKFLKSDAS----------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~----------~~~~~~gt~~y~aPE~  219 (219)
                      +........          ......||+.|+|||+
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV  193 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCee
Confidence            987653221          1123578999999983

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=8.3e-29  Score=200.07  Aligned_cols=165  Identities=28%  Similarity=0.394  Sum_probs=140.3

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhc--CCCCccceeEeEEEeCC--
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE--TRHRNIVKFYGFCSHAR--  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~--  115 (219)
                      ..++|++.+.||+|+||.||+|.. +++.||+|.+..       .....+.+|+.++..  ++||||+++++++...+  
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc-------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            347899999999999999999966 478999999853       123456778888877  78999999999998775  


Q ss_pred             --cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhh--------hCCCCCeEecCCCCCCEEeCCCC
Q 039002          116 --HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH--------HDCFPPIVHRDVSSKNLLLDLEY  185 (219)
Q Consensus       116 --~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dlkp~nili~~~~  185 (219)
                        ..+++||++.+++|.+++...    .+++..++.++.|++.|+.|||        ..   +++|+||||+||+++.++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence              789999999999999999643    3788899999999999999999        66   999999999999999999


Q ss_pred             cEEEeeccceeeecCCCCc----ccccccccccccCCC
Q 039002          186 EAHVADFGIAKFLKSDASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       186 ~~kl~dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~  219 (219)
                      .++|+|||++.........    .....||+.|+|||+
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  222 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  222 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHH
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhh
Confidence            9999999999877654321    234579999999994

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.5e-29  Score=203.56  Aligned_cols=172  Identities=26%  Similarity=0.409  Sum_probs=137.6

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcE--EEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREV--VAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~--~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|. ..++..  +++|.+....   .......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            4789999999999999999994 445654  4889876422   122334578899999999 89999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          117 SFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      .+++||++++++|.+++.....             ...+++..++.++.|++.|+.|||+.   +++|+||||+||+++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE  177 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcC
Confidence            9999999999999999975421             12478889999999999999999999   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.++|+|||++....... ......+++.|+|||+
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  212 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIES  212 (327)
T ss_dssp             GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHH
T ss_pred             CCeEEEcccCcCccccccc-cccCCCCCccccChhh
Confidence            9999999999987433221 1233467888999983

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=4.3e-29  Score=200.88  Aligned_cols=170  Identities=26%  Similarity=0.400  Sum_probs=141.2

Q ss_pred             hCCCCCcceeccccceeEEEEE-----cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-----LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|.     ..+++.||+|.+...    .......+.+|+.+++.++|+||+++++++...+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            4668999999999999999996     346888999998642    2234467889999999999999999999986543


Q ss_pred             --cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          116 --HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       116 --~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                        ..+++||++++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence              7899999999999999997543  2378888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCc---ccccccccccccCCC
Q 039002          194 IAKFLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      ++.........   .....++..|+|||.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  219 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPES  219 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHH
T ss_pred             chhhccccccccccccCCCCceeEECchh
Confidence            99877544321   123467788999983

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.9e-29  Score=201.51  Aligned_cols=168  Identities=26%  Similarity=0.396  Sum_probs=134.6

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC--CCCccceeEeEEEeC---
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET--RHRNIVKFYGFCSHA---  114 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~---  114 (219)
                      ..++|++.+.||+|+||.||+|... ++.||+|.+...       ......+|..++...  +|+||+++++++...   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3478999999999999999999654 789999997421       223344555555544  899999999999877   


Q ss_pred             -CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC-----CCCeEecCCCCCCEEeCCCCcEE
Q 039002          115 -RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC-----FPPIVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       115 -~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlkp~nili~~~~~~k  188 (219)
                       +..+++|||+.+++|.+++...    .+++..+..++.|++.|+.|||+..     ..+++||||||+||+++.++.+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence             6789999999999999999643    3788899999999999999999751     12799999999999999999999


Q ss_pred             EeeccceeeecCCCCcc----cccccccccccCCC
Q 039002          189 VADFGIAKFLKSDASNW----TEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~~~~----~~~~gt~~y~aPE~  219 (219)
                      |+|||++..+.......    ....||+.|+|||+
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  217 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV  217 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHH
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhh
Confidence            99999998765433221    24589999999994

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=1.8e-29  Score=205.48  Aligned_cols=175  Identities=18%  Similarity=0.204  Sum_probs=128.1

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      .+.....++|++.+.||+|+||.||+|. ..+++.||+|++.....     ......+++..++.++||||+++++++..
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            4456778999999999999999999994 56788999998854321     12234667888888999999999999966


Q ss_pred             CCc-------ceEEEEecCCCCHHHHhcc-cchhhccCHHHHHHHHHHHHHHHHhhh--hCCCCCeEecCCCCCCEEeCC
Q 039002          114 ARH-------SFLLCEFLERGSLAAILNT-DAAAQELGWSQRMSVIKGVADALSYLH--HDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       114 ~~~-------~~lv~e~~~~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~~~i~H~dlkp~nili~~  183 (219)
                      .+.       .+++|||+.+ ++...+.. ......+++..+..++.|++.|+.|+|  +.   +++||||||+||+++.
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence            443       7899999976 55443322 111233677888899999999999999  87   9999999999999996


Q ss_pred             -CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 -EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 -~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                       ++.++|+|||++........ .....||+.|+|||+
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~  202 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPEL  202 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHH
T ss_pred             CCCcEEEeeCCCceecCCCCC-cccccCCcceeCHHH
Confidence             89999999999987654432 244688999999983

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.9e-29  Score=202.64  Aligned_cols=171  Identities=25%  Similarity=0.430  Sum_probs=134.6

Q ss_pred             hCCCCCcceeccccceeEEEEEcC-C----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP-S----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~-~----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|... +    +..||+|.+....   .......+.+|+.+++.++||||+++++++...+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            356777899999999999999532 2    2359999986432   2334456889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence            9999999999999999986532  2378889999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCc---ccccccccccccCCC
Q 039002          196 KFLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      .........   .....+|+.|+|||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~  221 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEA  221 (333)
T ss_dssp             ----------------CCCGGGSCHHH
T ss_pred             hhhccccccccccCCCCccccccCchh
Confidence            876543221   122345788999983

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=3.4e-29  Score=205.05  Aligned_cols=165  Identities=25%  Similarity=0.411  Sum_probs=137.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc--
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS--  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~--  117 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+....  ........+.+|+.+++.++||||+++++++...+..  
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            478999999999999999999 56688999999987543  2233456778999999999999999999999877655  


Q ss_pred             ----eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          118 ----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       118 ----~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                          +++||++. +++...+..     .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             ceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence                99999996 688877743     278889999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++......   .....||+.|+|||+
T Consensus       190 ~a~~~~~~---~~~~~~t~~y~aPE~  212 (371)
T 4exu_A          190 LARHADAE---MTGYVVTRWYRAPEV  212 (371)
T ss_dssp             CC-----------CTTCCCTTSCHHH
T ss_pred             cccccccC---cCCcccCccccCHHH
Confidence            99865433   234688999999983

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=1.7e-29  Score=202.27  Aligned_cols=173  Identities=23%  Similarity=0.321  Sum_probs=140.1

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE----eC
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS----HA  114 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~  114 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+...    .......+.+|+.+++.++||||+++++++.    ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            35789999999999999999994 578889999987531    2334567889999999999999999999986    23


Q ss_pred             CcceEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      ...++++|++.+++|.+++.... ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence            47899999999999999886521 113478899999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCc---------ccccccccccccCCC
Q 039002          194 IAKFLKSDASN---------WTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~---------~~~~~gt~~y~aPE~  219 (219)
                      ++.........         .....||+.|+|||+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  214 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL  214 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGG
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhH
Confidence            98765322111         123457999999994

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.3e-29  Score=198.00  Aligned_cols=169  Identities=22%  Similarity=0.321  Sum_probs=137.0

Q ss_pred             CCCCcceeccccceeEEEEEc-CCC---cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc-
Q 039002           43 DFDAKYCIGNGGHASVYRAEL-PSR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS-  117 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~-~~~---~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-  117 (219)
                      .|++.+.||+|+||.||+|.. .++   ..+|+|.+..   .........+.+|+.+++.++||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR---ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT---CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc---cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            345568999999999999953 332   3699998864   22333456788999999999999999999999876655 


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            99999999999999997532  2367888899999999999999999   999999999999999999999999999975


Q ss_pred             ecCCC----CcccccccccccccCCC
Q 039002          198 LKSDA----SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~----~~~~~~~gt~~y~aPE~  219 (219)
                      .....    .......+++.|+|||.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~  199 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALES  199 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHH
T ss_pred             ccCCcccccccCcCCCCCccccChhh
Confidence            53321    12234578899999983

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=202.85  Aligned_cols=170  Identities=22%  Similarity=0.428  Sum_probs=132.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcE----EEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREV----VAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~----~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+|. ..+++.    +++|.+....   .......+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            4789999999999999999995 445543    5777765322   2234567889999999999999999999998754


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                       .++++|++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             -ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence             789999999999999986543  2378888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCc--ccccccccccccCCC
Q 039002          196 KFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      .........  .....+|+.|+|||.
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             ---------------CCCGGGSCHHH
T ss_pred             eEccCccccccccCCCccccccCHHH
Confidence            876543322  123356788999983

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=8.4e-30  Score=208.08  Aligned_cols=173  Identities=20%  Similarity=0.301  Sum_probs=134.5

Q ss_pred             hCCCCCcceeccccceeEEEEEcCC------CcEEEEEecCCCCCCCc-------hhhHHHHHHHHHHHhcCCCCcccee
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPS------REVVAVKKFHSPLPSDQ-------TVDQKEFLTEVKALTETRHRNIVKF  107 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~------~~~~aik~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~  107 (219)
                      .++|++.+.||+|+||.||+|....      ++.||+|.+........       ........+|+..++.++|+||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999995443      46899998754211000       0001123445667788899999999


Q ss_pred             EeEEEeC----CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-
Q 039002          108 YGFCSHA----RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-  182 (219)
Q Consensus       108 ~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-  182 (219)
                      ++++...    ...+++|||+ +++|.+++....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            9998764    4489999999 999999986532  3488999999999999999999999   999999999999999 


Q ss_pred             -CCCcEEEeeccceeeecCCCCc-------ccccccccccccCCC
Q 039002          183 -LEYEAHVADFGIAKFLKSDASN-------WTEFAGTYGYVALGI  219 (219)
Q Consensus       183 -~~~~~kl~dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~  219 (219)
                       .++.+||+|||+++.+......       .....||+.|+|||+
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  232 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA  232 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHH
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHH
Confidence             8899999999999876533211       133469999999984

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=3.3e-29  Score=201.79  Aligned_cols=172  Identities=21%  Similarity=0.321  Sum_probs=140.1

Q ss_pred             hCCCCCc-ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcc
Q 039002           41 TNDFDAK-YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHS  117 (219)
Q Consensus        41 ~~~y~~~-~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~  117 (219)
                      .+.|.+. +.||+|+||.||+| ...+++.||+|.+......  ......+.+|+.+++.+. ||||+++++++...+..
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG--QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT--EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            4677777 88999999999999 5567899999998653322  223466788999999995 69999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEeeccc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVADFGI  194 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~dfg~  194 (219)
                      +++|||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.   .+.++|+|||+
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            999999999999998854322 3478899999999999999999999   9999999999999987   78999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +........ .....||+.|+|||+
T Consensus       181 a~~~~~~~~-~~~~~gt~~y~aPE~  204 (327)
T 3lm5_A          181 SRKIGHACE-LREIMGTPEYLAPEI  204 (327)
T ss_dssp             CEEC----------CCCGGGCCHHH
T ss_pred             ccccCCccc-cccccCCcCccCCee
Confidence            987654322 244689999999984

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=1.9e-29  Score=203.08  Aligned_cols=171  Identities=25%  Similarity=0.328  Sum_probs=128.3

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEE------
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCS------  112 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~------  112 (219)
                      ..+|++.+.||+|+||.||+|. ..+++.||+|.+...    .......+.+|+..++.+. ||||+++++++.      
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3579999999999999999995 568889999987532    2334566788999999996 999999999984      


Q ss_pred             --eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeCCCCcEE
Q 039002          113 --HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLDLEYEAH  188 (219)
Q Consensus       113 --~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~~~~~~k  188 (219)
                        .....++++|++. |+|.+++........+++..+..++.|++.|+.|||..   +  ++|+||||+||+++.++.++
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence              3344789999995 68988886422223478899999999999999999998   8  99999999999999999999


Q ss_pred             EeeccceeeecCCCCc------------ccccccccccccCCC
Q 039002          189 VADFGIAKFLKSDASN------------WTEFAGTYGYVALGI  219 (219)
Q Consensus       189 l~dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~  219 (219)
                      |+|||++.........            .....||+.|+|||+
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI  221 (337)
T ss_dssp             BCCCTTCBCCSSCC-----------------------------
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhh
Confidence            9999999876543211            113469999999994

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=5.1e-29  Score=207.73  Aligned_cols=166  Identities=19%  Similarity=0.289  Sum_probs=138.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC------CCCccceeEeEEEe
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET------RHRNIVKFYGFCSH  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~  113 (219)
                      ..+|++.+.||+|+||.||+| ...+++.||+|.+..     .......+.+|+.+++.+      +|+||+++++++..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            356999999999999999999 566788999999864     223345567788877776      56799999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc--EEEee
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE--AHVAD  191 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~--~kl~d  191 (219)
                      .+..+++||++. ++|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.  +||+|
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence            999999999995 689988865432 2378889999999999999999999   9999999999999998887  99999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++......   ....+||+.|+|||+
T Consensus       246 FG~a~~~~~~---~~~~~gt~~y~aPE~  270 (429)
T 3kvw_A          246 FGSSCYEHQR---VYTYIQSRFYRAPEV  270 (429)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHH
T ss_pred             cccceecCCc---ccccCCCCCccChHH
Confidence            9999764432   234689999999994

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=4e-30  Score=219.88  Aligned_cols=175  Identities=21%  Similarity=0.396  Sum_probs=144.8

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      +.|....++|++.+.||+|+||.||+|....+..||+|.++...     .....+.+|+.+++.++|+||+++++++.. 
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            34555677899999999999999999987777789999986432     133568899999999999999999999866 


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             ccceEeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence            679999999999999999975321 2378889999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCC-CcccccccccccccCCC
Q 039002          195 AKFLKSDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ++...... .......++..|+|||+
T Consensus       410 a~~~~~~~~~~~~~~~~~~~y~aPE~  435 (535)
T 2h8h_A          410 ARLIEDNEYTARQGAKFPIKWTAPEA  435 (535)
T ss_dssp             TTTCCCHHHHTTCSTTSCGGGSCHHH
T ss_pred             ceecCCCceecccCCcCcccccCHHH
Confidence            97654221 11122356788999983

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=2.1e-29  Score=199.57  Aligned_cols=173  Identities=23%  Similarity=0.359  Sum_probs=139.7

Q ss_pred             HHHhCCCCCcc-eeccccceeEEEEEc---CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           38 VKATNDFDAKY-CIGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        38 ~~~~~~y~~~~-~lg~g~~g~V~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ....++|++.+ .||+|+||.||+|..   .+++.+|+|.+....  ........+.+|+.+++.++||||+++++++ .
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            33456788888 999999999999932   356789999987542  2223356788999999999999999999998 5


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      .+..+++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence            677899999999999999997543   378888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcc---cccccccccccCCC
Q 039002          194 IAKFLKSDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      ++..........   ....+++.|+|||.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  191 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPEC  191 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHH
Confidence            998765443221   22346688999983

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=4e-29  Score=219.26  Aligned_cols=163  Identities=25%  Similarity=0.387  Sum_probs=137.1

Q ss_pred             hCCCCCcceeccccceeEEEEEc-C-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc--
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-P-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH--  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--  116 (219)
                      .++|++.+.||+|+||.||+|.. . +++.||+|.+...   ........+.+|+.+++.++||||+++++++...+.  
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            37899999999999999999954 3 6889999988642   223345567899999999999999999999987665  


Q ss_pred             ---ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          117 ---SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       117 ---~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                         .|+||||+.+++|.+++..     .+++..+..++.|++.||.|+|+.   +|+||||||+||+++.+ .+||+|||
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence               6999999999999887653     378899999999999999999999   99999999999999875 89999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++.....    ....||+.|+|||+
T Consensus       227 ~a~~~~~~----~~~~gt~~y~aPE~  248 (681)
T 2pzi_A          227 AVSRINSF----GYLYGTPGFQAPEI  248 (681)
T ss_dssp             TCEETTCC----SCCCCCTTTSCTTH
T ss_pred             cchhcccC----CccCCCccccCHHH
Confidence            99876543    34589999999994

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=2.9e-29  Score=198.24  Aligned_cols=173  Identities=21%  Similarity=0.336  Sum_probs=129.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+....  ........+.++...++.++||||+++++++...+..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            578999999999999999999 45688899999986532  122223334455556888899999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +||++. +++.+++.... ....+++..+..++.|++.|+.|||+..  +++|+||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999997 58877765311 1234788999999999999999999842  8999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... .....||+.|+|||+
T Consensus       161 ~~~~~-~~~~~~t~~y~aPE~  180 (290)
T 3fme_A          161 VDDVA-KDIDAGCKPYMAPER  180 (290)
T ss_dssp             ----------CCCCCCSCHHH
T ss_pred             ccccc-ccccCCCccccChhh
Confidence            54332 234579999999984

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.2e-29  Score=206.37  Aligned_cols=168  Identities=23%  Similarity=0.388  Sum_probs=127.4

Q ss_pred             CCCcceeccccceeEEEEEc--CC--CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE-eCCcce
Q 039002           44 FDAKYCIGNGGHASVYRAEL--PS--REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS-HARHSF  118 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~--~~--~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~  118 (219)
                      |++.+.||+|+||.||+|..  .+  +..+|+|.+...   ........+.+|+.+++.++||||+++++++. ..+..+
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            56678999999999999953  22  235899987642   22334567889999999999999999999865 456789


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ++|||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus       168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999997543  2367788889999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCC----cccccccccccccCCC
Q 039002          199 KSDAS----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~----~~~~~~gt~~y~aPE~  219 (219)
                      .....    ......+|+.|+|||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~  267 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALES  267 (373)
T ss_dssp             ---------------CCGGGSCHHH
T ss_pred             cccccccccccCCCCCcccccChHH
Confidence            43221    1133467788999983

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=204.70  Aligned_cols=172  Identities=22%  Similarity=0.253  Sum_probs=133.8

Q ss_pred             hCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCc-------hhhHHHHHHHHHHHhcCCCCccceeEe
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQ-------TVDQKEFLTEVKALTETRHRNIVKFYG  109 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~  109 (219)
                      .++|++.+.||+|+||.||+|...    ++..+|+|.+........       ......+.+|+..++.++|+||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999543    567899998864321100       001123567888899999999999999


Q ss_pred             EEEe----CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC
Q 039002          110 FCSH----ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY  185 (219)
Q Consensus       110 ~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~  185 (219)
                      ++..    .+..+++||++ +++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9987    67899999999 899999997643   488899999999999999999999   999999999999999777


Q ss_pred             --cEEEeeccceeeecCCCC-------cccccccccccccCCC
Q 039002          186 --EAHVADFGIAKFLKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       186 --~~kl~dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                        .++|+|||+++.+.....       ......||+.|+|||+
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  231 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDA  231 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHH
Confidence              999999999987643221       1144589999999984

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=3.9e-29  Score=201.18  Aligned_cols=174  Identities=24%  Similarity=0.372  Sum_probs=138.6

Q ss_pred             HhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH  113 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  113 (219)
                      ..++|++.+.||+|+||.||+|..      .++..||+|.+...   ........+.+|+.+++.++||||+++++++..
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            357899999999999999999963      35678999998642   223345678899999999999999999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccch----hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC---Cc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAA----AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE---YE  186 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~---~~  186 (219)
                      .+..+++||++.+++|.+++.....    ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.+   ..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence            9999999999999999999975321    12377888999999999999999999   99999999999999844   46


Q ss_pred             EEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          187 AHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       187 ~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ++|+|||++........  ......+|+.|+|||.
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhH
Confidence            99999999875533221  1233467899999983

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=3e-29  Score=217.43  Aligned_cols=162  Identities=24%  Similarity=0.356  Sum_probs=130.7

Q ss_pred             eeccccceeEEEEEc---CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEecC
Q 039002           49 CIGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        49 ~lg~g~~g~V~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .||+|+||.||+|..   .++..||+|.++...   .......+.+|+.+++.++||||+++++++.. +..++||||+.
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~  418 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG  418 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence            799999999999953   245679999987532   22345678999999999999999999999976 56999999999


Q ss_pred             CCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc-
Q 039002          126 RGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN-  204 (219)
Q Consensus       126 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-  204 (219)
                      +++|.+++....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++.+...... 
T Consensus       419 ~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          419 GGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             TCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             CCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            999999986542  2478899999999999999999999   9999999999999999999999999999865432211 


Q ss_pred             --ccccccccccccCCC
Q 039002          205 --WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 --~~~~~gt~~y~aPE~  219 (219)
                        .....+++.|+|||+
T Consensus       494 ~~~~~~~~~~~y~APE~  510 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPEC  510 (613)
T ss_dssp             --------CCTTSCHHH
T ss_pred             eeccCCCCccceeCHhh
Confidence              122245688999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=4.7e-29  Score=207.43  Aligned_cols=165  Identities=26%  Similarity=0.308  Sum_probs=131.1

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC----C-
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA----R-  115 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----~-  115 (219)
                      .+|++.+.||+|+||.||+|. ..+++.||+|++.....        ...+|+.+++.++|+||+++++++...    + 
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            358999999999999999995 56789999999864211        123589999999999999999988542    1 


Q ss_pred             -cceEEEEecCCCCHHHHhccc-chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-CcEEEeec
Q 039002          116 -HSFLLCEFLERGSLAAILNTD-AAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADF  192 (219)
Q Consensus       116 -~~~lv~e~~~~~~l~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-~~~kl~df  192 (219)
                       .++++|||+.+ ++...+... .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence             26789999975 666655421 1123478888999999999999999998   99999999999999965 67899999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |+++.+..... .....||+.|+|||+
T Consensus       202 G~a~~~~~~~~-~~~~~~t~~y~aPE~  227 (420)
T 1j1b_A          202 GSAKQLVRGEP-NVSYICSRYYRAPEL  227 (420)
T ss_dssp             TTCEECCTTCC-CCSCCSCTTSCCHHH
T ss_pred             hhhhhcccCCC-ceeeeeCCCcCCHHH
Confidence            99987654332 244688999999994

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=4.4e-29  Score=201.31  Aligned_cols=169  Identities=27%  Similarity=0.434  Sum_probs=132.1

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHH--HHHHhcCCCCccceeEeEEEe---
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTE--VKALTETRHRNIVKFYGFCSH---  113 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e--~~~l~~l~h~ni~~~~~~~~~---  113 (219)
                      ...++|++.+.||+|+||.||+|.. +++.||+|.+...       ....+..|  +..+..++|+||+++++.+..   
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-------chhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            3468999999999999999999965 6789999998531       12233334  444556899999999986532   


Q ss_pred             --CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC------CCCeEecCCCCCCEEeCCCC
Q 039002          114 --ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC------FPPIVHRDVSSKNLLLDLEY  185 (219)
Q Consensus       114 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~------~~~i~H~dlkp~nili~~~~  185 (219)
                        ...++++|||+++++|.+++....    .++..+..++.|++.|+.|||+..      ..+++||||||+||+++.++
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence              235789999999999999996532    467888899999999999999862      12799999999999999999


Q ss_pred             cEEEeeccceeeecCCC--------CcccccccccccccCCC
Q 039002          186 EAHVADFGIAKFLKSDA--------SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       186 ~~kl~dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~  219 (219)
                      .+||+|||++..+....        .......||+.|+|||+
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  199 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV  199 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHH
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchh
Confidence            99999999998765321        11234579999999994

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=5.7e-29  Score=196.69  Aligned_cols=172  Identities=22%  Similarity=0.410  Sum_probs=143.6

Q ss_pred             HHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ...++|++.+.||+|+||.||+|. ..+++.||+|.+......  ......+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            345789999999999999999995 557889999998543222  22346688999999999999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC---CcEEEeeccc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE---YEAHVADFGI  194 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~---~~~kl~dfg~  194 (219)
                      ++++|++.+++|.+.+....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.+   +.++|+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999988876432   378889999999999999999999   99999999999999754   4799999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +....... ......+++.|+|||+
T Consensus       171 ~~~~~~~~-~~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          171 STCFQQNT-KMKDRIGTAYYIAPEV  194 (287)
T ss_dssp             GGTBCCCS-SCSCHHHHHTTCCHHH
T ss_pred             ceeecCCC-ccccccCcccccChHH
Confidence            87654332 2234578999999983

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=1e-28  Score=197.45  Aligned_cols=178  Identities=22%  Similarity=0.358  Sum_probs=132.9

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEc-C---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAEL-P---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS  112 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~-~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  112 (219)
                      +....++|++.+.||+|+||.||+|.. .   ++..||+|.+.....  .......+.+|+.+++.++||||+++++++.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344567788999999999999999943 2   445799999865322  2234466889999999999999999999997


Q ss_pred             eCC-----cceEEEEecCCCCHHHHhccc---chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC
Q 039002          113 HAR-----HSFLLCEFLERGSLAAILNTD---AAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE  184 (219)
Q Consensus       113 ~~~-----~~~lv~e~~~~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~  184 (219)
                      ..+     ..++++|++.+++|.+++...   .....+++..++.++.|++.|+.|||+.   +++|+||||+||+++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            654     359999999999999998421   1123478899999999999999999999   99999999999999999


Q ss_pred             CcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          185 YEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +.++|+|||++........  ......+++.|+|||.
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  220 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES  220 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchh
Confidence            9999999999986643321  1233467888999983

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=2.2e-29  Score=198.14  Aligned_cols=167  Identities=25%  Similarity=0.391  Sum_probs=133.1

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-Ccc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-RHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~  117 (219)
                      ...++|++.+.||+|+||.||+|... ++.+|+|.+...      .....+.+|+.+++.++|+||+++++++... +..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            34578999999999999999999654 778999998642      1335678899999999999999999987544 578


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++++|++.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccc
Confidence            999999999999999975432 2367888999999999999999999   999999999999999999999999999876


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .....   ....+++.|+|||+
T Consensus       167 ~~~~~---~~~~~~~~y~aPE~  185 (278)
T 1byg_A          167 ASSTQ---DTGKLPVKWTAPEA  185 (278)
T ss_dssp             ------------CCTTTSCHHH
T ss_pred             ccccc---cCCCccccccCHHH
Confidence            54332   23467889999983

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=6.9e-29  Score=195.54  Aligned_cols=171  Identities=20%  Similarity=0.326  Sum_probs=137.4

Q ss_pred             HhCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ..++|++.+.||+|+||.||+|...    ++..||+|.+....   .......+.+|+.+++.++||||+++++++.. +
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            3578999999999999999999532    23469999986432   22345678899999999999999999999865 4


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++||++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             CCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence            5789999999999999996532  2378888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC-cccccccccccccCCC
Q 039002          196 KFLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ........ ......+++.|+|||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~  185 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPES  185 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHH
T ss_pred             cccccccccccccCCCCcceeCchh
Confidence            86644321 1233467889999983

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=1.2e-28  Score=197.15  Aligned_cols=167  Identities=23%  Similarity=0.363  Sum_probs=131.6

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE-------
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS-------  112 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-------  112 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+...    .......+.+|+.+++.++||||+++++++.       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            4789999999999999999994 556889999988632    2334567889999999999999999999873       


Q ss_pred             -------eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-CC
Q 039002          113 -------HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LE  184 (219)
Q Consensus       113 -------~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-~~  184 (219)
                             ..+..+++||++. ++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||||+||+++ .+
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED  157 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence                   3467899999997 6999988642    377888899999999999999999   999999999999997 56


Q ss_pred             CcEEEeeccceeeecCCC---CcccccccccccccCCC
Q 039002          185 YEAHVADFGIAKFLKSDA---SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ~~~kl~dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~  219 (219)
                      +.++|+|||++.......   .......+|+.|+|||.
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL  195 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHH
Confidence            799999999998664321   12234467899999983

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=4e-29  Score=206.82  Aligned_cols=168  Identities=23%  Similarity=0.348  Sum_probs=123.2

Q ss_pred             CCCCC-cceeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CC
Q 039002           42 NDFDA-KYCIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--AR  115 (219)
Q Consensus        42 ~~y~~-~~~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~  115 (219)
                      +.|++ .++||+|+||.||+|...   +++.||+|.+....      ....+.+|+.+++.++||||+++++++..  ..
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            34665 457999999999999643   57789999986421      22457789999999999999999999954  67


Q ss_pred             cceEEEEecCCCCHHHHhcccch------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe----CCCC
Q 039002          116 HSFLLCEFLERGSLAAILNTDAA------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL----DLEY  185 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili----~~~~  185 (219)
                      ..+++|||+. +++.+++.....      ...+++..+..++.|++.||.|||+.   +|+||||||+||++    +..+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            8999999996 588877753221      11378888999999999999999999   99999999999999    6778


Q ss_pred             cEEEeeccceeeecCCC---CcccccccccccccCCC
Q 039002          186 EAHVADFGIAKFLKSDA---SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       186 ~~kl~dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~  219 (219)
                      .+||+|||++..+....   ......+||+.|+|||+
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL  206 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHH
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchh
Confidence            99999999998765432   22244689999999994

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=5.6e-29  Score=203.69  Aligned_cols=168  Identities=11%  Similarity=0.052  Sum_probs=121.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHH---HHHhcCCCCccceeE-------e
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEV---KALTETRHRNIVKFY-------G  109 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~ni~~~~-------~  109 (219)
                      ..+|++.+.||+|+||.||+|. ..+++.||+|.+...... .......+.+|+   ..++. +|||+++++       +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence            3458999999999999999995 568889999998764322 223445566774   45555 799988755       4


Q ss_pred             EEEeC-----------------CcceEEEEecCCCCHHHHhcccchhhccCHHHH------HHHHHHHHHHHHhhhhCCC
Q 039002          110 FCSHA-----------------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQR------MSVIKGVADALSYLHHDCF  166 (219)
Q Consensus       110 ~~~~~-----------------~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~lh~~~~  166 (219)
                      ++...                 ...++||||+. ++|.+++.....  .+++..+      ..++.|++.|+.|||+.  
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--  213 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK--  213 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence            44433                 23799999998 899999976432  2344444      56779999999999999  


Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       167 ~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                       +++||||||+||+++.++.+||+|||+++.....   .....+|+.|+|||+
T Consensus       214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~  262 (371)
T 3q60_A          214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREF  262 (371)
T ss_dssp             -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHH
T ss_pred             -CCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhh
Confidence             9999999999999999999999999999865432   124467799999994

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=9.3e-29  Score=200.99  Aligned_cols=165  Identities=24%  Similarity=0.404  Sum_probs=135.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc---
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH---  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---  116 (219)
                      .++|.+.+.||+|+||.||+| ...+++.||+|.+....  ........+.+|+.+++.++||||+++++++...+.   
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            378999999999999999999 45688999999986532  223345667899999999999999999999987654   


Q ss_pred             ---ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          117 ---SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       117 ---~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                         .+++||++. ++|.+++..     .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             ceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence               499999996 588776642     278888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++......   .....+|+.|+|||.
T Consensus       172 ~~~~~~~~---~~~~~~t~~y~aPE~  194 (353)
T 3coi_A          172 LARHADAE---MTGYVVTRWYRAPEV  194 (353)
T ss_dssp             CTTC-----------CCSBCCSCHHH
T ss_pred             cccCCCCC---ccccccCcCcCCHHH
Confidence            99765432   234578999999983

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=3.6e-29  Score=199.98  Aligned_cols=175  Identities=23%  Similarity=0.321  Sum_probs=134.4

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCch--hhHHHHHHHHHHHhcC----CCCccceeEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQT--VDQKEFLTEVKALTET----RHRNIVKFYG  109 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~--~~~~~~~~e~~~l~~l----~h~ni~~~~~  109 (219)
                      .....++|++.+.||+|+||.||+|. ..+++.||+|.+.........  .....+.+|+.+++.+    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34456889999999999999999995 567889999998653321110  1112245688888888    8999999999


Q ss_pred             EEEeCCcceEEEEe-cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-CCCcE
Q 039002          110 FCSHARHSFLLCEF-LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LEYEA  187 (219)
Q Consensus       110 ~~~~~~~~~lv~e~-~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-~~~~~  187 (219)
                      ++...+..++++|+ +.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            99999999999999 78899999987533   378899999999999999999999   999999999999999 78999


Q ss_pred             EEeeccceeeecCCCCcccccccccccccCCC
Q 039002          188 HVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       188 kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +|+|||++.......  .....|++.|+|||+
T Consensus       180 kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~  209 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP--YTDFDGTRVYSPPEW  209 (312)
T ss_dssp             EECCCSSCEECCSSC--BCCCCSCTTTSCHHH
T ss_pred             EEEEcchhhhcccCc--ccccCCcccccCcee
Confidence            999999998765432  345679999999983

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=3.6e-28  Score=192.39  Aligned_cols=168  Identities=20%  Similarity=0.328  Sum_probs=134.5

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEE-EeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~  117 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+......      ..+.+|+.+++.++|++++..+..+ ...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            34789999999999999999994 578889999986542211      2367799999999988776665555 677788


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe---CCCCcEEEeeccc
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADFGI  194 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili---~~~~~~kl~dfg~  194 (219)
                      +++||++ +++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||++   +.++.++|+|||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            9999999 899999986432  2378899999999999999999999   99999999999999   6889999999999


Q ss_pred             eeeecCCCC-------cccccccccccccCCC
Q 039002          195 AKFLKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                      +........       ......||+.|+|||.
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHH
Confidence            987765432       1234689999999983

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=1.4e-28  Score=194.41  Aligned_cols=172  Identities=25%  Similarity=0.387  Sum_probs=131.4

Q ss_pred             hCCCCCcceeccccceeEEEEEc--CCCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL--PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~--~~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.+  .++.  .||+|.+....... ......+.+|+.+++.++|+||+++++++...+ 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            46899999999999999999953  2333  58999886543222 234567889999999999999999999998755 


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            899999999999999986532  2378889999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc---ccccccccccccCCC
Q 039002          197 FLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      ........   .....+|+.|+|||+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPES  195 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHH
T ss_pred             cccccccchhhhccCCCCceeeCchh
Confidence            76543321   123467788999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=7.5e-29  Score=214.78  Aligned_cols=172  Identities=27%  Similarity=0.396  Sum_probs=142.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  113 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+....   .......+.+|+.+++.++||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            4889999999999999999994 5678899999986532   23345678899999999999999999998755      


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCc---EEEe
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYE---AHVA  190 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~---~kl~  190 (219)
                      ++..+++|||+.+++|.+++........+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.   ++|+
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            677899999999999999997644333477888999999999999999999   9999999999999997664   8999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||++....... ......||+.|+|||+
T Consensus       167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~  194 (676)
T 3qa8_A          167 DLGYAKELDQGE-LCTEFVGTLQYLAPEL  194 (676)
T ss_dssp             SCCCCCBTTSCC-CCCCCCSCCTTCSSCS
T ss_pred             cccccccccccc-ccccccCCcccCChHH
Confidence            999998765433 2345689999999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=6.4e-29  Score=216.08  Aligned_cols=163  Identities=24%  Similarity=0.374  Sum_probs=131.1

Q ss_pred             ceeccccceeEEEEEc---CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           48 YCIGNGGHASVYRAEL---PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      +.||+|+||.||+|.+   ..++.||+|.++...  ........+.+|+.+++.++|+||+++++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence            3799999999999943   356789999986532  222345678999999999999999999999864 5688999999


Q ss_pred             CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC-
Q 039002          125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS-  203 (219)
Q Consensus       125 ~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  203 (219)
                      .+++|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.+..... 
T Consensus       452 ~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          452 ELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             TTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            9999999996532   378889999999999999999999   999999999999999999999999999986643321 


Q ss_pred             --cccccccccccccCCC
Q 039002          204 --NWTEFAGTYGYVALGI  219 (219)
Q Consensus       204 --~~~~~~gt~~y~aPE~  219 (219)
                        ......+|+.|+|||+
T Consensus       526 ~~~~~~~~~t~~y~APE~  543 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPEC  543 (635)
T ss_dssp             ---------CGGGSCHHH
T ss_pred             cccccCCCCceeeeChhh
Confidence              1122356788999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=2.5e-28  Score=196.57  Aligned_cols=166  Identities=17%  Similarity=0.273  Sum_probs=138.9

Q ss_pred             hCCCCCcceeccccceeEEEEE--cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC------ccceeEeEEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR------NIVKFYGFCS  112 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~--~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~  112 (219)
                      .++|++.+.||+|+||.||+|.  ..+++.||+|.+..     .......+.+|+.+++.++|+      +++++++++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            4789999999999999999994  34678899999853     223446678899998888665      4999999999


Q ss_pred             eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---------
Q 039002          113 HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---------  183 (219)
Q Consensus       113 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---------  183 (219)
                      ..+..+++||++ ++++.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.         
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            999999999999 8899998865432 2367888999999999999999999   9999999999999987         


Q ss_pred             ----------CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 ----------EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                                ++.++|+|||++......   .....||+.|+|||+
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~  205 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEV  205 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHH
T ss_pred             ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHH
Confidence                      668999999999865432   234689999999984

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=6.8e-29  Score=199.37  Aligned_cols=174  Identities=23%  Similarity=0.319  Sum_probs=142.8

Q ss_pred             HHHhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCch--hhHHHHHHHHHHHhcCC--CCccceeEeEEE
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQT--VDQKEFLTEVKALTETR--HRNIVKFYGFCS  112 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~--~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~  112 (219)
                      ....++|++.+.||+|+||.||+| ...+++.||+|.+.........  .....+.+|+.+++.++  |+|++++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            445688999999999999999999 5678889999998653322110  01123456889999996  599999999999


Q ss_pred             eCCcceEEEEecCC-CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC-CCCcEEEe
Q 039002          113 HARHSFLLCEFLER-GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD-LEYEAHVA  190 (219)
Q Consensus       113 ~~~~~~lv~e~~~~-~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~-~~~~~kl~  190 (219)
                      ..+..++++|++.+ ++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++ .++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999976 89999986532   378888999999999999999999   999999999999999 77999999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||++.......  .....||+.|+|||+
T Consensus       193 Dfg~~~~~~~~~--~~~~~gt~~y~aPE~  219 (320)
T 3a99_A          193 DFGSGALLKDTV--YTDFDGTRVYSPPEW  219 (320)
T ss_dssp             CCTTCEECCSSC--BCCCCSCGGGSCHHH
T ss_pred             eCcccccccccc--ccCCCCCccCCChHH
Confidence            999998765432  234579999999983

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.95  E-value=1.9e-28  Score=213.76  Aligned_cols=171  Identities=20%  Similarity=0.345  Sum_probs=137.1

Q ss_pred             HhCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      ..++|++.+.||+|+||.||+|...    .+..+|+|.+...   ........+.+|+.+++.++||||+++++++. .+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            3466888999999999999999542    2456999987642   22334467889999999999999999999984 46


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++|||+.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence            7899999999999999986532  2378888999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCc-ccccccccccccCCC
Q 039002          196 KFLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      ......... .....+|+.|+|||+
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~  563 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPES  563 (656)
T ss_dssp             CSCCC----------CCGGGCCHHH
T ss_pred             eecCCCcceeccCCCCCcceeCHHH
Confidence            876443221 122456789999983

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.95  E-value=6.4e-28  Score=191.08  Aligned_cols=167  Identities=20%  Similarity=0.332  Sum_probs=137.7

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEE-EeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFC-SHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+.....      ...+.+|+.+++.++|++++..+..+ ...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            4789999999999999999995 57888999998764321      12467899999999988766655554 6677889


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC---CCCcEEEeeccce
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD---LEYEAHVADFGIA  195 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~---~~~~~kl~dfg~~  195 (219)
                      ++||++ +++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++   .++.++|+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            999999 899999986432  2478899999999999999999999   999999999999994   7789999999999


Q ss_pred             eeecCCCC-------cccccccccccccCCC
Q 039002          196 KFLKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                      ........       ......||+.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHH
T ss_pred             ccccccccccccccccccccccccccCChhh
Confidence            87765432       1244689999999984

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.95  E-value=3.9e-28  Score=196.25  Aligned_cols=165  Identities=22%  Similarity=0.301  Sum_probs=119.2

Q ss_pred             hCCCCCcc-eeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe----C
Q 039002           41 TNDFDAKY-CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH----A  114 (219)
Q Consensus        41 ~~~y~~~~-~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~  114 (219)
                      .++|++.+ .||+|+||.||+| ...+++.||+|.+..     ..   ....+....++.++|+||+++++++..    .
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SP---KARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES-----SH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC-----cH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            47899865 5999999999999 456789999999853     11   111223334667799999999999976    4


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEee
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVAD  191 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~d  191 (219)
                      ...+++|||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.   ++.++|+|
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            458999999999999999976432 2478899999999999999999999   9999999999999986   45699999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++.......  .....||+.|+|||+
T Consensus       175 fg~~~~~~~~~--~~~~~~t~~y~aPE~  200 (336)
T 3fhr_A          175 FGFAKETTQNA--LQTPCYTPYYVAPEV  200 (336)
T ss_dssp             CTTCEEC---------------------
T ss_pred             cccceeccccc--cccCCCCcCccChhh
Confidence            99998665332  234588999999995

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.95  E-value=5.4e-29  Score=202.35  Aligned_cols=165  Identities=19%  Similarity=0.304  Sum_probs=135.5

Q ss_pred             hCCCCCcceeccccceeEEEEEcC---------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccce-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELP---------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK-----  106 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~-----  106 (219)
                      .++|++.+.||+|+||.||+|...         .++.||+|.+...         ..+.+|+.+++.++|+||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence            378999999999999999999544         3778999997532         24678999999999999987     


Q ss_pred             ----------eEeEEEe-CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCC
Q 039002          107 ----------FYGFCSH-ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVS  175 (219)
Q Consensus       107 ----------~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  175 (219)
                                +++++.. .+..+++||++ +++|.+++.... ...+++..+..++.|++.|+.|||+.   +++|||||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dik  186 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVT  186 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCC
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCC
Confidence                      5666665 67889999999 999999997542 13488999999999999999999999   99999999


Q ss_pred             CCCEEeCCCC--cEEEeeccceeeecCCCC-------cccccccccccccCCC
Q 039002          176 SKNLLLDLEY--EAHVADFGIAKFLKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       176 p~nili~~~~--~~kl~dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                      |+||+++.++  .++|+|||+++.+.....       ......||+.|+|||+
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  239 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL  239 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence            9999999988  899999999987653221       1134589999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=2.6e-28  Score=196.29  Aligned_cols=173  Identities=25%  Similarity=0.342  Sum_probs=124.2

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHH-HHhcCCCCccceeEeEEEeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVK-ALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+....   .......+.+|+. +++.++||||+++++++...+..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            35889999999999999999994 5688899999986532   2223344555555 77888999999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccc--hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          118 FLLCEFLERGSLAAILNTDA--AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      +++||++.+ ++.+++....  ....+++..+..++.|++.|+.|||+..  +++|+||||+||+++.++.+||+|||++
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            999999975 7777765311  1123778889999999999999999852  7999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ........ .....||+.|+|||+
T Consensus       174 ~~~~~~~~-~~~~~gt~~y~aPE~  196 (327)
T 3aln_A          174 GQLVDSIA-KTRDAGCRPYMAPER  196 (327)
T ss_dssp             CC----------------------
T ss_pred             eecccccc-cccCCCCccccCcee
Confidence            87654322 233479999999995

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=1.2e-28  Score=197.90  Aligned_cols=172  Identities=22%  Similarity=0.359  Sum_probs=137.3

Q ss_pred             HhCCCCCcceeccccceeEEEEEc--CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC---CCCccceeEeEEE--
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAEL--PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET---RHRNIVKFYGFCS--  112 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~--  112 (219)
                      ..++|++.+.||+|+||.||+|..  .+++.||+|.+........  ....+.+|+.+++.+   +||||+++++++.  
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            357899999999999999999954  4678899998864322211  112345677666655   8999999999987  


Q ss_pred             ---eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039002          113 ---HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV  189 (219)
Q Consensus       113 ---~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl  189 (219)
                         .....++++|++. ++|.+++..... ..+++..+..++.|++.|+.|||..   +++|+||||+||+++.++.++|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence               4567899999997 699998865332 2378889999999999999999999   9999999999999999999999


Q ss_pred             eeccceeeecCCCCcccccccccccccCCC
Q 039002          190 ADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       190 ~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +|||++....... ......||+.|+|||+
T Consensus       162 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  190 (326)
T 1blx_A          162 ADFGLARIYSFQM-ALTSVVVTLWYRAPEV  190 (326)
T ss_dssp             CSCCSCCCCCGGG-GGCCCCCCCTTCCHHH
T ss_pred             ecCcccccccCCC-CccccccccceeCHHH
Confidence            9999997654322 2344688999999983

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.95  E-value=2.3e-28  Score=201.01  Aligned_cols=167  Identities=24%  Similarity=0.385  Sum_probs=136.5

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC--------CCccceeEeEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR--------HRNIVKFYGFC  111 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~ni~~~~~~~  111 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+..     .......+.+|+.+++.++        |+||+++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            478999999999999999999 566788999999853     2334566788999999885        78899999998


Q ss_pred             E----eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC--
Q 039002          112 S----HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY--  185 (219)
Q Consensus       112 ~----~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~--  185 (219)
                      .    .....+++||++ ++++.+.+..... ..+++..+..++.|++.||.|||+.+  +++||||||+||+++.++  
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence            7    556789999999 5566666543221 23788999999999999999999853  799999999999999775  


Q ss_pred             -----------------------------------------------cEEEeeccceeeecCCCCcccccccccccccCC
Q 039002          186 -----------------------------------------------EAHVADFGIAKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       186 -----------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                                                                     .++|+|||++......   .....||+.|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence                                                           7999999999876543   23458999999998


Q ss_pred             C
Q 039002          219 I  219 (219)
Q Consensus       219 ~  219 (219)
                      +
T Consensus       264 ~  264 (397)
T 1wak_A          264 V  264 (397)
T ss_dssp             H
T ss_pred             h
Confidence            4

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=2e-28  Score=195.79  Aligned_cols=170  Identities=20%  Similarity=0.315  Sum_probs=137.1

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC--CCccceeEeEEEeCCcc
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR--HRNIVKFYGFCSHARHS  117 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~  117 (219)
                      ..++|++.+.||+|+||.||+|...+++.+|+|.+.....  .......+.+|+.+++.++  |+||+++++++...+..
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3467999999999999999999777788999999864322  2334567789999999997  59999999999999999


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++|| +.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++ ++.++|+|||++..
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecccccc
Confidence            99999 55789999987543   377888899999999999999999   999999999999996 48999999999987


Q ss_pred             ecCCCC--cccccccccccccCCC
Q 039002          198 LKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ......  ......||+.|+|||+
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~  199 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEA  199 (313)
T ss_dssp             --------------CCGGGCCHHH
T ss_pred             ccCccccccccCCCCCCCcCCHHH
Confidence            643322  1234579999999984

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=1.1e-27  Score=202.05  Aligned_cols=167  Identities=21%  Similarity=0.347  Sum_probs=138.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC-CccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||||.+......      ..+.+|+.+++.++| +++..+..++...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            4789999999999999999994 578889999987543211      236779999999987 55666666677888899


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe---CCCCcEEEeeccce
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL---DLEYEAHVADFGIA  195 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili---~~~~~~kl~dfg~~  195 (219)
                      ++||++ +++|.+++....  ..+++..++.++.|++.||.|||..   +|+||||||+|||+   +.++.++|+|||++
T Consensus        80 lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            999999 899999996432  2488999999999999999999999   99999999999999   57889999999999


Q ss_pred             eeecCCCCc-------ccccccccccccCCC
Q 039002          196 KFLKSDASN-------WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~-------~~~~~gt~~y~aPE~  219 (219)
                      +.+......       .....||+.|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  184 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNT  184 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHH
Confidence            887654322       125689999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=1.9e-28  Score=204.57  Aligned_cols=166  Identities=25%  Similarity=0.347  Sum_probs=126.2

Q ss_pred             CCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceEEE
Q 039002           43 DFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      .|.+.+.||+|+||.||.+...+++.||+|.+..       .....+.+|+.+++.+ +||||+++++++.+.+..+++|
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~-------~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG-------GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH-------HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            3455688999999999877666789999998753       1234567899999876 8999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhc----cCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC-------------
Q 039002          122 EFLERGSLAAILNTDAAAQE----LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-------------  184 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~----l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~-------------  184 (219)
                      |++. ++|.+++........    ..+..+..++.|++.|+.|||+.   +++||||||+||+++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence            9995 699999975432111    12334567899999999999999   99999999999999754             


Q ss_pred             CcEEEeeccceeeecCCCCc----ccccccccccccCCC
Q 039002          185 YEAHVADFGIAKFLKSDASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       185 ~~~kl~dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~  219 (219)
                      +.++|+|||+++........    .....||+.|+|||+
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  203 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL  203 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHH
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHH
Confidence            48999999999877543321    234589999999994

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=3.7e-29  Score=200.31  Aligned_cols=175  Identities=23%  Similarity=0.340  Sum_probs=139.6

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA  114 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  114 (219)
                      .++....++|++.+.||+|+||.||+|....  .+++|.+.......  .....+.+|+.+++.++|+||+++++++.+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE--DQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC--CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH--HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            4455667899999999999999999996543  48999886543222  1223456789999999999999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +..++++|++.+++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++ ++.++|+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence            99999999999999999997543  2377888999999999999999999   999999999999998 68999999999


Q ss_pred             eeeecCC-----CCcccccccccccccCCC
Q 039002          195 AKFLKSD-----ASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~-----~~~~~~~~gt~~y~aPE~  219 (219)
                      +......     ........|++.|+|||+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~  205 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEI  205 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHH
T ss_pred             ccccccccccccccccccCCCcccccChHH
Confidence            8754321     122234579999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.95  E-value=8e-28  Score=197.59  Aligned_cols=168  Identities=21%  Similarity=0.267  Sum_probs=136.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CC-----ccceeEeEEEe
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HR-----NIVKFYGFCSH  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----ni~~~~~~~~~  113 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+..     .......+.+|+.+++.++ |+     +++++++++..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            578999999999999999999 456788999999863     2233455677888888775 44     49999999999


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC--CCCcEEEee
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD--LEYEAHVAD  191 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~--~~~~~kl~d  191 (219)
                      .+..++|||++. ++|.+++..... ..+++..+..++.|++.|+.|||... .+|+||||||+||+++  .++.+||+|
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999995 599998865432 23788889999999999999999521 1899999999999995  468899999


Q ss_pred             ccceeeecCCCCcccccccccccccCCC
Q 039002          192 FGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ||++......   .....||+.|+|||+
T Consensus       205 FG~a~~~~~~---~~~~~~t~~y~aPE~  229 (382)
T 2vx3_A          205 FGSSCQLGQR---IYQYIQSRFYRSPEV  229 (382)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHH
T ss_pred             ccCceecccc---cccccCCccccChHH
Confidence            9999876433   234689999999994

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.95  E-value=4.1e-28  Score=202.35  Aligned_cols=166  Identities=22%  Similarity=0.351  Sum_probs=129.6

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..+|++.+.||+|+||.|+.....+++.||||++.....       ..+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            345888999999999997665556788999999864211       1235799999999 79999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---C--CcEEEeeccc
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---E--YEAHVADFGI  194 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~--~~~kl~dfg~  194 (219)
                      +||++. ++|.+++.....  ...+..+..++.|++.|+.|||+.   +|+||||||+||+++.   +  ..++|+|||+
T Consensus        96 v~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            999996 599999865432  134445678899999999999999   9999999999999953   2  3578999999


Q ss_pred             eeeecCCC---CcccccccccccccCCC
Q 039002          195 AKFLKSDA---SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~---~~~~~~~gt~~y~aPE~  219 (219)
                      ++......   .......||+.|+|||+
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~  197 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEM  197 (432)
T ss_dssp             EECC------------CCSCTTSCCGGG
T ss_pred             eeeccCCCcceeeccccCCCcCccChhh
Confidence            98765332   22244679999999994

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=6.4e-28  Score=192.92  Aligned_cols=171  Identities=22%  Similarity=0.296  Sum_probs=123.6

Q ss_pred             HhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      ..++|++.+.||+|+||.||+|. ..+++.||+|.+....  ........+.++..+++.++||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            35789999999999999999995 5578899999986532  12222233444556788889999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++||++ ++.+..+.....  ..+++..+..++.|++.|+.|||+ .   +++|+||||+||+++.++.++|+|||++..
T Consensus       101 lv~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            999999 556655554321  237888899999999999999998 5   899999999999999999999999999976


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... ......||+.|+|||.
T Consensus       175 ~~~~~-~~~~~~~~~~y~aPE~  195 (318)
T 2dyl_A          175 LVDDK-AKDRSAGCAAYMAPER  195 (318)
T ss_dssp             -------------CCTTCCHHH
T ss_pred             ccCCc-cccccCCCccccChhh
Confidence            64432 2234579999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=1.4e-27  Score=193.44  Aligned_cols=166  Identities=19%  Similarity=0.269  Sum_probs=136.0

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCC-cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc------cceeEeEEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSR-EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN------IVKFYGFCS  112 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~-~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~~~  112 (219)
                      .++|++.+.||+|+||.||+|. ..++ ..||+|.+..     .......+.+|+.+++.++|++      ++.+++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            4789999999999999999994 4454 6899999853     1234456778999999887655      889999999


Q ss_pred             eCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEe-----------
Q 039002          113 HARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLL-----------  181 (219)
Q Consensus       113 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili-----------  181 (219)
                      ..+..+++||++ ++++.+.+..... ..+++..+..++.|++.||.|||+.   +++||||||+||++           
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence            999999999999 5677666654321 2378889999999999999999999   99999999999999           


Q ss_pred             --------CCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          182 --------DLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       182 --------~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                              +.++.++|+|||++......   .....||+.|+|||+
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~  210 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEV  210 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHH
T ss_pred             cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCee
Confidence                    56789999999999864432   234689999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=1.4e-26  Score=183.32  Aligned_cols=145  Identities=11%  Similarity=0.088  Sum_probs=126.2

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+|. ..+++.||+|.+....... ......+.+|+..++.++|+||+++++++...+..|++
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            779999999999999999994 5568899999987643322 23446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      |||+.+++|.+++...     ........++.|++.|+.|+|+.   +++||||||+||+++.+|.++|++++..
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecccc
Confidence            9999999999998642     23446778899999999999999   9999999999999999999999977654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.94  E-value=2.4e-27  Score=193.67  Aligned_cols=167  Identities=22%  Similarity=0.319  Sum_probs=137.2

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-----------CCccceeE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-----------HRNIVKFY  108 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~  108 (219)
                      .++|++.+.||+|+||.||+|. ..+++.||+|.+..     .......+.+|+.+++.++           |+||++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            4789999999999999999994 56888999999853     2234456778999888876           78999999


Q ss_pred             eEEEeCC----cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC--
Q 039002          109 GFCSHAR----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD--  182 (219)
Q Consensus       109 ~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~--  182 (219)
                      +++...+    ..++++|++ +++|.+++..... ..+++..+..++.|++.|+.|||+.+  +++||||||+||+++  
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence            9997654    688999999 8899999865322 23788889999999999999999942  899999999999994  


Q ss_pred             ----CCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          183 ----LEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       183 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                          ..+.++|+|||++.......   ....||+.|+|||+
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE~  206 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEV  206 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHH
T ss_pred             CCCcCcceEEEcccccccccCCCC---CCCCCCccccCcHH
Confidence                34589999999998765432   34589999999984

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.5e-27  Score=203.85  Aligned_cols=158  Identities=16%  Similarity=0.236  Sum_probs=119.9

Q ss_pred             CCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCch----hhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           45 DAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQT----VDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ...+.||+|+||.||+|.. .+..+++|+..........    .....+.+|+.+++.++||||+++..++...+..+++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999944 4567888876543222211    1134578999999999999999666666677888999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+++++|.+++..           ...++.|++.++.|||++   +|+||||||+||+++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999998864           346789999999999999   9999999999999998  999999999998754


Q ss_pred             CCCc-------ccccccccccccCCC
Q 039002          201 DASN-------WTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~-------~~~~~gt~~y~aPE~  219 (219)
                      ....       ...++||+.|+|||+
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv  507 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEI  507 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHH
Confidence            3221       135689999999994

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=9.4e-26  Score=179.29  Aligned_cols=147  Identities=23%  Similarity=0.358  Sum_probs=125.6

Q ss_pred             hCCCCCc-ceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHH-hcCCCCccceeEeEEEe----
Q 039002           41 TNDFDAK-YCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL-TETRHRNIVKFYGFCSH----  113 (219)
Q Consensus        41 ~~~y~~~-~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~----  113 (219)
                      .++|.+. +.||+|+||.||+| ...+++.||+|.+..         ...+.+|+.++ +..+||||+++++++..    
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            4778887 77999999999999 556888999999852         13456788877 66689999999999976    


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEe
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVA  190 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~  190 (219)
                      .+..+++|||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.   ++.++|+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence            6778999999999999999975432 2378899999999999999999999   9999999999999997   7889999


Q ss_pred             eccceeeecC
Q 039002          191 DFGIAKFLKS  200 (219)
Q Consensus       191 dfg~~~~~~~  200 (219)
                      |||++.....
T Consensus       163 Dfg~a~~~~~  172 (299)
T 3m2w_A          163 DFGFAKETTG  172 (299)
T ss_dssp             CCTTCEECTT
T ss_pred             cccccccccc
Confidence            9999987653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.92  E-value=2.8e-25  Score=184.26  Aligned_cols=169  Identities=16%  Similarity=0.119  Sum_probs=122.1

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC-Cccce-------------
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVK-------------  106 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~-------------  106 (219)
                      .+|...+.||+|+||.||+|. ..+++.||||.+....... ......+.+|+.+++.++| +|...             
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            346677899999999999995 6789999999987432222 2234668889999999977 22211             


Q ss_pred             --------eEeEEEe-----CCcceEEEEecCCCCHHHHhccc----chhhccCHHHHHHHHHHHHHHHHhhhhCCCCCe
Q 039002          107 --------FYGFCSH-----ARHSFLLCEFLERGSLAAILNTD----AAAQELGWSQRMSVIKGVADALSYLHHDCFPPI  169 (219)
Q Consensus       107 --------~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  169 (219)
                              +..++..     ...++++|+.+ +++|.+++...    .....+++..+..++.|++.||.|||+.   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                    1111111     12356777765 67999888421    1112366778888999999999999999   99


Q ss_pred             EecCCCCCCEEeCCCCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       170 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +||||||+|||++.++.+||+|||+++.....   ....+| +.|+|||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~  278 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPET  278 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchh
Confidence            99999999999999999999999998865433   344578 99999994

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=6.9e-25  Score=173.15  Aligned_cols=145  Identities=17%  Similarity=0.193  Sum_probs=112.7

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCch--------------hhHHHHHHHHHHHhcCCCC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQT--------------VDQKEFLTEVKALTETRHR  102 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~  102 (219)
                      +......|++.+.||+|+||.||+|...+++.+|+|.++........              .....+.+|+.+++.++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            34445556677999999999999996678899999998643211110              12456789999999998  


Q ss_pred             ccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC
Q 039002          103 NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD  182 (219)
Q Consensus       103 ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~  182 (219)
                      | +.+.+++.. +..+++|||+++++|.+ +..         .....++.|++.|+.|+|+.   +++||||||+||+++
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence            4 666665544 56799999999999987 421         22346889999999999999   999999999999999


Q ss_pred             CCCcEEEeeccceeeec
Q 039002          183 LEYEAHVADFGIAKFLK  199 (219)
Q Consensus       183 ~~~~~kl~dfg~~~~~~  199 (219)
                       ++.++|+|||++....
T Consensus       228 -~~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          228 -EEGIWIIDFPQSVEVG  243 (282)
T ss_dssp             -TTEEEECCCTTCEETT
T ss_pred             -CCcEEEEECCCCeECC
Confidence             9999999999997543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.5e-21  Score=152.22  Aligned_cols=143  Identities=20%  Similarity=0.201  Sum_probs=106.9

Q ss_pred             CCCcceeccccceeEEEEEc-CCCcE--EEEEecCCCCCCCc--------------------hhhHHHHHHHHHHHhcCC
Q 039002           44 FDAKYCIGNGGHASVYRAEL-PSREV--VAVKKFHSPLPSDQ--------------------TVDQKEFLTEVKALTETR  100 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~-~~~~~--~aik~~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~  100 (219)
                      |++.+.||+|+||.||+|.. .+|+.  ||+|.++.......                    ......+.+|+..++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999965 67888  99998754321110                    011235778999999998


Q ss_pred             CCcc--ceeEeEEEeCCcceEEEEecCC-C----CHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhh-hCCCCCeEec
Q 039002          101 HRNI--VKFYGFCSHARHSFLLCEFLER-G----SLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH-HDCFPPIVHR  172 (219)
Q Consensus       101 h~ni--~~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~  172 (219)
                      |+++  +..+..    +..++||||+.+ |    +|.+....      .++..+..++.|++.++.++| ..   +++||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            8754  333332    367899999942 3    66665432      223456788899999999999 88   99999


Q ss_pred             CCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          173 DVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       173 dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||||.|||++.  .++|+|||++.....+
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            99999999988  9999999999876443

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=2.4e-19  Score=146.12  Aligned_cols=149  Identities=9%  Similarity=0.077  Sum_probs=103.8

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCc----------hhh--------HHHHHHHHHHHhcC
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ----------TVD--------QKEFLTEVKALTET   99 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~----------~~~--------~~~~~~e~~~l~~l   99 (219)
                      .....-|++...||+|++|.||+|...+|+.||||.++....+..          ...        .....+|+..+.++
T Consensus        91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            333344899999999999999999878899999998764221100          000        01123567777777


Q ss_pred             CCCccceeEeEEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCE
Q 039002          100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNL  179 (219)
Q Consensus       100 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~ni  179 (219)
                      .+..+.....+..  ...+|+|||+.++++..+...         .....++.|++.++.++|..   +++||||||.||
T Consensus       171 ~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NI  236 (397)
T 4gyi_A          171 YEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNI  236 (397)
T ss_dssp             HHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             HhcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            5444332222211  234799999998887654321         22346778999999999998   999999999999


Q ss_pred             EeCCCC----------cEEEeeccceeeecC
Q 039002          180 LLDLEY----------EAHVADFGIAKFLKS  200 (219)
Q Consensus       180 li~~~~----------~~kl~dfg~~~~~~~  200 (219)
                      |++.+|          .+.|+||+.+.....
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccCCC
Confidence            998776          389999998876443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=1.5e-12  Score=101.13  Aligned_cols=148  Identities=15%  Similarity=0.055  Sum_probs=110.1

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARH  116 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  116 (219)
                      ....++|++...++.|+.+.||++... +..+++|........    ....+.+|+.+++.+. +..++++++++...+.
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~----~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC----CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            345678998888998999999999654 568999987532111    1123677899998884 6778899999988889


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC-------------------------------
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC-------------------------------  165 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-------------------------------  165 (219)
                      .|++||+++|.++.+....        ......++.++..++..||+..                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             eEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999888775321        1223356678888888898710                               


Q ss_pred             -------------------------CCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          166 -------------------------FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       166 -------------------------~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                                               ...++|+|++|.||+++..+.+.|+||+.+...
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                                     025899999999999986555679999987643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=2.6e-11  Score=93.52  Aligned_cols=140  Identities=19%  Similarity=0.129  Sum_probs=95.7

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc--cceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN--IVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~  118 (219)
                      ..++.+....+.|..+.||++...+|..+++|.....       ....+.+|+..++.+.+.+  +.+++++....+..+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            3455554443456679999997777778999986532       1123567888888885433  567888888878899


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC---------------------------------
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC---------------------------------  165 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---------------------------------  165 (219)
                      ++||+++|.++.  ...      ..   ...++.+++..+..+|...                                 
T Consensus        92 ~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            999999987774  211      11   1133455556666666531                                 


Q ss_pred             ----------------------CCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          166 ----------------------FPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       166 ----------------------~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                                            ...++|+|++|.||+++.++.+.++||+.+...
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                  012999999999999987666679999998653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=2.9e-10  Score=92.20  Aligned_cols=144  Identities=14%  Similarity=0.221  Sum_probs=100.9

Q ss_pred             CCcceeccccceeEEEEEcCCCcEEEEEecC--CCCCCCchhhHHHHHHHHHHHhcCCC--CccceeEeEEEeC---Ccc
Q 039002           45 DAKYCIGNGGHASVYRAELPSREVVAVKKFH--SPLPSDQTVDQKEFLTEVKALTETRH--RNIVKFYGFCSHA---RHS  117 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~--~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~---~~~  117 (219)
                      ...+.++.|.++.||+....+ ..+++|+..  .....   .....+.+|+.+++.+..  ..+++++.++.+.   +..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            346789999999999997654 478888764  21111   112346779999998874  4578888888765   458


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC--------------------------------
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC--------------------------------  165 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--------------------------------  165 (219)
                      |++||+++|.++.+...     ..++......++.+++..+..+|...                                
T Consensus       117 ~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            99999998876643111     12455666777888899999998721                                


Q ss_pred             -----------------------CCCeEecCCCCCCEEeCCCC-c-EEEeeccceee
Q 039002          166 -----------------------FPPIVHRDVSSKNLLLDLEY-E-AHVADFGIAKF  197 (219)
Q Consensus       166 -----------------------~~~i~H~dlkp~nili~~~~-~-~kl~dfg~~~~  197 (219)
                                             ...++|+|+++.||+++.++ . +.++||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                   13689999999999999765 3 58999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.53  E-value=5.1e-07  Score=71.32  Aligned_cols=137  Identities=22%  Similarity=0.227  Sum_probs=88.1

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCc--cceeEeEEEeCC---cceEE
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRN--IVKFYGFCSHAR---HSFLL  120 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--i~~~~~~~~~~~---~~~lv  120 (219)
                      .+.++.|..+.||+..    ..+++|....      ......+.+|+..++.+. +..  +.+++......+   ..|++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568899999999763    3578887532      123456788999998873 333  345544433332   35899


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhC------------------------------------
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD------------------------------------  164 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~------------------------------------  164 (219)
                      |++++|.++.....     ..++..+...++.+++..+..+|+.                                    
T Consensus        95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            99999877654221     1133344444555555555555531                                    


Q ss_pred             -------------------CCCCeEecCCCCCCEEeCC--CCcEEEeeccceeee
Q 039002          165 -------------------CFPPIVHRDVSSKNLLLDL--EYEAHVADFGIAKFL  198 (219)
Q Consensus       165 -------------------~~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~  198 (219)
                                         ....++|+|++|.||+++.  .+.+.++||+.+...
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                               1125799999999999997  456789999988654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.50  E-value=3e-06  Score=67.09  Aligned_cols=75  Identities=12%  Similarity=0.041  Sum_probs=53.1

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC---ccceeEeEEE-eCCcceEEEE
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR---NIVKFYGFCS-HARHSFLLCE  122 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~-~~~~~~lv~e  122 (219)
                      ...++.|....||+.    +..+++|.-.      .......+.+|+.+++.+.+.   .+.+++.+.. ..+..|++||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456788888899987    4567888742      122345678899999998652   3556666664 4566889999


Q ss_pred             ecCCCCHHH
Q 039002          123 FLERGSLAA  131 (219)
Q Consensus       123 ~~~~~~l~~  131 (219)
                      +++|.++..
T Consensus        94 ~i~G~~l~~  102 (306)
T 3tdw_A           94 KVQGQILGE  102 (306)
T ss_dssp             CCCSEECHH
T ss_pred             ccCCeECch
Confidence            999877654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=3.9e-06  Score=64.90  Aligned_cols=146  Identities=15%  Similarity=0.106  Sum_probs=93.6

Q ss_pred             HHHhCCCCCcceeccccce-eEEEEEcC-CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeC
Q 039002           38 VKATNDFDAKYCIGNGGHA-SVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHA  114 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g-~V~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  114 (219)
                      ......|+.. .+..|..+ .||+.... ++..+.+|.-..       .....+.+|+..++.+. +-.+.+++.++.+.
T Consensus        21 ~~~l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~   92 (272)
T 4gkh_A           21 DADLYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP   92 (272)
T ss_dssp             HHHHTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             hccccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC
Confidence            3444555543 34445443 68887544 455688887432       13345678999888874 34577888998889


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhC------------------------------
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD------------------------------  164 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~------------------------------  164 (219)
                      +..|++||++++.++.+......       .....+..++...+.-||..                              
T Consensus        93 ~~~~lvme~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (272)
T 4gkh_A           93 DDAWLLTTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDAS  165 (272)
T ss_dssp             TEEEEEEECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGG
T ss_pred             CeEEEEEEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhh
Confidence            99999999999877766542211       11122333444444444421                              


Q ss_pred             -------------------------CCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          165 -------------------------CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       165 -------------------------~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                                               ....++|+|+.+.||+++..+.+-|+||+.+...
T Consensus       166 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          166 DFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             GCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             hccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                                     0013799999999999987776779999988643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.03  E-value=1.1e-05  Score=64.87  Aligned_cols=82  Identities=5%  Similarity=0.019  Sum_probs=50.6

Q ss_pred             ccee-ccccceeEEEEEcC-------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC---CccceeEeEEEeC-
Q 039002           47 KYCI-GNGGHASVYRAELP-------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH---RNIVKFYGFCSHA-  114 (219)
Q Consensus        47 ~~~l-g~g~~g~V~~~~~~-------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~-  114 (219)
                      .+.| +.|..+.+|+....       ++..+++|......... ......+.+|+.+++.+..   -.+.+++.+..+. 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            3566 78888999988543       25578888754311000 0001234567887777742   3567777776554 


Q ss_pred             --CcceEEEEecCCCCH
Q 039002          115 --RHSFLLCEFLERGSL  129 (219)
Q Consensus       115 --~~~~lv~e~~~~~~l  129 (219)
                        +..|++||+++|.++
T Consensus       104 ~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTSSCEEEEECCCCBCC
T ss_pred             ccCCceEEEEecCCCCh
Confidence              457899999987554

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.00  E-value=5.5e-05  Score=61.84  Aligned_cols=79  Identities=13%  Similarity=0.069  Sum_probs=48.0

Q ss_pred             cceeccccceeEEEEEcC-CCcEEEEEecCCCCC--CCc-hhhHHHHHHHHHHHhcCCC--C-ccceeEeEEEeCCcceE
Q 039002           47 KYCIGNGGHASVYRAELP-SREVVAVKKFHSPLP--SDQ-TVDQKEFLTEVKALTETRH--R-NIVKFYGFCSHARHSFL  119 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~-~~~~~aik~~~~~~~--~~~-~~~~~~~~~e~~~l~~l~h--~-ni~~~~~~~~~~~~~~l  119 (219)
                      .+.+|.|..+.||++... ++..+++|.......  ... ......+..|...++.+..  + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567999999999999643 467899997643211  000 0122345668888877632  2 34455543  4556789


Q ss_pred             EEEecCCC
Q 039002          120 LCEFLERG  127 (219)
Q Consensus       120 v~e~~~~~  127 (219)
                      +||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.91  E-value=0.0001  Score=58.61  Aligned_cols=30  Identities=27%  Similarity=0.400  Sum_probs=27.3

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      .++|+|+.+.|++++.++.+.++||+.+..
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            799999999999998788999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.45  E-value=0.002  Score=51.02  Aligned_cols=75  Identities=24%  Similarity=0.230  Sum_probs=56.7

Q ss_pred             cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC---CCccceeEeEEEeCCcceEEEEe
Q 039002           47 KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR---HRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      ...|+.|....+|+.... +..+++|....       .....+..|+..++.+.   ...+++++.+....+..|++||+
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~-------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINER-------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEG-------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCc-------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            467899999999999754 55788887532       12345678888888873   35678888888877889999999


Q ss_pred             cCCCCH
Q 039002          124 LERGSL  129 (219)
Q Consensus       124 ~~~~~l  129 (219)
                      +++.++
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.45  E-value=0.0012  Score=51.64  Aligned_cols=74  Identities=9%  Similarity=0.085  Sum_probs=43.8

Q ss_pred             CCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCcc-ceeEeEEEeCCcceEEEE
Q 039002           44 FDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI-VKFYGFCSHARHSFLLCE  122 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e  122 (219)
                      +.-.+.|+.|..+.+|+.     ..+++|.........     ....+|+..++.+....+ .+++..  +.+..++++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccce-----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            333788988999999998     457888765321110     112347777766642222 455543  3444688999


Q ss_pred             ec-CCCCH
Q 039002          123 FL-ERGSL  129 (219)
Q Consensus       123 ~~-~~~~l  129 (219)
                      ++ ++.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 65433

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.43  E-value=0.0048  Score=50.72  Aligned_cols=30  Identities=13%  Similarity=0.317  Sum_probs=26.6

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      .++|+|++|.||+++.++ +.++||+.+...
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            799999999999998776 999999988643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.34  E-value=0.0025  Score=49.53  Aligned_cols=76  Identities=20%  Similarity=0.218  Sum_probs=52.6

Q ss_pred             CCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC---CccceeEeEEEeCCcceEE
Q 039002           44 FDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH---RNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~~~~~lv  120 (219)
                      ..-+..+|.|..+.||+....+|+.+.+|........    ....+..|+..|+.+..   -.+++++.+    +..+++
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv   88 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA----LDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLA   88 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC----CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEE
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc----hhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEE
Confidence            4456789999999999999999999999986432211    12345678888888743   234455543    235889


Q ss_pred             EEecCCC
Q 039002          121 CEFLERG  127 (219)
Q Consensus       121 ~e~~~~~  127 (219)
                      ||++.++
T Consensus        89 ~e~l~~~   95 (288)
T 3f7w_A           89 MEWVDER   95 (288)
T ss_dssp             EECCCCC
T ss_pred             EEeeccc
Confidence            9998654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.04  E-value=0.017  Score=45.45  Aligned_cols=74  Identities=14%  Similarity=0.098  Sum_probs=45.7

Q ss_pred             ceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC--ccceeEeE-----EEeCCcceEE
Q 039002           48 YCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR--NIVKFYGF-----CSHARHSFLL  120 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~-----~~~~~~~~lv  120 (219)
                      ..++ |....||+....+|+.+++|.......     ....+..|...++.+...  .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 777889998766677789998753211     223455677777766422  23444332     1234556789


Q ss_pred             EEecCCC
Q 039002          121 CEFLERG  127 (219)
Q Consensus       121 ~e~~~~~  127 (219)
                      +++++|.
T Consensus       106 ~~~i~G~  112 (328)
T 1zyl_A          106 FPSVGGR  112 (328)
T ss_dssp             EECCCCE
T ss_pred             EEecCCC
Confidence            9999764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.04  E-value=0.017  Score=45.41  Aligned_cols=159  Identities=14%  Similarity=0.152  Sum_probs=80.6

Q ss_pred             ccHHHHHHHhCCCCC-----cceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCC--cc
Q 039002           32 ILYDEIVKATNDFDA-----KYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHR--NI  104 (219)
Q Consensus        32 ~~~~~~~~~~~~y~~-----~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--ni  104 (219)
                      ++.+.+......|.+     .+.|+.|....+|+....++ .+++|......      ....+..|+..++.+...  .+
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~v   79 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSC   79 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCC
Confidence            444555555556654     24566687888999866555 67888875321      112234566666665321  13


Q ss_pred             ceeEeE------EEeCCcceEEEEecCCCCHH-----HH---------hc----ccchhh--cc---CHHHHHH------
Q 039002          105 VKFYGF------CSHARHSFLLCEFLERGSLA-----AI---------LN----TDAAAQ--EL---GWSQRMS------  149 (219)
Q Consensus       105 ~~~~~~------~~~~~~~~lv~e~~~~~~l~-----~~---------~~----~~~~~~--~l---~~~~~~~------  149 (219)
                      .+++..      ....+..++++++++|.++.     ..         +.    ......  ..   .|.....      
T Consensus        80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (322)
T 2ppq_A           80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  159 (322)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence            333321      12345678999999874321     00         00    000000  00   0111000      


Q ss_pred             ------HHHHHHHHHHhhhhC----CCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          150 ------VIKGVADALSYLHHD----CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       150 ------i~~~i~~~l~~lh~~----~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                            +...+...+..+...    ....++|+|+.+.||+++.++.+.++||+.+..
T Consensus       160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                  001122333444321    112689999999999998766668999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.02  E-value=0.0057  Score=48.48  Aligned_cols=31  Identities=42%  Similarity=0.415  Sum_probs=26.9

Q ss_pred             CeEecCCCCCCEEeCCC----CcEEEeeccceeee
Q 039002          168 PIVHRDVSSKNLLLDLE----YEAHVADFGIAKFL  198 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~----~~~kl~dfg~~~~~  198 (219)
                      .++|+|+.+.||+++.+    +.+.++||+.+...
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            78999999999999864    67899999988643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.90  E-value=0.0044  Score=50.37  Aligned_cols=142  Identities=16%  Similarity=0.226  Sum_probs=76.5

Q ss_pred             cceeccccceeEEEEEcC--------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcc
Q 039002           47 KYCIGNGGHASVYRAELP--------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHS  117 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~--------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~  117 (219)
                      .+.+..|....+|++..+        ++..+.+|.....     ......+.+|..+++.+. +.-..++++.+.+    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            356777888889999764        2467888885321     112234567888888874 3233566666543    


Q ss_pred             eEEEEecCCCCHHH--------------Hhc---cc-ch-hhccC--HHHHHHHHHHHHH-------------------H
Q 039002          118 FLLCEFLERGSLAA--------------ILN---TD-AA-AQELG--WSQRMSVIKGVAD-------------------A  157 (219)
Q Consensus       118 ~lv~e~~~~~~l~~--------------~~~---~~-~~-~~~l~--~~~~~~i~~~i~~-------------------~  157 (219)
                      .+++|+++|.++..              .+.   .. .. .....  +.++..+..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            38999997643321              000   00 00 00011  2333333322211                   1


Q ss_pred             HHh----hhhC-CCCCeEecCCCCCCEEeCCC----CcEEEeeccceee
Q 039002          158 LSY----LHHD-CFPPIVHRDVSSKNLLLDLE----YEAHVADFGIAKF  197 (219)
Q Consensus       158 l~~----lh~~-~~~~i~H~dlkp~nili~~~----~~~kl~dfg~~~~  197 (219)
                      +..    +... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            222    2211 11258999999999999876    7899999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.73  E-value=0.0066  Score=50.15  Aligned_cols=70  Identities=20%  Similarity=0.287  Sum_probs=45.4

Q ss_pred             cceeccccceeEEEEEcCC--------CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc-cceeEeEEEeCCcc
Q 039002           47 KYCIGNGGHASVYRAELPS--------REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN-IVKFYGFCSHARHS  117 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~--------~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~  117 (219)
                      .+.|+.|....+|++..++        +..+.+|....+   .   ....+..|..+++.+...+ .+++++.+.+    
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E---TESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---C---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            4567888889999996542        467888887431   1   1133457888888774333 3566665532    


Q ss_pred             eEEEEecCC
Q 039002          118 FLLCEFLER  126 (219)
Q Consensus       118 ~lv~e~~~~  126 (219)
                      .+++||++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            388998875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.50  E-value=0.044  Score=45.65  Aligned_cols=72  Identities=18%  Similarity=0.158  Sum_probs=44.2

Q ss_pred             cceeccccceeEEEEEcCC-CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCcc-ceeEeEEEeCCcceEEEEec
Q 039002           47 KYCIGNGGHASVYRAELPS-REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNI-VKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~-~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~  124 (219)
                      .+.|+.|-...+|++...+ +..+++|......  .....   ..+|..+++.+...++ +++++.+.  +  .+++||+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIIN---REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            4567788889999997654 4678888764321  11111   1468888888864444 56777662  2  3599998


Q ss_pred             CCC
Q 039002          125 ERG  127 (219)
Q Consensus       125 ~~~  127 (219)
                      ++.
T Consensus       184 ~G~  186 (458)
T 2qg7_A          184 DGY  186 (458)
T ss_dssp             CSE
T ss_pred             CCc
Confidence            763

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.73  E-value=0.097  Score=41.61  Aligned_cols=31  Identities=19%  Similarity=0.310  Sum_probs=27.5

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      .++|+|+.+.|++++.++.+.++||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            6899999999999988788999999887643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.21  E-value=0.064  Score=44.19  Aligned_cols=73  Identities=7%  Similarity=0.014  Sum_probs=44.6

Q ss_pred             cceeccccceeEEEEEcCC--------CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcc
Q 039002           47 KYCIGNGGHASVYRAELPS--------REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHS  117 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~--------~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~  117 (219)
                      .+.+..|....+|+....+        +..+++|......  ....   ...+|..+++.+. +.-..++++.+    .-
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~i---dR~~E~~~l~~L~~~gi~P~l~~~~----~~  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFY---DSKVELDVFRYLSNINIAPNIIADF----PE  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCC---CHHHHHHHHHHHHHTTSSCCEEEEE----TT
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhc---CHHHHHHHHHHHHhcCCCCCEEEEc----CC
Confidence            4567778888999996552        5678888864321  1111   1245777777774 22345566533    23


Q ss_pred             eEEEEecCCCC
Q 039002          118 FLLCEFLERGS  128 (219)
Q Consensus       118 ~lv~e~~~~~~  128 (219)
                      ++++||++|.+
T Consensus       146 ~~I~efI~G~~  156 (424)
T 3mes_A          146 GRIEEFIDGEP  156 (424)
T ss_dssp             EEEEECCCSEE
T ss_pred             CEEEEEeCCcc
Confidence            78999998744

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.18  E-value=0.74  Score=34.19  Aligned_cols=84  Identities=10%  Similarity=0.035  Sum_probs=58.4

Q ss_pred             CCCccceeEeEEEeCCcceEEEEecCCC-CHHHHhcccchhhccCHHHHHHHHHHHHHHHH-hhhhCCCCCeEecCCCCC
Q 039002          100 RHRNIVKFYGFCSHARHSFLLCEFLERG-SLAAILNTDAAAQELGWSQRMSVIKGVADALS-YLHHDCFPPIVHRDVSSK  177 (219)
Q Consensus       100 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~lh~~~~~~i~H~dlkp~  177 (219)
                      .||.+  -..+-.+.+.+.+.++.-+++ ++. .+.      .++....+.++.+++.... +++.     -.|.-+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            46666  334446777777777765443 443 332      2566777788888776655 4554     478889999


Q ss_pred             CEEeCCCCcEEEeeccceee
Q 039002          178 NLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       178 nili~~~~~~kl~dfg~~~~  197 (219)
                      |++++.++.+++.-.|+-..
T Consensus       114 NL~f~~~~~p~i~hRGi~~~  133 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES  133 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT
T ss_pred             eEEEeCCCcEEEEEcCCccc
Confidence            99999999999999997543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.72  E-value=0.88  Score=33.67  Aligned_cols=84  Identities=2%  Similarity=0.034  Sum_probs=58.6

Q ss_pred             CCCccceeEeEEEeCCcceEEEEecCC-CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCC
Q 039002          100 RHRNIVKFYGFCSHARHSFLLCEFLER-GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKN  178 (219)
Q Consensus       100 ~h~ni~~~~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~n  178 (219)
                      .||+++.. .+-.+.+.+.+.++.-+. -++.. +      ...+....+.++.+++....+++..     .|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            56777765 455666766666665542 23322 2      2356677788888887776555543     788899999


Q ss_pred             EEeCCCCcEEEeecccee
Q 039002          179 LLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       179 ili~~~~~~kl~dfg~~~  196 (219)
                      ++++.++.+++.-.|+..
T Consensus       110 L~f~~~~~p~i~~RGik~  127 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQN  127 (215)
T ss_dssp             EEECTTSCEEESCCEETT
T ss_pred             EEEcCCCCEEEEEccCcc
Confidence            999999999999998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.11  E-value=0.22  Score=39.86  Aligned_cols=72  Identities=11%  Similarity=0.108  Sum_probs=40.4

Q ss_pred             cceeccccceeEEEEEcCC---------CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCc-cceeEeEEEeCCc
Q 039002           47 KYCIGNGGHASVYRAELPS---------REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN-IVKFYGFCSHARH  116 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~---------~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~  116 (219)
                      ...++.|....+|+....+         +..+++|......   .  .......|..+++.+...+ .+++++..    .
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---D--ELYNTISEFEVYKTMSKYKIAPQLLNTF----N  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---G--GTSCHHHHHHHHHHHHHTTSSCCEEEEE----T
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---c--ceecHHHHHHHHHHHHhcCCCCceEEec----C
Confidence            4567778888999986543         2578888764311   1  1111245777777774333 44666544    2


Q ss_pred             ceEEEEecCCC
Q 039002          117 SFLLCEFLERG  127 (219)
Q Consensus       117 ~~lv~e~~~~~  127 (219)
                      -++++|+++|.
T Consensus       109 ~~~v~e~i~G~  119 (369)
T 3c5i_A          109 GGRIEEWLYGD  119 (369)
T ss_dssp             TEEEEECCCSE
T ss_pred             CcEEEEEecCC
Confidence            47899999764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.72  E-value=0.11  Score=43.37  Aligned_cols=63  Identities=10%  Similarity=-0.036  Sum_probs=17.8

Q ss_pred             CCcceeccccceeEEEEEcCC-CcEEEE------EecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEE
Q 039002           45 DAKYCIGNGGHASVYRAELPS-REVVAV------KKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCS  112 (219)
Q Consensus        45 ~~~~~lg~g~~g~V~~~~~~~-~~~~ai------k~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~  112 (219)
                      .+.+.+|   ||.||+|.+.. ..+||+      |..+.....  ......+.+|..+++..+|+|+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~--~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS--EKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccccc--ccccccccccccccccccccccCCCcceEE
Confidence            4456676   99999996543 356777      655432111  122345677888888899999999887764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.22  E-value=0.71  Score=37.49  Aligned_cols=29  Identities=24%  Similarity=0.453  Sum_probs=24.7

Q ss_pred             eEecCCCCCCEEe------CCCCcEEEeeccceee
Q 039002          169 IVHRDVSSKNLLL------DLEYEAHVADFGIAKF  197 (219)
Q Consensus       169 i~H~dlkp~nili------~~~~~~kl~dfg~~~~  197 (219)
                      ++|+|+.+.||++      +..+.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      3457799999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	219
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-37
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-37
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-36
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-36
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-35
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-35
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-33
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-32
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-32
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-32
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-32
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-31
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-30
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-30
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-29
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-28
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-28
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-27
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-27
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-27
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-27
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-26
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-24
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-23
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-22
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-22
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-22
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-13

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 2e-39
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 11/178 (6%)

Query: 40  ATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
             +DF+    +G G    V++    PS  V+A K  H      +   + + + E++ L E
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHE 60

Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
                IV FYG         +  E ++ GSL  +L     A  +       V   V   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +YL       I+HRDV   N+L++   E  + DFG++  L    +    F GT  Y++
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMS 171

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-38
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 12/177 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
                   IG+G   +VY+ +      VAVK  +   P+ Q    + F  EV  L +TRH
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NI+ F G+ +      ++ ++ E  SL   L+      +    + + + +  A  + YL
Sbjct: 64  VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVA 216
           H      I+HRD+ S N+ L  +    + DFG+A      + +  + + +G+  ++A
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 7e-37
 Identities = 38/176 (21%), Positives = 76/176 (43%), Gaps = 11/176 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            D      +G G    V   +   +  VA+K        + ++ + EF+ E K +    H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSH 58

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
             +V+ YG C+  R  F++ E++  G L   L            Q + + K V +A+ YL
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYL 116

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD-ASNWTEFAGTYGYVA 216
                   +HRD++++N L++ +    V+DFG+++++  D  ++         +  
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 9e-37
 Identities = 43/180 (23%), Positives = 85/180 (47%), Gaps = 8/180 (4%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           D++  Y IG G +    +       +++  K+      ++   +++  ++EV  L E +H
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKH 62

Query: 102 RNIVKFYGFCSHARHS--FLLCEFLERGSLAAILNTDAAAQE-LGWSQRMSVIKGVADAL 158
            NIV++Y       ++  +++ E+ E G LA+++      ++ L     + V+  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 159 SYLH--HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
              H   D    ++HRD+   N+ LD +    + DFG+A+ L  D S    F GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-36
 Identities = 33/176 (18%), Positives = 73/176 (41%), Gaps = 11/176 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
                   +G G    V+         VAVK          ++    FL E   + + +H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
           + +V+ Y   +     +++ E++E GSL   L T +   +L  ++ + +   +A+ ++++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW-TEFAGTYGYVA 216
                   +HRD+ + N+L+       +ADFG+A+ ++ +             + A
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (319), Expect = 3e-36
 Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 22/195 (11%)

Query: 27  PEVGKILYDEIVKATNDFDAKY----CIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSD 81
           P+V ++ + +      D +  +     IG+G   +VY A  + + EVVA+KK        
Sbjct: 2   PDVAELFFKD------DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55

Query: 82  QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQE 141
                ++ + EV+ L + RH N +++ G       ++L+ E+    +   +       + 
Sbjct: 56  NE-KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KP 111

Query: 142 LGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD 201
           L   +  +V  G    L+YLH      ++HRDV + N+LL       + DFG A  +   
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168

Query: 202 ASNWTEFAGTYGYVA 216
                 F GT  ++A
Sbjct: 169 ----NSFVGTPYWMA 179

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 8e-36
 Identities = 34/176 (19%), Positives = 75/176 (42%), Gaps = 11/176 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           ++      IG+G    V+     +++ VA+K        +  + +++F+ E + + +  H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSH 59

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
             +V+ YG C       L+ EF+E G L+  L T            + +   V +    +
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEG---M 114

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE-FAGTYGYVA 216
            +     ++HRD++++N L+       V+DFG+ +F+  D    +        + +
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 2e-35
 Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 10/176 (5%)

Query: 42  NDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            DF+    +G G   +VY A    S+ ++A+K           V + +   EV+  +  R
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 64

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H NI++ YG+   A   +L+ E+   G++   L       +    +  + I  +A+ALSY
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            H      ++HRD+  +NLLL    E  +ADFG +    S         GT  Y+ 
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--LCGTLDYLP 172

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (313), Expect = 2e-35
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 26/201 (12%)

Query: 34  YDEIVKATNDFDAKY---------CIGNGGHASVYRAELPS----REVVAVKKFHSPLPS 80
           +++  +A  +F  +           IG G    V    L         VA+K   S    
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 81  DQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQ 140
            Q   +++FL+E   + +  H N++   G  + +    ++ EF+E GSL + L  +    
Sbjct: 69  KQ---RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
                Q + +++G+A  + YL        VHRD++++N+L++      V+DFG+++FL+ 
Sbjct: 126 T--VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 201 DASNWTE-----FAGTYGYVA 216
           D S+ T            + A
Sbjct: 181 DTSDPTYTSALGGKIPIRWTA 201

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-35
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 13/187 (6%)

Query: 34  YDEIVKATN---DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEF 89
           Y+ + +  N    ++    +G+G    VY+A+   +  + A K     + +    + +++
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV----IDTKSEEELEDY 56

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           + E+  L    H NIVK      +  + ++L EF   G++ A++      + L  SQ   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQV 114

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           V K   DAL+YLH      I+HRD+ + N+L  L+ +  +ADFG++            F 
Sbjct: 115 VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171

Query: 210 GTYGYVA 216
           GT  ++A
Sbjct: 172 GTPYWMA 178

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 7e-35
 Identities = 38/191 (19%), Positives = 75/191 (39%), Gaps = 11/191 (5%)

Query: 27  PEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQ 86
           P+   +  D           +  +G G    V+         VA+K          T+  
Sbjct: 2   PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSP 56

Query: 87  KEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQ 146
           + FL E + + + RH  +V+ Y   S     +++ E++ +GSL          + L   Q
Sbjct: 57  EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQ 114

Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT 206
            + +   +A  ++Y+        VHRD+ + N+L+       VADFG+A+ ++ +     
Sbjct: 115 LVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171

Query: 207 E-FAGTYGYVA 216
           +       + A
Sbjct: 172 QGAKFPIKWTA 182

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (301), Expect = 1e-33
 Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 11/185 (5%)

Query: 34  YDEIVKATNDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTE 92
           YD+      D   K+ +G G +  VY          VAVK        + T++ +EFL E
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 63

Query: 93  VKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
              + E +H N+V+  G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 122

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN-WTEFAGT 211
            ++ A+ YL        +HRD++++N L+   +   VADFG+++ +  D           
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 212 YGYVA 216
             + A
Sbjct: 180 IKWTA 184

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-33
 Identities = 39/204 (19%), Positives = 77/204 (37%), Gaps = 35/204 (17%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPS------REVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
            + +    +G+G    V  A             VAVK          + +++  ++E+K 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 93

Query: 96  LTE-TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT------------------- 135
           +T+   H NIV   G C+ +   +L+ E+   G L   L +                   
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 136 -DAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI 194
            +     L +   +     VA  + +L        VHRD++++N+L+       + DFG+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 195 AKFLKSDASN--WTEFAGTYGYVA 216
           A+ + SD++            ++A
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMA 234

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 8e-33
 Identities = 42/176 (23%), Positives = 71/176 (40%), Gaps = 15/176 (8%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            +      IG G    V   +    +V AVK   +          + FL E   +T+ RH
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKND------ATAQAFLAEASVMTQLRH 59

Query: 102 RNIVKFYGFCSHARHS-FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
            N+V+  G     +   +++ E++ +GSL   L        LG    +     V +A+ Y
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L        VHRD++++N+L+  +  A V+DFG+ K   S             + A
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTA 168

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-32
 Identities = 47/181 (25%), Positives = 70/181 (38%), Gaps = 23/181 (12%)

Query: 49  CIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
            IG G    V+R +    EV AVK F S     +         E+      RH NI+ F 
Sbjct: 10  SIGKGRFGEVWRGKWRGEEV-AVKIFSS-----REERSWFREAEIYQTVMLRHENILGFI 63

Query: 109 GFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
              +    +    +L+ ++ E GSL   LN       +     + +    A  L++LH +
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHME 119

Query: 165 CF-----PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW----TEFAGTYGYV 215
                  P I HRD+ SKN+L+       +AD G+A    S             GT  Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 216 A 216
           A
Sbjct: 180 A 180

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-32
 Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 15/173 (8%)

Query: 50  IGNGGHASVYRAELPSRE---VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G G   SV +     R+    VA+K         +  D +E + E + + +  +  IV+
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
             G C  A    L+ E    G L   L      +E+  S    ++  V+  + YL     
Sbjct: 74  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--- 127

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE---FAGTYGYVA 216
              VHRD++++N+LL   + A ++DFG++K L +D S +T          + A
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 3e-32
 Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 14/173 (8%)

Query: 50  IGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G   +VY+     +   VA  +      +    +++ F  E + L   +H NIV+FY
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 109 GFCSHA----RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
                     +   L+ E +  G+L   L      + +      S  + +   L +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 165 CFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             PPI+HRD+   N+ +        + D G+A   ++  +      GT  ++A
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMA 181

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-32
 Identities = 45/192 (23%), Positives = 78/192 (40%), Gaps = 24/192 (12%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPS---REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTE 98
           ND   +  IG G    V +A +     R   A+K+       D   D ++F  E++ L +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 66

Query: 99  -TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-------------NTDAAAQELGW 144
              H NI+   G C H  + +L  E+   G+L   L               ++ A  L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 145 SQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN 204
            Q +     VA  + YL        +HRD++++N+L+   Y A +ADFG+++  +     
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 205 WTEFAGTYGYVA 216
                    ++A
Sbjct: 184 TM-GRLPVRWMA 194

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 4e-32
 Identities = 45/178 (25%), Positives = 66/178 (37%), Gaps = 12/178 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            D+D    +G G +  V  A    + E VAVK              +    E+       
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLN 61

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H N+VKFYG        +L  E+   G L   +  D     +           +   + Y
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 118

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVA 216
           LH      I HRD+  +NLLLD      ++DFG+A   + +       +  GT  YVA
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 7e-32
 Identities = 39/173 (22%), Positives = 78/173 (45%), Gaps = 15/173 (8%)

Query: 50  IGNGGHASVYRAELPSR---EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G   +V +     +   + VAVK   +   ++    + E L E   + +  +  IV+
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
             G C       L+ E  E G L   L  +   + +     + ++  V+  + YL     
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125

Query: 167 PPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW---TEFAGTYGYVA 216
              VHRD++++N+LL  ++ A ++DFG++K L++D + +   T       + A
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-31
 Identities = 42/199 (21%), Positives = 76/199 (38%), Gaps = 30/199 (15%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           N       +G G    V  A         +   VAVK      PS    +++  ++E+K 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79

Query: 96  LTE-TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILN---------------TDAAA 139
           L+    H NIV   G C+    + ++ E+   G L   L                 +   
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
             L     +S    VA  +++L        +HRD++++N+LL       + DFG+A+ +K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 200 SDASNW--TEFAGTYGYVA 216
           +D++            ++A
Sbjct: 197 NDSNYVVKGNARLPVKWMA 215

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  115 bits (290), Expect = 1e-31
 Identities = 35/178 (19%), Positives = 74/178 (41%), Gaps = 13/178 (7%)

Query: 42  NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           + +D    +G+G    V+R  E  +  V   K  ++P P    +D+     E+  + +  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLH 84

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H  ++  +          L+ EFL  G L   +  +    ++  ++ ++ ++   + L +
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKH 142

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +H      IVH D+  +N++ + +  + V   DFG+A  L  D         T  + A
Sbjct: 143 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAA 196

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-31
 Identities = 42/180 (23%), Positives = 82/180 (45%), Gaps = 16/180 (8%)

Query: 42  NDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL 96
            D   KY     IG G   +VY A ++ + + VA+++ +      Q   ++  + E+  +
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVM 71

Query: 97  TETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
            E ++ NIV +          +++ E+L  GSL  ++        +   Q  +V +    
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQ 127

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           AL +LH +    ++HRD+ S N+LL ++    + DFG    +  + S  +   GT  ++A
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  115 bits (288), Expect = 2e-31
 Identities = 37/193 (19%), Positives = 77/193 (39%), Gaps = 16/193 (8%)

Query: 27  PEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVD 85
           P+  +I +D ++   + +D    +G G    V+R  E  +    A K   +P  SD+   
Sbjct: 14  PQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--- 67

Query: 86  QKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS 145
            +    E++ ++  RH  +V  +          ++ EF+  G L   +       ++   
Sbjct: 68  -ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSED 124

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDAS 203
           + +  ++ V   L ++H +     VH D+  +N++   +    +   DFG+   L    S
Sbjct: 125 EAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181

Query: 204 NWTEFAGTYGYVA 216
                 GT  + A
Sbjct: 182 VKV-TTGTAEFAA 193

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 1e-30
 Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 13/168 (7%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           +G G    V+R  E  S++    K         +  DQ     E+  L   RHRNI+  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHLH 67

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                     ++ EF+    +   +NT   A EL   + +S +  V +AL +LH      
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 169 IVHRDVSSKNLLLDLEYEAHV--ADFGIAKFLKSDASNWTEFAGTYGY 214
           I H D+  +N++      + +   +FG A+ LK   +    F     Y
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (280), Expect = 1e-30
 Identities = 45/204 (22%), Positives = 79/204 (38%), Gaps = 35/204 (17%)

Query: 42  NDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           N+ +    IG G    V++A  P         +VAVK       +D    Q +F  E   
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAAL 69

Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL---------------------N 134
           + E  + NIVK  G C+  +   LL E++  G L   L                      
Sbjct: 70  MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 135 TDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI 194
           +      L  ++++ + + VA  ++YL        VHRD++++N L+       +ADFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 195 AKFLKSDASNW--TEFAGTYGYVA 216
           ++ + S          A    ++ 
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMP 210

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 4e-30
 Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 9/177 (5%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET- 99
            DF     +G G    V+ AE   + +  A+K     +      D +  + E + L+   
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECTMVEKRVLSLAW 60

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
            H  +   +       + F + E+L  G L   +    +  +   S+       +   L 
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQ 117

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +LH      IV+RD+   N+LLD +    +ADFG+ K      +    F GT  Y+A
Sbjct: 118 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 5e-30
 Identities = 41/181 (22%), Positives = 65/181 (35%), Gaps = 10/181 (5%)

Query: 39  KATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
           K   DF     +G G  ++V  A EL +    A+K         +         E   ++
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMS 63

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
              H   VK Y         +    + + G L   +           +        +  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSA 120

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW--TEFAGTYGYV 215
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L  ++       F GT  YV
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 216 A 216
           +
Sbjct: 178 S 178

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-29
 Identities = 41/182 (22%), Positives = 68/182 (37%), Gaps = 14/182 (7%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSR----EVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
            D      +G+G    V R E  +       VAVK     + S       +F+ EV A+ 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVNAMH 66

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
              HRN+++ YG         ++ E    GSL   L                    VA+ 
Sbjct: 67  SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEG 123

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW---TEFAGTYGY 214
           + YL        +HRD++++NLLL       + DFG+ + L  +  ++         + +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 215 VA 216
            A
Sbjct: 181 CA 182

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  109 bits (273), Expect = 2e-29
 Identities = 39/177 (22%), Positives = 69/177 (38%), Gaps = 8/177 (4%)

Query: 41  TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
            + +D +  +G G  + V  AE   ++++VA+K             +     E+  L + 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---KKALEGKEGSMENEIAVLHKI 64

Query: 100 RHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALS 159
           +H NIV          H +L+ + +  G L   +                +I  V DA+ 
Sbjct: 65  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVK 121

Query: 160 YLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           YLH         +  +     LD + +  ++DFG++K      S  +   GT GYVA
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVA 177

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 3e-29
 Identities = 43/212 (20%), Positives = 81/212 (38%), Gaps = 20/212 (9%)

Query: 14  LHIQLNRLDGSIPPEVGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELP----SREVV 69
           +HI L+ L+  +   V  ++        + F+    IG G    VY   L      +   
Sbjct: 2   VHIDLSALNPELVQAVQHVVIGPSSLIVH-FNEV--IGRGHFGCVYHGTLLDNDGKKIHC 58

Query: 70  AVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC-EFLERGS 128
           AVK  +         +  +FLTE   + +  H N++   G C  +  S L+   +++ G 
Sbjct: 59  AVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115

Query: 129 LAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH 188
           L   +  +     +       +          +        VHRD++++N +LD ++   
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVK 170

Query: 189 VADFGIAKFLKSD----ASNWTEFAGTYGYVA 216
           VADFG+A+ +         N T       ++A
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  107 bits (269), Expect = 1e-28
 Identities = 34/178 (19%), Positives = 63/178 (35%), Gaps = 11/178 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAELP-SREVVAVKKFHSPLPSDQTVDQ--KEFLTEVKALTE 98
           NDF     IG GG   VY      + ++ A+K         +  +         +  ++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 99  TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADAL 158
                IV              + + +  G L   L+      E   +        +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGL 120

Query: 159 SYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            ++H+     +V+RD+   N+LLD      ++D G+A        + +   GT+GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMA 173

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-28
 Identities = 38/189 (20%), Positives = 78/189 (41%), Gaps = 17/189 (8%)

Query: 36  EIVKATNDFDAKYCIGNGGHASVYRAELPS-----REVVAVKKFHSPLPSDQTVDQKEFL 90
            I+K T +F     +G+G   +VY+          +  VA+K+      +      KE L
Sbjct: 4   RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEIL 59

Query: 91  TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSV 150
            E   +    + ++ +  G C  +    L+ + +  G L   +        +G    ++ 
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNW 116

Query: 151 IKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW--TEF 208
              +A  ++YL       +VHRD++++N+L+       + DFG+AK L ++   +     
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173

Query: 209 AGTYGYVAL 217
                ++AL
Sbjct: 174 KVPIKWMAL 182

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 4e-28
 Identities = 49/169 (28%), Positives = 72/169 (42%), Gaps = 8/169 (4%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFH-SPLPSDQTVDQKEFLTEVKALTETRHRNIVKF 107
           +G G  A+VY+A    + ++VA+KK         +    +  L E+K L E  H NI+  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
                H  +  L+ +F+E      I +       L  S   + +      L YLH     
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
            I+HRD+   NLLLD      +ADFG+AK   S    +T    T  Y A
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 168

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 4e-28
 Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 14/180 (7%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
              +   CIG G    V++    S E     VA+K             +++FL E   + 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMR 63

Query: 98  ETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
           +  H +IVK  G  +     +++ E    G L + L        L  +  +     ++ A
Sbjct: 64  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTA 120

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK-SDASNWTEFAGTYGYVA 216
           L+YL        VHRD++++N+L+       + DFG++++++ S     ++      ++A
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  105 bits (262), Expect = 5e-28
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 8/167 (4%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYG 109
           IG G +  VY+A+    E  A+KK    L  +        + E+  L E +H NIVK Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPI 169
                +   L+ E L++     +   +     L      S +  + + ++Y H      +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRV 121

Query: 170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           +HRD+  +NLL++ E E  +ADFG+A+        +T    T  Y A
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (261), Expect = 1e-27
 Identities = 36/176 (20%), Positives = 65/176 (36%), Gaps = 11/176 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
            DF     +G G    V+      +    A+K     +        +    E   L+   
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVT 62

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H  I++ +G    A+  F++ +++E G L ++L                     A+    
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA------AEVCLA 116

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L +     I++RD+  +N+LLD      + DFG AK++           GT  Y+A
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIA 169

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  103 bits (258), Expect = 1e-27
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 15/184 (8%)

Query: 41  TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           ++ ++    +G GG + V+ A  L     VAVK   + L  D +     F  E +     
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS-FYLRFRREAQNAAAL 64

Query: 100 RHRNIVKFYGFCSHARHS----FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            H  IV  Y        +    +++ E+++  +L  I++T+     +   + + VI    
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADAC 121

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTE---FAGTY 212
            AL++ H      I+HRDV   N+++       V DFGIA+ +    ++ T+     GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 213 GYVA 216
            Y++
Sbjct: 179 QYLS 182

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-27
 Identities = 42/190 (22%), Positives = 82/190 (43%), Gaps = 18/190 (9%)

Query: 35  DEIVKATNDFDAKYCIGNGGHASVYRAELPS-----REVVAVKKFHSPLPSDQTVDQKEF 89
            EI    +    +  IG G    VY+  L +        VA+K   +     Q   + +F
Sbjct: 2   TEI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDF 56

Query: 90  LTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMS 149
           L E   + +  H NI++  G  S  +   ++ E++E G+L   L       E    Q + 
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVG 114

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW---T 206
           +++G+A   + + +      VHRD++++N+L++      V+DFG+++ L+ D       +
Sbjct: 115 MLRGIA---AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 207 EFAGTYGYVA 216
                  + A
Sbjct: 172 GGKIPIRWTA 181

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 4e-27
 Identities = 41/176 (23%), Positives = 67/176 (38%), Gaps = 8/176 (4%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           NDFD    +G G    V       +    A+K     +   +  +    +TE + L  TR
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNTR 63

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
           H  +               + E+   G L   L+ +    E             A+ +S 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSA 117

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           L +     +V+RD+  +NL+LD +    + DFG+ K   SD +    F GT  Y+A
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-27
 Identities = 33/190 (17%), Positives = 74/190 (38%), Gaps = 21/190 (11%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
                   +G G    VY               VA+K  +    +    ++ EFL E   
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 76

Query: 96  LTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNT-------DAAAQELGWSQRM 148
           + E    ++V+  G  S  + + ++ E + RG L + L +       +        S+ +
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWT 206
            +   +AD ++YL+       VHRD++++N ++  ++   + DFG+ + +          
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 207 EFAGTYGYVA 216
           +      +++
Sbjct: 194 KGLLPVRWMS 203

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  100 bits (250), Expect = 2e-26
 Identities = 42/181 (23%), Positives = 75/181 (41%), Gaps = 14/181 (7%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKE-----FLTEVKAL 96
           +++ K  +G G  + V R    P+ +  AVK          + ++ +      L EV  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 97  TETR-HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            +   H NI++           FL+ + +++G L   L        L   +   +++ + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           + +  LH      IVHRD+  +N+LLD +    + DFG +  L        E  GT  Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYL 176

Query: 216 A 216
           A
Sbjct: 177 A 177

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 5e-26
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 10/171 (5%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G +  V  A +  ++  VA+KK     P +     +  L E+K L   RH NI+   
Sbjct: 16  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                     +   +L    + A L      Q L        +  +   L Y+H      
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN---WTEFAGTYGYVA 216
           ++HRD+   NLLL+   +  + DFG+A+    D  +    TE+  T  Y A
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 5e-26
 Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 8/175 (4%)

Query: 43  DFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
           +F     IG G +  VY+A    + EVVA+KK      ++        + E+  L E  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG--VPSTAIREISLLKELNH 60

Query: 102 RNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYL 161
            NIVK           +L+ EFL +     +  +      +      S +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118

Query: 162 HHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
           H      ++HRD+  +NLL++ E    +ADFG+A+        +T    T  Y A
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 3e-25
 Identities = 38/199 (19%), Positives = 75/199 (37%), Gaps = 30/199 (15%)

Query: 42  NDFDAKYCIGNGGHASVYRAELPSR--------EVVAVKKFHSPLPSDQTVDQKEFLTEV 93
           +       +G G    V  AE              VAVK   S        D  + ++E+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEM 69

Query: 94  KALTE-TRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAIL-------------NTDAAA 139
           + +    +H+NI+   G C+     +++ E+  +G+L   L              +    
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 140 QELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK 199
           ++L     +S    VA  + YL        +HRD++++N+L+  +    +ADFG+A+ + 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

Query: 200 SDASNWT--EFAGTYGYVA 216
                           ++A
Sbjct: 187 HIDYYKKTTNGRLPVKWMA 205

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 3e-25
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 13/173 (7%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSD--QTVDQKEFLTEVKALTETR--HRNI 104
           +G+GG  SVY    +     VA+K       SD  +  +      EV  L +       +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71

Query: 105 VKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHD 164
           ++   +        L+ E  E         T+     L      S    V +A+ + H+ 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN- 128

Query: 165 CFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
               ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSP 177

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 4e-25
 Identities = 45/178 (25%), Positives = 74/178 (41%), Gaps = 19/178 (10%)

Query: 43  DFDAKYCIGNGGHASVYRAEL-PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH 101
            +     IGNG    VY+A+L  S E+VA+KK           D++    E++ + +  H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDH 72

Query: 102 RNIVKFYGFCSHA------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVA 155
            NIV+   F   +       +  L+ +++         +   A Q L        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 156 DALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAH-VADFGIAKFLKSDASNWTEFAGTY 212
            +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 4e-25
 Identities = 38/198 (19%), Positives = 72/198 (36%), Gaps = 29/198 (14%)

Query: 42  NDFDAKYCIGNGGHASVYRA------ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKA 95
           +       +G G    V  A      +  +   VAVK            + +  ++E+K 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKI 69

Query: 96  LTETRHR-NIVKFYGFCSHARHS-FLLCEFLERGSLAAILNT-------------DAAAQ 140
           L    H  N+V   G C+       ++ EF + G+L+  L +             D    
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 141 ELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS 200
            L     +     VA  + +L        +HRD++++N+LL  +    + DFG+A+ +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 201 DASNW--TEFAGTYGYVA 216
           D       +      ++A
Sbjct: 187 DPDYVRKGDARLPLKWMA 204

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.7 bits (242), Expect = 5e-25
 Identities = 40/188 (21%), Positives = 78/188 (41%), Gaps = 21/188 (11%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           + ++    IG G    V++A    + + VA+KK    + +++       L E+K L   +
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLK 67

Query: 101 HRNIVKFYGFCSHA--------RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIK 152
           H N+V     C              +L+ +F E      + N      +   S+   V++
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQ 124

Query: 153 GVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK----SDASNWTEF 208
            +   L+ L++     I+HRD+ + N+L+  +    +ADFG+A+       S  + +T  
Sbjct: 125 ML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 209 AGTYGYVA 216
             T  Y  
Sbjct: 182 VVTLWYRP 189

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (238), Expect = 1e-24
 Identities = 39/166 (23%), Positives = 72/166 (43%), Gaps = 9/166 (5%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG G + +V++A+   + E+VA+K+    L  D        L E+  L E +H+NIV+ +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
                 +   L+ EF ++       + +      G      V   +   L  L       
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 169 IVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
           ++HRD+  +NLL++   E  +A+FG+A+        ++    T  Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 2e-24
 Identities = 34/174 (19%), Positives = 65/174 (37%), Gaps = 14/174 (8%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFH--SPLPSDQTVDQKEFLTEVKALTETRHRNIVK 106
           +G+G  A V +  E  +    A K         S + V +++   EV  L E +H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 107 FYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCF 166
            +    +     L+ E +  G L           E          + +   L+ +++   
Sbjct: 78  LHEVYENKTDVILILELVAGGEL------FDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 167 PPIVHRDVSSKNLLLDLE----YEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
             I H D+  +N++L           + DFG+A  +    + +    GT  +VA
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVA 184

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 9e-24
 Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 23/176 (13%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT-ETRHRNIVKF 107
           +G G +  V +     ++E  A+K            D  +   EV+     ++  +IV+ 
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 70

Query: 108 YGFCSHA----RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
                +     +   ++ E L+ G L + +  D   Q     +   ++K + +A+ YLH 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 164 DCFPPIVHRDVSSKNLLLDLEYE---AHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                I HRDV  +NLL   +       + DFG AK   S  S  T    T  YVA
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVA 181

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 2e-23
 Identities = 35/181 (19%), Positives = 69/181 (38%), Gaps = 12/181 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT 97
            +F+    +G G +  V+         + ++ A+K         +    +   TE + L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 98  ETRHR-NIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVAD 156
             R    +V  +          L+ +++  G L   L+      E      +       +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 157 ALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWT-EFAGTYGYV 215
            +  L H     I++RD+  +N+LLD      + DFG++K   +D +    +F GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 216 A 216
           A
Sbjct: 198 A 198

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 3e-23
 Identities = 37/183 (20%), Positives = 71/183 (38%), Gaps = 11/183 (6%)

Query: 36  EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFL 90
           E+ K   +  A Y     +G+G + +V  A +  +   VA+KK + P  S+     K   
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAY 65

Query: 91  TEVKALTETRHRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTD-AAAQELGWSQRMS 149
            E++ L   RH N++      +         +F                 ++LG  +   
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125

Query: 150 VIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFA 209
           ++  +   L Y+H        HRD+   NL ++ + E  + DFG+A+   S+ + +    
Sbjct: 126 LVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182

Query: 210 GTY 212
              
Sbjct: 183 WYR 185

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 90.2 bits (223), Expect = 4e-22
 Identities = 33/175 (18%), Positives = 57/175 (32%), Gaps = 11/175 (6%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           + FD    +G G    V   +   S    A+K              +  L E + L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAVN 99

Query: 101 HRNIVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSY 160
              +VK         + +++ E++  G + + L                    +     Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEY 156

Query: 161 LHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYV 215
           LH      +++RD+  +NLL+D +    V DFG AK             GT   +
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEAL 205

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 89.9 bits (222), Expect = 4e-22
 Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 22/178 (12%)

Query: 42  NDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR 100
           +D+     +G G ++ V+ A  + + E V VK           V +K+   E+K L   R
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLR 87

Query: 101 -HRNIVKFYGFCSH--ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADA 157
              NI+          +R   L+ E +       +       Q L        +  +  A
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKA 141

Query: 158 LSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDASNWTEFAGTYGY 214
           L Y H      I+HRDV   N+++D E  +  + D+G+A+F       +     +  +
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYF 195

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 89.5 bits (221), Expect = 4e-22
 Identities = 31/178 (17%), Positives = 59/178 (33%), Gaps = 22/178 (12%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G    +Y    + + E VA+K               +   E K     +    +   
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTI 68

Query: 109 GFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP 168
            +C       ++   L   SL  + N    +++      + +   +   + Y+H      
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--- 123

Query: 169 IVHRDVSSKNLL---LDLEYEAHVADFGIAKFLKSDASN-------WTEFAGTYGYVA 216
            +HRDV   N L          ++ DFG+AK  +   ++            GT  Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 8e-22
 Identities = 38/188 (20%), Positives = 75/188 (39%), Gaps = 18/188 (9%)

Query: 39  KATNDFDAKYCIGNGGHASVYRAE--LPSREVVAVKKFHSPLPSDQTVDQKEFLTEV--- 93
           +A   ++    IG G +  V++A         VA+K+    + + +       + EV   
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVL 61

Query: 94  KALTETRHRNIVKFYGFCSHAR-----HSFLLCEFLERGSLAAILNTDAAAQELGWSQRM 148
           + L    H N+V+ +  C+ +R        L+ E +++     +         +      
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIK 119

Query: 149 SVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEF 208
            ++  +   L +LH      +VHRD+  +N+L+    +  +ADFG+A+   S     T  
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSV 175

Query: 209 AGTYGYVA 216
             T  Y A
Sbjct: 176 VVTLWYRA 183

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 83.7 bits (206), Expect = 5e-20
 Identities = 31/181 (17%), Positives = 59/181 (32%), Gaps = 26/181 (14%)

Query: 50  IGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRN-IVKF 107
           IG G    ++    L + + VA+K         +  D  +   E +          I   
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 108 YGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFP 167
           Y F     H+ L+ + L       +       ++          K +   +  +H     
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---K 120

Query: 168 PIVHRDVSSKNLLLDLEYEAH-----VADFGIAKFLKSDASN-------WTEFAGTYGYV 215
            +V+RD+   N L+      +     V DFG+ KF +   +            +GT  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 216 A 216
           +
Sbjct: 181 S 181

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 2e-19
 Identities = 42/187 (22%), Positives = 71/187 (37%), Gaps = 19/187 (10%)

Query: 36  EIVKATNDFDAKY----CIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFL 90
           E+ K   +   +Y     +G+G + SV  A    +   VAVKK   P  S      K   
Sbjct: 8   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTY 65

Query: 91  TEVKALTETRHRNIVKFYGFCSHAR-----HSFLLCEFLERGSLAAILNTDAAAQELGWS 145
            E++ L   +H N++      + AR     +   L   L    L  I+      Q+L   
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDD 121

Query: 146 QRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNW 205
               +I  +   L Y+H        HRD+   NL ++ + E  + DFG+A+    + + +
Sbjct: 122 HVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178

Query: 206 TEFAGTY 212
                  
Sbjct: 179 VATRWYR 185

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.7 bits (203), Expect = 2e-19
 Identities = 34/174 (19%), Positives = 65/174 (37%), Gaps = 19/174 (10%)

Query: 50  IGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFY 108
           IG+G    V  A +      VA+KK   P  +      K    E+  +    H+NI+   
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHKNIISLL 82

Query: 109 GFCSHARHS------FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLH 162
              +  +        +L+ E ++      I        EL   +   ++  +   + +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH 136

Query: 163 HDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASNWTEFAGTYGYVA 216
                  +HRD+   N+++  +    + DFG+A+   +     T +  T  Y A
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRA 186

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.5 bits (190), Expect = 2e-18
 Identities = 31/183 (16%), Positives = 56/183 (30%), Gaps = 26/183 (14%)

Query: 50  IGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTV------DQKEFLTEVKALTETRHRN 103
           +G G  ++V+           VK       S + V          F            R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 104 IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH 163
           + K  G      +++      E  ++   L        +       V+  + + ++  +H
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 164 DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK---------FLKSDASNWTE-FAGTYG 213
                IVH D+S  N+L+  E    + DF  +           L+ D  N    F+ TY 
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYR 177

Query: 214 YVA 216
              
Sbjct: 178 TEK 180

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 65.4 bits (158), Expect = 3e-13
 Identities = 34/193 (17%), Positives = 69/193 (35%), Gaps = 28/193 (14%)

Query: 45  DAKY----CIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET 99
           DA+Y     +G G  ++V+ A+ + +   VA+K           V  +    E+K L   
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRV 66

Query: 100 RHRN-----------IVKFYGFCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWS--Q 146
              +           I+K     +H   + +    +       +L      +  G     
Sbjct: 67  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126

Query: 147 RMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE-YEAHVADFGIAKFLKSDAS-- 203
              + K +   L Y+H  C   I+H D+  +N+L+++     ++    IA    +     
Sbjct: 127 VKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184

Query: 204 NWTEFAGTYGYVA 216
           ++T    T  Y +
Sbjct: 185 HYTNSIQTREYRS 197

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	219
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.98
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.98
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.59
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.08
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.78
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.59
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.46
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.41

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-41  Score=263.31  Aligned_cols=168  Identities=23%  Similarity=0.434  Sum_probs=148.5

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+|+.||+|++....    ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc----ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            457999999999999999999 46689999999986422    1234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||+++|+|.+++...    .+++..+..++.|++.|+.|||++   +|+||||||+|||++.+|.+||+|||+++.+.
T Consensus        95 vmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            99999999999987542    378899999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .........+||+.|+|||+
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~  187 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEV  187 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHH
T ss_pred             cccccccccccCCCccChhh
Confidence            65555566789999999994

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=264.09  Aligned_cols=170  Identities=26%  Similarity=0.388  Sum_probs=145.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+......   .....+.+|+.++++++||||+++++++.+++..|+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence            578999999999999999999 4568999999998643211   223457899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||+++|+|.+++....   .+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        81 vmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            999999999999986543   388999999999999999999999   99999999999999999999999999999775


Q ss_pred             CCC--CcccccccccccccCCC
Q 039002          200 SDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ...  ......+||+.|+|||+
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~  176 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPEL  176 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHH
T ss_pred             cCCccccccceeeCcCccCHhH
Confidence            432  22345689999999994

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=261.64  Aligned_cols=171  Identities=26%  Similarity=0.407  Sum_probs=147.3

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      +.+.|++.+.||+|+||.||+| ...+++.||+|.+....    ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            3467999999999999999999 56688999999986432    223356788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +||||+++|+|.+++....  ..+++..+..++.|++.|+.|||++   +|+||||||+|||++.+|.+||+|||+++..
T Consensus        86 lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhcc
Confidence            9999999999999875432  2378899999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+||+.|+|||+
T Consensus       161 ~~~~~~~~~~~Gt~~y~APE~  181 (288)
T d2jfla1         161 TRTIQRRDSFIGTPYWMAPEV  181 (288)
T ss_dssp             HHHHHHHTCCCSCCTTCCHHH
T ss_pred             CCCcccccccccccccCCHHH
Confidence            544333345689999999994

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-40  Score=255.79  Aligned_cols=170  Identities=28%  Similarity=0.456  Sum_probs=146.7

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++.+.||+|+||.||+| ...+++.||+|.+...... +......+.+|+.+++.++||||+++++++.+++..|+
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            468999999999999999999 5568889999987532111 12234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||+++|+|.+++....   .+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 vmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence            999999999999987543   388899999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...  .....||+.|+|||+
T Consensus       158 ~~~--~~~~~Gt~~Y~APE~  175 (263)
T d2j4za1         158 SSR--RTTLCGTLDYLPPEM  175 (263)
T ss_dssp             CCC--CEETTEEGGGCCHHH
T ss_pred             CCc--ccccCCCCcccCHHH
Confidence            432  345689999999994

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-40  Score=262.86  Aligned_cols=173  Identities=25%  Similarity=0.312  Sum_probs=150.8

Q ss_pred             HhCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           40 ATNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      .+++|++++.||+|+||.||+| ...+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            3578999999999999999999 5678999999998542111 1123456789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +||||+++|+|..++...+   .+++..+..++.|++.|+.|+|++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus        82 iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             cceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence            9999999999999987643   378888999999999999999999   9999999999999999999999999999977


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+||+.|+|||+
T Consensus       156 ~~~~~~~~~~~GT~~Y~aPE~  176 (337)
T d1o6la_         156 ISDGATMKTFCGTPEYLAPEV  176 (337)
T ss_dssp             CCTTCCBCCCEECGGGCCGGG
T ss_pred             ccCCcccccceeCHHHhhhhh
Confidence            665555567899999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-40  Score=264.46  Aligned_cols=168  Identities=27%  Similarity=0.408  Sum_probs=145.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.++...   .......+.+|+.+++.++||||++++++|.+.+++++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            468999999999999999999 46688999999986532   22344678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      ||||+.+|+|.+++...+   .+++..+..++.|++.|+.|||+ +   +|+||||||+|||++.+|.+||+|||+|+.+
T Consensus        82 VmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999997543   38889999999999999999996 5   8999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....  ....+||+.|+|||+
T Consensus       156 ~~~~--~~~~~GT~~Y~APEv  174 (322)
T d1s9ja_         156 IDSM--ANSFVGTRSYMSPER  174 (322)
T ss_dssp             HHHT--C---CCSSCCCCHHH
T ss_pred             CCCc--cccccCCccccCchH
Confidence            5432  245699999999994

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-40  Score=255.56  Aligned_cols=177  Identities=24%  Similarity=0.403  Sum_probs=134.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe--CCcc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH--ARHS  117 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  117 (219)
                      .++|++.+.||+|+||.||+| ...+|+.||+|.+.....  .......+.+|+.+++.++||||+++++++.+  .+.+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            367999999999999999999 567899999999865432  23345668899999999999999999999864  4568


Q ss_pred             eEEEEecCCCCHHHHhcccc-hhhccCHHHHHHHHHHHHHHHHhhhhCCC--CCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          118 FLLCEFLERGSLAAILNTDA-AAQELGWSQRMSVIKGVADALSYLHHDCF--PPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      |++|||+++|+|.+++.... ....+++..++.++.|++.|+.|||++..  .+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            99999999999999986432 12348899999999999999999998610  1399999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.+..........+||+.|+|||+
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~  185 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQ  185 (269)
T ss_dssp             HHHC-----------CCCSCCCHHH
T ss_pred             eeecccCCCccccCCCCcccCCHHH
Confidence            9887655444456799999999994

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-39  Score=257.26  Aligned_cols=167  Identities=26%  Similarity=0.407  Sum_probs=143.9

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ..|+.++.||+|+||.||+| ...+++.||||.+...... .......+.+|+.+++.++||||+++++++.+.+..|++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            45899999999999999999 5678889999998653222 233446688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      ||||.+|++..+....   ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999887666543   2388999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      .    ....||+.|+|||+
T Consensus       168 ~----~~~~GT~~Y~APE~  182 (309)
T d1u5ra_         168 A----NSFVGTPYWMAPEV  182 (309)
T ss_dssp             B----CCCCSCGGGCCHHH
T ss_pred             C----CccccCccccCHHH
Confidence            2    34689999999994

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=256.69  Aligned_cols=171  Identities=23%  Similarity=0.350  Sum_probs=143.7

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            57999999999999999999 4568999999987532111 112345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      |||+++|+|.+++...+   .+++..+..++.|++.|+.|+|++   +|+||||||+||+++.+|.+||+|||+|+.+..
T Consensus        87 mEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999886543   388899999999999999999999   999999999999999999999999999998753


Q ss_pred             CC--CcccccccccccccCCC
Q 039002          201 DA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~--~~~~~~~gt~~y~aPE~  219 (219)
                      ..  ......+||+.|+|||+
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~  181 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPEL  181 (288)
T ss_dssp             ---------CCCCGGGCCHHH
T ss_pred             CCcccccccccCCccccCcee
Confidence            32  22345689999999994

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-39  Score=252.46  Aligned_cols=172  Identities=25%  Similarity=0.437  Sum_probs=140.6

Q ss_pred             HHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           38 VKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        38 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ....++|++.+.||+|+||.||+|....  .||||.++.....  ......+.+|+.++++++||||+++++++. .+..
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~   78 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL   78 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence            3456889999999999999999997643  5999998654322  334567889999999999999999999864 4678


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++|||+++|+|.+++....  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence            99999999999999986433  2378899999999999999999998   999999999999999999999999999987


Q ss_pred             ecCCC--CcccccccccccccCCC
Q 039002          198 LKSDA--SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~--~~~~~~~gt~~y~aPE~  219 (219)
                      .....  .......||+.|+|||+
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~  177 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEV  177 (276)
T ss_dssp             ------------CCCCGGGCCHHH
T ss_pred             ccccCCcccccccccCcccCCHHH
Confidence            64322  22345689999999994

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-39  Score=256.52  Aligned_cols=174  Identities=24%  Similarity=0.397  Sum_probs=147.6

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      |....++|++.+.||+|+||.||+|. ..+++.||+|+++...     ...+.+.+|+.+++.++||||+++++++.+++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            33445789999999999999999995 5578899999986421     23456889999999999999999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++|||+++|++.+++..... ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eeEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence            99999999999999999864322 3478889999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCc-ccccccccccccCCC
Q 039002          196 KFLKSDASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~-~~~~~gt~~y~aPE~  219 (219)
                      +........ .....|++.|+|||+
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~  187 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPES  187 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHH
T ss_pred             eecCCCCceeeccccccccccChHH
Confidence            876544322 233468899999984

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-39  Score=250.96  Aligned_cols=173  Identities=19%  Similarity=0.383  Sum_probs=146.8

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      |..+.++|++.+.||+|+||.||+|...+++.||||++....     .....+.+|+.++++++||||+++++++.+ +.
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~   81 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence            444567899999999999999999988888889999986421     234568999999999999999999998754 66


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++||||+++|+|.+++..... ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence            8999999999999998765432 3488999999999999999999998   99999999999999999999999999999


Q ss_pred             eecCCCC-cccccccccccccCCC
Q 039002          197 FLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      ....... ......||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~  181 (272)
T d1qpca_         158 LIEDNEYTAREGAKFPIKWTAPEA  181 (272)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHH
T ss_pred             EccCCccccccccCCcccccChHH
Confidence            8754332 2234578999999994

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-39  Score=248.59  Aligned_cols=168  Identities=22%  Similarity=0.403  Sum_probs=136.3

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      ++|++.+.||+|+||.||+|...+++.||||++...     ......+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            578999999999999999998878888999998642     223456899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+++|+|.+++....  ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        80 E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            9999999999886543  2377888999999999999999999   9999999999999999999999999999877544


Q ss_pred             CCc-ccccccccccccCCC
Q 039002          202 ASN-WTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~-~~~~~gt~~y~aPE~  219 (219)
                      ... .....||+.|+|||+
T Consensus       155 ~~~~~~~~~gt~~y~aPE~  173 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEV  173 (263)
T ss_dssp             ----------CTTSCCHHH
T ss_pred             CceeecceecCcccCChHH
Confidence            322 234578999999994

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-38  Score=255.10  Aligned_cols=169  Identities=20%  Similarity=0.362  Sum_probs=146.8

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++.+.||+|+||.||+| ...+|+.||+|.+...    .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            468999999999999999999 4678999999998642    22345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC--CCcEEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL--EYEAHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~  197 (219)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||.|||++   +++||||||+|||++.  ++.+||+|||+++.
T Consensus       101 vmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            999999999999985432  2388999999999999999999999   9999999999999964  57899999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.... ......||+.|||||+
T Consensus       176 ~~~~~-~~~~~~gT~~Y~aPEv  196 (350)
T d1koaa2         176 LDPKQ-SVKVTTGTAEFAAPEV  196 (350)
T ss_dssp             CCTTS-CEEEECSCTTTCCHHH
T ss_pred             ccccc-ccceecCcccccCHHH
Confidence            75443 3355789999999994

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.2e-39  Score=255.07  Aligned_cols=169  Identities=24%  Similarity=0.366  Sum_probs=145.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++.+.||+|+||.||+|. ..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            5789999999999999999994 568999999998532111 12234667899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||+.+|++..++....   .+++..+..++.|++.|+.|+|++   +|+||||||+|||++.+|.+||+|||+|+...
T Consensus        82 vmE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             EECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence            999999999999887543   367788888999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...   ...+||+.|+|||+
T Consensus       156 ~~~---~~~~Gt~~Y~APE~  172 (316)
T d1fota_         156 DVT---YTLCGTPDYIAPEV  172 (316)
T ss_dssp             SCB---CCCCSCTTTCCHHH
T ss_pred             ccc---ccccCcccccCHHH
Confidence            432   35689999999994

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-38  Score=246.19  Aligned_cols=168  Identities=22%  Similarity=0.369  Sum_probs=139.9

Q ss_pred             CCC-CCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe----CC
Q 039002           42 NDF-DAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH----AR  115 (219)
Q Consensus        42 ~~y-~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~  115 (219)
                      ++| ++.++||+|+||.||+| ...+++.||+|.+......  ......+.+|+.+++.++||||+++++++.+    ..
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            444 66778999999999999 5567889999998653222  2334568899999999999999999999865    34


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCC--eEecCCCCCCEEeC-CCCcEEEeec
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPP--IVHRDVSSKNLLLD-LEYEAHVADF  192 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~nili~-~~~~~kl~df  192 (219)
                      .+|++|||+++|+|.+++....   .+++..+..++.|++.|+.|||++   +  |+||||||+|||++ .++.+||+||
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            5899999999999999986543   378889999999999999999998   6  99999999999996 5789999999


Q ss_pred             cceeeecCCCCcccccccccccccCCC
Q 039002          193 GIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |+++.....  .....+||+.|+|||+
T Consensus       160 Gla~~~~~~--~~~~~~GT~~Y~aPE~  184 (270)
T d1t4ha_         160 GLATLKRAS--FAKAVIGTPEFMAPEM  184 (270)
T ss_dssp             TGGGGCCTT--SBEESCSSCCCCCGGG
T ss_pred             CcceeccCC--ccCCcccCccccCHHH
Confidence            999754333  2345789999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-38  Score=252.84  Aligned_cols=169  Identities=25%  Similarity=0.378  Sum_probs=129.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .+.|++.+.||+|+||.||+| ...+++.||+|.+......   .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            356999999999999999999 4568899999998653322   123457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC---CCCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD---LEYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~  196 (219)
                      ||||+++|+|.+++...+   .+++..+..++.|++.|+.|||++   +++||||||+||++.   .++.+||+|||+++
T Consensus        85 vmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999999997543   388999999999999999999999   999999999999995   46899999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...... .....+||+.|+|||+
T Consensus       159 ~~~~~~-~~~~~~GT~~y~APE~  180 (307)
T d1a06a_         159 MEDPGS-VLSTACGTPGYVAPEV  180 (307)
T ss_dssp             ---------------CTTSCHHH
T ss_pred             EccCCC-eeeeeeeCccccCcHH
Confidence            664332 2345689999999994

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.9e-38  Score=253.06  Aligned_cols=169  Identities=20%  Similarity=0.340  Sum_probs=146.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| +..+++.||+|.+...    .......+.+|+.+++.++||||++++++|.+++.+|+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            367999999999999999999 5678999999998642    22334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeC--CCCcEEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLD--LEYEAHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~--~~~~~kl~dfg~~~~  197 (219)
                      |||||++|+|.+.+....  ..+++..+..++.|++.||.|||++   +|+||||||+|||++  .++.+||+|||+|+.
T Consensus       104 vmE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         104 ILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence            999999999998876543  2388999999999999999999999   999999999999998  568999999999988


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +.... ......||+.|+|||+
T Consensus       179 ~~~~~-~~~~~~gt~~y~aPE~  199 (352)
T d1koba_         179 LNPDE-IVKVTTATAEFAAPEI  199 (352)
T ss_dssp             CCTTS-CEEEECSSGGGCCHHH
T ss_pred             cCCCC-ceeeccCcccccCHHH
Confidence            76443 2345689999999984

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=245.82  Aligned_cols=171  Identities=23%  Similarity=0.339  Sum_probs=146.9

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCC--chhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcce
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSD--QTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      +.|++.+.||+|+||.||+| ...+|+.||+|.+.......  .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999 45789999999986533222  1223567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC----cEEEeeccc
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY----EAHVADFGI  194 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~----~~kl~dfg~  194 (219)
                      +||||+++|+|.+++...+   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++    .+|++|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999987543   388899999999999999999999   999999999999998776    599999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +....... ......||+.|+|||+
T Consensus       164 a~~~~~~~-~~~~~~~t~~y~APE~  187 (293)
T d1jksa_         164 AHKIDFGN-EFKNIFGTPEFVAPEI  187 (293)
T ss_dssp             CEECTTSC-BCSCCCCCGGGCCHHH
T ss_pred             hhhcCCCc-cccccCCCCcccCHHH
Confidence            98775443 2345689999999994

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.9e-37  Score=241.50  Aligned_cols=171  Identities=25%  Similarity=0.393  Sum_probs=147.8

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCch-----hhHHHHHHHHHHHhcCC-CCccceeEeEEEeC
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQT-----VDQKEFLTEVKALTETR-HRNIVKFYGFCSHA  114 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~-----~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  114 (219)
                      ++|++.+.||+|+||.||+| ...+++.+|+|++.........     .....+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999 4568899999998654332211     12245788999999997 99999999999999


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      +.+|++|||+++|+|.+++...+   .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997543   388999999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.+..... ....+||+.|+|||+
T Consensus       157 a~~~~~~~~-~~~~~gt~~y~~PE~  180 (277)
T d1phka_         157 SCQLDPGEK-LREVCGTPSYLAPEI  180 (277)
T ss_dssp             CEECCTTCC-BCCCCSCGGGCCHHH
T ss_pred             eeEccCCCc-eeeeeccCCCCCHHH
Confidence            998755432 345689999999984

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-37  Score=239.17  Aligned_cols=168  Identities=23%  Similarity=0.416  Sum_probs=146.2

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEE
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLC  121 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  121 (219)
                      ++|++.++||+|+||.||+|..+++..||||.++...     .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            6899999999999999999988888899999987532     23356899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||+++|++..++....  ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            9999999999876543  2377888999999999999999998   9999999999999999999999999999876544


Q ss_pred             CC-cccccccccccccCCC
Q 039002          202 AS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~-~~~~~~gt~~y~aPE~  219 (219)
                      .. ......||+.|+|||+
T Consensus       154 ~~~~~~~~~~t~~y~aPE~  172 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEV  172 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHH
T ss_pred             CceeecccCCCCCcCCcHH
Confidence            32 2234678999999994

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-38  Score=250.20  Aligned_cols=172  Identities=23%  Similarity=0.322  Sum_probs=145.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHH-hcCCCCccceeEeEEEeCCcce
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKAL-TETRHRNIVKFYGFCSHARHSF  118 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~~~~~~  118 (219)
                      .++|++.+.||+|+||.||+| ...+++.||+|.+....... ......+..|..++ +.++||||+++++++.+++.+|
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence            368999999999999999999 56689999999985321111 11234455666655 5789999999999999999999


Q ss_pred             EEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          119 LLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       119 lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                      +||||+++|+|.+++....   .+++..+..++.|++.|+.|||++   +++||||||+|||++..+.+|++|||+++..
T Consensus        80 ivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhc
Confidence            9999999999999997543   378889999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCCCcccccccccccccCCC
Q 039002          199 KSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       199 ~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ...........||+.|+|||+
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~  174 (320)
T d1xjda_         154 MLGDAKTNTFCGTPDYIAPEI  174 (320)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHH
T ss_pred             ccccccccccCCCCCcCCHHH
Confidence            655555566789999999994

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-38  Score=252.53  Aligned_cols=169  Identities=21%  Similarity=0.250  Sum_probs=146.4

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++++.||+|+||.||+| ...+|+.||+|.+...... .......+.+|+.+++.++||||+++++++...+..++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            367999999999999999999 5668999999987532111 11234567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.+|++...+...+   .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       119 v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            999999999999986543   388899999999999999999999   99999999999999999999999999999875


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..   .....||+.|||||+
T Consensus       193 ~~---~~~~~Gt~~Y~APE~  209 (350)
T d1rdqe_         193 GR---TWTLCGTPEALAPEI  209 (350)
T ss_dssp             SC---BCCCEECGGGCCHHH
T ss_pred             cc---cccccCccccCCHHH
Confidence            43   245689999999994

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-37  Score=245.11  Aligned_cols=171  Identities=25%  Similarity=0.438  Sum_probs=131.9

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCc---EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSRE---VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~---~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.. .+++   .||+|.+...   ......+.+.+|+.++++++||||+++++++...+.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            35688889999999999999954 3332   5888987542   223345678999999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+++|+|.+++....  ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccce
Confidence            999999999999999886543  2378899999999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCCcc-----cccccccccccCCC
Q 039002          197 FLKSDASNW-----TEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~-----~~~~gt~~y~aPE~  219 (219)
                      .+.......     ....||+.|+|||+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~  204 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEA  204 (299)
T ss_dssp             -------------------CGGGSCHHH
T ss_pred             EccCCCCcceeeecccccCCccccCHHH
Confidence            765432211     12357899999984

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-37  Score=252.27  Aligned_cols=170  Identities=20%  Similarity=0.235  Sum_probs=141.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHH---HHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLT---EVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      +++|++.+.||+|+||.||+| ...+|+.||+|.+....... ......+.+   ++.+++.++||||+++++++.+.+.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch-hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            578999999999999999999 46689999999874311110 111222333   4667778899999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +|+||||+++|+|.+++....   .+++..+..++.|++.|+.|||++   +++||||||+|||++.+|.+||+|||+|+
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            999999999999999987543   377888999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCCC
Q 039002          197 FLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      .+....  ....+||+.|+|||+
T Consensus       156 ~~~~~~--~~~~~GT~~y~APE~  176 (364)
T d1omwa3         156 DFSKKK--PHASVGTHGYMAPEV  176 (364)
T ss_dssp             ECSSSC--CCSCCSCGGGCCHHH
T ss_pred             ecCCCc--ccccccccccchhHH
Confidence            775443  345689999999994

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-37  Score=243.99  Aligned_cols=171  Identities=26%  Similarity=0.339  Sum_probs=143.2

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++++.||+|+||.||+| ...+++.||+|.++.....  ......+.+|+.++++++||||+++++++.+++..++
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            368999999999999999999 5678999999998654322  2234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +||++.++.+........  ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.+|++|||+++...
T Consensus        79 v~e~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EEECCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             EEeecCCchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceecc
Confidence            999997644443333222  3488999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCcccccccccccccCC
Q 039002          200 SDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE  218 (219)
                      .+........||+.|+|||
T Consensus       154 ~~~~~~~~~~gt~~y~apE  172 (298)
T d1gz8a_         154 VPVRTYTHEVVTLWYRAPE  172 (298)
T ss_dssp             CCSBCTTCCBCCCTTCCHH
T ss_pred             CCcccceeecccceeeehh
Confidence            6655556678999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-37  Score=246.19  Aligned_cols=177  Identities=22%  Similarity=0.355  Sum_probs=142.8

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEc-CCC-----cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAEL-PSR-----EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~-~~~-----~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      |..+.++|++.+.||+|+||.||+|.. ..+     ..||+|.+....   .......+.+|+.+++++ +||||+++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            334567899999999999999999953 222     368999876432   222345678899999988 8999999999


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhcccch--------------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCe
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTDAA--------------------AQELGWSQRMSVIKGVADALSYLHHDCFPPI  169 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  169 (219)
                      ++.+.+..++||||+++|+|.+++.....                    ...+++..+..++.|++.|+.|||++   +|
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~I  185 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC  185 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            99999999999999999999999964321                    12377888999999999999999999   99


Q ss_pred             EecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc--ccccccccccccCCC
Q 039002          170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       170 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      +||||||+||+++.++.+||+|||+|+........  .....||+.|||||+
T Consensus       186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  237 (325)
T d1rjba_         186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  237 (325)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHH
Confidence            99999999999999999999999999876554332  234578999999994

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=243.64  Aligned_cols=170  Identities=21%  Similarity=0.409  Sum_probs=138.9

Q ss_pred             HhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      ..++|++.+.||+|+||.||+|...+++.||||.+....     .....+.+|+.++++++|+||+++++++. .+..++
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~l   88 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   88 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEE
Confidence            357899999999999999999987777789999986422     23456899999999999999999999985 466899


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      ||||+.+|++..++..... ..+++..+..++.|++.|+.|||..   +++||||||+||+++.++.+||+|||+++...
T Consensus        89 v~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence            9999999999988865432 3488999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCC-CcccccccccccccCCC
Q 039002          200 SDA-SNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~-~~~~~~~gt~~y~aPE~  219 (219)
                      ... .......||+.|+|||+
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~  185 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEA  185 (285)
T ss_dssp             -----------CCGGGSCHHH
T ss_pred             CCCceeeccccccccccChHH
Confidence            332 22233578999999984

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-36  Score=240.68  Aligned_cols=168  Identities=24%  Similarity=0.320  Sum_probs=145.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      .++|++.+.||+|+||.||+| +..+++.||+|.++..     ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            368999999999999999999 5668889999998642     2234557899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCC--CcEEEeeccceee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLE--YEAHVADFGIAKF  197 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~--~~~kl~dfg~~~~  197 (219)
                      |||||.+++|.+++...+  ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+  ..++++|||++..
T Consensus        79 vmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence            999999999999997543  2378999999999999999999999   99999999999999854  5899999999987


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..... ......+|+.|+|||.
T Consensus       154 ~~~~~-~~~~~~~t~~y~ape~  174 (321)
T d1tkia_         154 LKPGD-NFRLLFTAPEYYAPEV  174 (321)
T ss_dssp             CCTTC-EEEEEESCGGGSCHHH
T ss_pred             cccCC-cccccccccccccchh
Confidence            65432 3345689999999983

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-37  Score=239.45  Aligned_cols=170  Identities=24%  Similarity=0.424  Sum_probs=135.6

Q ss_pred             CCCCCcceeccccceeEEEEEcCC-C----cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPS-R----EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~-~----~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      ++|+..+.||+|+||.||+|.+.. +    ..||||++...   ........+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            568889999999999999995432 2    36999998642   223344568899999999999999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++||++.++++.+.+....  ..+++..+..++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            999999999999998876543  2478899999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc---ccccccccccccCCC
Q 039002          197 FLKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      ........   .....||+.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~  184 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEA  184 (283)
T ss_dssp             ---------------CCCGGGSCHHH
T ss_pred             cccCCCccceEeccCCCCccccCHHH
Confidence            76543221   233468999999994

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-37  Score=242.08  Aligned_cols=168  Identities=30%  Similarity=0.359  Sum_probs=137.7

Q ss_pred             CcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCc-hhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEe
Q 039002           46 AKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQ-TVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEF  123 (219)
Q Consensus        46 ~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  123 (219)
                      .++.||+|+||.||+|. ..+++.||||+++....... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999995 56789999999865322211 11234578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCC
Q 039002          124 LERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS  203 (219)
Q Consensus       124 ~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  203 (219)
                      +.++++..+.....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            98877776665332   377888999999999999999999   999999999999999999999999999987765554


Q ss_pred             cccccccccccccCCC
Q 039002          204 NWTEFAGTYGYVALGI  219 (219)
Q Consensus       204 ~~~~~~gt~~y~aPE~  219 (219)
                      .....+||+.|+|||+
T Consensus       156 ~~~~~~gt~~y~aPE~  171 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPEL  171 (299)
T ss_dssp             CCCCSCCCCTTCCHHH
T ss_pred             cccceecChhhccHHH
Confidence            4455689999999994

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-36  Score=237.41  Aligned_cols=169  Identities=24%  Similarity=0.345  Sum_probs=139.9

Q ss_pred             CCCCCcc-eeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcc
Q 039002           42 NDFDAKY-CIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHS  117 (219)
Q Consensus        42 ~~y~~~~-~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  117 (219)
                      ++|.+.+ +||+|+||.||+|...   ++..||||.++..   ......+.+.+|+.++++++||||+++++++.+ +..
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            4566666 4999999999999532   4457999998643   223445678999999999999999999999865 568


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            99999999999999875432  2478899999999999999999999   999999999999999999999999999998


Q ss_pred             ecCCCCc---ccccccccccccCCC
Q 039002          198 LKSDASN---WTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~---~~~~~gt~~y~aPE~  219 (219)
                      +......   .....||+.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~  183 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPEC  183 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHH
T ss_pred             ccccccccccccccccCccccChHH
Confidence            7543321   233478999999994

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-36  Score=235.30  Aligned_cols=163  Identities=24%  Similarity=0.366  Sum_probs=133.4

Q ss_pred             ceeccccceeEEEEEcC---CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEEEEec
Q 039002           48 YCIGNGGHASVYRAELP---SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLLCEFL  124 (219)
Q Consensus        48 ~~lg~g~~g~V~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  124 (219)
                      ++||+|+||.||+|.+.   +++.||+|.++....  +......+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence            47999999999999532   456799999865332  22345678999999999999999999999865 4578999999


Q ss_pred             CCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCCCCc
Q 039002          125 ERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDASN  204 (219)
Q Consensus       125 ~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  204 (219)
                      ++|+|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||+++.+......
T Consensus        90 ~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          90 ELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             TTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            9999999987543   388899999999999999999998   9999999999999999999999999999877544322


Q ss_pred             ---ccccccccccccCCC
Q 039002          205 ---WTEFAGTYGYVALGI  219 (219)
Q Consensus       205 ---~~~~~gt~~y~aPE~  219 (219)
                         .....||+.|+|||.
T Consensus       164 ~~~~~~~~gt~~y~APE~  181 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPEC  181 (277)
T ss_dssp             EEC----CCCGGGCCHHH
T ss_pred             cccccccCCCceecCchh
Confidence               133578999999993

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.5e-36  Score=235.55  Aligned_cols=171  Identities=25%  Similarity=0.393  Sum_probs=138.6

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----c
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----H  116 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~  116 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|.++.....+ ......+.+|+.+++.++||||+++++++...+    .
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            67999999999999999999 56789999999987644333 334567889999999999999999999997654    3


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      +|+||||+++++|..++...+   .+++..+..++.|++.|+.|||++   +++||||||+||+++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999886543   378899999999999999999998   99999999999999999999999999987


Q ss_pred             eecCCCC---cccccccccccccCCC
Q 039002          197 FLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      .......   .....+||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~  185 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQ  185 (277)
T ss_dssp             ECC----------------TTCCHHH
T ss_pred             hhccccccccccccccCcccccCHHH
Confidence            6643322   2344689999999994

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-36  Score=239.86  Aligned_cols=165  Identities=25%  Similarity=0.328  Sum_probs=138.5

Q ss_pred             hCCCCCcc-eeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHh-cCCCCccceeEeEEEe----
Q 039002           41 TNDFDAKY-CIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALT-ETRHRNIVKFYGFCSH----  113 (219)
Q Consensus        41 ~~~y~~~~-~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~----  113 (219)
                      .++|++.. .||+|+||.||+| ...+++.||||.+..         ...+.+|+.++. ..+||||++++++|.+    
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            47899876 5999999999999 567899999999852         134667888765 4589999999999875    


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEe
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVA  190 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~  190 (219)
                      .+.+|++||||++|+|.+++...+. ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.   .+.+||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            3568999999999999999975432 3478899999999999999999999   9999999999999985   4679999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||+++....... ....+||+.|+|||+
T Consensus       157 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~  184 (335)
T d2ozaa1         157 DFGFAKETTSHNS-LTTPCYTPYYVAPEV  184 (335)
T ss_dssp             CCTTCEECCCCCC-CCCCSCCCSSCCCCC
T ss_pred             ccceeeeccCCCc-cccccCCcccCCcHH
Confidence            9999987765433 355689999999995

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.5e-36  Score=237.40  Aligned_cols=171  Identities=25%  Similarity=0.344  Sum_probs=142.7

Q ss_pred             hCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceEE
Q 039002           41 TNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFLL  120 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  120 (219)
                      +++|++.++||+|+||.||+|...+++.||+|++.....  .......+.+|+.++++++||||+++++++.+.+..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            368999999999999999999778899999999865432  223346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecC
Q 039002          121 CEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKS  200 (219)
Q Consensus       121 ~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  200 (219)
                      +|++.++.+..+....   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|++|||.+.....
T Consensus        79 ~e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             EECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EEeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            9999877776666543   3488999999999999999999998   999999999999999999999999999987665


Q ss_pred             CCCcccccccccccccCCC
Q 039002          201 DASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       201 ~~~~~~~~~gt~~y~aPE~  219 (219)
                      +........+++.|+|||+
T Consensus       153 ~~~~~~~~~~~~~y~~pE~  171 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDV  171 (286)
T ss_dssp             ---------CCCTTCCHHH
T ss_pred             CccccceecccchhhhHHH
Confidence            5444455689999999983

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-36  Score=234.04  Aligned_cols=171  Identities=24%  Similarity=0.345  Sum_probs=141.0

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchh--hHHHHHHHHHHHhcCC--CCccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTV--DQKEFLTEVKALTETR--HRNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~--~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~  115 (219)
                      .++|++.+.||+|+||.||+| +..+++.||+|.+......+...  ....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            368999999999999999999 56789999999986533222111  1123457999999986  899999999999999


Q ss_pred             cceEEEEecCC-CCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-CCcEEEeecc
Q 039002          116 HSFLLCEFLER-GSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-EYEAHVADFG  193 (219)
Q Consensus       116 ~~~lv~e~~~~-~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-~~~~kl~dfg  193 (219)
                      ..+++||++.+ +++.+++....   .+++..+..++.|++.|+.|||++   +++||||||+||+++. .+.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            99999999975 67777775432   378899999999999999999999   9999999999999985 4799999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++......  ....+||+.|+|||+
T Consensus       157 ~a~~~~~~~--~~~~~GT~~y~aPE~  180 (273)
T d1xwsa_         157 SGALLKDTV--YTDFDGTRVYSPPEW  180 (273)
T ss_dssp             TCEECCSSC--BCCCCSCGGGSCHHH
T ss_pred             cceeccccc--ccccccCCCcCCHHH
Confidence            998764432  345789999999994

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-36  Score=233.27  Aligned_cols=171  Identities=20%  Similarity=0.349  Sum_probs=131.1

Q ss_pred             HhCCCCCcceeccccceeEEEEEcC----CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC
Q 039002           40 ATNDFDAKYCIGNGGHASVYRAELP----SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR  115 (219)
Q Consensus        40 ~~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  115 (219)
                      +.++|++.+.||+|+||.||+|...    .+..||+|.++..   ........+.+|+.+++.++||||+++++++. .+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            4578999999999999999999543    2346889887542   23334567889999999999999999999985 46


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++|||+++|++.+++....  ..+++..+..++.|++.|+.|+|++   +++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             eEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence            7999999999999999875432  2378899999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC-cccccccccccccCCC
Q 039002          196 KFLKSDAS-NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~-~~~~~~gt~~y~aPE~  219 (219)
                      +.+..... ......||+.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~  180 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPES  180 (273)
T ss_dssp             ---------------CCGGGCCHHH
T ss_pred             eeccCCcceeccceecCcccchhhH
Confidence            87654322 2234578999999984

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-35  Score=233.42  Aligned_cols=177  Identities=25%  Similarity=0.395  Sum_probs=145.2

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeE
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGF  110 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  110 (219)
                      +..+.++|++.+.||+|+||.||+|++.      +++.||||++....   .......+.+|+.+++.++||||++++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3345678999999999999999999542      45689999986432   23345678999999999999999999999


Q ss_pred             EEeCCcceEEEEecCCCCHHHHhcccc---------------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCe
Q 039002          111 CSHARHSFLLCEFLERGSLAAILNTDA---------------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPI  169 (219)
Q Consensus       111 ~~~~~~~~lv~e~~~~~~l~~~~~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i  169 (219)
                      +...+..++++|++.+|+|.+++....                     ....+++..+..++.|++.|+.|+|+.   ++
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence            999999999999999999999885311                     112367888999999999999999999   99


Q ss_pred             EecCCCCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          170 VHRDVSSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       170 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      +||||||+||+++.++.+||+|||+++.......  ......||+.|+|||+
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  213 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence            9999999999999999999999999986643321  2234678899999984

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-35  Score=232.11  Aligned_cols=179  Identities=21%  Similarity=0.336  Sum_probs=135.9

Q ss_pred             HHHHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCcccee
Q 039002           35 DEIVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKF  107 (219)
Q Consensus        35 ~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  107 (219)
                      ++|..+.++|++.+.||+|+||.||+|...      +++.||+|.++...   .......+.+|...+.++ +|+||+.+
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            455566788999999999999999999531      34679999986422   223345667777777766 68899999


Q ss_pred             EeEEEeC-CcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecC
Q 039002          108 YGFCSHA-RHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRD  173 (219)
Q Consensus       108 ~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  173 (219)
                      ++++... +.++++|||+++|+|.+++.....             ...+++..+..++.|++.|+.|||++   +|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence            9987654 568999999999999999864321             12377889999999999999999999   999999


Q ss_pred             CCCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          174 VSSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       174 lkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      |||+|||++.++.+||+|||+++.......  ......||+.|+|||+
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~  207 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  207 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHH
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhH
Confidence            999999999999999999999987654332  2244689999999994

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-35  Score=233.83  Aligned_cols=169  Identities=22%  Similarity=0.433  Sum_probs=135.3

Q ss_pred             CCCCCcceeccccceeEEEEE-cCCCc----EEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           42 NDFDAKYCIGNGGHASVYRAE-LPSRE----VVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~-~~~~~----~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .+|++.+.||+|+||.||+|. ..+++    .||+|+++..   ......+.+.+|+.++++++||||+++++++.++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            579999999999999999995 44554    5888987642   2223456789999999999999999999999765 5


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .++++|++.++++.+.+....  ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             eeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence            778889999999998876543  2478889999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCCC
Q 039002          197 FLKSDASN--WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~--~~~~~gt~~y~aPE~  219 (219)
                      ........  .....||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~  184 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALES  184 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHH
T ss_pred             ecccccccccccccccCccccChHH
Confidence            76543322  233468999999994

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=230.33  Aligned_cols=167  Identities=25%  Similarity=0.386  Sum_probs=134.2

Q ss_pred             HHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe-CCcc
Q 039002           39 KATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH-ARHS  117 (219)
Q Consensus        39 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~  117 (219)
                      ...++|++.+.||+|+||.||+|.. .++.||+|.++..      ...+.+.+|+.++++++||||+++++++.. .+.+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            3467889999999999999999976 4678999998642      233568899999999999999999998854 4678


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      ++||||+++|+|.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||+++.
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccccee
Confidence            999999999999999865332 3478899999999999999999998   999999999999999999999999999986


Q ss_pred             ecCCCCcccccccccccccCCC
Q 039002          198 LKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....   .....+|+.|+|||+
T Consensus       153 ~~~~---~~~~~~~~~y~aPE~  171 (262)
T d1byga_         153 ASST---QDTGKLPVKWTAPEA  171 (262)
T ss_dssp             ------------CCTTTSCHHH
T ss_pred             cCCC---CccccccccCCChHH
Confidence            5433   234578999999994

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-34  Score=225.33  Aligned_cols=171  Identities=22%  Similarity=0.313  Sum_probs=148.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCcceE
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  119 (219)
                      +++|++++.||+|+||.||+| ...+++.||||+++....  .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            368999999999999999999 567889999999865432  23345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeec
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLK  199 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  199 (219)
                      +++++.++++..++...+   .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+|++|||.++...
T Consensus        79 v~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             Eeeecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhccc
Confidence            999999988888776543   377888999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCcccccccccccccCCC
Q 039002          200 SDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       200 ~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ..........+++.|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~  172 (292)
T d1unla_         153 IPVRCYSAEVVTLWYRPPDV  172 (292)
T ss_dssp             SCCSCCCSCCSCGGGCCHHH
T ss_pred             CCCccceeeccccchhhhhH
Confidence            66555555677888888873

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=228.80  Aligned_cols=168  Identities=28%  Similarity=0.339  Sum_probs=133.9

Q ss_pred             CCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----cc
Q 039002           42 NDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----HS  117 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~  117 (219)
                      .+|.+.+.||+|+||.||+|+. +|+.||||.+...     .........|+..++.++||||+++++++...+    ..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            3567788999999999999975 5779999998531     112222234555667789999999999997654    57


Q ss_pred             eEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCC-----CCCeEecCCCCCCEEeCCCCcEEEeec
Q 039002          118 FLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDC-----FPPIVHRDVSSKNLLLDLEYEAHVADF  192 (219)
Q Consensus       118 ~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlkp~nili~~~~~~kl~df  192 (219)
                      |+||||+.+|+|.+++...    .+++..+..++.|++.|+.|+|...     ..+|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            8999999999999999753    3788999999999999999999621     128999999999999999999999999


Q ss_pred             cceeeecCCCCc----ccccccccccccCCC
Q 039002          193 GIAKFLKSDASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       193 g~~~~~~~~~~~----~~~~~gt~~y~aPE~  219 (219)
                      |+++........    .....||+.|+|||+
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  183 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHH
T ss_pred             CccccccCCCcceeccccceecccCcCChhh
Confidence            999987654322    234689999999994

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=226.40  Aligned_cols=172  Identities=25%  Similarity=0.392  Sum_probs=132.2

Q ss_pred             hCCCCCcceeccccceeEEEEEc--CCC--cEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL--PSR--EVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~--~~~--~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|..  .++  ..||+|.+....... ....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~   84 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP   84 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence            36799999999999999999953  233  368999987544333 3345678999999999999999999999966 46


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecccee
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAK  196 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~  196 (219)
                      .+++|||+.++++.+.+....  ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             hheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            789999999999998876543  2388899999999999999999998   99999999999999999999999999999


Q ss_pred             eecCCCCcc---cccccccccccCCC
Q 039002          197 FLKSDASNW---TEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~~---~~~~gt~~y~aPE~  219 (219)
                      .+.......   ....|+..|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~  185 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPES  185 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHH
T ss_pred             hcccCCCcceecCccccCcccCCHHH
Confidence            875443221   23467889999984

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-34  Score=230.94  Aligned_cols=169  Identities=26%  Similarity=0.371  Sum_probs=137.9

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|++++.||+|+||.||+| +..+++.||||++...   ........+.+|+.+++.++|||++++++++....    
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh---cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            367999999999999999999 5678999999998642   22344567889999999999999999999997643    


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..+++++++.+++|.+++...    .+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            234555666789999998643    388999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC---cccccccccccccCCC
Q 039002          196 KFLKSDAS---NWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~---~~~~~~gt~~y~aPE~  219 (219)
                      ........   .....+||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~  183 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEI  183 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGG
T ss_pred             eeccCCCccceeeccccccceechHHH
Confidence            87654322   1244579999999994

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=230.29  Aligned_cols=172  Identities=26%  Similarity=0.416  Sum_probs=138.6

Q ss_pred             hCCCCCcceeccccceeEEEEEc-CCCc--EEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEeEEEeCCc
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL-PSRE--VVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYGFCSHARH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~--~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  116 (219)
                      .++|++.+.||+|+||.||+|.+ .++.  .||||++.....   ......+.+|+.+++++ +||||+++++++.+++.
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC---hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            36889999999999999999954 4554  477887753221   12345688999999998 79999999999999999


Q ss_pred             ceEEEEecCCCCHHHHhcccc-------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          117 SFLLCEFLERGSLAAILNTDA-------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      .++||||+++|+|.+++....             ....+++..+..++.|++.|+.|+|+.   +++||||||+|||++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE  162 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcC
Confidence            999999999999999986431             123478899999999999999999999   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          184 EYEAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ++.+||+|||+++....... .....||+.|+|||.
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~  197 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIES  197 (309)
T ss_dssp             GGCEEECCTTCEESSCEECC-C----CCTTTCCHHH
T ss_pred             CCceEEcccccccccccccc-ccceecCCcccchHH
Confidence            99999999999976543322 234578999999984

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=230.41  Aligned_cols=177  Identities=23%  Similarity=0.343  Sum_probs=147.3

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEc------CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCccceeEe
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAEL------PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKFYG  109 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~  109 (219)
                      |..+.++|++.+.||+|+||.||+|.+      .+++.||||+++...   .......+.+|+.+++++ +||||+++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            334567899999999999999999953      356689999987532   234456788999999999 6999999999


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhcccc---------------hhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTDA---------------AAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV  174 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  174 (219)
                      ++.+.+..+++|||+++|++.+++....               ....+++..+..++.|++.|+.|||++   +++||||
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDL  171 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDL  171 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccc
Confidence            9999999999999999999999986432               112377888999999999999999999   9999999


Q ss_pred             CCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          175 SSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       175 kp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ||+||+++.++.++++|||.++.......  ......||+.|+|||+
T Consensus       172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~  218 (311)
T d1t46a_         172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES  218 (311)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred             ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHH
Confidence            99999999999999999999987654332  2234689999999984

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-34  Score=229.80  Aligned_cols=166  Identities=23%  Similarity=0.392  Sum_probs=136.5

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeCC----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHAR----  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  115 (219)
                      .++|++++.||+|+||.||+| +..+++.||||+++....  .......+.+|+.+++.++||||++++++|...+    
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            478999999999999999999 567899999999875432  2334567889999999999999999999997654    


Q ss_pred             --cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          116 --HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       116 --~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                        .++++|||+ +.++..++...    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++++|||
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence              479999999 56787776532    388999999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++......   +...||+.|+|||+
T Consensus       167 ~a~~~~~~~---~~~~~t~~y~aPE~  189 (346)
T d1cm8a_         167 LARQADSEM---TGYVVTRWYRAPEV  189 (346)
T ss_dssp             TCEECCSSC---CSSCSCGGGCCTHH
T ss_pred             ceeccCCcc---ccccccccccCHHH
Confidence            998765432   45689999999983

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6e-34  Score=227.81  Aligned_cols=162  Identities=22%  Similarity=0.362  Sum_probs=137.6

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeC--Cc
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHA--RH  116 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~  116 (219)
                      .++|+++++||+|+||.||+| ...+++.||+|+++..       ....+.+|+.+++.++ ||||+++++++...  ..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            367999999999999999999 5678999999998631       2356788999999995 99999999999744  56


Q ss_pred             ceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEEeeccce
Q 039002          117 SFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGIA  195 (219)
Q Consensus       117 ~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg~~  195 (219)
                      .+++|||+.+++|.....      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++ .++++|||++
T Consensus       107 ~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             EEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             eeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccc
Confidence            899999999999876542      378888999999999999999999   999999999999998665 6999999999


Q ss_pred             eeecCCCCcccccccccccccCCC
Q 039002          196 KFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       196 ~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      ....... .....++|+.|+|||.
T Consensus       178 ~~~~~~~-~~~~~~~t~~y~aPE~  200 (328)
T d3bqca1         178 EFYHPGQ-EYNVRVASRYFKGPEL  200 (328)
T ss_dssp             EECCTTC-CCCSCCSCGGGCCHHH
T ss_pred             eeccCCC-cccccccCccccCccc
Confidence            8765443 3355689999999983

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-34  Score=228.94  Aligned_cols=176  Identities=19%  Similarity=0.348  Sum_probs=145.3

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEcC------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeE
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAELP------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGF  110 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~  110 (219)
                      |....++|++.+.||+|+||.||+|.+.      +++.||||+++..   ........+.+|+.++++++||||++++++
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            4445688999999999999999999542      3568999998642   223344568899999999999999999999


Q ss_pred             EEeCCcceEEEEecCCCCHHHHhcccch-------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC
Q 039002          111 CSHARHSFLLCEFLERGSLAAILNTDAA-------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL  183 (219)
Q Consensus       111 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~  183 (219)
                      +...+..++|||++.+|+|.+++.....       ...+++..+..++.|++.|+.|||..   +++||||||+|||++.
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  168 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence            9999999999999999999998864321       11246778889999999999999999   9999999999999999


Q ss_pred             CCcEEEeeccceeeecCCCCc--ccccccccccccCC
Q 039002          184 EYEAHVADFGIAKFLKSDASN--WTEFAGTYGYVALG  218 (219)
Q Consensus       184 ~~~~kl~dfg~~~~~~~~~~~--~~~~~gt~~y~aPE  218 (219)
                      ++.+||+|||+++.+......  .....||+.|+|||
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe  205 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  205 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence            999999999999876543321  23347899999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-34  Score=225.98  Aligned_cols=171  Identities=23%  Similarity=0.349  Sum_probs=136.9

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  113 (219)
                      .++|++++.||+|+||.||+|. ..+++.||||++......  ......+.+|+.++++++|+|++++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            5899999999999999999994 678999999998654322  2234567899999999999999999998854      


Q ss_pred             --CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEee
Q 039002          114 --ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVAD  191 (219)
Q Consensus       114 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~d  191 (219)
                        .+..+++||++.++.+.......   ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.+|++|
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence              35689999999876665544332   2377888899999999999999999   999999999999999999999999


Q ss_pred             ccceeeecCCCC----cccccccccccccCCC
Q 039002          192 FGIAKFLKSDAS----NWTEFAGTYGYVALGI  219 (219)
Q Consensus       192 fg~~~~~~~~~~----~~~~~~gt~~y~aPE~  219 (219)
                      ||++..+.....    .....+||+.|+|||.
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~  192 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL  192 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHH
T ss_pred             cceeeecccccccccccccceecCHHHhhHHH
Confidence            999987653221    1233579999999983

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-34  Score=226.02  Aligned_cols=177  Identities=22%  Similarity=0.343  Sum_probs=141.0

Q ss_pred             HHHHhCCCCCcceeccccceeEEEEEc-C-------CCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC-CCCcccee
Q 039002           37 IVKATNDFDAKYCIGNGGHASVYRAEL-P-------SREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET-RHRNIVKF  107 (219)
Q Consensus        37 ~~~~~~~y~~~~~lg~g~~g~V~~~~~-~-------~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~  107 (219)
                      |..+.++|++.+.||+|+||.||+|+. .       ++..||+|+++...   .......+.+|...+.++ +||||+++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            345568999999999999999999953 2       23479999986532   223446678888888888 79999999


Q ss_pred             EeEEEeCCcceEEEEecCCCCHHHHhcccch-------------hhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCC
Q 039002          108 YGFCSHARHSFLLCEFLERGSLAAILNTDAA-------------AQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDV  174 (219)
Q Consensus       108 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  174 (219)
                      ++++.+++..++||||+.+|++.+++.....             ...+++..+..++.|++.|+.|||+.   +++||||
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDi  161 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL  161 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeee
Confidence            9999999999999999999999999964321             13478999999999999999999999   9999999


Q ss_pred             CCCCEEeCCCCcEEEeeccceeeecCCCC--cccccccccccccCCC
Q 039002          175 SSKNLLLDLEYEAHVADFGIAKFLKSDAS--NWTEFAGTYGYVALGI  219 (219)
Q Consensus       175 kp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~  219 (219)
                      ||+|||++.++.+||+|||+++.......  ......||+.|+|||+
T Consensus       162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  208 (299)
T d1fgka_         162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  208 (299)
T ss_dssp             SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHH
T ss_pred             cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhH
Confidence            99999999999999999999987754432  2244689999999983

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=227.84  Aligned_cols=164  Identities=26%  Similarity=0.284  Sum_probs=132.2

Q ss_pred             CCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC------C
Q 039002           43 DFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA------R  115 (219)
Q Consensus        43 ~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~  115 (219)
                      +|+..+.||+|+||.||+| ...+++.||||++.....        ...+|+.++++++|+||++++++|...      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            6888999999999999999 456899999999865321        123699999999999999999998543      3


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCC-cEEEeeccc
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEY-EAHVADFGI  194 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~-~~kl~dfg~  194 (219)
                      .++++|||++++.+..+.........+++..+..++.|++.||.|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            4789999997654444332222223488999999999999999999998   999999999999999775 899999999


Q ss_pred             eeeecCCCCcccccccccccccCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALG  218 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE  218 (219)
                      +..+.... .....+||+.|+|||
T Consensus       170 a~~~~~~~-~~~~~~gt~~y~aPE  192 (350)
T d1q5ka_         170 AKQLVRGE-PNVSYICSRYYRAPE  192 (350)
T ss_dssp             CEECCTTS-CCCSCCSCTTSCCHH
T ss_pred             hhhccCCc-ccccccccccccChH
Confidence            98765433 234568999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-33  Score=220.46  Aligned_cols=165  Identities=23%  Similarity=0.394  Sum_probs=135.7

Q ss_pred             cceeccccceeEEEEEcCC----CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe-CCcceEEE
Q 039002           47 KYCIGNGGHASVYRAELPS----REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH-ARHSFLLC  121 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~----~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~  121 (219)
                      .++||+|+||.||+|....    ...||||+++..   ........+.+|+.++++++||||+++++++.. ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            4689999999999996432    235899998642   233455778999999999999999999999865 46899999


Q ss_pred             EecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccceeeecCC
Q 039002          122 EFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFLKSD  201 (219)
Q Consensus       122 e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  201 (219)
                      ||++++++.+++....  ...++..+..++.|++.|+.|+|+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus       109 E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999999886543  2356778889999999999999999   9999999999999999999999999999876543


Q ss_pred             CCc----ccccccccccccCCC
Q 039002          202 ASN----WTEFAGTYGYVALGI  219 (219)
Q Consensus       202 ~~~----~~~~~gt~~y~aPE~  219 (219)
                      ...    .....||+.|+|||+
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~  205 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALES  205 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHH
T ss_pred             ccccceecccccccccccChHH
Confidence            221    133578999999984

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-34  Score=229.29  Aligned_cols=172  Identities=21%  Similarity=0.296  Sum_probs=144.9

Q ss_pred             hCCCCCcceeccccceeEEEEEc----CCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC-CccceeEeEEEeCC
Q 039002           41 TNDFDAKYCIGNGGHASVYRAEL----PSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKFYGFCSHAR  115 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~~----~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~  115 (219)
                      +++|++.+.||+|+||.||+|..    .+|+.||+|.++......+......+.+|+.++++++| |||+++++++.+.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            57899999999999999999942    35789999998653322222234456789999999976 89999999999999


Q ss_pred             cceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccce
Q 039002          116 HSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGIA  195 (219)
Q Consensus       116 ~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~~  195 (219)
                      ..++++|++.+++|.+++....   .+++..+..++.|++.|+.|+|++   +++||||||+||+++.+|.++|+|||++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999999987643   267788888999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC-cccccccccccccCC
Q 039002          196 KFLKSDAS-NWTEFAGTYGYVALG  218 (219)
Q Consensus       196 ~~~~~~~~-~~~~~~gt~~y~aPE  218 (219)
                      +.+..... ......|++.|+|||
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe  200 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPD  200 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHH
T ss_pred             hhhcccccccccccccccccchhH
Confidence            87754332 234568999999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-34  Score=225.56  Aligned_cols=171  Identities=21%  Similarity=0.345  Sum_probs=134.4

Q ss_pred             hCCCCCcceeccccceeEEEEE-cCC-CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcC---CCCccceeEeEEEe--
Q 039002           41 TNDFDAKYCIGNGGHASVYRAE-LPS-REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTET---RHRNIVKFYGFCSH--  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~~-~~~-~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~--  113 (219)
                      .++|++++.||+|+||.||+|. ..+ ++.||+|+++.......  ....+.+|+.+++.+   +||||++++++|..  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            4789999999999999999995 444 56799999864322221  122345677766655   89999999999853  


Q ss_pred             ---CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEe
Q 039002          114 ---ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVA  190 (219)
Q Consensus       114 ---~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~  190 (219)
                         ....++++|++.++.+........  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence               346889999998876655443322  3478888999999999999999999   99999999999999999999999


Q ss_pred             eccceeeecCCCCcccccccccccccCCC
Q 039002          191 DFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       191 dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      |||++....... ......||+.|+|||+
T Consensus       159 dfg~~~~~~~~~-~~~~~~gT~~Y~APE~  186 (305)
T d1blxa_         159 DFGLARIYSFQM-ALTSVVVTLWYRAPEV  186 (305)
T ss_dssp             SCCSCCCCCGGG-GGCCCCCCCTTCCHHH
T ss_pred             chhhhhhhcccc-cCCCcccChhhcCcch
Confidence            999987654332 3355789999999994

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-32  Score=215.42  Aligned_cols=166  Identities=20%  Similarity=0.324  Sum_probs=138.5

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC-CccceeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH-RNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~l  119 (219)
                      ++|++.+.||+|+||.||+| ...+++.||+|.+.....      ...+.+|+..++.+.| +|++.+++++..+...++
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            68999999999999999999 466888999998754221      1235678888888875 899999999999999999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC-----CCcEEEeeccc
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL-----EYEAHVADFGI  194 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~-----~~~~kl~dfg~  194 (219)
                      |||++ +++|.+++....  ..++..+...++.|++.|+.|+|+.   +++||||||+||+++.     .+.++|+|||+
T Consensus        79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            99999 689988886543  2478889999999999999999999   9999999999999974     57899999999


Q ss_pred             eeeecCCCC-------cccccccccccccCCC
Q 039002          195 AKFLKSDAS-------NWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~-------~~~~~~gt~~y~aPE~  219 (219)
                      ++.+.....       ....++||+.|+|||.
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~  184 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINT  184 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHH
Confidence            998764322       1245689999999994

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.1e-32  Score=222.12  Aligned_cols=167  Identities=25%  Similarity=0.396  Sum_probs=137.3

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEeC-----
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSHA-----  114 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----  114 (219)
                      .++|++++.||+|+||.||+| +..+++.||||++....  ........+.+|+.+++.++|+|++++++++...     
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            368999999999999999999 56789999999987543  2233445678999999999999999999998643     


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeeccc
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFGI  194 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg~  194 (219)
                      ...+++++++.+++|.+++...    .+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.++++|||+
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             CceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            3346677778899999998643    388899999999999999999999   999999999999999999999999999


Q ss_pred             eeeecCCCCcccccccccccccCCC
Q 039002          195 AKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       195 ~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +......   .....||+.|+|||+
T Consensus       168 a~~~~~~---~~~~~g~~~y~apE~  189 (348)
T d2gfsa1         168 ARHTDDE---MTGYVATRWYRAPEI  189 (348)
T ss_dssp             --CCTGG---GSSSCHHHHTSCHHH
T ss_pred             hcccCcc---cccccccccccCchh
Confidence            9765432   245689999999983

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.5e-32  Score=221.79  Aligned_cols=167  Identities=20%  Similarity=0.326  Sum_probs=129.1

Q ss_pred             hCCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccceeEeEEEe------
Q 039002           41 TNDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIVKFYGFCSH------  113 (219)
Q Consensus        41 ~~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------  113 (219)
                      .++|+++++||+|+||+||+| ...+|+.||||++.....  .......+.+|+.+++.++||||++++++|..      
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            478999999999999999999 566899999999876432  23344567899999999999999999999964      


Q ss_pred             CCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEEeecc
Q 039002          114 ARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHVADFG  193 (219)
Q Consensus       114 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl~dfg  193 (219)
                      .+..|++|||+.++.+.. +.     ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.++++|||
T Consensus        94 ~~~~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          94 FQDVYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             CCEEEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             CceeEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            367899999997654443 32     2378889999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecCCCCcccccccccccccCCC
Q 039002          194 IAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       194 ~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                      +++...... ......+|+.|+|||+
T Consensus       165 ~~~~~~~~~-~~~~~~~t~~y~aPE~  189 (355)
T d2b1pa1         165 LARTAGTSF-MMTPYVVTRYYRAPEV  189 (355)
T ss_dssp             C----------------CCTTCCHHH
T ss_pred             hhhcccccc-ccccccccccccChhh
Confidence            988665433 2345689999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=2.4e-31  Score=210.03  Aligned_cols=166  Identities=20%  Similarity=0.318  Sum_probs=132.4

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccc-eeEeEEEeCCcceE
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV-KFYGFCSHARHSFL  119 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~l  119 (219)
                      ++|++.+.||+|+||.||+| ...+++.||||.+.....      ...+..|+.+++.++|+|++ .+..++..++..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            57999999999999999999 567889999998764321      12367799999999876654 55666678888999


Q ss_pred             EEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCC---CCcEEEeecccee
Q 039002          120 LCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDL---EYEAHVADFGIAK  196 (219)
Q Consensus       120 v~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~---~~~~kl~dfg~~~  196 (219)
                      +||++ ++++...+....  ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.   +..++++|||+++
T Consensus        81 vme~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            99999 456666554322  3478899999999999999999999   9999999999999864   4579999999999


Q ss_pred             eecCCCCc-------ccccccccccccCCC
Q 039002          197 FLKSDASN-------WTEFAGTYGYVALGI  219 (219)
Q Consensus       197 ~~~~~~~~-------~~~~~gt~~y~aPE~  219 (219)
                      .+......       .....||+.|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  184 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINT  184 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHH
Confidence            87654321       244689999999983

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.94  E-value=4.8e-27  Score=189.62  Aligned_cols=167  Identities=20%  Similarity=0.250  Sum_probs=127.3

Q ss_pred             CCCCCcceeccccceeEEEE-EcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-----------CCccceeEe
Q 039002           42 NDFDAKYCIGNGGHASVYRA-ELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-----------HRNIVKFYG  109 (219)
Q Consensus        42 ~~y~~~~~lg~g~~g~V~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~  109 (219)
                      ++|++++.||+|+||.||+| ...+|+.||||+++..     ......+.+|+.+++.++           |+||+++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            56999999999999999999 4678999999998642     233456678888887775           478999998


Q ss_pred             EEEeC--CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-CCCCCeEecCCCCCCEEeCCCC-
Q 039002          110 FCSHA--RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-DCFPPIVHRDVSSKNLLLDLEY-  185 (219)
Q Consensus       110 ~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~nili~~~~-  185 (219)
                      ++...  ...+++++++..+..............+++..+..++.|++.|+.|||+ .   +|+||||||+|||++.++ 
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence            88643  4556667666544332222222222347788899999999999999998 5   899999999999998654 


Q ss_pred             -----cEEEeeccceeeecCCCCcccccccccccccCCC
Q 039002          186 -----EAHVADFGIAKFLKSDASNWTEFAGTYGYVALGI  219 (219)
Q Consensus       186 -----~~kl~dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  219 (219)
                           .++++|||.+.......   ...+||+.|+|||+
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~  200 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEV  200 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHH
T ss_pred             ccccceeeEeeccccccccccc---ccccccccccChhh
Confidence                 48999999998654432   45689999999994

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=6.9e-24  Score=156.44  Aligned_cols=140  Identities=19%  Similarity=0.209  Sum_probs=106.1

Q ss_pred             CCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCc--------------hhhHHHHHHHHHHHhcCCCCccceeEe
Q 039002           44 FDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQ--------------TVDQKEFLTEVKALTETRHRNIVKFYG  109 (219)
Q Consensus        44 y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~--------------~~~~~~~~~e~~~l~~l~h~ni~~~~~  109 (219)
                      +.+.++||+|+||.||+|...+|+.||+|.++....+..              ........+|+..+..+.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999777889999998754221100              111233456888999999999988876


Q ss_pred             EEEeCCcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhhCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039002          110 FCSHARHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHHDCFPPIVHRDVSSKNLLLDLEYEAHV  189 (219)
Q Consensus       110 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~nili~~~~~~kl  189 (219)
                      +.    ..+++||++.+..+..          ++......++.|++.++.|+|.+   +++||||||+|||++.+ .+++
T Consensus        82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            53    2479999998754422          34455667889999999999999   99999999999999865 5899


Q ss_pred             eeccceeeecCC
Q 039002          190 ADFGIAKFLKSD  201 (219)
Q Consensus       190 ~dfg~~~~~~~~  201 (219)
                      +|||.|.....+
T Consensus       144 iDFG~a~~~~~~  155 (191)
T d1zara2         144 IDFPQSVEVGEE  155 (191)
T ss_dssp             CCCTTCEETTST
T ss_pred             EECCCcccCCCC
Confidence            999999866433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.59  E-value=3.3e-07  Score=68.79  Aligned_cols=150  Identities=15%  Similarity=0.098  Sum_probs=93.0

Q ss_pred             HHHHHhCCCCCcceeccccceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeC
Q 039002           36 EIVKATNDFDAKYCIGNGGHASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHA  114 (219)
Q Consensus        36 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  114 (219)
                      ++......|+..+..+-++.+.||+.... +..+.+|+.......    ....+.+|...+..+. +-.+.+++.+...+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            34555678877766555556789988654 445677876432111    1223566888777664 44467888888888


Q ss_pred             CcceEEEEecCCCCHHHHhcccchhhccCHHHHHHHHHHHHHHHHhhhh-------------------------------
Q 039002          115 RHSFLLCEFLERGSLAAILNTDAAAQELGWSQRMSVIKGVADALSYLHH-------------------------------  163 (219)
Q Consensus       115 ~~~~lv~e~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-------------------------------  163 (219)
                      +..+++|+++++.++........        ....++.++...+..+|.                               
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CceEEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            89999999998877755432110        011112222333333332                               


Q ss_pred             ----------------------C---CCCCeEecCCCCCCEEeCCCCcEEEeeccceeee
Q 039002          164 ----------------------D---CFPPIVHRDVSSKNLLLDLEYEAHVADFGIAKFL  198 (219)
Q Consensus       164 ----------------------~---~~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  198 (219)
                                            .   ....++|+|+.|.|++++.++.+.++||+.+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                  0   0113799999999999987666679999987643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.08  E-value=1.3e-05  Score=59.33  Aligned_cols=74  Identities=22%  Similarity=0.147  Sum_probs=50.1

Q ss_pred             eecccc-ceeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCC--CccceeEeEEEeCCcceEEEEecC
Q 039002           49 CIGNGG-HASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRH--RNIVKFYGFCSHARHSFLLCEFLE  125 (219)
Q Consensus        49 ~lg~g~-~g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~  125 (219)
                      .+..|. .+.||+....++..+.+|.......       ..+..|...++.+..  -.+.+++.+..+++..+++|++++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            444554 3678999877777788887643211       124557777766632  346778888888888999999997


Q ss_pred             CCCH
Q 039002          126 RGSL  129 (219)
Q Consensus       126 ~~~l  129 (219)
                      +.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            7543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.78  E-value=0.00012  Score=57.97  Aligned_cols=80  Identities=14%  Similarity=0.081  Sum_probs=47.1

Q ss_pred             cceeccccceeEEEEEcC-CCcEEEEEecCCCC--CCC-chhhHHHHHHHHHHHhcCC-C--CccceeEeEEEeCCcceE
Q 039002           47 KYCIGNGGHASVYRAELP-SREVVAVKKFHSPL--PSD-QTVDQKEFLTEVKALTETR-H--RNIVKFYGFCSHARHSFL  119 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~-~~~~~aik~~~~~~--~~~-~~~~~~~~~~e~~~l~~l~-h--~ni~~~~~~~~~~~~~~l  119 (219)
                      .+.||.|....||++... +++.+++|...+..  ..+ -.....+...|+..++.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            457999999999999654 45678888643210  000 0111223456777776662 2  345555543  5566789


Q ss_pred             EEEecCCCC
Q 039002          120 LCEFLERGS  128 (219)
Q Consensus       120 v~e~~~~~~  128 (219)
                      +||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999987643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.59  E-value=0.0037  Score=47.69  Aligned_cols=66  Identities=14%  Similarity=0.103  Sum_probs=41.8

Q ss_pred             eeEEEEEcCCCcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCCCCccc--ee-----EeEEEeCCcceEEEEecCC
Q 039002           56 ASVYRAELPSREVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETRHRNIV--KF-----YGFCSHARHSFLLCEFLER  126 (219)
Q Consensus        56 g~V~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~--~~-----~~~~~~~~~~~lv~e~~~~  126 (219)
                      ..||++...+|..+++|...+...     ....+..|+..+..+....+.  ..     -..+...+..+.++++..|
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            579999888999999998764321     224466788877776422221  11     1122445667788888765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.46  E-value=0.0085  Score=46.85  Aligned_cols=71  Identities=18%  Similarity=0.228  Sum_probs=45.3

Q ss_pred             cceeccccceeEEEEEcCC--------CcEEEEEecCCCCCCCchhhHHHHHHHHHHHhcCC-CCccceeEeEEEeCCcc
Q 039002           47 KYCIGNGGHASVYRAELPS--------REVVAVKKFHSPLPSDQTVDQKEFLTEVKALTETR-HRNIVKFYGFCSHARHS  117 (219)
Q Consensus        47 ~~~lg~g~~g~V~~~~~~~--------~~~~aik~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~  117 (219)
                      ++.|+-|-...+|++..+.        +..+.++.....  .    ......+|..+++.+. +.-.+++++++.+    
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E----TESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            4678888899999996432        345677765421  1    1123456888888774 3334577777632    


Q ss_pred             eEEEEecCCC
Q 039002          118 FLLCEFLERG  127 (219)
Q Consensus       118 ~lv~e~~~~~  127 (219)
                      ++|+||+.+.
T Consensus       117 g~I~efi~g~  126 (395)
T d1nw1a_         117 GRLEEYIPSR  126 (395)
T ss_dssp             EEEECCCCEE
T ss_pred             ceEEEEeccc
Confidence            6888988753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.41  E-value=0.023  Score=42.62  Aligned_cols=30  Identities=20%  Similarity=0.210  Sum_probs=26.9

Q ss_pred             CeEecCCCCCCEEeCCCCcEEEeeccceee
Q 039002          168 PIVHRDVSSKNLLLDLEYEAHVADFGIAKF  197 (219)
Q Consensus       168 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~  197 (219)
                      +++|+|+.++|++++.++..-+.||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            799999999999999887778999998763